MAY 13-16

New Orleans

MEETING
PROGRAM
 AUA Publications:
The Definitive and
Collective Voice of Urology

LAUNCHING JANUARY 2023

Learn more at the Publications

Booth in
ENGAGE | EXPLORE
RELAX | REFUEL

AUA Café
AUA Central
Member Services AUAUniversity Store

Poster Gallery
Video Abstract Theater
AUA Census
AUA Publications
President’s Circle
Registration
Urology Care Foundation
Where will your patients go
with Myrbetriq®?

Find out at Booth #123

To learn more, visit MyrbetriqHCP.com
Myrbetriq, Astellas, and the flying star logo are registered trademarks of Astellas Pharma Inc.
©2022 Astellas Pharma US, Inc. All rights reserved. Printed in USA 057-5114-PM 2/22
 SETTING THE STANDARD
FOR UROLOGY WORLDWIDE
MORE MORE MORE
EDUCATION RESOURCES SAVINGS

join us!
Not a member? Visit the AUA Central Booth in
The Square to learn more!

AUAnet.org/join
 EXHIBITORS
Table of Contents
Board of Directors���������������������������������������������������������������������������������������������������������������������������������������������� 3

Committees������������������������������������������������������������������������������������������������������������������������������������������������������� 4

CME Information����������������������������������������������������������������������������������������������������������������������������������������������� 7

COURSES
Specialty Programs�������������������������������������������������������������������������������������������������������������������������������������������� 9

Exhibitors���������������������������������������������������������������������������������������������������������������������������������������������������������� 10

Office of Education Courses��������������������������������������������������������������������������������������������������������������������������� 13

Thursday

THURSDAY
Society of Academic Urologists (SAU)�������������������������������������������������������������������������������������������������������� 19
The Economics of Healthcare: Understanding Physician Compensation................................................. 20
Your Essential Guide to Congenitalism and Transitional Care Presented by the
AUA in Collaboration with GURS, SPU, and SUFU������������������������������������������������������������������������������������ 21
Friday
Plenary: Prime Time Friday Morning Session����������������������������������������������������������������������������������������������� 25
Plenary: Prime Time Friday Afternoon Session��������������������������������������������������������������������������������������������� 26

FRIDAY
Poster, Podium and Video Sessions (MP1–3, PD1–4, V1)����������������������������������������������������������������������������� 27
Indian American Urological Association (IAUA)���������������������������������������������������������������������������������������� 36
AQUA Forum & Breakfast����������������������������������������������������������������������������������������������������������������������������� 37
Confederación Americana de Urología (CAU)����������������������������������������������������������������������������������������� 37
Sexual Medicine Society of North America (SMSNA)�������������������������������������������������������������������������������� 38
Poster Sessions (MP4–6)������������������������������������������������������������������������������������������������������������������������������� 39

SATURDAY
AUA Robotics Theater Sponsored by Intuitive: Multiport Robotic Procedures—Prostate
and Kidney Cancers�������������������������������������������������������������������������������������������������������������������������������� 44
Podium and Video Sessions (MP5–8, V2)���������������������������������������������������������������������������������������������������� 44
Society of Genitourinary Reconstructive Surgeons (GURS)����������������������������������������������������������������������� 49
Poster Sessions (MP7–9)������������������������������������������������������������������������������������������������������������������������������� 50
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)�������������������������� 55

SUNDAY
Editorial Workshop: Getting Published and Beyond����������������������������������������������������������������������������������� 55
History of Urology Forum������������������������������������������������������������������������������������������������������������������������������ 56
Poster, Podium and Video Sessions (MP10–12, PD9–12, V3)����������������������������������������������������������������������� 57
Poster and Podium Sessions (MP13–15, PD13–16)������������������������������������������������������������������������������������� 68
Poster Sessions (MP16–18)��������������������������������������������������������������������������������������������������������������������������� 77
Saturday

MONDAY
Plenary: Prime Time Saturday Morning Session������������������������������������������������������������������������������������������ 85
Plenary: Prime Time Saturday Afternoon Session���������������������������������������������������������������������������������������� 85
Poster, Podium and Video Sessions (MP19–21, PD17–21, V4)��������������������������������������������������������������������� 86
Urologic Care for the Advanced Practice Provider������������������������������������������������������������������������������������ 98
Societies for Pediatric Urology (SPU)����������������������������������������������������������������������������������������������������������� 98
Society for Basic Urologic Research/Society of Urologic Oncology (SBUR/SUO)���������������������������������� 100
American College of Osteopathic Surgeons (ACOS)����������������������������������������������������������������������������� 100
Poster Sessions (MP22–24)������������������������������������������������������������������������������������������������������������������������� 100
AUA Robotics Theater Sponsored by Intuitive: Multiport Benign Innovation and
Surgical Procedures—Reconstruction and Bladder Cancer��������������������������������������������������������������� 106
Podium Sessions (PD22–25)����������������������������������������������������������������������������������������������������������������������� 107
Young Urologists Forum����������������������������������������������������������������������������������������������������������������������������� 111
Poster Sessions (MP25–27)������������������������������������������������������������������������������������������������������������������������� 111
Society of Urologic Oncology (SUO)��������������������������������������������������������������������������������������������������������� 117
Poster, Podium and Video Sessions (MP28–30, PD26–30, V5)������������������������������������������������������������������� 118
Asociación Española de Urología (AEU)�������������������������������������������������������������������������������������������������� 129
Society for Basic Urologic Research (SBUR)���������������������������������������������������������������������������������������������� 129
Brazilian/Portuguese Urology Program (BPUP)����������������������������������������������������������������������������������������� 130
Korean World Urologic Congress (KWUC)������������������������������������������������������������������������������������������������ 130

1
 Poster Sessions (MP31, 32)������������������������������������������������������������������������������������������������������������������������� 131
Sociedad Colombiana de Urología��������������������������������������������������������������������������������������������������������� 134
Clinical Controversies in Men’s Health������������������������������������������������������������������������������������������������������ 134
Podium and Video Sessions (PD31–34, V6)���������������������������������������������������������������������������������������������� 135
Medical Student Forum����������������������������������������������������������������������������������������������������������������������������� 140
Poster Sessions (MP33–35)������������������������������������������������������������������������������������������������������������������������� 141
Sunday
Plenary: Prime Time Sunday Morning Session������������������������������������������������������������������������������������������ 149
Plenary: Prime Time Sunday Afternoon Session���������������������������������������������������������������������������������������� 149
Residents Forum����������������������������������������������������������������������������������������������������������������������������������������� 150
Poster, Podium and Video Sessions (MP36–38, PD35–39, V7)������������������������������������������������������������������� 151
Society of Women in Urology (SWIU)��������������������������������������������������������������������������������������������������������� 162
Challenges for Urologic Research Symposium���������������������������������������������������������������������������������������� 162
Engineering and Urology Section of the Endourology Society (EUS)����������������������������������������������������� 163
American Society for Men’s Health (ASMH)��������������������������������������������������������������������������������������������� 163
Urologic Care for the Advanced Practice Provider���������������������������������������������������������������������������������� 164
Poster Sessions (MP39,40)������������������������������������������������������������������������������������������������������������������������� 164
AUA Robotics Theater Sponsored by Intuitive: Single Port Robotic Procedures�������������������������������������� 168
Podium and Video Sessions (PD40–44, V8)���������������������������������������������������������������������������������������������� 168
International Prostate Forum��������������������������������������������������������������������������������������������������������������������� 175
Poster Sessions (MP41–43)������������������������������������������������������������������������������������������������������������������������� 176
Urological Society for American Veterans (USAV)������������������������������������������������������������������������������������ 181
Society of Urologic Robotic Surgery (SURS)���������������������������������������������������������������������������������������������� 181
Poster, Podium and Video Sessions (MP44–46, PD45–48, V9)������������������������������������������������������������������� 182
Late-Breaking Abstract I – Cancer & BPH�������������������������������������������������������������������������������������������������� 193
Early Career Investigators Showcase�������������������������������������������������������������������������������������������������������� 193
Geriatric Urological Society (GUS)������������������������������������������������������������������������������������������������������������ 193
Engineering and Urology Section of the Endourology Society (EUS) Poster Session����������������������������� 194
Society for Infection and Inflammation (SIIU)������������������������������������������������������������������������������������������� 194
R. Frank Jones Urological Society (RFJUS)������������������������������������������������������������������������������������������������� 194
Society for the Study of Male Reproduction (SSMR)�������������������������������������������������������������������������������� 195
Urologic Society for Transplantation & Renal Surgery (USTRS)����������������������������������������������������������������� 195
Quality Improvement Summit�������������������������������������������������������������������������������������������������������������������� 196
Bladder Cancer Forum������������������������������������������������������������������������������������������������������������������������������ 196
British Association of Urological Surgeons/BJU International/Urological Society of Australia
and New Zealand/Scandinavian Association of Urology (BAUS/BJUI/USANZ/SCAUR)�������������������� 197
Sociedad Argentina de Urología (SAU)���������������������������������������������������������������������������������������������������� 198
Società Italiana di Urologia (SIU)�������������������������������������������������������������������������������������������������������������� 198
Poster, Podium and Video Sessions (MP47,48, PD49–51, V10)����������������������������������������������������������������� 199
Late-Breaking Abstract II – Benign Disease����������������������������������������������������������������������������������������������� 207
Poster Sessions (MP49–51)������������������������������������������������������������������������������������������������������������������������� 208
Monday
Plenary: Prime Time Monday Morning Session����������������������������������������������������������������������������������������� 217
Plenary: Prime Time Monday Afternoon Session��������������������������������������������������������������������������������������� 217
Research on Calculus Kinetics Society (ROCK) Non-CME Industry Sponsored
Breakfast Program���������������������������������������������������������������������������������������������������������������������������������� 217
Research on Calculus Kinetics Society (ROCK)��������������������������������������������������������������������������������������� 218
Research on Calculus Kinetics Society (ROCK) Non-CME Industry Sponsored
Lunch Program��������������������������������������������������������������������������������������������������������������������������������������� 218
Poster, Podium and Video Sessions (MP52,53, PD52–54, V11)����������������������������������������������������������������� 218
Society of Benign Prostate Disease����������������������������������������������������������������������������������������������������������� 226
Urological Association of Central America & the Caribbean (AUCA)��������������������������������������������������� 227
Poster, Podium and Video Sessions (MP54,55, PD55–57, V12)����������������������������������������������������������������� 227
Poster, Podium and Video Sessions (MP56–59, PD58–60, V13)����������������������������������������������������������������� 234

2
 2021–2022 Board of Directors
Officers of the Board of Directors
President...............................................................................................................Raju Thomas, MD, FACS, FRCS
President-Elect.....................................................................................................Edward M. Messing, MD, FACS
Immediate Past President.......................................................................................Scott K. Swanson, MD, FACS
Secretary..................................................................................................... John D. Denstedt, MD, FACS, FRCSC
Treasurer..................................................................................................................Thomas F. Stringer, MD, FACS

Section Representatives to the Board of Directors

Mid-Atlantic..................................................................................................................Kurt A. McCammon, MD
New England...................................................................................................................... Arthur Tarantino, MD
New York........................................................................................................................... Reza Ghavamian, MD
North Central.................................................................................................................. James C. Ulchaker, MD
Northeastern............................................................................................................... Hassan Razvi, MD, FRCSC
South Central......................................................................................................................Anthony Y. Smith, MD
Southeastern........................................................................................................... Martin K. Dineen, MD, FACS
Western.................................................................................................................................Eric J. Zeidman, MD

AUA Headquarters
American Urological Association, Inc.
1000 Corporate Boulevard
Linthicum, Maryland 21090
Telephone: 410-689-3700
FAX: 410-689-3800
Email: aua@auanet.org
Website: www.auanet.org

AUA Annual Business Meeting

Ernest N. Morial Convention Center 
Rivergate Room
Monday, May 16, 2022 @ 12:00–12:30 pm

3
 2022 Committees
Program Planning Committee
Dean Assimos Kurt McCammon
Paul Austin Linda McIntire
John Barry Patrick McKenna
Marc Bjurlin Akanksha Mehta
Timothy Brand Jeremy Myers
Serge Carrier Vernon Pais
Michael Chancellor Margaret Pearle
Ben Chew Anne Pelletier-Cameron
Michael Cookson Kristina Penniston
Nick Cowan David Penson
Lindsey Cox Michel Pontari
John Denstedt Raj Pruthi
Ananias Diokno Jay Raman
Ahmed Ghazi Polina Reyblat
David Ginsberg Benjamin Ristau
Leonard Gomella Neal Rowe
Tomas Griebling Andrew Rule
C. D. Anthony Herndon Brad Schwartz
James Hotaling Kymora Scotland
Haojie Huang Alp Sener
David Jarrard Ojas Shah
Steven Kaplan David Shin
Anil Kapoor James Smith
Susan Kasper Li-Ming Su
Mohit Khera Chandru Sundaram
Ziya Kirkali Ash Tewari
Tobias Kohler Simone Thavaseelan
Steven Kraus Jannah Thompson
Dolores Lamb Sandip Vasavada
Vincent Laudone Jeffrey Veale
Brian Matlaga James Wysock

Video Abstract Review Committee

Sero Andonian Tamsin Greenwell Wai Lee Marcelino Rivera
Angela Arlen Guillermo Gueglio Max Levine Kyle Rove
Clinton Bahler Mohan Gundeti Amy Luckenbaugh Matthew Rutman
Cooper Benson Justin Han Susan MacDonald Kristen Scarpato
Marc Bjurlin Gerard Henry Ayman Mahdy Ed Schaeffer
Ronald Boris Lindsey Herrel Rich Matulewicz Ariel Schulman
David Canes Sender Herschorn Andrew McIntosh Michael Schwartz
David Chen Mathias Hofer Francesco Montorsi J. Patrick Selph
Allen Chiu Stanton Honig Ryan Mori Michele Jo Semins
Sung Yong Cho Elias Hyams Rachel Moses Ahmed Shoma
Joseph Clark Brett Johnson Dena Moskowitz Ajay Singla
Elizabeth Corrales Pankaj Joshi Robert Nadler Michael Staehler
Akhil Das Matthew Kaag Gladys Ng Robert Stein
Carley Davis Taek Won Kang Kenneth Ogan Necole Streeper
Daniel Dugi Eric Kim Andrew Peterson Kristina Suson
Bradley Erickson John Knoedler Ruben Pinkhasov Chad Tracy
Gregg Eure Jason Kovac Sima Porten Krishnan Venkatesan
Sarah Faris Ryan Krlin James Porter Ramakrishna Venkatesh
Robert Figenshau Anant Kumar Erick Ramirez Perez Boyd Viers
Alvin Goh Costas Lallas Benjamin Ristau Eric Wallen
Hanan Goldberg Aaron Lay Chad Ritch Jennifer Yang

Program Abstract Review Committee

Philip Abbosh Horacio Aleman Jodi Antonelli J. Christopher Austin
Robert Abouassaly Husain Alenezi Andrés Arley Vargas Paul Austin
Nitya Abraham Zaki Almallah Monish Aron Riccardo Autorino
Andre Abreu Seth Alpert William Aronson Márcio Averbeck
Rosalyn Adam Joseph Alukal Hugo Arriaga Morales Timothy Averch
Rajesh Ahlawat Christopher Amling Dean Assimos Kara Babaian
Jennifer Ahn Christopher Anderson Anthony Atala Ketan Badani
Divya Ajay Kenneth Angermeier Melanie Aube Peterkin Gopal Badlani
4
Michael Bailey Craig Comiter Mark Garzotto Keith Jarvi
Linda Baker Pablo Contreras John Gatti Venkata Jayanthi
K. C. Balaji Michael Cookson Boris Gershman Lawrence Jenkins
D. Duane Baldwin Christopher Cooper Khurshid Ghani Travis Jerde
Chris Bangma Matthew Cooperberg Reza Ghavamian Emilie Johnson
Marcelo Baptistussi Hillary Copp Ahmed Ghazi Ted Johnson
Christopher Barbieri Nicholas Cost Gamal Ghoniem J. Stephen Jones
Paholo Barboglio Romo Nicholas Cowan Gianluca Giannarini Steven Joniau
Daniel Barocas Lindsey Cox Bradley Gill Mark Jordan
Aaron Bayne Jimena Cubillos Jason Gilleran Jean Joseph
Darren Beiko Anthony D’Amico Peter Gilling Kerstin Junker
Ryan Berglund Rajvir Dahiya David Ginsberg Ashish Kamat
Jonathan Bergman Daniel DaJusta Sidney Glina Christopher Kane
Norberto Bernardo Margot Damaser Ehud Gnessin Jihad Kaouk
Sara Best Siamak Daneshmand David Goldfarb Steven Kaplan
Naeem Bhojani Kassa Darge Howard Goldman Anil Kapoor
Trinity Bivalacqua Prokar Dasgupta Andrew Goldstein R. Jeffrey Karnes
Jennifer Bjazevic Timothy Daskivich Leonard Gomella Aaron Katz
Dale Bjorling Casey Dauw Alexander Gomelsky Louis Kavoussi
Peter Black Benjamin Davies Reynaldo Gomez Deborah Kaye
Michael Blute Kelvin Davies Mario Gonzalez Melise Keays
Stephen Boorjian John Davis Ricardo Gonzalez Michael Kennelly
Joseph Borer Shubha De Mark Gonzalgo Mohit Khera
Michael Borofsky Roger De Filippo Ronak Gor Adam Kibel
Luis Braga David DeGraff Jennifer Gordetsky Kathleen Kieran
Timothy Brand Christopher Deibert John Gore Fernando Kim
Steven Brandes Donna Deng E. Gormley Simon Kim
Robert Brannigan Ithaar Derweesh Angelo Gousse Adam Klausner
Ben Breyer Janak Desai Candace Granberg Thomas Knoll
Alberto Briganti Mihir Desai Michael Grasso Bodo Knudsen
Gerald Brock Heather Di Carlo Christian Gratzke Edmund Ko
Gregory Broderick Rian Dickstein Kirsten Greene Kathleen Kobashi
Joshua Broghammer Martin Dineen Andreas Gross Chester Koh
James Brooks Michael DiSanto Amy Guise Tobias Kohler
Benjamin Brucker Miroslav Djordjevic Gopal Gupta Paul Kokorowski
Jill Buckley Roger Dmochowski Mantu Gupta Peter Kolettis
Fiona Burkhard Steeve Doizi Priyanka Gupta Thomas Kolon
Frank Burks S. Machele Donat Khurshid Guru Kevin Koo
Arthur Burnett Tracy Downs Jorge Gutierrez-Aceves Robert Kovell
Jeremy Burton Beth Drzewiecki Georges Haber Amy Krambeck
Jeffrey Cadeddu David Duchene Judith Hagedorn Evgeniy Kreydin
Brian Caldwell James Eastham Ari Hakimi Aaron Krill
Jeff Campbell Mark Edney Joshua Halpern Bradley Kropp
Steven Campbell Scott Eggener Lindsay Hampson Tracey Krupski
Benjamin Canales Karyn Eilber Joanna Hannan Janet Kukreja
Glenn Cannon Brian Eisner Philip Hanno Sanjay Kulkarni
Stephen Canon Obi Ekwenna Kelly Healy Rajeev Kumar
Noah Canvasser Christopher Elliott Jason Hedges Ali Kural
Maude Carmel Daniel Elliott Marah Hehemann Michael Kurtz
Serge Carrier Sean Elliott Brian Helfand Eric Kurzrock
Peter Carroll Jonathan Ellison Wayne Hellstrom Alexander Kutikov
William Catalona Dean Elterman Sevann Helo M. Pilar Laguna
Toby Chai Carlos Estrada Ashok Hemal Henry Lai
Karim Chamie Masatoshi Eto C. D. Anthony Herndon Dolores Lamb
Michael Chancellor Christopher Evans Ty Higuchi Jaime Landman
Sam Chang Carlos Fajardo Rivera Jeffrey Holzbeierlein Dirk Lange
Earl Cheng Darren Feldman Sung Kyu Hong Alessandro Larcher
Tom Chi Amr Fergany Ryan Hsi Jerilyn Latini
Joseph Chin Jose Luis Fernandez Jim Hu John Lavelle
Christina Ching Mario Fernandez William C. Huang Benjamin Lee
Edmund Chiong Fernando Ferrer William J. Huang Byron Lee
Kellen Choi Christopher Filson Shu-Pin Huang Jason Lee
Matthew Christman Neil Fleshner Katherine Hubert Chan Kyu-Sung Lee
David Chu Brian Flynn Steven Hudak Una Lee
Kai-wen Chuang James Forde Mitchell Humphreys Gary Lemack
Bilal Chughtai Stephen Freedland Andrew Hung Sara Lenherr
Doreen Chung Michael Freeman Kathleen Hwang Herbert Lepor
Peter Clark Dominic Frimberger Brant Inman Seth Lerner
Quentin Clemens Gerhard Fuchs Vesna Ivancic Laurence Levine
Michael Coburn Pat Fulgham Micah Jacobs Daniel Liberman
Seth Cohen Allen Gao David Jarrard John Lieske

5
Daniel Lin Caleb Nelson Neal Rowe Elizabeth Takacs
Brian Linder Christian Nelson Rachel Rubin Hung-Jui (Ray) Tan
Michael Lipkin Casey Ng Michael Ruggieri Kazunari Tanabe
Larry Lipshultz J. Curtis Nickel Leticia Ruiz Stacy Tanaka
Michael Liss Alan Nieder Daniel Rukstalis Samir Taneja
Mark Litwin Amanda North Paul Russo Simon Tanguay
Dennis Liu Unwanaobong Nseyo Fred Saad Gregory Tasian
Kirk Lo Zeph Okeke Ravindra Sabnis Jennifer Taylor
Stacy Loeb Bulent Onal Hossein Sadeghi-Nejad Alexis Te
Bal Lokeshwar Michael Ordon Christopher Saigal Ryan Terlecki
Vinata Lokeshwar Kenneth Pace Andrea Salonia Martha Terris
Christopher Long Priya Padmanabhan Carolyn Salter Christopher Tessier
Armando Lorenzo Allan Pantuck Mary Samplaski Simone Thavaseelan
Yair Lotan Athanasios Papatsoris Martin Sanda John Thomas
Kevin Loughlin Gyan Pareek Jaspreet Sandhu Kay Thomas
Franklin Lowe William Parker Jay Sandlow Jannah Thompson
Alvaro Lucioni C. Lowell Parsons Grannum Sant R. Houston Thompson
Patrick Luke Sutchin Patel Richard Santucci Praveen Thumbikat
John Lynch John Pattaras Kemal Sarica Matt Tollefson
Thomas Lynch Stephen Pautler A. Oliver Sartor Karim Touijer
Danil Makarov Margaret Pearle Stephen Savage Edouard Trabulsi
Rena Malik Amy Pearlman Charles Scales Olivier Traxer
Stanley Malkowicz Anne Pelletier Cameron Anthony Schaeffer Landon Trost
Jodi Maranchie Kristina Penniston Douglas Scherr Thomas Turk
Vitaly Margulis David Penson Peter Schlegel Ben Turney
Christopher Marsh Ingrid Perscky Bruce Schlomer James Ulchaker
Puneet Masson Firas Petros Franz Schmidlin Robert Uzzo
Viraj Master Daniel Petrylak Anne Schuckman Andre van der Merwe
Timothy Masterson Curtis Pettaway Bradley Schwartz Brian VanderBrink
Ranjiv Mathews Michael Phelan Kymora Scotland Evan Vapnek
Surena Matin John Phillips Alp Sener Sandip Vasavada
Brian Matlaga Phillip Pierorazio Amlesh Seth Jeffrey Veale
Eduardo Mazzucchi Peter Pinto Ojas Shah Chad Vezina
Timothy McClure Joao Pippi Salle Joel Sheinfeld Sarah Vij
Elspeth McDougall Carol Podlasek Patrick Shenot Carlos Villanueva
Patrick McKenna Kamal Pohar Courtney Shepard Streur Bryan Voelzke
James McKiernan Hans Pohl Alan Shindel M. Chad Wallis
Erin McNamara Thomas Polascik Neal Shore Julian Wan
Kevin McVary Michel Pontari Aseem Shukla Peter Wang
Joshua Meeks Dix Poppas D. Robert Siemens Run Wang
Akanksha Mehta Francesco Porpiglia Karl-Dietrich Sievert Christopher Warlick
Alex Meller Christopher Porter Jennifer Singer Samuel Washington
Arturo Mendoza-Valdés Nicholas Power Eila Skinner Graham Watson
Paul Merguerian Kevin Pranikoff Andreas Skolarikos John Wei
Edward Messing Glenn Preminger Ted Skolarus Dana Weiss
Michael Metro Gail Prins Angela Smith Robert Weiss
Badar Mian Silvia Proietti Ariana Smith Blayne Welk
Nicole Miller Raj Pruthi Edwin Smith Charles Welliver
Jesse Mills Sarah Psutka Joseph Smith Hunter Wessells
Suks Minhas Yeong-Shiau Pu Norm Smith O. Lenaine Westney
Rosalia Misseri Sanoj Punnen Zachary Smith Michael Whalen
Nihal Mohamed J. Todd Purves Philippe Spiess John Wiener
Robert Moldwin Ronald Rabinowitz Armando Stabile Duncan Wilcox
Friedrich Moll Omer Raheem Arnulf Stenzl Stuart Wolf
Caroline Moore Ganesh Raj Heidi Stephany Kyle Wood
Allen Morey David Ralph Kevan Sternberg Guan Wu
Todd Morgan Ranjith Ramasamy Christian Stief Hsi-Yang Wu
Bradley Morganstern David Rapp Douglas Storm Faysal Yafi
Marco Moschini Andrew Rasmussen Lynn Stothers Claire Yang
Piruz Motamedinia Hassan Razvi Douglas Strand Elizabeth Yerkes
Judd Moul Leonardo Reis Kelly Stratton Ezekiel Young
M. Sherif Mourad William Ricke Seth Strope Richard Yu
John Mulhall Leslie Rickey Li-Ming Su Rebecca Zee
Alana Murphy Mack Roach Chandru Sundaram Lee Zhao
Katie Murray William Roberts Debasish Sundi Matthew Ziegelmann
Nicolas Muruve Claus Roehrborn Anne Suskind Armand Zini
Jamal Nabhani Nirit Rosenblum Suzette Sutherland Michael Zitzmann
Stephen Nakada Ashley Ross Robert Sweet Kevin Zorn
Nissrine Nakib Keith Rourke Konrad Szymanski
Neema Navai Jonathan Routh Rajeev T.P.
Roman Nawroth Eric Rovner Thomas Tailly

6
 CME Information
Statement of Need
Urology practitioners need thorough knowledge of the
most recent developments and techniques, as well as
established guidelines in urology, to ensure the highest
standards of patient care and safety.
Learning Objectives
At the conclusion of the 2022 Annual Meeting, partici-
pants should be able to:
● Describe recent developments in the medical and
surgical management of urology patients.
● Identify new technologies for the treatment of uro-
logical conditions.
● Integrate the latest guidelines on the management
of urological diseases into their practice.
● Incorporate evidence-based research and literature
into the shared decision-making process.
Method of Participation
Learners will participate by attending the in-person
session(s), logging into the live virtual session(s), or
logging into the on-demand (enduring) activity(ies)
beginning May 12, 2022 through August 31, 2022. Af-
ter completing selected sessions/activities, learners
will complete the credit claim attestation and activ-
ity evaluation.
Accreditation Statement
The American Urological Association (AUA) is accredit-
ed by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical ed-
ucation (CME) for physicians.
Credit Designation*
The AUA designates this other activity (live and endur-
ing materials) for a maximum of 457.5 AMA PRA Cate-
gory 1 Credits™. Physicians should claim only the credit
commensurate with the extent of their participation in
the activity. (*Note, the maximum credits is subject to
change if sessions are added or canceled prior to the
activity start date.)
Other Learners
The AUA is not accredited to offer credit to participants
who are not MDs or DOs. However, the AUA will issue
documentation of participation that states that the ac-
tivity was certified for AMA PRA Category 1 Credit™.
7
Evidence-Based Content
It is the policy of the AUA to ensure that the content
contained in this CME activity is valid, fair, balanced,
scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy
All persons in a position to control the content of an edu-
cational activity (i.e., activity planners, presenters, authors,
reviewers) are required to disclose to the provider any rel-
evant financial relationships with any commercial interest
during the previous 24 months. The AUA must determine
if the individual’s relationships may influence the educa-
tional content and mitigate any conflicts of interest prior
to the commencement of the educational activity. The in-
tent of this disclosure is not to prevent individuals with rel-
evant financial relationships from participating, but rather
to provide learners with information so they can make
their own judgments.
Disclosures are posted online at www.auanet.org/­
annualmeeting/speakers/disclosures.
Mitigation of Identified Conflict of Interest
All disclosures will be reviewed by the AUA Conflict of
Interest (COI) Review Work Group Chair and/or Vice
Chair for identification of conflicts of interest. The AUA
COI Review Work Group, working with Office of Educa-
tion staff, will document the mechanism(s) for manage-
ment and mitigation of the conflict of interest, and final
approval of the activity will be documented prior to im-
plementation. Any of the mechanisms below can/will
be used to mitigate conflict of interest:
● Peer review for valid, evidence-based content by the
AUA COI Review Work Group.
● Attestation that clinical recommendations are evi-
dence based and free of commercial bias.
● Introduction of a debate format (point-counter-
point).
● Inclusion of moderated panel discussion with unbi-
ased moderator.
● Publication of a parallel or rebuttal article for an arti-
cle that is felt to be biased.
● Divestiture of the relationship by faculty.
● Recusal from controlling relevant aspects of planning.
● Selection of alternative faculty for specific topic.
Off-Label or Unapproved Use of
Drugs or Devices
The audience is advised that this CME activity may
contain reference(s) to off-label or unapproved uses of
drugs or devices. Please consult the prescribing infor-
mation for full disclosure of approved uses.
 CME Information
Disclaimer
The opinions and recommendations expressed by
­faculty, authors, and other experts whose input is includ-
ed in this program are their own and do not necessarily
represent the viewpoint of the AUA.
Claiming Your Certificate of Attendance
You may receive your Certificate of Attendance using
one of the following options:
● Scan your badge onsite in the Registration Hall on
Sunday, May 15, 2022 or Monday, May 16, 2022.
● Log in to www.auanet.org/annualmeeting/attend-
ee-info/cme-credits.
Claiming Your CME Credits
To claim credit/participation hours:
1. Scan your badge upon entrance into accredited
sessions (except for in-person Plenary), log in to the
live virtual sessions or on-demand sessions.
8
2. Log in to the CME Credit Claim: www.auanet.org/­
annualmeeting/attendee-info/cme-credits.
3. Accredited sessions that you logged into or scanned
into will be listed.
4. Add any in-person Plenary sessions you attended to
your list of sessions.
5. For each session you attended, select the appropri-
ate number of credits/hours that correspond to your
participation in the session.
6. After you have completed all sessions, you must
complete the activity evaluation and attest to your fi-
nal credits/hours to have your credits added to your
AUA transcript. Note: No changes may be made af-
ter final submission of your credits/hours.
Note:
● You may participate in on-demand activities through
August 31, 2022. After this date, you will no longer
have access to view on-demand sessions.
● Credit/participation hours must be claimed by
­December 31, 2022.
Questions? Email education@AUAnet.org.
 Specialty Programs

Page
American College of Osteopathic Surgeons............................................................................................... 100
American Society for Men’s Health............................................................................................................... 163
Asociación Española de Urología................................................................................................................ 129
AUA/Brazilian Portuguese Urology Program................................................................................................. 130
AUA/Confederación Americana de Urología................................................................................................ 37
British Association of Urological Surgeons.................................................................................................... 197
Engineering and Urology Section of the Endourological Society............................................................... 163
Geriatric Urological Society........................................................................................................................... 193
Indian American Urological Association........................................................................................................ 36
Korean World Urologic Congress................................................................................................................... 130
R. Frank Jones Urological Society.................................................................................................................. 194
Research on Calculus Kinetics Society......................................................................................................... 218
Sexual Medicine Society of North America.................................................................................................... 38
Sociedad Argentina de Urología.................................................................................................................. 197
Sociedad Colombiana de Urología............................................................................................................. 134
Società Italiana di Urologia........................................................................................................................... 198
Societies for Pediatric Urology......................................................................................................................... 98
Society for Basic Urologic Research.............................................................................................................. 129
Society for Basic Urologic Research and Society of Urologic Oncology.................................................... 100
Society for Benign Prostate Disease.............................................................................................................. 226
Society for Infection and Inflammation in Urology....................................................................................... 194
Society for the Study of Male Reproduction................................................................................................. 195
Society of Women in Urology......................................................................................................................... 162
Society of Academic Urologists....................................................................................................................... 19
Society of Genitourinary Reconstructive Surgeons........................................................................................ 49
Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction...................................... 55
Society of Urologic Oncology........................................................................................................................ 117
Society of Urologic Robotic Surgery.............................................................................................................. 181
Urologic Society for Transplantation & Renal Surgery.................................................................................. 195
Urological Association of Central America & the Caribbean..................................................................... 227
Urological Society for American Veterans..................................................................................................... 181

9
 2022 Annual Meeting Exhibits

Booth(s) Booth(s) Booth(s)

A&E Endoscopy 2008 Dendreon Pharmaceuticals LLC 1017 McLeod Health 2259
A.M.I. Agency for Medical Innovations Department of Veterans Affairs 1856 Mcube Technology Co., Ltd. 1847
GmbH1044 Designs for Vision, Inc. 911 MDxHealth801
AAAASF2225 DOCTUS EQUIPAMENTOS MEDICOS Med Fibers, Inc. 663
AbbVie725 LTDA2417 MedicaMetrix, Inc. 2258
Accord BioPharma 2343 Dornier MedTech 1637 Medifix Inc. 1560
Acerus Pharmacueticals Ecleris USA 2058 Mediflex954
Corporation 2245, 2639 Edge Pharma 2318 Mediplus917
Advance Medical Designs 2007 Eigen Health 2349 Medispec Ltd. 1355
Advanced Accelerator Applications 2630 Electro Medical Systems SA 1036 Medpro1217
AGILITI1318 Elsevier1008 Medtronic1601
Akina Pharmacy 1562 EMD Serono/Pfizer Aliance 2229 Melzi1761
AmbiMedInc1843 Encore, Inc. 1961 Memorial Healthcare System 2220
Ambry Genetics 905 Endo Pharmaceuticals 1301, 2737 MenHealth1858
Ambu Inc 2001, 2736, 2741 Endoscopy Solutions 1946 Merck & Co., Inc. 1645, 2655
America Medic & Science, AMS 2065 Endourological Society, Inc. 1861 MicroGenDX1753
American Medical Endoscopy/ Ethicon2461 Mid-Atlantic Section of the AUA 1954
Strauss Surgical 1928 European Association of Urology 1908 Millennium Physician Group 1004
AngioDynamics1460 EVEXIAS Health Solutions 1762 MIM Software Inc. 1026
Antares Pharma, Inc 1455 Exact Sciences/Oncotype 647, 2567 miR Scientific LLC 945, 2743
Applaud Medical, Inc. 1862 Exelixis, Inc. 1945 Mitaka USA 2623
Asclepion Laser Technologies GmbH 2423 Exosome Diagnostics, a Bio-Techne Modernizing Medicine 1609
Asociación Urológica de brand461 Molecular Lab Partners 1559
Centroamerica y Caribe (AUCA) 2131 Fellow2329 Molecular Testing Labs 1661
Aspirus Health 1860 Firefly Global 1006 Moonstone Nutrition 1763
ASSI-Accurate Surgical & Scientific FirmTech Inc. 2538 Multiphze LLC 859
Inst1805 Flume Catheter Company 2439 My PCR Lab LLC 2626
Astellas Pharma US 123 Focal Healthcare, Inc. 1936 Myovant Sciences, Inc. and Pfizer,
AstraZeneca 617, 2661, 2760 Focal One 117 Inc. 1917, 2543, 2754
Auris Health 1207, 2654 Focalyx, LLC 1555 Myriad Genetics 2460, 2771
Avenda Health 854 Foundation Medicine, Inc. 1709 MysteryVibe2223
Axonics, Inc. 2145 Francis Medical 2666 NAED, Inc 1955
BARD1 Life Sciences Ltd 1841 Fujifilm1701 NanoEnTek America, Inc 961
Bayer1537 Genentech2005 Nanospectra Biosciences 958
BD 2627, 2637 GEOTEK Medical USA LLC. 2324 National Ultrasound 2230
Best Medical International 1963 Gilead Sciences, Inc. 2428 Neoscope20201461
Biobot Surgical 2327 Global Fair Play 2100 NeoTract | Teleflex 323
BioProtect Ltd. 1229 Global Medical Endoscopy 2000 New York Section Of The American
Biote Medical 1852 GloShield1959 Urological Association Inc 1859
BK Medical 1317, 2756 GoPath Diagnostics 2053 NextMed109
Blue Earth Diagnostics, Inc. 455 GOTOP Medical, Inc. 1022 NinoMed1501
Bonraybio CO., LTD. 1658 Guangzhou Red Pine Medical North Central Section of the AUA,
Boston Scientific 137, 2537, 2649 Instrument Co., Ltd 2523 Inc./South Central Section of the
Bostwick Laboratories 929 Guerbet, LLC 2317 AUA, Inc. 1962
Bristol Myers Squibb 2427, 2454 Health Best International LLC 2006 Northwell Health 2438
Butterfly Medical 857 Health First Medical Group 2429 Norton Children’s Urology, affiliated
Butterfly Network 2355 HealthTronics, Inc. 845 with the UofL School of Medicine 2104
Calyxo, Inc. 2561 Hispanic Urology Society North Ochsner Health 2463
Canadian Urological Association 1845 America1956 Officite1223
Candel Therapeutics 1020 Huger Medical Instrument Co. Ltd 1056 Ohio Valley Healthcare Solutions 1225
CareMed Specialty Pharmacy/ Hunan Vathin Medical Instrument Olympus537
Onco360 Oncology Pharmacy 2425 Co.,Ltd.2216 OPERATION HAPPENIS 2222
CAREstream America 2326 Imagin Medical 2555 OPKO Health, Inc. 747
Caris Life Sciences 2328 ImmunityBio, Inc. 559 Optical Integrity, Inc. 1060
Carle Health 2224 INB Medical 2109 Oruba Technology & Innovation 2358
Case Recruiters, Inc 963 Inform Diagnostics 2421 OSF HealthCare 2227
CellOxess Biotechnology 1654 Infuserve America 1942 OTU Medical Inc 1330
Celularity Inc. 1759 Innovex Medical 759 Pacey Medtech Ltd 2528
CG Oncology, Inc. 2526 inReach Health 1361 Pacific Edge Diagnostics 1829
CIVCO MEDICAL SOLUTIONS 2323 Insightec2465 Paige2360
Clarity Diagnostics 2260 Integra Life Sciences 2422 Palette Life Sciences 2264, 2265
Clarus Therapeutics 1507 Intermountain Healthcare 2221 Panacea Financial 1324
Cleveland Diagnostics, Inc. 2530 Intuitive 207, 2759, 2761 Pathnostics361
Colegio Mexicano de Urología Irrisept2111 Pelvic Wave 2527
Nacional, A. C. 2117 isoray2516 Perineologic257
Coloplast Corp. 707, 2667, 2673, 2772 IVUmed1328 Pfizer Oncology 337, 2643
Combat Medical Ltd. 959 Janssen Biotech, Inc. 1023, 2642, 2672, 2742 Philips717
CompHealth2110 Japanese Urological Association 2127 Photocure 2237, 2755
Confederación Americana de KARL STORZ Endoscopy - America,Inc. 1937 Porter Instrument 1659
Urología2117 Kidney Cancer Association 2108 PracticeLink.com2436
Connected Medical Services (CMS) 1760 Koelis1201 Practis1316
Convergent Laser Technologies 1309 Laborie Medical Technologies Corp. 517 Prairie Lakes Healthcare System 2419
Cook Medical 1325 Lantheus1337 PROCEPT BioRobotics 147, 2545, 2549
Cook MyoSite 1000 Lazarus 3D 1046 ProEndoscopy2325
CoolBeans Men’s Health Underwear 2361 LiNA Medical 755 Profound Medical 1447
Corinth MedTech 955 LithoLyte701 Prologics Healthcare 1322
Creative Medical Technology LocumTenens.com1821 Promaxo1009
Holdings Inc 2062 LP Surgical Fibers 1916 Prometheus Group, The 1837
CS Surgical, Inc 2231 LynxDx1663 Promis Dx 1757
Dartmouth-Hitchcock2056 Male From Home 1064 Prostate Conditions Education Council 1024
Deep Bio 2161 Marshfield Clinic Health System 2060 Prostatype Genomics AB 1365

10
Pusen Medical 101 Sontec Instruments 1900 United Endoscopy 1807
QDx Pathology Services 1801 Soundable Health 1924 United Medical Systems 1417
Quanta System SPA 447 Southeastern Section of the AUA, United States Navy Recruiting 2105
Quantib1944 Inc./Northeastern Section University Compounding Pharmacy 1547
Quibim2155 of the AUA, Inc. 1964 Urethrotech907
QuickChange/UI Medical 858 Specialty Networks, LLC 1221 URO-1, Inc 923
Qventus2106 Spectrum Health Lakeland 2518 UroChoice2219
Reditus Laboratories, LLC 2253 Spero Therapeutics 1907, 2766 UroGen Pharma Inc 837, 2775
Revive Rx 2165 Springfield Clinic 2159 Urology Surgical Consulting/
RG Medical 2052 SRS Medical Corp. 317 Better Body MD 1758
Rhosse Medical 2337 Stanford Medicine Technology Urology Times 1906
Richard Wolf Medical Instruments Enabled Clinical Improvement UrologyLocums.com2449
Corporation 1926, 1927 (TECI) Center 2517 UROTRAINER1904
Rigicon,Inc.1058 STERIS Corporation 1653 Urotronic1817
ROCAMED201 Strauss Surgical USA 2261 Urovant Sciences, Inc. 1001, 2748, 2768
Rose Micro Solutions LLC 1030, 2217 Stream Dx 1564 UroViu Corporation 355
RosmanSearch2004 Stryker2455 Utiva, by Szio+ 2254
Sagent Urology 919 Sun Pharma 1901 Valencia Technologies 2617
SCRUBS RRG 1219 Surgical Affiliates Management Vascular Technology 1409
Seagen, Inc. 1953 Group1463 Veracyte1563
SEPLOU INC. 1940 Surgical Science - Simbionix Verana Health 2529
Sesen Bio 2773 Simulators1016 VERU INC 2059, 2765
SH MEDICAL CORP 901 Surgitel1905 Verve Medical, Inc. 2747
Shanghai SeeGen Photoelectric Telix Pharmaceuticals (US) Inc. 655 Veterans Prostate Cancer
Technology Co.,Ltd. 2424 Tempus2163 Awareness Inc. 263
Siemens Healthineers 2137 Teradek2722 Viomerse2101
Signati Medical, Inc. 1823 The Gideons International 2459 Virtuoso Surgical Inc. 2548
Skagit Regional Health 2426 The Guthrie Clinic 2226 Wasatch Medical Specialties 2316
Sociedad Argentina de Urología 2121 The Permanente Medical Group 2622 Weatherby Healthcare 2339
Sociedade Brasileira de Theator1054 WebMD925
Urologia (SBU) 2123 Theralogix855 Well Lead Medical Co. Ltd. 1347
Sociedad Colombiana de Urología 2129 Tolmar Pharmaceuticals 527 Western Section American Urological
Société Internationale d’Urologie (SIU) 1958 TrackableMed2009 Association Inc (AUA) 1857
Society of Government Service Travere Therapeutics - Thiola EC 927 Wolters Kluwer 909
Urologists (SGSU) 1855 Uberlube2330 Xodus Medical 1465
Sonablate Corp 549 UC-CARE921 Yuma Regional Medical Center 1062
Soniquence1922 UFM Underwear for Men 2431 Zenflow, Inc. 2573
SonoMotion, Inc. 1909 UHS2320 Zimmer MedizinSystems 2322

List as of March 25, 2022.

11
NOTES
 OFFICE OF EDUCATION COURSES
ALL COURSES ARE APPROVED FOR AMA PRA CATEGORY 1 CREDITTM
Thursday, May 12, 2022
7:00 am – 5:00 pm
101HO HANDS-ON UROLOGIC ULTRASOUND (HOUU)
Pat Fulgham, Course Director
Majid Eshghi, Christopher Porter,
Daniel Rukstalis, Stephen Savage, Edouard Trabulsi,
Mohammad Bhatti, Lewis Chan, Craig Smith, Faculty
Level 2, R05 @ Ernest N. Morial Convention Center
Friday, May 13, 2022
7:30 am – 9:30 am
001IC PRACTICAL URODYNAMICS
Craig Comiter, Course Director
Sandip Vasavada
Room: 204 @ Ernest N. Morial Convention Center
002IC SHOULD I ORDER A PET SCAN?
INTEGRATING MOLECULAR IMAGING INTO
UROLOGIC ONCOLOGY CLINICAL PRACTICE:
CURRENT APPROACHES AND FUTURE
OPPORTUNITIES
Marc Bjurlin, Course Director
Thomas Hope, Michael Gorin, Tracy Rose
Room: 207 @ Ernest N. Morial Convention Center
003IC CASE-BASED DISCUSSION OF NEW LASER
TECHNOLOGY IN ENDOUROLOGY - UPPER
TRACT STONES/STRICTURES/TUMORS
Brian Eisner, Course Director
Ojas Shah, Silvia Proietti, Julie Riley
Room: 208 @ Ernest N. Morial Convention Center
004IC TELEUROLOGY: PRACTICAL GUIDE TO IMPROV-
ING PATIENT ACCESS TO UROLOGIC CARE
Aaron Martin, Emmanuel Abara, Course Directors
Room: 210 @ Ernest N. Morial Convention Center
005IC ADVANCING GENDER EQUITY IN UROLOGY:
ALLYSHIP FOR MEN AND ADVOCACY FOR WOMEN
Simone Thavaseelan, Akanksha Mehta, Course Directors
Mathew Sorensen, Nishant Patel, Maria Uloko,
Sam Chang
Room: 211 @ Ernest N. Morial Convention Center
028IC WELCOME TO THE CLASSROOM: HIGHLY
INTERACTIVE CASE-BASED DISCUSSIONS OF
ISSUES IN FEMALE PELVIC MEDICINE
Howard Goldman, Course Director
Victor Nitti, Elizabeth Takacs
Room: 219 @ Ernest N. Morial Convention Center
13
7:00 am – 5:00 pm
COURSES
7:30 am – 6:00 pm
9:00 am – 12:00 pm
103HO PROSTATE MR IMAGING: WHAT A UROLOGIST
SHOULD KNOW – LIVE VIRTUAL
Art Rastinehad, Jelle Barentsz, Course Directors
Vibeke Logager, Maarten de Rooij, Arvin George, Faculty
Timothy McClure, Srinivas Vourganti,
Byron Gaing, Svetlana Yablok, Proctors
10:00 am – 12:00 pm
007IC A GUIDELINES-BASED APPROACH TO RECUR-
RENT UTIS IN WOMEN
Jennifer Anger, Course Director
Una Lee, Toby Chai, Ann Stapleton
Room: 204 @ Ernest N. Morial Convention Center
008IC AVOIDING MEDICAL MALPRACTICE
Mitchell Benson, Course Director
Ben Rubinowitz
Room: 207 @ Ernest N. Morial Convention Center
009IC THE GENERAL UROLOGIST AND KIDNEY
TRANSPLANTATION
John Barry, Course Director
Brian Duty, Ian Metzler
Room: 208 @ Ernest N. Morial Convention Center
010IC DUST OR BUST: A BEGINNERS GUIDE TO
MODERN-DAY LASER LITHOTRIPSY STRATEGIES
FOR URETEROSCOPY
Khurshid Ghani, Course Director
William Roberts, Joel Teichman, Matthew Bultitude
Room: 210 @ Ernest N. Morial Convention Center
011IC ADVANCED URODYNAMICS:
INTERACTIVE COMPLEX CASES
Stephen Kraus, Course Director
Victor Nitti, E. Ann Gormley, Alvaro Lucioni,
Elizabeth Rourke
Room: 211 @ Ernest N. Morial Convention Center
012IC MANAGING PATIENTS WITH COMPLEX VOIDING
DYSFUNCTION: A “FLIPPED CLASSROOM” HOT
AIR BALLOON DEBATE
John Stoffel, Course Director
Anne Pelletier Cameron, Rose Khavari, Michael Kennelly,
Humphrey Atiemo
Room: 219 @ Ernest N. Morial Convention Center
 OFFICE OF EDUCATION COURSES
ALL COURSES ARE APPROVED FOR AMA PRA CATEGORY 1 CREDITTM
1:30 pm – 3:30 pm
013IC WINNING THE BATTLE AGAINST BURNOUT
Paul Maroni, Course Director
Amanda North, Ryan Terlecki
Room: 204 @ Ernest N. Morial Convention Center
014IC METABOLIC EVALUATION AND MEDICAL MAN-
AGEMENT FOR KIDNEY STONE PREVENTION
Michael Lipkin, Course Director
Brian Eisner, Jodi Antonelli, Sara Best
Room: 207 @ Ernest N. Morial Convention Center
015IC MALE RECONSTRUCTIVE UROLOGY FOR THE
GENERAL UROLOGIST
Joel Gelman, Course Director
Keith Rourke, Nima Baradaran, Faysal Yafi
Room: 208 @ Ernest N. Morial Convention Center
016IC COMMON PROBLEMS IN PEDIATRIC UROLOGY:
WHAT EVERY UROLOGIST SHOULD KNOW
Mark Cain, Course Director
Benjamin Whittam
Room: 210 @ Ernest N. Morial Convention Center
017IC A CASE-BASED APPROACH TO THE EVALUATION
AND MANAGEMENT OF URINARY
TRACT BLEEDING: NAVIGATING AUA
MICROHEMATURIA GUIDELINES TO
INTRACTABLE HEMORRHAGIC CYSTITIS
Stephen Boorjian, Course Director
Daniel Barocas, Jay Raman
Room: 211 @ Ernest N. Morial Convention Center
018IC WORK SMARTER, NOT HARDER - OPTIMIZING
EFFICIENCY IN CLINIC
Jyoti Chouhan, Course Director
Sarah Hecht, Kyle Rove
Room: 219 @ Ernest N. Morial Convention Center
Saturday, May 14, 2022
7:30 am – 9:30 am
006IC THE INDICATIONS FOR VAGINAL THERMOTHER-
APY: WHAT IT IS & IS THERE A ROLE FOR LASER
& RADIOFREQUENCY TREATMENTS
Roger Dmochowski, Course Director
Mickey Karram
Room: 211 @ Ernest N. Morial Convention Center
024IC NEW AUA BPH GUIDELINES: HOW TO BEST
DIAGNOSE AND HOW TO MOST EFFECTIVELY
AND SAFELY TREAT
Steven Kaplan, Course Director
Claus Roehrborn, Kevin McVary, Alexis Te, Lori Lerner
Room: 204 @ Ernest N. Morial Convention Center
025IC 2022 LOCALIZED PROSTATE CANCER
James Eastham, Course Director
Stephen Boorjian, Daniel Barocas, Alicia Morgans,
Sean McBride
Room: 207 @ Ernest N. Morial Convention Center
14
2:00 pm – 5:00 pm
105HO INTRODUCTION TO OFFICE-BASED
TRANSPERINEAL PROSTATE INTERVENTIONS:
SYSTEMATIC BIOPSY, RECTAL HYDROGEL
SPACER AND MR/US FUSION
Arvin George, John Wei, Course Directors
Abhinav Sidana, Timothy Byler, Faculty
Michael Gorin, Richard Szabo, John Dibianco, Amit Patel,
Amin Herati, Andre Luis Abreu,
Kevin Ginsburg, Wayne Brisbane, Proctors
Level 2, R05 @ Ernest N. Morial Convention Center
4:00 pm – 6:00 pm
019IC THE CHANGING FACE OF ADVANCED PROSTATE
CANCER 2022
Judd Moul, Course Director
Lawrence Karsh, Alicia Morgans
Room: 204 @ Ernest N. Morial Convention Center
020IC TRIMODALITY THERAPY FOR MANAGEMENT OF
MUSCLE INVASIVE BLADDER CANCER
Adam Feldman, Course Director
Jason Efstathiou, Matthew Wszolek, Richard Lee
Room: 207 @ Ernest N. Morial Convention Center
021IC AMERICAN UROLOGICAL ASSOCIATION
SURGICAL AND MEDICAL MANAGEMENT OF
STONE DISEASE GUIDELINES: UPDATE AND
COMPLEX CASES
Ojas Shah, Course Director
Brian Matlaga, Dean Assimos, John Lieske
Room: 208 @ Ernest N. Morial Convention Center
022IC OVERCOMING THE LEARNING CURVE
FOR RETZIUS-SPARING PROSTATECTOMY
Keith Kowalczyk, Course Director
Jim Hu, John Davis, Kirsten Greene
Room: 210 @ Ernest N. Morial Convention Center
7:30 am – 6:00 pm
026IC CURRENT UROLOGIC MANAGEMENT OF FEMALE
SEXUAL DYSFUNCTION
Irwin Goldstein, Course Director
Noel Kim, Rachel Rubin, Maria Uloko
Room: 219 @ Ernest N. Morial Convention Center
027IC ADAPTIVE PCNL: UTILIZING A CONTEMPORARY
TOOLBOX
Nishant Patel, Course Director
Ryan Hsi, Karen Stern, David Tzou, Rajat Jain
Room: 210 @ Ernest N. Morial Convention Center
053IC DIFFICULT CASES IN HIGH-RISK BLADDER
CANCER: AN EVIDENCE-BASED APPROACH
Michael Cookson, Course Director
Sanjay Patel, Jeffrey Holzbeierlein, Timothy Masterson
Room: 208 @ Ernest N. Morial Convention Center
 OFFICE OF EDUCATION COURSES
ALL COURSES ARE APPROVED FOR AMA PRA CATEGORY 1 CREDITTM
8:00 am – 12:00 pm 036IC EVALUATION AND MANAGEMENT OF PRIAPISM
102HO INTERVENTIONAL ULTRASONOGRAPHY:
A NEW UROLOGY PARADIGM FOR USING
RENAL ULTRASOUND TO GUIDE RENAL
ACCESS AND BIOPSIES
Thomas Chi, Roger Sur, Jaime Landman, Course
Directors
Gregory Tasian, Joel Abbott, Patrick Mufarrij, Seth
Bechis, Amy Krambeck, David Tzou, Ryan Hsi,
Thomas Tailly, Kaitlan Cobb, David Bayne, Roshan Patel,
Mantu Gupta, Noah Canvasser, Fadl Hamouche,
Justin Ahn, Proctors
Level 2, R05 @ Ernest N. Morial Convention Center
10:00 am – 12:00 pm INCONTINENCE
029IC COMPLICATIONS AND RECURRENCE AFTER
FOCAL THERAPY FOR PROSTATE CANCER
Andre Luis Abreu, Course Director
Inderbir Gill, Rafael Sanchez-Salas
Room: 211 @ Ernest N. Morial Convention Center
030IC 3D PRINTING, AUGMENTED REALITY, AND
VIRTUAL REALITY: WHY, HOW, WHAT TO
INCORPORATE INTO DAILY PRACTICE
Ahmed Ghazi, Course Director
Marc Bjurlin, Lauren Shepard
Room: 207 @ Ernest N. Morial Convention Center
031IC UROLOGICAL TRAUMA & RECONSTRUCTION
Steven Hudak, Course Director
Noel Armenakas, Michael Coburn
Room: 208 @ Ernest N. Morial Convention Center
032IC CURRENT CONCEPTS AND CONTROVERSIES
IN MALE HORMONE REPLACEMENT THERAPY
Wayne Hellstrom, Course Director
Martin Miner, John Mulhall, Mohit Khera
Room: 210 @ Ernest N. Morial Convention Center
034IC REPRODUCTIVE HEALTH AND FERTILITY
PRESERVATION IN UROLOGIC SURGEONS
AND TRAINEES
Christine Van Horn, Jennifer Yates Katherine Rotker,
Course Directors
Room: 219 @ Ernest N. Morial Convention Center
045IC CONTEMPORARY PHARMACOTHERAPY FOR
OVERACTIVE BLADDER 2022: MONOTHERAPY
AND COMBINED PHARMACOTHERAPY TO
OPTIMIZE TREATMENT
Eric Rovner, Course Director
Alan Wein, Christopher Chapple,
Room: 204 @ Ernest N. Morial Convention Center
1:30 pm – 3:30 pm
035IC DIVERSITY EQUITY AND INCLUSION IN
UROLOGY, WHAT DO WE NEED TO KNOW
Linda McIntire, Course Director
Tracy Downs, Yahir Santiago-Lastra, Gjanje Smith,
Alejandro Sanchez, David Bloom
Room: 204 @ Ernest N. Morial Convention Center
15
Martin Gross, Course Director
COURSES
Trinity Bivalacqua, Jay Simhan, Faysal Yafi
Room: 207 @ Ernest N. Morial Convention Center
037IC PRACTICAL VAGINAL SURGERY FOR THE
UROLOGIST 2022: A COURSE TO ENHANCE
PRACTICAL SURGICAL THINKING, APPROACHES,
AND TECHNIQUES TO COMMON UROLOGICAL
CONDITIONS
Victor Nitti, Course Director
Nirit Rosenblum, Benjamin Brucker, Ja-Hong Kim
Room: 208 @ Ernest N. Morial Convention Center
038IC COMPLEX MALE NON-NEUROGENIC URINARY
Francisco Martins, Course Director
Sarah Fraumann Faris, Matthias Hofer
Room: 210 @ Ernest N. Morial Convention Center
039IC OPTIMIZING SURGICAL OUTCOMES IN
OLDER ADULTS
Charles Scales, Course Director
Anne Suskind
Room: 211 @ Ernest N. Morial Convention Center
040IC AUA 2022 SPANISH COURSE ON
GENITOURINARY RECONSTRUCTIVE SURGERY
Ramon Virasoro, Course Director
Reynaldo Gomez, Javier Ponce De Leon
Room: 219 @ Ernest N. Morial Convention Center
2:00 pm – 5:00 pm
104HO INTRODUCTION TO PROSTATE TISSUE
ABLATION: HIGH INTENSITY FOCUSED
ULTRASOUND AND CRYOTHERAPY
Samir Taneja, Arvin George, Course Directors
Abhinav Sidana, Faculty
Amir Lebastchi, Arieh Shalhav, James Wysock, Puneet
Sindhwani, Aaron Katz, Derek Lomas,
Art Rastinehad, Fernando Kim, Proctors
Level 2, R05 @ Ernest N. Morial Convention Center
4:00 pm – 6:00 pm
033IC REFRACTORY OVERACTIVE BLADDER: HOW
TO SELECT 3RD-LINE THERAPIES AND
OPTIMIZE OUTCOMES
Kathleen Kobashi, Course Director
David Ginsberg, Sandip Vasavada
Room: 204 @ Ernest N. Morial Convention Center
041IC WOMEN’S HEALTH UPDATE: GYNECOLOGIC
CONSIDERATIONS FOR THE UROLOGIST
Ariana Smith, Course Director
Nirit Rosenblum, Una Lee
Room: 211 @ Ernest N. Morial Convention Center
042IC UPDATES IN THE MANAGEMENT OF PENILE
CANCER: A CASE-BASED APPROACH
Philippe Spiess, Course Director
Viraj Master, Timothy Masterson, Andrea Necchi,
Chris Protzel
Room: 207 @ Ernest N. Morial Convention Center
043IC GENITOURINARY CANCER SURVIVORSHIP: A
PRACTICAL MASTER CLASS
Steven Brandes, Course Director
Andrew Peterson, Cooper Benson, Shyam Sukumar,
Joseph Alukal
Room: 219 @ Ernest N. Morial Convention Center
 OFFICE OF EDUCATION COURSES
ALL COURSES ARE APPROVED FOR AMA PRA CATEGORY 1 CREDITTM
044IC HOW TO ESTABLISH A SUCCESSFUL MEN’S
HEALTH AND ANDROLOGY PRACTICE
Ranjith Ramasamy, Course Director
Jason Kovac, Ryan Smith, Libert Ramos
Room: 210 @ Ernest N. Morial Convention Center
Sunday, May 15, 2022
7:30 am – 9:30 am
047IC COMPLICATIONS OF ROBOTIC UROLOGICAL
SURGERY: PREVENTION, RECOGNITION AND
MANAGEMENT
Rene Sotelo, Course Director
Mihir Desai, Michael Stifelman, Richard Gaston
Room: 204 @ Ernest N. Morial Convention Center
048IC GENETIC TESTING IN PROSTATE CANCER:
CLINICAL IMPLICATIONS FOR EARLY DETEC-
TION AND MANAGEMENT OF LOCALIZED AND
ADVANCED DISEASE
Todd Morgan, Course Director
Heather Cheng, Leonard Gomella
Room: 207 @ Ernest N. Morial Convention Center
049IC SINGLE-PORT AND MULTI-PORT ADVANCED
ROBOTIC UROLOGIC ONCOLOGY: EXTREME
UNFORGETTABLE CASES AND THEIR
MANAGEMENT
Vipul Patel, Course Director
Alexandre Mottrie, Rafael Coelho, Bernardo Maria Rocco
Room: 208 @ Ernest N. Morial Convention Center
050IC SURGICAL CONSIDERATIONS AND COORDI-
NATED MEDICAL MANAGEMENT OF DIFFICULT
RETROPERITONEAL TUMORS
Clint Cary, Course Director
Timothy Masterson, Lawrence Einhorn
Room: 210 @ Ernest N. Morial Convention Center
051IC MANAGEMENT OF LOWER URINARY TRACT
DYSFUNCTION AFTER PROSTATE CANCER
TREATMENT
Jaspreet Sandhu, Course Director
Kurt McCammon, O. Lenaine Westney
Room: 211 @ Ernest N. Morial Convention Center
052IC RENAL MASS AND LOCALIZED RENAL CANCER:
EVALUATION, MANAGEMENT AND FOLLOW-UP -
A CASE-BASED APPROACH
Steven Campbell, Course Director
Phillip Pierorazio, Christopher Weight, Robert Uzzo
Room: 219 @ Ernest N. Morial Convention Center
16
046IC INTEGRATING CARE FOR ONCOLOGY PATIENTS:
ESTABLISHING A MULTIDISCIPLINARY ONCOLO-
GY CLINIC WITH ADVANCED THERAPEUTICS
Kelly Stratton, Course Director
Alicia Morgans, Kelvin Moses, Brian Shuch
Room: 208 @ Ernest N. Morial Convention Center
7:30 am – 6:00 pm
9:00 am – 12:00 pm
106HO SURGICAL ABLATIVE TECHNIQUES FOR BPH
Amy Krambeck, Course Director
Lori Lerner, Dean Elterman, John Knoedler, Faculty
Naeem Bhojani, Gregg Eure, Tobias Kohler, Kevin Zorn,
Smita De, Mark Assmus, Matthew Lee,
Joel Funk, Proctors
Level 2, R05 @ Ernest N. Morial Convention Center
10:00 am – 12:00 pm
054IC PROSTATE CANCER DIAGNOSTICS: BIOMARK-
ERS, MRI AND BIOPSY TECHNIQUES
Daniel Barocas, Course Director
John Wei, Scott Eggener, Jeffrey Tosoian, Sigrid Carlsson
Room: 207 @ Ernest N. Morial Convention Center
055IC BLADDER CANCER TREATMENT DILEMMAS:
THE CASES YOU FACE AND WHAT TO
DO ABOUT THEM
Sam Chang, James McKiernan, Course Directors
Kristen Scarpato, Christopher Anderson, Chad Ritch
Room: 208 @ Ernest N. Morial Convention Center
056IC EVALUATION AND MANAGEMENT OF ADRENAL
MASSES: A CASE-BASED APPROACH
Neal Rowe, Course Director
Thomas McGregor, Craig Rogers
Room: 204 @ Ernest N. Morial Convention Center
057IC NOCTURIA: ADVANCES IN DIAGNOSIS AND
MANAGEMENT INCLUDING TRANSLATIONAL
SCIENCE
Jeffrey Weiss, Course Director
Alan Wein, Jerry Blaivas, Lori Birder
Room: 211 @ Ernest N. Morial Convention Center
058IC VASECTOMY: A VERY PRACTICAL CASE-BASED
COURSE ON PREOPERATIVE, INTRAOPERATIVE
AND POSTOPERATIVE MANAGEMENT
Ira Sharlip, Course Director
Jay Sandlow, Stanton Honig
Room: 219 @ Ernest N. Morial Convention Center
023IC URINARY DIVERSION: CURRENT INDICATIONS,
TECHNIQUES AND MANAGEMENT OF
COMPLICATIONS
Siamak Daneshmand, Course Director
Anne Schuckman, Matthew Dunn
Room: 210 @ Ernest N. Morial Convention Center
 OFFICE OF EDUCATION COURSES
ALL COURSES ARE APPROVED FOR AMA PRA CATEGORY 1 CREDITTM

1:30 pm – 3:30 pm 4:00 pm – 6:00 pm

059IC CATASTROPHES, COMPLICATIONS AND COR- 065IC AUA GUIDELINES ON ADVANCED

RECTIONS IN PERCUTANEOUS RENAL SURGERY
Arthur Smith, Course Director
Mantu Gupta, Mahesh Desai, Ralph Clayman,
Arun Rai, Zeph Okeke
Room: 204 @ Ernest N. Morial Convention Center
060IC MALE INFERTILITY UPDATE 2022
Larry Lipshultz, Course Director
Robert Brannigan, Michael Eisenberg, Mary Samplaski
Room: 207 @ Ernest N. Morial Convention Center
061IC MANAGEMENT OF COMMON PROSTATE CANCER
DILEMMAS
Gerald Andriole, Course Director
Adam Kibel,Anthony D’Amico, A. Oliver Sartor
Room: 208 @ Ernest N. Morial Convention Center
062IC PROSTATE CANCER UPDATE 2022
William Catalona, Course Director
Douglas Dahl, Robert Nadler, Stacy Loeb,
Stanley Liauw, Russell Szmulewitz
Room: 210 @ Ernest N. Morial Convention Center
063IC ROBOTIC UPPER URINARY TRACT RECON-
STRUCTION: A TOP TO BOTTOM APPROACH
Lee Zhao, Course Director
Michael Stifelman, Daniel Eun, Raju Thomas
Room: 211 @ Ernest N. Morial Convention Center
064IC GETTING IT RIGHT THE FIRST TIME: AN
EVIDENCE-BASED APPROACH TO PRIMARY
HYPOSPADIAS REPAIR
Warren Snodgrass, Course Director
Nicol Bush
Room: 219 @ Ernest N. Morial Convention Center
2:00 pm – 5:00 pm TUMOR BOARD: A CASE-BASED APPROACH
107HO FUNDAMENTALS OF PCNL ACCESS
Robert Sweet, Course Director
D.Duane Baldwin, Benjamin Canales,
Bodo Knudsen, Thomas Chi, Zeph Okeke, Faculty
David Leavitt, David Hoenig, Jonathan Harper, Ian Met-
zler, Patrick Samson, Roshan Patel, Proctors
Level 2, R05 @ Ernest N. Morial Convention Center
COURSES
PROSTATE CANCER
Michael Cookson, Course Director
Adam Kibel, Kristen Scarpato, David Jarrard
Room: 204 @ Ernest N. Morial Convention Center
066IC PRACTICAL AND EVIDENCE-BASED MINIMALLY
INVASIVE AND ROBOTIC-ASSISTED SURGERY
IN PEDIATRIC UROLOGY
Patricio Gargollo, Course Director
Aseem Shukla, Michael Ost, Chester Koh
Room: 207 @ Ernest N. Morial Convention Center
067IC MALE INFERTILITY GUIDELINES: A PRACTICAL
GUIDE FOR THE PRACTICING UROLOGIST TO
ENHANCE EVALUATION AND TREATMENT OF
THE MAN IN AN INFERTILE RELATIONSHIP
BASED ON PUBLISHED EVIDENCE
Peter Schlegel, Course Director
Mark Sigman, Cigdem Tanrikut
Room: 210 @ Ernest N. Morial Convention Center
068IC SURGICAL & MEDICAL MANAGEMENT OF
HIGH-RISK RENAL CELL CARCINOMA: NEW
PARADIGMS FOR TREATMENT
Benjamin Lee, Course Director
A. Oliver Sartor, Chandru Sundaram
Room: 208 @ Ernest N. Morial Convention Center
069IC WHAT THE GENERAL UROLOGIST SHOULD
KNOW ABOUT CARE OF TRANSGENDER
PATIENTS
Polina Reyblat, Dmitriy Nikolavsky, Course Directors
Geolani Dy, Min Suk Jun
Room: 211 @ Ernest N. Morial Convention Center
070IC UPPER TRACT UROTHELIAL CARCINOMA
TO MANAGEMENT
Surena Matin, Course Director
Jean Hoffman-Censits, Jonathan Coleman
Room: 219 @ Ernest N. Morial Convention Center

Monday, May 16, 2022 7:30 am – 3:30 pm

7:30 am – 9:30 am 073IC DON’T CUT ME! A CASE-BASED GUIDE TO

SAFE ACTIVE SURVEILLANCE FOR SOLID
071IC MODERN CONCEPTS FOR PENILE
AND CYSTIC RENAL MASSES
PROSTHESIS SUCCESS
Phillip Pierorazio, Course Director
Tobias Kohler, Course Director
Mark Ball, Antonio Finelli, Sarah Psutka
Steven Wilson, Paul Perito
Room: 208 @ Ernest N. Morial Convention Center
Room: 204 @ Ernest N. Morial Convention Center
074IC PERSONAL FINANCE BOOTCAMP FOR THE
072IC INCORPORATING GENOMIC TESTING FOR
EARLY CAREER UROLOGIST
PROSTATE CANCER INTO YOUR PRACTICE
Richard Sarle, Course Director
Joseph Wagner, Course Director
Michael Fumo
Matthew Cooperberg, Daniel Lin, David Penson
Room: 210 @ Ernest N. Morial Convention Center
Room: 207 @ Ernest N. Morial Convention Center

17
 OFFICE OF EDUCATION COURSES
ALL COURSES ARE APPROVED FOR AMA PRA CATEGORY 1 CREDITTM

075IC GLOBAL PERSPECTIVES IN URETHRAL
RECONSTRUCTION: CONTROVERSIES IN
BULBAR URETHRAL STRICTURE DISEASE
Sanjay Kulkarni, Course Director
Evelyn Moshokoa, Course Director, Alex Vanni,
Pankaj Joshi
Room: 211 @ Ernest N. Morial Convention Center
082IC GERIATRIC UROLOGY: BEYOND THE BASICS - A
MODERATED CASE-BASED DEBATE
Tomas Griebling, Course Director
E.Camille Vaughan, Jonathan Bergman
Room: 219 @ Ernest N. Morial Convention Center
1:30 pm - 3:30 pm

076IC YOUR VIDEO, OUR COURSE: DEEP ANALYSIS OF 083IC ACTIVE SURVEILLANCE 2022
ATTENDEES SURGICAL VIDEO EXPERIENCES Laurence Klotz, Course Director
Marcelo Orvieto, Rafael Coelho, Course Directors Mark Emberton, Ian Thompson, Derya Tilki
Antonio Villamil, Vipul Patel, Bernardo Maria Rocco Room: 204 @ Ernest N. Morial Convention Center
Room: 219 @ Ernest N. Morial Convention Center 084IC NLUTD GUIDELINES COURSE
David Ginsberg, Course Director
10:00 am – 12:00 pm
Anne Pelletier Cameron, Stephen Kraus
077IC OPERATIONALIZING CHECKPOINT INHIBITORS Room: 207 @ Ernest N. Morial Convention Center
IN UROLOGIC PRACTICE
085IC INTERSTITIAL CYSTITIS AMENDMENT
Gautam Jayram, Course Director
Quentin Clemens, Course Director
Gordon Brown, Neal Shore
Henry Lai
Room: 204 @ Ernest N. Morial Convention Center
Room: 208 @ Ernest N. Morial Convention Center
078IC DIAGNOSIS AND MANAGEMENT OF LOCALIZED,
086IC REVISITING ENDOSCOPIC MANAGEMENT OF
LOCALLY ADVANCED AND ADVANCED KIDNEY
UROTHELIAL TUMORS
CANCER
Jonathan Silberstein, Course Director
W. Marston Linehan, Course Director
Mark Soloway, Joshua Meeks
Mark Ball, Ramaprasad Srinivasan, David McDermott
Room: 210 @ Ernest N. Morial Convention Center
Room: 207 @ Ernest N. Morial Convention Center
087IC SURGICAL MANAGEMENT OF UROLITHIASIS:
079IC CHEMOTHERAPY AND IMMUNOTHERAPY FOR
CONTROVERSIES AND CASE-BASED
THE UROLOGIST AND ADVANCED PRACTICE
DISCUSSION
PROVIDER
Stephen Nakada, Course Director
Costas Lallas, Course Director
Margaret Pearle
Edouard Trabulsi, Anne Calvaresi
Room: 211 @ Ernest N. Morial Convention Center
Room: 208 @ Ernest N. Morial Convention Center
088IC MANAGEMENT OF NON-MUSCLE INVASIVE
080IC A PRACTICAL APPROACH TO THE EVALUATION
BLADDER CANCER: PRACTICAL SOLUTIONS
AND MANAGEMENT OF CHRONIC MALE
FOR COMMON PROBLEMS
PELVIC PAIN
Kamal Pohar, Course Director
Ryan Smith, Course Director
Ashish Kamat, J. Witjes, Cheryl Lee
Parviz Kavoussi, Luriel Smith-Harrison, Sarah Krzastek,
Room: 219 @ Ernest N. Morial Convention Center
Reza Salajeghe
Room: 210 @ Ernest N. Morial Convention Center
081IC COMPLICATIONS OF VAGINAL MESH
Kamran Sajadi, Course Director
Farzeen Firoozi, Christopher Tenggardjaja
Room: 211 @ Ernest N. Morial Convention Center

18
Thursday, May 12, 2022 8:00 am – 5:30 pm

THURSDAY
SOCIETY OF ACADEMIC UROLOGISTS (SAU)
Room 225 @ Ernest N. Morial Convention Center

8:00 WELCOME AND INTRODUCTION UROLOGISTS AS POLICY LEADERS: AN

Chairs: Christopher Gonzalez, Kristen Scarpato E-CURRICULUM IN THE FUNDAMENTALS
OF HEALTH POLICY
8:07 AUA OFFICE OF EDUCATION UPDATE
Denise Asafu-Adjei
Jay Raman
CONFIDENCE AND COMPETENCE ASSESSMENT
8:14 RRC UPDATE
OF UROLOGICAL SURGERY RESIDENTS
Eric Wallen
Katie Murray
8:21 ABU UPDATE
DEVELOPMENT AND VALIDATION OF A NOVEL
J. Brantley Thrasher
UROLOGY RESIDENCY EVALUATION AND
8:28 AAMC UPDATE FEEDBACK SYSTEM
Mark Jordan Elizabeth Takacs
8:35 AUA OFFICE OF RESEARCH UPDATE DEVELOPING AN ORGANIZATIONAL LEADER-
Steven Kaplan SHIP CURRICULUM FOR UROLOGY CHIEF
8:42 R. FRANK JONES UPDATE RESIDENTS
Efe Ghanney Simons Kevin Koo

8:49 SWIU UPDATE ASSESSING READINESS FOR INDEPENDENT

Akanksha Mehta PRACTICE IN UROLOGY RESIDENCY TRAINING
Kate Kraft
8:56 SAU UPDATE
Society President: James Brown INTERACTIVE ONLINE MODULES: ASYNCHRO-
NOUS LEARNING TO IMPROVE MEDICAL
9:03 DISCUSSION/Q&A STUDENT UROLOGIC EDUCATION
9:10 EDUCATION AND RESEARCH IN THE MODERN Ezra Margolin
TRAINING PROGRAM THE ROLE OF RACE/ETHNICITY IN PERCEIVED
INCORPORATING QUALITY INITIATIVES INTO EXPOSURE, ACCESS AND TRAINING IN UROL-
YOUR DEPARTMENT AND RESIDENCY TRAINING OGY: EXPERIENCES AND PERSPECTIVES OF
Jennifer Robles UNDER-REPRESENTED IN MEDICINE (URM)
UROLOGISTS
STRATEGIES FOR ENGAGING FACULTY AND
Efe Ghanney Simons, Christopher Saigal
RESIDENTS IN HEALTH SERVICES RESEARCH
Martha Terris PILOT EVALUATION OF MIXED REALITY (MR)
TECHNOLOGIES FOR FEEDBACK AND GUIDANCE
STRATEGIES FOR ENGAGING FACULTY AND
DURING TRANSRECTAL ULTRASOUND BIOPSY
RESIDENTS IN TRANSLATIONAL RESEARCH
SIMULATION: A PROSPECTIVE, RANDOMIZED
David Jarrard
COMPARATIVE TRIAL
PANEL: WHAT CAN WE LEARN FROM EXISTING Ahmed Ghazi
MODELS AND WHICH IS BEST, AND HOW DO WE
DISCUSSION/Q&A
FUND THEM?
Panelists: David Jarrard, Matthew Nielsen, Andrew Peterson, 1:30 ATTRACTING MODERN FACULTY AND
Martha Terris APPLICANTS
DISCUSSION/Q&A FOSTERING AUTONOMY IN SURGICAL
TRAINING & FACILITATING
10:35 BREAK
ENTRUSTMENT BY FACULTY
10:50 BUSINESS, WORK-LIFE, AND LEADERSHIP IN Jill Buckley
TRANSITION TO PRACTICE
SUPPORTING PREGNANCY AND PARENTAL
MANAGING YOUR MONEY AND EMPLOYER LEAVE DURING TRAINING & PRACTICE
BENEFITS Mathew Sorensen
Eugene Rhee
ATTRACTING MEDICAL STUDENTS TO UROLOGY
MANAGING YOUR TIME AND WORK-LIFE BALANCE Kevin Rice
Sam Chang
SURGICAL SIMULATION IN 2022: WHERE
HOSPITAL LEADERSHIP: HOW, WHEN AND WHY SHOULD WE BE?
TO GET INVOLVED Ahmed Ghazi
Joel Nelson
DISCUSSION/Q&A
DISCUSSION/Q&A
2:20 PREPARING FOR THE 10-YEAR SITE VISIT
11:45 LUNCH/ANNUAL BUSINESS MEETING Kristin Baldea
12:45 SAU GRANT UPDATES DISCUSSION/Q&A
2:35 STARTING AN INTERNATIONAL TRAINING PROGRAM
Kashif Saddiqi
DISCUSSION/Q&A

*Presenting author 19
2:50 BENCHMARKING FOR COMPENSATION AND 4:30 SAU TASK FORCE UPDATES
PRODUCTIVITY IN ACADEMIC UROLOGY: INCORPORATION OF BEST PRACTICES IN AVOID-
SAU SURVEY ANCE OF BIAS & DISCRIMINATION IN RESIDENT
Raj Pruthi RECRUITMENT & TRAINING
DISCUSSION/Q&A Kate Kraft
3:05 RESIDENCY BUDGET AND DEPARTMENT EXPAN- ASSESSING RESIDENCY APPLICANTS IN THE
SION: WHAT DO YOU NEED AND HOW CAN YOU POST-USMLE STEP 1 SCORE ERA
GET MORE? Patrick Shenot
Scott Delacroix OPTIMIZING THE APPLICANT EXPERIENCE IN
DISCUSSION/Q&A THE VIRTUAL INTERVIEW ERA
Gary Lemack
3:20 BREAK
RESIDENT MENTAL WELLBEING AND SUICIDE
3:30 WHAT HAVE WE LEARNED FROM THE COVID
PREVENTION
PANDEMIC?
Moben Mirza
VIRTUAL INTERVIEWS: PROS/CONS AND THE
DISCUSSION/Q&A
WAY FORWARD
Sarah Faris, Davis Viprakasit 5:25 CLOSING REMARKS
Chairs: Christopher Gonzalez, Kristen Scarpato
PREFERENCE SIGNALING: OUTCOMES &
PERCEPTIONS APPROVED FOR AMA PRA CATEGORY 1
Simone Thavaseelan CREDITTM
DIGITAL RESIDENT RECRUITING:
HOW TO SUCCESSFULLY HIGHLIGHT
YOUR PROGRAM & PROMOTE YOUR FACULTY
Benjamin Breyer
DISCUSSION/Q&A

Thursday, May 12, 2022 8:30 am – 5:00 pm

Forums
THE ECONOMICS OF HEALTHCARE: UNDERSTANDING PHYSICIAN COMPENSATION
Room 353–355 @ Ernest N. Morial Convention Center
8:30 WELCOME & INTRODUCTION OF THE AUA INSTI- 2:15
CRITICAL ASPECTS OF EMPLOYMENT AGREE-
TUTE FOR LEADERSHIP & BUSINESS MENTS BEYOND COMPENSATION
Course Co-Director: John McConnell Faculty: Jennifer Miles-Thomas
8:40 GENERAL HEALTHCARE ECONOMICS THAT AF- 2:45 BREAK
FECT PHYSICIAN COMPENSATION 3:00 LEGAL ASPECTS OF EMPLOYMENT AND CON-
Course Co-Director: John McConnell TRACTUAL AGREEMENTS
9:15
COMPLEXITY OF RVU-BASED COMPENSATION: 3:30 KNOW YOUR VALUE
THE GOOD, THE BAD, THE UGLY Course Co-Director: Kenneth Berger
Faculty: Mark Painter
4:15 ROUND TABLE DISCUSSIONS: ACADEMIC,
10:05 BREAK HEALTH SYSTEM EMPLOYED, INDEPENDENT
10:20 UNDERSTANDING OVERHEAD COSTS AND THE GROUP PRACTICE
IMPACT OF PRACTICE EFFICIENCY 5:00 WRAP-UP/COURSE ADJOURNS
11:10 ROUND TABLE DISCUSSIONS: ACADEMIC, Course Co-Directors: John McConnell, Kenneth Berger
HEALTH SYSTEM EMPLOYED, INDEPENDENT
GROUP PRACTICE
12:00 LUNCH BREAK
1:30
STRATEGIES FOR NEGOTIATING COMPENSA-
TION
Faculty: Brad Lerner

20
Thursday, May 12, 2022 12:30 pm – 5:00 pm

THURSDAY
Forums
YOUR ESSENTIAL GUIDE TO CONGENITALISM AND TRANSITIONAL CARE PRESENTED BY THE AUA
IN COLLABORATION WITH GURS, SPU, AND SUFU
Room 262 @ Ernest N. Morial Convention Center
1:00 WELCOME 3:05
METABOLIC CONSIDERATIONS AND BONE
Course Co-Directors: Hadley Wood, Melissa Kaufman HEALTH IN NON-WEIGHT BEARING PATIENTS
Faculty: Robert Kovell
1:15 UROLOGIC SURVEILLANCE
Faculty: David Joseph 3:15 CASE DISCUSSIONS
Faculty: Dean Assimos, Nicole Miller, Robert Kovell
1:25 MEN’S HEALTH
Faculty: John Wiener 3:30 AUGMENT RUPTURE/BLADDER PERFORATION
Faculty: Rosalia Misseri
1:35
NEUROGENIC LOWER URINARY TRACT
DYSFUNCTION 3:50 PREGNANCY AND DELIVERY MANAGEMENT
Faculty: Tracey Wilson Faculty: Dan Wood
1:45 PERIOPERATIVE CONSIDERATIONS 4:10
ACUTE RETENTION RELATED TO INABILITY TO
Faculty: Sean Elliott CATHETERIZE
Faculty: Erin McNamara
2:15 Q&A
4:30
PRACTICE HACKS—PRACTICAL IDEAS TO HELP
2:30 BREAK
PATIENTS BE SUCCESSFUL NAVIGATING
2:45 BLADDER AND POUCH STONES COMPLEX CARE
Faculty: Nicole Miller Faculty: Melissa Kaufman
2:55
MANAGEMENT OF UPPER TRACT STONES IN 4:50 Q&A
COMPLEX CONGENITAL PATIENTS
Faculty: Dean Assimos

*Presenting author 21
NOTES
NOTES
NOTES
 MP = Moderated Poster Session, PD = Podium Session

Friday, May 13, 2022 Plenary: Prime Time Friday Morning Session 7:30 am – 11:30 am

Great Hall A @ Ernest N. Morial Convention Center

7:30 SECOND OPINION CASES: FOCAL THERAPY FOR PROSTATE CANCER: SHOULD IT REPLACE STANDARD OF CARE?
Moderator: Michael Koch
Panelists: Kelly Stratton, Scott Eggener
7:50 STATE-OF-THE-ART LECTURE: PSMA DIAGNOSTICS AND THERANOSTICS

FRIDAY
Presenter: William Aronson
8:05 PANEL DISCUSSION:  WOMEN IN UROLOGIC ONCOLOGY: PAST, PRESENT AND FUTURE
Moderator: Eila Skinner
Panelists: Cheryl Lee, Sarah Psutka, Sima Porten, Kristen Scarpato
8:25 PANEL DISCUSSION: WHAT IS THE OPTIMAL MULTIDISCIPLINARY TEAM IN 2022: DRAFTING FOR THE FUTURE
Moderator: Leonard Gomella
Panelists: Michael Cookson, Neal Shore
8:45 PANEL DISCUSSION: BEST PROSTATE BIOPSY TECHNIQUES IN 2022: MPMRI/US FUSION, TRANSPERINEAL,
STANDARD, MICRO-ULTRASOUND, LIQUID BIOPSY
Moderator: Laurence Klotz
Panelists: Arvin George, Benjamin Ristau
9:15 PANEL DISCUSSION: MANAGEMENT OF INCIDENTALLY DISCOVERED 3 CM SOLID RENAL MASS CANCER
Moderator: Costas Lallas
Panelists: Brian Lane, Lee Ponsky, Jaime Landman
9:45 PANEL DISCUSSION: CONFRONTING RESISTANCE TO IMMUNOTHERAPY—WHAT’S NEXT?
Panelist: Padmanee Sharma
10:05 SURVIVOR DEBATE: NON-MUSCLE INVASIVE BLADDER CANCER REFRACTORY TO BCG: CYSTECTOMY,
SYSTEMIC IMMUNOTHERAPY, INTRAVESICAL CHEMOTHERAPY
Moderator: Tracy Downs
Panelists: James McKiernan, Seth Lerner
10:35 BATTLE OF THE ROBOTS: WHICH IS SUPERIOR? SINGLE-PORT VS MULTI-PORT ROBOTIC PROSTATECTOMY
Moderator: Li-Ming Su
Debater (Multi-port): Jeffrey Cadeddu
Debater (Single-Port): Jihad Kaouk
11:05 LATE-BREAKING ABSTRACT: PLLBA-01: FINAL CLINICAL RESULTS OF PIVOTAL TRIAL OF IL-15RaFC
SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
CIS AND PAPILLARY COHORTS
Presenter: Karim Chamie
11:13 LATE-BREAKING ABSTRACT: PLLBA-02: IMPACT OF 18F-RHPSMA-7.3 PET ON UPSTAGING OF PATIENTS WITH
PROSTATE CANCER RECURRENCE: RESULTS FROM THE PROSPECTIVE, PHASE 3, MULTICENTER, SPOTLIGHT
STUDY
Presenter: Mark Fleming
11:21 LATE-BREAKING ABSTRACT: PLLBA-03: EFFICACY AND SAFETY OF A NOVEL GENE THERAPY (URO-902; PVAX/
HSLO) IN FEMALE PATIENTS WITH OVERACTIVE BLADDER AND URGE URINARY INCONTINENCE: RESULTS FROM
A PHASE 2A TRIAL
Presenter: Kenneth Peters

*Presenting author 25
Friday, May 13, 2022 Plenary: Prime Time Friday Afternoon Session 1:00 pm – 4:30 pm

Great Hall A @ Ernest N. Morial Convention Center

1:00 SEMI-LIVE/SURGICAL TECHNIQUES: ONCOLOGY
Surgeon: Kenneth Goldberg
2:00 AUA GUIDELINES: LOCALIZED PROSTATE CANCER
Presenter: James Eastham
2:15 CONFEDERACIÓN AMERICANA DE UROLOGÍA (CAU) LECTURE: THE FINE BORDERLINE BETWEEN HIGH-RISK,
LOCALLY-ADVANCED AND OLIGOMETASTATIC PROSTATE CANCER
Presenter: Rafael Sanchez-Salas
2:30 UROLOGICAL ASSOCIATION OF ASIA (UAA) LECTURE: NOVEL GERMLINE MUTATION IN PROSTATE CANCER—THE
NEXT FRONTIER IN PERSONALIZED THERAPY FOR ASIA AND BEYOND
Presenter: Damien Bolton
2:45 AUA GUIDELINES UPDATE: RENAL MASS
Presenter: Steven Campbell
3:00 CONTROVERSIES IN UROLOGY DEBATE: FOCAL ABLATION VERSUS ACTIVE SURVEILLANCE IN A 65M WITH
GGG2, MRI CONCORDANT UNILATERAL PROSTATE CANCER
Moderator: Kirsten Greene
Debaters: Dipen Parekh, Robert Reiter
3:30 PANEL DISCUSSION: RADICAL PROSTATECTOMY WITH BOTH SEVERE INCONTINENCE AND SEVERE ERECTILE
DYSFUNCTION
Panelists: Paul Chung, Arthur Burnett
3:50 SEMI-LIVE/SURGICAL TECHNIQUES: ENDOUROLOGY
Surgeons: Sri Sivalingam, Bodo Knudsen

26
Friday, May 13, 2022
Moderated Poster Session 1
BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY I
Room 228 @ Ernest N. Morial Convention Center
Moderators: Dean Elterman, Bradley Gill & James Forde
ABSTRACT
NUMBER TITLE
MP01-01 EXIME® URETHRAL STENT IMPLANTATION
(EUSI) AS INITIAL TREATMENT FOR
PATIENTS PRESENTING WITH ACUTE
URINARY RETENTION (AUR) FOR THE FIRST
TIME AS A RESULT OF BPH
Nordine Amara*, Leffrinckoucke, France, Tarek Al
Youssef, Jordan Massa, Elias Elkhouri, Dunker-
que, France, Belur Patel, Temple, TX
MP01-02 THE “BUTTERFLY” TRANSURETHRAL
RETRACTION DEVICE FOR BPH – OVER 1
YEAR FOLLOW UP
Ran Katz*, Muhamad Abu Ahmed, Ali Safadi,
Safed, Israel, Shmuel Roizman, Amnon Zisman,
Rishon Lezion, Israel, Maharan Kabha, Yoram
Dekel, Haifa, Israel, Jack Baniel, Shachar Aharo-
ni, Petach Tikva, Israel
MP01-03 TRANSURETHRAL ULTRASOUND ABLATION
FOR BENIGN PROSTATIC HYPERPLASIA:
THREE-MONTH CLINICAL OUTCOMES OF A
PHASE 1-2 STUDY
Mikael Anttinen*, Antti Viitala, Turku, Finland,
Pouya Doerwald, Hamburg, Germany, Pietari
Mäkelä, Pekka Taimen, Roberto Blanco Sequei-
ros, Peter Boström, Turku, Finland
MP01-04 LONG-TERM GROSS HEMATURIA
IMPROVEMENTS AFTER PROSTATIC ARTERY
EMBOLIZATION: COMPARING RESULTS IN
GLAND VOLUMES OF ≤80ML VERSUS >80ML
Saumik Rahman, Taylor Powell, Lawrence Staib,
Raj Ayyagari*, New Haven, CT
MP01-05 PROSTATIC ARTERY EMBOLIZATION
COMPARED TO TRANS-URETHRAL
RESECTION OF THE PROSTATE AND
PROSTATIC URETHRAL LIFT: A REAL-
WORLD POPULATION-BASED STUDY
Brendan L. Raizenne*, Montréal, Canada, Xinyan
Zheng, New York, NY, Kussil Oumedjbeur, Mon-
treal, Canada, Jialin Mao, New York, NY, Kevin C.
Zorn, Montréal, Canada, Dean Elterman, Toronto,
Canada, Naeem Bhojani, Montréal, Canada,
Art Sedrakyan, Bilal Chughtai, New York, NY
MP01-06 OFFICE BASED TRANSPERINEAL LASER
ABLATION FOR BENIGN PROSTATIC
HYPERPLASIA: 3 & 6 MONTHS OUTCOMES.
Luna Eusebio*, Luis Avila, Alberto Lopez-Prieto,
Edward Gheiler, Ariel Kaufman, David Cohen,
Fernando Bianco, Miami, FL
MP01-07 FACTORS ASSOCIATED WITH USE OF
PROSTATIC URETHRAL LIFT (PUL)
Samantha L. Thorogood*, Tenny R. Zhang,
Christina Sze, Gina DeMeo, Mary O. Strasser,
Richard K. Lee, Bilal Chughtai, Alexis Te,
Jim C. Hu, New York, NY
*Presenting author
7:00 am – 8:15 am
ABSTRACT
NUMBER TITLE
FRIDAY
MP01-08 CONVECTIVE WATER VAPOR THERMAL
THERAPY (CWVTT) IMPROVES NOCTURIA
AND SUBJECTIVE SLEEP QUALITY
Aya Bsatee*, Gaurav Pahouja, Michael Felice,
Hiten D. Patel, Kevin T. McVary, Maywood, IL
MP01-09 RISK FACTORS FOR A DELAYED
IMPROVEMENT IN LOWER URINARY TRACT
SYMPTOMS FOLLOWING CONVECTIVE
WATER VAPOR THERMAL THERAPY
Sarang Janakiraman*, Michael Felice, Aya Bsatee,
Gaurav Pahouja, Kevin T. McVary, Maywood, IL
-
MP01-10 EFFICACY OF REZUM WATER VAPOR THERMAL
THERAPY FOR SURGICAL MANAGEMENT
OF BENIGN PROSTATIC HYPERPLASIA IN
PROSTATES OVER 80 GRAMS
Adam M. Jenks*, Tiffany Damm, Robert Petros-
sian, Kristin Delfino, Danuta Dynda, Nicholas
Tadros, Springfield, IL
MP01-11 LARGE, MULTI-CENTER, PROSPECTIVE
-
REGISTRY OF REZUM WATER VAPOR
THERAPY BENIGN PROSTATIC
ENLARGEMENT
Dean Elterman*, Toronto, Canada, Naeem Bho-
jani, Montreal, Canada, Bilal Chughtai, New York,
NY, Kevin C Zorn, Montreal, Canada
MP01-12 PHARMACOTHERAPY VS MINIMALLY
INVASIVE THERAPIES AS INITIAL THERAPY
FOR PATIENTS WITH BENIGN PROSTATE
HYPERPLASIA: A MICROSIMULATION MODEL
Yeva Sahakyan, Aysegul Erman, Toronto, Canada,
Naeem Bhojani, Montreal, Canada, Bilal Chughtai,
New York, NY, Kevin C Zorn, Montreal, Canada,
Beate Sander, Dean Elterman*, Toronto, Canada
MP01-13 COMPARISON OF TRADITIONAL OUTCOME
MEASURES AND SELF-ASSESSED GOAL
ACHIEVEMENT IN PATIENTS TREATED
SURGICALLY FOR BENIGN PROSTATIC
HYPERPLASIA
Manolis Pratsinis*, Gautier Müllhaupt, Sabine
Güsewell, Patrick Betschart, Valentin Zumstein,
Daniel Engeler, Hans-Peter Schmid, St. Gallen,
Switzerland, Dominik Abt, Biel, Switzerland
MP01-14 ASSOCIATION BETWEEN INDUSTRY
PAYMENTS AND PUBLISHED POSITION ON
USE OF DEVICES FOR THE TREATMENT OF
LOWER URINARY TRACT SYMPTOMS
Armaan Singh*, Sarah Faris, Piyush Agarwal,
Luke Reynolds, Parth Modi, Chicago, IL
MP01-15 SEDATION AS AN ALTERNATIVE
ANESTHETIC TECHNIQUE FOR FRAGILE
PATIENTS IN TRANSURETHRAL RESECTION
OF THE PROSTATE
Christian Ayoub*, Nassib Abou Heidar, Adnan El-Ach-
kar, Hani Tamim, Albert El Hajj, Beirut, Lebanon
27
 MP01-16 FUNCTIONAL AND SURGICAL OUTCOMES MP01-19 MINIMALLY INVASIVE AND ENDOSCOPIC
OF AQUABLATION IN ELDERLY MEN THERAPIES FOR BENIGN PROSTATIC
Brendan L. Raizenne*, Montréal, Canada, David HYPERPLASIA: HEAD-TO-HEAD
Bouhadana, Montreal, Canada, Kevin C. Zorn, COMPARISON OF SHORT-TERM OUTCOMES
Montréal, Canada, Bilal Chughtai, New York, NY, BY NETWORK META-ANALYSIS
Dean Elterman, Toronto, Canada, Naeem Bhojani, Linda Hamed, Jamaal Jackson*, Ephrem Olweny,
Montréal, Canada Chicago, IL
MP01-17 IMPACT OF ASA ON POST-OPERATIVE MP01-20 A RANDOMIZED CONTROLLED TRIAL FOR
HOLEP OUTCOMES AND COMPLICATIONS OPIOID-LIMITING PAIN CONTROL AFTER
Mary Soyster*, Indianapolis, IN, Deepak Agarwal, TRANSURETHRAL RESECTION OF THE
Minneapolis, MN, Austen Slade, Erica Sahm, Tim PROSTATE: MULTIMODAL PAIN REGIMEN
Large, Marcelino Rivera, Indianapolis, IN WITH EDUCATIONAL INTERVENTION
VERSUS STANDARD OF CARE
MP01-18 GREENLIGHT PHOTOVAPORIZATION OF
Adam Daily*, Seattle, WA, Ryan Donahue,
THE PROSTATE IN HIGH-MEDICAL-RISK
San Antonio, TX, Andrew Stamm, Silverdale,
PATIENTS: AN ANALYSIS OF THE GLOBAL
WA, Paul Kozlowski, Christopher Porter, Fred
GREENLIGHT GROUP (GGG) DATABASE
Govier, Nicholas Cowan, Alvaro Lucioni, Chris-
David-Dan Nguyen, Claudia Deyirmendjian*, Kyle
tian Kuhr, Kathleen Kobashi, Seattle, WA, Neil
Law, Naeem Bhojani, Montreal, Canada, Dean
Hanson, Minneapolis, MN, John Corman, Una
Elterman, Toronto, Canada, Bilal Chughtai, New
Lee, Seattle, WA
York, NY, Franck Bruyere, Centre Val de Loire,
France, Luca Cindolo, Giovanni Ferrari, Modena, APPROVED FOR AMA PRA CATEGORY 1.25

Italy, Carlos Vasquez-Lastra, Mexico City, Mexico, CREDITSTM
Tiago Borelli-Bovo, Sao Paulo, Brazil, Edgardo
Becher, Buenos Aires, Argentina, Hannes Cash,
Magdeburg, Germany, Maximillian Reimann,
Berlin, Germany, Enrique Rijo, Barcelona, Spain,
Vincent Misrai, Toulouse, France, Kevin Zorn,
Montreal, Canada

Friday, May 13, 2022 7:00 am – 8:15 am

Moderated Poster Session 2

INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: KIDNEY & BLADDER I
Room 225 @ Ernest N. Morial Convention Center
Moderators: Christina Ching, Joel Teichman & Michael Liss

ABSTRACT
NUMBER TITLE
MP02-01 COMPARATIVE TRANSCRIPTOMICS
SUGGESTS CONVERGENT AND DIVERGENT
PROPERTIES OF UROPATHOGENIC
ESCHERICHIA COLI
Jacob Hogins*, Richardson, TX, Philippe Zim-
mern, Dallas, TX, Larry Reitzer, Richardson, TX SUGGEST ALTERNATE ENTRY MECHANISMS
MP02-02 COMPARISON OF UROPATHOGENIC AND
NON-PATHOGENIC ESCHERICHIA COLI
GROWTH CHARACTERISTICS IN THE
PRESENCE OF AN ANTIMICROBIAL PEPTIDE
AND LIMITING NUTRIENT AVAILABILITY
Samuel Kusin*, Dallas, TX, Jacob Hogins,
Richardson, TX, Philippe Zimmern, Dallas, TX,
Larry Reitzer, Richardson, TX Wu, Ellen Shapiro*, New YORK, NY
MP02-03 GENETIC ADAPTATIONS OF ENTEROCOCCUS
FAECALIS TO FITNESS AND PERSISTENCE
IN THE URINARY TRACT
Belle Sharon*, Dennise Palacious Araya,
Moutusee Islam, Richardson, TX,
Philippe Zimmern, Dallas, TX, Kelli Palmer,
Nicole De Nisco, Richardson, TX
ABSTRACT
NUMBER TITLE
MP02-04 INVASION AND ASSESSMENT OF
INTRACELLULAR BACTERIAL COLONY (IBC)
FORMATION IN UROEPITHELIAL CELLS
BY UROPATHOGENIC E. COLI (UPEC) OF
DIFFERENT PHYLOGENETIC GROUPS
Jacob Hogins*, Richardson, TX, Philippe Zim-
mern, Dallas, TX, Larry Reitzer, Richardson, TX
MP02-05 CDKN2A REGULATES OXIDATIVE STRESS
AND AUTOPHAGY IN UROTHELIAL
DEFENSE AGAINST URINARY TRACT
INFECTION
Yan Liu, Hongying Huang, Herbert Lepor, Xue-Ru
MP02-06 URINARY TRACT INFECTION ON SOCIAL
MEDIA: EXAMINING YOUTUBE CONTENT
AS A SOURCE OF PATIENT EDUCATIONAL
INFORMATION
Zhenyue Huang*, Rosen Jeong, Edwin Lee,
Heng Ruan, Tal Meir Cohen, Jason Kim, Stony
Brook, NY

28
 MP02-07 THE IMPACT OF COVID-19 AND TELEMEDICINE
ON EMPIRIC UTI TREATMENT IN WOMEN
Madeline Epsten*, Jennifer Ferraro, Fareesa
Khan, Cynthia Brincat, Kristin Jacobs, Chicago, IL
MP02-08 RAPID DETECTION OF BACTERIAL
UTIS VIA REPORTER PHAGE-BASED
BIOLUMINESCENCE ASSAY
Lorenz Leitner*, Jiemin Du, Susanne Meile,
MP02-15 IMPACT OF MV140 ON PATIENT RELATED
BURDEN OF DISEASE ASSOCIATED WITH
THE MANAGEMENT OF RECURRENT
URINARY TRACT INFECTIONS (RUTI)
J. Curtis Nickel*, Kingston, Canada, Stephen
Foley, Reading, United Kingdom, Miguel Casa-
novas, Raquel Caballero, Madrid, Spain, María
Fernanda Lorenzo-Gómez, Salamanca, Spain

FRIDAY
Shawna McCallin, Vera Neumeier, Thomas M. MP02-16 LONG-TERM OUTCOMES AFTER
Kessler, Martin J. Loessner, Samuel Kilcher, ELECTROFULGURATION FOR ANTIBIOTIC-
Matthew Dunne, Zürich, Switzerland REFRACTORY RECURRENT URINARY TRACT
INFECTIONS
MP02-09 A NOVEL PROPIDIUM MONOAZIDE-BASED
Shivani Gaitonde*, Alana L. Christie, Philippe E.
PCR ASSAY CAN DETECT VIABLE BUT NON-
Zimmern, Dallas, TX
CULTURABLE BACTERIA IN URINE AFTER
ANTIBIOTIC TREATMENT OF UTI MP02-17 MOLECULAR ANALYSIS OF
Albert Lee, Olivia Lamanna, Kenji Ishida, Elaise CETYLPYRIDINIUM CHLORIDE FOR USE IN
Hill, Michael Hsieh*, Washington, DC BLADDER INSTILLATION THERAPY IN THE
ADVANCED MANAGEMENT OF RECURRENT
MP02-10 GENUS-LEVEL IDENTIFICATION OF
URINARY TRACT INFECTIONS
BLADDER-RESIDENT BACTERIA ASSOCIATED
Samuel Chang*, Namrata Sawant, Richardson,
WITH RECURRENT URINARY TRACT
TX, William Warner, Punta Gorda, FL, Philippe
INFECTION IN POST-MENOPAUSAL WOMEN
Zimmern, Dallas, TX, Nicole De Nisco,
BY FLUORESCENCE IN-SITU HYBRIDIZATION
Richardson, TX
Parker R.M. Kenee*, Dallas, TX, Jashkaran
Gadhvi, Fatima Khan, Richardson, TX, Alana L. MP02-18 COMPARING COSTS ASSOCIATED
Christie, Dallas, TX, Nicole J. De Nisco, Richard- WITH MANAGEMENT OF ANTIBIOTIC-
son, TX, Philippe E. Zimmern, Dallas, TX REFRACTORY RECURRENT URINARY
TRACT INFECTIONS FOR ONE YEAR PRE-
MP02-11 CHARACTERIZATION OF COMPLEMENT
AND POST-ELECTROFULGURATION OF
RESISTANCE FACTOR TRAT ENCODED
TRIGONITIS
IN DRUG RESISTANCE PLASMIDS OF
Shivani Gaitonde*, Jacob A. Stevens, Joseph J.
UROPATHOGENIC ESCHERICHIA COLI
Crivelli, Philippe E. Zimmern, Dallas, TX
Chae Hee Lim*, Aryana Bhati, Katelyn Lott,
Jazmyn Whitfield, John Land, Tatyana Sysoeva, MP02-19 PROSPECTIVE RANDOMIZED CLINICAL
Huntsville, AL TRIAL TO ASSESS THE UTILITY OF
URINALYSIS PRIOR TO OFFICE UROLOGY
MP02-12 PRO AND ANTI-INFLAMMATORY CYTOKINES
PROCEDURES
ARE DIFFERENTIALLY ABUNDANT DURING
Alexa Rose*, Aleah Warden, Sara Best, Tudor
RECURRENT URINARY TRACT INFECTIONS
Borza, Vani Tadakala, E. Jason Abel, Daniel D.
IN POSTMENOPAUSAL WOMEN
Shapiro, David F. Jarrard, Kyle A. Richards,
Jessica Komarovsky*, Tahmineh Ebrahimzadeh,
Madison, WI
Richardson, TX, Philippe Zimmern, Dallas, TX,
Nicole De Nisco, Richardson, TX MP02-20 DECREASED RISK OF URINARY INFECTION
IS ASSOCIATED WITH SINGLE USE
MP02-13 IS CYSTOSCOPY INDICATED IN THE
URETEROSCOPES
EVALUATION OF FEMALE PATIENTS WITH
Rei Unno*, Xavier Cortez, Leslie Charondo, Kevin
RECURRENT URINARY TRACT INFECTIONS?
Chang, Nizar Hakam, Carter Chan, Heiko Yang,
Tanner Corse, Linda Dayan, Hunter Hasley*,
Gregory Hosier, Fadl Hamouche, David Bayne,
Nutley, NJ, Simon Gelman, Hackensack, NJ,
Marshall Stoller, Thomas Chi, San Francisco, CA
Debra Fromer, Nutley, NJ
APPROVED FOR AMA PRA CATEGORY 1.25
MP02-14 RE-IMAGINING URINARY TRACT INFECTION
CREDITSTM
IN WOMEN: CLUES FROM THE UROBIOME
OF ASYMPTOMATIC HEALTHY CONTROLS
VS VACCINATED WOMEN WITH RECURRENT
URINARY TRACT INFECTION
J. Curtis Nickel*, R. Christopher Doiron, Ker-
ri-Lynn Kelly, Kingston, Canada, Nicolle Diaz,
Caleb D. Phillips, Craig D. Tipton, Lubbock, TX

*Presenting author 29
Friday, May 13, 2022
Moderated Poster Session 3
BLADDER CANCER: INVASIVE I
Room 222 @ Ernest N. Morial Convention Center
Moderators: Siamak Daneshmand, S. Machele Donat & Stanley Malkowicz
ABSTRACT
NUMBER TITLE
MP03-01 ROBOT-ASSISTED RADICAL CYSTECTOMY
WITH EXTRACORPOREAL URINARY
DIVERSION DOES NOT INCREASE
URETEROENTERIC STRICTURE RATE:
OUTCOMES FROM A RANDOMIZED TRIAL
COMPARING OPEN VERSUS ROBOTIC
CYSTECTOMY
Chun Huang, Moose Jaw, Canada, Melissa
Assel, Benjamin Beech*, Nicole Benfante, Daniel
Sjoberg, Jonathan Coleman, Guido Dalbagni,
Harry Herr, S. Machele Donat, Vincent Laudone,
Andrew Vickers, Bernard Bochner, Alvin Goh,
New York, NY
MP03-02 ASSOCIATION BETWEEN VISIBLY
COMPLETE TRANSURETHRAL RESECTION
OF BLADDER TUMOR AND PATHOLOGIC
DOWNSTAGING FOLLOWING NEOADJUVANT
CHEMOTHERAPY AND RADICAL
CYSTECTOMY FOR MUSCLE-INVASIVE
BLADDER CANCER
Bryce Baird*, Jacksonville, FL, Augustus
Anderson, New Orleans, LA, Christian Ericson,
Gianpiero Carames, Paul Young, Timothy Lyon,
Jacksonville, FL
MP03-03 TARGETING V1/CHASE TO OVERCOME
GEMCITABINE RESISTANCE
Semih Sarcan*, Lübeck, Germany, Daley S.
Morera, Augusta, GA, Marie C. Hupe, Lübeck,
Germany, Karina Aguilar, Anuj Sharma, Sung
Alexander, Joseph McDaniels, Huabin Zhu,
Augusta, GA, Martin Hennig, Lübeck, Germany,
Martha Terris, Augusta, GA, Axel S. Merse-
burger, Lübeck, Germany, Vinata B. Lokeshwar,
Augusta, GA
MP03-04 ANALYSIS OF COMPLICATIONS AFTER
ROBOT-ASSISTED RADICAL CYSTECTOMY
BETWEEN 2005-2020: RESULTS FROM THE
INTERNATIONAL ROBOTIC CYSTECTOMY
CONSORTIUM
Holly Houenstein, Umar Iqbal, Zhe Jing, Ahmed
S. Elsayed, Yousuf Ramahi*, Buffalo, NY, Michael
Stöckle, Homburg, Germany, Carl Wijburg,
Arnhem, Netherlands, Abolfazl Hosseini, Peter
Wiklund, Solna, Sweden, Eric Kim, St. Louis, MO,
Jihad Kaouk, Cleveland, OH, Prokar Dasgupta,
Mohammed S. Khan, London, United Kingdom,
Andrew A. Wagner, Boston, MA, Johar R. Syed,
James O. Peabody, Detroit, MI, Ketan K. Badani,
Lee Richstone, New York, NY, Alexandre Mottrie,
Aalst, Belgium, Thomas J. Maatman, Wyoming,
MI, Derya Balbay, Istanbul, Turkey, Juan P. Redor-
ta, Barcelona, Spain, Koon Ho Rha, Seoul, Korea,
Republic of, Franco Gaboardi, Milan, Italy, Morgan
Roupret, Paris, France, Ahmed Aboumohamed,
Bronx, NY, Ahmed A. Hussein, Khurshid A. Guru,
Buffalo, NY
30
7:00 am – 8:15 am
ABSTRACT
NUMBER TITLE
MP03-05 HOW DOES THE TYPE OF URINARY
DIVERSION AFFECT HEALTH RELATED
QUALITY OF LIFE (HRQOL) IN THE
COURSE OF FOUR YEARS AFTER RADICAL
CYSTECTOMY? - A PROPENSITY SCORE-
MATCHED ANALYSIS
Yannic Volz*, Lennert Eismann, Benedikt Ebner,
Paulo Pfitzinger, Jan-Friedrich Jokisch, Gerald
Schulz, Thilo Westhofen, Alexander Karl, Boris
Schlenker, Christian Stief, Alexander Kretschmer,
Munich, Germany
MP03-06 PROSPECTIVE STUDY ON FDG-PET/
CT FOR ON-TREATMENT ASSESSMENT
OF RESPONSE TO NEOADJUVANT OR
INDUCTION CHEMOTHERAPY IN INVASIVE
BLADDER CANCER
Sarah Einerhand*, Charlotte Voskuilen, Elies
Fransen van de Putte, Maarten Donswijk, Anne-
marie Bruining, Michiel Van der Heijden, Laura
Mertens, Kees Hendricksen, Erik Vegt, Bas van
Rhijn, Amsterdam, Netherlands
MP03-07 IMPACT OF PRIOR INTRAVESICAL BACILLUS
CALMETTE-GUERIN THERAPY FOR NON-
MUSCLE INVASIVE BLADDER CANCER ON
THE EFFICACY OF PEMBROLIZUMAB IN
PATIENTS WITH METASTATIC UROTHELIAL
CARCINOMA
Rikiya Taoka*, Kagawa, Japan, Takashi Kobayas-
hi, Yu Hidaka, Hiroyasu Abe, Satoshi Morita,
Osamu Ogawa, Kyoto, Japan, Hiroyuki Nishi-
yama, Tsukuba, Japan, Hiroshi Kitamura, Toyama,
Japan, Mikio Sugimoto, Kagawa, Japan
MP03-08 ASSOCIATION BETWEEN URETERAL
CLAMPING TIME AND ACUTE KIDNEY
INJURY DURING ROBOT-ASSISTED RADICAL
CYSTECTOMY
Yudai Ishiyama*, Tsunenori Kondo,
Hiroki Ishihara, Arakawa, Japan,
Kazuhiko Yoshida, Junpei Iizuka, Kazunari
Tanabe, Toshio Takagi, Tokyo, Japan
MP03-09 IMPACT OF VARIANT HISTOLOGY AND
IMMUNOHISTOCHEMISTRY ON RESPONSE
TO ADJUVANT CHEMOTHERAPY IN
UROTHELIAL MUSCLE-INVASIVE BLADDER
CANCER
Florestan Koll*, Luis Kluth, Felix Chun, Severin
Banek, Katrin Bankov, Jens Köllermann, Henning
Reis, Peter Wild, Frankfurt am Main, Germany
 MP03-10 LIFE EXPECTANCY IN METASTATIC
UROTHELIAL BLADDER CANCER PATIENTS
ACCORDING TO RACE/ETHNICITY
Francesco Chierigo*, Genova, Italy, Christoph
Würnschimmel, Hamburg, Germany, Rocco
Simone Flammia, Rome, Italy, Benedikt Horle-
mann, Montreal, Canada, Gabriele Sorce, Milan,
Italy, Benedikt Hoeh, Frankfurt, Germany, Zhe
Tian, Fred Saad, Montreal, Canada, Markus
Graefen, Hamburg, Germany, Michele Gallucci,
Rome, Italy, Alberto Briganti, Francesco Montorsi,
Milan, Italy, Felix K.H. Chun, Frankfurt, Germany,
Shahrokh F. Shariat, Vienna, Austria, Guglielmo
Mantica, Maro Borghesi, Nazareno Suardi, Carlo
Terrone, Genova, Italy, Pierre I Karakiewicz,
Montreal, Canada
MP03-11 HIGH EXPRESSION OF AHNAK2 IS
ASSOCIATED WITH BIOLOGICALLY
AGGRESSIVE FINDINGS AND POOR
SURVIVAL IN PATIENTS TREATED WITH
RADICAL CYSTECTOMY
Dai Koguchi*, Kazumasa Matsumoto, Yuriko
Shimizu, Noriyuki Amano, Soichiro Shimura,
Masaomi Ikeda, Hideyasu Tsumura, Ken Ichi
Tabata, Yuichi Sato, Masatsugu Iwamura,
Sagamihara, Japan AFTER PEMBROLIZUMAB USAGE: A
MP03-12 ASSOCIATION OF USE OF POTASSIUM
COMPETITIVE ACID BLOCKERS AND
EFFECTIVENESS OF PEMBROLIZUMAB IN
PATIENTS WITH METASTATIC UROTHELIAL
CARCINOMA
Wataru Fukuokaya*, Takahiro Kimura, Tokyo,
Japan, Kazumasa Komura, Taizo Uchimoto,
Kazuki Nishimura, Osaka, Japan, Yu Oyama,
Hirokazu Abe, Chiba, Japan, Haruhito Azuma,
Osaka, Japan, Jun Miki, Shin Egawa, Tokyo,
Japan RELATED ADVERSE EVENTS AND
MP03-13 IDENTIFICATION OF MUSCLE-INVASION
STATUS IN BLADDER CANCER PATIENTS
USING NATURAL LANGUAGE PROCESSING
AND MACHINE LEARNING
Ruixin Yang, Di Zhu, Lauren Howarda, Amanda
De Hoedt, Durham, NC, Zachary Klaassen, Au-
gusta, GA, Stephen Freedland, Los Angeles, CA,
Stephen Williams, Galveston, TX, Ruixin Yang*,
Durham, NC
MP03-14 NEOADJUVANT VERSUS ADJUVANT
CHEMOTHERAPY IN BLADDER CANCER: A
NATIONWIDE COHORT STUDY
Se Young Choi, Taekyu Huh, Joonhee Gook, Jae
Hun Shim*, Jong Hyun Tae, Byung Hoon Chi, Jin
Wook Kim, In Ho Chang, Tae-Hyoung Kim, Soon
Chul Myung, Seoul, Korea, Republic of
*Presenting author
MP03-15 PRIMARY VERSUS SECONDARY MUSCLE
INVASIVE BLADDER CANCER: COMPARING
THE PATHOLOGIC AND ONCOLOGIC
OUTCOMES BETWEEN BOTH FORMS
OF MUSCLE INVASIVE DISEASE WHEN
TREATED WITH STANDARD OF CARE
Tarik Benidir*, Zaeem Lone, Ao Zhang, Carlos
Munoz-Lopez, Pranay Hegde, Kevin Fung, Jesse
FRIDAY
Fajnzylber, Eric Klein, Mohammed Eltemamy, Jihad
Kaouk, Georges Pascal-Haber, Nima Almassi,
Christopher Weight, Byron Lee, Cleveland, OH
MP03-16 FEASIBILITY, USABILITY AND UTILITY OF
A REMOTE SYMPTOM ASSESSMENT TOOL
AFTER RADICAL CYSTECTOMY
Heather Huelster*, Logan Zemp, Brian Gonzalez,
Heather Jim, Michael Poch, L Robert Gore, Scott
Gilbert, Tampa, FL
MP03-17 PATIENT, PHYSICIAN, HOSPITAL FACTORS
ASSOCIATED WITH READMISSION AFTER
RADICAL CYSTECTOMY
Kassem Faraj*, Lanyu Mi, Mark Tyson, Phoenix, AZ
MP03-18 CHRONOLOGICAL TRANSITION IN OUTCOME
OF SECOND-LINE TREATMENT IN PATIENTS
WITH METASTATIC UROTHELIAL CANCER
MULTICENTER ANALYSIS
Teruki Isobe*, Taku Naiki, Yosuke Sugiyama,
Aya Naiki, Takashi Nagai, Toshiki Etani, Satoshi
Nozaki, Keitaro Iida, Yusuke Noda, Nobuhiko
Shimizu, Nami Tomiyama, Nagoya City, Japan,
Rika Banno, Konan City, Japan, Hiroki Kubota,
Yatomi City, Japan, Shuzo Hamamoto, Ryosuke
Ando, Noriyasu Kawai, Takahiro Yasui, Nagoya
City, Japan
MP03-19 ASSOCIATION BETWEEN IMMUNE-
SURVIVAL OF PATIENTS WITH METASTATIC
UROTHELIAL CARCINOMA TREATED WITH
PEMBROLIZUMAB
Kazutaka Nakamura*, Fukushima, Japan, Takagi
Toshio, Tokyo, Japan, Yuki Nemoto, Saitama,
Japan, Yudai Ishiyama, Hiroki Ishihara, Hideka-
zu Tachibana, Hironori Fukuda, Tokyo, Japan,
Hiroaki Shinmura, Fukushima, Japan, Yasunobu
Hashimoto, Saitama, Japan, Tsunenori Kondo,
Kazuhiko Yoshida, Junpei Iizuka, Hideki Ishida,
Kazunari Tanabe, Tokyo, Japan
MP03-20 CONTEMPORARY ANALYSIS OF
CYSTECTOMY COMPLICATIONS
Kevin Chua*, Hiren Patel, Arnav Srivastava, Sai
Krishnaraya Doppalapudi, Benjamin Lichtbroun,
Sammy Elsamra, Eric Singer, Thomas Jang,
Saum Ghodoussipour, New Brunswick, NJ
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
31
Friday, May 13, 2022 7:00 am – 9:00 am

Podium Session 1
KIDNEY CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY I
Room 252 @ Ernest N. Morial Convention Center
Moderator: Peter Clark & Ari Hakimi

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
7:00 PD01-01 VHL-MEDIATED UBIQUITINATION OF THE 8:10 PD01-08 COMPARISON OF MUTATIONAL PROFILE
KINASE MPS1 REGULATES THE MITOTIC OF PRIMARY VERSUS ORGAN-SPECIFIC
CHECKPOINT IN CLEAR CELL RENAL CELL METASTATIC TUMORS IN CLEAR CELL
CARCINOMA RENAL CELL CARCINOMA
Mark Woodford*, Sarah Backe, Rebecca Sager, Sari Khaleel*, New York, NY, Renzo DiNatale,
Oleg Shapiro, Imad Nsouli, Laura Wengert, Seattle, WA, Benjin Freeman, Ritesh Kotecha,
Gennady Bratslavsky, Dimitra Bourboulia, Robert Motzer, Paul Russo, Jonathan Coleman,
Mehdi Mollapour, Syracuse, NY Eduard Reznik, Ari Hakimi, New York, NY
7:10 PD01-02 CITRATE TRANSPORTER – A POTENTIAL 8:20 PD01-09 PROTEOGENOMIC AND CLINICAL
TUMOR SUPPRESSOR AND BIOMARKER IN IMPLICATIONS OF RECURRENT SPLICE
RENAL CELL CARCINOMA VARIANTS IN CLEAR CELL RENAL CELL
Andre Jordan*, Metairie, LA, Huabin Zhu, Augus- CARCINOMA
ta, GA, Soum Lokeshwar, New Haven, CT, Semih Andrew Chang*, Paul Stewart, Nicholas Cha-
Sarcan, Karina Aguilar, Anuj Sharma, Martha kiryan, Alex Soupir, Yijun Tian, Dongliang Du,
Terris, Vinata Lokeshwar, Augusta, GA Jie Teer, Youngchul Kim, Philippe Spiess, Jad
Chahoud, Yonghong Zhang, John Koomen,
7:20 PD01-03 ALANINE–SERINE–CYSTEINE TRANSPORTER
Anders Berglund, Timothy Robinson, Liang Wang,
2 IN GLUTINE METABOLISM IS A
Brandon Manley, Tampa, FL
THERAPEUTIC TARGET FOR RENAL CELL
CARCINOMA 8:30 PD01-10 WHOLE TRANSCRIPTOME SEQUENCING
Yoshinari Muto*, Makoto Sumitomo, Masanobu OF CLEAR CELL RENAL CELL CARCINOMA
Saruta, Atsuhiko Yoshizawa, Kiyoshi Takahara, REVEALS A MULTIGENE EXPRESSION
Ryoichi Shiroki, Toyoake, Japan PROGNOSTIC SIGNATURE
Srinivas Nallandhighal, Rohit Mehra, Marcin
7:30 PD01-04 GLUTINE BLOCKADE INDUCES CELLULAR
Cieslik, y Kasputis, Brittney Cotta, Todd Morgan,
SENESCENCE IN RENAL CELL CARCINOMA
Simpa Sali*, Ann Arbor, MI
BY TARGETING SLC1A5
Issei Kawaki*, Hirofumi Yosino, Wataru Fukumo- 8:40 PD01-11 CHARACTERIZATION OF WILMS TUMOR
to, Motoki Tai, Shunsuke Okura, Hideki Enokida, AND HUMAN FETAL KIDNEY USING SPATIAL
kagoshima, Japan TRANSCRIPTOMICS
Astgik Petrosyan, Valentina Villani, Paola Aguiari,
7:40 PD01-05 MIR-182-5P INHIBITS THE TUMORIGENESIS
Matthew Thornton, Zhou Shengmei, Brendan
OF CLEAR CELL RENAL CELL CARCINOMA
Grubbs, Marie Csete, Roger De Filippo, Kevin
BY REPRESSING UBE2T
Lemley, Sargis Sedrakyan, Stefano Da Sacco,
Wu Yucai*, Gong Yanqing, Li Xuesong, Beijing,
Laura Perin*, Los Angeles, CA
China, People’s Republic of, Zhou Liqun, Beijing,
China, People’s Republic of 8:50 PD01-12 PAN-CANCER CHARACTERIZATION OF THE
TUMOR MICROENVIRONMENT REVEALS
7:50 PD01-06 GCN5L1 REGULATES MITOCHONDRIAL
STROMA AND IMMUNE ENRICHED SUBTYPE
ACETYLATION, LIPID ACCUMULATION AND
WITH DISTINCT MOLECULAR, CLINICAL,
CELL GROWTH IN VHL-DEFICIENT CLEAR
AND PROGNOSTIC FEATURES IN DIFFERENT
CELL RENAL CELL CARCINOMA
GENITOURINARY CANCERS
Bradley Webster*, Allen Seylani, Michael Danesh-
Mark Farha*, Brittney Cotta, Srinivas Nallan-
var, Alexis Rompre-Brodeur, Raprasad Srinivasan,
dhighal, Kevin Hu, Ann Arbor, MI, Steven Golden-
Bethesda, MD
thal, Columbus, OH, Aaron Udager, Simpa Sali,
8:00 PD01-07 THE TUMOR SUPPRESSOR FLCN Ann Arbor, MI
REGULATES THE WARBURG EFFECT

APPROVED FOR AMA PRA CATEGORY 2.0
IN RENAL CELL CARCINOMA
CREDITSTM
THROUGH INHIBITION OF LACTATE
DEHYDROGENASE-A
Mark R Woodford, Rebecca A Sager*, Sarah J
Backe, Fiza Hashmi, Priyanka Kancherla, Alexan-
dr Pinkhasov, Syracuse, NY, W Marston Linehan,
Bethesda, MD, Dimitra Bourboulia, Gennady
Bratslavsky, Mehdi Mollapour, Syracuse, NY

32
Friday, May 13, 2022 7:00 am – 9:00 am

Podium Session 2
PEDIATRIC UROLOGY: NEUROGENIC BLADDER, RECONSTRUCTION & DSD
Room 255 @ Ernest N. Morial Convention Center
Moderator: Courtney Shepard Streur

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE

7:00 PD02-01 PRENATAL CLOSURE OF
MYELOMENINGOCELE IS ASSOCIATED WITH
HIGHER RISK FOR EARLY SECONDARY
SPINAL CORD TETHERING
Hsin-Hsiao Wang*, Duncan Morhardt, Benjamin
Warf, Lawrence Karlin, Asal Hojjat, Shahram
Khoshbin, Erin Mcnamara, Carlos Estrada,
Stuart Bauer, Boston, MA
7:10 PD02-02 CHARACTERIZING CLINICAL HETEROGENEITY
IN HOSTILE BLADDER CRITERIA AMONG
NEUROGENIC BLADDER CHILDREN
Ranveer Vasdev*, Minneapolis, MN, Kenneth
Softness, Rachel Saunders, Carlos Estrada, Jr.,
Scott Wang, Boston, MA Yenokyan, John Gearhart, Baltimore, MD
7:20 PD02-03 THE UTILITY OF URODYNAMICS IN YOUNG
CHILDREN WITH SPINA BIFIDA
Ruthie Su*, Rocio Goodman, Jennika Finup,
Vinaya Bhatia, Ann Byrne, Walid Farhat, Shannon
Cannon, Madison, WI Joshua Roth*, Konrad Szymanski, Rosalia
7:30 PD02-04 VARIABILITY IN CYSTATIN C AND
CREATININE BASED EQUATIONS FOR
CHRONIC KIDNEY DISEASE STAGING IN
ADULT SPINA BIFIDA PATIENTS
Meera Ganesh*, Mitali Kini, David Chu, Stephanie
Kielb, Diana Bowen, Chicago, IL MI, Peter Lee, David Mauger, Hershey, PA, David
7:40 PD02-05 EFFICACY AND SAFETY OF VIBEGRON AS
ADJUVANT TREATMENT ON REFRACTORY
NEUROGENIC BLADDER DYSFUNCTION IN
CHILDREN WITH SPINA BIFIDA
Kazuyuki Nishinaka*, Naoya Masumori, Sapporo,
Japan Ashley W. Johnston*, Indianapolis, IN, Mimi S.
7:50 PD02-06 COMPARISON OF LONG TERM ADVERSE
EVENTS AND RENAL OUTCOMES BETWEEN
ILEOVESICOSTOMY AND CONTINENT
BLADDER AUGMENTATIONS AT A SINGLE
PEDIATRIC INSTITUTION
Viktor Flores*, Mikhael Matthew, Heidi Chen, Ben-
jamin Abelson, Abby S Taylor, Stacy T Tanaka,
Cyrus M Adams, Mark C Adams, John C Thomas,
John C Pope 4th, John W Brock 3rd, Douglass B
Clayton, Nashville, TN Lefkothea Karaviti, Paul F Austin, Houston, TX
FRIDAY
8:00 PD02-07 FINANCIAL TOXICITY OF SPINA BIFIDA:
INITIAL DEVELOPMENT OF A PATIENT-
REPORTED OUTCOME MEASURE
Leonid Aksenov*, Kevin Hobbs, Rebecca Fairch-
ild, Rohit Tejwani, John Wiener, Jonathan Routh,
Durham, NC
8:10 PD02-08 BLADDER CAPACITY AND GROWTH IN
CLASSIC BLADDER EXSTROPHY: A NOVEL
PREDICTIVE TOOL
Tamir Sholklapper*, Mahir Maruf, Jiafeng Zhu,
Jason Michaud, Mohammad Zaman, John Jay-
man, Roni Manyevitch, Rachel Davis, Wayland
Wu, Thomas Harris, Heather DiCarlo, Gayane
8:20 PD02-09 DECISIONAL REGRET IN ADULTS WITH
SPINA BIFIDA REGARDING SURGERIES
THEY HAD AS CHILDREN FOR NEUROGENIC
BLADDER
Misseri, Indianapolis, IN
8:30 PD02-10 CHANGES IN THE APPROACH OF SPU
MEMBERS TO DSD MANAGEMENT
Barry Kogan*, Albany, NY, Melissa Gardner, Ann
Arbor, MI, Kristina Suorsa-Johnson, Ann Arbor,
Sandberg, Ann Arbor, MI
8:40 PD02-11 WHEN AND HOW TO DISCLOSE GENITAL
SURGERY TO GIRLS WITH CAH?
EXPERIENCES AND PREFERENCES OF
WOMEN WITH CAH
Kim, Paul Kokorowski, Los Angeles, CA, Devon J.
Hensel, Indianapolis, IN, Patrice M. Yasuda, Los
Angeles, CA, Konrad M. Szymanski, on behalf of
Life with Congenital Adrenal Hyperplasia, Indian-
apolis, IN
8:50 PD02-12 THE RISK OF GONADAL MALIGNANCY IN
PATIENTS WITH ANDROGEN INSENSITIVITY
SYNDROME
Pratik Kanabur*, Soo Jeong Kim, Sagar Patel,
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM

*Presenting author 33
Friday, May 13, 2022
Podium Session 3
PROSTATE CANCER: EPIDEMIOLOGY & NATURAL HISTORY I
Room 245 @ Ernest N. Morial Convention Center
Moderator: Christopher Kane
ABSTRACT
TIME NUMBER TITLE
7:00 PD03-01 MRI AS FIRST INVESTIGATION IN MEN
WITH ELEVATED PSA. POPULATION-BASED
COHORT STUDY
David Robinsson*, Eksjö, Sweden, Hans Garmo,
Uppsala, Sweden, Delshad Nasrollah, Jönköping,
Sweden, Tiago Bonde Miranda, Malmö, Sweden,
Pär Stattin, Uppsala, Sweden
7:10 PD03-02 LONG-TERM EFFECTS OF 5α-REDUCTASE
INHIBITORS ON PROSTATE CANCER
MORTALITY - A LARGE POPULATION-BASED
PROSPECTIVE STUDY
Lars Björnebo*, Tobias Nordström, Andrea Discac-
ciati, Thorgerdur Palsdottir, Markus Aly, Henrik Grön-
berg, Martin Eklund, Anna Lantz, Solna, Sweden
7:20 PD03-03 ASSOCIATION BETWEEN 5α-REDUCTASE
INHIBITOR AND INCIDENCE, TUMOR
GRADING AND SURVIVAL OF PROSTATE
CANCER
Peng-Yen Wu*, Li-Weng Chang, Sheng-Chun
Hung, Jian-Ri Li, Kun-Yuan Chiu, Kevin Lu, Shi-
an-Shiang Wang, Chuan-Shu Chen, Chen-Kuang
Yang, Cheng-Che Chen, Shu-Chi Wang, Chia-Yen
Lin, Chen-Li Cheng, Taichung, Taiwan E. Shoag, Cleveland, OH
7:30 PD03-04 
SYSTEMATIC REVIEW OF THE IMPACT OF A
PLANT-BASED DIET ON PROSTATE CANCER
INCIDENCE AND OUTCOMES
Natasha Gupta*, Jacob Taylor, James Borin,
New York, NY, Kenneth Jacobsohn, Milwaukee,
WI, Stacey Kenfield, San Francisco, CA, Scott
Eggener, Chicago, IL, Hiten Patel, Maywood,
IL, Carrie Price, Towson, MD, Meena Davuluri,
Nataliya Byrne, New York, NY, Trinity Bivalacqua,
Philadelphia, PA, Stacy Loeb, New York, NY
7:40 PD03-05 PROGNOSTIC VALUE OF LYMPH NODE
COUNT VERSUS LYMPH NODE DENSITY FOR
MEN WITH PATHOLOGICAL NODE-POSITIVE
PROSTATE CANCER
Aurash Naser-Tavakolian*, Timothy Daskivich, Mi-
chael Luu, Zachary Zumsteg, Los Angeles, CA Minett, Louise Flaxman, Jessica Smyth, Natasha
7:50 PD03-06 GRADE MIGRATION OF PROSTATE CANCER
AT DIAGNOSIS FOLLOWING THE US
PREVENTIVE SERVICES TASK FORCE
RECOMMENDATIONS ON PROSTATE
CANCER SCREENING
Leonardo Borregales*, Gina DeMeo, Emily
Cheng, Xiagnmei Gu, New York, NY, Jonathan
Shoag, Cleveland, OH, Sigrid Carlsson, Andrew
Vickers, Jim Hu, New York, NY
8:00 PD03-07 ASSOCIATION BETWEEN ADVERSE
SURGICAL PATHOLOGY AND OVERALL
SURVIVAL AMONG PATIENTS WITH LOW-
RISK PROSTATE CANCER
Grace Lee*, Eileen Lee, Zev Leopold, Sinae Kim,
New Brunswick, NJ, Michael S. Leapman, Isaac
Y. Kim, New Haven, CT
34
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
8:10 PD03-08 THE IMPACT OF MEDICAID EXPANSION ON
INSURANCE COVERAGE AND METASTATIC
DISEASE AT DIAGNOSIS IN PROSTATE
CANCER PATIENTS
David Schroeder*, Solange Bassale, Brian Duty,
Ryan Kopp, Portland, OR
8:20 PD03-09 THE NATURAL HISTORY OF A
DETECTABLE SERUM PSA AFTER RADICAL
PROSTATECTOMY
Julie A. Szymaniak*, Samuel L. Washington III,
Janet E. Cowan, Matthew R. Cooperberg, Peter
E. Lonergan, Hao G. Nguyen, Peter R. Carroll,
San Francisco, CA
8:30 PD03-10 EFFECT OF ADVANCES IN TREATMENT
ON POPULATION-LEVEL SURVIVAL OF
PATIENTS WITH METASTATIC PROSTATE
CANCER
Danly O. Omil-Lima, Xian Wu, Mercedes A. Kent,
Camilo Arenas Gallo*, Ilon Weinstein, Sarah C.
Markt, Jennifer C. Cullen, Lee E. Ponsky, Jorge A.
Garcia, Cleveland, OH, Jim C. Hu, Christopher E.
Barbieri, New York, NY, Daniel E. Spratt, Jonathan
8:40 PD03-11 PATIENT-REPORTED DELAYS IN TREATMENT
FOR UROLOGIC CANCERS DURING THE
COVID-19 PANDEMIC: A NATIONAL CROSS-
SECTIONAL ANALYSIS
Jacob Lang*, Sree Jambunathan, Toledo, OH,
Eashwar Somasundaram, Cleveland, OH,
Nagalakshmi Nadiminty, Firas Petros, Ahmed
El-Zawahry, Obi Ekwenna, Puneet Sindhwani,
Toledo, OH
8:50 PD03-12 COVID-19 DISRUPTION TO PROSTATE
CANCER MANAGEMENT IN A UK TERTIARY
REFERRAL CENTRE
Matthew Byrne, Nithesh Ranasinha*, Claudia
Mercader, Mutie Raslan, Caroline Gordon, Kate
Hutton, Sarah Head, Ruth MacPherson, Charlotte
Young, Fergus Gleeson, Clare Verrill, Richard
Colling, Francisco Lopez, Richard Bell, Tom
Leslie, Richard Bryant, Freddie Hamdy, Alastair D.
Lamb, Oxford, United Kingdom
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
Friday, May 13, 2022 7:00 am – 9:00 am

Podium Session 4
ADRENAL
Room 244 @ Ernest N. Morial Convention Center
Moderators: Amr Fergany, Neal Rowe & Chris Weight

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE

FRIDAY
7:00 PD04-01 CORTISOL REGULATES ADRENALINE 7:40 PD04-05 CLINICAL CURE VS A NOVEL TRIFECTA
SYNTHESIS VIA PHENYLETHANOLAMINE SYSTEM FOR EVALUATING LONG-TERM
N-METHYLTRANSFERASE IN SURGICAL OUTCOMES OF MINIMALLY-INVASIVE
SPECIMENS OF PHEOCHROMOCYTOMA PARTIAL OR TOTAL ADRENALECTOMY FOR
Kazuyuki Numakura*, Yuya Sekine, Yumina UNILATERAL PRIMARY ALDOSTERONISM:
Muto, Mizuki Kobayashi, Soki Kashima, Ryohei RESULTS OF A MULTICENTRIC SERIES
Yamamoto, Atsushi Koizumi, Taketoshi Nara, Umberto Anceschi*, Riccardo Mastroianni, Gabriele
Mitsuru Saito, Shintaro Narita, Tomonori Habuchi, Tuderti, Alfredo Maria Bove, Aldo Brassetti, Mariacon-
Akita, Japan siglia Ferriero, Marilda Mormando, Rome, Italy, Ales-
sandro Carrara, Trento, Italy, Bernardino De Concilio,
7:10 PD04-02 THE MALE GENDER AND DIFFERENT
Bassano del Grappa, Italy, Leonardo Misuraca, Rome,
CUT-OFF VALUE OF KI-67 INDEX
Italy, Orazio Zappalà, Trento, Italy, Cristian Fiori, Orb,
MAY PREDICT METASTASIS RISK
Italy, Marialuisa Appetecchia, Rome, Italy, Antonio
OF PHEOCHROMOCYTOMA AND
Celia, Bassano del Grappa, Italy, Francesco Porpiglia,
PARAGANGLIOMA
Orbassano, Italy, Giuseppe Tirone, Trento, Italy,
Peng Chen*, Tzu-Chun Wei, Yen-Hwa Chang,
Michele Gallucci, Giuseppe Simone, Rome, Italy
Hsiao-Jen Chung, Eric Yi-Hsiu Huang, Tzu-Ping
Lin, Alex T.L. Lin, William J. Huang, Taipei, 7:50 PD04-06 PERIRENAL FAT THICKNESS AND TUMOR
Taiwan SIZE ARE INDEPENDENT PREDICTORS
FOR PERIOPERATIVE OUTCOMES OF
7:20 PD04-03 DIAGNOSTIC DILEMMAS: A MULTI-
LAPAROSCOPIC ADRENALECTOMY
INSTITUTIONAL RETROSPECTIVE ANALYSIS
Michikata Hayashida*, Shotaro Yasuoka, Masashi
OF ADRENAL INCIDENTALOMA PATHOLOGY
Koshiba, Makoto Tanaka, Naoto Tanaka, Takahiro
BASED ON RADIOGRAPHIC SIZE
Oshina, Suguru Oka, Kazushige Sakaguchi, Shinji
David Zekan*, Morgantown, WV, Robert King,
Urakami, Tokyo, Japan
Charleston, WV, Ali Hajiran, Morgantown, WV,
Apexa Patel, Samuel Deem, Charleston, WV, 8:00 PD04-07 ANALYSIS OF HIGH-RISK FACTORS FOR
Adam Luchey, Morgantown, WV ADRENAL CRISIS AFTER ADRENAL SURGERY
Quanliang Liu, Yuhua Zou, Xiaofeng Zou*, Guoxi
7:30 PD04-04 THE FATE OF THE INCIDENTAL ADRENAL
Zhang, Yuanhu Yuan, Rihai Xiao, Gengqing Wu,
MASS, CONTINUED SURVEILLANCE VERSUS
Biao Qian, Xiaoning Wang, Hui Xu, Ganzhou,
SURGICAL EXCISION
China, People’s Republic of
Wansuk Kim*, Seoul, Korea, Republic of, Stefanie
van Uem, Stanford, CA, Francesco Del Giudice,
APPROVED FOR AMA PRA CATEGORY 2.0
Rome, Italy, Benjamin Chung, Stanford, CA CREDITSTM

Friday, May 13, 2022 7:00 am – 9:00 am

Video Session 1
UPPER TRACT RECONSTRUCTION
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Susan MacDonald, Erick Ramirez Perez & Ryan Mori

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
7:00 V01-01 COLON CONDUIT URINARY DIVERSION: 7:20 V01-03 USE OF INTESTINAL BOWEL
CONSIDERATIONS FOR THE SEGMENTS FOR ADVANCED ROBOTIC
RECONSTRUCTIVE UROLOGIST RECONSTRUCTIVE SURGERY
Kevin Hebert*, Rano Matta, Kiarad Fendereski, Igor Voznesensky*, Raju Thomas, Erik Castle,
Benjamin McCormick, Jeremy Myers, Salt Lake New Orleans, LA
City, UT
7:30 V01-04 COMPLETELY INTRACORPOREAL ROBOT-
7:10 V01-02 USE OF SPY FLUORESCENT ANGIOGRAPHY ASSISTED LAPAROSCOPIC BILATERAL
DURING URINARY DIVERSION ILEAL URETER REPLACEMENT COMBINED
Grace Prillaman, Clinton Yeaman*, Sumit Isharw- WITH ILEAL AUGMENTATION CYSTOPLASTY
al, Tracey Krupski, Charlottesville, VA Silu Chen, Kunlin Yang, Weijie Zhu, Zhihua Li,
Zhenyu Li, Liqun Zhou, Xuesong Li*, Beijing,
China, People’s Republic of

*Presenting author 35
7:40 V01-05 SINGLE INSTITUTIONAL EXPERIENCE 8:30 V01-10 ROBOTIC-ASSISTED LAPAROSCOPIC
WITH ROBOTIC-ASSISTED LAPAROSCOPIC URETEROCALICOSTOMY AND
URINARY TRACT FISTULA REPAIR PYELOLITHOTOMY FOR PROXIMAL
Margaret Higgins*, Gary Shahinyan, Brian Flynn, URETERAL STRICTURE
Aurora, CO Grace Lee*, Hiren V. Patel, Joshua Sterling,
Sammy Elsamra, New Brunswick, NJ
7:50 V01-06 OWN FLAP URETEROPLASTY-NEW
SOLUTION FOR LONG STRICTURE 8:40 V01-11 ROBOTIC NON TRANSECTING
Alexander Kheifets*, Ben Valery Sionov, Masha PYELOPLASTY FOR URETEROPELVIC
Ben Zvi, Alexander Tsivian, Holon, Israel OBSTRUCTION WITH CROSSING VESSEL
Felicia Balzano*, Jonathan Warner,
8:00 V01-07 SINGLE-PORT ROBOTIC RETROPERITONEAL
Rochester, MN
BUCCAL MUCOSAL GRAFT URETEROPLASTY
WITH PERINEPHRIC FAT WRAP 8:50 V01-12 ROBOT ASSISTED URETERAL
Nathan Cheng*, Hackensack, NJ, Suzannah REIMPLANTATION SIDE-TO-SIDE WITH
Sorin, Michael Stifelman, Nutley, NJ BOARI FLAP
Abdel Bakayoko*, Mehdi El Akri, Lucas Freton,
8:10 V01-08 ROBOTIC ANASTOMOTIC STRICTURE
Juliette Hascoet, Zinne-Eddine Khene, Vivien
REVISION OF THE TRANSPLANT KIDNEY:
Grafeille, Gregory Verhoest, Andrea Manunta,
TECHNICAL CONSIDERATIONS AND
Mathieu Romain, Karim Bensalah, Rennes,
OUTCOMES
France, Lee Zhao, New York, NY, Benoit
Felicia Balzano*, Boyd Viers, Rochester, MN
Peyronnet, Rennes, France
8:20 V01-09 URETEROCALICOSTOMY IN TWO PATIENTS

APPROVED FOR AMA PRA CATEGORY 2.0
WITH MULTIPLE FAILED PYELOPLASTIES
CREDITSTM
Michael Gross*, Jason Scovell, Robert Stein,
Cleveland, OH

Friday, May 13, 2022 7:00 am – 12:00 pm

INDIAN AMERICAN UROLOGICAL ASSOCIATION (IAUA)
St. James Ballroom @ Hilton New Orleans Riverside
Chairs: Ranjith Ramasamy & Raveen Syan
7:00 CONTINENTAL BREAKFAST & POSTER 9:20
DEBATE: MALE RECONSTRUCTIVE SURGERY—
PRESENTATIONS SLING VERSUS AUS IN THE NON-RADIATED
MODERATE SUI MALE PATIENT
7:55 INTRODUCTION AND WELCOME
Moderator: Jaspreet Sandhu
Society President: Puneet SindhwanI
Debaters: Jay Simhan, Krishnan Venkatesan
8:00
DEBATE: RENAL STONES—IS ECIRS HYPE OR
9:40 DEBATE: PEDIATRIC UROLOGY—ROBOT-
HOPE?
ASSISTED LAPAROSCOPIC VERSUS OPEN
Moderator: Ravindra Sabnis
URETERAL REIMPLANTATION IN THE
Hope: Rohit Joshi
PEDIATRIC POPULATION
Hype: Mantu Gupta
Moderator: Hans Arora
8:20
DEBATE: SPERM COUNTS ARE DECLINING—YES Debater-Pro: Sameer Mittal
OR NO? Debater-Con: Kunj Sheth
Moderator: Sriram Eleswarapu
10:00 BREAK
Debater-Pro: Anand Shridharan
Debater-Con: Mehul Patel 10:15
DEBATE: TRANSVAGINAL REPAIR OF APICAL
PROLAPSE—IS HYSTERECTOMY NECESSARY?
8:40
DEBATE: PROSTATE CANCER—OLIGOMETASTAT-
Moderator: Ajay Singla
IC DISEASE ON PSMA PET/CT IN SETTING OF
Debater-Pro: Rena Malik
NEGATIVE CONVENTIONAL STAGING STUDIES
Debater-Con: Raveen Syan
SHOULD IMPACT TREATMENT DECISION: AGREE
OR DISAGREE? 10:35 DEBATE: OPTIMAL BPH MANAGEMENT FOR THE
Moderator: Thenappan Chandrasekar 40 GRAM PROSTATE GLAND—ENUCLEATION
Debater-Pro: Nirmish Singla VERSUS MIST?
Debater-Con: Sanoj Punnen Moderator: Ramgopal Satyanarayana
Debaters: Nishant Patel, Hemendra Shah
9:00
DEBATE: BLADDER CANCER—RADICAL CYSTEC-
TOMY VS TRIMODAL THERAPY FOR MUSCLE IN- 11:05 CHAKRABORTY FELLOWS PODIUM
VASIVE BLADDER CANCER—THE UROLOGIST’S PRESENTATIONS
PERSPECTIVE SURVEILLANCE AFTER REPAIR OF BLADDER
Moderator: Sima Porten EXSTROPHY: ROLE OF URINARY BIOMARKERS
Debater-Pro: Sumeet Bhanvadia Podium Presenter: Kashish Khanna
Debater-Con: Vikram Narayan
ROBOT ASSISTED VESICO-VAGINAL FISTULA
REPAIR:OUR TECHNIQUE AND EXPERIENCE
Podium Presenter: Girdhar Singh Bora

36
11:15 USI PRESIDENT LECTURE: PCNL IN ANOMALOUS 11:45 RECOVERY OF SEXUAL AND URINARY FUNC-
KIDNEY TION FOLLOWING RADICAL PROSTATECTOMY
Ravindra Sabnis Mohit Khera
11:25
DEBATE: MANAGEMENT OF STRESS URINARY APPROVED FOR AMA PRA CATEGORY 1
INCONTINENCE—BULKAMID VERSUS SLING? CREDITTM
Moderator: Sneha Vaish
Debater-Pro: Aqsa Khan
Debater-Con: Nitya Abraham

FRIDAY
Friday, May 13, 2022 8:00 am – 10:00 am
AQUA FORUM & BREAKFAST
Rivergate Room @ Ernest N. Morial Convention Center

Friday, May 13, 2022 8:00 am – 4:30 pm

CONFEDERACIÓN AMERICANA DE UROLOGÍA (CAU)
LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention Center
MORNING SESSION 1:30 CONTROVERSIES IN UROLOGY
Moderator: Jorge Gutierrez-Aceves
PROSTATE BIOPSY: TRANSRECTAL VERSUS
STATE-OF-THE-ART LECTURES: UPDATE 2022— TRANSPERINEAL
ALL YOU NEED TO KNOW Debaters: Amir Lebastchi, Samir Taneja
8:00 WELCOME FOCAL THERAPY FOR MODERATE AND
Chair: Jorge Gutierrez-Aceves HIGH-RISK PROSTATE CANCER
Debater-Pro: Behfar Ehdaie
8:05 PRIAPISM AND PEYRONIE’S DISEASE: WHAT
Debater-Con: Michael Cookson
HAVE I LEARNED?
Tom Lue LASER LITHOTRIPSY: MOSES HOYAG VERSUS
THULIUM FIBER LASER
8:30 LOWER URINARY TRACT RECONSTRUCTIVE
Debaters: Khurshid Ghani, Mitchell Humphreys
SURGERY
Reynaldo Gomez ROBOTIC SURGERY: SINGLE PORT VERSUS
MULTIPLE PORT
8:55 PROSTATE CANCER
Debaters: Mihir Desai, Jihad Kaouk
Peter Carroll
3:00 NEW TECHNOLOGY
9:20 BLADDER CANCER AND UPPER TRACT TCC
Joan Palou NEW ALTERNATIVE FOR ROBOTIC SURGERY:
WHAT IS DIFFERENT?
9:45 RENAL CANCER
Ruben Olivares
Ketan Badani
BURST WAVE LITHOTRIPSY (BWL)
10:10 TESTICULAR CANCER
Jonathan Harper
Robert Hamilton
10:35 STRESS URINARY INCONTINENCE AND 3:20 STEP-BY-STEP SURGERY: SEMI-LIVE TIPS AND
TRICKS
OVERACTIVE BLADDER
W. Stuart Reynolds HOW TO CORRECT GENITOURINARY
COMPLICATIONS AFTER GENDER-AFFIRMING
11:00 LUTS AND BENIGN PROSTATIC HYPERPLASIA
SURGERY
Ricardo Gonzalez
Dmitriy Nikolavsky
11:25 AUA/CAU REMARKS
SINGLE PORT AND MULTIPLE PORT ROBOTIC
11:35 RENAL STONES KIDNEY TRANSPLANT
Manoj Monga Mohamed Eltemamy
12:00 LUNCH BREAK RADICAL AND PARTIAL NEPHRECTOMY
AFTERNOON SESSION Michael Stifelman
Moderator: Jorge Gutierrez-Aceves 4:25 CLOSING REMARKS
1:00 COMPLICATIONS IN SURGERY: HOW TO ESCAPE APPROVED FOR AMA PRA CATEGORY 1
FROM NIGHTMARES CREDITTM
COMPLICATIONS OF ENDOUROLOGY AND
STONE TREATMENT
Moderator: Arthur Smith
Discussants:Marcelo Baptistussi, Brian Eisner,
Stephen Nakada, Margaret Pearle

*Presenting author 37
Friday, May 13, 2022 8:00 am – 5:00 pm
SEXUAL MEDICINE SOCIETY OF NORTH AMERICA (SMSNA)
Grand Ballroom A @ Hilton New Orleans Riverside
8:00 PRESIDENTIAL WELCOME 11:50 NON-CME INDUSTRY SPONSORED SYMPOSIUM
Society President: Serge Carrier Location: Grand Salon @Hilton New Orleans Riverside
8:05 CME ACTIVITY ANNOUNCEMENTS 1:00
SESSION 3: LOW INTENSITY SHOCKWAVE THER-
Mohit Khera APY—WHERE ARE WE TODAY?
Moderators: Thomas Masterson, Luiz Otavio Torres
8:10
SESSION 1: HORMONAL AND MEDICAL THERA-
PIES ELECTROMAGNETIC VS ELECTROHYDRAULIC:
Moderators: Carlo Bettocchi, Mohit Khera BEST FOR LIST?
Ranjith Ramasamy
WHICH TESTOSTERONE THERAPY IS BEST FOR
MY PATIENT? TOPIC: SHOCKWAVE THERAPY—IS IT ETHICAL
Faysal Yafi TO OFFER AND CHARGE FOR ERECTILE DYS-
FUNCTION OR OTHER SEXUAL DYSFUNCTIONS?
PENILE TRACTION THERAPY AND VACUUM
Moderator: James Hotaling
DEVICES IN 2021: WHEN TO USE AND WHAT TO
Debater-Pro: Gregory Broderick
EXPECT
Debater-Con: Gerald Brock
Matthew Ziegelmann
AUA WHITE PAPER UPDATE: LIST
SLEEP APNEA AND MEN’S HEALTH
Trinity Bivalacqua
John Mulhall
Q & A
Q&A
1:50
SESSION 4: EJACULATORY & PELVIC
SEXUAL DYSFUNCTION IN PATIENTS WITH MEN-
DYSFUNCTION
TAL HEALTH DISORDERS
Moderators: Petar Bajic, Wayne Hellstrom
Daniela Wittmann
CHANGING PARADIGMS IN THE DIAGNOSIS AND
SEXUAL SUPPLEMENTS: UNDERSTANDING
MANAGEMENT OF ORGASMIC DISORDERS
THEIR SAFETY AND EFFICACY
Lawrence Hakim, Alan Shindel, Landon Trost
Lawrence Jenkins
DIAGNOSING AND TREATING MALE NEUROGEN-
Q&A
IC SEXUAL DYSFUNCTION
9:20 BREAK/EXHIBITORS Stacy Elliott
9:40 SESSION 2: SURGICAL THERAPIES Q & A
Moderators: Rafael Carrion, Ashley Tapscott
2:40 BREAK/EXHIBITORS
WHAT IS THE BEST WAY TO TREAT HOURGLASS
3:00 SESSION 5: STATE-OF-THE ART LECTURES
DEFORMITY?
Moderators: Helen Bernie, Nelson Bennett
Tom Lue, Jesse Mills, Justin Parker
PRIAPISM: OPTIMAL MANAGEMENT AND
Q&A
PREVENTION AND NEW AUA GUIDELINES
CONTROVERSIAL SURGERIES IN SEXUAL Arthur Burnett
MEDICINE
HOW TO USE SOCIAL MEDIA IN SEXUAL
Barbara Chubak, Laurence Levine, Run Wang
MEDICINE
Q & A Stacy Loeb
THE IMPACT OF PENILE IMPLANT SURGERY ON BASIC SCIENCE STATE-OF-THE ART LECTURE:
PATIENT AND PARTNER SATISFACTION CHRONIC ERECTILE DYSFUNCTION AFTER
Christian Nelson PROSTATECTOMY: A RACE AGAINST TIME
DIAGNOSIS AND MANAGEMENT OF PENILE BETWEEN CAVERNOUS NERVE REGENERATION
FRACTURE VERSUS IRREVERSIBLE CHANGES TO THE
Omer Raheem PENILE ARCHITECTURE
Kelvin Davies
Q & A
Q & A
11:20 IPP: TRICKS AND TIPS
3:55 SESSION 6: THE IRA SHARLIP LECTURE
SST/FLOPPY GLANS Moderators: Serge Carrier, Ira Sharlip
Steven Wilson
TELEMEDICINE AND US: CHALLENGES AND
IMPLANT CHECKLIST PRIOR TO SURGERY OPPORTUNITIES
(IPPPLAN) Keynote Speaker: Hossein Sadeghi-Nejad
Tobias Kohler
4:10
SESSION 7: ADDRESSING DIVERSITY IN PA-
11:40 SUPS PRESIDENTIAL LECTURE
TIENT’S SEXUAL ORIENTATION
TOPIC: INFECTION PREVENTION STRATEGIES IN Moderators: Gregory Broderick, Amy Pearlman
PROSTHETIC UROLOGY—WHERE ARE WE NOW, PSYCHIATRIC ASSESSMENTS/SUPPORT
AND WHAT’S COMING? Annamaria Giraldi
Ricardo Munarriz
SURGERY MALE TO FEMALE
Ethan Grober

38
 SURGERY FEMALE TO MALE
Maurice Garcia
HOMOSEXUAL MEN WITH FOCUS ON CANCER
SURVIVORSHIP
Raul Fernandez-Crespo
Q & A
Friday, May 13, 2022
Moderated Poster Session 4
BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY II
Room 228 @ Ernest N. Morial Convention Center
Moderators: Jason Hedges & Peter Gilling
ABSTRACT
NUMBER TITLE
MP04-01 IMPACT OF 5-ALPHA REDUCTASE
INHIBITORS ON FUNCTIONAL OUTCOMES
OF GREENLIGHT PHOTOVAPORIZATION OF
THE PROSTATE (PVP): AN ANALYSIS OF
3500 MEN IN THE GLOBAL GREENLIGHT
GROUP (GGG) DATABASE
Iman Sadri*, Ville Mont-Royal, Canada, Da-
vid-Dan Nguyen, Kyle Law, Adel Arezki, David
Bouhadana, Naeem Bhojani, Montreal, Canada,
Dean Elterman, Toronto, Canada, Ahmed S.
Zakaria, Thunder Bay, Canada, Franck Bruyère,
Tours, France, Luca Cindolo, Giovanni Ferrari,
Modena, Italy, Carlos Vasquez-Lastra, Mexico
City, Mexico, Tiago Borelli-Bovo, Sao Paulo,
Brazil, Edgardo F. Becher, Buenos Aires, Argen-
tina, Hannes Cash, Maximillian Reimann, Berlin,
Germany, Enrique Rijo, Barcelona, Spain, Vincent
Misrai, Toulouse, France, Kevin C. Zorn, Montreal,
Canada
MP04-02 ANALYSIS OF EX-VIVO HUMAN BPH TISSUE
TREATED BY HISTOTRIPSY: DOSE AND
PARAMETER EFFECTS
Zorawar Singh*, Albany, NY, Yashwanth N.
Kumar, Yak-Nam Wang, Adam Maxwell, Matthew
Bruce, Rishi Sekar, Seattle, WA, Eli Vlaisavljevich,
Blacksburg, VA, Lawrence D. True, George R.
Schade, Seattle, WA
MP04-03 CAN HANDHELD POINT OF CARE
ULTRASOUND PROBES RELIABLY MEASURE
TRANSABDOMINAL PROSTATE VOLUME? A
PROSPECTIVE RANDOMIZED STUDY
Henry Wright*, Chicago, IL, Hermen Brar, Fabrice
Henry, Dillon Corrigan, Smita De, Cleveland, OH
MP04-04 RISK FACTORS FOR A FAILED TRIAL
WITHOUT CATHETER FOLLOWING
CONVECTIVE WATER VAPOR THERMAL
THERAPY (REZUM)
Michael Felice*, Kaylin Kim, William Adams, May-
wood, IL, Erin Fruth, Chicago, IL, Ahmer Farooq,
Kevin McVary, Maywood, IL
MP04-05 INCREASED BLEEDING RISK IS ASSOCIATED
WITH 30-DAY MORTALITY AFTER TURP
Zafardjan Dalimov*, Philadelphia, PA, Ellen
Lutnick, Emily C. Ellmann, Ali Houjaij, Nader D.
Nader, Oussama M. Darwish, Buffalo, NY Nicolò Schifano, Rayan Matloob, Milan, Italy,
*Presenting author
4:50 CLOSING REMARKS
Serge Carrier
APPROVED FOR AMA PRA CATEGORY 1
CREDITTM
FRIDAY
8:45 am – 10:00 am
ABSTRACT
NUMBER TITLE
MP04-06 INCIDENCE OF URETHRAL STRICTURE
FOLLOWING ENDOSCOPIC PROSTATE
SURGERY: A SYSTEMATIC REVIEW AND
META-ANALYSIS OF PROSPECTIVE,
RANDOMIZED TRIALS
Ee Jean Lim*, Vineet Gauhar, Singapore,
Singapore, Giacomo Maria Pirola, Arezzo, Italy,
Emanuele Rubilotta, Verona, Italy, Marcelo Langer
Wroclawski, São Paulo, Brazil, Dong Le Quy
Nguyen, Danang, Vietnam, Marilena Gubbiotti,
Arezzo, Italy, Vinson Wai, Shun Chan, Leeds,
United Kingdom, Mariela Corrales, Paris, France,
Esther Garcia Rojo, Madrid, Spain, Thomas R.W.
Herrman, Frauenfeld, Switzerland, Jeremy Yuen,
Chun Teoh, Hong Kong, Hong Kong, Daniele
Castellani, Ancona, Italy
MP04-07 EX-VIVO COMPARISON OF DEPTH OF
COAGULATION OF HOLMIUM, MOSESTM
AND THULIUM FIBER LASER IN HUMAN
PROSTATE TISSUE
Ruben Blachman-Braun*, Jonathan E Katz,
Nicholas A Smith, Oleksii Iakymenko, Oleksandr
N Kryvenko, Hemendra N Shah, Miami, FL
MP04-08 TRANEXAMIC ACID TO IMPROVE SAME-DAY
DISCHARGE RATES AFTER HOLMIUM
LASER ENUCLEATION OF THE PROSTATE:
A RANDOMIZED, CONTROLLED
PROSPECTIVE TRIAL
Mark Assmus, Matthew Lee*, Meera Ganesh,
Jessica Helon, Amy Krambeck, Chicago, IL
MP04-09 TRENDS IN HOLMIUM LASER ENUCLEATION
OF THE PROSTATE FOR TREATMENT OF
BENIGN PROSTATIC HYPERPLASIA
Tenny R. Zhang*, Mary O. Strasser, Samantha L.
Thorogood, Christina Sze, Bilal Chughtai, Alexis
Te, Richard K. Lee, Jim C. Hu, New York, NY
MP04-10 RISK OF ORGASMIC FUNCTION IMPAIRMENT
AFTER HOLEP – FINDINGS OF A
PROSPECTIVE REAL-LIFE TRIAL (EXPHO)
Paolo Capogrosso*, Varese, Italy, Eugenio Ven-
timiglia, Giuseppe Fallara, Antonio Costa, Franc-
esco Pellegrino, Luigi Candela, Edoardo Pozzi,
Federico Belladelli, Mario De Angelis, Gianmarco
Colandrea, Walter Cazzaniga, Daniele Cignoli,
Federico Dehò, Varese, Italy, Vincenzo Scattoni,
Andrea Salonia, Francesco Montorsi, Milan, Italy
39
 MP04-11 MOSESTM TECHNOLOGY FOR HOLMIUM
ENUCLEATION OF THE PROSTATE:
EXTENDED OUTCOMES FROM A
PROSPECTIVE DOUBLE-BLIND RANDOMIZED
CONTROL TRIAL
Shaan Setia*, Nicholas Kavoussi, Nicole Miller,
Nashville, TN
MP04-12 EN-BLOC ENUCLEATION TECHNIQUE WITH
EARLY APICAL RELEASE AND URINARY
SPHINCTER PRESERVATION USING PULSE
MODULATION (VIRTUAL BASKET) VS
EN-BLOC HOLEP
Moises Elias Socarras*, Javier Reinoso Elbers,
Fabio Esposito, Isabella Greco, Julio Fernandez
del Alamo, Vanesa Cuadros Rivera, Diego Carrion
Monsalve, Juan Gomez Rivas, Luis Llanes Gon-
zalez, Luis Llanes Gonzalez, Fernando Gomez
Sancha, Madrid, Spain
MP04-13 ONE-LOBE-TECHNIQUE PROVIDES
SUPERIOR SURGICAL EFFICIENCY
COMPARED TO THREE-LOBE-TECHNIQUE
FOR HOLMIUM LASER ENUCLEATION OF
THE PROSTATE (HOLEP)
Thilo Westhofen*, Alexander Buchner, Boris
Schlenker, Patrick Keller, Melanie Schott, Michael
Atzler, Christian G. Stief, Giuseppe Magistro,
Munich, Germany France, Matthieu Durand, Nice, France
MP04-14 PATIENTS ADHERING TO STANDARDIZED
PROTOCOLS FOR PFMT AFTER HOLEP
SHOW HIGHER RATES OF POSTOPERATIVE
INCONTINENCE: REAL-LIFE IMPLICATIONS
FOR A RATIONAL MANAGEMENT WORK-UP
Giuseppe Fallara*, Manuela Tutolo, Valentina
Specchio, Donatella Giraudo, Shivani Ghazaleh
Mathur, Federico Belladelli, Antonio Costa, Dan-
iele Cignoli, Nicolò Schifano, Francesco Pellegri-
no, Luigi Candela, Mario De Angelis, Gianmarco
Colandrea, Milan, Italy, Paolo Capogrosso, Var-
ese, Italy, Eugenio Ventimiglia, Andrea Salonia,
Francesco Montorsi, Milan, Italy Mutahar Ahmed, Michael Stifelman, Hackensack,
MP04-15 PERIOPERATIVE EFFICACY OUTCOMES
OF THULIUM LASER VS. VAPOR TUNNEL
PULSE-MODULATED HOLMIUM LASER
ENUCLEATION OF THE PROSTATE
Ahmed Elshabrawy*, Furkan Dursun, Hanzhang
Wang, Harshit Garg, Michael Liss, Ahmed M.
Mansour, San Antonio, TX Alfredo Maria Bove*, Aldo Brassetti, Gabriele
MP04-16 THULIUM YAG VS THULIUM FIBER LASER
ENUCLEATION OF THE PROSTATE
(THULEP VS TFLEP): A MULTI-INSTITUTION
TRIAL TO COMPARE INTRA AND EARLY
APPROVED FOR AMA PRA CATEGORY 1.25
POSTOPERATIVE OUTCOMES
40
Matteo Maltagliati, Lorenzo Berti, Busto Arsizio,
Italy, Salvatore Micali, Modena, Italy, Umber-
to Besana, Carlo Buizza, Busto Arsizio, Italy,
Bernardo Rocco, Maria Chiara Sighinolfi, Milano,
Italy, Andrea Pacchetti, Genova, Italy, Jean Bap-
tiste Roche, Bordeaux, France, Giorgio Bozzini*,
Como, Italy
MP04-17 A MATCHED-PAIRED COMPARISON OF A
NOVEL PULSED THULIUM:YAG LASER
WITH A CONTINUOUS WAVE THULIUM
FIBRE LASER AND A HOLMIUM:YAG LASER
FOR ENDOSCOPIC ENUCLEATION OF THE
PROSTATE (EEP)
Christopher Netsch*, Benedikt Becker, Clemens
Rosenbaum, Andreas Gross, Hamburg, Germany
MP04-18 ROBOT-ASSISTED SIMPLE PROSTATECTOMY
VERSUS HOLMIUM LASER ENUCLEATION
FOR LARGE PROSTATE GLANDS (>100ML):
COMPLICATIONS AND PERIOPERATIVE
OUTCOMES
Louis Vignot*, Nice, France, Julien Anract, Paris,
France, Imad Bentellis, Nice, France, Albert
Semaan, Paris, France, Fabrizio Sartorio, Brann-
wel Tibi, Youness Ahallal, Nice, France, Michael
Peyromaure, Paris, France, Daniel Chevallier,
Nice, France, Nicolas Barry Delongchamps, Paris,
MP04-19 SINGLE-PORT TRANSVESICAL
VS MULTIPORT ROBOTIC SIMPLE
PROSTATECTOMY: A MULTI-INSTITUTIONAL
MATCHED-PAIR COMPARISON
Mahmoud Abou Zeinab*, Cleveland, OH, Tanner
Corse, Hackensack, NJ, Kennedy Okhawere,
New York, NY, Luca Morgantini, Chicago, IL, Nour
Abdallah, Alp T. Beksac, Ethan Ferguson, Aaron
Kaviani, Joao Pedro Emrich Accioly, Cleveland,
OH, Robert Harrison, Bilal Khan, Hackensack,
NJ, Indu Saini, Chiya Abramowitz, New York, NY,
Susan Talamini, Simone Crivellaro, Chicago, IL,
NJ, Ketan K. Badani, New York, NY, Jihad Kaouk,
Cleveland, OH
MP04-20 IMPACT OF OBESITY ON PERI-OPERATIVE
AND LONG-TERM FUNCTIONAL OUTCOMES
AFTER ROBOTIC ASSISTED SIMPLE
PROSTATECTOMY
Tuderti, Umberto Anceschi, Mariaconsiglia Ferri-
ero, Leonardo Misuraca, Riccardo Mastroianni,
Giuseppe Simone, Rome, Italy
CREDITSTM
Friday, May 13, 2022
Moderated Poster Session 5
STONE DISEASE: BASIC RESEARCH & PATHOPHYSIOLOGY
Room 225 @ Ernest N. Morial Convention Center
Moderators: Benjamin Canales & Dean Assimos
ABSTRACT
NUMBER TITLE
MP05-01 VALIDATING THE KIDNEY INJURY TEST (KIT)
AS A POINT OF CARE DIAGNOSTIC FOR
URINARY STONE RECURRENCE
Xavier Cortez*, San Francisco, CA, Srinka Ghosh,
Reuben Sarwal, Nick Titzler, Wanzin Yazar,
Brisbane, CA, Marshall Stoller, Minnie Sarwal,
Thomas Chi, San Francisco, CA Salhi, Alessia Martoccia, Lorenzo Capone, Silvio
MP05-02 THE PRELIMINARY EXPLORATION OF
ROLES MIRNAS DERIVED FROM URINARY
EXOSOMES PLAY IN KIDNEY STONE
FORMATION
Yuanyuan Yang*, Senyuan Hong, Shaogang
Wang, Wuhan, China, People’s Republic of AND VARIABLE FORMATION BY SURFACE
MP05-03 HYPOXIA-INDUCIBLE PROLYL
HYDROXYLASE INHIBITOR (ROXADUSTAT)
SUPPRESSES KIDNEY STONE FORMATION.
Kengo Kawase*, Shuzo Hamamoto, Tatsuya
Hattori, Ryosuke Chaya, Tomoki Okada, Yutaro
Tanaka, Takeru Sugino, Rei Unno, Kazumi
Taguchi, Ryosuke Ando, Atsushi Okada, Takahiro
Yasui, Takahiro Yasui, Nagoya, Japan URETEROSCOPY?
MP05-04 DISCOVERY OF DRUGS THAT PROMOTE THE
PHAGOCYTIC ABILITY OF MACROPHAGES
TO CALCIUM OXALATE CRYSTALS USING
THE FDA-APPROVED DRUG LIBRARY
Atsushi Okada*, Hiroshi Takase, Masahiko Isogai,
Tomoki Okada, Tatsuya Hattori, Ryosuke Chaya,
Kengo Kawase, Yutaro Tanaka, Taiki Kato, Ter-
uaki Sugino, Rei Unno, Kazumi Taguchi, Shuzo
Hamamoto, Ryosuke Ando, Tadahiro Hashita,
Keiichi Tozawa, Tamihide Matsunaga, Kenjiro
Kohri, Takahiro Yasui, Nagoya, Japan
MP05-05 SODIUM-GLUCOSE COTRANSPORTER (SGLT)
INHIBITOR SUPPRESSES RENAL STONE
FORMATION - A NOVEL THERAPEUTIC
APPROACH FOR NEPHROLITHIASIS
Go Anan*, Takuo Hirose, Daisuke Kikuchi,
Chika Takahashi, Seiko Yamakoshi, Makoto Sato,
Takefumi Mori, Sendai, Japan
MP05-06 GENETIC ANALYSIS OF KIDNEY STONE
DISEASE IN A MULTI-ETHNIC COHORT:
INSIGHTS FROM GENOME-WIDE AND
PHENOME-WIDE ASSOCIATION STUDIES
Parth Patel*, Vidhya Venkateswaran, Bogdan
Pasanuic, Kymora Scotland, Los Angeles, CA
MP05-07 IN VITRO AND IN VIVO ASSESSMENT OF
PATHOGENIC PROPERTIES OF PROTEUS
MIRABILIS IN URINARY TRACT INFECTION
AND STRUVITE STONE FORMATION
Roman Herout*, Sara Khoddami, Alina Reicherz,
Ben Chew, Dirk Lange, Vancouver, Canada
*Presenting author
8:45 am – 10:00 am
ABSTRACT
NUMBER TITLE
FRIDAY
MP05-08 POSSIBLE ROLE OF THE MICROBIOTA IN
URINARY STONES: A PROSPECTIVE STUDY
TO CORRELATE RADIOLOGICAL DENSITY
(HOUNSFIELD UNITS) AND CULTURAL
EXAMINATION OF URINARY CALCULI
Antonio Luigi Pastore*, Andrea Fuschi, Yazan Al
Scalzo, Paolo Pietro Suraci, Onofrio Antonio Rera,
Fabio Maria Valenzi, Alice Antonioni, Antonio
Carbone, Latina, Italy
MP05-09 URETERAL STENT BIOFILMS EXHIBIT
COMPLEX INTERACTION NETWORKS
MATERIAL AND MICROBIAL STRAIN
Glenn T. Werneburg, Daniel Hettel*, Ava Adler,
Smita De, Raymond Rackley, Daniel Shoskes,
Aaron Miller, Cleveland, OH
MP05-10 MIXING IT UP: ARE PATIENTS WITH
MIXED URINE CULTURES AT HIGHER
RISK OF POSTOPERATIVE SEPSIS AFTER
Young Son*, Julia Scali, Stratford, NJ, Ian Mad-
ison, Philadelphia, PA, Benjamin Fink, Katelyn
Klimowich, Dayna DeVincentz, Paul Chialastri,
Thomas Mueller, Stratford, NJ
MP05-11 MULTI-SPECIES, METABOLIC REDUNDANCY
IN OXALATE-FORMATE HANDLING IN THE
GUT MICROBIOTA
Sromona Mukherjee*, Aaron Miller,
Cleveland, OH
MP05-12 DEPENDENT ANTIBIOTIC AND OXALATE
INTERACTIONS IMPACT ATHEROSCLEROSIS
AND CALCIUM OXALATE STONES IN THE
KIDNEYS
Jose Agudelo*, Lucas Osborn, Beckey DeLu-
cia, Mark Brown, Ava Adler, Jan Claesen, Jane
Nguyen, Aaron Miller, Cleveland, OH
MP05-13 IMPACT OF URETERAL STENTS ON
FACTORS CONTRIBUTING TO STRICTURE
PATHOGENESIS
Karen Doersch*, Rochester, NY, Khaled Almutairi,
Ben Chew, Dirk Lange, Vancouver, Canada
MP05-14 RAISE YOUR GLASS! AMERICAN CHESTNUT
LEAVES CAN REDUCE TEA OXALATE
CONTENT
Bergen Lemack*, Willim Donelan, Tania Quesa-
da, Gainesville, FL, Dakota Matthews, Syracuse,
NY, Saeed Khan, Vincent Bird, Gainesville, FL,
William Powel, Syracuse, NY, Benjamin Canales,
Paul Dominguez-Gutierrez, Gainesville, FL
41
 MP05-15 THE GULO(-/-) MOUSE: A USEFUL MODEL
FOR STUDYING ENDOGENOUS OXALATE
PRODUCTION FROM ASCORBIC ACID
TURNOVER
Joseph Crivelli*, Xingsheng Li, Sonia Fargue, Kyle
Wood, Dean Assimos, Ross Holmes, John Knight,
Birmingham, AL
MP05-16 NEW PERSPECTIVES ON AN OLD
GROUPING: THE GENOMIC AND
PHENOTYPIC DIFFERENCES OF
OXALOBACTER FORMIGENES
John Chmiel*, London, Canada, Robertson Ven-
ema, Vancouver, Canada, Charles Carr, Toronto,
Canada, Kait Al, London, Canada, Ryan Chanyi,
Palmerston North, New Zealand, Sergio Ari
Domínguez Romero, Gerrit Stuivenberg, Hassan
Razvi, Jennifer Bjazevic, Jeremy Burton, London,
Canada
MP05-17 INFLAMMATORY CYTOKINES PROMOTE
FIBROSIS IN OBSTRUCTED URETERS
Alina Reicherz*, Felipe Eltit, Khaled Almutairi, Ro-
 A
man Herout, Michael Cox, Ben Chew, Dirk Lange,
Vancouver, Canada
Friday, May 13, 2022
Moderated Poster Session 6
BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY I
Room 222 @ Ernest N. Morial Convention Center
Moderators: David DeGraff, Philip Abbosh & Leonardo Reis
ABSTRACT
NUMBER TITLE
MP06-01 NON-MUSCLE INVASIVE BLADDER CANCER
SUBTYPES WITH DIFFERENTIAL RESPONSE
TO INTRAVESICAL BACILLUS CALMETTE-
GUERIN TREATMENT
Florus C de Jong*, Rotterdam, Netherlands,
Teemu D Laajala, Rotterdam, Finland, Robert F
Hoedemaeker, Rotterdam, Netherlands, Sébast-
ien Rinaldetti, Luxembourg, Luxembourg, Kimber-
ley R Jordan, Denver, CO, Angelique CJ van der
Made, Rotterdam, Netherlands, Bart Nieuwkamer,
Delft, Netherlands, Deric KE van der Schoot,
Breda, Netherlands, Egbert R Boevé, Rotterdam,
Netherlands, Emiel AM Janssen, Stavanger,
Norway, Tokameh Mahmoudi, Joost L Boormans,
Rotterdam, Netherlands, Dan Theodorescu, Los
Angeles, CA, James C Costello, Denver, CO,
Tahlita CM Zuiverloon, Rotterdam, Netherlands Jose Garcia*, Funda Vakar-Lopez, Martine Roudi-
MP06-02 NON-MUSCLE-INVASIVE MICROPAPILLARY
BLADDER CANCER HAS A DISTINCT
LNCRNA PROFILE ASSOCIATED WITH
UNFAVORABLE PROGNOSIS
Joep de Jong*, Rotterdam, Netherlands, Begoña
Valderrama, Sevilla, Spain, Julia Perera, Nuria
Juanpere, Barcelona, Spain, Paloma Cejas,
Henry Long, Boston, MA, Mar Alba, Barcelona,
Spain, Ewan Gibb, Vancouver, Canada, Joaquim
Bellmunt, Boston, MA Johannes Schneider, Bastian Amend, Falko Fend,
42
MP05-18 DOES HYPERTENSION AFFECT THE
RECOVERY OF RENAL FUNCTIONS
FOLLOWING REVERSIBLE UNILATERAL
URETERIC OBSTRUCTION?
Fayez Hammad*, Loay Lubbad, Al Ain, United
Arab Emirates
MP05-19 IS THE THULIUM FIBER LASER COST
EFFECTIVE COMPARED TO THE HOLMIUM
LASER WHEN TREATING RENAL STONES?
Akin S. Amasyali*, Nikoli Brown, Cayde Ritchie,
Jason Groegler, Joshua D. Belle, Daniel Baldwin,
Mohammad Hajiha, D.Duane Baldwin, Loma
Linda, CA
MP05-20 THE HEAT IS ON: MOSES 2.0 POPCORNING
IN A NOVEL BENCHTOP 3D KIDNEY MODEL
REACHES THERMAL DAMAGE THRESHOLDS
RAPIDLY
Zachary Dionise*, Christian Tabib, Sabrina
Tran, Francois Soto-Palou, Pei Zhong, Glenn
Preminger, Michael Lipkin, Durham, NC
 PPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
8:45 am – 10:00 am
ABSTRACT
NUMBER TITLE
MP06-03 DISCOVERY AND VALIDATION OF
NITROXOLINE AS A NOVEL STAT3 INHIBITOR
IN DRUG-RESISTANT UROTHELIAL BLADDER
CANCER
Peng Huang*, Wenfeng Lin, Motoo Araki, Masami
Watanbe, Yasutomo Nasu, Okayama, Japan
MP06-04 EXPLORING A NOVEL SYNERGISTIC
INTRAVESICAL ONCOLYTIC VIROTHERAPY
FOR TREATMENT OF NON-MUSCLE
INVASIVE BLADDER CANCER
Woodson Smelser*, Jian Wang, Sam Chang,
Austin Kirschner, Nashville, TN
MP06-05 UROTHELIAL CANCER RAPID AUTOPSY
PROGRAM: BIOSPECIMENS AND PATIENT-
DERIVED PRECLINICAL MODELS
er, Petros Grivas, Evan Y. Yu, Heather Cheng, Mi-
chael T. Schweizer, Michael Haffner, John K. Lee,
Eva Corey, Bruce Montgomery, Andrew Hsieh,
Jonathan L. Wright, Hung-Ming Lam, Seattle, WA
MP06-06 ESTABLISHMENT AND EVALUATION OF
A SIMPLIFIED APPROACH TO PATIENT
DERIVED BLADDER CANCER ORGANOIDS
USING URINE
Paul Pollehne, Ivonne Aidee Montes Mojarro,
Arnulf Stenzl, Wilhelm K. Aicher, Niklas Harland*,
Tuebingen, Germany
 MP06-07 APPLICATION OF BLADDER CANCER
PATIENT-DERIVED ORGANOIDS AS PRE-
CLINICAL MODEL FOR PERSONALIZED
MEDICINE
Martina Minoli, Mirjam Kiener, Bern, Switzerland,
Thomas Cantore, Tarcisio Fedrizzi, Paola Gaspar-
ini, Francesca Demichelis, Trento, Italy, George
N. Thalmann, Roland Seiler-Blarer, Marianna
Kruithof-de Julio*, Bern, Switzerland Japan
MP06-08 SINGLE-CELL SEQUENCING OF PARENTAL
BLADDER CANCER AND SUBSEQUENT
ORGANOIDS REVEALS DIFFERENTIAL CELL
PRESERVATION
Roland Seiler*, Martina Minoli, Bern, Switzerland,
Franziaks Singer, Anne Bertolini, Ulrike Menzel,
Christian Beisel, Zurich, Switzerland, Marianna
Kruithof-de Julio, Bern, Switzerland yama, Yoko Koh, Makoto Matsushita, Taigo Kato,
MP06-09 SINGLE CELL ANALYSES OF MURINE
UROTHELIAL CARCINOMA CELLS
REVEAL A ROLE OF TUMOR-ASSOCIATED
MACROPHAGES IN RESPONSE TO ANTI-PD1
THERAPY
Dongbo Xu*, Li Wang, Yali Zhang, Yanqing
Wang, Xiaojing Zhang, Yue Wu, Gary Smith, Bo
Xu, Prashant Singh, Yuesheng Zhang, David
Goodrich, Jianmin Wang, Qiang Li, Buffalo, NY public of, Ji Young Mun, Daegu, Korea, Republic
MP06-10 KDM6A DEFICIENCY IN UROTHELIUM
PRODUCES A DISTINCT IMMUNE
PHENOTYPE IN A MOUSE MODEL OF
BLADDER CANCER
Ao Zhang*, Hong Qiu, Timothy Chan, Byron Lee,
Cleveland, OH PATIENTS WITH BLADDER CANCER
MP06-11 MAGNITUDE OF STING SIGNALING
DETERMINES ANTITUMOR OUTCOMES, AND
CD8+ T CELL MEMORY BY BCG-STING IN
UROTHELIAL TUMORS
Alok Singh*, Monali Praharaj, Kara Lombar-
do, Liang Zhao, Joy Huang, Max Kates, David
McConkey, William Bishai, Baltimore, MD, Trinity
Bivalacqua, Philadelphia, PA MP06-19 ANTI-TUMOR EFFECT IN BLADDER CANCER
MP06-12 A WT1 ORAL CANCER VACCINE USING A
BIFIDOBACTRERIUM VECTOR SUPPRESSES
GROWTH OF ANTI-PD-1 ANTIBODY-
RESISTANT MOUSE BLADDER TUMOR
Toshiro Shirakawa*, Koichi Kitagawa, Hideto Ueki,
Junya Furukawa, Kobe, Japan, Nobuyuki Hinata,
Hiroshima, Japan, Masato Fujisawa, Kobe,
Japan
MP06-13 TARGETING THE ANDROGEN RECEPTOR
AXIS TO IMPROVE RESPONSE TO BLADDER
CANCER IMMUNOTHERAPY
Typhaine Gris*, Marjorie Besançon, France-
Hélène Joncas, Valérie Picard, Alain Bergeron,
Yves Fradet, Paul Toren, Quebec, Canada
MP06-14 ROLE OF LATROPHILINS AS KEY
DOWNSTREAM EFFECTORS OF THE
ANDROGEN RECEPTOR IN MODULATING
UROTHELIAL TUMORIGENESIS
Takuro Goto*, Yuki Teramoto, Masato Yasui,
Guiyang Jiang, Yujiro Nagata, Rochester, NY,
George Netto, Birmingham, AL, Hiroshi Miyamoto,
Rochester, NY
*Presenting author
MP06-15 THE LONG ARM OF CHROMOSOME 9
CONTAINS A GENE THAT REGULATES
PPARγ IN BLADDER CANCER
Ryutaro Shimizu*, Masashi Honda, Shogo Tera-
oka, Tetsuya Yumioka, Bunya Kawamoto, Noriya
Yamaguchi, Hideto Iwamoto, Panagiota Tsounapi,
Shuichi Morizane, Katsuya Hikita, Takahito Ohira,
Hiroyuki Kugoh, Atsushi Takenaka, Yonago,
FRIDAY
MP06-16 CIRCULATING EXTRACELLULAR VESICLES
CARRYING FIRMICUTES COULD PREDICT
RESPONSE TO PEMBROLIZUMAB IN
UROTHELIAL CARCINOMA
Atsunari Kawashima*, Kentaro Jingushi, Daisuke
Motooka, Akinaru Yamamoto, Toshihiro Uemura,
Gaku Yamamichi, Koichi Okada, Eisuke Tomi-
Koji Hatano, Motohide Uemura, Hisashi Wada,
Norio Nonomura, Suita, Japan
MP06-17 ALPHA-2-MACROGLOBULIN IN URINARY
EXTRACELLULAR VESICLES IS A NOVEL
PROTEIN MARKER FOR DIAGNOSIS OF
HUMAN BLADDER CANCER
Jinsung Park*, Uijeongbu-si, Korea, Republic of,
Jisu Lee, Yun Hee Kang, Daejeon, Korea, Re-
of, Hyun-Woo Oh, Daejeon, Korea, Republic of,
Yoon-Kyoung Cho, Ulsan, Korea, Republic of,
Myung-Shin Lee, Daejeon, Korea, Republic of
MP06-18 A GENOMIC URINE ASSAY TO DETECT
URINARY TRACT RECURRENCES IN
TREATED WITH RADIOTHERAPY
Florus C de Jong*, Iris I Iflé, Denise Kooper,
Angelique CJ van der Made, Joep J De Jong,
Tahlita CM Zuiverloon, Luca Incrocci, Rotterdam,
Netherlands, Wim Van Criekinge, Gent, Belgium,
Martine Franckena, Joost L Boormans, Ellen C
Zwarthoff, Rotterdam, Netherlands
MODEL OF TUMOR VASCULATURE-
TARGETED 10B DELIVERY MEDIATED BORON
NEUTRON CAPTURE THERAPY
Tohru Yoneyama*, Shingo Hatakeyama, Mihoko
Sutoh Yoneyama, Hirosaki, Japan, Taku Yoshiya,
Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki,
Osaka, Japan, Shingo Hachinohe, Kamikita-gun,
Japan, Shintaro Ishiyama, Hirosaki, Japan, Mo-
tohiro Nonaka, Kyoto, Japan, Michiko N. Fukuda,
La jolla, Japan, Chikara Ohyama, Hirosaki,
Japan
MP06-20 EFFICACY OF RECOMBINANT BACILLUS
CALMETTE-GUÉRIN–DLTA IN THREE-
DIMENSIONAL BIOPRINTED BLADDER
CANCER-ON-A-CHIP WITH MICROFLUIDIC
SYSTEM
Joongwon Choi*, Jung Hoon Kim, Jae Hun Shim,
Jong Hyun Tae, Se Young Choi, Byung Hoon Chi,
Tae-Hyoung Kim, Tae Young Jung, In Ho Chang,
Seoul, Korea, Republic of
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
43
Friday, May 13, 2022
Podium Session 5
STONE DISEASE: MEDICAL & DIETARY THERAPY
Room 252 @ Ernest N. Morial Convention Center
Moderator: Ryan Hsi, Margaret Pearle & TBD
ABSTRACT
TIME NUMBER TITLE
9:30 PD05-01 ASSOCIATION BETWEEN ON-
TREATMENT FOLLOW-UP TESTING
AND MEDICATION ADHERENCE AMONG
PATIENTS PRESCRIBED PREVENTIVE
PHARMACOLOGIC THERAPY FOR URINARY
STONE DISEASE
Joseph Crivelli*, Birmingham, AL, Phyllis Yan,
Ann Arbor, MI, Ryan Hsi, Nashville, TN, Vahakn
Shahinian, Brian Denton, John Hollingsworth,
Ann Arbor, MI Angeles, CA, David Miller, Pittsburgh, PA, Ryan
9:40 PD05-02 ADHERENCE AND MEDICATION BELIEFS
AMONGST PATIENTS PRESCRIBED
THIAZIDES AND ALKALI FOR STONE
PREVENTION AND THEIR ASSOCIATION
WITH STONE RELATED QUALITY OF LIFE
Christopher Haas*, Shuang Li, Stephen Y.
Nakada, Kristina L. Penniston, Madison, WI PERCUTANEOUS NEPHROLITHOTOMY: A
9:50 PD05-03 EFFICACY AND SAFETY OF LUMASIRAN IN
PATIENTS WITH PRIMARY HYPEROXALURIA
TYPE 1: 24-MONTH ANALYSIS OF THE
ILLUMINATE-A TRIAL
John Lieske*, Rochester, MN, Jaap Groothoff,
Amsterdam, Netherlands, Yaacov Frishberg,
Jerusalem, Israel, Anne-Laure Sellier-Leclerc,
Bron, France, Hadas Shasha-Lavsky, Nahariya,
Israel, Jeffrey Saland, New York, NY, Wesley
Hayes, London, United Kingdom, Daniella Magen,
Haifa, Israel, Shabbir Moochhala, London, United
Kingdom, Martin Coenen, Bonn, Germany, Eva
Simkova, Dubai, United Arab Emirates, Taylor
Ngo, John Gansner, Cambridge, MA, Sally-Anne
Hulton, Birmingham, United Kingdom
10:00 PD05-04 EFFECT OF PHYTATE ON HYPERCALCIURIA
SECONDARY TO BONE RESORPTION IN
PATIENTS WITH URINARY STONES
Jordi Guimera*, Ana Martinez Moreno, Jose Luis
Bauza Quetglas, Pilar Sanchis Cortes, Enrique
Pieras Ayala, Feliciano Grases Freixedas, Palma
de Mallorca, Spain
10:10 PD05-05 SINGLE CENTRE EXPERIENCE OF
CHELATING AGENTS IN CYSTINURIA
Bitar Nadia, Purvor Trevor, Foran Niamh, Wells
Hayley, Rottenberg Giles, Game David, Bultitude
Matthew*, Thomas Kay, London, United Kingdom
44
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:20 PD05-06 PROSPECTIVE RANDOMIZED TRIAL OF 2
WEEKS VS 3 MONTHS OF POSTOPERATIVE
ANTIBIOTICS AFTER PERCUTANEOUS
NEPHROLITHOTOMY IN COMPLEX
PATIENTS WITH INFECTION-RELATED
KIDNEY STONES
Ben Chew*, Alina Reicherz, Vancouver, Canada,
Amy E. Krambeck, Chicago, IL, Nicole Miller,
Ryan Hsi, Nashville, TN, Kymora Scotland, Los
Paterson, Victor KF Wong, Vancouver, Canada,
Michelle Semins, Pittsburgh, PA, Dirk Lange,
Vancouver, Canada
10:30 PD05-07 THE EFFICACY AND SAFETY OF
TRANEXAMIC ACID IN THE MANAGEMENT
OF PERIOPERATIVE BLEEDING AFTER
SYSTEMATIC REVIEW AND META-ANALYSIS
OF COMPARATIVE STUDIES
Min Joon Lee, Jin K Kim*, Jennifer Tang, Toronto,
Canada, Jessica Ming, Albuquerque, NM, Michael
Chua, Toronto, Canada
10:40 PD05-08 PHARMACOLOGIC MANAGEMENT OF
URETERAL STENT-RELATED SYMPTOMS:
A DRUG-CLASS AND DRUG SPECIFIC
BAYESIAN NETWORK META-ANALYSIS
David E. Hinojosa-Gonzalez*, Brian H. Eisner,
Boston, MA
10:50 PD05-09 IMPROVED STONE QUALITY OF LIFE IN
PATIENTS WITH OBSTRUCTING URETERAL
STONE ON ALPHA-BLOCKER MEDICAL
EXPULSIVE THERAPY
Brijesh Patel*, St. Louis, MO, Tarik Phillips,
Joshua Palk, Joel Vetter, St. Loius, MO, Mark
Biebel, St. Louis, MO, Alexander Chow, Chicago,
IL, Alethea Paradis, Alana Desai, St. Louis, MO,
Kenneth Sands, Ramakrishna Venkatesh, St.
Loius, MO
11:00 PD05-10 CHARACTERIZATION OF MIXED URINARY
STONE COMPOSITION WITH DUAL-SOURCE
DUAL-ENERGY COMPUTED TOMOGRAPHY
IN VIVO COMPARED WITH INFRARED
SPECTROSCOPY
Xianghu Meng*, Xueying Sun, Rong Cong, Liang
Qi, Zengjun Wang, Rijin Song, Nanjing, China,
People’s Republic of
11:10 PD05-11 USE OF MINI SIPIT BEHAVIORAL
INTERVENTION INCREASES FLUID INTAKE
IN PATIENTS WITH KIDNEY STONES
Necole Streeper*, James Marks, Jason Fairbourn,
Hershey, PA, Emily Frith, University Park, PA,
Edison Thomaz, Austin, TX, Nilam Ram, Stanford,
CA, David Conroy, University Park, PA
Friday, May 13, 2022
Podium Session 6
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: FEMALE INCONTINENCE: THERAPY I
Room 255 @ Ernest N. Morial Convention Center
Moderators: Lynn Stothers, Donna Deng & Doreen Chung
ABSTRACT
TIME NUMBER TITLE
9:30 PD06-01 REAL WORLD OUTCOMES OF URETHRAL
INJECTION OF POLYACRYLAMIDE
HYDROGEL (BULKAMID®) FOR STRESS
URINARY INCONTINENCE WITH INTRINSIC
SPHINCTER DEFICIENCY, PRIOR URETHRAL
SURGERY, OR PRIOR MESH SLING EXCISION
Justina Tam*, Hannah Koenig, Shreeya Popat,
Deborah Sparks, Alvaro Lucioni, Kathleen
Kobashi, Una Lee, Seattle, WA
9:40 PD06-02 LONG-TERM OUTCOMES FROM THE REMEEX
SYSTEM® IN FEMALE PATIENTS WITH
INTRINSIC SPHINCTERIC DEFICIENCY AND
RECURRENT URINARY INCONTINENCE:
DATA FROM A MINIMUM OF 12 YEARS OF
FOLLOW-UP
Phil Hyun Song*, Jong Gyun Ha, Jae Youn Jang, Yeo-
ng Uk Kim, Jae Young Choi, Young Hwii Ko, Ki Hak
Moon, Hee Chang Jung, Daegu, Korea, Republic of
9:50 PD06-03 MINDFULNESS BASED-STRESS REDUCTION
IS ASSOCIATED WITH DECREASED
LEVELS OF PATIENTS′ ANXIETY AFTER
URODYNAMICS - A PROSPECTIVE
RANDOMIZED CONTROLLED TRIAL
Ruby Kuang*, Sydney Drury, Akin Amasyali,
Hillary Wagner, Forrest Jellison, Andrea Staack,
Loma Linda, CA
10:00 PD06-04 A DECEPTION STUDY TO AVOID RECALL
BIAS FOR 3 VALIDATED QUESTIONNAIRES
IN THE OFFICE OR OVER THE PHONE FOR
WOMEN WITH OR WITHOUT URINARY
INCONTINENCE
Meghana Reddy*, Samuel B. Kusin, Alana L.
Christie, Philippe E. Zimmern, Dallas, TX MI, Catherine S. Bradley, Iowa City, IA, Kimberly
10:10 PD06-05 FRACTIONAL CARBON DIOXIDE VAGINAL
LASER FOR THE TREATMENT OF URINARY
SYMPTOMS: 12 MONTHS RESULTS
Ly Hoang Roberts*, Royal Oak, MI, Annah Vollst-
edt, Iowa City, IA, Hailey Eisner, Royal Oak, MI,
Lauren Tennyson, Fair Haven, NJ, Evelyn Shea,
Lisa Vargos, Danielle Tenney, Royal Oak, MI, Ber-
nadette Zwaan, Larry Sirls, Priya Padmanabhan,
Kenneth Peters, Royal Oak, MI
*Presenting author
11:20 PD05-12 WHAT IS THE BEST PLANT-BASED YOGURT
FOR PATIENTS WITH KIDNEY STONES AND/
OR CHRONIC KIDNEY DISEASE?
James Borin*, New York, NY, John Knight, Ross
Holmes, Birmingham, AL, Shivam Joshi, David
Goldfarb, Wilson Lin, Stacy Loeb, New York, NY
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
FRIDAY
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:20 PD06-06 AUTOLOGOUS FASCIAL SLINGS: OFTEN
DISCUSSED, BUT RARELY UTILIZED – A
POPULATION-BASED ASSESSMENT OF
CALIFORNIA STATEWIDE DATA 2013-2018
Allison Sih*, Seth Cohen, Fornati Bedell, Duarte,
CA, Karyn Eilber, Victoria Scott, Los Angeles, CA,
Kai Dallas, Duarte, CA
10:30 PD06-07 REAL-WORLD URINARY TRACT INFECTION
RATES AND ANTIBIOTIC PRACTICE
WITH URETHRAL INJECTION OF
POLYACRYLAMIDE HYDROGEL (BULKAMID®)
Shreeya Popat*, Justina Tam, Hannah Koenig,
Alvaro Lucioni, Kathleen Kobashi, Una Lee,
Seattle, WA
10:40 PD06-08 ROBOTIC FEMALE ARTIFICIAL URINARY
SPHINCTER IMPLANTATION VS MALE
ARTIFICIAL URINARY SPHINCTER
IMPLANTATION FOR NON-NEUROGENIC
STRESS URINARY INCONTINENCE
Benoit Peyronnet*, Alexandre Dubois, Valentine
Lethuillier, Rennes, France, Imad Bentellis, Nice,
France, Quentin Vesval, Camille Haudebert,
Claire Richard, Romain Mathieu, Lucas Freton,
Mehdi El-Akri, Karim Bensalah, Andrea Manunta,
Juliette Hascoet, Rennes, France
10:50 PD06-09 RELATIONSHIPS BETWEEN LONGITUDINAL
URINARY SYMPTOMS AND PHYSICAL AND
PSYCHOSOCIAL FACTORS IN WOMEN IN
THE SYMPTOMS OF LOWER URINARY
TRACT DYSFUNCTION RESEARCH
NETWORK
Abigail R. Smith*, Sarah A. Mansfield, Ann Arbor,
Kenton, Chicago, IL, Margaret Helmuth, Anne P.
Cameron, Ann Arbor, MI, Ziya Kirkali, Bethesda,
MD, C. Emi Bretschneider, Chicago, IL, Victor An-
dreev, Aruna Sarma, Giulia Lane, Ann Arbor, MI,
Sarah Collins, David Cella, Chicago, IL, H. Henry
Lai, St. Louis, MO, Kathryn E. Flynn, Milwaukee,
WI, Steve Harte, Ann Arbor, MI, James W. Griffith,
Chicago, IL
45
11:00 PD06-10 PREDICTORS OF URINARY INCONTINENCE
AMONG HISPANIC/LATINA WOMEN IN THE
UNITED STATES: FINDINGS FROM THE
HISPANIC COMMUNITY HEALTH STUDY/
STUDY OF LATINOS (HCHS/SOL)
Daniel Gonzalez*, Isildinha Reis, Christina Cor-
11:20 PD06-12 USAGE AND COST OF URINARY
dero, Marc Gellman, Miami, FL, Krista Perreira,
Chapel Hill, NC, Martha Daviglus, Olga Gar-
cia-Bedoya, Chicago, IL, Katherine Amin, Raveen
Syan, Miami, FL
11:10 PD06-11 REVISITING ADHERENCE TO THE AUA
PUBLICATION GUIDELINES FOR SUI
LITERATURE
Amber Bauer*, Yu Zheng, Daniel Furlong, Eric
Rovner, Charleston, SC
INCONTINENCE PRODUCTS IN WOMEN
Leah Chisholm*, Elisabeth Sebesta, Stephanie
Gleicher, Melissa Kaufman, Roger Dmochowski,
W. Stuart Reynolds, Nashville, TN
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM

Friday, May 13, 2022 9:30 am – 11:30 am

Podium Session 7
PROSTATE CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY I
Room 245 @ Ernest N. Morial Convention Center
Moderators: K. C. Balaji, Christopher Barbieri & Christian Stief

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
9:30 PD07-01 3JC48-3, A NOVEL MYC/MAX DIMERIZATION 10:20 PD07-06 SPATIAL TRANSCRIPTOMIC PROFILING
INHIBITOR DECREASES GROWTH IN OF PROSTATE CANCER REVEALS ZONE
PROSTATE CANCER SPECIFIC ANDROGEN RECEPTOR
Victor Chalfant*, Carlos Riveros, Sanjeev Shukla, SIGNALING AND IMMUNE INFILTRATION
Teruko Osumi, KC Balaji, Jacksonville, FL Parth Patel*, Srinivas Nallandhighal, Ann Arbor,
MI, David Scoville, Seattle, WA, Lynn Tran, Au-
9:40 PD07-02 TARGETING WNT5A/FZD2 SIGNALING
gusta, GA, Brittney Cotta, Aaron Udager, Arvind
OVERCOMES RESISTANCE TO
Rao, Ganesh Palapattu, Vipulkumar Dadhania,
ENZALUTAMIDE IN ADVANCED PROSTATE
Sethu Pitchiaya, Simpa Salami, Ann Arbor, MI
CANCER
Shu Ning, Chengfei Liu, Wei Lou, Alan Lombard, 10:30 PD07-07 MOLECULAR SUBTYPING OF >80,000
leandro D’Abronzo, Aiming Yu, Christopher PROSTATE CANCER TRANSCRIPTOMES
Evans, Allen Gao*, Sacramento, CA IDENTIFIES FOUR CLASSES WITH
DISTINCT BIOLOGICAL AND CLINICAL
9:50 PD07-03 AN ORAL FIRST-IN-CLASS SMALL
CHARACTERISTICS WITH IMPLICATIONS
MOLECULE RSK INHIBITOR SUPPRESSES
FOR TARGETED THERAPIES
AR VARIANTS AND TUMOR GROWTH IN
Adam Weiner*, Chicago, IL, Yang Liu, San Diego,
PROSTATE CANCER
CA, Ashley Ross, Chicago, IL, Felix Feng, San
Masaki Shiota*, Miho Ushijima, Takashi Matsu-
Francisco, CA, Phuoc Tran, Baltimore, MD,
moto, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi
Nicholas Zaorsky, Hershey, PA, Angela Jia, Balti-
Eto, Fukuoka, Japan
more, MD, Xin Zhao, Alex Hakansson, Vinnie Liu,
10:00 PD07-04 PRE-CLINICAL STUDIES FOR ADVANCING James Proudfoot, Ewan Gibb, Elai Davicioni, San
CIRMTUZUMAB-BASED ANTI-ROR1 Diego, CA, Daniel Spratt, Cleveland, OH, Edward
THERAPIES IN METASTATIC PROSTATE Schaeffer, Chicago, IL
CANCER
10:40 PD07-08 FIBROBLAST ACTIVATION PROTEIN-
Michelle Muldong, Sanghee Lee, Theresa Mendo-
SPECIFIC MRI PROVIDES IMPROVED
za, Danielle Burner, Christina Wu, Jamillah Mur-
TUMOUR MAPPING IN AN ORTHOTOPIC
tadha, Evodie Koutouan, Naomi Pineda, Gabriel
MODEL OF PROSTATE CANCER COMPARED
Pineda, Kathleen Lennon, Hao Pham, Karl Willert,
TO PROSTATE SPECIFIC MEMBRANE
La Jolla, CA, Nicholas Cacalano, Los Angeles,
ANTIGEN
CA, Catriona Jamieson, Terry Gaasterland, Chris-
Nicole Dmochowska*, Valentina Milanova, Anil
topher Kane, Anna Kulidjian, Christina Jamieson*,
Shetty, Adelaide, Australia, Ramesh Mukkamala,
La Jolla, CA
Lafayette, IN, Madduri Srinivasarao, Lafayette, IN,
10:10 PD07-05 IDENTIFICATION OF IDH1 MUTATION Eric Walser, Galveston, TX, Phil Low, Lafayette,
AND CANDIDATE DRUG IN PROSTATE IN, Benjamin Thierry, Adelaide, Australia
ADENOCARCINOMA BY INTEGRATED
10:50 PD07-09 MEIS PROTEINS INHIBIT HOXB13-
BIOINFORMATIC ANALYSIS: IMPLICATIONS
DEPENDENT PROSTATE CANCER
FOR NEXT GENERATION OF PROSTATE
METASTASIS AND ANDROGEN RECEPTOR
ADENOCARCINOMA MANAGEMENT?
SIGNALING
Chen-Yueh Wen*, Wei-Ting Kuo, Chia-Cheng Yu,
Srikanth Perike*, Calvin VanOpstall, Mathias
Jen-Tai Lin, Kaohsiung, Taiwan
Morales, Sophia Lamperis, Steve Kregel, Ryan
Brown, Donald J Vander Griend, Chicago, IL

46
11:00 PD07-10 STROMAL ANDROGEN RECEPTOR INHIBITS
PROSTATE TUMOR PROGRESSION BY
RESTRAINING SECRETORY LUMINAL
EPITHELIAL CELLS
Zhu Wang*, Yueli Liu, Santa Cruz, CA, Jiawen
Wang, Beijing, China, People’s Republic of,
Corrigan Horton, Joshua Stefanson, Qing Xie,
Santa Cruz, CA Patrick Gomella, Maria Merino, Bradford Wood,
11:10 PD07-11 VITAMIN D HAS A STRONGER IMPACT ON
PROSTATE TUMOR GENE EXPRESSION IN
BLACK MEN
Neil Mistry*, Cordero McCall, Chicago, IL,
Moray Campbell, Columbus, OH, Adam Murphy,
Chicago, IL
Friday, May 13, 2022
Podium Session 8
INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: INTERSTITIAL CYSTITIS
Room 244 @ Ernest N. Morial Convention Center
Moderators: H. Henry Lai, Praveen Thumbikat & John Lavelle
ABSTRACT
TIME NUMBER TITLE
9:30 PD08-01 B-CELL CLONOTYPE IN PATIENTS WITH
INTERSTITIAL CYSTITIS/BLADDER PAIN
SYNDROME PRESENTING WITH HUNNER
LESIONS
Inna Tabansky, Mahasset, NY, Min Liu, New Ha-
ven, CT, Robert Moldwin, Manhasset, NY, Souhel
Najjar, New York, NY, Derin Keskin, Boston, MA,
Vishaan Nursey, Manhasset, NY, Johannes Yeh,
Cold Spring Harbor, NY, Vladimir Brusic, Ningbo,
China, People’s Republic of, Guanglan Zhang,
Boston, MA, Joel N.H. Stern*, Hempstead, NY
9:40 PD08-02 URINARY DIVERSION FOR INTERSTITIAL
CYSTITIS/BLADDER PAIN SYNDROME:
PREVALENCE AND PERIOPERATIVE
COMPLICATION RATE
Paige Kuhlmann*, Los Angeles, CA, Kai Dallas,
Duarte, CA, Peris Castaneda, Victoria Scott, Los
Angeles, CA, Jennifer Anger, San Diego, CA,
Karyn Eilber, Los Angeles, CA
9:50 PD08-03 CAPTURING REAL TIME EVIDENCE OF
UROTHELIAL PERMEABILITY IN LIVE
RODENT BY MRI
Pradeep Tyagi*, Nishant Singh, Lesley Foley,
T. Kevin Hitchens, Jodi Maranchie, Christopher
Chermansky, Naoki Yoshimura, Jonathan
Kaufman, Pittsburgh, PA Ji-Ae Jang, Hyun-Jung Cho, Daegu, Korea,
10:00 PD08-04 CYSTOSCOPIC DETECTION OF HUNNER
LESIONS ASSISTED WITH MACHINE
LEARNING-BASED ALGORITHM IN
INTERSTITIAL CYSTITIS/BLADDER PAIN
SYNDROME (IC/BPS) PATIENTS
Tomohiro Ueda*, Kyoto, Japan, Andrey Grush-
nikov, Yuki Matsuda, Tokyo, Japan, Naoki Yoshi-
mura, Pittsburgh, PA Robert Moldwin, Lake Success, NY
*Presenting author 47
11:20 PD07-12 IDENTIFICATION OF CHROMATIN
SIGNATURES PREDICTIVE OF PROSTATE
CANCER PROGRESSION
Michael Rothberg*, Jacob Enders, Cheyenne
Williams, Michael Daneshvar, Nitin Yerram,
Sohyoung Kim, Saori Fujiwara, Lorenzo Rinaldi,
Songjoon Baek, Luke O’Connor, Qizong Kim,
FRIDAY
Peter Choyke, Baris Turkbey, Gordon Hager,
Peter Pinto, Bethesda, MD
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:10 PD08-05 COMPARING CONCENTRATION OF
INFLMATORY CYTOKINES IN IC, OAB, UTI,
AND BLADDER CANCER URINE SPLES
Elijah Ward, Sarah Bartolone, Alexander Varabu-
lea, Prasun Sharma, Joseph Janicki, Royal Oak,
MI, Melissa Laudano, Nitya Abrah, New York,
NY, Christopher Smith, Houston, TX, Bernadette
Zwaans, Michael Chancellor*, Royal Oak, MI,
Laura Lb, Ann Arbor, MI
10:20 PD08-06 PREVALENCE OF URGE URINARY
INCONTINENCE ONG WOMEN WITH
INTERSTITIAL CYSTITIS/BLADDER PAIN
SYNDROME
Alexandra Dubinskaya*, Beverly Hills, CA, Lauren
Tholemeier, Los Angeles, CA, Tyler Erickson,
anda De Hoedt, Durh, NC, Kil Barbour, Atlanta,
GA, Jayoung Kim, Stephen Freedland,
Los Angeles, CA, Jennife Anger, La Jolla, CA
10:30 PD08-07 ANTIFIBROSIS TREATMENT IMPROVES
BLADDER DYSFUNCTION AND PAIN
PERCEPTION IN A MOUSE MODEL
OF BLADDER PAIN WITH CENTRAL
SENSITIZATION MIMICKING
INTERSTITIAL CYSTITIS
Joonbeom Kwon*, Hye-RI Park, Eun-Ju Lee,
Republic of, Naoki Yoshimura, Pittsburgh, PA
10:40 PD08-08 IMPROVEMENT IN PAIN CATASTROPHIZING
RELATED TO IMPROVED OUTCOMES IN
PATIENTS WITH CHRONIC PELVIC PAIN (CPP)
Jacob Gaines*, Daniel Alaiev, Lindsey Nyman,
Shashank Pandya, Danielle Wang, Kate Kunkle,
Jennifer Fariello-Moldwin, Stephanie Goldstein,
10:50 PD08-09 THE ROLE OF VIRTUAL SUPPORT GROUPS
IN THE MANAGEMENT OF PATIENTS WITH
INTERSTITIAL CYSTITIS
David Mauler, Gina Toma*, Aqsa Khan, Phoenix, AZ Iowa City, IA, John Farrar, Philadelphia, PA,
11:00 PD08-10 DEHYDRATED HUMAN NION-CHORION
MEMBRANES CAN ELIORATE INTERSTITIAL
CYSTITIS IN RATS BY DOWN-REGULATING
INFLMATORY CYTOKINES AND PROTEIN
CODING GENES
Che Hsueh Yang*, Yi Sheng Lin, Wei Chun Weng,
Chin Heng Lu, Chao Yu Hsu, Min Che Tung, Chi
Chien Lin, Yen Chuan Ou, Taichung, Taiwan 11:20 PD08-12 EFFICACY OF PERCUTANEOUS TIBIAL
11:10 PD08-11 USING A MOBILE PHONE APPLICATION TO
DISCOVER PELVIC PAIN PROFILE CLUSTERS
IN UROLOGIC CHRONIC PELVIC PAIN
SYNDROME (UCPPS)
Friday, May 13, 2022
Video Session 2
BPH/MALE VOIDING DYSFUNCTION/INFECTION/MISC. IMAGING
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderator: Marcelino Rivera, Gregg Eure & Taek Won Kang
ABSTRACT
TIME NUMBER TITLE
9:30 V02-01 DESIGN AND VALIDATION OF A NON-
BIOHAZARDOUS SIMULATION MODEL FOR
HOLMIUM LASER ENUCLEATION OF THE
PROSTATE (HOLEP)
Ahmed Ghazi*, Rachel Melnyk, John Melnyk,
Rajat Jain, Scott Quarrier, Rochester, NY, Amy
Krambeck, Chicago, IL, Nicole Miller, Nashville,
TN, Narang Gopal, Mitchell Humphreys,
Phoenix, AZ
9:40 V02-02 CHARACTERIZATION OF LUMENIS 120H
LASER POWER OUTPUT MODES FOR
HOLMIUM LASER ENUCLEATION OF
PROSTATE
Seung-June Oh*, Hyuk Dal Jung, Min Soo Choo,
Seoul, Korea, Republic of, Seong Jin Jeong,
Seongnam, Korea, Republic of
9:50 V02-03 TRANSPERINEAL FUSION PROSTATE
LASER ABLATION FOR THE TREATMENT
OF BENIGN PROSTATIC HYPERPLASIA:
TECHNIQUE AND RESULTS
Fernando Bianco*, Luis Avila, Eusebio Luna,
Alberto Lopez-Prieto, Ariel Kaufman, Pedro Gon-
zalez, David Cohen, Edward Gheiler, Miami, FL
10:00 V02-04 SINGLE-PORT TRANSVESICAL SIMPLE
PROSTATECTOMY FOR BIG MEDIAN LOBE
Mahmoud Abou Zeinab*, Aaron Kaviani, Ethan
Ferguson, Alp T. Beksac, Jihad Kaouk,
Cleveland, OH
48
Bradley Erickson*, Iowa City, IA, Bayley Taple,
Jes Griffith, Chicago, IL, Mengying You, Weng-
hseng Guo, Philadelphia, PA, Catherine Bradley,
Priyanka Gupta, Ann Arbor, MI, Karl Kreder, Iowa
City, IA, Henry Lai, St. Louis, MO, Bruce Naliboff,
Los Angeles, CA, Diane Newman, Philadelphia,
PA, Larissa Rodriguez, Los Angeles, CA, Theresa
Spitznagle, Siobhan Sutcliffe, St. Louis, MO,
Suzette Sutherland, Seattle, WA, Richard Landis,
Philadelphia, PA
NERVE STIMULATION (PTNS) FOR
INTERSTITIAL CYSTITIS / BLADDER PAIN
SYNDROME (IC/BPS) RELATED LOWER
URINARY TRACT AND PELVIC SYMPTOMS
Abdelrahman S. Abdalla*, Sean W. Berquist,
Stanford, CA, Chen Shenhar, Tikva, Israel, Ste-
fanie van Uem, Ashu Mohmad, Amy D. Dobberfu-
hl, Stanford, CA
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:10 V02-05 ROBOTIC TRANSVESICAL SIMPLE
PROSTATECTOMY: OUR EXPERIENCE AND
TECHNIQUE
Shirin Razdan*, Burak Ucpinar, Kennedy E.
Okhawere, Indu Saini, New York City, NY, Tara
Tomy, New York, NY, Ketan K. Badani, New York
City, NY
10:20 V02-06 FUNCTIONAL OUTCOMES OF
EXTRAPERITONEAL LAPAROSCOPIC
ADENOMECTOMY
Roberto Hugo Martinez Rodriguez*, Alberto
Robles Samaniego, Cristina Gutierrez Ruiz, Leire
Portilla Maediavilla, Valladolid, Spain, Alejandro
Garcia Viña, Valladoldi, Spain, Jose H. Amon
Sesmero, Valladolid, Spain
10:30 V02-07 LAPAROSCOPIC URETHRA-SPARING
SIMPLE PROSTATECTOMY IN AVERAGE SIZE
PROSTATES: A PARADIGM SHIFT?
André Barcelos*, Pedro Bargão Santos, Estêvão
Lima, Lisbon, Portugal
10:40 V02-08 ARTIFICIAL URINARY SPHINCTER CUFF
MODIFICATION AND OTHER “TRICKS OF
THE TRADE”
Jane Kurtzman, Preston Kerr*, Steven Brandes,
New York City, NY
10:50 V02-09 A NOVEL IMPLANTATION TECHNIQUE FOR
THE ADJUSTABLE CONTINENCE THERAPY
DEVICE (PROACT)
Hasan Jhaveri*, Kenan Ashouri, Troy Larson,
Lawrence Yeung, Gainesville, FL
11:00 V02-10 LONG TERM EVALUATION OF THE ARGUS-T® 11:20 V02-12 LARGE VOLUME STONE EXTRACTION FOR
ADJUSTABLE MALE SLING: A PROSPECTIVE THE TREATMENT OF CHRONIC PROSTATITIS
STUDY George Koch*, Sarah Flury, Nashville, TN
Rafael Zanotti*, André Costa Matos, Felipe

APPROVED FOR AMA PRA CATEGORY 2.0
Pinho, Claudio Hideki Toi, Sergio Paolillo, Giovani
CREDITSTM
Demartino, Marcel Takada, Bruno Hirata, Luís
Gustavo Morato de Toledo, São Paulo, Brazil
11:10 V02-11 NEPHROSTOMY BALLOON & SHEATH

FRIDAY
SUPRAPUBIC TUBE PLACEMENT: A
MINIMALLY INVASIVE APPROACH TO LARGE
CALIBER SUPRAPUBIC TUBE PLACEMENT
Kevin Flynn*, Charles Schlaepfer, Faizan Khawa-
ja, Bradley Erickson, Iowa City, IA

Friday, May 13, 2022 10:00 am – 5:00 pm

SOCIETY OF GENITOURINARY RECONSTRUCTIVE SURGEONS (GURS)
LaNouvelle Orleans Ballroom B @ Ernest N. Morial Convention Center
10:00 PRESIDENTIAL ADDRESS SMALL BOWEL AUGMENTATION WITH
Society President: Francisco Martins CATHETERIZABLE CHANNELS IN ADULTS
John Stoffel
10:10 BRANTLEY SCOTT LECTURE: CONGENITAL
UROLOGY CONTINENT CATHETERIZABLE
Moderator: Tamsin Greenwell ILEOCECOCYSTOPLASTY AND SIGMOID
Keynote Speaker: Hadley Wood COLON AUGMENT
Jeremy Myers
Q&A
CHANNEL REPAIR / REPLACEMENT
10:40 TRANSGENDER SURGERY
Lindsay Hampson
SURGICAL TECHNIQUES: PENILE PROSTHESIS
LONG-TERM COMPLICATIONS AFTER
PLACEMENT IN TRANSMASCULINE SURGERY
AUGMENTATION CYSTOPLASTY
Moderators: Marta Bizic, James Hotaling, Joseph Pariser
Blayne Welk
Panelists: Miroslav Djordjevic, Geolani Dy, Lee Zhao
Q&A
Q&A
2:20 WHAT IS NEW IN URETHRAL STRICTURES?
KNOWLEDGE GAPS IN GENDER AFFIRMATION
Moderators: Francisco Martins, O. Lenaine Westney
SURGERY
Moderators: Brad Figler, Rachel Moses, Dmitriy Nikolavsky UPDATE ON RECTAL MUCOSA GRAFTING
Speaker: Richard Santucci Alex Vanni
HOW TO SET UP A GENDER-AFFIRMATION SUR- MINIMALLY INVASIVE TREATMENT WITH ANTI-FI-
GERY PROGRAM BRINOLYTICS FOR URETHRAL STRICTURES
Moderators: Bradley Figler, Rachel Moses, Dimitry Nikolavsky Ramon Virasoro
Speaker: Polina Reyblat
SURGICAL TECHNIQUE: NON-TRANSECTING
Q&A BULBAR URETHROPLASTY
Keith Rourke
TOP 2 INNOVATIVE PAPERS IN RECONSTRUC-
TIVE UROLOGY 2021 Q&A
Bradley Erickson
3:00 BREAK
12:00 LUNCH
3:15 URETERAL REPAIR
1:00 CHARLES DEVINE LECTURE Moderators: Frank Burks, Hadley Wood
Moderator: Miroslav Djordjevic
EVIDENCE UNDERLYING SPY ANGIOGRAPHY
GLOBAL UROLOGY Boyd Viers
Keynote Speaker: Catherine deVries
ILEAL URETER OUTCOMES
Q&A Brian Flynn
1:30 FOCUS ON SURGICAL MANAGEMENT OF BUCCAL GRAFT URETERAL RECONSTRUCTION
NEUROGENIC BLADDER Jill Buckley
1:30
SURGICAL TECHNIQUES: AUGMENTATION APPENDIX ONLAY / SUBSTITUTION
CYSTOPLASTY Daniel Eun
Moderators: Sean Elliott, Tasmin Greenwell,
Q&A
Judith Hagedorn

*Presenting author 49
4:15 GURS INITIATIVES
YOUNG RECONSTRUCTIVE UROLOGIST’S
COMMITTEE
Andrew Cohen
GURS 2ND ANNUAL ACADEMIC CONGRESS:
MONTREAL
Francisco Martins
UROLOGY: GURS OFFICIAL JOURNAL
Bradley Erickson
Friday, May 13, 2022
Moderated Poster Session 7
BLADDER & URETHRA: ANATOMY, PHYSIOLOGY & PHARMACOLOGY
Room 228 @ Ernest N. Morial Convention Center
Moderator: Rosalyn Adam & Travis Jerde
ABSTRACT
NUMBER TITLE
MP07-01 RESTORATION OF BLADDER, URETHRAL
AND ANAL SPHINCTER FUNCTION AFTER
SURGICAL REINNERVATION IN LOWER
MOTOR NEURON LESIONED CANINES
Ekta Tiwari*, Lucas Hobson, Danielle Porreca,
Alan Braverman, Nagat Frara, Geneva Cruz,
Dania Giaddui, Philadelphia, PA, Justin Brown,
Boston, MA, Michael Mazzei, Michel Pontari, Ida
Wagner, Mary Barbe, Michael Ruggieri,
Philadelphia, PA
MP07-02 LONG-TERM BLADDER DECENTRALIZATION
IN CANINES CHANGES THE LOCATION AND
PHARMACOLOGY OF NEUROMUSCULAR
NICOTINIC RECEPTORS IN THE
INTRAMURAL GANGLION NEURONS
Nagat Frara*, Dania Giaddui, Alan S. Braverman,
Danielle S. Porreca, Ekta Tiwari, Lucas J. Hob-
son, Courtney L. Testa, Philadelphia, PA, Justin
M. Brown, Boston, MA, Michael Mazzei, Ida J.
Wagner, Michel A. Pontari, Mary F. Barbe, Michael
R. Ruggieri, Sr., Philadelphia, PA
MP07-03 BIOMECHANICAL PROPERTIES OF BLADDER
AFTER MID-THORACIC CONTUSION IN RAT
MODEL
Jonathan Hu*, Blaine Christiansen, Stephanie
Osborn, Tanya Garcia-Nolen, Eric Kurzrock,
Sacramento, CA
MP07-04 DEVELOPMENT OF A PORCINE MODEL TO
QUANTIFY AFFERENT NERVE SIGNALING:
A PRELIMINARY STUDY
Christopher Bednarz*, Michael Shields, Graham
Pingree, Abraham Alattar, David Lester, Ashley
Cardenas, Sean Bryant, William Visser, John
Speich, Adam Klausner, Richmond, VA
50
PRESENTATION OF 2021 GRADUATING
FELLOWS’ DIPLOMAS
Keith Rourke
AWARDS AND RECOGNITION, OUTGOING
PRESIDENT AND BOARD MEMBERS
Francisco Martins
APPROVED FOR AMA PRA CATEGORY 1
CREDITTMf
10:30 am – 11:45 am
ABSTRACT
NUMBER TITLE
MP07-05 BLADDER OXIDATIVE STRESS AND ERK
SIGNALING CONTRIBUTE TO BLADDER PAIN
MEDIATED BY MACROPHAGE MIGRATION
INHIBITORY FACTOR AND HIGH MOBILITY
GROUP BOX 1
Shaojing Ye, Fei Ma, Dlovan Mahmood, Lexing-
ton, KY, Katherine Meyer-Siegler, St Petersburg,
FL, Lin Leng, Richard Bucala, New Haven, CT,
Pedro Vera*, Lexington, KY
MP07-06 SPECIALIZED PRO-RESOLUTION MEDIATORS
IN THE BLADDER: RECEPTOR EXPRESSION
AND RECOVERY OF BLADDER FUNCTION
FROM CYSTITIS
Francis Hughes*, Armand Allkanjari, Michael
Odom, J. Todd Purves, Durham, NC
MP07-07 5-AMINOLEVULINIC ACID PREVENTS
CYCLOPHOSPHAMIDE-INDUCED BLADDER
DYSFUNCTION IN RATS
Takahira Kuno*, Takahiro Shimizu, Chiaki Kawa-
da, Atsushi Kurabayashi, Zou Suo, Hiroki Moga-
wa, Masayuki Tsuda, Motoaki Saito, Keiji Inoue,
Kochi, Japan
MP07-08 CD44 EXPRESSION IS REDUCED IN LICHEN
SCLEROSUS
Ali Ghasemzadeh*, Brian Walczak, Chad Vezina,
Wade Bushman, Wei Huang, Matthew Grimes,
Madison, WI
MP07-09 TREATMENT WITH LEVOTHYROXINE
AND TESTOSTERONE AFFECT BLADDER
CONTRACTILITY AND HISTOMORPHOLOGY
DIFFERENTLY IN THE RAT MODEL
OF PROPYLTHIOURACIL-INDUCED
HYPOTHYROIDISM
Serap Gur*, Didem Yilmaz-Oral, Ankara, Turkey
MP07-10 TRANSVAGINAL ULTRASONOGRAPHY FOR
TRIGONITIS DIAGNOSIS IN WOMEN
Leopoldo Ribeiro-Filho*, Natália Doratioto Serrano
Faria Braz, Amaury Padilha Balsimelli, Caio Vinícius
Suartz, Daniel Imbassahy de Sá Bittencourt Câmara
e Silva, William C. Nahas, Sao Paulo, Brazil
 MP07-11 REAL WORLD MEDICATION PERSISTENCE IN MP07-16 DETRUSOR CONTRACTILITY IN RESPONSE
TREATMENT OF WOMEN WITH OVERACTIVE TO PGF2α IS INCREASED IN DIABETIC MICE
BLADDER ACCORDING TO LARGE SCALE WITH UAB
PRESCRIPTION CLAIMS DATA Michael Odom*, Francis Hughes, Huixia Jin, J.
Chen Shenhar*, Petah Tikva, Israel, Karin Lifshitz, Todd Purves, Durham, NC
Igor Mintz, Yariv Shtabholtz, Ofer Yossepowitch,
MP07-17 MECHANISMS INVOLVED IN NICOTINAMIDE
Tel Aviv, Israel, Jack Baniel, Shachar Aharony,
ADENINE DINUCLEOTIDE PHOSPHATE
Petah Tikva, Israel
(NADPH) OXIDASE (NOX)-DERIVED

FRIDAY
MP07-12 INHIBITION OF SMOOTH MUSCLE REACTIVE OXYGEN SPECIES (ROS)
CONTRACTION IN ISOLATED HUMAN MODULATION OF MUSCLE FUNCTION IN
DETRUSOR TISSUES BY MIRABEGRON HUMAN BLADDERS
REQUIRES CONCENTRATIONS OUT OF Nagat Frara*, Dania Giaddui, Alan S. Braverman,
THERAPEUTIC RANGE, AND IS LIMITED TO Mary F. Barbe, Philadelphia, PA, Changhao Wu,
NEUROGENIC CONTRACTIONS Surrey, United Kingdom, Michael R. Ruggieri, Sr.,
Ru Huang*, Alexander Tamalunas, Raphaela Philadelphia, PA
Waidelich, Frank Strittmatter, Christian G. Stief,
MP07-18 IDENTIFICATION OF THE MAJOR NADPH
Martin Hennenberg, Munich, Germany
OXIDASE SUBTYPE IN THE MICTURITION
MP07-13 MEDICATIONS MOSTLY ASSOCIATED CENTRE – PATHOLOGICAL IMPLICATIONS
WITH HAEMATURIA: ASSESSMENT OF Qin Wu, Yancheng, China, People’s Republic of,
THE EUDRAVIGILANCE (EV) AND FOOD Ayse Gurpinar, Patrizia Camelliti, Maxwell Rob-
AND DRUG ADMINISTRATION (FDA) erts, Guildford, United Kingdom, Michael Ruggieri,
PHARMACOVIGILANCE DATABASES Sr., Philadelphia, PA, Changhao Wu*, Guildford,
ENTRIES United Kingdom
Lorenzo Maria Rovesti*, Rome, Italy, Antonio Nac-
MP07-19 INCREASED FEMALE DETRUSOR
chia, Ferdinando Di Giacomo, Giuseppe Disabato,
MITOCHONDRIAL RESPIRATION
Rionero in Vulture, Italy, Carmen Gravina, Giaco-
IS REFLECTED IN UPREGULATED
mo Gallo, Jordi Stira, Beatrice Turchi, Alessandro
MITOCHONDRIAL PROTEOME
Guercio, Riccardo Lombardo, Antonio Cicione,
Hanna LK. Long*, Elena S. Pak, Kelsey Fisher-Well-
Olivia Alessandra Voglino, Valeria Baldassarri,
man, Johannan L. Hannan, Greenville, NC
Giorgio Guarnotta, Elisa Mancini, Antonio Franco,
Simone D’Annunzio, Andrea Tubaro, Cosimo De MP07-20 CENTRALLY ADMINISTERED
Nunzio, Rome, Italy CORTICOTROPIN-RELEASING FACTOR
INDUCES FACILITATION OF THE RAT
MP07-14 DIABETIC BLADDER DYSFUNCTION IN MALE
MICTURITION VIA BRAIN GLUTAMATERGIC
AKITA MICE PROGRESSES DIRECTLY TO AN
RECEPTORS
UNDERACTIVE PHENOTYPE
Takahiro Shimizu*, Yurika Hata, Suo Zou, Masaki
Armand Allkanjari*, Francis Hughes, J Todd
Yamamoto, Hideaki Ono, Yohei Shimizu, Takaaki
Purves, Durham, NC
Aratake, Shogo Shimizu, Youichirou Higashi,
MP07-15 THE EFFECTS OF TMEM16A CHLORIDE Takashi Karashima, Motoaki Saito, Nankoku,
CHANNEL ACTIVATOR ON CYSTOMETRY Japan
IN RATS WITH METABOLIC SYNDROME
APPROVED FOR AMA PRA CATEGORY 1.25

INDUCED ACONTRACTILE DETRUSOR
CREDITSTM
Yuh-Chen Kuo, Cheng-An Kuo*, Hong-Chiang
Chang, Ju-Ton Hsieh, Taipei, Taiwan

*Presenting author 51
Friday, May 13, 2022
Moderated Poster Session 8
PEDIATRIC UROLOGY: PENIS & SCROTUM
Room 225 @ Ernest N. Morial Convention Center
Moderator: Charlotte Wu
ABSTRACT
NUMBER TITLE
MP08-01 OPERATIVE OUTCOMES OF PEDIATRIC
NON-CONGENITAL URETHROPLASTY AT A
SINGLE TERTIARY CARE INSTITUTION
James Ding*, Sameer Mittal, Jason Van Bata-
via, Dana Weiss, Stephen Zderic, Mark Zaontz,
Aseem Shukla, Arun Srinivasan, Christopher
Long, Robert Kovell, Philadelphia, PA Yacov, Israel
MP08-02 ARE YOU A MORNING PERSON? THE
IMPACT OF MODIFIABLE PERIOPERATIVE
AND OPERATIVE VARIABLES ON EARLY
POSTOPERATIVE COMPLICATIONS
FOLLOWING PRIMARY HYPOSPADIAS
REPAIR (HR)
Christopher Cooper*, Douglas Storm, Gina Lock-
wood, Megan Bonnett, Benjamin Cooper, Logan
Harris, Iowa City, IA
MP08-03 FLOW RATES AND FLOW INDEXES IN
PEDIATRIC PATIENTS AFTER HYPOSPADIAS
URETHROPLASTY: UROFLOW PARAMETERS
IN 458 REPAIRED HYPOSPADIAC AND 1,081
NORMAL FLOWS
Joseph Boroda*, Mineola, NY, Paul Zelkovic,
Westchester, NY, Alexander Fang, Jordan Gitlin,
Mineola, NY, Israel Franco, New Haven, CT
MP08-04 USE OF PRE-OPERATIVE TESTOSTERONE
PRIOR TO DISTAL HYPOSPADIAS REPAIR
DOES NOT INCREASE POST-OPERATIVE
COMPLICATIONS
Sahar Eftekharzadeh*, Sameer Mittal, Nathan
Hyacinthe, Dana A. Weiss, Jason Van Batavia,
Aseem R. Shukla, Arun K. Srinivasan, Thomas F.
Kolon, Stephen A. Zderic, Douglas A. Canning,
Mark R. Zaontz, Christopher J. Long, Philadel-
phia, PA COVER NEWBORN CIRCUMCISION THERE
MP08-05 EVALUATING THE QUALITY OF ONLINE
HEALTH EDUCATIONAL RESOURCES
REGARDING HYPOSPADIAS DIAGNOSIS AND
TREATMENT
Yash Shah*, Nathan Hyacinthe, Philadelphia,
PA, Nicolas Fernandez, Seattle, WA, Carlos
Villanueva, Phoenix, AZ, Paige Bosse, Melise
Keays, Ottawa, Canada, Christopher Long,
Philadelphia, PA ester, NY, Tanya Logvinenko, Saafia Masoom,
52
10:30 am – 11:45 am
ABSTRACT
NUMBER TITLE
MP08-06 USE OF A MID-URETHRAL STENT
(CONTINENT) FOR HYPOSPADIAS SURGERY
IN TOILET-TRAINED CHILDREN
Eyal Kord, Ryan Nasseri, Kobi Stav, Amnon
Zisman, Neena Carr*, Beer Yacov, Israel, Martin
Koyle, Toronto, Canada, Amos Neheman, Beer
MP08-07 LONG TERM CONSEQUENCES OF FAILURE
TO REPAIR CORPUS SPONGIOSUM IN
DISTAL HYPOSPADIAS
David Ali*, Paterson, NJ, Moneer Hanna, New
York, NY
MP08-08 PREDICTORS FOR COSMETIC OUTCOMES
IN HYPOSPADIAS REPAIR: PROSPECTIVE
ASSESSMENT BASED ON VALIDATED
QUESTIONNAIRES
Amos Neheman, Neena Carr*, Ilia Beberash-
vili, Amnon Zisman, Beer Yacov, Israel, Yuval
Bar-Yosef, Tel Aviv, Israel, Kobi Stav, Beer Yacov,
Israel
MP08-09 RECOMMENDATIONS TO IMPROVE
NEONATAL CIRCUMCISION TRAINING
Emilie Johnson*, Ilina Rosokija, Ryan Walton,
Derek Matoka, Catherine Seager, Max Maizels,
Jane Holl, Chicago, IL
MP08-10 DIFFERENTIAL INCENTIVES CREATED BY
PRIVATE VERSUS PUBLIC INSURANCE PLAN
COVERAGE OF PEDIATRIC CIRCUMCISION
Sophia Kamanzi*, Ryan Walton, Ilina Rosokli-
ja, Lauren Corona, Jane Holl, Emilie Johnson,
Chicago, IL
MP08-12 IN STATES WERE MEDICAID DOES NOT
IS AN INCREASE IN OPERATIVE FORESKIN
PROCEDURES AND FORESKIN MORBIDITY
Chung-Yon Lin*, Carlos Villanueva Del Rio, Gwen
Grimsby, Phoenix, AZ
MP08-13 SUCCESSFUL ADOLESCENT
VARICOCELECTOMY IMPROVES TOTAL
MOTILE SPERM COUNT
Michael Kurtz, Boston, MA, Raymond Lay, Roch-
Ozge Yetistirici, Boston, MA, David Diamond*,
Rochester, NY
MP08-14 LONG TERM FERTILITY IMPLICATIONS
FOLLOWING ADOLESCENT TESTICULAR
TORSION: A RETROSPECTIVE ANALYSIS OF
A NEW YORK STATE ALL-PAYER DATABASE
Angela Hacksel-Newmark*, Mountain Home, TN,
Alexandr M. Pinkhasov, Anthony Tracey, Matthew
Mason, Rachel Yakubov, Jeffrey Villanueva,
Syracuse, NY
 MP08-15 ATTITUDES TOWARD FERTILITY-RELATED
CARE AND EDUCATION OF YOUTH AND
YOUNG ADULTS WITH DIFFERENCES OF SEX
DEVELOPMENT: INFORMING FUTURE CARE
MODELS
Lauren E Corona*, Josephine Hirsch, Ilina
Rosoklija, Elizabeth B Yerkes, Emilie K Johnson,
Chicago, IL Zaontz, Christopher Long, Philadelphia, PA
MP08-16 NOVEL BIOMATERIAL FOR SLOW-RELEASE
DRUG DELIVERY TO THE URETHRA
Courtney K. Rowe*, Hartford, CT, Christopher
Foster, Farmington, CT, Wei Ruan, Kelly A. Burke,
Storrs, CT Nelson, Boston, MA
MP08-17 SPINAL ANESTHESIA FOR INFANT
OUTPATIENT GENITAL SURGERY
Jack Elder*, Andrew Chen, Jacquelin Peck,
Christine Mai, Diana Liu, David August, Chang A
Liu, Boston, MA Tanidir, Tufan Tarcan, Selcuk Yucel, Istanbul,
Friday, May 13, 2022
Moderated Poster Session 9
PROSTATE CANCER: DETECTION & SCREENING I
Room 222 @ Ernest N. Morial Convention Center
Moderators: Daniel Barocas & Benjamin Davies
ABSTRACT
NUMBER TITLE
MP09-01 THE ROLE OF PROPHYLACTIC ANTIBIOTICS
IN TRANSPERINEAL PROSTATE BIOPSY: A
SYSTEMATIC REVIEW AND METANALYSIS
Spyridon Basourakos*, New York, NY, Mark
Alshak, Baltimore, MD, Patrick Lewicki, Emily
Cheng, Michael Tzeng, Antonio DeRosa, New
York, NY, Matthew Allaway, Cumberland, MD,
Ashley Ross, Edward Schaeffer, Hiten Patel,
Chicago, IL, Jim Hu, New York, NY, Michael
Gorin, Cumberland, MD
MP09-02 IS IT CLINICALLY AND ONCOLOGICALLY
SAFE TO OMIT PROSTATE BIOPSY IN LOW
RISK STRATIFIED PATIENTS?
Henning Bahlburg*, Karl Heinrich Tully, Vincent
Hoffmann, Herne, Germany, Julian Hanske, Reck-
linghausen, Germany, Nicolas von Landenberg,
Florian Roghmann, Rein-Jueri Palisaar, Joachim
Noldus, Sebastian Berg, Herne, Germany, Marko
Brock, Recklinghausen, Germany
MP09-03 THE EFFICACY OF ADJUVANT AMIKACIN TO
ORAL LEVOFLOXACINE FOR PREVENTION
OF FEBRILE COMPLICATIONS FOLLOWING
TRANSRECTAL PROSTATE BIOPSY
Yoshitsugu Nasu*, Taiki Kanbara, Okayama,
Japan
*Presenting author
MP08-18 CAUDAL ANESTHESIA IS NOT ASSOCIATED
WITH COMPLICATIONS FOLLOWING DISTAL
HYPOSPADIAS REPAIR
Katherine Fischer*, Jason VanBatavia, Nathan Hy-
acinthe, Sameer Mittal, Karl Godlewski, Stephen
Zderic, Aseem Shukla, Arun Srinivasan, Dana
Weiss, Thomas Kolon, Douglas Canning, Mark
FRIDAY
MP08-19 FACTORS AFFECTING ORCHIOPEXY
GUIDELINE ADHERENCE
Andrea Balthazar*, Ted Lee, Tanya Logvinenko,
Caleb Nelson, Hsin-Hsiao Scott Wang, Caleb
MP08-20 THE COMPARISON OF ANXIETY LEVELS IN
CHILDREN WHO UNDERWENT INVASIVE OR
NON-INVASIVE URODYNAMIC STUDIES
Cagri Akin Sekerci, Onur Can Ozkan*, Yiloren
Turkey
 APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
10:30 am – 11:45 am
ABSTRACT
NUMBER TITLE
MP09-04 A UNIQUE COMPARISON OF PROSTATE
CANCER DETECTION RATES BETWEEN
TRANSRECTAL VERSUS TRANSPERINEAL
MRI-TRUS FUSION PROSTATE BIOPSY
AMONG 794 CASES
Renée Hogenhout*, Henk B. Luiting, Daniël F.
Osses, Monique J. Roobol, Rotterdam,
Netherlands
MP09-05 COMPREHENSIVE ANALYSIS OF MORBIDITY
FOLLOWING TRANSPERINEAL PROSTATE
BIOPSY
Vassilios Skouteris*, Athens, Greece, Nelson
Stone, New York, NY
MP09-06 PROSTATE CANCER DETECTION AND
COMPLICATIONS OF TRANSPERINEAL
VERSUS TRANSRECTAL MRI-FUSION
GUIDED PROSTATE BIOPSIES
Dylan Buller*, Jessa Sahl, Ilene Staff, Joseph
Tortora, Kevin Pinto, Tara McLaughlin, Laura
OlivoValintin, Joseph Wagner, Hartford, CT
MP09-07 SAFETY PROFILE OF ROBOTIC-ASSISTED
TRANSPERINEAL MRI-US-FUSION GUIDED
BIOPSY OF THE PROSTATE
Christian Wetterauer*, Walter Manuel, Pawel Trot-
senko, Matthias Marc, Winkel David Jean, Breit
Christian, Meyer Anja, Seifert Hans Helge, Basel,
Switzerland
53
 MP09-08 PATIENT-REPORTED PREFERENCE MP09-16 QUALITY OF INFORMATION IN SPANISH ON
BETWEEN TRANSRECTAL AND BRCA AND GENETIC TESTING IN PROSTATE
TRANSPERINEAL PROSTATE BIOPSY CANCER ON YOUTUBE
Sana N. Siddiqui*, Zorawar Singh, Hugh A. G. Brett Friedman*, Auburn Hills, MI, Kevin Pineault,
Fisher, Ronald P. Junior Kaufman, Badar M. Mian, Tatiana Sanchez Nolasco, New York, NY, Hala
Albany, NY Borno, San Francisco, CA, Veda Giri, Philadel-
phia, PA, Stacy Loeb, New York, NY
MP09-09 THE RESULTS OF TRANSPERINEAL VERSUS
TRANSRECTAL PROSTATE BIOPSY: AN MP09-17 PREDICTING INCIDENCE VERSUS
UPDATED SYSTEMATIC REVIEW AND MORTALITY FOR CANCERS ASSOCIATED
META-ANALYSIS WITH OVERDIAGNOSIS: AN OVERLOOKED
Jindong Dai*, Jiyu Yang, Chengdu, China, ISSUE FOR POLYGENIC RISK SCORES AND
People’s Republic of, Xingming Zhang, Chengdu, CANCER SCREENING
China, People’s Republic of, Pengfei Shen, Hao Andrew Vickers*, New York, NY, Amit Sud,
Zeng, Chengdu, China, People’s Republic of London, United Kingdom, Jonine Bernstein,
New York, NY, Richard Houlston, London,
MP09-10 QUANTIFICATION OF PERINEURAL
United Kingdom
INVASION BY PROSTATE CANCER ON
NEEDLE CORE BIOPSY: IMPLICATION MP09-18 LONGITUDINAL OUTCOMES FOLLOWING
FOR RISK STRATIFICATION IMPLEMENTATION OF BASELINE PSA RISK
Yuki Teramoto, Ying Wang, Hiroshi Miyamoto*, STRATIFICATION OF MEN IN THEIR FORTIES
Rochester, NY Zoe Michael*, Srinath Kotamarti, Rohith Arcot,
Kostantinos Morris, Anand Shah, John Ander-
MP09-11 THE RELATIVE IMPACT OF SPATIAL
son, Andrew Armstrong, Rajan Gupta, Glenn M.
PARAMETERS ON THE PERFORMANCE OF
Preminger, Judd W. Moul, Kevin Oeffinger, Kevin
MRI-US FUSION BIOPSY VS. MRI IN-BORE
Shah, Thomas J. Polascik, Durham, NC
BIOPSY OF THE PROSTATE
Mitch Hayes*, Solange Bassale, Sudhir Isharwal, MP09-19 PROSTATE CANCER STAGING WITH
Christopher Amling, Bryan Foster, Fergus Coak- 18
F-PSMA PET/CT AFTER BONE
ley, Jen-Jane Liu, Portland, OR SCINTIGRAPHY IN MEN WITH AN
INCREASED RISK OF HAVING METASTATIC
MP09-12 PARTIAL PROSTATE GLAND ABLATION:
DISEASE. A HEAD-TO-HEAD COMPARATIVE
LESION LOCATION USING TRANSPERINEAL
ASSESSMENT
MAPPING BIOPSY (TPMB)
Yves Bodar, Wietske Luining*, Amsterdam,
Nelson Stone*, New York, NY, Vassilios Skouteris,
Netherlands, Bram Keizer, Hoorn, Netherlands,
Athens, Greece
Dennie Meijer, Amsterdam, Netherlands, Annelies
MP09-13 THE VALUE OF [F-18]FLORASTAMINR Vellekoop, Amstelveen, Netherlands, Maarten
PROSTATE SPECIFIC MEMBRANOUS Schaaf, Harry Hendrikse, Jeroen van Moorselaar,
ANTIGEN (PSMA) PET/CT AT INITIAL Daniela Oprea-Lager, André Vis, Amsterdam,
DIAGNOSIS OF PROSTATE CANCER Netherlands
COMPARED WITH MULTI-PARAMETRIC
MP09-20 PROSTATE BIOPSY TARGETED TO
MAGNETIC RESONANCE IMAGING (MPMRI)
PROSTATE SPECIFIC MEMBRANE
Hyeok Jae Kwon*, Chang Eil Yoon, Dongho Shin,
ANTIGEN (PSMA) FOCI
Hyong Woo Moon, Yong Hyun Park, Woong Jin
David Kuppermann*, Jeremie Calais, Los
Bae, Hyuk Jin Cho, U-Syn Ha, Sung-Hoo Hong,
Angeles, CA, Wayne Brisbane, Gainesville, FL,
Sae Woong Kim, Ji Youl Lee, Seoul, Korea,
Elizabeth Tran, Lorna Herbert, Matthias Benz,
Republic of
Johannes Czernin, Leonard Marks,
MP09-14 STIMULATED RAMAN HISTOLOGY ALLOWS Los Angeles, CA
FOR RAPID PATHOLOGIC EXAMINATION

APPROVED FOR AMA PRA CATEGORY 1.25
OF UNPROCESSED, FRESH PROSTATE
CREDITSTM
BIOPSIES
Miles P. Mannas*, Derek Jones, Fang-Ming Deng,
Deepthi Hoskoppal, Jonathan Melamed, Daniel
Orringer, Samir S Taneja, New York, NY
MP09-15 INVESTIGATION OF FROZEN SECTION
BIOPSY UTILIZATION IN MAGNETIC
RESONANCE IMAGING–ULTRASONOGRAPHY
FUSION-TARGETED PROSTATE BIOPSY FOR
HIGH-RISK PROSTATE CANCER
Seung Bin Kim*, Jong Hyun Tae, Hyun Jung Jin,
Tae Il Noh, Ji Sung Shim, Seok Ho Kang, Jun
Cheon, Jeong Gu Lee, Sung Gu Kang, Seoul,
Korea, Republic of

54
Friday, May 13, 2022 12:30 pm – 4:30 pm
SOCIETY OF URODYNAMICS, FEMALE PELVIC MEDICINE & UROGENITAL RECONSTRUCTION (SUFU)
Grand Ballroom C @ Hilton New Orleans Riverside
Chairs: Jaspreet Sandhu & Blayne Welk
12:30
WELCOME AND INTRODUCTION: GUIDELINES 2:45
URODYNAMICS: MINI-CASES—HIGHLIGHTING
APPLICABLE TO SUFU THE UTILITY OF URODYNAMICS
Chairs: Jaspreet Sandhu, Blayne Welk Moderator: Alan Wein
Debaters: Humphrey Atiemo, Howard Goldman,

FRIDAY
12:35 AUA GUIDELINE PROCESS
Richard K. Lee
Peter Clark
3:15 INCONTINENCE AFTER PROSTATE TREATMENT:
12:45 DIAGNOSIS AND TREATMENT OF NON-NEURO-
OVERVIEW AND RATIONALE
GENIC OVERACTIVE BLADDER (OAB) IN ADULTS:
Kurt McCammon
AN AUA/SUFU GUIDELINE
Sandip Vasavada 3:25
DEBATE: INCONTINENCE AFTER PROSTATE
TREATMENT—EFFECT OF RADIATION ON PPI
12:55
DEBATE: FIRST LINE MEDICAL THERAPY FOR A
(TIMING OF XRT IN PATIENTS CONSIDERING
60 YEAR OLD FEMALE WITH OAB—BETA AGO-
ANTI-INCONTINENCE SURGERY)
NISTS VERSUS ANTICHOLINERGICS
Moderator: Kurt McCammon
Moderator: Sandip Vasavada
Debaters: Brian Linder, Polina Reyblat, Jaspreet Sandhu
Debaters: Michael Chancellor, Tomas Griebling
3:40
DEBATE: INCONTINENCE AFTER PROSTATE
1:10
DEBATE: OPTIMAL THIRD LINE THERAPY FOR
TREATMENT—ROLE OF URINARY DIVERSION IN
OAB FOR SAME WOMAN
PATIENTS WITH MULTIPLE AUS FAILURES AND/
Moderator: Sandip Vasavada
OR INTRACTABLE BNC
Debaters: Doreen Chung, Charles Powell
Moderator: Kurt McCammon
1:30 FEMALE SUI GUIDELINE Debaters: Melissa Kaufman, Alvaro Lucioni
Kathleen Kobashi
3:55 RECURRENT UTI IN WOMEN: OVERVIEW AND
1:40
DEBATE: MANAGEMENT OF RECURRENT SUI RATIONALE
POST TVT—REPEAT THE MIDURETHRAL SLING Jennifer Anger
VS NON-MESH SLING
4:05
RECURRENT UTI IN WOMEN: 40 YEAR OLD WITH
Moderator: Kathleen Kobashi
RECURRENT UTI’S TREATED - IS THERE A ROLE
Debaters: Ekene Enemchukwu, Anne Suskind
FOR CRANBERRY OR OTHER NON-ANTIBIOTIC
2:00
DEBATE: HOW TO APPROACH THE WOMAN WHO SOLUTIONS?
ISN’T SURE ABOUT THE SAFETY OF A SYNTHET- Moderator: Jennifer Anger
IC MIDURETHRAL SLING—REASSURE HER VS Debaters: A. Ackerman, Katherine Amin, Bilal Chughtai
ENCOURAGE THE ALTERNATIVES
4:20
RECURRENT UTI IN WOMEN: IS LONG-TERM
Moderator: Rena Malik
ANTIBIOTIC PROPHYLAXIS APPROPRIATE FOR A
Debaters: Anne Pelletier Cameron, W. Stuart Reynolds,
WOMEN WITH RUTI’S?
Ariana Smith
Moderator: Jennifer Anger
2:20 BREAK Debaters: Nitya Abraham, Toby Chai
2:35 URODYNAMICS: WHO REALLY NEEDS URODY- 4:30 CLOSING REMARKS/ADJOURN
NAMICS Blayne Welk
Alan Wein
APPROVED FOR AMA PRA CATEGORY 1
CREDITTM

Friday, May 13, 2022 1:00 pm – 3:00 pm

EDITORIAL WORKSHOP: GETTING PUBLISHED AND BEYOND
Room 345 @ Ernest N. Morial Convention Center
EDITORIAL WORKSHOP: GETTING PUBLISHED
AND BEYOND
Panelists: John Davis, John D. Denstedt, J. Stephen
Jones, Rena D. Malik, D. Robert Siemens

*Presenting author 55
Friday, May 13, 2022 1:00 pm – 5:00 pm

Forums
HISTORY OF UROLOGY FORUM
Room 355 @ Ernest N. Morial Convention Center

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
1:00 HISTORY FORUM POSTERS HF02-13 A BOHNE FIDE TITAN OF UROLOGY
Isaac Palma-Zamora*, Craig Rogers, James
HF02-01 COVID-19 AND SEX
Peabody, Naveen Kachroo, Detroit, MI
Zachary Seymour*, San Antonio, TX, Michael
Moran, Columbia, SC HF02-14 HERMAN KRETSCHMER: FROM
GENITOURINARY PATHOLOGY TO
HF02-02 THOMAS ROWLANDSON AND THE ENGLISH
PRESIDENCY
PENII
Alice Cheung*, Albany, NY
Michael Moran*, Columbia, SC
1:30 HF01-01 RAINER ENGEL, THE GATEKEEPER OF
HF02-03 ANCIENT AKKADIAN SEX-IMPOTENCE
UROLOGIC HISTORY
RITUALS
Brian Meyerson*, Albany, NY
Tyler Bunting*, Michael Moran, Columbia, SC
1:37 HF01-02 MAKING THE PRIVATES PUBLIC:
HF02-04 THE STATISTICS OF HUMAN SEXUALITY
IMPOTENCE TRIALS IN PREREVOLUTIONARY
Hannah Moreland*, Michael Moran,
FRANCE
Columbia, SC
Jacob Gaines*, Robert Moldwin, Lake Success,
HF02-05 FROM STERILE TO CLEAN: DRAMATIC NY
CHANGES IN CATHETERIZATION DURING
1:44 HF01-03 SMALLPOX VACCINATION: A PHYSICIAN, A
THE 1970s
MINISTER AND AN AFRICAN SLAVE WIN THE
Aaron Huang*, Jacob Gaines, Andrew Winer,
REVOLUTIONARY WAR
Brooklyn, NY
Joseph Hartnett*, Howard Adler, Stony Brook, NY
HF02-06 THE HISTORY OF THE CATHETERIZABLE
1:51 HF01-04 THE BIRTH OF UROLOGY AS A SURGICAL
CHANNEL
SPECIALTY AFTER THE FRENCH
Daniel Tennenbaum*, Brooklyn, NY, Jordan Gitlin,
REVOLUTION
Mineola, NY
Philip Van Kerrebroeck*, Berchem, Belgium
HF02-07 HISTORY OF PERIPHERAL TIBIAL NERVE
1:58 DEBATE: THE INFLATABLE PENILE PROSTHESIS
STIMULATION IN UROLOGY
IS FIRST-LINE THERAPY FOR ED
Adam Visca*, Raymond Lay, Annette E. Sessions,
Moderaters: Ronald Rabinowitz, Irwin Goldstein
Ronald Rabinowitz, Divya Ajay, Rochester, NY
Judges: Barbara Chubak, Kevin Pranikoff, Jennif-
HF02-08 QUANTIFYING THE EDUCATIONAL HISTORY er Gordetsky
OF THE ENDOUROLOGICAL SOCIETY Debaters: Helen Levey Bernie, Gerald Brock
FELLOWSHIP PROGRAMS IN THE UNITED
2:18 HF01-05 DYSURIA: THE DOWNFALL OF AN
STATES
EMPEROR? A UROLOGIC HISTORY OF
Sutchin R. Patel*, Lake Forest, IL, Stephen Y.
NAPOLEON BONAPARTE
Nakada, Madison, WI
Charan Mohan*, Robert Waldbaum, Arthur Smith,
HF02-09 THE EVOLUTION OF THE DIAGNOSTIC Arun Rai, New Hyde Park, NY
LANDSCAPE OF RENAL MASSES
2:25 HF01-06 JOHN WEISS: FROM HIS DEBUT IN
Elizabeth Ellis*, Edward Messing, Rochester,
LITHOTRIPSY TO POP CULTURE
NY
Sana N. Siddiqui*, Albany, NY
HF02-10 MEDICAL METALS: A BIOGRAPHY OF
2:32 HF01-07 SAVE THE CHILDREN: A HISTORY OF
CISPLATIN
FERTILITY PRESERVATION IN MALE
Arnav Srivastava*, Hiren Patel, Thomas Jang,
CHILDREN AND ADOLESCENTS
Eric Singer, Saum Ghodoussipour, New
Lauren Gochenaur, Alexis Steinmetz, Kit Yuen*,
Brunswick, NJ
Joseph Gabrielsen, Ronald Rabinowitz,
HF02-11 PROFESSION IGLESIAS – PHYSICIAN, Rochester, NY
INVENTOR, AND POLITICAL PRISONER
2:39 HF01-08 INDIA’S HISTORY OF MASS STERILIZATION
Janmejay Hingu*, Matthew Davis, Newark, NJ,
Rainjade Chung*, Jane Kurtzman, Steven
Mubashir Billah, Bloomfield, NJ, Hossein
Brandes, New York, NY
Sadeghi-Nejad, East Orange, NJ
2:46 HF01-09 THE FIRST GERMAN UNIVERSITY
HF02-12 REINHOLD WAPPLER: AN IMMIGRANT
LECTURESHIP FOR SEXOLOGY AT
ENGINEER WHO TRANSFORMED THE
KOENIGSBERG (TODAY: KALININGRAD).
PRACTICE OF UROLOGY
WHY THERE, WHY JESSNER?
Eric Macdonald*, Ella Taubenfeld, Robert Wald-
Friedrich Moll*, Cologne, Germany,
baum, Lake Success, NY
Thorsten Halling, Richard Kühl, Nils Hansson,
Matthis Krischel, Duesseldorf, Germany

56
2:53 HF01-10 FRANK B. BICKNELL: PIONEER IN
PEDIATRIC UROLOGY AND FOUNDER OF
THE AMERICAN UROLOGICAL ASSOCIATION
HISTORY FORUM
Sutchin R. Patel*, Madison, WI, David A. Bloom,
Ann Arbor, MI, Anthony A. Caldamone,
Providence, RI 4:17 HF01-17 PENILE STRETCHING PRACTICES THROUGH
3:00 2021 RETROSPECTROSCOPE AWARDS
Dr. Adam K. Russon of Buffalo
Dr. Alexis R. Steinmetz of Rochester
(Honorable Mention)
3:05 BICKNELL LECTURE: WORDS MATTER—
TRACING THE LANGUAGE OF SEXUAL
DYSFUNCTION
Sue Goldstein
3:35 HF01-11 “VAGINA” IS NOT A BAD WORD: HISTORICAL
AND CONTEMPORARY CENSORSHIP OF THE
WORD “VAGINA”
Shreeya Popat*, Seattle, WA, Rainey Horwitz, St.
Louis, MO, Karyn Eilber, Los Angeles, CA, Una
Lee, Seattle, WA
3:42 HF01-12 UPDATES TO THE HISTORY OF GENDER-
AFFIRMING VAGINOPLASTY TECHNIQUE
Andrew Zilavy*, Albuquerque, NM, Richard San-
tucci, Austin, TX, Maxx Gallegos, Albuquerque,
NM
3:49 HF01-13 FROM TORTURE TO THERAPY: THE HISTORY
OF HUMAN CASTRATION
Antonio Nacchia*, Rionero in Vulture, Italy, Riccar-
do Lombardo, Cosimo De Nunzio, Andrea Tubaro,
Rome, Italy
3:56 HF01-14 DESCENDING THROUGH THE HISTORY
OF CRYPTORCHIDISM AND TESTICULAR
TUMORS
Alexis Steinmetz*, Kit Yuen, David Diamond,
Ronald Rabinowitz, Rochester, NY
Friday, May 13, 2022
Moderated Poster Session 10
EDUCATION RESEARCH I
Room 228 @ Ernest N. Morial Convention Center
Moderators: Lee Richstone, Elizabeth Takacs & Peter Wang
ABSTRACT
TIME NUMBER TITLE
MP10-01 FACTORS IN UROLOGY JOURNALS THAT
DETERMINE FEMALE AUTHORSHIP
REPRESENTATION: RETROSPECTIVE
REVIEW FROM 2015 TO 2020
Maria Camila Suarez*, Daniel E. Nassau, Miami,
FL, Arjun Watane, New Heaven, CT, Aayush
Shah, Ranjith Ramasamy, Miami, FL
MP10-02 UROLOGY RESIDENT AUTONOMY
COMPARED TO GENERAL SURGERY
RESIDENT AUTONOMY
Kunj Jain*, Totowa, NJ, Janmejay Hingu, Anh
Nguyen, Devashish Anjaria, Joseph B. Oliver,
Hossein Sadeghi-Nejad, Newark, NJ Mason, Ryan Hankins, Ross Krasnow, Jordan
*Presenting author
4:03 HF01-15 FIRST SEX - THE NATUFIAN STATUE
Nikil Sairam*, Michael Moran, Columbia, SC
4:10 HF01-16 EVOLUTION OF THE IDEAL PENIS: PENILE
PREFERENCES THROUGHOUT THE AGES
Leah Beland*, New Hyde Park, NY
TIME AND CULTURE
FRIDAY
John Sigalos*, Sriram Eleswarapu, Jesse Mills,
Los Angeles, CA
4:24 HF01-18 THINK INSIDE THE BOX - REICH’S THEORIES
ON ORGASM AND THE ORGONE
Jonathan Xu*, Burlington, MA, Erin Piermarini,
Worcester, MA, Octavia Devon, Burlington, MA
4:31 HF01-19 EX MACHINA: HISTORIES OF ROBOTIC SEX
Loren Smith*, Michael Moran, Columbia, SC
4:38 HF01-20 THE ARCHER OF MEUDON: THE MYTH OF
THE FIRST PYELOLITHOTOMY
Albert Ha*, Gina Badalato, New York, NY
4:45 HF01-21 A BRIEF HISTORY OF THE ARTIFICIAL
PENILE PEARL
Adam M. Jenks*, Megan R. McMurray,
M. Francesca Monn, Springfield, IL
4:52 HF01-22 REV YOUR ENGINES: HOW AN AUTO
WORKER BROUGHT HOPE TO THOSE WITH
ERECTILE DYSFUNCTION
William Du Comb*, Steven Allegro, Detroit, MI,
Esther Liu, Detroit, MI, Joshua Palka, Detroit, MI
4:59 HF01-23 FREDERICK AUGUSTINE RUPP, M.D. AND
LETTERS TO DAUGHTERS - SEX AND THE
2000s
Victoria Stowasser*, Michael Moran,
Columbia, SCs
1:00 pm – 2:15 pm
ABSTRACT
TIME NUMBER TITLE
MP10-03 SURGICAL AUTONOMY OF UROLOGY
RESIDENTS WITHIN THE VETERANS
AFFAIRS HEALTHCARE SYSTEM.
Janmejay Hingu*, Anh Nguyen, Kunj Jain,
Newark, NJ, Devashish Anjaria, Joseph Oliver,
Hossein Sadeghi-Nejad, East Orange, NJ
MP10-04 IMPLEMENTATION OF ONLINE
INSTRUCTIONAL VIDEOS IMPROVES
NURSING COMFORT WITH COMMONLY
ENCOUNTERED URINARY CATHETER CARE
SCENARIOS
Akhil Muthigi*, Christopher Dall, Erin Hays, James
Alger, Washington, DC
57
 MP10-05 TIME TO OPTIMIZE UROLOGY TRAINEE MP10-13 AUTHORSHIP IN UROLOGY: A GENDER
EDUCATION AND PREPARATION FOR REVEAL
SURGERY: VIDEO-BASED SURGICAL Leah Beland*, New Hyde Park, NY, Ginnie Jeng,
LEARNING Uniondale, NY, Tareq Aro, Jessica Kreshover,
Miyad Movassaghi*, Rainjade Chung, New York, New Hyde Park, NY
NY, Zoe Cohen, New York, NY, Rashed Kosber,
MP10-14 MODELING THE UROLOGY RESIDENCY
Doreen Chung, New York, NY
APPLICATION AND MATCH PROCESS:
MP10-06 A NOVEL ONLINE PHYSICIAN GROUP- A MATHEMATICAL ARGUMENT FOR
COACHING PROGRAM TO REDUCE APPLICATION AND INTERVIEW LIMITS
BURNOUT IN FEMALE TRAINEES: A Sameer Farooq*, Akanksha Mehta, Atlanta, GA
RANDOMIZED CONTROLLED TRIAL
MP10-15 BUILDING A REAL-TIME FEEDBACK SYSTEM
Kerri Thurmon*, Aurora, CO, Pari Shah, Denver,
TO IMPROVE PERFORMANCE ON A ROBOTIC
CO, Krithika Suresh, Nathalie Dieujuste, Christine
TISSUE DISSECTION TASK
Jones, Adrienne Mann, Tyra Fainstad, Aurora,
Jasper Laca*, Los Angeles, CA, Rafal Kocielnik,
CO
Pasadena, CA, Jessica H Nguyen, Ryan Tsang,
MP10-07 THE RELATIONSHIP OF TECHNICAL SKILLS Jonathan You, Alvin Hui, Los Angeles, CA, Anima
AND COGNITIVE WORKLOAD TO ERRORS Anandkumar, Pasadena, CA, Andrew J Hung, Los
DURING ROBOTIC SURGICAL EXERCISES Angeles, CA
Sidney I Roberts*, Steven Cen, Jessica H
MP10-16 INTERACTIVE ONLINE UROLOGY
Nguyen, Laura C Perez, Luis G Medina, Runzhuo
CURRICULUM FOR MEDICAL STUDENTS: A
Ma, Los Angeles, CA, Sandra P Marshall, Solana
MULTI-INSTITUTIONAL PILOT STUDY
Beach, CA, Rafal Kocielnik, Anima Anandkumar,
Ezra Margolin*, Jane Kurtzman, Rachel Gordon,
Pasadena, CA, Andrew J Hung, Los Angeles,
Christopher Anderson, Gina Badalato, New York,
CA
NY
MP10-08 LONGITUDINAL COMPARISON OF SURGICAL
MP10-17 DEVELOPMENT AND VALIDATION OF THE
CASE LOGS BETWEEN FEMALE AND MALE
END-TO-END ASSESSMENT OF SUTURING
UROLOGY RESIDENTS
EXPERTISE (EASE)
Kathryn A Marchetti*, Emma C Bethel, Stephanie
Taseen F Haque*, Alvin Hui, Jonathan You, Run-
Daignault - Newton, Charlie Ferrer, Ann Arbor,
zhuo Ma, Steven Cen, Xiaomeng Li, Monish Aron,
MI, Suzanne Merril, Aurora, CO, Thomas Guzzo,
Los Angeles, CA, Justin W Collins, London, Unit-
Philadelphia, PA, Adam Klausner, Richmond, VA,
ed Kingdom, Hooman Djaladat, Los Angeles, CA,
Richard Lee, New York, NY, John Lynch, Wash-
Ahmed Ghazi, Rochester, NY, Kenneth A Yates,
ington, DC, Jay D Raman, Hershey, PA, Adam
Andre L Abreu, Siamak Danseshmand, Mihir M
Reese, Patrick Shenot, Philadelphia, PA, R Hou-
Desai, Los Angeles, CA, Alvin C Goh, Jim C Hu,
ston Thompson, Rochester, MN, Stanley Zaslau,
New York, NY, Amir H Lebastchi, Los Angeles,
Morgantown, WV, Kate H Kraft, Ann Arbor, MI
CA, Thomas S Lendvay, James Porter, Seattle,
MP10-09 ACADEMIC PRODUCTIVITY AMONGST WA, Anne K Schuckman, Rene Sotelo, Los Ange-
UNDERREPRESENTED MINORITY les, CA, Chandru P Sundaram, Indianapolis, IN,
UROLOGISTS AT ACADEMIC INSTITUTIONS Jessica H Nguyen, Inderbir Gill, Andrew J Hung,
David Tella*, Bahrom Ostad, Charlottesville, VA, Los Angeles, CA
David Barquin, Roanoke, VA, Caleigh Smith,
MP10-18 URETEROSCOPY STANDARDIZATION
Charlottesville, VA, Rebecca King, Roanoke, VA,
AND ITS IMPACT ON EFFICIENCY IN THE
Christopher Ballantyne, Tracy Downs, Kirsten
OPERATING ROOM
Greene, Nora Kern, Charlottesville, VA
Jordan Goldwag*, Laila Bangash, Andrew Harris,
MP10-10 HEAD-TO-HEAD COMPARISON OF Lexington, KY
HYDROGEL MODELS TO CADAVERS FOR
MP10-19 NEEDS AND EXPERIENCES OF U.S. FEMALE
INFLATABLE PENILE PROSTHESIS (IPP)
UROLOGY RESIDENTS
TRAINING
Michelle Sheng*, Almira Catic, Dattatraya Patil,
Patrick Saba*, Rachel Melnyk, Michael Witthaus,
Lindsey Hartsell, Akanksha Mehta, Atlanta, GA
Christopher Wanderling, Tyler Holler, Ahmed
Ghazi, Rochester, NY MP10-20 MEDICAL MALPRACTICE LAWSUITS
INVOLVING UROLOGY TRAINEES
MP10-11 REPRESENTATION IN UROLOGY RESIDENTS
Roei Golan*, Tallahassee, FL, Manish Kuchakulla,
AND FULL-TIME ACADEMIC UROLOGY
New York, NY, Arjun Watane, New Haven, CT,
FACULTY: A SNAPSHOT OF DIVERSITY AND
Raghuram Reddy, Miami, FL, Ravi Parikh, New
INCLUSION IN MEDICINE AND UROLOGY
York, NY, Ranjith Ramasamy, Miami, FL
Michelle Chen*, Jeffrey Ellis, Justin Friedlander,
Philadelphia, PA  A
 PPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
MP10-12 A QUALITY IMPROVEMENT STUDY OF
RESIDENT & FELLOW EXPERIENCE WITH
URINARY CATHETER INSERTION
Peris Castaneda*, Jenna Stelmar, Shannon
Smith, Aurash Naser-Tavakolian, Maurice Garcia,
Los Angeles, CA

58
Friday, May 13, 2022
Moderated Poster Session 11
PEDIATRIC UROLOGY: NEUROGENIC BLADDER, RECONSTRUCTION & UROLOGIC EMERGENCIES
Room 225 @ Ernest N. Morial Convention Center
Moderators: Deborah Jacobson & Rajeev Chaudhary
ABSTRACT
TIME NUMBER TITLE
MP11-01 USE OF EDUCATIONAL VIDEO TO
IMPROVE PARENT UNDERSTANDING AND
ADHERENCE TO RECOMMENDATIONS IN
CHILDREN WITH DYSFUNCTIONAL VOIDING
Eniola Ogundipe*, Marguerite Korber, Gemma
Beltran, Alan Quach, Carter Sevick, Vijaya
Vemulakonda, AURORA, CO
MP11-02 USE OF A MANUAL TRIGGER WITH
A TRADITIONAL MOISTURE ALARM
FOR TREATMENT OF PRIMARY
MONOSYMPTOMATIC NOCTURNAL
ENURESIS
Gina Lockwood*, Denise Juhr, Caitlin Ward, Meg-
an Bonnett, Christopher Cooper, Douglas Storm,
Iowa City, IA, D. Preston Smith, Knoxville, TN
MP11-03 FALSE POSITIVE PREGNANCY TESTS
AMONG PEDIATRIC PATIENTS WITH
AUGMENTATION ENTEROCYSTOPLASTIES
Zoë Baker, Arthi Hannallah*, Hannah Dillon, Yud-
ing Wang, Evalynn Vasquez, Los Angeles, CA
MP11-04 PELVIC ORGAN PROLAPSE IS NOT
UNCOMMON AMONG WOMEN WITH
SPINA BIFIDA
Joshua Roth*, Rosalia Misseri, Devon Hensel,
Indianapolis, IN, Susan Ernst, Ann Arbor, MI,
Melissa Kaufman, Nashville, TN, Raimund Stein,
Mannheim, Germany, John Weiner, Durham, NC,
Konrad Szymanski, Indianapolis, IN PA, Joseph Borer, Boston, MA
MP11-05 FACTORS ASSOCIATED WITH PERIOPERATIVE
COMPLICATIONS FOLLOWING AUGMENTATION
CYSTOPLASTY: A CONTEMPORARY
POPULATION-BASED ANALYSIS
Hriday Bhambhvani*, Kritika Sharma, Kunj Sheth,
Stanford, CA
MP11-06 ENDOSCOPIC INJECTION OF THE
BLADDER NECK USING DEXTRANOMER
HYALURONATE (DX/HA) IN THE PEDIATRIC
PATIENT: RESULTS OF A SINGLE CENTER
ANALYSIS WITH LONG TERM FOLLOW UP
Jennifer M. Lovin*, Nelson Kuete, Shuvro De,
Andrew J. Kirsch, Atlanta, GA Preeya Khandge*, Kelly Harris, Wayland Wu,
MP11-07 A TECHNIQUE TO PREVENT STOMAL
STENOSIS IN RECONSTRUCTIVE UROLOGY
Stephen Sekoulopoulos, Akshilkumar Patel, Ellius
Kwok, Suzanne Boltz, Ross Decter*, Hershey, PA
MP11-08 RESTRICTED ACCESS TO MIRABEGRON IN
CHILDREN WITH NEUROGENIC BLADDER
Christopher Jaeger*, Andrea Balthazar, Caleb
Nelson, Tanya Logvinenko, Hsin-Hsiao Scott
Wang, Boston, MA
*Presenting author
1:00 pm – 2:15 pm
ABSTRACT
TIME NUMBER TITLE
FRIDAY
MP11-09 SURVIVAL ANALYSIS AMONG UTAH
RESIDENTS WITH SPINA BIFIDA BORN
BETWEEN 1950 AND 2015
Cynthia Sharadin*, Suzanne Lange, JJ Horns,
Chad Wallis, Glen Lau, Anthony Schaeffer, Salt
Lake City, UT
MP11-10 SPINA BIFIDA ONLINE EDUCATION FOR
TRANSITIONAL PATIENTS IN THE ERA OF
COVID-19
Anessa Sax-Bolder*, Alan Quach, Denver, CO,
Cindy Buchanan, Ty Higuchi, Aurora, CO
MP11-11 THE DIFFERENCE OF FECAL MICROBIOTA
COMPOSITION IN PEDIATRIC PATIENTS
WITH SPINA BIFIDA: PROSPECTIVE
CASE-CONTROL STUDY
Yong Seung Lee*, Sang Woon Kim, Sowon Park,
Hong Koh, Sang Won Han, Seoul, Korea,
Republic of
MP11-12 PRENATAL DIAGNOSIS OF BLADDER AND
CLOACAL EXSTROPHY OVER 20 YEARS
Ted Lee*, Boston, MA, Dana Weiss, Philadel-
phia, PA, Elizabeth Roth, Milwaukee, WI, Sahar
Eftekharzadeh, Philadelphia, PA, Saafia Masoom,
Boston, MA, Susan Jarosz, John Kryger, Milwau-
kee, WI, Aseem Shukla, Philadelphia, PA, Travis
Groth, Michael Mitchell, Milwaukee, WI, Richard
Lee, Boston, MA, Douglas Canning, Philadelphia,
MP11-13 SHORT AND LONG TERM RENAL OUTCOMES
IN CLINICALLY MATCHED COHORTS OF
NEWBORNS WITH PUV MANAGED BY
PRIMARY VESICOSTOMY VERSUS PRIMARY
VALVE ABLATION
Nora Haney*, Shwetha Mudalegundi, Angelica
Griggs-Demmin, Tamir Sholklapper, Edwin Smith,
Charlotte Wu, Baltimore, MD
MP11-14 ACHIEVING GOAL CAPACITY FOR
CONTINENCE SURGERY: A CUMULATIVE
EVENT ANALYSIS OF BLADDER EXSTROPHY
PATIENTS
Mahir Maruf, Baltimore, MD, Hiten Patel,
Maywood, IL, Heather Di Carlo, John Gearhart,
Baltimore, MD
MP11-15 PATIENT REPORTED REASONS FOR
DELAYED PRESENTATION TO HOSPITAL
WITH TORSION AND IMPACT ON
TESTICULAR OUTCOMES
Thawatchai Mangonsrisuk, Nicholas Mitsakakis,
Luis Guerra, Melise Keays*, Ottawa, Canada
MP11-16 PREDICTORS FOR TESTICULAR ATROPHY
AFTER EMERGENCY ORCHIDOPEXY FOR
TESTICULAR TORSION
Thawatchai Mangonsrisuk, Luis Guerra, Nicholas
Mitsakakis, Melise Keays*, Ottawa, Canada
59
 MP11-17 IMPROVING AWARENESS OF TESTICULAR
TORSION AMONG BOYS, THEIR PARENTS
AND SCHOOL NURSES TO DECREASE
DELAYS IN CARE FOR ACUTE TESTICULAR
PAIN
Benjamin Abelson*, Kyle Mason, Cyrus Adams,
Mark Adams, John Brock III, John C Pope IV,
Stacy Tanaka, John Thomas, Douglass B Clayton,
Viktor Flores, Abby S Taylor, Nashville, TN
MP11-18 IS AMBULATORY STATUS ASSOCIATED WITH
SEXUAL FUNCTION AND ACTIVITY IN THE
YOUNG ADULT SPINA BIFIDA POPULATION?
Shane Batie*, Janelle Traylor, Shaheer Ali, Sam-
uel Gold, Yvonne Chan, Bruce Schlomer, Micah
Jacobs, Dallas, TX
Friday, May 13, 2022
Moderated Poster Session 12
KIDNEY CANCER: ADVANCED (INCLUDING DRUG THERAPY) I
Room 222 @ Ernest N. Morial Convention Center
Moderators: Sarah Psutka, Vitaly Margulis & Michael Whalen
ABSTRACT
TIME NUMBER TITLE
MP12-01 C-REACTIVE PROTEIN KINETICS TO
PREDICT RECURRENCE AFTER RADICAL
SURGERY FOR HIGH-RISK RENAL CELL
CARCINOMA
Yudai Ishiyama*, Tsunenori Kondo, Hiroki Ishiha-
ra, Arakawa, Japan, Kazuhiko Yoshida, Junpei
Iizuka, Kazunari Tanabe, Toshio Takagi, Tokyo,
Japan
MP12-02 PROSPECTIVE EVALUATION OF
CIRCULATING TUMOR DNA (CTDNA)
IN DETECTING EARLY PROGRESSION
ON IMMUNE CHECKPOINT INHIBITORS
IN PATIENTS WITH ADVANCED
GENITOURINARY CANCERS
Albert Jang*, Ellen Jaeger, Grant Rauterkus, Alex
Liberman, Isabelle Sussman, Malcolm Light, Minqi
Huang, Charlotte Manogue, Sydney Caputo, Pat-
rick Miller, Brian Lewis, Jodi Layton, Oliver Sartor,
New Orleans, LA, Earle Burgess, Charlotte, NC,
Tiffany Farmer, Hayley Widden, Carrie Flippen,
Alexey Aleshin, San Carlos, CA, Claud Grigg,
New York, NY, Pedro Barata, New Orleans, LA
MP12-03 IL-7 AND CCL19 PRODUCING CAR-T CELLS
PREVENT ANTIGEN-LOSS TUMOR RELAPSE
AND ENHANCE ANTITUMOR EFFICACY
AGAINST SOLID CANCER
Shunsuke Goto*, Fukuoka, Japan, Koji Tamada,
Ube, Japan, Masatoshi Eto, Fukuoka, Japan Giorgio Brembilla, Luigi Nocera, Federico Bell-
MP12-04 PREDICTIVE IMPACT OF EARLY CHANGES
IN SERUM C-REACTIVE PROTEIN LEVELS IN
NIVOLUMAB PLUS IPILIMUMAB THERAPY
FOR METASTATIC RENAL CELL CARCINOMA
Hidekazu Tachibana*, Yuki Nemoto, Saitama,
Japan, Hiroki Ishihara, Hironori Fukuda, Kazuhiko
Yoshida, Junpei Iizuka, Tokyo, Japan, Yasunobu
Hashimoto, Saitama, Japan, Tsunenori Kondo,
Kazunari Tanabe, Toshio Takagi, Tokyo, Japan
60
MP11-19 THE ART OF INTRODUCING CLEAN
INTERMITTENT CATHETERIZATION:
HOW FAMILIES RESPOND & ADAPT. A
QUALITATIVE STUDY
Stuart B Bauer, MD*, Rachel Saunders, BA, Saa-
fia Masoom, BA, Lillian Hayes, PhD, Diane Price,
MSW, Paige Sable, LICSW, Kennary Choung,
RN, Ashley Shimmel, MS, Boston, MA
MP11-20 SIGNIFICANT ANTIBIOTIC USE VARIATIONS
IN PEDIATRIC TESTICULAR TORSION
SURGERY AMONG US FREE-STANDING
CHILDREN’S HOSPITALS
John Panagides*, Dylan Cahill, Rachel Saunders,
Hsin-Hsiao Wang, Boston, MA
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
1:00 pm – 2:15 pm
ABSTRACT
TIME NUMBER TITLE
MP12-05 PSOAS MUSCLE MASS PREDICTS THE
OUTCOME OF NIVOLUMAB TREATMENT FOR
RENAL CELL CARCINOMA
Hideto Ueki*, Yasuyoshi Okamura, Yukari Bando,
Takuto Hara, Tomoaki Terakawa, Junya
Furukawa, Yuzo Nakano, Masato Fujisawa,
Kobe, Japan
MP12-06 ONCOLOGIC OUTCOMES IN PATIENTS
DIAGNOSED WITH PT3AN0M0 RENAL CELL
CANCER ACCORDING TO RENAL VEIN
THROMBUS OR FAT INVASION
Giuseppe Fallara, Giuseppe Rosiello, Andrea
Necchi, Daniele Raggi, Walter Cazzaniga, Al-
berto Martini, Giuseppe Basile*, Daniele Cignoli,
Gianmarco Colandrea, Gianfranco Baiamonte,
Federico Belladelli, Giacomo Musso, Frances-
co Cei, Cristina Giancristofaro, Andrea Ieva,
Daniela Canibus, Alberto Briganti, Roberto Bertini,
Francesco Montorsi, Andrea Salonia, Alessandro
Larcher, Umberto Capitanio, Milan, Italy
MP12-07 THE ANATOMICAL LOCATION OF
LYMPHADENOPATHIES AT IMAGING
PREDICTS THE RISK OF LYMPH NODE
INVASION AT FINAL PATHOLOGY IN
PATIENTS WITH RENAL CELL CARCINOMA
Giuseppe Rosiello*, Giuseppe Fallara, Giuseppe
Basile, Daniele Cignoli, Francesco De Cobelli,
adelli, Gianmarco Colandrea, Daniela Canibus,
Giacomo Musso, Francesco Cei, Chiara Re,
Cristina Giancristofaro, Alberto Briganti, Roberto
Bertini, Andrea Necchi, Daniele Raggi, Milan, Italy,
Alexandre Mottrie, Aalst, Belgium, Pierre I. Kar-
akiewicz, Montreal, Canada, Francesco Montorsi,
Andrea Salonia, Alessandro Larcher, Umberto
Capitanio, Milan, Italy
 MP12-08 OUTCOMES OF NEPHRECTOMY FOR
RENAL CELL CARCINOMA WITH VENOUS
THROMBUS FOLLOWING IMMUNE
CHECKPOINT INHIBITOR THERAPY: A
MULTICENTER COLLABORATIVE STUDY
Alireza Ghoreifi*, Los Angeles, CA, Thomas
Gerald, Dallas, TX, Randall Lee, Philadelphia,
PA, Jeffrey Howard, Dallas, TX, Aeen Asghar, Los
Angeles, CA, Abhinav Khanna, Rochester, MN,
David Quinn, Inderbir Gill, Los Angeles, CA, R
Houston Thompson, Rochester, MN, Robert Uzzo,
Philadelphia, PA, Vitaly Margulis, Dallas, TX,
Hooman Djaladat, Los Angeles, CA
MP12-09 PROGNOSTIC MODEL OF UPFRONT
CYTOREDUCTIVE NEPHRECTOMY IN
PATIENTS WITH METASTATIC RENAL CELL
CARCINOMA TREATED WITH IMMUNE-
CHECKPOINT INHIBITORS AND/OR
TYROSINE KINASE INHIBITORS
Jun Teishima*, Keisuke Goto, Yohei Sekino, Tetsu-
taro Hayashi, Nobuyuki Hinata, Hiroshima, Japan
MP12-10 POTENTIAL SURVIVAL BENEFIT OF DEFERRED
NEPHRECTOMY IN PATIENTS TREATED
WITH NIVOLUMAB PLUS IPILIMUMAB FOR
METASTATIC RENAL CELL CARCINOMA
Maki Yoshino*, Hiroki Ishihara, Tokyo, Japan, Yuki
Nemoto, Saitama, Japan, Kazutaka Nakamura,
Fukushima, Japan, Hidekazu Tachibana, Satita-
ma, Japan, Hironori Fukuda, Kazuhiko Yoshida,
Hirohito Kobayashi, Junpei Iizuka, Tokyo, Japan,
Shimmura Hiroaki, Fukushima, Japan, Yasunobu
Hashimoto, Saitama, Japan, Toshio Takagi, Tsune-
nori Kondo, Kazunari Tanabe, Tokyo, Japan nori Kondo, Toshio Takagi, Tokyo, Japan
MP12-11 NEOADJUVANT THERAPY IN
THE MANAGEMENT OF LOCAL
RETROPERITONEAL RECURRENCE OF
RENAL CELL CARCINOMA AFTER RADICAL
NEPHRECTOMY
Jiwei Huang*, Yueming Wang, Shanghai, China,
People’s Republic of, Cuijian Zhang, Beijing,
China, People’s Republic of, Xiaoyi Hu, Shang-
hai, China, People’s Republic of, Ping Wang,
Hangzhou, China, People’s Republic of, Guohai
Shi, Jin Zhang, Wen Kong, Yonghui Chen, Yiran
Huang, Dingwei Ye, Shanghai, China, People’s
Republic of, Dan Xia, Hangzhou, China, People’s
Republic of, Jianming Guo, Shanghai, China,
People’s Republic of, Zhisong He, Beijing, China,
People’s Republic of, Wei Xue, Shanghai, China,
People’s Republic of
MP12-12 SURGICAL MANAGEMENT AND ONCOLOGIC
OUTCOMES FOR LOCAL RETROPERITONEAL
RECURRENCE OF RENAL CELL CARCINOMA
AFTER RADICAL NEPHRECTOMY
Jiwei Huang*, Yueming Wang, Shanghai, China,
People’s Republic of, Cuijian Zhang, Beijing,
China, People’s Republic of, Xiaoyi Hu, Shang-
hai, China, People’s Republic of, Ping Wang,
Hangzhou, China, People’s Republic of, Guohai
Shi, Liang Dong, Jin Zhang, Wen Kong, Yonghui
Chen, Dingwei Ye, Shanghai, China, People’s
Republic of, Dan Xia, Hangzhou, China, Peo-
ple’s Republic of, Jianming Guo, Wei Xue, Yiran
Huang, Shanghai, China, People’s Republic of,
Zhisong He, Beijing, China, People’s Republic of
*Presenting author
MP12-13 THE ROLE OF NEPHRECTOMY IN
METASTATIC RENAL CELL CARCINOMA
IN THE ERA OF IMMUNE-COMBINATION
THERAPIES: A META-ANALYSIS
Keiichiro Mori*, Fahad Quhal, Takafumi Yanag-
isawa, Satoshi Katayama, Benjamin Pradere,
Ekaterina Laukhtina, Pawel Rajwa, Hadi Mosta-
faei, Reza Sari Motlagh, Vienna, Austria, Takahiro
FRIDAY
Kimura, Shin Egawa, Tokyo, Japan, Karim
Bensalah, Rennes, France, Pierre Karakiewicz,
Montreal, Canada, Manuela Schmidinger,
Shahrokh Shariat, Vienna, Austria
MP12-14 SITE-SPECIFIC EARLY RESPONSE
PATTERNS IN ADVANCED RCC PATIENTS
TREATED WITH NIVOLUMAB AND
IPILIMUMAB COMPARED WITH SUNITINIB
THERAPY
Renpei Kato*, Tomohiko Matsuura, Shigekatsu
Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo
Takata, Wataru Obara, Yahaba, Japan
MP12-15 EFFECTS OF FIRST-LINE IMMUNE
CHECKPOINT INHIBITORS IN PATIENTS
WITH METASTATIC RENAL CELL
CARCINOMA NOT MEETING TRIAL
ELIGIBILITY CRITERIA
Yuki Nemoto*, Saitama, Japan, Hiroki Ishihara,
Tokyo, Japan, Kazutaka Nakamura, Fukushima,
Japan, Hidekazu Tachibana, Saitama, Japan,
Hironori Fukuda, Kazuhiko Yoshida, Hirohito
Kobayashi, Junpei Iizuka, Tokyo, Japan, Hiroaki
Shimmura, Fukushima, Japan, Yasunobu Hashi-
moto, Saitama, Japan, Kazunari Tanabe, Tsune-
MP12-16 OPTIMIZING TARGETED DRUG SELECTION
IN COMBINATION THERAPY FOR PATIENTS
WITH ADVANCED OR METASTATIC RENAL
CELL CARCINOMA: A SYSTEMATIC REVIEW
AND NETWORK META-ANALYSIS OF SAFETY
Ruiyang Xie*, Bingqing Shang, Weixing Jiang,
Chuanzhen Cao, Hongzhe Shi, Jianzhong Shou,
Beijing, China, People’s Republic of
MP12-17 IMMUNOTHERAPY-BASED COMBINATIONS
IN THE FIRST-LINE TREATMENT OF
METASTATIC RENAL CELL CARCINOMA
WITH SARCOMATOID FEATURES: A
SYSTEMATIC REVIEW AND NETWORK META-
ANALYSIS
Fahad Quhal*, Keiichiro Mori, Ekaterina Laukhti-
na, Benjamin Pradere, Hadi Mostafaei, Pawel Raj-
wa, Shahrokh F. Shariat, Manuela Schmidinger,
Vienna, Austria
MP12-18 IMMUNE-RELATED ADVERSE EVENTS
ASSOCIATED WITH BETTER SURVIVAL
OUTCOMES FOR METASTATIC RENAL CELL
CARCINOMA TREATED WITH NIVOLUMAB
PLUS IPILIMUMAB
Kazuyuki Numakura*, Akita, Japan, Shingo Ha-
takeyama, Hirosaki, Japan, Yuya Sekine, Yumina
Muto, Mizuki Kobayashi, Soki Kashima, Ryohei
Yamamoto, Atsushi Koizumi, Taketoshi Nara, Mit-
suru Saito, Shintaro Narita, Akita, Japan, Chikara
Ohyama, Hirosaki, Japan, Tomonori Habuchi,
Akita, Japan
61
 MP12-19 ADJUVANT SYSTEMIC TREATMENT FOR MP12-20 FIRST-LINE IMMUNOTHERAPY-BASED
RENAL CANCER AFTER SURGERY: A COMBINATIONS FOR METASTATIC RENAL
NETWORK META-ANALYSIS CELL CARCINOMA: SYSTEMATIC REVIEW
Niranjan Sathianathen*, Marc Furrer, Declan Mur- AND NETWORK META-ANALYSIS
phy, Parkville, Australia, Christopher Weight, Shil- Fahad Quhal*, Keiichiro Mori, Ekaterina Laukhti-
pa Gupta, Cleveland, OH, Nathan Lawrentschuk, na, Benjamin Pradere, Hadi Mostafaei, Shahrokh
Parkville, Australia F. Shariat, Manuela Schmidinger, Vienna, Austria

APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM

Friday, May 13, 2022 1:00 pm – 3:00 pm

Forums
AUA ROBOTICS THEATER SPONSORED BY INTUITIVE: MULTIPORT ROBOTIC PROCEDURES—PROSTATE
AND KIDNEY CANCERS
S&T Hall C: Booth 311 @ Ernest N. Morial Convention Center
Chair: Ashutosh Tewari
AUA ROBOTICS THEATER: MULTIPORT ROBOTIC PROCEDURES - PROSTATE AND KIDNEY
CANCERS
Program Leaders: Ashok Hemal, Mani Menon
Panelists: Bocciardi Aldo, Inderbir Gill, Alex Mottrie

Friday, May 13, 2022 1:00 pm – 3:00 pm

Podium Session 9
INFERTILITY: EPIDEMIOLOGY & EVALUATION I
Room 252 @ Ernest N. Morial Convention Center
Moderator: Sarah Vij

ABSTRACT
TIME NUMBER TITLE
1:00 PD09-01 LOW BIRTH WEIGHT IS ASSOCIATED
WITH SPERM DNA FRAGMENTATION AND
ASSISTED REPRODUCTIVE TECHNOLOGY
OUTCOMES IN PRIMARY INFERTILE MEN –
RESULTS OF A CROSS-SECTIONAL STUDY
Luca Boeri*, Federico Belladelli, Edoardo Pozzi, Gi-
useppe Fallara, Massimiliano Raffo, Christian Cors-
ini, Luigi Candela, Antonio Costa, Daniele Cignoli,
Nicolò Schifano, Alessia d’Arma, Milan, Italy, Paolo
Capogrosso, Varese, Italy, Eugenio Ventimiglia, Luca
Pagliardini, Enrico Papaleo, Milan, Italy, Vincenzo
Mirone, Naples, Italy, Federico Dehò, Varese, Italy,
Francesco Montorsi, Andrea Salonia, Milan, Italy
1:10 PD09-02 USE OF A NEW EPIGENETIC SPERM
QUALITY TEST (SPERMQT) FOR MEN
SEEKING FERTILITY CARE
Chad Pollard, Provo, UT, Ryan Miller, Kristin
Brogaard, Salt Lake City, UT, Larry Lipshultz*,
Houston, TX
1:20 PD09-03 IDENTIFICATION OF Y CHROMOSOME
MICRODELETIONS AND ASSOCIATIONS
WITH ADVERSE HEALTH OUTCOMES IN
THE UK BIOBANK
Dylan J. Peterson*, Michael L. Eisenberg,
Stanford, CA
ABSTRACT
TIME NUMBER TITLE
1:30 PD09-04 INCREASED FREQUENCY OF CYSTIC
FIBROSIS TRANSMEMBRANE
CONDUCTANCE REGULATOR GENE
CARRIER MUTATIONS IN NON-CBAVD
INFERTILE MALES
Thomas Garcia*, J. Sam Fisher, Kenny Kim, Larry
Lipshultz, Houston, TX
1:40 PD09-05 USE OF FRESH EJACULATED SEMEN
SAMPLES ON THE DAY OF PLANNED MTESE
IN MEN WITH “AZOOSPERMIA”
Jessica Marinaro*, Caroline Kang, Nahid Punjani,
Peter Schlegel, New York, NY
1:50 PD09-06 ELEVATED FOLLICLE STIMULATING
HORMONE (FSH) PREDICTS DECLINE IN
SEMEN PARAMETERS AMONG MEN WITH
NORMAL INDEX SEMEN ANALYSIS
Richard Fantus*, Minh Pham, Cecilia Chang,
Justin Dubin, Robert Brannigan, Joshua Halpern,
Chicago, IL
2:00 PD09-07 HYPERESTROGENISM IS ASSOCIATED WITH
SEXUAL FUNCTION IMPAIRMENT IN MEN
– FINDINGS FROM A CROSS-SECTIONAL,
REAL-LIFE STUDY
Luca Boeri*, Milan, Italy, Paolo Capogrosso,
Varese, Italy, Giuseppe Fallara, Walter Cazzan-
iga, Luigi Candela, Federico Belladelli, Edoardo
Pozzi, Massimiliano Raffo, Antonio Costa, Chris-
tian Corsini, Daniele Cignoli, Nicolò Schifano,
Gianmarco Colandrea, Alessia d’Arma, Eugenio
Ventimiglia, Rayan Matloob, Milan, Italy, Federico
Dehò, Varese, Italy, Francesco Montorsi, Andrea
Salonia, Milan, Italy

62
2:10 PD09-08 PREVALENCE AND PREDICTORS OF
TESTOSTERONE DEFICIENCY AMONG
ADULT MEN IN THE UNITED STATES.
John Ernandez*, Steven Chang, Martin Kathrins,
Boston, MA New York, NY, Hira Chaudhry, Philadelphia, PA,
2:20 PD09-09 PREDICTORS OF MALE FACTOR INFERTILITY
MANAGEMENT BY REPRODUCTIVE
ENDOCRINOLOGIST VERSUS REFERRAL TO
A NEARBY UROLOGIST
Julie Shabto*, Dattatraya Patil, Katherine Poulose,
Mackenzie Bennett, Angel Xiao, Heather Hipp,
Jennifer Kawwass, Akanksha Mehta, Atlanta, GA
2:30 PD09-10 SHEAR WAVE ELASTOGRAPHY IN
VARICOCELE PATIENTS WITH OLIGO-
ASTHENO-TERATOZOOSPERMIA:
PROSPECTIVE STUDY TO INVESTIGATE
CORRELATION WITH SEMEN PARAMETERS
AND HISTOLOGICAL FINDINGS
Antonio Luigi Pastore, Andrea Fuschi*, Yazan Al
Salhi, Alessia Martoccia, Lorenzo Capone, Silvio
Scalzo, Paolo Pietro Suraci, Onofrio Antonio Rera,
Fabio Maria Valenzi, Alice Antonioni, Antonio
Carbone, Latina, Italy
Friday, May 13, 2022
Podium Session 10
BLADDER CANCER: INVASIVE II
Room 255 @ Ernest N. Morial Convention Center
Moderator: Zachary Smith, Amlesh Seth & Sanjay Patel
ABSTRACT
TIME NUMBER TITLE
1:00 PD10-01 DISEASE-FREE SURVIVAL WITH LONGER
FOLLOW-UP FROM THE CHECKMATE 274
TRIAL OF ADJUVANT NIVOLUMAB IN
PATIENTS AFTER SURGERY FOR HIGH-
RISK MUSCLE-INVASIVE UROTHELIAL
CARCINOMA
Matthew Galsky*, New York, NY, Johannes
Alfred Witjes, Nijmegen, Netherlands, Jürgen E.
Gschwend, Munich, Germany, Michael Schenker,
Craiova, Romania, Begoña P Valderrama, Sevilla,
Spain, Yoshihiko Tomita, Niigata, Japan, Aris-
totelis Bamias, Athens, Greece, Thierry Lebret,
Versailles, France, Shahrokh F. Shariat, Vienna,
Austria, Se Hoon Park, Seoul, Korea, Republic
of, Mads Agerbaek, Aarhus, Denmark, Gautam
Jha, Minneapolis, MN, Frank Stenner Stenner,
Basel, Switzerland, Sandra Collette, Braine-l’Al-
leud, Belgium, Keziban Unsal-Kacmaz, Federico
Nasroulah, Joshua Zhang, Princeton, NJ, Dean F.
Bajorin, New York, NY
*Presenting author
2:40 PD09-11 VEIN DIAMETER ON ULTRASOUND AS
PREDICTOR OF SEMEN PARAMETER
IMPROVEMENT AFTER VARICOCELECTOMY
Leon Telis*, Alan Paniagua Cruz, Kirolos Meilika,
Michael Huaman, Brooklyn, NY, Boback M.
Berookhim, New York, NY
2:50 PD09-12 IS THE SEMEN MICROBIOME PROFILE
FRIDAY
IN MEN WITH NON-OBSTRUCTIVE
AZOOSPERMIA DIFFERENT FROM FERTILE
CONTROLS?
Joseph M. Israeli*, Maria Camila Suarez, Daniel
E. Nassau, Kevin Y. Chu, Emad Ibrahim, Ranjith
Ramasamy, Miami, FL
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
1:00 pm – 3:00 pm
ABSTRACT
TIME NUMBER TITLE
1:10 PD10-02 AVELUMAB FIRST-LINE MAINTENANCE FOR
ADVANCED UROTHELIAL CARCINOMA:
LONG-TERM FOLLOW-UP RESULTS FROM
THE JAVELIN BLADDER 100 TRIAL
Petros Grivas, Seattle, WA, Joaquim Bellmunt*,
Boston, MA, Se Hoon Park, Seoul, Korea, Re-
public of, Eric Voog, Le Mans, France, Claudia
Caserta, Terni, Italy, Begoña P. Valderrama,
Seville, Spain, Howard Gurney, Sydney, Australia,
Yohann Loriot, Villejuif, France, Srikala S. Sridhar,
Toronto, Canada, Norihiko Tsuchiya, Yamagata,
Japan, Cora N. Sternberg, New York, NY, Jeanny
B. Aragon-Ching, Fairfax, VA, Daniel P. Petrylak,
New Haven, CT, John A. Blake-Haskins, La Jolla,
CA, Robert J. Laliberte, Jing Wang, Cambridge,
MA, Nuno Costa, Porto Salvo, Portugal, Thomas
Powles, London, United Kingdom
1:20 PD10-03 HRQOL AFTER ROBOTIC-ASSISTED VERSUS
OPEN RADICAL CYSTECTOMY: ANALYSIS OF
A RCT
Matthew Clements*, Benjamin Beech, Thomas
Atkionson, Guido Dalbagni, Yuelin Li, Andrew
Vickers, Harry Herr, S. Machele Donat, Jaspreet
Sandhu, Daniel Sjoberg, Amy Tin, Jonathan Cole-
man, Bruce Rapkin, Vincent Laudone, Bernard
Bochner, New York, NY
63
1:30 PD10-04 CHARACTERIZING MALE ERECTILE
FUNCTION AFTER RADICAL
CYSTECTOMY
Benjamin Beech*, Matthew Clements, Thomas
Atkinson, Yuelin Li, Guido Dalbagni, Andrew
Vickers, Harry Herr, S. Machele Donat, Daniel
Sjoberg, Amy Tin, John Mulhall, New York, NY,
Bruce Rapkin, Bronx, NY, Bernard Bochner, New
York, NY
1:40 PD10-05 PERIOPERATIVE BLOOD TRANSFUSION
IS ASSOCIATED WITH INCREASED RISK
OF VENOUS THROMBOEMBOLISM AFTER
RADICAL CYSTECTOMY
Amanda Myers*, Jacksonville, FL, Igor Frank,
Paras H. Shah, Robert F. Tarrell, Rochester, MN,
Giovanni A Gonzalez, Jacksonville, FL, R. Jeffrey
Karnes, Houston Thompson, Matthew K. Tollef-
son, Stephen A. Boorjian, Rochester, MN, Timothy
D. Lyon, Jacksonville, FL
1:50 PD10-06 A PHASE 1/2 STUDY OF RAPAMYCIN
AND CISPLATIN/GEMCITABINE FOR
TREATMENT OF PATIENTS (PTS) WITH
MUSCLE-INVASIVE BLADDER CANCER
(NCT01938573)
Dimitrios Makrakis*, Martine Roudier, Yan
Wang, Funda Vakar-Lopez, Jose Garcia, Atreya
Dash, Daniel Lin, George Schade, Elahe A Mo-
staghel, Heather Cheng, Michael T. Schweizer,
Sarah K Holt, John L. Gore, Evan Yu, Hung-
Ming Lam, Jonathan L. Wright, Bruce Montgom-
ery, Seattle, WA
2:00 PD10-07 UPDATE OF TRUCE-01: NEOADJUVANT
TISLELIZUMAB COMBINED WITH NAB-
PACLITAXEL FOR MUSCLE-INVASIVE
UROTHELIAL BLADDER CARCINOMA
Hailong Hu*, Yuanjie Niu, Haitao Wang, Chong
Shen, Gangjian Zhao, La Da, Lili Wang, Zhouliang
Wu, Zhi Li, Houyuan Chen, Xuejian Zhan, Zhan
Jiang, Zhe Zhang, Tianjin, China, People’s
Republic of
2:10 PD10-08 THE IMPACT OF BASELINE HEALTH-
RELATED QUALITY OF LIFE ON BLADDER-
CANCER-SPECIFIC SURVIVAL IN PATIENTS
TREATED WITH RADICAL CYSTECTOMY
Thilo Westhofen*, Lennert Eismann, Alexander
Buchner, Boris Schlenker, Clemens Gießen-Jung,
Armin Becker, Christian G. Stief, Alexander Kret-
schmer, Munich, Germany
64
2:20 PD10-09 IDENTIFICATION OF A 3-GENE PANEL IN THE
PREDICTION AND PROGNOSIS OF BLADDER
CANCER
Shiv Verma*, Eswar Shankar, Spencer Lin, Vaib-
hav Singh, Ricky Chan, Shufen Cao, Pingfu Fu,
Gregory MacLennan, Lee Ponsky, Sanjay Gupta,
Cleveland, OH
2:30 PD10-10 SIGNIFICANCE OF PREOPERATIVE
COGNITIVE FUNCTION SCREENED BY
THE MINI-COG TEST FOR PREDICTING
POSTOPERATIVE SELF-CARE ABILITY OF
THE UROSTOMY
Shugo Yajima*, Yasukazu Nakanishi, Naoya Oku-
bo, Shunnya Matsumoto, Kenji Tanabe, Madoka
Kataoka, Kashiwa, Japan
2:40 PD10-11 GLOBAL VARIATION IN QUALITY OF
TRANSURETHRAL RESECTION OF BLADDER
SURGERY, RESULTS FROM THE RESECT
STUDY
Kevin Gallagher*, Edinburgh, United Kingdom, Niki-
ta Bhatt, Norfolk, United Kingdom, Keiran Clement,
Glasgow, United Kingdom, Eleanor Zimmermann,
Plymouth, United Kingdom, Sinan Khadhouri, Aber-
deen, United Kingdom, Meghana Kulkarni, London,
United Kingdom, Thineskrishna Anbarasan, Edin-
burgh, United Kingdom, Vinson Wai-Shun Chan,
Leeds, United Kingdom, Alexander Light, London,
United Kingdom, Chon Meng Lam, Aqua Asif,
Leicester, United Kingdom, Fortis Gaba, Glasgow,
United Kingdom, Sabrina Rossi, Cambridge, United
Kingdom, Chuanyu Gao, Kent, United Kingdom, Ar-
jun Nathan, Tim O’Brien, London, United Kingdom,
Steven Maclennan, Aberdeen, United Kingdom,
Matthew Nielsen, Chapel Hill, NC, Paramananthan
Mariappan, Edinburgh, United Kingdom, Veeru
Kasivisvanathan, RESECT STUDY Global collabo-
rators, London, United Kingdom
2:50 PD10-12 THE EFFECT OF PERIOPERATIVE BLOOD
TRANSFUSION ON THE DEVELOPMENT OF
VENOUS THROMBOEMBOLISM AT THE TIME
OF RADICAL CYSTECTOMY
Kassem Faraj*, Charlotte Pougnier, Adri Durant,
Yu-Hui Chang, Mark Tyson, Phoenix, AZ
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
Friday, May 13, 2022 1:00 pm – 3:00 pm

Podium Session 11
PROSTATE CANCER: DETECTION & SCREENING II
Room 245 @ Ernest N. Morial Convention Center
Moderators: Arturo Mendoza-Valdes & J. Stephen Jones

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE

FRIDAY
1:00 PD11-01 CORRELATION BETWEEN NSAID USE 1:50 PD11-06 BASELINE PSA BELOW 1.0 NG/ML, AND
AND DETECTION RATE IN MEN WHO THEN? VERIFICATION OF THE EAU 2021
UNDERWENT PROSTATE BIOPSY. SHOULD POSITION AND RECOMMENDATION ON
WE REDUCE THE PSA CUTOFF FOR MEN RISK-ADAPTED EARLY DETECTION USING
IN CHRONIC THERAPY? A MULTICENTER ERSPC ROTTERDAM DATA WITH MORE
STUDY THAN 20 YEARS OF DETAILED FOLLOW-UP
Francesco Chierigo*, Guglielmo Mantica, Genova, Monique Roobol*, Sebastiaan Remmers, Renée
Italy, Farzana Cassim, Cape Town, South Africa, Hogenhout, Ivo de Vos, ERSPC Rotterdam study
Rafaela Malinaric, Genova, Italy, Andrea Benelli, group, Rotterdam, Netherlands
Garbagnate Milasene, Italy, Stefano Parodi,
2:00 PD11-07 AWARENESS OF RISK OF PROSTATE
Genova, Italy, Federico Dotta, Cape Town, South
CANCER (PCA) REMAINS POOR IN FAMILIES
Africa, Marco Ennas, Martina Beverini, Genova,
WITH GERMLINE MUTATIONS IN DNA-
Italy, Chiara Vaccaro, Garbagnate Milasene, Italy,
REPAIR GENES
Salvatore Smelzo, Milano, Italy, Francesca Am-
Giuseppe Chiarelli*, Pieve Emanuele, Italy, Rodol-
brosini, Stefano Tappero, Genova, Italy, Salvatore
fo Hurle, Paolo Casale, Alberto Saita, Rozzano,
Dioguardi, Palermo, Italy, Gioanni Guano, Maro
Italy, Giovanni Lughezzani, Vittorio Fasulo, Pieve
Borghesi, Nazareno Suardi, Carlo Introini, Gen-
Emanuele, Italy, Alessio Benetti, Rozzano, Italy,
ova, Italy, Virginia Varca, Garbagnate Milasene,
Giorgio Guazzoni, Pieve Emanuele, Italy, Mas-
Italy, Alchiede Simonato, Palermo, Italy, Andrea
simo Lazzeri, Rozzano, Italy, NicolòMaria Buffi,
Gregori, Garbagnate Milasene, Italy, Franco
Pieve Emanuele, Italy, Monica Zuradelli, Massimo
Gaboardi, Milano, Italy, Andre Van der Merwe,
Lazzeri, Rozzano, Italy
Cape Town, South Africa, Carlo Terrone,
Genova, Italy 2:10 PD11-08 A COMBINED BIOMARKER/MPMRI
APPROACH PROVIDES ENHANCED CLINICAL
1:10 PD11-02 EVALUATION OF VARIETY AND
INFORMATION PRIOR TO PROSTATE BIOPSY
PERFORMANCE BETWEEN PSA ASSAYS
Alexander Kretschmer, MD*, Munich, Germa-
AND PHI IN A CLINICAL COHORT OF MEN
ny, Johan Skog, PhD, Waltham, MA, Christian
UNDERGOING PROSTATE BIOPSY FOR
Fischer, PhD, Martinsreid, Germany, Jason Alter,
SUSPECTED PROSTATE CANCER
PhD, Waltham, MA, Mikkel Noerholm, PhD,
Basil Kaufmann*, Paloma Pellegrino, Noémie
Martinsreid, Germany
Lautenbach, Katharina Spanaus, Arnold von
Eckardstein, Thomas Hermanns, Cédric Poyet, 2:20 PD11-09 PERIOPERATIVE BLOOD LEVELS OF
Zurich, Switzerland PROSTATE-SPECIFIC EXTRACELLULAR
VESICLES IN LOCALIZED PROSTATE
1:20 PD11-03 ACCURACY AND RACIAL/ETHNIC
CANCER TREATED WITH RADICAL
REPRESENTATION OF PROSTATE CANCER
PROSTATECTOMY
SCREENING VIDEOS ON YOUTUBE AND TIKTOK
Ali Arafa*, Yohan Kim, Mohamed Ahmed, Vidhu
Max Abramson*, Nathan Feiertag, Darius Javidi,
Joshi, Eugene Kwon, Fabrice Lucien-Matteoni,
Bronx, NY, Stacy Loeb, New York, NY, Kara
Rochester, MN
Watts, Bronx, NY
2:30 PD11-10 COMPLICATIONS AFTER TRANSPERINEAL
1:30 PD11-04 THE LIMITED UTILITY OF PROSTATE HEALTH
PROSTATE BIOPSY WITHOUT ANTIBIOTIC
INDEX IN AFRICAN AMERICAN MEN WITH A
PROPHYLAXIS: A CONTRIBUTION TO THE
PSA 4-10
EFFORT TO CONTROL THE SPREAD OF
Kostantinos Morris*, Judd Moul, Srinath Kotamar-
ANTIBIOTICS RESISTANCE
ti, Durham, NC
Renée Hogenhout*, Henk B. Luiting, Daniël F.
1:40 PD11-05 ACQUIRED AND CONGENITAL SPINAL Osses, Monique J. Roobol, Rotterdam,
CORD INJURY IS ASSOCIATED WITH LOWER Netherlands
LIKELIHOOD OF PSA SCREENING
Stacy Jeong*, Cleveland Heights, OH, Glenn
Werneburg, Robert Abouassaly, Hadley Wood,
Cleveland, OH

*Presenting author 65
2:40 PD11-11 A URINARY EXOSOME ASSAY
INTERROGATING SMALL NON-CODING
RNAS ACCURATELY IDENTIFIES AND
STRATIFIES PROSTATE CANCER INTO LOW-
INTERMEDIATE- OR HIGH-RISK DISEASE
Laurence Klotz*, Toronto, Canada, Winnie Wang,
Rensselaer, NY, Alvin Lopez Pujals, Caguas,
Puerto Rico, Deepak Kapoor, New Hyde Park, NY,
Rebecca DeVaux, Greg DiRienzo, Rensselaer,
NY, Federico Corica, Ann Anderson, San Juan,
Puerto Rico, Carl Olsson, New Hyde Park, NY,
Alberto Corica, San Juan, Puerto Rico, James
Libby, Stockbridge , GA, Martin Tenniswood,
Rensselaer, NY
2:50 PD11-12 ASSOCIATIONS OF SERUM-BASED AND
URINE-BASED MOLECULAR DIAGNOSTICS
WITH HISTOLOGIC SUBTYPING ON
PROSTATE BIOPSY
Claire de la Calle*, Nancy Greenland, Janet Cow-
an, Vittorio Fasulo, Martina Maggi, Emily Chan,
Bradley Stohr, Jeffry Simko, Katsuto Shinohara,
Matthew Cooperberg, Peter Carroll, Hao Nguyen,
San Francisco, CA
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM

Friday, May 13, 2022 1:00 pm – 3:00 pm

Podium Session 12
BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY II
Room 244 @ Ernest N. Morial Convention Center
Moderators: Byron Lee & Peter Black

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
1:00 PD12-01 BLADDER TUMOR MICROBIOME MAY 1:50 PD12-06 DIFFERENTIAL MYELOID INFLAMMATORY
AUGMENT RESPONSE TO BCG IN NON- RESPONSE AND TUMORIGENESIS BY GENDER
MUSCLE INVASIVE BLADDER CANCER IN MOUSE MODEL OF BLADDER CANCER
Jacob Knorr*, Glenn Werneburg, Ava Adler, Jose Lauren Folgosa Cooley*, Joseph Podojil, Khyati
Agudelo, Prithvi Murthy, Rebecca Campbell, Meghani, Yanni Yu, Stephen Miller, Joshua
Petar Bajic, Nima Almassi, Christopher Weight, Meeks, Chicago, IL
Georges-Pascal Haber, Aaron Miller, Byron Lee,
2:00 PD12-07 ADDITION OF ANTI-PD-L1 ENHANCES
Cleveland, OH
ANTITUMOR EFFICACIES OF BCG AND
BCG-STING BY CD8+ T CELL EXPANSION
1:10 PD12-02 PATIENT-DERIVED BLADDER TUMOR
IN A MURINE SYNGENEIC MB49 MODEL OF
ORGANOIDS FOR INDIVIDUALIZED
UROTHELIAL CARCINOMA
PRECLINICAL CHARACTERIZATION
Kara Lombardo*, Monali Praharaj, Russell Becker,
OF NADOFARAGENE FIRADENEOVEC
Kelly Harris, William Bishai, Andres Matoso, Bal-
INTERFERON GENE THERAPY
timore, MD, Trinity Bivalacqua, Philadelphia, PA,
Tanner Miest, Houston, TX, Jan Rudzinski*,
Alok Singh, Baltimore, MD
Houston, TX, Sharada Mokkapati, Akshay Sood,
Anirban Mitra, Colin Dinney, Houston, TX 2:10 PD12-08 CRYOTHERAPY FOR SUPERFICIAL BLADDER
CANCER IN A SWINE MODEL
1:20 PD12-03 INTERFERON α GENE THERAPY ALTERS
Gilad Amiel*, Eyal Kochavi, Camille Malshy, Yaron
TUMOR METABOLISM IN BLADDER CANCER
Ofer, Azik Hoffman, Haifa, Israel
Sharada Mokkapati, Jan Rudzinski*, Tanner Mi-
est, Anirban Mitra, Akshay Sood, David McCon- 2:20 PD12-09 ELEVATED SEMAPHORIN-6A FACILITATES
key, Colin Dinney, Houston, TX FLT4-MEDITATED TUMOR MIGRATION AND
ASSOCIATES WITH IMMUNE SUPPRESSION
1:30 PD12-04 SURVEY OF B AND PLASMA CELLS IN
IN BLADDER CANCER
BLADDER CANCER ACROSS TUMOR
Wenjie Luo*, Yiping Zhu, Hailiang Zhang, Yuanyu-
MICROENVIRONMENTS
an Qu, Dingwei Ye, Shanghai, China, People’s
Yuanshuo Wang*, New York, NY, Jorge Daza,
Republic of
Buffalo, NY, Emilie Grasset, New York, NY, Giuli-
ana Magri, Barcelona, Spain, Daniel Ranti, Kristin 2:30 PD12-10 URINE COMPREHENSIVE GENOMIC
Beaumont, Adam Farkas, Michelle Tran, Li Wang, PROFILING OF UROTHELIAL CARCINOMA
Rachel Brody, Reza Mehrazin, Peter Wiklund, PATIENTS UNDERGOING INTRAVESICAL
Robert Sebra, Jun Zhu, Matthew Galsky, Nina THERAPY ENABLES DETECTION OF
Bhardwaj, John Sfakianos, Amir Horowitz, New ACTIONABLE DNA MUTATIONS ASSOCIATED
York, NY WITH DRUG RESPONSE AND RISK
STRATIFICATION
1:40 PD12-05 SPATIAL TRANSCRIPTOMICS PROVIDES
Goran Rac*, Shalin Desai, Hiten D. Patel, Chirag
EVIDENCE FOR ALTERNATIVE CHECKPOINT
Doshi, Ryan Dornbier, Maywood, IL, Vincent Ca-
AXES IN BCG-TREATED NMIBC
ruso, Peter Lentz, Brian C. Mazzarella, Kevin G.
Daniel Ranti*, Yuanshuo Wang, Jorge Daza,
Phillips, Trevor Levin, South San Francisco, CA,
Sanjana Shroff, Kristin Beaumont, Amir Horowitz,
Alan J. Wolfe, Gopal N. Gupta, Maywood, IL
John Sfakianos, New York, NY

66
2:40 PD12-11 CASTRATION IMPACT ON PATTERN
RECOGNITION RECEPTORS (PRRS) BOOSTS
TOLL-LIKE RECEPTOR-4 EXPRESSION IN AN
IMMUNOCOMPETENT BLADDER CANCER
MALE MODEL
Leonardo Reis*, Campinas, Brazil Japan, Atsushi Irie, Yasuharu Nishimura,
Friday, May 13, 2022
Video Session 3
UROLITHIASIS/ENDOUROLOGY
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Michele Jo Semins, Necole Streeper & Sung Yong Cho
ABSTRACT
TIME NUMBER TITLE
1:00 V03-01 AUTOMATED KIDNEY STONE
SEGMENTATION DURING URETEROSCOPY
USING COMPUTER VISION TECHNIQUES
Chase Floyd*, Columbia, SC, Zachary Stoebner,
Daiwei Lu, Ipek Oguz, Nicholas Kavoussi,
Nashville, TN Osama Al-Alao, Michael Palese, New York, NY
1:10 V03-02 EX-VIVO URETEROSCOPY FOR THE
TREATMENT OF NEPHROLITHIASIS IN A
DECEASED DONOR KIDNEY PRIOR TO
TRANSPLANTATION
Marcus Jamil*, Jack Vercnocke, Patrick Etta,
Adhnan Mohamed, Mohit Butaney, Mahdi Bazzi,
Simon Zetuna, Lauren Malinzak, David Leavitt,
Detroit, MI
1:20 V03-03 ULTRA-LOW-DOSE INTRAOPERATIVE CT
IMAGING DURING PCNL
Xavier Glover*, Eric Ballon-Landa, Mark Sawyer,
Denver, CO Roman Sukhanov, Petr Glybochko, Moscow,
1:30 V03-04 IN VIVO FEASIBILITY TEST USING FLEXIBLE
URETEROSCOPIC ROBOTIC SYSTEM,
EASYURETERO FOR RENAL STONE
RETRIEVAL IN PORCINE MODEL
Hyun Ho Han*, Young Joon Moon, Seoul, Korea,
Republic of, Hae Do Jung, Gunpo, Korea, Repub-
lic of, Joonhwan Kim, Byungsik Cheon, Jungmin
Han, Daejeon, Korea, Republic of, Sung Yong
Cho, Seoul, Korea, Republic of, Dong-Soo Kwon,
Daejeon, Korea, Republic of, Joo Yong Lee,
Seoul, Korea, Republic of 2:50 V03-12 THULIUM LASER FIBER PERFORMANCE
1:40 V03-05 SINGLE-PORT ROBOTIC CYSTOLITHOTOMY
AND PYELOLITHOTOMY FOR ENCRUSTED
URETERAL STENT REMOVAL
Nathan Cheng*, Hackensack, NJ, Jason
Elyaguov, Valhalla, NY, Christine Cumarasamy,
Mutahar Ahmed, Nutley, NJ
1:50 V03-06 ECTOPIC PYELOLITHOTOMY VIA A COMBINED
ROBOTIC AND ENDOSCOPIC APPROACH
Andrew Higgins*, Alex Nourian, Joshua Cohn,
Justin Friedlander, Philadelphia, PA
*Presenting author 67
2:50 PD12-12 TUMOR ANTIGEN VACCINE ENHANCES
ANTI-TUMOR EFFECTS OF IMMUNE
CHECKPOINT INHIBITORS AGAINST
REFRACTORY CANCERS
Shohei Ueda*, Miho Ushjima, Fukuoka-shi,
Kumamoto-shi, Japan, Masatoshi Eto,
Fukuoka-shi, Japan
FRIDAY
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
1:00 pm – 3:00 pm
ABSTRACT
TIME NUMBER TITLE
2:00 V03-07 INTRACORPOREAL ROBOTIC
PYELOLITHOTOMY USING THE BOSTON
SCIENTIFIC SWISS LITHOCLAST® TRILOGY
LITHOTRIPTER
Micah Levy*, Chih Peng Chin, Krishna T. Ravivarapu,
2:10 V03-08 MECHANISMS OF LASER LITHOTRIPSY
REVEALED WITH ULTRAHIGH-SPEED VIDEO
MICROSCOPY OF STONE FRAGMENTATION
IN AIR AND WATER
Yuri Pishchalnikov*, William Behnke-Parks,
Marshall Stoller, San Francisco, CA
2:20 V03-09 THULIUM FIBER LASER: A UNIVERSAL
DEVICE IN UROLOGY. FROM BENCH TO
BEDSIDE
Dmitry Enikeev*, Mark Taratkin, Camilla Azil-
gareeva, Anastasia Shpikina, Leonid Rapoport,
Russian Federation
2:30 V03-10 THULIUM LASER VS DUAL
ACTION ULTRASONIC/BALLISTIC
CYSTOLITHOLAPAXY
Matthew Beamer*, Scott Weiner, Syracuse, NY
2:40 V03-11 NOVEL USE OF THULIUM LASER FOR THE
MANAGEMENT OF BILIARY CALCULI
Akshay Reddy*, Nicholas Freidberg, MD, Patrick
Mufarrij, MD, Washington, DC
FOR SIMULTANEOUS TREATMENT OF A
URETERAL TUMOR, A URETERAL STONE,
AND A KIDNEY STONE: THE SKY IS THE
LIMIT!
Willian Ito*, Kenneth Schmanke, Bristol Whiles,
Wilson Molina, Kansas City, KS
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
Friday, May 13, 2022 2:45 pm – 4:00 pm

Moderated Poster Session 13

HEALTH SERVICES RESEARCH: PRACTICE PATTERNS, QUALITY OF LIFE AND SHARED DECISION MAKING I
Room 228 @ Ernest N. Morial Convention Center
Moderators: Mark Litwin & Caroline Moore

ABSTRACT ABSTRACT
NUMBER TITLE NUMBER TITLE
MP13-01 PATIENT PERSPECTIVES IN GENITAL MP13-09 UNDERREPRESENTATION OF MINORITIES
GENDER-AFFIRMING SURGERY: THE AND WOMEN IN 20 YEARS OF
NEED FOR PATIENT REPORTED OUTCOME GENITOURINARY CANCER CLINICAL TRIALS
MEASURES Juan Javier-DesLoges*, Arman Walia, Marga-
Nnenaya Agochukwu-Mmonu, Elijah Castle*, ret Meagher, John Perry, San Diego, CA, Mimi
Lee Zhao, Asa Radix, Rachel Bluebond-Langner, Nguyen, San Diego, CA, Rekha Narasimhan, San
Daphna Harel, Danil Makarov, New York, NY, Diego, CA, Madison Chakoumakos, San Diego,
Clarissa Ospina-Norvell, San Francisco, CA, CA, Ava Saidian, Brent Rose, Maria Elena Mar-
Carolyn Berry, New York, NY tinez, James D. Murphy, Ithaar Derweesh, San
Diego, CA
MP13-02 PATTERNS OF TELE-HEALTH USAGE
AFTER THE COVID-19 PANDEMIC AMONG MP13-10 CAN YOU HAVE IT ALL? PARENTING IN
SURGICAL SPECIALTIES AND UROLOGY UROLOGY AND WORK-LIFE BALANCE
Maheetha Bharadwaj*, Muhieddine Labban, Bjo- SATISFACTION
ern Langbein, Adam S. Kibel, Steven L. Chang, Catherine S. Nam*, Stephanie Daignault-Newton,
Quoc-Dien Trinh, Boston, MA Lindsey A. Herrel, Kate H. Kraft, Ann Arbor, MI
MP13-03 ASSESSMENT OF PATIENT UNDERSTANDING MP13-11 EHR-BASED CLINICAL DECISION SUPPORT
PRIOR TO UROLOGICAL SURGERIES TO FOR UROLOGIC SURGERY: USER
IMPROVE PATIENT EDUCATION & QUALITY PERSPECTIVES AND NEEDS
OF CARE Hung-Jui Tan*, Chapel Hill, NC, Brooke Spratte,
Alison Schulz*, Priya Dave, Nitya Abraham, Durham, NC, Allison Deal, Antonia Bennett,
Bronx, NY Susan Blalock, Chapel Hill, NC, Arlene Chung,
Durham, NC, David Gotz, Matthew Nielsen, Dan
MP13-04 ONABOTULINUMTOXINA IMPROVES
Reuland, Chapel Hill, NC, Alex Sox-Harris,
IDIOPATHIC OVERACTIVE BLADDER
Stanford, CA, Ethan Basch, Chapel Hill, NC
SYMPTOMS IN PATIENTS REFRACTORY TO
ORAL MEDICATIONS MP13-12 PRACTICE PATTERNS AND PREDICTORS
Elisabeth Carlsson Farrelly*, Stockholm, Sweden, OF URINARY STONE MATERIAL
Maria-Fernando Lorenzo-Gomez, Salamanca, SUBMISSION FOR ANALYSIS FOLLOWING
Spain, Heinrich Schulte-Baukloh, Berlin, Germa- URETEROSCOPY: RESULTS FROM A
ny, Mariana Nelson, Irvine, CA, Rizwan Hamid, STATEWIDE SURGICAL COLLABORATIVE
London, United Kingdom Isaac Palma-Zamora*, Detroit, MI, Stephanie Daig-
nault-Newton, Ann Arbor, MI, Mohit Butaney, Grace
MP13-05 UROLOGIST HIRING PRACTICES: DATA
Yaguchi, David Leavitt, Detroit, MI, Casey Dauw,
FROM THE AMERICAN UROLOGICAL
Khurshid Ghani, Ann Arbor, MI, Naveen Kachroo,
ASSOCIATION 2020 CENSUS
Detroit, MI, for the Michigan Urological Surgery
Christina Shin*, Justin Loloi, Bronx, NY, Raymond
Improvement Collaborative, Ann Arbor, MI
Fang, Linthicum, MD, William Meeks, Maryland,
MD, Andrew Harris, Lexington, KY, Amanda MP13-13 ASSOCIATION BETWEEN COMPLEXITY OF
North, Bronx, NY PELVIC SURGICAL FIELD AND OUTCOMES
OF RADICAL CYSTECTOMY WITH URINARY
MP13-06 PERSONALITY TRAITS AND BURNOUT
DIVERSION
AMONG PRACTICING UROLOGISTS
Leilei Xia*, Raju Chelluri, Ruchika Talwar, Daniel
Gopal Narang*, Lanyu Mi, Kevin Wymer, Chris-
Lee, Thomas Guzzo, Philadelphia, PA
topher Wolter, Mitchell Humphreys, Karen Stern,
Phoenix, AZ MP13-14 IMPACT OF COVID AND TELEHEALTH UPON
CLINIC VISITS BY UNIVERSITY-BASED
MP13-07 PROFESSIONAL BURNOUT OF ADVANCED
UROLOGISTS: IMPLICATIONS FOR ACCESS
PRACTICE PROVIDERS BASED ON AUA
Kim Thai*, Ryan Terlecki, Winston-Salem, NC
CENSUS DATA
Kavita Gupta*, Justin Loloi, Bronx, NY, Raymond MP13-15 ONE YEAR OF TELEMEDICINE IN THE
Fang, Linthicum, MD, Amanda North, Bronx, NY, MANAGEMENT OF GENITOURINARY
William Meeks, Linthicum, MD MALIGNANCIES
Ezra Margolin*, Saveliy Kelebeyev, Luis Pina
MP13-08 ADVANCED PRACTICE PROVIDERS AND
Martina, Christopher Anderson, New York, NY
WAIT TIMES IN UROLOGY PRACTICES: A
SECRET SHOPPER STUDY MP13-16 THE AUA GUIDELINES: AN EVALUATION OF
Armaan Singh*, Jared Lassner, Marc Sleiman, EVIDENCE GRADE BACKING STATEMENTS
Parth Modi, Chicago, IL Chris Du*, Kuemin Hwang, John Hill, Howard L.
Adler, Stony Brook, NY

68
 MP13-17 COGNITIVE BIAS AGAINST AGE IN
THE TREATMENT OF PATIENTS WITH
INTERMEDIATE-RISK PROSTATE CANCER
Aaron Brant*, Patrick Lewicki, Tenny Zhang,
Christina Sze, Jeffrey Johnson, New York, NY,
Anise Bowman, Ilon Weinstein, Jonathan Shoag,
Cleveland, OH John M. DiBianco, Ann Arbor, MI, S. Mohammad
MP13-18 IMPACT OF COMPREHENSIVE HEALTH
INSURANCE COVERAGE ON QUALITY OF
LIFE IN LOW-INCOME MEN WITH PROSTATE
CANCER
Allen E. D. Siapno*, Thomas W. Gaither, Megha
D. Tandel, Lorna Kwan, Ying-Ying Meng, Sally
Maliski, Arlene Fink, Mark S. Litwin,
Los Angeles, CA
MP13-19 DISPARITIES IN DISTRESS FOR PATIENTS
WITH CANCER
Connor Lough, BS*, Geoffrey Rosen, MD, Cath-
erine Muzzey, RN BSN, Edward Johnson, Katie
Murray, DO, Columbia, MO
Friday, May 13, 2022
Moderated Poster Session 14
STONE DISEASE: SURGICAL THERAPY (INCLUDING ESWL) I
Room 225 @ Ernest N. Morial Convention Center
Moderators: Norberto Bernardo, Noah Canvasser & Bodo Knudsen
ABSTRACT
NUMBER TITLE
MP14-01 EVALUATING THE QUALITY OF SOCIAL
MEDIA CONTENT ON UROLITHIASIS
PROCEDURES
Parris Diaz*, Los Angeles, CA, Rebecca A.
Takele, Blacksburg, VA, Sapna Thaker, Karan N.
Thaker, Jorge Ballon, Mayra Lucas, Kevin Kunit-
sky, Kymora B. Scotland, Los Angeles, CA
MP14-02 THE SOCIAL IMPACT OF SURGERY FOR
NEPHROLITHIASIS: RESULTS FROM
THE ENDOUROLOGIC SOCIETY TOWER
RESEARCH COLLABORATIVE
Amanda Jones*, Christian Rodriguez, George Lin,
Hanna Stambakio, Philadelphia, PA, Ben Chew,
Vancouver, Canada, Joshua Stern, Park City, UT,
Justin Ziemba, Philadelphia, PA
MP14-03 DOES THE POSITION AND SIZE OF THE
URETERAL ACCESS SHEATH AFFECT RENAL
PRESSURES DURING URETEROSCOPY?
INTRARENAL PRESSURE MEASUREMENT
USING A CONCEPT SINGLE-USE DIGITAL
FLEXIBLE URETEROSCOPE
Ben H. Chew*, Nabil Shalabi, K.F. Victor Wong,
Roman Herout, Alina Reicherz, Vancouver,
Canada, Naeem Bhojani, Montreal, Canada PREGNANCY
MP14-04 IN VIVO AND BENCH TESTING OF A
CONCEPT SINGLE USE URETEROSCOPE
BSC COMPARED TO REFERENCE SINGLE
USE AND REUSABLE URETEROSCOPES
Naeem Bhojani*, Montreal, Canada, Nabil
Shalabi, K.F. Victor Wong, Roman Herout, Alina
Reicherz, Ben H. Chew, Vancouver, Canada PERCUTANEOUS NEPHROLITHOTOMY
*Presenting author
MP13-20 PREOPERATIVE URINE TESTING FOR
URETEROSCOPY IN THE STATE OF
MICHIGAN: AMERICAN UROLOGICAL
ASSOCIATION GUIDELINE ADHERENCE AND
CLINICAL IMPLICATIONS
Hyung Joon Kim*, Stephanie Daignault-Newton,
Jafri, Royal Oak, MI, J. Rene Frontera, Saint
FRIDAY
Claire Shores, MI, Brian Seifman, Royal Oak,
Troy, MI, Khurshid R. Ghani, Casey A. Dauw, for
the Michigan Urological Surgery Improvement
Collaborative, Ann Arbor, MI
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
2:45 pm – 4:00 pm
ABSTRACT
NUMBER TITLE
MP14-05 URETEROSCOPY UNDER CONSCIOUS
SEDATION FOR UPPER TRACT PATHOLOGY
Kunal Jain*, Winnipeg, Canada, Esha Jain, St.
John’s, Antigua and Barbuda, Ruben Blach-
man-Braun, Miami, FL, Amanda Eng, Brian
Peters, Premal Patel, Winnipeg, Canada
MP14-06 URETERAL STENTS ASSOCIATED WITH
LOWER COMPLICATION RATES VERSUS
PERCUTANEOUS NEPHROSTOMY TUBES
IN THE TREATMENT OF MATERNAL
NEPHROLITHIASIS
Matthew Mason*, Sirpi Nackeeran, Marisa Carino
Mason, Miami, FL, Taylor Kohn, Baltimore, MD,
Ranjith Ramasamy, Miami, FL
MP14-07 COMPARATIVE RADIATION EXPOSURE FOR
PREGNANT PATIENTS WHO REQUIRED
INTERVENTION FOR SYMPTOMATIC
NEPHROLITHIASIS
Madison Lyon*, Alec Sun, Anup Shah, Natalia Lla-
rena, Carrie Bennet, Sri Sivalingam, Juan Calle,
Anna Zampini, Smita De, Cleveland, OH
MP14-08 NEONATAL OUTCOMES AFTER
INTERVENTION FOR RENAL COLIC IN
Alec Sun*, Carrie Bennett, Anup Shah, Madison
Lyon, Sri Sivalingam, Juan Calle, Anna Zampini,
Smita De, Cleveland, OH
′LOW-DOSE′ FLUOROSCOPY TECHNIQUE
MP14-09 
DRASTICALLY DECREASES PATIENT
RADIATION EXPOSURE DURING
Galen Cheng*, Timothy Campbell, Changyong
Feng, Scott Quarrier, Rajat Jain, Rochester, NY
69
 MP14-10 MECHANISMS OF PULSE MODULATED
HOLMIUM:YAG LITHOTRIPSY: PULSE
TRANSMISSION AND SHOCK WAVE
PRESSURE
Jason King*, Austin, TX, Nitesh Katta, Irvine,
CA, Joel Teichman, Vancouver, Canada, James
Tunnell, Austin, TX, Thomas Milner, Irvine, CA
MP14-11 PROPENSITY SCORE-MATCHED ANALYSIS
COMPARING RETROGRADE INTRARENAL
SURGERY WITH PERCUTANEOUS
NEPHROLITHOTOMY IN ANOMALOUS
KIDNEYS
Ee Jean Lim*, Singapore, Singapore, Jeremy
Yuen-Chun Teoh, Hong Kong, China, People’s
Republic of, Khi Yung Fong, Singapore, Sin-
gapore, Esteban Emiliani, Barcelona, Spain,
Nariman Gadzhiev, Dmitry Gorelov, Saint-Pe-
tersburg, Russian Federation, Yiloren Tanidir,
Istanbul, Turkey, Fabio Sepulveda, San Paulo,
Brazil, Abdullah Al-Terki, Kuwait, Kuwait, Sanjay
Khadgi, Lalitpur, Nepal, Abhay Mahajan, Aurang-
abad, India, Deepak Ragoori, Banjara Hills, India,
Govindarajan Ramalingam, Tamil Nadu, India,
Vaddi Chandra Mohan, Hyderabad, India, Arvind
Prakash Ganpule, Gujarat, India, Santosh Kumar,
Vellore, India, Daniele Castellani, Ancona, Italy,
Manoj Monga, California, CA, Scoffone Cesare,
Turin, Italy, Fabio Vicentini, São Paulo, Brazil,
Olivier Traxer, Paris, France, Bhaskar Kumar
Somani, Southampton, United Kingdom, Vineet
Gauhar, Singapore, Singapore Sivalingam, Cleveland, OH, Matthew Dunn, Santa
MP14-12 SPONTANEOUS PASSAGE RATE OF
URETERAL STONES AND PREDICTIVE
FACTORS AFTER PRE-STENTING
Yasmin Trachsel*, Beat Förster, Hubert John,
Christoph Schregel, Winterthur, Switzerland Shan Wang, Kunj Sheth, Simon Conti, Joseph
MP14-13 PREDICTING FACTORS AND STONE FREE
RATE OF IMPACTED URETERAL STONES
Tae Hoon Oh, Seung Chul Park, Ill Young Seo*,
Iksan, Korea, Republic of IN PREGNANT PATIENTS COMPARED WITH
MP14-14 MINI-PCNL OUTCOMES IN THE OBESE
POPULATION, A RETROSPECTIVE REVIEW
Austen Slade*, Tim Large, Erica Sahm, Marcelino
Rivera, Indianapolis, IN
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
70
MP14-15 PREDICTORS OF SUCCESSFUL SECOND
LOOK FLEXIBLE NEPHROSCOPY AFTER
PERCUTANEOUS NEPHROLITHOTOMY
Jessica Dai*, Hersh Trivedi, Vineeth Kommidi,
Brett Johnson, Jodi Antonelli, Margaret Pearle,
Dallas, TX
MP14-16 POST-OPERATIVE PAIN AND RECOVERY
IN PATIENTS WITH NEPHROLITHIASIS:
RESULTS FROM THE ENDOUROLOGIC
SOCIETY TOWER RESEARCH
COLLABORATIVE
Amanda Jones*, Christian Rodriguez, George Lin,
Hanna Stambakio, Philadelphia, PA, Ben Chew,
Vancouver, Canada, Joshua Stern, Park City, UT,
Justin Ziemba, Philadelphia, PA
MP14-17 MORTALITY ASSOCIATED WITH SEPSIS
POST-URETEROSCOPY AMONG A US-BASED
COMMERCIAL POPULATION
Naeem Bhojani*, Montreal, Canada, Brian Eisner,
Boston, MA, Manoj Monga, San Diego, CA, Rutu-
gandha Paranjpe, Benjamin Cutone, Boston, MA,
Ben H. Chew, Vancouver, Canada
MP14-18 ROBOTIC-ASSISTED ELECTROMAGNETIC
GUIDANCE IMPROVES SUCCESS IN
GAINING PERCUTANEOUS ACCESS FOR
NEPHROLITHOTOMY BY NOVICES
Mitchell Humphreys*, Kevin Wymer, Phoenix, AZ,
Ben Chew, Vancouver, Canada, Janet Zhen, Red-
wood City, CA, Fuad Elkhoury, Los Angelas, CA, Sri
Monica, CA, Michael Borofsky, Minneapolis, MN
MP14-19 MAGNETIC CLEARANCE OF KIDNEY STONE
FRAGMENTS: INITIAL IN VITRO EXPERIENCE
Tianjia Jessie Ge*, Timothy Chang, Kathy Mach,
Liao, Palo Alto, CA
MP14-20 COMPARISON OF THE EFFECT OF ACTIVE
SURGICAL TREATMENT OF UROLITHIASIS
SERIAL URETERAL STENTING ON THE
PROBABILITY OF NATURAL DELIVERY
Pavel Nizin, Sergey Kotov*, Perov Roman,
Moscow, Russian Federation
Friday, May 13, 2022
Moderated Poster Session 15
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY I
Room 222 @ Ernest N. Morial Convention Center
Moderators: Neil Fleshner, Kara Babaian & Jim Hu
ABSTRACT
NUMBER TITLE
MP15-01 LONGITUDINAL PATIENT-REPORTED
OUTCOMES MEASURES DEMONSTRATE
CONTINUED IMPROVEMENTS IN URINARY
AND ERECTILE FUNCTION AFTER RADICAL
PROSTATECTOMY THROUGH 30 MONTHS
Daniel Frendl, Wesley Chou*, Matthew Wszolek,
Francis McGovern, Adam Feldman, Michael Blute,
Jeffrey Twum-Ampofo, Marcela del Carmen, Marilyn
Heng, Rachel Sisodia, Douglas Dahl, Boston, MA Mazzone, Milano, Italy, Nicola Fossati, Andrea
MP15-02 DEEP LEARNING USING MRI AND
INTRAOPERATIVE VIDEO IMAGES
STRONGLY PREDICTS RECOVERY OF
URINARY CONTINENCE AFTER ROBOT-
ASSISTED RADICAL PROSTATECTOMY
Makoto Sumitomo*, Atsushi Teramoto, Wataru
Nakamura, Kenji Zennami, Takuhisa Nukaya,
Masashi Takenaka, Kosuke Fukaya, Manabu
Ichino, Kiyoshi Takahara, Hitomi Sasaki, Ryoichi
Shiroki, Toyoake, Japan DIAGNOSED WITH IUSP ≤ 2 PROSTATE
MP15-03 PROGNOSTIC VALUE OF LYMPHOVASCULAR
INVASION IN PATIENTS TREATED WITH
SALVAGE RADICAL PROSTATECTOMY FOR
RADIATION-RECURRENT PROSTATE CANCER
Stephan Brönimann*, Fahad Quhal, Ekaterina
Laukhtina, Benjamin Pradere, Vienna, Austria, Al-
berto Briganti, Milan, Italy, Pawel Rajwa, Vienna,
Austria, Axel Heidenreich, Cologne, Germany,
Shahrokh F. Shariat, Vienna, Austria
MP15-04 SAFETY AND FEASIBILITY OF SALVAGE
RADICAL PROSTATECTOMY FOLLOWING
PRIMARY IRE TREATMENT FOR RECURRENT
LOCALIZED PROSTATE CANCER: AN
INTERNATIONAL AND MULTICENTER ANALYSIS
Luigi A.M.J.G. van Riel*, Amsterdam, Nether-
lands, Alexander Blazevski, Darlinghurst, Austral-
ia, Ertunc Kabaktepe, Amsterdam, Netherlands,
Bart Geboers, Darlinghurst, Australia, Daan
Reesink, Pascal Stijns, Nieuwegein, Netherlands,
Philip D. Stricker, Darlinghurst, Australia, Juan
Casanova, Jose Luis Dominguez-Escrig, Valencia,
Spain, Theo M. de Reijke, Matthijs J. Scheltema,
Jorg R. Oddens, Amsterdam, Netherlands Theodoros Karagiotis*, Jorn H. Witt, Mikolaj Men-
*Presenting author
2:45 pm – 4:00 pm
ABSTRACT
NUMBER TITLE
FRIDAY
MP15-05 TOPOGRAPHIC DESCRIPTION OF THE SITE
OF POSITIVE MPMRI AND IMPACT ON THE
RISK OF POSITIVE SURGICAL MARGINS
AT ROBOT-ASSISTED NERVE SPARING
RADICAL PROSTATECTOMY. IMPLICATIONS
FOR ACCURATE SURGICAL APPROACHES
Francesco Barletta*, Giorgio Gandaglia, Giuseppe
Rosiello, Simone Scuderi, Armando Stabile, Elio
Gallina, Lugano, Switzerland, Emanuele Zaffuto,
Umberto Capitanio, Alessandro Larcher, Milan, It-
aly, Andrea Salonia, Milano, Italy, Federico Dehò,
Varese, Italy, Pierre I. Karakiewicz, Montreal,
Canada, Shahrokh F. Shariat, Vienna, Austria,
Vincenzo Mirone, Napoli, Italy, Francesco Montor-
si, Alberto Briganti, Milano, Italy
MP15-06 RISK OF ADVERSE RADICAL
PROSTATECTOMY OUTCOMES IN PATIENTS
CANCER ON MRI/TRUS FUSION BIOPSY
Claudia Kesch*, Vlad Pantea, Essen, Germany,
Timo Soeterik, Nieuwegein-Utrecht, Nether-
lands, Alessandro Marquis, Turin, Italy, Giulia La
Bombarda, Allesandro Morlacco, Padova, Italy,
Francesco Barletta, Milan, Italy, Felix Preisser,
Frankfurt, Germany, Fabio Zattoni, Padova, Italy,
Giancarlo Marra, Turin, Italy, Roderik C. N. van
den Bergh, Nieuwegein-Utrecht, Netherlands, Jan
Philipp Radtke, Boris Hadaschik, Essen, Germa-
ny, Giorgio Gandaglia, Milan, Italy
MP15-07 IMIPRAMINE DELAYS CLINICAL
PROGRESSION OF PROSTATE CANCER
Seung-hwan Jeong*, Jang Hee Han, Hyeo-
ng-Dong Yuk, Chang-Wook Jeong, Hyeon-Hoe
Kim, Ja-Hyeon Ku, Cheol Kwak, Seoul, Korea,
Republic of
MP15-08 PATHOLOGICAL, FUNCTIONAL AND
ONCOLOGICAL BEST-CASE SCENARIOS
AFTER ROBOT-ASSISTED RADICAL
PROSTATECTOMY, CAN WE IMPROVE
QUALITY OF LIFE?
drek, Christian Wagner, Andreas Schuette, Nikola-
os Liakos, Pawel Rachubinski, Katarina Urbano-
va, Matthias Oelke, Sami-Ramzi Leyh-Bannurah,
Gronau, Germany
MP15-09 SURVIVAL ESTIMATES OF MEN WITH
BIOCHEMICALLY RECURRENT PROSTATE
CANCER AFTER RADICAL PROSTATECTOMY
IN A NATIONAL COHORT
Kristian Stensland*, Jennifer Burns, Jordan
Sparks, Varsha Vedapudi, Christina Chapman,
Megan Caram, Chris Shin, Alexander Zaslavsky,
Alexander Tsodikov, Ted Skolarus, Ann Arbor, MI
71
 MP15-10 IMPACT OF DISEASE STATUS
HETEROGENEITY OF THE STAMPEDE TRIAL
ARM J POPULATION ON ONCOLOGICAL
OUTCOMES IN HIGH-RISK NONMETASTATIC
PROSTATE CANCER
Shingo Hatakeyama*, Toshikazu Tanaka, Takuma
Narita, Daisuke Noro, Teppei Okamoto, Noritaka
Ishi, Ryuma Tanaka, Takuya Oishi, Hikari Miura,
Takahiro Yoneyama, Chikara Ohyama, Hirosaki,
Japan
MP15-11 OUTCOMES OF SALVAGE ROBOT-ASSISTED
RADICAL PROSTATECTOMY ( S-RARP) POST
FOCAL ABLATION FOR PROSTATE CANCER
IN COMPARISON WITH PRIMARY ROBOT-
ASSISTED RADICAL PROSTATECTOMY
(RARP); A MATCHED ANALYSIS
Seetharam Bhat, Celebration, FL, Marcio Covas
Moschovas*, kissimee, FL, Jonathan Noel, Travis
Rogers, Roshane Pereira, Sunil Reddy, Vipul Pa-
tel, Celebration, FL, Marco Sandri, Milan, Italy
MP15-12 EFFICACY OF THE OPENED LEGS POSITION
FOR PREVENTING POSTOPERATIVE
RHABDOMYOLYSIS AFTER ROBOT-ASSISTED
RADICAL PROSTATECTOMY(RARP)
Hiroshi Matsuzaki*, Kazuna Tsubouchi, Naotaka
Gunge, Takeshi Miyazaki, Yu Okabe, Nobuyuki
Nakamura, Hirofumi Matsuoka, Nobuhiro Haga,
fukuoka-shi, Japan
MP15-13 OUTCOMES COMPARISON BETWEEN
THE ROBOT-ASSISTED RADICAL
PROSTATECTOMY WITH EXTENDED
PELVIC LYMPH NODE DISSECTION AND
NEOADJUVANT CHEMOHORMONAL
THERAPY WITHOUT EXTENDED PELVIC
LYMPH NODE DISSECTION IN PATIENTS
WITH ORGAN CONFINED HIGH-RISK
PROSTATE CANCER
Shingo Hatakeyama*, Hirosaki, Japan, Ryuji
Tabata, Daiji Fujimori, Mamoru Fukuda, Tetsuo
Shinozaki, Ageo, Japan, Hiromichi Iwamura,
Teppei Okamoto, Takahiro Yoneyama, Hirosa-
ki, Japan, Satoshi Sato, Ageo, Japan, Chikara
Ohyama, Hirosaki, Japan reno Suardi, Genoa, Italy, Francesco De Cobelli,
MP15-14 PRESERVATION OF ENDOPELVIC FASCIA,
PUBOPROSTATIC LIGAMENTS, DORSAL
VENOUS COMPLEX AND HYDRODISSECTION
OF THE NEUROVASCULAR BUNDLES IMPROVE
RATES AND TIME TO CONTINENCE AFTER
ROBOT-ASSISTED RADICAL PROSTATECTOMY:
A PROPENSITY-SCORE MATCHED ANALYSIS
Ahmed S. Elsayed, Yousuf Ramahi*, Ayat A. Shah,
Hannah B. Ely, Zhe Jing, Holly Houenstein, Julian
Joseph, Sharifeh Almasaid, Gaybrielle James,
Buffalo, NY, James O. Peabody, Detroit, MI, Ahmed
A. Hussein, Khurshid A. Guru, Buffalo, NY
MP15-15 IS POSTOPERATIVE PELVIC PAIN AFTER
ROBOT-ASSISTED RADICAL PROSTATECTOMY
ASSOCIATED WITH SUTURE MATERIAL USED
FOR SEWING THE ANASTOMOSIS?
A PROSPECTIVE RANDOMIZED TRIAL
Beatrice Breu*, Beat Förster, Donat Jost, Roman
Rechner, Hubert John, Zurich, Switzerland
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
72
MP15-16 VALIDATION OF EAU RECOMMENDATION
FOR SALVAGE RADICAL PROSTATECTOMY
CANDIDATES
Felix Preisser*, Frankfurt, Germany, Christoph Würn-
schimmel, Randi Marisa Pose, Alexander Heinze,
Thomas Steuber, Michl Uwe, Georg Salomon, Ham-
burg, Germany, Felix K H Chun, Frankfurt, Germany,
Markus Graefen, Derya Tilki, Hamburg, Germany
MP15-17 RETZIUS-SPARING ROBOT ASSISTED
RADICAL PROSTATECTOMY HAS SIMILAR
1-YEAR FUNCTIONAL AND ONCOLOGICAL
OUTCOMES AS STANDARD ROBOT-ASSISTED
RADICAL PROSTATECTOMY: RESULTS FROM
A HIGH VOLUME UK CENTRE
Paolo Umari*, Tushar Aditya Narain, Dominic
Eden, Declan Cahill, Christopher Eden, Prasanna
Sooriakumaran, London, United Kingdom
MP15-18 RATES OF SOCIAL CONTINENCE AND
SEXUAL FUNCTION IN HIGH-RISK PROSTATE
CANCER PATIENTS: RESULTS FROM A
STATEWIDE COLLABORATIVE
Kyle Johnson*, Ji Qi, Stephanie Ferrante, Ann Ar-
bor, MI, Keving Ginsburg, Detroit, MI, Brian Lane,
Grand Rapids, MI, Arvin George, Alice Semerjian,
for the Michigan Urological Surgery Improvement
Collaborative”, Ann Arbor, MI
MP15-19 CAN LOW RISK DISEASE OUTSIDE THE
INDEX LESION BE LEFT UNTREATED IN
MEN SUITABLE FOR FOCAL THERAPY?
DEVELOPMENT OF NOVEL CRITERIA TO
IDENTIFY POTENTIAL CANDIDATES FOR
FOCAL THERAPY AMONG PATIENTS WITH
INTERMEDIATE RISK PROSTATE CANCER
AND POSITIVE MULTI-PARAMETRIC MRI
Armando Stabile*, Giorgio Gandaglia, Elio
Mazzone, Francesco Barletta, Daniele Robesti,
Giuseppe Cirulli, Donato Cannoletta, Francesco
Pellegrino, Luigi Nocera, Gabriele Sorce, Milan,
Italy, Thomas Seisen, Morgan Roupret, Paris,
France - Metropolitan, Jeffrey R. Karnes, Roches-
ter, MN, Vito Cucchiara, Giuseppe Rosiello, Milan,
Italy, Nicola Fossati, Lugano, Switzerland, Naza-
Antonio Esposito, Giorgio Brembilla, Milan, Italy,
Shahrokh Shariat, Vienna, Austria, Francesco
Montorsi, Alberto Briganti, Milan, Italy
MP15-20 SURVIVAL AFTER RADICAL
PROSTATECTOMY VS. RADIATION THERAPY
IN DUCTAL CARCINOMA OF THE PROSTATE
Francesco Chierigo*, Genova, Italy, Christoph
Würnschimmel, Hamburg, Germany, Rocco
Simone Flammia, Rome, Italy, Benedikt Horle-
mann, Montreal, Canada, Gabriele Sorce, Milan,
Italy, Benedikt Hoeh, Frankfurt, Germany, Zhe
Tian, Fred Saad, Montreal, Canada, Markus
Graefen, Hamburg, Germany, Michele Gallucci,
Rome, Italy, Alberto Briganti, Francesco Montorsi,
Milan, Italy, Felix K.H. Chun, Frankfurt, Germany,
Shahrokh F. Shariat, Vienna, Austria, Guglielmo
Mantica, Maro Borghesi, Nazareno Suardi, Carlo
Terrone, Genova, Italy, Pierre I Karakiewicz, Mon-
treal, Canada
Friday, May 13, 2022
Podium Session 13
PROSTATE CANCER: EPIDEMIOLOGY & NATURAL HISTORY II
Room 252 @ Ernest N. Morial Convention Center
Moderators: James Eastham, Ashley Ross & Steven Joniau
ABSTRACT
TIME NUMBER TITLE
3:30 PD13-01 THE CONTINUING IMPACT OF THE COVID-19
PANDEMIC ON PROSTATE CANCER
MANAGEMENT: A POPULATION BASED
ANALYSIS
Marlon Perera*, Nathan Papa, Melbourne, Aus-
tralia, Matthew Roberts, Brisbane, Australia Drevik, Philadelphia, PA, Ilaha Isali, Cleveland,
3:40 PD13-02 AGE-INDEPENDENT SECULAR BASELINE
PSA POPULATION TRENDS AMONG YOUNG
LATIN AMERICAN MALES
Diego M. Capibaribe, Walker W. Laranja, Wilmar
Azal Neto, Danilo L. Andrade, Rodrigo G. Bocos,
Natássia C. C. Truzzi, Campinas, Brazil, José
C.C.I. Truzzi, Sao Paulo;, Brazil, Leonardo Reis*,
Campinas, Brazil PRELIMINARY ANALYSIS OF THE MIND-P
3:50 PD13-03 LACK OF AWARENESS AND
UNDERUTILIZATION OF GENETIC TESTING
IN PROSTATE CANCER
Sameer Thakker*, Stacy Loeb, New York, NY,
Veda Giri, Philadelphia, PA, Richard Matulewicz,
New York, NY
4:00 PD13-04 TRENDS IN DIAGNOSIS AND TREATMENT
OF T1A, T1B PROSTATE CANCER IN THE
UNITED STATES, 2010-2017
Eyal Kord*, Hannah Koenig, On Ho, John Paul
Flores, Christopher Porter, Seattle, WA
4:10 PD13-05 CHANGES WITH TIME IN PROGNOSTIC
FACTORS IN LOCALIZED PROSTATE
CANCER SURVIVORS AFTER LOW-DOSE-
RATE PERMANENT SEED IMPLANT
BRACHYTHERAPY WITH IODINE-125;
CONDITIONAL SURVIVAL ANALYSIS
Masanori Hasegawa*, Kanagawa, Japan, Shiro
Saito, Atsunori Yorozu, Monma Tetsuo, Toru
Nishiyama, Yasuto Yagi, Keisuke Shigeta, Tokyo,
Japan, Sunao Shoji, Akira Miyajima, Kanagawa,
Japan
4:20 PD13-06 COMPREHENSIVE RETROSPECTIVE
ASSESSMENT OF CLINICAL OUTCOMES
WITH RADICAL PROSTATECTOMY
AND RADIOTHERAPY IN PROSTATE
CANCER REVEALS INADEQUACIES IN
OBSERVATIONAL DATASETS
Udit Singhal*, Stephanie Daignault-Newton,
Allison K.C. Furgal, Ann Arbor, MI, Yilun Sun,
Cleveland, OH, Jeffrey J. Tosoian, Nashville,
TN, Lauren J. Beesley, Robert T. Dess, William
C. Jackson, Brent K. Hollenbeck, Ann Arbor,
MI, Daniel A. Hamstra, Houston, TX, Ganesh S.
Palapattu, Ann Arbor, MI, Felix Y. Feng, San Fran-
cisco, CA, Jeremy M.G. Taylor, Ann Arbor, MI,
Daniel E. Spratt, Cleveland, OH, Todd M. Morgan,
Ann Arbor, MI
*Presenting author
3:30 pm – 5:30 pm
ABSTRACT
TIME NUMBER TITLE
FRIDAY
4:30 PD13-07 COST-EFFECTIVENESS ANALYSIS OF
ARTERIAL CATHETER INSERTION ON
ROBOTIC-ASSISTED LAPAROSCOPIC
PROSTATECTOMY
Rogelio Valdez*, Cleveland, OH, Johnathan
OH, Alexander Kutikov, Philadelphia, PA, Mohit
Sindhani, Delhi, India, Megan Prunty, Adam Cala-
way, Lee Ponsky, Cleveland, OH, Alberto Castro
Bigalli, Laura Bukavina, Philadelphia, PA
4:40 PD13-08 A PROSPECTIVE AND LONGITUDINAL
COHORT STUDY ASSESSING MENTAL
WELLBEING IN PROSTATE CANCER:
STUDY
Oliver Brunckhorst*, Callum James, Jack Fan-
shawe, Mohamed Hammadeh, London, United
Kingdom, Madeleine Williams, Robert Thomas,
Bedford, United Kingdom, Shahid Khan, Redhill,
United Kingdom, Matin Sheriff, Gillingham, United
Kingdom, Hashim Ahmed, Mieke Van Hemelri-
jck, Robert Stewart, Prokar Dasgupta, Kamran
Ahmed, London, United Kingdom
4:50 PD13-09 TRENDS IN SURVIVAL FOR MEN WITH DE
NOVO METASTATIC PROSTATE CANCER
Nina Wyatt*, Christopher Filson, Atlanta, GA
5:00 PD13-10 DIABETES AND PROSTATE CANCER
OUTCOMES IN MEN WITH NONMETASTATIC
CASTRATE-RESISTANT PROSTATE CANCER:
RESULTS FROM THE SEARCH COHORT
Andrei Sergeyev*, Lin Gu, Amanda De Hoedt, Dur-
ham, NC, Christopher Amling, Portland, OR, William
Aronson, Los Angeles, CA, Matthew Cooperberg,
San Francisco, CA, Christopher Kane, San Diego,
CA, Zachary Klaassen, Martha Terris, Augusta, GA,
Lourdes Rivera, San Juan, Puerto Rico, Stephen
Freedland, Ilona Csizmadi, Los Angeles, CA
5:10 PD13-11 DISEASE TRAJECTORIES AND OUTCOMES
FOR MEN WITH CASTRATION RESISTANT
PROSTATE CANCER BY USE OF NATION-WIDE
POPULATION-BASED OBSERVATIONAL DATA
Eugenio Ventimiglia*, Milan, Italy, Anna Bill-Axel-
son, Uppsala, Sweden, Markus Aly, Gothenburg,
Sweden, Martin Eklund, Stokholm, Sweden, Par
Stattin, Hans Garmo, Uppsala, Sweden
5:20 PD13-12 DUCTAL AND INTRADUCTAL CARCINOMA
OF THE PROSTATE AT RADICAL
PROSTATECTOMY: DIAGNOSTIC ACCURACY
OF BIOPSY, MRI-VISIBILITY, AND OUTCOMES
Gaurav Pahouja*, Shalin Desai, Hiten D. Patel,
Goran Rac, Teresa Cheng, Yudai Okabe,
Alexander Gorbonos, Marcus L. Quek, Robert
C. Flanigan, Maria M. Picken, Gopal N. Gupta,
Maywood, IL
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
73
Friday, May 13, 2022
Podium Session 14
BLADDER CANCER: EPIDEMIOLOGY & EVALUATION I
Room 255 @ Ernest N. Morial Convention Center
Moderators: Hung-Jui (Ray) Tan, Edward Messing & Marco Moschini
ABSTRACT
TIME NUMBER TITLE
3:30 PD14-01 RETROSPECTIVE REVIEW OF PATIENTS
PRESENTING TO THE EMERGENCY
DEPARTMENT WITH GROSS HEMATURIA
AND NEWLY DIAGNOSED GENITOURINARY
MALIGNANCY: NOT AS COMMON AS WE
THOUGHT?
Deepansh Dalela*, Stephen Wertheimer, Jackson
Darling, Callie Bartkowiak, Humphrey Atiemo,
Detroit, MI Nikhil Waingankar, New York, NY
3:40 PD14-02 CRITICAL EVALUATION OF THE 2020
MICROHEMATURIA GUIDELINES: ARE WE
STILL WORKING UP TOO MANY PATIENTS?
Eric Macdonald*, Jacob Gaines, Max Kuster,
Michelle Ou, Ella Taubenfeld, Adam Diamond,
Tavya Benjamin, Michael Diefenbach, Manish
Vira, Simon Hall, Lake Success, NY MULTICENTER STUDY
3:50 PD14-03 ANALYSIS OF TWO INDEPENDENT RISK
STRATIFICATION EVALUATION TOOLS IN A
COHORT OF PATIENTS WITH MICROSCOPIC
HEMATURIA
Thomas Williams*, Lake Success, NY, Eric Mac-
donald, Max Kuster, Michelle Ou, Tavya Benjamin,
Manish Vira, Simon Hall, New Hyde Park, NY
4:00 PD14-04 INTERRUPTIONS IN BLADDER CANCER
CARE DURING THE COVID-19 PUBLIC
HEALTH EMERGENCY
Jason Reynolds*, Kristin Follmer, Michael Nash,
On Ho, Bryan Comstock, Larry Kessler, Erika
Wolff, Seattle, WA, Angela Smith, Chapel Hill, NC,
John Gore, CISTO Collaborative, Seattle, WA
4:10 PD14-05 LONG-TERM FOLLOW-UP OF INTRAVESICAL
GEMCITABINE AND DOCETAXEL AS RESCUE
THERAPY FOR NON-MUSCLE INVASIVE
BLADDER CANCER
Phani T. Chevuru*, Ian M. McElree, Alexander C.
Martin, Jordan R. Richards, Sarah L. Mott, Paul T.
Gellhaus, Kenneth G. Nepple, Ryan L. Steinberg,
Michael A. O’Donnell, Vignesh T. Packiam, Iowa
City, IA
4:20 PD14-06 IS A RESTAGING TURBT NECESSARY
IN HIGH RISK NON-MUSCLE INVASIVE
BLADDER CANCER IF THE INITIAL TURBT
WAS PERFORMED USING BLUE LIGHT?
Muhannad Alsyouf*, Sanam Ladi Seyedian, Los
Angeles, CA, Badrinath Konety, Minneapolis, MN,
Kamal Pohar, Columbus, OH, Jeffrey M. Holzbeier-
lein, Kansas City, KS, Max Kates, Baltimore, MD,
Brian Willard, West Columbia, SC, Jennifer M. Taylor,
Houston, TX, Joseph C Liao, Palo Alto, CA, Hristos
Z. Kaimakliotis, Indianapolis, CA, Sima P. Porten,
San Francisco, CA, Gary D. Steinberg, New York,
NY, Mark D. Tyson, Phoenix, AZ, Yair Lotan, Dallas,
TX, Siamak Daneshmand, Los Angeles, CA
74
3:30 pm – 5:30 pm
ABSTRACT
TIME NUMBER TITLE
4:30 PD14-07 LONG-TERM CYSTOSCOPY SURVEILLANCE
OF PATIENTS WITH NON-RECURRING
NMIBC: IDENTIFYING THE POINT OF
DIMINISHING RETURNS
Daniel Ranti*, Ralph Grauer, Yuanshuo Wang,
New York, NY, Linda Dey, Lotta Renström, Gunnar
Steinbeck, Abolfazl Hosseini, Stockholm, Sweden,
Peter Wiklund, Reza Mehrazin, John Sfakianos,
4:40 PD14-08 COMPARATIVE OUTCOMES OF PRIMARY
AND RECURRENT HIGH GRADE NON-
MUSCLE INVASIVE AND PRIMARY AND
PROGRESSIVE MUSCLE-INVASIVE BLADDER
CANCER AFTER RADICAL CYSTECTOMY:
RESULTS FROM A RETROSPECTIVE
Nico Grossmann*, Lucerne, Switzerland, Benjamin
Pradere, Frederik König, Pawel Rajwa, Fahad
Quhal, Hadi Mostafaei, Ekaterina Laukhtina, Keiichi-
ro Mori, Reza Motlagh, Satoshi Katayama, Vienna,
Austria, Christian Fankhauser, Zurich, Switzerland,
Agostino Mattei, Lucerne, Switzerland, Marco
Moschini, Milan, Italy, Piotr Chlosta, Krakow, Poland,
Bas van Rhijn, Amsterdam, Netherlands, Jeremy
Teoh, Hong Kong, China, People’s Republic of, Eva
Compérat, Vienna, Austria, Marek Babjuk, Prague,
Czech Republic, Mohammad Abufaraj, Amman,
Jordan, Pierre Karakiewicz, Montreal, Canada,
Shahrokh Shariat, Vienna, Austria
4:50 PD14-09 ANALYZING DIFFERENCES IN SOMATIC
MUTATIONS IN LOCALIZED BLADDER
CANCER PATIENTS BY RACE AND SEX: AN
ANALYSIS OF DATA FROM THE CBIOPORTAL
FOR CANCER GENOMICS
Kelsey Baker*, Yaw Nyame, Mary Redman,
Robert Montgomery, Petros Grivas,
Jonathan Wright, Seattle, WA
5:00 PD14-10 PROSPECTIVE EVALUATION OF A
COMPREHENSIVE GERIATRIC ASSESSMENT
(CGA) IN MULTIDISCIPLINARY BLADDER
CANCER CARE: FEASIBILITY AND IMPACT
ON DECISIONAL CONFLICT
Sarah Psutka*, John Gore, Sarah Holt, Erin Dwyer,
George Schade, Petros Grivas, Andrew Hsieh,
John Lee, R. Bruce Montgomery, Michael Schweiz-
er, Todd Yezefski, Evan Yu, Jonathan Chen, Jay
Liao, Emily Weg, Jing Zeng, Tristan Alving, Samia
Jannat, Jonathan Wright, Seattle, WA
5:10 PD14-11 USE OF A PHYSICAL ACTIVITY MONITOR
TO TRACK PERIOPERATIVE ACTIVITY OF
RADICAL CYSTECTOMY PATIENTS: OUR
FIRST GLIMPSE AT WHAT OUR PATIENTS
ARE REALLY DOING BEFORE AND AFTER
SURGERY
Alex Zhu, DO*, Joel Berends, MD, Stephanie
Daignault-Newton, MS, Ann Arbor, MI, Deborah
5:20 PD14-12 ARE UROLOGIC MALIGNANCIES IN
PATIENTS WITH LYNCH SYNDROME
ASSOCIATED WITH AN INCREASED RISK
OF DEATH AND SHOULD MORE PATIENTS
UNDERGO RIGOROUS UROLOGIC
SCREENING?
Christian Ericson*, Anthony Compton, Bryce
Baird, Raymond Pak, Jacksonville, FL

FRIDAY
Kaye, MD, Durham, NC, Christine Schafer, BS,
APPROVED FOR AMA PRA CATEGORY 2.0

Steven Thelen-Perry, BS, Chrissy Parker, MS,
CREDITSTM
Heidi Iglay-Reger, PhD, Yongmei Qin, MD, Todd
M. Morgan, MD, Alon Z. Weizer, MD, Samuel D.
Kaffenberger, MD, Lindsey A. Herrel, MD, Khaled
Hafez, MD, Ann Arbor, MI, Cheryl T. Lee, MD,
Columbus, OH, Ted A. Skolarus, MD, Michael
Englesbe, MD, Jeffrey S. Montgomery, MD, Ann
Arbor, MI

Friday, May 13, 2022 3:30 pm – 5:30 pm

Podium Session 15
KIDNEY CANCER: EPIDEMIOLOGY & EVALUATION/STAGING/SURVEILLANCE I
Room 245 @ Ernest N. Morial Convention Center
Moderators: Gopal Gupta, Ithaar Derweesh & Masatoshi Eto

ABSTRACT
TIME NUMBER TITLE
3:30 PD15-01 EVALUATING 99M TC-SESTAMIBI
SINGLE PHOTON EMISSION COMPUTED
TOMOGRAPHY/COMPUTED TOMOGRAPHY
CONCORDANCE WITH SURGICAL
PATHOLOGY FOR RENAL MASSES
Shilpa Argade*, Carrie Ronstrom, Joel Vetter,
Brijesh Patel, Mark Biebel, Joyce Mhlanga,
Robert Figenshau, St. Louis, MO sah, Ramesh Thurairaja, Shamim Khan, Sachin
3:40 PD15-02 PEAK EARLY ENHANCEMENT RATIO
RELIABLY DIFFERENTIATES BENIGN
ONCOCYTIC RENAL TUMORS FROM
CHROMOPHOBE RENAL CELL CARCINOMA
Hiten D. Patel, Kevin Huai, Deanna L. Thorson,
Nicholas Elliott*, Goran Rac, Maria M. Picken,
Marcus L. Quek, Davide Bova, Gopal N. Gupta,
Maywood, IL Autorino, Richmond, VA, Reza Mehrazin, New York,
3:50 PD15-03 AVOIDANCE OF BENIGN RENAL
ONCOCYTOMA RESECTION USING BIOPSY
CD117 IMMUNOSTAIN WITH RADIOGRAPHIC
TUMOR:CORTEX PEER SCORE: 8-YEAR
EXPERIENCE
Jorge Daza*, Arun Menon, Ahmed A. Hussein, Tash-
ionna White, Gaybrielle James, Michael Petroziello, Bo
Xu, Charles Roche, Eric C Kauffman, Buffalo, NY
4:00 PD15-04 GENOTYPE-PHENOTYPE
CHARACTERIZATION OF LYNCH SYNDROME
ASSOCIATED UPPER TRACT UROTHELIAL
CARCINOMA (UTUC)
Craig Labbate*, Donika Saporito, Mehrad Adibi,
Maureen Mork, Eduardo Vilar Sanchez, Bogdan
Czerniak, Charles Guo, Eric Jonasch, Surena
Matin, Houston, TX
ABSTRACT
TIME NUMBER TITLE
4:10 PD15-05 PROGNOSTIC VALUE OF EARLY DYNAMIC
CHANGE OF NEUTROPHIL TO LYMPHOCYTE
RATIO (NLR) IN PATIENTS WITH UPPER-
TRACT UROTHELIAL CARCINOMA (UTUC)
TREATED WITH NEPHROURETERECTOMY
Natalie Kowshiga George*, Yasmin Abu-Ghanem,
Ko Ko Zayar Toe, Akinlolu Oluwole-Ojo, Elsie Men-
Malde, Rajesh Nair, London, United Kingdom
4:20 PD15-06 ELEVATED HEMOGLOBIN:CREATININE
RATIO IS A NOVEL PREOPERATIVE MARKER
FOR WORSENED SURVIVAL OUTCOMES IN
UPPER TRACT UROTHELIAL CARCINOMA:
ANALYSIS FROM THE ROBUUST REGISTRY
Margaret Meagher*, San Diego, CA, Riccardo
NY, Daniel Eun, Philadelphia, PA, Vitaly Margulis,
Dallas, TX, Robert Uzzo, Philadelphia, PA, James
Porter, Seattle, WA, Chandru Sundaram, Indianapo-
lis, IN, Firas Abdollah, Detroit, MI, Alexandre Mottrie,
Aalst, Belgium, Andrea Minervini, Florence, Italy,
Matteo Ferro, Milan, Italy, Hooman Dialadat, Los
Angeles, CA, Zhenjie Wu, Shanghai, China, Peo-
ple’s Republic of, Kevin Hakimi, Ava Saidian, Arman
Walia, San Diego, CA, Riccardo Tellini, Philadelphia,
PA, Alessandro Veccia, Richmond, VA, Koon Rha,
Seoul, Korea, Republic of, Mark Gonzalgo, Miami,
FL, Ithaar Derweesh, San Diego, CA

*Presenting author 75
4:30 PD15-07 RENAL CELL CARCINOMA 5:00 PD15-10 LONG TERM FOLLOW UP IN PATIENTS
PARANEOPLASTIC SYNDROME SCORE: UNDERGOING RENAL BIOPSY - SEEDING IS
CONSTRUCTION AND VALIDATION NOT ANECDOTAL
Shady Soliman*, La Jolla, CA, Sabrina Noyes, Grand Michael Staehler*, Melaine Schott, Alexander
Rapids, MI, Margaret Meagher, Joel Rosenberg, Aus- Tamalunas, Chistian Stief, Annabel Graser, Sever-
tin Leonard, Kevin Hakimi, Julia Yuan, Arman Walia, in Rodler, Munich, Germany
Ava Saidian, Fady Ghali, Juan Javier-Desloges,
5:10 PD15-11 TRANSLOCATION RCC: PROGRESSION-FREE
Devin Patel, Rana McKay, Ithaar Derweesh, La Jolla,
AND OVERALL SURVIVAL BY TUMOR STAGE
CA, Brian Lane, Grand Rapids, MI
AND SURGICAL PROCEDURE AT A HIGH-
4:40 PD15-08 WHEN TO DE-INTENSIFY ONCOLOGIC VOLUME ACADEMIC CENTER
SURVEILLANCE SCHEME FOR NON-CLEAR Jason Farrow*, Nate Hollowell, Connor Drake,
CELL RENAL CELL CARCINOMA Leo Song, Clint Cary, Clinton Bahler, Ronald
Alberto Martini, Daniele Cignoli, Giuseppe Ros- Boris, Chandru sundaram, Indianapolis, IN
iello, Giuseppe Fallara, Giuseppe Basile, Luigi
5:20 PD15-12 IMPACT OF THE AFFORDABLE CARE ACT
Nocera, Federico Belladelli, Gianmarco Colan-
ON SOCIOECONOMIC DISPARITIES IN
drea*, Daniela Canibus, Chiara Re, Giacomo
DIAGNOSIS AND SURVIVAL OF RENAL CELL
Musso, Francesco Cei, Francesco De Cobelli,
CARCINOMA
Giorgio Brembilla, Alberto Briganti, Andrea Nec-
Chih Peng Chin*, Micah Levy, Evan Garden,
chi, Daniele Raggi, Roberto Bertini, Francesco
Krishna Ravivarapu, Joseph Sewell Araya, New
Montorsi, Andrea Salonia, Alessandro Larcher,
York, NY, Alexander Small, Bronx, NY, Michael
Umberto Capitanio, Milan, Italy
Palese, New York, NY
4:50 PD15-09 UPDATED OUTCOMES FOR ACTIVE
APPROVED FOR AMA PRA CATEGORY 2.0

SURVEILLANCE RECOMMENDED TO
CREDITSTM
ALL SMALL RENAL MASS PATIENTS
LACKING PROGRESSION CRITERIA FOR
INTERVENTION
Muammer Altok, Arun Menon, Ahmed Aly, Tash-
ionna White, James Gaybriella, Bo Xu, Michael
Petroziello, Charles Roche, Eric Kauffman*,
Buffalo, NY

Friday, May 13, 2022 3:30 pm – 5:30 pm

Podium Session 16
BENIGN PROSTATIC HYPERPLASIA: BASIC RESEARCH & PATHOPHYSIOLOGY
Room 244 @ Ernest N. Morial Convention Center
Moderators: Gail Prins & Brian Helfand

ABSTRACT
TIME NUMBER TITLE
3:30 PD16-01 THE DIVERSITY OF PROSTATIC MICROBIOTA IS
ASSOCIATED WITH PROSTATE ENLARGEMENT
Koihic Okada*, Takahiro Imanaka, Sohei
Kuribayashi, Yosuke Sekii, Kentaro Takezawa,
Shinichiro Fukuhara, Hiroshi Kiuchi, Norio Nono-
mura, Suita, Japan Ricke, Madison, WI
3:40 PD16-02 ULTRASTRUCTURAL FINDINGS OF COVID-19
INFECTION IN THE PROSTATE
Rohit Reddy*, Eliyahu Kresch, Natoli Farber,
Parris Diaz, Ranjith Ramasamy, Miami, FL PROGRESSION OF BENIGN PROSTATIC
3:50 PD16-03 INVOLVEMENT OF YES-ASSOCIATED
PROTEIN 1 IN INFLAMMATION-INDUCED
BENIGN PROSTATIC HYPERPLASIA
Dongxu Lin*, Zhong Chen, Wuhan, China, Peo-
ple’s Republic of
4:00 PD16-04 THE PROTECTIVE EFFECTS OF CSF-
1R INHIBITION ON BLADDER OUTLET
OBSTRUCTION (BOO) INDUCED
REMODELING
Wei Wang*, Xiaoshuai Gao, Liao Peng, Lede
Lin, Kaiwen Xiao, Liang Zhou, Chengdu, China,
People’s Republic of
ABSTRACT
TIME NUMBER TITLE
4:10 PD16-05 LOSS OF OSTEOPONTIN IMPROVES
URINARY FUNCTION AND ALTERS THE
PROSTATIC IMMUNE ENVIRONMENT
Petra Popovics*, Kegan O. Skalitzky, Elise
Schroeder, Asha Jain, Chad M. Vezina, William A.
4:20 PD16-06 SHIFT CHANGE OF THE ACTIVATED
COMPLEMENT PATHWAY IN THE
FIBROTIC PROCESS ASSOCIATED WITH
HYPERPLASIA
Junya Hata*, Yusuke Kirihana, Tomoyuki Kumeka-
wa, Hiroki Natsuya, Yusuke Hakozaki, Syunsuke
Yoshioka, Hitomi Imai, Kanako Matsuoka, Tomoyuki
Koguchi, Yuichi Sato, Hidenori Akaihata, Masao
Kataoka, Yoshiyuki Kojima, Fukushima, Japan
4:30 PD16-07 REASSESSMENT OF THE EFFECT OF
LOWER URINARY TRACT OBSTRUCTION
ON UROTHELIAL TISSUE: EVALUATION VIA
HOLEP AND ANIMAL STUDY
Young-min Yang*, Katsumi Shigemura, Koki
Maeda, Yuzo Nakano, Masato Fujisawa, Kobe,
Japan

76
4:40 PD16-08 ALTERNATE ANDROGEN-INDEPENDENT
ESTROGEN SIGNALING FOR PROSTATIC
GROWTH
Christina Sharkey*, Boston, MA, Xingbo Long,
Guangzhou, China, People’s Republic of, Ra’ad Al-
Faouri, Zongwei Wang, Aria F. Olumi, Boston, MA
4:50 PD16-09 THE ROLE OF GPER SIGNALING
IN DEVELOPMENT OF PROSTATIC
ENLARGEMENT IN HIGH FAT DIET INDUCED
OBESITY RAT MODEL
Shinsuke Mizoguchi*, Kenichi Mori, Toshitaka
Shin, Hiromitsu Mimata, Yufu, Japan 5:20 PD16-12 AGE AND RACE SPECIFIC GENE SIGNATURE:
5:00 PD16-10 5-ALPHA REDUCTASE INHIBITORS
SUPPRESS DIHYDROTESTOSTERONE
IN BENIGN PROSTATE HYPERPLASIA
REQUIRING SURGERY, AND CAUSE
STEROIDOGENESIS VIA 5ARI INDUCED
PATHWAY
Connor Forbes*, Nicole L Miller, Thomas Case,
Nashville, TN, Douglas Strand, Dallas, TX, Qi Liu,
Marisol Ramirez-Solano, Justin M Cates, Ned A
Porter, Hye-Young H Kim, Phillip Wages, Nash-
ville, TN, James L Mohler, Buffalo, NY, Robert J
Matusik, Ren Jie Jin, Nashville, TN
Friday, May 13, 2022
Moderated Poster Session 16
HEALTH SERVICES RESEARCH: QUALITY IMPROVEMENT & PATIENT SAFETY I
Room 228 @ Ernest N. Morial Convention Center
Moderators: Timothy Averch, Roger Dmochowski & Christopher Filson
ABSTRACT
NUMBER TITLE
MP16-01 EFFECT OF SURGERY-SPECIFIC FINANCIAL
INCENTIVE ON OPIOID PRESCRIBING
PRACTICES: OUTCOMES OF A STATEWIDE
SURGICAL COLLABORATIVE
John Michael DiBianco*, Stephanie Daignault-New-
ton, Bronson Conrado, Ann Arbor, MI, David
Wenzler, Royal Oak, MI, Hector Pimentel, Grand
Rapids, MI, S. Mohammad Jafri, Royal Oak, MI,
Rebn Frontera, Rochester Hills, MI, Jessica Phelps,
John Hollingsworth, Khurshid R. Ghani, Casey A.
Dauw, for the Michigan Urological Surgery Improve-
ment Collaborative, Ann Arbor, MI
MP16-02 IMPLEMENTATION AND USABILITY OF
AN ELECTRONIC MEDICAL RECORD
BASED STENT TRACKER TO DECREASE
COMPLICATIONS AFTER URETERAL
STENT PLACEMENT AT A DIVERSE URBAN
ACADEMIC CENTER
Kavita Gupta*, Daniel Jacobs, Angela Alaimo,
Kara Watts, Alexander Small, Bronx, NY
MP16-03 STONE MANAGEMENT IN THE SOLITARY
KIDNEY, ARE WE DOING THINGS
DIFFERENTLY? RESULTS FROM A
STATEWIDE CLINICAL REGISTRY
Mohit Butaney*, Detroit, MI, Stephanie Daig-
nault-Newton, Ann Arbor, MI, Isaac Palma-Zamora,
Grace Yaguchi, David Leavitt, Detroit, MI, Casey
Dauw, Khurshid Ghani, Ann Arbor, MI, Naveen
Kachroo, Detroit, MI, for the Michigan Urological
Surgery Improvement Collaborative, Ann Arbor, MI
*Presenting author
5:10 PD16-11 TRANS-ETHNIC GENOME-WIDE
ASSOCIATION STUDY REVEALS NEW
THERAPEUTIC TARGETS FOR BENIGN
PROSTATIC HYPERPLASIA
Michael Ng, Oxford, United Kingdom, Koichi
Matsuda, Chizu Tanikawa, Tokyo, Japan, Chikashi
Terao, Yokohama, Japan, Yoichiro Kamatani,
Tokyo, Japan, Wei Wang, Adam Auton,* 23and-
FRIDAY
me Research Team, Sunnyvale, CA, Benjamin
Turney, Richard Bryant*, Dominic Furniss, Oxford,
United Kingdom
AN INDEPENDENT PREDICTOR OF
PROSTATE CANCER IN RACIALLY DIVERSE
MILITARY COHORT OF AFRICAN AND
CAUCASIAN AMERICAN PATIENTS
Shashwat Sharad*, Bethesda, MD, Darryl Nou-
some, Frederick, MD, Gregory Chesnut, Hua Li,
Bethesda, MD
APPROVED FOR AMA PRA CATEGORY 2.0
CREDITSTM
4:30 pm – 5:45 pm
ABSTRACT
TIME NUMBER TITLE
MP16-04 PRACTICE-LEVEL VARIATION IN RATES
POSITIVE SURGICAL MARGINS AT PARTIAL
NEPHRECTOMY: A MUSIC-KIDNEY ANALYSIS
Mohit Butaney*, Detroit, MI, Sonia Bhayani, St. Lou-
is, MO, Ji Qi, Anna Johnson, Ann Arbor, MI, Sara
Perkins, Detroit, MI, Sabrina Noyes, Grand Rapids,
MI, Alon Weizer, Ann Arbor, MI, Lewis Johnson, Kal-
amazoo, MI, Amit Patel, Detroit, MI, Alice Semerjian,
Ypsilanti, MI, Brian Lane, Grand Rapids, MI, Craig
Rogers, Detroit, MI, for the Michigan Urological
Surgery Improvement Collaborative, Ann Arbor, MI
MP16-05 QUALITY IMPROVEMENT OF SURGICAL
TEAM COMMUNICATION OF REQUIRED
PERCUTANEOUS NEPHROLITHOTOMY
EQUIPMENT
Mark Assmus*, Matt Lee, Jessica Helon, Amy
Krambeck, Chicago, IL
MP16-06 FOLEY CATHETER BALLOON RUPTURE AND
RISK OF FREE FRAGMENT FORMATION
Jason L. Lui*, Nathan M. Shaw, Nizar Hakam,
Behnam Nabavizadeh, Behzad Abassi, Patrick
Low, Kevin D. Li, Benjamin N. Breyer, San
Francisco, CA
MP16-07 FRAILTY AS A PREDICTOR OF SACRAL
NEUROMODULATION OUTCOMES
Colby Souders*, Dallas, TX, Mary Enoh Adakama,
Riverside, CA, Allison Sih, Seth Cohen, San Fran-
cisco, CA, Maude Carmel, Dallas, TX, Jennifer
Anger, La Jolla, CA, Karyn Eilber, Los Angeles,
CA, Kai Dallas, San Francisco, CA
77
 MP16-08 MAJOR SHIFT IN ANTIBIOTIC PROPHYLAXIS MP16-15 LOW MEDICATION COMPLIANCE IN NEW
PATTERNS FOLLOWING IMPLEMENTATION OF FEMALE UROGYNECOLOGY PATIENTS
GUIDELINES BASED CYSTOSCOPY SURVEY Crystal Cisneros*, Tamara Grisales, Ja-Hong Kim,
Kelly R. Pekala*, Danielle Sharbaugh, Jonathan Victor W. Nitti, Amy E. Rosenman, Christopher M.
G. Yabes, Adam J. Sharbaugh, Michelle Yu, Tarnay, A. Lenore Ackerman, Los Angeles, CA
Valentina Grajales, Oluwaseun Orikogbo, Her-
MP16-16 WORK-RELATED PAIN AND ERGONOMICS
moon Worku, Jordan M. Hay, Toby S. Zhu, Kody
EDUCATION AMONG UROLOGISTS: A
M. Armann, Chandler N. Hudson, Benjamin J.
SURVEY STUDY
Davies, Bruce L. Jacobs, Pittsburgh, PA
Jennifer Chyu*, Edward Chang, Erin Dwyer, Sarah
MP16-09 DETERMINING THE PREVALENCE OF Holt, Atreya Dash, Mathew Sorensen, Seattle, WA
INAPPROPRIATE PATIENT BEHAVIOR IN THE
MP16-17 MULTIMODAL PAIN CONTROL UTILIZING
OUTPATIENT UROLOGY CLINIC
BUPRENORPHINE FOR ROBOTIC ASSISTED
Caroline Lu*, James Kearns, Myra Robinson,
LAPAROSCOPIC PROSTATECTOMY: A
Sarah Matthews, Elizabeth Korede, Maxim
QUALITY IMPROVEMENT COMPARISON TO
McKibben, Charlotte, NC
CONVENTIONAL OPIOID MANAGEMENT
MP16-10 EXPLORING THE VALUE OF USING PATIENT- Jo Ann Johnson, Ivan Muchiutti, Sonia Wraich,
ORIENTED MRI REPORTS IN CLINICAL Aviram Assidon, Akin S. Amasyali, Mohammad
PRACTICE Hajiha*, Donna Lien, Ruth Belay, Jonathan
Nathan Perlis, Antonio Finelli, Mike Lovas, Alexis Maldonado, Ashley Li, Mohamed Keheila, Kanha
Lund*, Amelia DiMeo, Katherine Lajkosz, Alejandro Shete, Gary Stier, Leonard Soloniuk, Patrick
Berlin, Janet Papadakos, Sangeet Ghai, Dominik Hogue, Brian Hu, D. Duane Baldwin, Herbert
Deniffel, Eric Meng, David Wiljer, Shabbir Alibhai, Ruckle, Loma Linda, CA
Vasiliki Bakas, Adam Badzynski, Odelia Lee, Jo-
MP16-18 SURVIVORSHIP DISPARITIES AMONG
seph Cafazzo, Masoom Haider, Toronto, Canada
PATIENTS <65 YEARS UNDERGOING
MP16-11 VALIDATION OF A SINGLE ITEM SCREENING A RADICAL CYSTECTOMY BASED ON
MEASURE OF UROLOGIC PATIENT INSURANCE STAUTS
FINANCIAL DISTRESS Yousef Rafati*, Aditya Srinivasan, Jacques
Daniel Au*, Jared Starkey, Jessica Hamilton, Jeff- Baillargeon, Stephen Williams, Laith Alzweri,
ery Thompson, William Parker, Kansas City, KS Galveston, TX
MP16-12 PREDICTORS OF PATIENT-REPORTED MP16-19 CAN ARTIFICIAL INTELLIGENCE ENHANCE
OUTCOMES COMPLETION IN PATIENTS CLINICAL OUTCOMES AND PATIENT FLOW
UNDERGOING RADICAL PROSTATECTOMY IN A UROLOGY WALK-IN CLINIC?
AND ASSOCIATIONS BETWEEN RESPONSE Jonathan Miles Charnock*, Olesya Kovyzhenko, Tet
FREQUENCY AND FUNCTIONAL OUTCOMES Yap, Raveen Sandher, London, United Kingdom
Daniel Frendl, Wesley Chou*, Douglas Dahl,
MP16-20 PREDICTORS OF DISCHARGE TO HOME
Jeffrey Twum-Ampofo, Adam Feldman, Francis
FOLLOWING MAJOR SURGERY FOR
McGovern, Michael Blute, Marcela del Carmen,
UROLOGIC MALIGNANCIES
Marilyn Heng, Rachel Sisodia, Matthew Wszolek,
Nehizena Aihie*, Deukwoo Kwon, Matthew Ma-
Boston, MA
son, Helen Yang Hougen, Dimple Chananmolu,
MP16-13 CAN WE USE THE PROSTATE HEALTH INDEX Sanoj Punnen, Bruno Nahar, Dipen Parekh, Mark
TO AVOID A PROSTATE BIOPSY IN AFRICAN Gonzalgo, Chad Ritch, MIAMI, FL
AMERICAN MEN?

APPROVED FOR AMA PRA CATEGORY 1.25
Kostantinos Morris*, Srinath Kotamarti, Judd
CREDITSTM
Moul, Durham, NC
MP16-14 APIXABAN VERSUS ENOXAPARIN FOR
POST-SURGICAL EXTENDED DURATION VTE
PROPHYLAXIS: A PROSPECTIVE QUALITY
IMPROVEMENT STUDY
Mary Westerman*, New Orleans, LA, Kelly Bree,
Cheryl Mantaring, Innocent Rukundo, Martha
Garcia-Gonzalez, Ashlee Lafleur, Robbie Best,
Colin Dinney, Ashish Kamat, Neema Navai, Louis
Pisters, Christopher Wood, Jose Karam, John
Papadopoulos, Lisly Chery, Mehrad Adibi, Brian
Chapin, John Ward, Curtis Pettaway, John Davis,
Justin Gregg, William Graber, Thomas Smith, O.
Lenaine Westney, Desiree Valle, LaShena Crump,
Raji Varghese, Miguel Saucedo, Jeff Cunning-
ham, Kelly Casteel, Surena Matin, Houston, TX

78
Friday, May 13, 2022
Moderated Poster Session 17
PEDIATRIC UROLOGY: UPPER & LOWER URINARY TRACT
Room 225 @ Ernest N. Morial Convention Center
Moderators: Nicolette Janzen & Berk Burgu
ABSTRACT
NUMBER TITLE
MP17-01 ARE PRE-OPERATIVE URINE CULTURES
AND CYSTOSCOPIES BEFORE URETERAL
REIMPLANTATION CLINICALLY USEFUL OR
COST EFFECTIVE?
Mark Quiring*, Erin Davis, Dawson Hinkley, Tyler
Hamby, Kristy Reyes, Kirk Pinto, Fort Worth, TX Rickard, Toronto, Canada, Karen Milford, Johan-
MP17-02 PREDICTIVE FACTORS FOR IMPROVEMENT/
RESOLUTION OF VESICOURETERAL REFLUX
IN DUPLEX KIDNEYS
Clinton Yeaman*, Kathryn Morgan, Fionna Sun,
Charlottesville, VA, Sherry Ross, Jamie Michael,
Chapel Hill, NC, Rebecca Zee, Richmond, VA,
Hans Pohl, Daniel Casella, Bruce Sprague, Wash-
ington, DC, C.D. Anthony Herndon, Richmond,
VA, Nora Kern, Charlottesville, VA Paris, France, Yesica Quiroz Madarriaga, Barce-
MP17-03 COMPLICATION RATES AMONG
DIFFERENT TREATMENT MODALITIES
FOR THE SURGICAL MANAGEMENT OF
VESICOURETERAL REFLUX IN CHILDREN
Andres Guillen Lozoya*, Candace Granberg,
Patricio Gargollo, Rochester, MN
MP17-04 PILOT STUDY OF MACHINE LEARNING
IN THE TASK OF DISTINGUISHING HIGH
AND LOW GRADE HYDRONEPHROSIS IN
CHILDREN ON ULTRASOUND
Matthew Sloan*, Clark Judge, Hui Li, Li Lan, Ma-
son Vierra, Gabriel Kaufmann, Maryellen Giger,
Mohan Gundeti, Chicago, IL Vineet Gauhar, Singapore, Singapore, Bhaskar
MP17-05 CONFIGURATION AND VALIDATION OF THE
TORONTO NOMOGRAM OF ANTENATAL
ULTRASOUND INDEX GENERATED FROM
BAYESIAN META-REGRESSION ANALYSIS
IN PREDICTING POSTERIOR URETHRAL
VALVES (PUV)
Michael Chua, Jin Kyu (Justin) Kim*, Tim Van
Miegham, Joana Dos Santos, Eric Mackay, Lau-
ren Erdman, Marta Skreta, Daniel Keefe, Marisol
Lolas, Priyank Yadav, Armando Lorenzo, Mandy
Rickard, Toronto, Canada
MP17-06 EVALUATION OF RENAL MEASUREMENTS
OF ISOLATED HIGH-GRADE CONGENITAL
HYDRONEPHROSIS (HGH) IN BOTH SUPINE
AND PRONE POSITIONS
Amr Hodhod*, Carolina Fermin-Risso, Mutaz
Farhad, Anthony Cook, Jarrah Aburezeq, Steven
Lu, Bryce Weber, Calgary, Canada
MP17-07 IMPACT OF DELAY IN SURGICAL
INTERVENTION ON FUNCTIONAL OUTCOME
IN CHILDREN WITH UNILATERAL URETERO-
PELVIC JUNCTION OBSTRUCTION
Mohamed Soltan*, Ahmed Abdelhalim, Ahmed
Elkashef, Mohamed Edwan, Ahmed Atwa, Mohamed
Abou-El_Ghar, Tamer Helmy, Ashraf Tarek, Mo-
hamed Dawaba, Ahmed Shokier, Mansoura, Egypt
*Presenting author
4:30 pm – 5:45 pm
ABSTRACT
NUMBER TITLE
FRIDAY
MP17-08 ATTAINING COMPETENCY AND
PROFICIENCY IN OPEN PYELOPLASTY: A
LEARNING CURVE CONFIGURATION USING
CUMULATIVE SUM ANALYSIS
Jin Kyu (Justin) Kim*, Michael Chua, Mandy
nesburg, South Africa, Daniel Keefe, Armando
Lorenzo, Toronto, Canada
MP17-09 OUTCOMES AND LESSONS LEARNT FROM
PRACTICE OF RETROGRADE INTRARENAL
SURGERY (RIRS) IN A PAEDIATRIC SETTING
OF VARIOUS AGE GROUPS: A GLOBAL
STUDY ACROSS 8 CENTRES
Ee Jean Lim*, Singapore, Singapore, Olivier Traxer,
lona, Spain, Daniele Castellani, Ancona, Italy, Khi
Yung Fong, Singapore, Singapore, Vinson Wai
Shun Chan, Leeds, United Kingdom, Anna Bujons
Tur, Barcelona, Spain, Amelia Pietropaolo, South-
amptom, United Kingdom, Deepak Ragoori, Banjara
Hills, India, Anil Shrestha, Kathmandu, Nepal,
Chandra Mohan Vaddi, Hyderabad, India, Tanuj
Paul Bhatia, Haryana, India, Mriganka Mani, Patrick
Juliebø-Jones, Stephen Griffin, Southamptom,
United Kingdom, Esther García Rojo, Madrid, Spain,
Mariela Corrales, Paris, France, Cagri Akin Sekerci,
Yiloren Tanidir, Istanbul, Turkey, Jeremy Yuen-Chun
Teoh, Hong Kong, China, People’s Republic of,
Kumar Somani, Southampton, United Kingdom
MP17-10 INCREASED LITHOGENIC RISK IN PLANT-
BASED MEAT PRODUCTS FOR CHILDREN
AND INFANTS
Garrett Ungerer*, Christine Liaw, Aaron Potretzke,
David Sas, Patricio Gargollo, Candace Granberg,
Kevin Koo, Rochester, MN
MP17-11 USE OF LOW DOSE COMPUTED
TOMOGRAPHY IN CHILDREN WITH
NEPHROLITHIASIS: A MULTI-
INSTITUTIONAL ANALYSIS
Ashley Pittman*, Wauwatosa, WI, Neil Paloian,
Madison, WI, Amy Pan, Liyun Zhang, Andrea
Moyer, Robert Medairos, Pooja Thakrar, Wauwa-
tosa, WI, Jonathan Ellison, Wauwatosa, WI
MP17-12 PROXIMITY TO FOOD DESERTS INCREASES
RISK OF PEDIATRIC NEPHROLITHIASIS
Arthi Hannallah*, Aurash Naser-Tavakolian, Zoë
Baker, Shirley Saker, Thalia Bajakian, Nadine
Khouzam, Andrew Freedman, S. Scott Sparks,
Los Angeles, CA
MP17-13 EVALUATION OF RENAL FUNCTION IN
PEDIATRIC PATIENTS UNDERGOING
UROLOGIC SURGERY USING NSQIP-P DATA
Victor Chalfant*, Carlos Riveros, Andrew Stec,
Jacksonville, FL
79
 MP17-14 IS EXCRETORY PHASE COMPUTERIZED MP17-17 PREDICTION OF WILMS’ TUMOR RELAPSE
TOMOGRAPHY IMPORTANT FOR EVALUATION RISK USING GENETIC AND METABOLOMIC
OF HIGH GRADE RENAL TRAUMA?: RESULTS MARKERS
FROM THE TRAUMATIC RENAL INJURY Ahmed Abdelhalim*, Mariam AbdelMonem,
COLLABORATION FOR KIDS (TRICK) Asmaa Ahmed, Amira Awadalla, Mohamed Ab-
Ching Man Carmen Tong*, Birmingham, AL, delhameed, Mansoura, Egypt, Ranim Mahmoud,
Jacob Lucas, Philadelphia, PA, Albert Lee, Masnoura, Egypt, Om Ali El-khawaga, Ashraf
Washington D.C., DC, Vinaya Bhatia, Houston, Hafez, Mansoura, Egypt
TX, Benjamin Abelson, Nashville, TN, Christopher
MP17-18 A PIPE DREAM? OPIOID-FREE ANESTHESIA
Long, Dana Weiss, Philadelphia, PA, Christina
IN PEDIATRIC UROLOGY
Ho, Washington D.C., DC, Jeffrey Ellis, Philadel-
Michael Richman*, Yuanting Zha, Annie Galloway,
phia, PA, Harold Lovvorn, Nashville, TN, Teressa
Daniel Low, Paul Merguerian, Seattle, WA
Duong, Birmingham, AL, Jonathan Gerber, Hou-
ston, TX, Gabriella Crane, Nashville, TN, Xiaoyi MP17-19 PARENTAL PERCEPTIONS ON CONTRAST
Zhuo, Houston, TX, Robert Russell, Birmingham, ENHANCED VOIDING ULTRASONOGRAPHY
AL, Soo Kim, Ming-Hsien Wang, Houston, TX, VS VOIDING CYSTOURETHROGRAPHY
Douglass Clayton, Nashville, TN, David Kitchens, Dylan Hutchison*, Sean Corbett, Susie Leroy,
Birmingham, AL Kathryn Morgan, Reza Daugherty, Grace Prilla-
man, Nora Kern, Charlottesville, VA
MP17-15 PEDIATRIC INGUINAL HERNIA
MANAGEMENT BETWEEN PEDIATRIC MP17-20 THE NATURAL HISTORY OF CHILDREN
SURGEONS AND PEDIATRIC UROLOGISTS WITH ANTENATAL HYDRONEPHROSIS AND
Teressa Duong*, Vincent Mortellaro, David Kitch- ASYMPTOMATIC VESICOURETERAL REFLUX
ens, David Joseph, Ching Man Carmen Tong, INCLUDING VCUG ORDERING PRACTICES
Birmingham, AL Jeremy Goodman*, Walid Farhat, Madison, WI,
Fardod O’Kelly, Dublin, Ireland, Jennika Finup,
MP17-16 LONG-TERM OUTCOMES FOR PATIENTS
Ryan McAdams, Kara Gill, Matthew W Harer,
WITH ANAPLASTIC BILATERAL WILMS
Madison, WI
TUMORS ENROLLED ON COG AREN0534
Rodrigo LP Romao*, Halifax, Canada, Jennifer H
APPROVED FOR AMA PRA CATEGORY 1.25
Aldrink, Columbus, OH, Brett Tornwall, Gaines- CREDITSTM
ville, FL, Kathleen Kieran, Seattle, WA, Andrew
Murphy, Andrew Davidoff, Memphis, TN, Daniel
Benedetti, Nashville, TN, Jeffrey Dome, Wash-
ington DC, DC, Elizabeth Perlman, Chicago, IL,
Ethan Smith, Cincinnati, OH, Conrad Fernandez,
Halifax, Canada, James Geller, Cincinnati, OH,
Jack Brzezinski, Toronto, Canada, Lindsay Renf-
ro, Monrovia, CA, Marcus Malek, Pittsburgh, PA,
David Mansur, Cleveland, OH, Elizabeth Mullen,
Boston, MA, Nicholas Cost, Denver, CO, Robert
C Shamberger, Boston, MA, Peter F Ehrlich, Ann
Arbor, MI

Friday, May 13, 2022 4:30 pm – 5:45 pm

Moderated Poster Session 18

URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: NON-NEUROGENIC
VOIDING DYSFUNCTION I
Room 222 @ Ernest N. Morial Convention Center
Moderators: Maude Carmel & Michael Kennelly

ABSTRACT
NUMBER TITLE
MP18-01 THE EFFECT OF AGING ON URINE
NATRIURETIC PEPTIDES IN NOCTURIA AND
NOCTURNAL POLYURIA
Lakshay Khosla*, Joseph U. Boroda, Joshua
Salama, Brooklyn, NY, Syed N. Rahman, New
Haven, CT, Danielle J. Gordon, Brooklyn, NY,
Matthew W. Moy, Westlake, OH, Yonatan Akivis,
Alla Akivis, Jason M. Lazar, Jeffrey P. Weiss,
Brooklyn, NY, Lori A. Birder, Pittsburgh, PA
ABSTRACT
NUMBER TITLE
MP18-02 EFFECT OF NOCTURIA IN PATIENTS WITH
DIFFERENT SEVERITY OF OBSTRUCTIVE
SLEEP APNEA ON POLYSOMNOGRAPHY
YuFeng Chuang*, Chin-Heng Lu, Chao-Yu Hsu,
Min-Che Tung, Yen-Chuan Ou, Taichuang,
Taiwan
MP18-03 PHENOTYPING PATIENTS WITH POLYURIA
George Fisch, Tel Aviv-Yafo, Israel, Alexander
Fang*, Connelly Miller, Claire Choi, New York, NY,
Thomas Monaghan, Dallas, TX, Edward Smith,
Learta Prishtina, Jeffrey Weiss, Jerry Blaivas,
New York, NY

80
 MP18-04 ENURESIS AND LOWER URINARY TRACT
DYSFUNCTION: A RELATIONSHIP NOT
TRULY DISCUSSED
Ana Castro, Glicia Abreu, Bruna Venturini,
Eliakim Massuqueto, Ubirajara Barroso Jr*,
Salvador, Brazil
MP18-05 EXTRA VOIDS IN PATIENTS WITH
OVERACTIVE BLADDER
Kevin Rychik, New York, NY, Max Edeson, Nutley,
NJ, Edward Smith*, New York, NY, Jeffrey Weiss,
Brooklyn, NY, Wade Bushman, Madison, WI, Jerry
Blaivas, New York, NY
MP18-06 EFFICACY OF PULSED ELECTROMAGNETIC
FIELD (PEMF) THERAPY FOR PELVIC
PAIN REDUCTION AND SYMPTOM
IMPROVEMENT IN INTERSTITIAL CYSTITIS:
A PILOT STUDY
Dylan T. Wolff*, Peyton Lee, Christina Ross,
Robert J. Evans, Gopal Badlani, Tyler Overholt,
Raymond Xu, Catherine A. Matthews, Stephen J.
Walker, Winston-Salem, NC
MP18-07 ASSESSMENT OF BLADDER ‘PRESSURE’
AND ‘DISCOMFORT’ SYMPTOMS – HOW
DO OVERACTIVE BLADDER DIFFER FROM
INTERSTITIAL CYSTITIS/BLADDER PAIN
SYNDROME PATIENTS?
Angelíca Gousse, Joel Vetter, H. Henry Lai*, St
Louis, MO
MP18-08 NOVEL MACHINE LEARNING ALGORITHMS
ARE ACCURATE AND NONINFERIOR
TO HUMAN EXPERTS IN PREDICTING
SUBJECTIVE PATIENT OUTCOMES
FOLLOWING THIRD LINE THERAPY FOR
OVERACTIVE BLADDER
Glenn T. Werneburg*, Cleveland, OH, Eric
Werneburg, Stony Brook, NY, Howard Goldman,
Cleveland, OH, Andrew Mullhaupt, Stony Brook,
NY, Sandip Vasavada, Cleveland, OH OF PROSTATE REFLECTED BY THE
MP18-09 DOES SOCIOECONOMIC STATUS IMPACT
CONTINUATION OF ONABOTULINUM
TOXIN THERAPY FOR URGENCY URINARY
INCONTINENCE?
Zhina Sadeghi*, Emma C Bethel, Stephanie Daig-
nault-Newton, Paholo G Barboglio Romo, Anne
P Cameron, J Quentin Clemens, Priyanka Gupta,
Yooni Yi, John T Stoffel, Ann Arbor, MI MP18-18 STATISTICAL SHAPE MODELING OF VIDEO
MP18-10 EVALUATION OF CLINICAL PERFORMANCE
AND SAFETY FOR THE RECHARGEABLE
INTERSTIMTM MICRO IN OVERACTIVE
BLADDER SUBJECTS: 3-MONTH RESULTS
FROM THE GLOBAL POST-MARKET ELITE
STUDY
Keith Xavier, Arlington, TX, Colin Goudelocke*,
New Orleans, LA, Barry Pecha, Jeffersonville, IN,
Kimberly Burgess, Greenville, SC, Marie-Aimée
Perrouin-Verbe, Nantes, France, Ryan Krlin,
New Orleans, LA, Jodi Michaels, Woodbury, MN,
Sagar Shah, Jacksonville, FL, Benoît Peyronnet,
Rennes, France, Stanley Zaslau, Morgantown,
WV, Bianca Papi, Katie Bittner, Minneapolis, MN,
Dean Elterman, Toronto, Canada, Victor Nitti, Los
Angeles, CA
*Presenting author
MP18-11 URGE URINARY INCONTINENCE IS
ASSOCIATED WITH FOOD INSECURITY
Chihiro Okada*, Joseph Kim, Nicole Roselli,
Priyanka Kadam Halani, Nitya Abraham, Bronx, NY
MP18-12 ASSESSING THE UTILIZATION OF THE
HEALTHCARE SYSTEM IN PATIENTS WITH
OVERACTIVE BLADDER
Elisabeth Sebesta*, Stephanie Gleicher, Melissa
FRIDAY
Kaufman, Roger Dmochowski, W. Stuart Reyn-
olds, Nashville, TN
MP18-13 THE SENSATION METER: A NOVEL NON-
INVASIVE APPROACH TO UNDERSTANDING
BLADDER SENSATION EVENTS
Elizabeth Rourke*, New Orleans, LA, W. Stuart
Reynolds, Nashville, TN
MP18-14 METFORMIN IN THE TREATMENT OF
OVERACTIVE BLADDER – A RETROSPECTIVE
NESTED CASE-CONTROL, POPULATION-
BASED ANALYSIS
Sarah Neu*, Jennifer Locke, Toronto, Canada,
Rano Matta, Salt Lake City, UT, Natalie Troke,
Mina Tadrous, Refik Saskin, Robert Nam, Sender
Herschorn, Toronto, Canada
MP18-15 REAL WORLD MALE VOIDING BEHAVIOR
AND VARIABILITY USING AN AUDIO-BASED
UROFLOWMETRY APPLICATION
Ramy Goueli*, Dallas, TX, Min Gyeong Kim, San
Francisco, CA, Kenneth Goldberg, Dallas, TX,
Catherine Song, San Francisco, CA, Claus Roehr-
born, Dallas, TX
MP18-16 VOIDING TIME AS A PROXY FOR URINARY
OBSTRUCTION IN MEN WITH LOWER
URINARY TRACT SYMPTOMS
Gaurav Pahouja*, Parth Patel, Enrique Blanco
Martinez, Kevin T. McVary, Maywood, IL
MP18-17 THE MICROSCOPIC STRUCTURAL CHANGES
APPARENT DIFFUSION COEFFICIENT VALUE
AFFECT LOWER URINARY TRACT FUNCTION
Hidenori Akaihata*, Yusuke Hakozaki, Hiroki Nat-
suya, Tomoyuki Kumekawa, Shunsuke Yoshioka,
Hitomi Imai, Akifumi Onagi, Kanako Matsuoka, To-
moyuki Koguchi, Junya Hata, Yuichi Sato, Masao
Kataoka, Yoshiyuki Kojima, Fukushima, Japan
URODYNAMICS: FROM FORM TO FUNCTION
Kelsey Gallo*, Lindsey Burnett, San Diego, CA,
Megan Routzong, La Jolla, CA, Marianna Alperin,
Yahir Santiago-Lastra, San Diego, CA
MP18-19 URODYNAMICS (UDS) USAGE FOR BENIGN
PROSTATIC HYPERPLASIA (BPH)
Samantha L. Thorogood*, Tenny R. Zhang,
Christina Sze, Mary O. Strasser, Gina DeMeo,
Richard K. Lee, Bilal Chughtai, Alexis Te,
Jim C. Hu, New York, NY
MP18-20 EVALUATION OF QUALITY OF LIFE,
VOIDING, AND SEXUAL DYSFUNCTION IN
PATIENTS FOLLOWING ROBOT-ASSISTED
VESICOVAGINAL FISTULA REPAIR
Pawan Kaundal, Ravimohan Mavuduru*, Girdhar
Bora, Shrawan K Singh, Chandigarh, India
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
81
NOTES
NOTES
NOTES
 MP = Moderated Poster Session, PD = Podium Session

Saturday, May 14, 2022 Plenary: Prime Time Saturday Morning Session 7:30 am – 11:30 am
Great Hall A @ Ernest N. Morial Convention Center
7:30 HOW I DO IT: COMMON UROLOGIC PROCEDURES
Moderator: Gopal Badlani
Panelists: Li-Ping Xie, John Wei, Jaspreet Sandhu
8:30 WHEN DISASTER STRIKES: PREVENTING AND MANAGING NIGHTMARE CASES IN UROLOGY
Moderator: Randall Meacham
Panelists: Brian Cross, Rene Sotelo, Tobias Kohler, Lindsay Hampson
9:30
RAMON GUITERAS LECTURE: HOW TO REACH EXCELLENCE IN UROLOGY: CHALLENGES AND
OPPORTUNITIES
Presenter: Francesco Montorsi

SATURDAY
9:55 JOHN K. LATTIMER LECTURE: TESTOSTERONE, SCIENCE AND HUMAN DIGNITY
Presenter: Abraham Morgentaler
10:20 JOURNAL OF UROLOGY LECTURE: ENGAGING PATIENTS: A CHALLENGE TO OUR CARE DELIVERY AND
RESEARCH PRIORITIES
Presenter: Angela Smith
10:40 PRESIDENTIAL ADDRESS
AUA President: Raju Thomas
11:05 PRESENTATION OF HONORARY MEMBERS & SECRETARY COMMENDATIONS FOR GLOBAL LEADERSHIP
AUA Past President: Scott Swanson
AUA Secretary: John Denstedt
11:15 UROLOGY CARE FOUNDATION PRESIDENTIAL ADDRESS
UCF President: Harris Nagler

Saturday, May 14, 2022 Plenary: Prime Time Saturday Afternoon Session 1:00 pm – 4:00 pm
Great Hall A @ Ernest N. Morial Convention Center
1:00 STATE-OF-THE-ART LECTURE: SINGLE-USE URETEROSCOPES AND NEW TECHNOLOGY: WHAT IS IN STORE?
Presenter: Ben Chew
1:15 STATE-OF-THE-ART LECTURE: THULIUM FIBER LASER LITHOTRIPSY: IS IT LIVING UP TO THE HYPE?
Presenter: Dmitry Enikeev
1:30 PANEL DISCUSSION: RESIDUAL FRAGMENTS AFTER STONE SURGERY: LEAVE OR CHASE?
Moderator: Daron Smith
Panelists: Thomas Tailly, Amy Krambeck
1:50 CROSSFIRE: CONTROVERSIES IN UROLOGY DEBATE: DO WE REALLY NEED STONE ANALYSIS AND METABOLIC
URINE TESTING?
Moderator: Glenn Preminger
Debaters: Justin Friedlander, Sara Best, Ryan Hsi, Kymora Scotland
2:20 PANEL DISCUSSION: PRESSURE IRRIGATION IN URETEROSCOPY
Moderator: Olivier Traxer
Panelists: Alex Meller, Michelle Semins, Helene Jung, Etienne Keller
2:50 SECOND OPINION CASES: TREATMENT OF SYMPTOMATIC NON-OBSTRUCTING CALYCEAL CALCULI: TO TREAT
OR NOT
Moderator: Nicole Miller
Panelists: Francis Keeley, Manoj Monga, Naeem Bhojani, Marianne Brehmer
3:10 STATE-OF-THE-ART LECTURE: GENETIC TESTING FOR EARLY ONSET KIDNEY STONE DISEASE
Presenter: Gregory Tasian
3:25 PANEL DISCUSSION: STENT ASSOCIATED SYMPTOMS AFTER URETEROSCOPY: INSIGHTS FROM THE USDRN
STENTS STUDY
Moderator: Necole Streeper
Panelists: Alana Desai, Henry Lai, Charles Scales

*Presenting author 85
Saturday, May 14, 2022
Moderated Poster Session 19
EDUCATION RESEARCH II
Room 228 @ Ernest N. Morial Convention Center
Moderators: Andrew Hung & Jennifer Taylor
ABSTRACT
NUMBER TITLE
MP19-01 RACIAL AND ETHNIC DIFFERENCES IN
MEDICAL STUDENT TIMING AND PERCEIVED
QUALITY OF EXPOSURE TO UROLOGY
Efe Chantal Ghanney Simons*, Natalia Garcia
Peñaloza, Los Angeles, CA, Kassandra E. Zaila
Ardines, Cleveland, OH, Serena Does, Utrecht,
Netherlands, Samuel L. Washington III, San Fran-
cisco, CA, Megha Tandel, Clarence H. Braddock
III, Los Angeles, CA, Tracy M. Downs, Charlottes-
ville, VA, Christopher Saigal, Los Angeles, CA
MP19-02 
ADDRESSING MEDICAL EDUCATION
CURRICULUM GAPS IN UROLOGICAL CARE
FOR LGBTQIA PATIENTS: A CERTIFICATE
TO ADVANCE TRAINING IN GENDER AND
SEXUAL MINORITY HEALTH
Caleb Bercu*, Joseph Nickel, Scott Rhodes,
Winston-Salem, NC, Bradley Figler, Chapel Hill,
NC, Ram Pathak, Winston-Salem, NC
MP19-03 
TRENDS IN RACE AND ETHNICITY AMONG
APPLICANTS TO US UROLOGY RESIDENCY
PROGRAMS
Efe Chantal Ghanney Simons*, Parris A. Diaz,
Los Angeles, CA, Rebecca Takele, Blacksburg,
VA, Serena Does, Utrecht, Netherlands, Samuel
L. Washington III, San Francisco, CA, Benjamin
N. Breyer, San Francisco, CA, Holly Wilhalme,
Los Angeles, CA, Tracy M. Downs, Charlottes-
ville, VA, Christopher Saigal, Los Angeles, CA
MP19-04 
PEDIATRIC UROLOGY ACROSS US
RESIDENCY PROGRAMS: A SURVEY OF
RESIDENCY PROGRAM DIRECTORS TO
IDENTIFY DIFFERENCES IN EDUCATION
Daniel Tennenbaum*, Brooklyn, NY, Lane Palmer,
New Hyde Park, NY
MP19-05 
LANDSCAPE ANALYSIS OF THE USE OF
HOLISTIC REVIEW IN THE UROLOGY
RESIDENCY MATCH PROCESS
Efe Chantal Ghanney Simons*, Parris A. Diaz,
Los Angeles, CA, Rebecca Takele,
Blacksburg, VA, Serena Does, Utrecht, Nether-
lands, Nicholas J. Jackson, Los Angeles, CA,
Samuel L. Washington III, San Francisco, CA,
Benjamin N. Breyer, San Francisco, CA, Tracy M.
Downs, Charlottesville, VA, Christopher Saigal,
Los Angeles, CA
MP19-06 
PROSPECTIVE EVALUATION OF
POSTOPERATIVE PAIN AND OPIOID USE
AFTER MINOR UROLOGIC SURGERY
Bonnie Liu*, Kevin Feng, Jeffrey Campbell,
London, Canada
86
7:00 am – 8:15 am
ABSTRACT
NUMBER TITLE
MP19-07 
CHARACTERIZING THE USE OF TWITTER
AMONGST ACADEMIC UROLOGISTS
Alberto Castro Bigalli*, Philadelphia, PA, Clara
Sun, Ilaha Isali, Cleveland, OH, Andrew Gi-
anakopoulos, Justin Dubin, Chicago, IL, Seyed
Behzad Jazayeri, Jacksonville, FL, Mohit Sind-
hani, New Delhi, India, Laura Bukavina,
Philadelphia, PA
MP19-08 AN ANALYSIS EXPLORING SELF-IDENTIFIED
GENDER AMONG UROLOGISTS INCLUDED IN
TOP DOCTOR MAGAZINE LISTS
Elizabeth Adams*, Chicago, IL, Marne Louters,
Ann Arbor, MI, Brandon Ansbro, Chicago, IL,
Simone Thavaseelan, Providence, RI, Stephanie
Kielb, Chicago, IL
MP19-09 OPEN ACCESS JOURNALS HAVE HIGHER
METRICS THAN NON-OPEN ACCESS
JOURNALS: ANALYSIS OF EUROPEAN
UROLOGY AND JOURNAL OF UROLOGY
METRICS
Riccardo Lombardo*, Antonio Cicione, Rome,
Italy, Antonio Nacchia, Rionero in Vulture, Italy,
Beatrice Turchi, Giacomo Gallo, Carmen Gravina,
Alessandro Guercio, Jordi Stira, Lorenzo Maria
Rovesti, Antonio Franco, Giorgio Guarnotta, Elisa
Mancini, Olivia Alessandra Voglino, Valeria Bal-
dassarri, Simone D’Annunzio, Sara Riolo, Andrea
Tubaro, Cosimo De Nunzio, Rome, Italy
MP19-10 DETERMINING THE EFFECTIVENESS
OF A DELIBERATE PRACTICE TRAINING
PLATFORM IN A VIRTUAL REALITY
(VR) URETHROVESICAL ANASTOMOSIS
CURRICULUM
Kit Yuen*, Alexis Steinmetz, Rachel Melnyk, Na-
than Schuler, Galen Cheng, Dennis Phan, Ahmed
Ghazi, Rochester, NY
MP19-11 VIRTUAL CLASSROOM PROFICIENCY BASED
PROGRESSION FOR ROBOTIC SURGERY
TRAINING (VROBOT): A PROSPECTIVE,
CROSS-OVER, EFFECTIVENESS STUDY
Alexander Ng*, Arjun Nathan, Sonam Patel, Maria
Georgi, London, United Kingdom, Monty Fricker,
Newcastle, United Kingdom, Kien Hang, London,
United Kingdom, William Mullins, Cambridge,
United Kingdom, Aqua Asif, Leicester, United
Kingdom, Alexander Light, Nader Francis, John
Kelly, Justin Collins, Ashwin Sridhar, London,
United Kingdom
 MP19-12 THE LEARNING CURVE FOR ROBOT-
ASSISTED RADICAL CYSTECTOMY: A
SYSTEMATIC REVIEW
Andrey Morozov*, Diana Babaevskaya, Mark
Taratkin, Jasur Inoyatov, Ekaterina Laukhtina,
Moscow, Russian Federation, Marco Moschini,
Milan, Italy, Nirmish Singla, Baltimore, MD, Juan
Gomez Rivas, Madrid, Spain, Jeremy Teoh, Hong
Kong, China, People’s Republic of, Petr Glyboch-
ko, Dmitry Enikeev, Moscow, Russian Federation
MP19-13 HAND DOMINANCE DECISION-MAKING
AND OPERATING ROOM CHALLENGES
EXPERIENCED BY LEFT-HANDED UROLOGY
MP19-17 DEMAND FOR EXPANDED VIRTUAL
EDUCATION EVIDENT AMONG UROLOGY
TRAINEES TWO YEARS INTO COVID-19
Kyle Blum*, Lauren Conroy, Justin Mehr,
Skyler Howell, Leyla Akhverdiyeva, David Tuke,
Steven Canfield, Houston, TX
MP19-18 NOMOGRAM PREDICTING RENAL FUNCTION
RECOVERY POST DIVERSION IN PATIENTS
WITH OBSTRUCTIVE UROPATHY
Gopal Sharma*, Sudheer K. Devana,
Ravimohan S. Mavuduru, Kalpesh M. Parmar,
Chandigarh, India
MP19-19 PREDICTING PROFICIENCY DURING

TRAINEES
Christopher Tam*, Maia Anderson, Mary Byrnes,
Julian Wan, Bryan Sack, Ann Arbor, MI
MP19-14 A NOVEL GENITOURINARY MEDICINE
FELLOWSHIP PROGRAM, OUR EXPERIENCE
AND FUTURE VISION
Tareq Aro*, Louis Kavoussi, Lloyd Minsky,
Michael Ziegelbaum, New Hyde Park, NY Robert Smith, Alvin Goh, New York, NY
MP19-15 NEW YORK CITY COVID-19 CONSULTS: AN
ALGORITHM FOR SAFE, EFFICIENT, QUALITY
CARE
Benjamin Eilender*, Joseph Baiocco, Conner
Brown, Vannita Simma-Chiang, Jay A. Motola,
New York, NY Yongseok Kho*, Sung Yong Cho, Seoul, Korea,
MP19-16 EXAMINING THE 1-YEAR IMPACT OF
COVID-19 ON UROLOGY RESIDENT
SURGICAL EXPERIENCE: AN ANALYSIS OF
NATIONAL SURGICAL CASE LOGS
Travis LeBlanc*, Rourke Keith, Edmonton,
­Canada
SATURDAY
ROBOTIC PROSTATECTOMY OF UROLOGY
TRAINEES USING A NOVEL, SYSTEMIC
SURGICAL TRAINING PROGRAM
Rand Wilcox Vanden Berg*, Ashwin Ramaswamy,
Emily Vertosick, Eugene Cha, Jonathan Coleman,
Timothy Donahue, James Eastham,
Behfar Ehdaie, Vincent Laudone, Eugene Pietzak,
MP19-20 EFFECTIVENESS OF A NEWLY-DEVELOPED
TRAINING MODULE USING 3D PRINTING
FOR THE NAVIGATION DURING
RETROGRADE INTRARENAL SURGERY
Gyoohwan Jung, Seongnam, Korea, Republic of,
Republic of
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM

Saturday, May 14, 2022 7:00 am – 8:15 am

Moderated Poster Session 20

TRAUMA/RECONSTRUCTION/DIVERSION: EXTERNAL GENITALIA RECONSTRUCTION AND UROTRAUMA
(INCLUDING TRANSGENDER SURGERY) I
Room 225 @ Ernest N. Morial Convention Center
Moderators: Steven Brandes & Reynaldo Gomez

ABSTRACT
NUMBER TITLE
MP20-01 OPIOID AND MULTIMODAL ANALGESIA USE
FOLLOWING UROLOGICAL TRAUMA
Mary Rostom*, Andrew Gabrielson,
Ryan Fransman, Shirley Wang, Albert Holler,
Isabella Pan, Nikita Gupta, Joseph Sakran,
Andrew Cohen, Baltimore, MD Abimbola Ayangbesan, Rohan Bhalla,
MP20-02 PROTECTIVE ROLE OF METFORMIN IN
ACUTE RENAL ISCHEMIC REPERFUSION
INJURY
Junrong Zou, Xiaofeng Zou*, Guoxi Zhang,
Kecheng Lou, Shangzhi Feng, Guancheng Xiao,
Hailan He, Ganzhou, China, People’s Republic of
ABSTRACT
NUMBER TITLE
MP20-03 SELECT INTERMEDIATE-GRADE BLUNT
RENAL INJURIES ARE APPROPRIATE FOR
EARLY DISCHARGE
George Koch*, Madeleine Ball, Craig Hill,
Jackson Cabo, Helen Gambrah,
Niels Johnsen, Nashville, TN
MP20-04 GRADE V RENAL TRAUMA: SUCCESS ROLE
FOR CONSERVATIVE MANAGEMENT IN THE
NATIONAL TRAUMA DATABANK
Nizar Hakam*, Nathan Shaw, Jason Lui,
Behnam Nabavizadeh, Kevin Li, Patrick Low,
Benjamin Breyer, San Francisco, CA

*Presenting author 87
 MP20-05 LATE COMPLICATIONS AFTER BLUNT
RENAL TRAUMA: A FRENCH MULTICENTER
STUDY
Godefroi Brenot, Saint Mandé, France, Inès
Dominique, Paris, France, Benoît Peyronnet,
Rennes, France, Pierre-Henri Savoie, Toulon,
France, Paul Chiron*, Saint Mandé, France
MP20-06 PERIRENAL FAT THICKNESS IS ASSOCIATED
WITH RENAL TRAUMA INJURY GRADE
Nizar Hakam*, Jason Lui, Nathan Shaw, Behnam
Nabavizadeh, Patrick Low, Kevin Li, Benjamin
Breyer, San Francisco, CA
MP20-07 UROLOGY CONSULTATION IS ASSOCIATED
WITH ADHERENCE TO IMAGING GUIDELINES
AND DECREASED NEPHRECTOMY IN HIGH
GRADE RENAL TRAUMA
Shirley Wang, Pranjal Agrawal*, Mary Rostom,
Nikita Gupta, Albert Holler, Isabelle Pan,
Kent Stevens, Raymond Fang, Elliott Haut,
Ryan Fransman, Renu Berry, Andrew Cohen,
Baltimore, MD
MP20-08 THE EFFECT OF COLPECTOMY ON
LOWER URINARY TRACT FUNCTION IN
TRANSGENDER MEN
Brechje L. Ronkes, Freek P.W. de Rooij, Freek A.
Groenman, Mark-Bram Bouman, Jakko A. Nieu-
wenhuijzen, R. Jeroen A. van Moorselaar, Garry
L.S. Pigot*, Amsterdam, Netherlands
MP20-09 COMPARISON OF CLINICAL OUTCOMES
AFTER PHALLOPLASTY WITH VERSUS
WITHOUT URETHRAL LENGTHENING IN
TRANSGENDER MEN
Freek P.W. de Rooij, Wouter B. van der Sluis,
Brechje L. Ronkes, Thomas D. Steensma,
Muhammed Al-Tamimi, R. Jeroen A. van
Moorselaar, Mark-Bram Bouman, Garry L.S.
Pigot*, Amsterdam, Netherlands
MP20-10 A PILOT STUDY OF OUTCOMES AFTER
ROBOT-ASSISTED SIGMOID VAGINOPLASTY
FOR GENDER DYSPHORIA
Tatyana Yatsenko*, Brooklyn, NY, Peter Wiklund,
Rajveer Purohit, Miroslav Djordjevic,
New York, NY
MP20-11 A NOMOGRAM TO PREDICT VAGINAL
DEPTH, BASED ON AVAILABLE PENILE AND
SCROTAL SKIN, FOR PENILE INVERSION
VAGINOPLASTY: A USEFUL TOOL FOR
DECISION MAKING AND SURGICAL
PLANNING
Shannon Smith*, Los Angeles, CA, Nance Yuan,
Pasadena, CA, Michael Zaliznyak, Jenna Stelmar,
Maurice Garcia, Los Angeles, CA
MP20-12 ASSESSMENT OF NEOPHALLUS LENGTH
FOLLOWING METOIDIOPLASTY
Hannah Glick*, Stephanie Diagnault-Newton,
Miriam Hadj-Moussa, Ann Arbor, MI
88
MP20-13 QUANTIFYING TIME TO ORGASM AFTER
GENDER AFFIRMING VAGINOPLASTY
Gaines Blasdel*, Elijah Castle, New York, NY,
Carmen Kloer, Durham, NC, Augustus Parker,
Rachel Bluebond-Langner, Lee Zhao,
New York, NY
MP20-14 URETHRAL COMPLICATIONS AFTER
MUSCULOCUTANEOUS LATISSIMUS DORSI
PHALLOPLASTY IN TRANSGENDER MEN
Borko Stojanovic*, Marko Bencic, Marta Bizic,
Miroslav L. Djordjevic, Belgrade, Serbia
MP20-15 DELAYED PRIMARY CLOSURE OF POST-
DEBRIDEMENT FOURNIER’S GANGRENE
WOUNDS REDUCES COST
Andrew Zilavy, Peter Sam*, Carolyn Ice,
Maxx Gallegos, Albuquerque, NM
MP20-16 CLINICAL TRANSLATION OF ENGINEERED
PENILE TISSUE
Sita Somara, Teresa Burnette, Namrata Sangha,
Lindsey Creahan, Tsghe Abraha, Kathryn Krupp,
Tiana Stewart, Torie Westendorf,
Brad Damratoski, Lisa Hinshaw, Todd Meinecke,
Darren Hickerson, Cynthia Wilkins-Port, Ryan
Terlecki, James Yoo, Julie Allickson, Anthony
Atala, John Jackson*, Winston Salem, NC
MP20-17 CORPOROPLASTY: A SIMPLIFIED
TECHNIQUE FOR CLITOROPLASTY
Ubirajara Barroso Jr*, Marcelo Villalta,
Leidy Casas, Eliakim Massuqueto,
Bruna Venturini, Salvador, Brazil
MP20-18 HEINEKE-MIKULICZ PREPUTIOPLASTY:
SURGICAL TECHNIQUE AND OUTCOMES
Alex Xu*, Kirtishri Mishra, Lee Zhao,
New York, NY
MP20-19 EARLY ENDOSCOPIC REALIGNMENT OF
POST TRAUMATIC URETHRAL DISRUPTION
Camille Haudebert*, Juliette Hascoet,
Vivien Graffeille, Karim Bensalah, Gregory
Verhoest, Zine Eddine Khene, Romain Mathieu,
Andrea Manunta, Benoit Peyronnet,
Lucas Freton, Rennes, France
MP20-20 HIGH 30-DAY COMPLICATIONS AFTER
BURIED PENIS REPAIR SUGGEST ROLE FOR
PREOPERATIVE OPTIMIZATION
Ethan Matz*, Rahul Dutta, Nicholas Deebel,
Justin Refugia, Kim Thai, Ryan Terlecki,
Winston-Salem, NC
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
Saturday, May 14, 2022
Moderated Poster Session 21
SEXUAL FUNCTION/DYSFUNCTION: EVALUATION I
Room 222 @ Ernest N. Morial Convention Center
Moderator: Ranjith Ramasamy
ABSTRACT
NUMBER TITLE
MP21-01 CONTEMPORARY COMORBIDITY PROFILE
OF MEN WITH ERECTILE DYSFUNCTION
Garrick Greear*, Tristan Nicholson, Sarah Holt,
Marah Hehemann, Hunter Wessells, Thomas
Walsh, Seattle, WA CA, Dylan Isaacson, Chicago, IL, Erin Duralde,
MP21-02 PREDICTORS OF CORPORO-VENOCCLUSIVE
DYSFUNCTION (CVOD) IN MEN WITH
BILATERAL NERVE-SPARING RADICAL
PROSTATECTOMY (RP)
Jose M Flores*, Carolyn A Salter,
Nicole Benfante, Elizabeth Schofield,
John P Mulhall, NYC, NY TREATMENT OR PREVIOUSLY EXPOSED
MP21-03 USING DATA MINING TO IDENTIFY CLINICAL
PREDICTORS OF DELAYED EJACULATION
Evan Mulloy*, Michael Eisenberg,
Amy Zhang, Palo Alto, CA
MP21-04 TRENDS OF REPORTING PREMATURE
EJACULATION AMONG MEN WITH ERECTILE
DYSFUNCTION – FINDINGS FROM A REAL-
LIFE CROSS-SECTIONAL STUDY
Edoardo Pozzi*, Giuseppe Fallara, Federico
Belladelli, Christian Corsini, Massimiliano Raffo,
Luigi Candela, Antonio Costa, Daniele Cignoli,
Nicolò Schifano, Alessia d’Arma, Paolo Capo-
grosso, Luca Boeri, Eugenio Ventimiglia, Rayan
Matloob, Milan, Italy, Vincenzo Mirone, Naples,
Italy, Francesco Montorsi, Andrea Salonia,
Milan, Italy
MP21-05 PERCEPTIONS OF MARIJUANA USE ON
MALE HEALTH AMONG REDDIT USERS:
NATURAL LANGUAGE PROCESSING AND
THEMATIC ANALYSIS
Gary Shahinyan*, Denver, CO, Ming-Yeah Hu,
Tommy Jiang, Vadim Osadchiy, John Sigalos,
Jesse Mills, Los Angeles, CA, Naveen Kachroo,
Detroit, MI, Sriram Eleswarapu, Los Angeles, CA
MP21-06 IMPACT OF SEXUAL DYSFUNCTION ON
QUALITY OF LIFE IN WOMEN AFTER PELVIC
FRACTURE
Helen Gambrah*, Niels Vass Johnsen, MD, MPH,
Nashville, TN
MP21-07 EXPLORING SEXUAL HEALTH OF
TRANSFEMININE INDIVIDUALS: AN
OPPORTUNITY TO EDUCATE MEDICAL
PROVIDERS
Andrew Denisenko*, Andrew Salib,
Jessica Bulafka, Sabina Spigner,
Vishal Swaminathan, Peyton Stauffer, Cassra B.
Clark, Andrew Shumaker, Rosemary Frasso,
Paul H. Chung, Philadelphia, PA
*Presenting author
7:00 am – 8:15 am
ABSTRACT
NUMBER TITLE
MP21-08 MASTURBATORY ORGASM PARAMETERS OF
SEXUALLY ACTIVE CISGENDER MEN AND
WOMEN
Jenna Stelmar*, Michael Zaliznyak, Los Angeles,
SATURDAY
Boston, MA, Thomas Gaither, Shannon Smith,
Nance Yuan, Los Angeles, CA, Kimberly Topp,
San Francisco, CA, Maurice Garcia,
Los Angeles, CA
MP21-09 DRUG-RELATED SEXUAL DYSFUNCTION
ISSUES AMONG PATIENTS UNDER
TO SELECTIVE SEROTONIN REUPTAKE
INHIBITORS (SSRIS) – A MANAGEMENT
CHALLENGE?
Nicolò Schifano*, Milan, Italy, Paolo Capogrosso,
Varese, Italy, Giuseppe Fallara, Edoardo Pozzi,
Federico Belladelli, Luigi Candela,
Christian Corsini, Massimiliano Raffo, Antonio
Costa, Daniele Cignoli, Alessia d’Arma,
Luca Boeri, Eugenio Ventimiglia, Rayan Matloob,
Milan, Italy, Vincenzo Mirone, Naples, Italy,
Federico Dehò, Varese, Italy, Francesco
Montorsi, Andrea Salonia, Milan, Italy
MP21-10 WHEN GENITO-PELVIC DYSESTHESIA DOES
NOT ORIGINATE IN THE GENITO-PELVIC
REGION: MANAGEMENT OF PATIENTS WITH
SACRAL RADICULOPATHY
Irwin Goldstein*, Choll Kim, Sue Goldstein,
Maria Uloko, Noel Kim, San Diego, CA,
Barry Komisaruk, Newark, NJ
MP21-11 SEVERITY OF PENILE CURVATURE IN
PEYRONIE’S DISEASE DOES NOT CORELATE
WITH SHIM OR PDQ SCORES
Thomas Masterson*, Isaac Zucker,
Pranusha Atuluru, Emad Ibrahim, Manuel Molina,
Bruce Kava, Ranjith Ramasamy, Miami, FL
MP21-12 STILL ONE OUT OF FIVE MEN PRESENTING
FOR ERECTILE DYSFUNCTION ARE YOUNG
THAN 40 YEARS OF AGE: FINDINGS OF A
REAL-LIFE CROSS-SECTIONAL STUDY OVER
LAST DECADE
Edoardo Pozzi*, Milan, Italy, Paolo Capogrosso,
Varese, Italy, Giuseppe Fallara, Luca Boeri,
Christian Corsini, Daniele Cignoli, Massimiliano
Raffo, Luigi Candela, Nicolò Schifano, Alessia
d’Arma, Rayan Matloob, Milan, Italy, Federico
Dehò, Varese, Italy, Vincenzo Mirone, Naples,
Italy, Francesco Montorsi, Andrea Salonia,
Milan, Italy
89
 MP21-13 OBESITY IMPAIRS HYPOGONADISM
COMPENSATION LEADING TO AGE-RELATED
TESTOSTERONE DECLINE
Taciana Tiraboschi, Feira de Santana, Brazil,
Eduardo Miranda*, Fortaleza, Brazil, Monique No-
vaes, Caroline Silva, Jean Zambrano-Contreras,
Anna Ribeiro, Neyara Oliveira, Matheus Pauferro,
Rodolfo Pimenta, Ricardo Figueiredo, Feira de
Santana, Brazil, Jose Murillo Netto, Juiz de Fora,
Brazil, Cristiano Gomes, Sao Paulo, Brazil, Jose
Bessa Jr, Feira de Santana, Brazil
MP21-14 U-SHAPED ASSOCIATION BETWEEN
SECONDARY HYPOGONADISM AND BODY
MASS INDEX: A RETROSPECTIVE ANALYSIS
OF MEN WITH TESTOSTERONE DEFICIENCY
Aaron A. Gurayah*, Miami, FL, John M. Mas-
terson, Los Angeles, CA, Atil Y. Kargi, Ranjith
Ramasamy, Miami, FL
MP21-15 PREDICTORS OF LOW TOTAL
TESTOSTERONE (TT) LEVELS AFTER
RADICAL ORCHIECTOMY (RO) FOR TESTIS
CANCER (TC)
Jose M Flores*, Nicole Benfante, John P Mulhall,
NYC, NY
MP21-16 DEMOGRAPHICS AND INCIDENTAL
DIAGNOSES OF MEN WITH PRIAPISM
Evan Mulloy*, Shufeng Li, Michael Eisenberg,
Palo Alto, CA
MP21-17 THE EFFECT OF SURGICAL TREATMENT
OF URETHRAL STRICTURE ON ERECTILE
FUNCTION
Alexey Klimenko*, Sergei Kotov, Michael Iritsyan,
Moscow, Russian Federation
90
MP21-18 NEW FINDINGS REGARDING SURGEON
VARIATIONS IN PERIOPERATIVE
EVALUATION OF PENILE PROSTHESIS
PATIENTS
David Barham*, Orange, CA, Martin Gross,
Lebanon, NH, Aubrey Reeves, Colton, CA,
Cobi Reisman, Amsterdam, Netherlands, Eric
Chung, Brisbane St Lucia, Australia, Faysal Yafi,
Orange, CA
MP21-19 AN ALGORITHM TO PREDICT PENILE
DOPPLER ULTRASOUND FINDINGS IN MEN
WITH ERECTILE DYSFUNCTION
Federico Belladelli*, Massimiliano Raffo, Gi-
useppe Fallara, Edoardo Pozzi, Luigi Candela,
Antonio Costa, Christian Corsini, Daniele Cignoli,
Nicolò Schifano, Alessia d’Arma, Milan, Italy, Pao-
lo Capogrosso, Varese, Italy, Luca Boeri, Eugenio
Ventimiglia, Rayan Matloob, Milan, Italy, Vincenzo
Mirone, Naples, Italy, Francesco Montorsi, An-
drea Salonia, Milan, Italy
MP21-20 EXPLORING ERECTILE HEMODYNAMICS
IN MEN COMPLAINING OF HARD-FLACCID
SYNDROME (HFS)
John Sullivan*, Dublin, NY, Carolyn Salter, Jose
Flores, Pat Guhring, Marilyn Parker, John Mulhall,
New York, NY
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
Saturday, May 14, 2022
Podium Session 17
PROSTATE CANCER: DETECTION & SCREENING III
Room 252 @ Ernest N. Morial Convention Center
Moderators: Adam Kibel, Stacy Loeb & Andres Arley-Vargas
ABSTRACT
TIME NUMBER TITLE
7:00
PD17-01 DERIVATION AND EXTERNAL VALIDATION
OF A RAPID RISK SCORE FOR PREDICTING
CLINICALLY SIGNIFICANT PROSTATE
CANCER IN MEN WITH AN MRI VISIBLE
LESION: A MULTINATIONAL COHORT STUDY
Max Peters*, Utrecht, Netherlands, David El-
dred-Evans, London, United Kingdom, Piet Kurv-
er, Utrecht, Netherlands, Ugo Giovanni Falagario,
Foggia, Italy, Martin J. Connor, London, United
Kingdom, Joost J.C. Verhoeff, Utrecht, Nether-
lands, Giuseppe Carrieri, Luigi Cormio, Foggia,
Italy, Pekka Taimen, Hannu J Aronen, Juha Knaa-
pila, Ileana Montoya Perez, Otto Ettala, Turku,
Finland, Armando Stabile, Giorgio Gandaglia,
Nicola Fossati, Alberto Martini, Vito Cucchiara,
Alberto Briganti, Milan, Italy, Anna Lantz, Solna,
Sweden, Wolfgang Picker, Oslo, Norway, Erik
Haug, Tønsberg, Norway, Tobias Nordström,
Stockholm, Sweden, Mariana Bertoncelli Tanaka,
Feargus Hosking-Jervis, Deepika Reddy, Edward
Bass, London, United Kingdom, Peter SN van
Rossum, Utrecht, Netherlands, Suchita Joshi,
Elizabeth Pegers, Kathie Wong, Henry Tam,
David Hrouda, London, United Kingdom, Stuart
McCraken, Sunderland, United Kingdom, Mathias
Winkler, Stephen Gordon, Hasan Qazi, London,
United Kingdom, Peter J. Boström, Ivan Jambor,
Turku, Finland, Hashim U. Ahmed, London,
United Kingdom
7:10
PD17-02 COST IMPLICATIONS OF INFECTIOUS
COMPLICATIONS FOLLOWING PROSTATE
BIOPSIES IN THE UNITED STATES
Sharon White*, Eric Ballon-Landa, MD, Michael
Bronsert, Denver, CO, Boris Gershman, Boston,
MA, Peter Clark, Charlotte, NC, Granville Lloyd,
Jeffrey Morrison, Rodrigo Rodrigues-Pessoa,
Denver, CO, Marc Smaldone, Philadelphia, PA,
Anessa Sax-Bolder, Simon Kim, Denver, CO
7:20
PD17-03 COMPARATIVE ANALYSES OF MICRO-
ULTRASOUND VERSUS MRI-TARGETED
BIOPSY FOR THE DIAGNOSIS OF
CLINICALLY SIGNIFICANT PROSTATE
CANCER. PRELIMINARY RESULTS FROM
THE PROSPECTIVE US-MIRROR TRIAL
Simone Scuderi*, Armando Stabile, Gabriele
Sorce, Mario De Angelis, Luigi Nocera, Franc-
esco Pellegrino, Francesco Barletta, Milan, Italy,
Andrea Salonia, Milano, Italy, Giuseppe Cirulli,
Milan, Italy, Lucia D’Ambrosio, Milano, Italy,
Giorgio Gandaglia, Vito Cucchiara, Elio Maz-
zone, Giuseppe Rosiello, Milan, Italy, Riccardo
Leni, Donato Cannoletta, Milano, Italy, Antony
Pellegrino, Milan, Italy, Nicola Fossati, Lugano,
Switzerland, Shahrokh Shariat, Vienna, Austria,
Francesco Montorsi, Alberto Briganti, Milan, Italy
*Presenting author
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
7:30
PD17-04 PROSTATE CANCERS DETECTED AT MULTI-
PARAMETRIC MRI TARGETED VERSUS
SYSTEMATIC BIOPSIES: ARE THEY
EQUAL? RESULTS FROM A LARGE MULTI-
INSTITUTIONAL SERIES
SATURDAY
Francesco Barletta*, Milano, Italy, Elio Mazzone,
Giorgio Gandaglia, Milan, Italy, Guillaume Plous-
sard, Razvan-George Rahota, Toulouse, France,
Massimo Valerio, Lausanne, Switzerland, Riccar-
do Campi, Andrea Mari, Florence, Italy, Agostino
Mattei, Lucerne, Switzerland, Giancarlo Marra,
Turin, Italy, Jean Baptiste Beauval, Mathieu Rou-
miguiè, Toulouse, France, Luca Afferi, Lucerne,
Italy, Marco Moschini, Lucerne, Switzerland,
Paolo Gontero, Turin, Italy, Roderick van den
Bergh, Utrecht, Netherlands, Junlong Zhuang,
Hongqian Tuo, Jiangsu, China, People’s Republic
of, Armando Stabile, Milan, Italy, Nicola Fossati,
Lugano, Switzerland, Francesco De Cobelli,
Antonio Esposito, Giorgio Brembilla, Francesco
Montorsi, Alberto Briganti, Milan, Italy
7:40
PD17-05 CHARACTERISTICS AND OUTCOMES OF
PATIENTS WITH PIRADS 5 LESIONS AND
NEGATIVE BIOPSIES
Eric Li*, Mohammad Siddiqui, Jonathan Aguiar,
Brandon Ansbro, Parth Shah, Moataz Soliman,
Jordan Rich, Jasmine Lin, Johan Alfaro Carballo,
Mary Kate Keeter, Quan Mai, Edward Schaeffer,
Ashley Ross, Chicago, IL
7:50
PD17-06 ACTIVE SURVEILLANCE DISCONTINUATION
AMONG LOW-RISK PROSTATE CANCER
PATIENTS: RESULTS FROM A LARGE
NATIONAL DATABASE
Rashid Sayyid*, Augusta, GA, Laurence Klotz,
Toronto, Canada, John Benton, Martha Terris, Au-
gusta, GA, Christopher Wallis, Toronto, Canada,
Zachary Klaassen, Augusta, GA
8:00
PD17-07 PSA TESTING AND COLORECTAL CANCER
SCREENING TRENDS FROM 2012 TO 2020:
ANALYSIS OF THE CDC BEHAVIORAL RISK
FACTOR SURVEILLANCE SYSTEM (BRFSS)
Anh Nguyen*, John Fastenau, Gabriel Fernan-
dez, Courtney Berg, Amjad Alwaal, Evan Kovac,
Robert Weiss, Newark, NJ
8:10
PD17-08 RACIAL AND ETHNIC DISPARITIES
MAGNIFIED AFTER U.S. PREVENTATIVE
SERVICES TASK FORCE CATEGORY D
RECOMMENDATION FOR PSA SCREENING
Caleb Bercu*, Ram Pathak, Adam Cohen, Timo-
thy Craven, Ashok Hemal, Winston-Salem, NC
91
8:20
PD17-09 DISPARITIES REGARDING SHARED 8:50 PD17-12 EXTENDED-TARGETED-PLUS-REGIONAL
DECISION-MAKING IN PROSTATE CANCER - MRI-DIRECTED BIOPSY APPROACH
SCREENING IN PROSTATE CANCER DIAGNOSIS – A
Michael Basin*, Alina Basnet, Oleg Shapiro, SYSTEMATIC REVIEW AND META-ANALYSIS
Joseph Jacob, Gennady Bratslavsky, Hanan Marinus Hagens*, Mar Fernandez Salamanca,
Goldberg, Syracuse, NY Amsterdam, Netherlands, Anwar Padhani,
Northwood, United Kingdom, Pim van Leeuwen,
8:30
PD17-10 PROSTATE SPECIFIC ANTIGEN SCREENING
Henk van der Poel, Ivo Schoots, Amsterdam,
ON A NATIONWIDE LEVEL: FEATURING
Netherlands
THE CONTRIBUTION OF RACE AND LIFE
EXPECTANCY IN DECISION MAKING APPROVED FOR AMA PRA CATEGORY 2
Nicholas J. Corsi*, Deepansh Dalela, Austin CREDITSTM
Piontkowski, Ivan Rakic, Sami E. Majdalany,
Shravan Morisetty, Detroit, MI, Taylor Malchow,
Dayton, OH, Marcus Jamil, Detroit, MI, Akshay
Sood, Houston, TX, Sohrab Arora, Craig Rogers,
Detroit, MI, Mara Schonberg, Boston, MA, Firas
Abdollah, Detroit, MI
8:40
PD17-11 COMPARISON BETWEEN TARGET VS
TARGET PLUS STANDARD BIOPSY FOR
PROSTATE CANCER DIAGNOSIS IN
BIOPSY NAÏVE PATIENTS: A RANDOMIZED
CONTROLLED TRIAL
Enrico Checcucci, Matteo Manfredi, Sabrina De
Cillis, Daniele Amparore, Federico Piramide,
Alberto Piana, Gabriele Volpi, Michele Sica,
Paolo Verri, Stefano Granato, Stefano Piscitello,
Mariano Burgio, Ola Luciano, Beatrice Carbonaro,
Davide Zamengo, Alberto Quarà, Marcello Della
Corte, Edoardo Dibilio, Paolo Alessio, Angela
Pecoraro, Ilaria Sturia, Orbassano (Turin), Italy,
Giuseppe Migliaretti, Turin, Italy, Cristian Fiori,
Stefano De Luca, Francesco Porpiglia*,
Orbassano (Turin), Italy

Saturday, May 14, 2022 7:00 am – 9:00 am

Podium Session 18
KIDNEY CANCER: EPIDEMIOLOGY & EVALUATION/STAGING/SURVEILLANCE II
Room 255 @ Ernest N. Morial Convention Center
Moderators: J. Stuart Wolf, Deborah Kaye & M. Pilar Laguna

ABSTRACT
TIME NUMBER TITLE
7:00
PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN
PATIENTS RECEIVING TKI THERAPY
VERSUS IMMUNE CHECKPOINT INHIBITOR
THERAPY: ANALYSIS OF THE REMARCC
REGISTRY
Margaret Meagher*, San Diego, CA, Andrea
Minervini, Florence, Italy, Maria Mir, Giacomo
Rebez, Valencia, Spain, Riccardo Autorino,
Richmond, VA, Riccardo Campi, Florence, Italy,
Maximilian Kriegmair, Mannheim, Germany, Es-
tefania Linares, Vital Hevia, Madrid, Spain, Mireia
Musquera, Mauricio D’Anna, Barcelona, Spain,
Eduard Rousel, Maarten Albersen, Leuven,
Belgium, Nicola Pavan, Francesco Claps, Trieste,
Italy, Alessandro Antonelli, Verona, Italy, Michele
Marchioni, Chieti, Italy, Selcuk Erdem, Istanbul,
Turkey, Ithaar Derweesh, San Diego, CA
ABSTRACT
TIME NUMBER TITLE
7:10
PD18-02 EXTERNAL VALIDATION OF THE ASSURE
MODEL TO PREDICT ONCOLOGICAL
OUTCOMES AFTER RESECTION OF HIGH-
RISK RENAL CELL CARCINOMAS
Zine-Eddine Khene*, Rennes, France, Alessandro
Larcher, Milan, Italy, Jean-Christophe Bernhard,
Bordeaux, France, Nicolas Doumerc, Toulouse,
France, Romain Boissier, Marseille, France,
Idir Ouzaid, Paris, France, Philippe Barthelemy,
Strasbourg, France, Morgan Roupret, Paris,
France, Francesco Montorsi, Milan, Italy, Pierre
Bigot, Angers, France, Karim Bensalah, Rennes,
France

92
7:20
PD18-03 PROPOSAL FOR RECLASSIFICATION OF
T1 AND T2A RENAL CELL CARCINOMA:
RESULTS OF A MULTI-INSTITUTIONAL
ANALYSIS
Margaret Meagher*, Ava Saidian, San Diego, CA,
Riccardo Autorino, Richmond, VA, Brian Lane,
Grand Rapids, MI, Yasuhisa Fujii, Tokyo, Japan,
Michele Marchioni, Chieti, Italy, Hajime Tanaka,
Tokyo, Japan, Dattatraya Patil, Atlanta, GA,
Francesco Porpiglia, Turin, Italy, Sabrina Noyes,
Grand Rapids, MI, Ryan Nasseri, San Diego,
CA, Chandru Sundaram, Indianapolis, IN, James
Porter, Seattle, WA, Andrea Minervini, Florence,
Italy, Umberto Capitanio, Francesco Montorsi,
Milan, Italy, Viraj Master, Atlanta, Georgia, Ithaar
Derweesh, San Diego, CA
7:30
PD18-04 HAZARD OF DEATH IN VON HIPPEL-
LINDAU DISEASE PATIENTS DEPENDS ON
GENOTYPE AND ONSET AGE AS WELL AS
FIRST AFFECTED LESION
Kaifang Ma*, Lin Cai, Kan Ging, Beijing, China,
People’s Republic of
7:40
PD18-05 CLINICAL CHARACTERISTICS AND RISK
FACTORS FOR SURVIVAL IN AFFECTED
OFFSPRING OF VON HIPPEL-LINDAU
DISEASE PATIENTS
kenan Zhang*, Cai Lin, wuping Yang, Kan Gong,
Yawei Xu, Beijing, China, People’s Republic of Schmidt, Beth Ryan, W. Marston Linehan, Mark
7:50
PD18-06 NEPHROMETRY SCORES PREDICTING
VALUE OF TRIFECTA ACHIEVEMENT IN
A MULTICENTER ANALYSIS (ROSULA
DATABASE) OF ROBOTIC PARTIAL
NEPHRECTOMY FOR TOTALLY ENDOPHYTIC
DEEP RENAL MASSES
Gabriele Tuderti*, Riccardo Mastroianni, Umberto
Anceschi, Alfredo Maria Bove, Aldo Brassetti,
Mariaconsiglia Ferriero, Leonardo Misuraca,
Salvatore Guaglianone, Rome, Italy, Riccardo
Autorino, Richmond, VA, Jihad Kaouk, Cleveland,
OH, Clayton Lau, Duarte, CA, Francesco Por-
piglia, Turin, Italy, Ithaar Derweesh, Ava Saidian,
Mimi Nguyen, San Diego, La Jolla, CA, Alexandre
Mottrie, Aalst, Belgium, Andrea Mari, Florence,
Italy, Manuela Costantini, Roma, Italy, Andrea
Minervini, Florence, Italy, Michele Gallucci,
Giuseppe Simone, Roma, Italy CREDITSTM
8:00
PD18-07 PERFORMANCE OF GFR CALCULATORS:
CKD-EPI 2021, CKD-EPI 2009, AND MDRD IN
ESTIMATION OF KIDNEY FUNCTION PRIOR
TO NEPHRECTOMY
Maria Antony*, Aditi Chaurasia, Nikhil Gopal,
Pouria Yazdian, Zach Kozel, Sandeep Gurram,
Marston Linehan, Mark Ball, Bethesda, MD
*Presenting author
8:10
PD18-08 PROGNOSTIC VALUE OF NEUTROPHIL-TO-
LYMPHOCYTE RATIO AND PLATELET-TO-
LYMPHOCYTE RATIO FOR SMALL RENAL
CELL CARCINOMAS AFTER IMAGE-GUIDED
CRYOABLATION (CRYO) OR RADIO-
FREQUENCY ABLATION (RFA)
Aqua Asif*, Leicester, United Kingdom, Filzah
Hanis Osman, Jasmine Sze-Ern Koe, Leeds,
United Kingdom, Alexander Ng, London, United
Kingdom, Jon Cartledge, Michael Kimuli, Naveen
Vasudev, Christy Ralph, Satinder Jagdev, Selina
Bhattarai, Jonathan Smith, James Lenton, Vinson
Wai-Shun Chan, Tze Min Wah, Leeds, United
Kingdom
SATURDAY
8:20
PD18-09 A NOVEL PROGNOSTIC BIOMARKER TO
PREDICT TUMOR MUTATION BURDEN
BASED ON DEEP LEARNING FROM
SLIDE IMAGES
Jian Lu*, Ji De He, Ye Yan, Zhen Yu Liu, Xue Hua
Zhu, Jie Tian, Ze Nan Liu, Jian Gang Liu, Xiang
Yu Liu, Beijing, China, People’s Republic of
8:30
PD18-10 GERMLINE TESTING IN RENAL CELL
CARCINOMA: CAN ENRICHMENT FEATURES
HELP PREDICT GERMLINE ALTERATIONS?
Alexis Rompre-Brodeur*, Nikhil Gopal, Jeunice
Owens-Walton, Bradley Webster, Michael Dane-
shvar, Christopher Ricketts, Cathy Vocke, Laura
W. Ball, Bethesda, MD
8:40
PD18-11 FIRST IN-HUMAN RESULTS OF 68GA-EMP-100
PET FOR IMAGING C-MET EXPRESSION IN
RENAL CELL CARCINOMA
Michael Staehler*, Melanie Schott, Alexander
Tamalunas, Chistian Stief, Annabel Graser,
Severin Rodler, Lena Unterrainer,
Peter Bartenstein, Munich, Germany
8:50
PD18-12 INVESTIGATION OF RACE AND ASSOCIATED
SOCIOECONOMIC FACTORS IN SURVIVAL
OUTCOMES FOR PATIENTS WITH RENAL
CELL CARCINOMA
Ridwan Alam*, Mary Rostom, Sunil Patel,
Baltimore, MD, Solomon Woldu, Dallas, TX,
Yasser Ged, Nirmish Singla, Baltimore, MD
APPROVED FOR AMA PRA CATEGORY 2
93
Saturday, May 14, 2022
Podium Session 19
STONE DISEASE: SURGICAL THERAPY (INCLUDING ESWL) II
Room 245 @ Ernest N. Morial Convention Center
Moderators: Pablo Contreras & Jorge Gutierrez Aceves
ABSTRACT
TIME NUMBER TITLE
7:00
PD19-01 RANDOMIZED CONTROLLED TRIAL (RCT)
COMPARING HOLMIUM LASER WITH MOSES
TECHNOLOGY AND SUPERPULSED LASER
SYSTEM WITH THULIUM LASER FOR RENAL
AND URETERAL STONES: PRELIMINARY
SINGLE CENTER RESULTS
Christopher Haas*, Margaret Knoedler, Shuang
Li, Kristina L. Penniston, Sara Best, Stephen Y.
Nakada, Madison, WI
7:10
PD19-02 COMPARISON OF SUPERPULSE THULIUM
FIBER LASER VS. HOLMIUM LASER FOR
ABLATION OF RENAL CALCULI IN AN IN
VIVO PORCINE MODEL
Andrew Afyouni*, Zhamshid Okhunov, Pengbo
Jiang, Sohrab Ali, Hosseini Sharifi, Linda Huynh,
Nina Kar, Douglas Schneider, Maged Ayad, Krista
Larson, Roshan Patel, Jaime Landman, Ralph
Clayman, Orange, CA CA, Naren Nimmagadda, Nicholas Kavoussi,
7:20
PD19-03 ASSESSMENT OF FACTORS INVOLVED IN
LASER FIBER DEGRADATION WITH THULIUM
FIBER LASER
Thibault Germain, Laurent Berthe, Frédéric Pan-
thier, Cyril Gorny, Olivier Traxer, Steeve Doizi*,
Paris, France
7:30
PD19-04 NOBODY LIKES BURNT POPCORN: THE
MOST EFFICIENT POPCORNING SETTINGS
IN A NOVEL 3D-KIDNEY MODEL THAT LIMITS
THERMAL INJURY
Christian Tabib*, Zachary Dionise, Sabrina
Tran, Francois Soto-Palou, Pei Zhong, Glenn
Preminger, Michael Lipkin, Durham, NC
7:40
PD19-05 BASKETING VERSUS DUSTING
LITHOTRIPSY FOR KIDNEY STONES DURING
FLEXIBLE URETEROSCOPY: RANDOMIZED
CONTROLLED TRIAL AND COMPUTERIZED
TOMOGRAPHY FOLLOW UP
Alex Meller*, Rafael Astolfi, Gustavo Freschi,
Raphael Carrera, Marcus Sadi, São Paulo, Brazil
7:50
PD19-06 URETERAL STENT DECOMPRESSION IS
ASSOCIATED WITH DECREASED LENGTH
OF STAY IN OBSTRUCTIVE, INFECTED
URETERAL STONES: A MULTICENTER,
RETROSPECTIVE CASE CONTROL STUDY
Albert S Ha*, Gregory W Hruby, David S Han,
Rainjade Chung, Jeffrey Johnson, Isaac H
Michaels, Aaron Brant, Christina Sze, Annanias
Motta Burgos, Spyridon Basourakos, Patrick
Lewicki, Timothy McClure, Ojas Shah,
New York, NY
94
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
8:00
PD19-07 ARE PATIENTS STENTED FOR SEPTIC
URETERAL STONES MORE LIKELY TO
EXPERIENCE INFECTIOUS COMPLICATIONS
AT TIME OF DEFINITIVE MANAGEMENT
THAN THOSE STENTED FOR NON-
INFECTIOUS INDICATIONS?
Ginnie Jeng*, Hempstead, NY, Simon J Hall, New
Hyde Park, NY
8:10
PD19-08 SYSTEMIC INFLAMMATORY RESPONSE
SYNDROME AND QUICK SEQUENTIAL
ORGAN FAILURE ASSESSMENT SCORE FOR
PREDICTION OF SEPTIC SHOCK AFTER
PERCUTANEOUS NEPHROLITHOTOMY:
A SUB-ANALYSIS OF A MULTI-CENTER
PROSPECTIVE TRIAL FROM THE EDGE
CONSORTIUM
Jillian J. Gerrity*, Jonathan H. Berger, San Diego,
Nashville, TN, Tony T. Chen, San Diego, CA, Amy
E. Krambeck, Chicago, IL, Tim Large, Indianap-
olis, IN, Seth K. Bechis, San Diego, CA, David F.
Friedlander, Chapel Hill, NC, Manoj Monga, San
Diego, CA, Ryan S. Hsi, Nicole L. Miller, Nash-
ville, TN, Ben H. Chew, Dirk Lange, Vancouver,
Canada, Bodo Knudsen, Michael W. Sourial,
Columbus, OH, Mitchell R. Humphreys, Karen L.
Stern, Scottsdale, AZ, Ojas Shah, New York, NY,
Joel E. Abbott, Garen Abedi, Roger L. Sur, San
Diego, CA
8:20
PD19-09 SEEING IS BELIEVING: OPTIMIZING
RENAL PELVIC PRESSURE IMPROVES
VISUALIZATION DURING ENDOSCOPIC
COMBINED INTRARENAL SURGERY
Cayde Ritchie*, John Hartman, Akin Amasyali,
John Jung, Aviram Assidon, Joshua Belle, D.
Duane Baldwin, Loma Linda, CA
8:30
PD19-10 DOES POWER MATTER? A COMPARISON
OF HOLMIUM LASERS IN AN AUSTRALIAN
TERTIARY CENTRE
Romy Mondschein*, Prahran, Australia,
Philip McCahy, Clayton, Australia
8:40
PD19-11 NARCOTIC FREE URETEROSCOPIC
LASER LITHOTRIPSY: A PROSPECTIVE
RANDOMIZED STUDY
Jacob Bamberger*, Brooklyn, NY, Blair Gallante,
Anna Zampini, William M Atallah, Johnathan A
Khusid, Areeba S Sadiq, Alan Yaghoubian, Mantu
Gupta, New York, NY
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
Saturday, May 14, 2022
Podium Session 20
INFERTILITY: EPIDEMIOLOGY & EVALUATION II
Room 244 @ Ernest N. Morial Convention Center
Moderators: Akanksha Mehta & Sidney Glina
ABSTRACT
TIME NUMBER TITLE
7:00
PD20-01 AGE AT PRESENTATION OF INFERTILE
MEN HAS STABLY INCREASED OVER THE
LAST TWO DECADES: ANALYSIS FROM A
LONGITUDINAL STUDY
Luca Boeri*, Milan, Italy, Paolo Capogrosso,
Varese, Italy, Giuseppe Fallara, Federico
Belladelli, Edoardo Pozzi, Massimiliano Raffo,
Christian Corsini, Luigi Candela, Antonio Costa,
Daniele Cignoli, Nicolò Schifano, Alessia d’Arma,
Eugenio Ventimiglia, Luca Pagliardini,
Enrico Papaleo, Milan, Italy, Vincenzo Mirone,
Naples, Italy, Francesco Montorsi,
Andrea Salonia, Milan, Italy
7:10
PD20-02 SEMEN QUALITY IMPROVEMENT BY PRE-
CONCEPTION CARE FOR MALE PARTNERS
OF INFERTILITY COUPLES
Akira Komiya*, Mayuko Kato, Tomokazu Sazuka,
Yusuke Imamura, Shinichi Sakamoto, Tomohiko
Ichikawa, Makiko Tajima, Yuko Takayanagi, Yurie
Nako, Kenichiro Hiraoka, Nozomi Uchida, Saki
Ichikawa, Kiyotaka Kawai, Chiba-shi, Japan
7:20
PD20-03 ALDH2 EXPRESSION, ALCOHOL INTAKE,
AND SEMEN PARAMETERS AMONG EAST
ASIAN MEN
Daniel R. Greenberg*, Chicago, IL, Hriday P.
Bhambhvani, Satvir S. Basran, Brett P. Salazar,
Sin-Jin Li, Che-Hong Chen, Daria Mochly-Rosen,
Michael L. Eisenberg, Stanford, CA Reddy, Kajal Khodamoradi, Miami, FL, Jesse Ory,
7:30
PD20-04 DOES AIR POLLUTION IMPACT ON SEMEN
PARAMETERS: FINDINGS FROM A REAL-
LIFE CROSS-SECTIONAL STUDY IN WHITE-
EUROPEAN INFERTILE MEN
Federico Belladelli*, Giuseppe Fallara, Edoardo
Pozzi, Massimiliano Raffo, Christian Corsini, Luigi
Candela, Antonio Costa, Daniele Cignoli, Nicolò
Schifano, Alessia d’Arma, Milan, Italy, Paolo Cap-
ogrosso, Varese, Italy, Luca Boeri, Eugenio Ven-
timiglia, Rayan Matloob, Luca Pagliardini, Enrico
Papaleo, Milan, Italy, Vincenzo Mirone, Naples,
Italy, Francesco Montorsi, Andrea Salonia, Milan,
Italy
7:40
PD20-05 HIGH PREVALENCE OF HORMONAL
ABNORMALITIES IN MEN WITHOUT
OLIGOSPERMIA
Matthew Hudnall*, Bailey Goyette, Minh Pham,
Jeremy Lai, Justin Dubin, Chicago, IL, Richard
Fantus, Evanston, IL, James Wren,
Nelson Bennett, Robert Brannigan, Joshua
Halpern, Chicago, IL
*Presenting author
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
7:50
PD20-06 CHALLENGING THE EAU GUIDELINES ON
SPERM DNA FRAGMENTATION TESTING IN
PRIMARY INFERTILE MEN
Edoardo Pozzi*, Giuseppe Fallara, Federico
Belladelli, Christian Corsini, Massimiliano Raffo,
SATURDAY
Luigi Candela, Antonio Costa, Daniele Cignoli,
Nicolò Schifano, Alessia d’Arma, Milan, Italy,
Paolo Capogrosso, Varese, Italy, Luca Boeri,
Luca Pagliardini, Eugenio Ventimiglia, Rayan
Matloob, Francesco Montorsi, Andrea Salonia,
Milan, Italy
8:00
PD20-07 ELEVATED ROS LEVELS AND DNA
FRAGMENTATION IN SPERM FROM
CONVALESCENT MEN IN SARS-COV-2
INFECTION
Jorge Hallak*, Felipe Bernardes, Thiago Afonso
Carvalho Celestino Teixeira, Paulo Hilario
Nascimento Saldiva, Esper Georges Kallas, Elia
Tamaso Espin Garcia Caldini, Amaro Nunes
Duarte Neto, Heloisa Faquineti, Vinicius Luiz
Menezes Jesus, São Paulo, Brazil, Raul Segundo
Sanchez Gutierrez, Temuco, Chile, Joel R Drevet,
Clermont-Ferrand, France
8:10
PD20-08 CONCERNS ABOUT FERTILITY: A MAJOR
CAUSE OF COVID-19 VACCINE HESITANCY
IN THE UNITED STATES
Parris Diaz*, John Zizzo, Navin C. Balaji, Rohit
Halifax, Canada, Ranjith Ramasamy, Miami, FL
8:20
PD20-09 VARICOCELE IS UNDERDIAGNOSED
IN MEN EVALUATED FOR INFERTILITY:
EXAMINATION OF MULTI-CENTER LARGE
SCALE ELECTRONIC HEALTH RECORD DATA
Chase Carto, Vinayak Madhusoodanan*, Sirpi
Nackeeran, Ranjith Ramasamy, Miami, FL
8:30
PD20-10 MICROSURGICAL VARICOCELECTOMY
IS ASSOCIATED WITH IMPROVEMENT
IN CAP-SCORETM AND PROBABILITY OF
GENERATING A PREGNANCY IN INFERTILE
MEN
Jessica Marinaro*, Aaron Brant, Christopher Gaffney,
Philip Xie, Nahid Punjani, Caroline Kang, Gianpiero
Palermo, James Kashanian, New York, NY
8:40
PD20-11 WOMEN IN MEDICINE: CAREER VS FAMILY.
CAN WE HAVE BOTH?
Niki Parikh*, Manaf Alom, Mohamed Ahmed,
Maraika Robinson, Sarah McGriff, Elizabeth Ol-
ive, Tobias Kohler, Matthew Ziegelmann, Sevann
Helo, Rochester, MN
8:50
PD20-12 VASECTOMY REVERSAL SEARCH TRENDS
AND ADVERTISING IN THE UNITED STATES
Vivian Hua*, Lin Chen, Scott Lundy, Sarah Vij,
Cleveland, OH
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
95
Saturday, May 14, 2022 7:00 am – 9:00 am

Podium Session 21
INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: KIDNEY & BLADDER II
Room 243 @ Ernest N. Morial Convention Center
Moderators: Anne Suskind & J. Todd Purves

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
7:00
PD21-01 PATHOLOGICAL CHANGES IN THE KIDNEYS 8:20
PD21-09 IDENTIFICATION OF KEY MOLECULAR
IN PATIENTS WITH ACUTE RENAL INJURY PLAYERS IN THE DEVELOPMENT OF
DUE TO CORONAVIRUS INFECTION RADIATION CYSTITIS THROUGH RNA
Valentin Pavlov*, Dmitry Vishnyakov, Anushavan SEQUENCING
Papoyan, Aleksandr Alekseev, Ildar Kabirov, Ufa, Elijah Ward*, Alexander Carabulea,
Russian Federation Sarah Bartolone, Laura Lamb, Michael Chancellor,
Bernadette Zwaans, Royal Oak, MI
7:10
PD21-02 NOVEL MECHANISMS OF INJURY IN
MEMBRANOUS NEPHROPATHY 8:30
PD21-10 HETEROGENEITY IN THE MANAGEMENT
Qi Zhang, Los Angeles, CA, Paolo Cravedi, New OF RADIATION-INDUCED HEMORRHAGIC
York, NY, Astgik Petrosyan, Valentina Villani, CYSTITIS
Roger De Filippo, Laura Perin, Stefano Da Brendan K. Wallace*, Anton M. Gillespie, George
Sacco*, Los Angeles, CA W. Moran, Michael B. Smigelski, Christopher B.
Anderson, New York, NY
7:20
PD21-03 A NOVEL PHOTO-CROSSLINKABLE KIDNEY
ECM-DERIVED BIOINK FOR RENAL TISSUE 8:40
PD21-11 WITHIN STATE VARIABILITY OF
REGENERATION ANTIMICROBIAL SUSCEPTIBILITY:
Sang Jin Lee, Gabriel Carreno Galeano, MISSOURI AS AN ARCHETYPE TO ASSESS
Mohamed Ali, John Jackson*, James Yoo, GUIDELINES FOR ANTIMICROBIAL
Anthony Atala, Winston Salem, NC PROPHYLAXIS FOR TRANSURETHRAL
PROCEDURES
7:30
PD21-04 UNDERUTILIZATION OF THE BOSNIAK
Corbin Wright, Geoffrey Rosen*,
CLASSIFICATION SYSTEM FOR
Shubham Kanake, Mojgan Golzy, Katie Murray,
DESCRIPTION OF RENAL CYSTS
Columbia, MO
Caleb S Miller*, Austin Martin, Danica N May,
Jill Jones, David A Duchene, Kansas City, KS 8:50
PD21-12 MICROBIOTA AND METABOLITES ARE
CONSISTENTLY PRESENT ON IMPLANTED
7:40
PD21-05 EVALUATION OF EARLY SCORING
UROLOGICAL DEVICES AND DIFFER
PREDICTORS FOR EXPEDITED CARE IN A
SIGNIFICANTLY BASED ON INFECTION
LARGE PROSPECTIVE PATIENTS’ COHORT
STATUS AND DEVICE TYPE
WITH EMPHYSEMATOUS PYELONEPHRITIS
Glenn T. Werneburg*, Ava Adler,
Arun Chawla, Sunil Pillai, Ravi Taori,
Sandip Vasavada, Howard Goldman,
Arun Chawla*, Manipal, India
Raymond Rackley, Daniel Hettel, Bradley Gill,
7:50
PD21-06 INFLAMMATORY MYOFIBROBLASTIC Kenneth Angermeier, Hadley Wood, Petar Bajic,
TUMOR OF THE GENITOURINARY TRACT: A Smita De, Daniel Shoskes, Jacqueline Zillioux,
SYSTEMATIC REVIEW Aaron Miller, Cleveland, OH
Nikolas Moring*, Daniel Swerdloff, Mahmut Akgul,
APPROVED FOR AMA PRA CATEGORY 2
Tipu Nazeer, Badar Mian, Albany, NY
CREDITSTM
8:00
PD21-07 OBESITY INFLUENCE ON BLADDER
INFLAMMATION: A CYSTITIS MODEL
Cristiano T. de Andrade, Marina Z. C. dos Santos,
Guilherme Z. Rocha, Karen L. Ferrari, Campinas,
Brazil, Rodolfo B. dos Reis, Ribeirão Preto, Brazil,
Leonardo Reis*, Campinas, Brazil
8:10
PD21-08 THE INCIDENCE OF NEW OR WORSENING
OAB SYMPTOMS IN PATIENTS WITH PRIOR
SARS COV-2 INFECTION
Ly Hoang Roberts*, Bernadette Zwaan, Michael
Chancellor, Kenneth Peters, Priya Padmanabhan,
Royal Oak, MI

96
Saturday, May 14, 2022 7:00 am – 9:00 am

Video Session 4
LOWER TRACT RECONSTRUCTION
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Justin Han, Cooper Benson & Tamsin Greenwell

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
7:00
V04-01 TRANSANAL APPROACH TO ROBOTIC 8:10
V04-08 ROBOT-ASSISTED REPAIR OF BENIGN
REPAIR OF A RECTOURETHRAL FISTULA DISTAL URETEROENTERIC STRICTURES
Jennifer Rosen*, J. Patrick Selph, Daniel Chu, FOLLOWING RADICAL CYSTECTOMY
Birmingham, AL Victoria Maxon*, Honolulu, HI, Alvin Goh,
New York, NY
7:10
V04-02 SIMULTANEOUS REPAIR OF RECTOVESICAL

SATURDAY
FISTULA WITH BLADDER NECK 8:20
V04-09 UNDOUBLED BLADDER IN THE SAGITTAL
CONTRACTURE AFTER RADICAL PLANE WITH ONE EXSTROPHIC BLADDER:
PROSTATECTOMY. A NOVEL ROBOTIC A CASE REPORT ON RECONSTRUCTIVE
TECHNIQUE TECHNIQUE
Aref S. Sayegh*, Laura C. Perez, Anibal La Riva, Wietse Claeys*, Caroline Jamaer,
David G. Ortega, Luis G. Medina, Edward For- Camille Berquin, Irina Verbakel,
syth, Ryan Powers, Christine Hsieh, Rene Sotelo, Achilles Ploumidis, Erik Van Laecke,
Los Angeles, CA Piet Hoebeke, Anne-Françoise Spinoit,
Ghent, Belgium
7:20
V04-03 PATIO REPAIR FOR URETHROCUTANEOUS
FISTULA 8:30
V04-10 GENDER-AFFIRMING PHALLOPLASTY WITH
Sabrina Stair*, Kirtishri Mishra, Christopher ANTEROLATERAL THIGH FLAP
Agocs, Lee Zhao, New York, NY Ömer Acar*, Alexi Millman, Luca Morgantini,
Loren Schechter, Ervin Kocjancic, Chicago, IL
7:30
V04-04 NEW SURGICAL TECHNIQUE: A SINGLE
LONG SPIRAL PREPUTIAL GRAFT FOR 8:40
V04-11 COMBINATION OF ROBOTIC-ASSISTED
PANURETHRAL STRICTURE LAPAROSCOPIC PEDICLED PERITONEAL
Pankaj Joshi*, Marco Bandini, Shreyas Bhad- FLAP VAGINOPLASTY WITH PENILE
ranawar, Vipin Sharma, Sandeep Bafna, Sanjay SKIN INVERSION TECHNIQUE IN MALE-
Kulkarni, Pune, India TO-FEMALE TRANSGENDER SURGERY.
INSTRUCTIVE VIDEO-ARTICLE
7:40 V04-05 POST TURP OBLITERATIVE STRICTURES
Eusebio Luna*, Sidhbh Gallagher, Edward
Pankaj Joshi*, Vipin Sharma, Sandeep Bafna,
Gheiler, Ariel Kaufman, Luanda Perez, Dailianys
Shreyas Bhadranawar, Marco Bandini, Sanjay
Barrios, Melanie Milanes, Fernando Bianco,
Kulkarni, Pune, India
Miami, FL
7:50
V04-06 TRANSPERINEAL BULBOVESICAL
8:50
V04-12 A SINGLE STAGE URETHROPLASTY
ANASTOMOSIS AND STAGED ARTIFICIAL
FOR PRIMARY PENOSCROTAL ADULT
URINARY SPHINCTER IMPLANTATION
HYPOSPADIAS
FOR EXTENSIVE POSTERIOR URETHRAL
Pankaj Joshi*, Vipin Sharma, Sandeep Bafna,
STENOSES
Shreyas Bhadranawar, Marco Bandini,
Akio Horiguchi*, Masayuki Shinchi, Kenichiro
Sanjay Kulkarni, Pune, India
Ojima, Yusuke Hirano, Ryuichi Azuma,
Keiichi Ito, Saitama, Japan APPROVED FOR AMA PRA CATEGORY 2
CREDITTM
8:00
V04-07 SURGICAL EXCISION OF NEAR-CIRCULAR
FEMALE URETHRAL DIVERTICULUM AND
CIRCULAR URETHRAL WRAP WITH
MARTIUS FLAP
Anna V. van Lingen*, J.L.H. Ruud Bosch,
Ronald I. Nooter, Rotterdam, Netherlands

*Presenting author 97
Saturday, May 14, 2022 7:30 am – 5:15 pm

Forums
UROLOGIC CARE FOR THE ADVANCED PRACTICE PROVIDER
Room 271 @ Ernest N. Morial Convention Center
8:00 WELCOME/INTRODUCTION 11:55
PODIUM PRESENTATION: A DEHISCED PERINE-
Co-Course Directors: Anne Lizardi-Calvaresi, AL URETEROSTOMY WALKS INTO THE UROLOGY
James Kovarik CLINIC: TIPS FOR OPTIMIZING COMPLEX-GENI-
TOURINARY WOUND HEALING
8:10 PRE-TEST #1
Speaker: Erika Orban
Co-Course Directors: Anne Lizardi-Calvaresi,
James Kovarik 12:10 POST-TEST #1
Co-Course Directors: Anne Lizardi-Calvaresi,
8:15 TESTICULAR CANCER UPDATE FOR APPS
James Kovarik
Co-Course Director: Anne Lizardi-Calvaresi
1:35 AUAUNIVERSITY UPDATE
8:55
PODIUM PRESENTATION: AN ADVANCED
Co-Course Director: James Kovarik
PRACTICE PROVIDER CAN DECREASE HOSPITAL
LENGTH OF STAY FOR PATIENTS UNDERGOING 1:45 PRE-TEST #2
UROLOGIC ONCOLOGY SURGERY Co-Course Directors: Anne Lizardi-Calvaresi,
Speaker: Michael Humphrey James Kovarik
9:10
UNDERSTANDING BIOMARKERS FOR PROSTATE 1:50 BPH GUIDELINE UPDATE FOR APPS
CANCER Co-Course Director: James Kovarik
Faculty: Rachel Hastings
2:30
EJACULATORY DYSFUNCTION GUIDELINE
10:05
PODIUM PRESENTATION: ADVANCED PRACTICE (2021) UPDATE
PROVIDER-LED TRANSPERINEAL PROSTATE Faculty: Alan Shindel
BIOPSY CLINIC: INITIAL EXPERIENCE AND
3:25
GETTING AHEAD OF THE CURVE—DIAGNOSIS
OUTCOMES
AND TREATMENT FOR PEYRONIE’S DISEASE
Speaker: Alex O’Hara
Faculty: Lynn Allmond
10:20 OVERACTIVE BLADDER FUNDAMENTALS
4:05
PODIUM PRESENTATION: SETTING THE MOOD:
Faculty: Susan Flick
IMPROVING SATISFACTION FOR MALE PATIENTS
11:00
INTERSTITIAL CYSTITIS: UPDATES IN MEDICAL DURING PENILE ASSESSMENT
MANAGEMENT Speaker: Elise Tentis
Faculty: Christina Hicks
4:20
PODIUM PRESENTATION: PENILE AMPUTATION—
11:40
PODIUM PRESENTATION: PREVENTION OF LOW- BEGINNING TO END—AN INFORMATIVE CASE
ER URINARY TRACT SYMPTOMS (PLUS): ROLE STUDY WITH MULTIDISCIPLINARY CARE
OF AN APP IN NIH-FUNDED RESEARCH Speaker: Hillary Durstein
Speaker: Diane Newman
4:35 PODIUM PRESENTATION: PENILE CALAPHYLAXIS
Speaker: Maria Pinnock
4:50 POST-TEST #2
Co-Course Directors: Anne Lizardi-Calvaresi,
James Kovarik

Saturday, May 14, 2022 7:55 am – 6:00 pm

SOCIETIES FOR PEDIATRIC UROLOGY (SPU)
Grand Ballroom CD @ Hilton New Orleans Riverside
7:55 WELCOME 8:45
LANDMARK PAPERS IN PEDIATRIC UROLOGY:
Chairs: Gina Lockwood, Rosalia Misseri REFLECTIONS FROM THE AUTHORS
Society President: C.D. Anthony Herndon Moderator: John Thomas
8:00 NEUROGENIC BLADDER…BEYOND SPINA BIFIDA MODIFIED TUBULARIZED TRANSVERSE PREPU-
Moderator: Travis Groth TIAL ISLAND FLAP REPAIR FOR SEVERE PROXI-
MAL HYPOSPADIAS
CEREBRAL PALSY
Doug Canning
Sean Elliott
THE VALVE BLADDER SYNDROME: PATHOPHYS-
TRANSVERSE MYELITIS
IOLOGY AND TREATMENT WITH NOCTURNAL
Micah Jacobs
BLADDER EMPTYING
SPINAL CORD INJURY Stephen Koff
Jennifer Hagerty
TRANS-APPENDICULAR CONTINENT CYSTOSTO-
DISCUSSION MY IN THE MANAGEMENT OF THE NEUROGENIC
BLADDER INTERVIEW WITH PAUL MITROFANOF
Matthieu Peycelon
DISCUSSION

98
9:30 PEDIATRIC ONCOLOGY WORKING GROUP
Moderator: Nicholas Cost
INTRODUCTION AND BROAD OVERVIEW OF COG
RENAL TUMOR COMMITTEE
Nicholas Cost
DISCUSSION OF CURRENT STANDARDS OF
CARE FOR UNILATERAL WILMS
Rodrigo Romao
DISCUSSION OF CURRENT STANDARDS OF
CARE FOR BILATERAL WILMS/UNILATERALLY
PREDISPOSED
Kathleen Kieran
REFLUXING URETEROVESICOSTOMY
Armando Lorenzo
ENDOSCOPIC APPROACHES
Diana Bowen
LAPAROSCOPIC AND ROBOTIC APPROACHES
Renea Sturm
DISCUSSION
2:40 BREAK—VISIT EXHIBITS
3:00
WHAT IS YOUR NEXT STEP? POINT/COUNTER-
POINT WITH AUDIENCE PARTICIPATION
Moderator: Vijaya Vemulakonda

SATURDAY
SPECIFIC DISCUSSION ABOUT ROLE OF BIOPSY BLADDER NECK RECONSTRUCTION
AND HOW THAT IMPACTS TREATMENT OF WILMS Dominic Frimberger, Brian VanderBrink
Amanda Saltzman
HIGH INTRA-ABDOMINAL TESTICLE
DISCUSSION Seth Alpert, Casey Seideman
10:15 BREAK—VISIT EXHIBITS TECHNIQUES FOR UTI PREVENTION IN NGB
Douglas Storm, Stacy Tanaka
10:45 PRESENTATION OF SPU RESEARCH GRANT
Linda Baker DISCUSSION
10:55
WHEN SHOULD THE BALL DROP? 3:50
EVOLUTION OF ROBOTIC SURGERY IN PEDIAT-
CONSEQUENCES OF CRYPTORCHIDISM RIC UROLOGY: WHERE ARE WE NOW?
Moderator: Dana Giel Moderator: Miguel Castellan
TUMOR UPPER TRACT
Clint Cary Benjamin Whittam
TIMING LOWER TRACT
Christopher Bayne Aseem Shukla
FERTILITY EVOLUTION
Richard Yu Kate Kraft
DISCUSSION DISCUSSION
11:35 SPU PRESIDENTIAL ADDRESS: UPDATE ON SPU 4:25
NON-HYPOSPADIAS PENILE ANOMALIES: THE
Society President: C.D. Anthony Herndon BENT, OBSCURE, AND TWISTED
Moderator: Hillary Copp
12:00 LUNCH ON OWN
PENILE CURVATURE
1:15 MEREDITH CAMPBELL LECTURE
Nicolas Fernandez
Moderator: C.D. Anthony Herndon
BURIED PENIS AND PENILE TORSION
PEER REVIEW, OPEN ACCESS, PREDATORY
Anne-Françoise Spinoit
JOURNALISM AND THE FUTURE OF SCIENTIFIC
COMMUNICATION DISCUSSION
Keynote Speaker: Anthony Caldamone
5:00 SPU RECEPTION
2:15 CONTROVERSIES IN THE SURGICAL MANAGE-
APPROVED FOR AMA PRA CATEGORY 1 CREDITTM
MENT OF THE INFANT NON-REFLUXING
MEGAURETER
Moderator: Armando Lorenzo

*Presenting author 99
Saturday, May 14, 2022 8:00 am – 11:50 am
SOCIETY FOR BASIC UROLOGIC RESEARCH/SOCIETY OF UROLOGIC ONCOLOGY (SBUR/SUO)
LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention Center
Chairs: Daniel Lin & William Ricke
8:00 WELCOME AND INTRODUCTORY REMARKS 10:05 THE AGING BLADDER, MITOCHONDRIAL DYS-
Chairs: Daniel Lin, William Ricke FUNCTION, AND CANCER
Cathy Mendelsohn
8:05 DON COFFEY LECTURESHIP: AGING HALL-
MARKS IN NORMAL AGING AND DISEASE PRO- 10:35 BREAK
GRESSION—THE SCIENCE AND THE TRAINING
10:45 MECHANISM OF CASTRATION RESISTANCE IN
Keynote Speaker: Judy Campisi
CANCER PROGRESSION
9:05 SENESCENCE PROMOTES AGING AND CANCER Colm Morrissey
Darren Baker
11:15 ANDROGEN RECEPTOR FUNCTION IN CASTRA-
9:35 SENESCENT CELLS IN THE LOWER URINARY TION RESISTANT PROSTATE CANCERS
TRACT AND CANCER: CLINICAL AND BASIC SCI- Amina Zoubeidi
ENCE APPROACHES
APPROVED FOR AMA PRA CATEGORY
David Jarrard
1 CREDITTM

Saturday, May 14, 2022 8:00 am – 5:15 pm

AMERICAN COLLEGE OF OSTEOPATHIC SURGEONS (ACOS)
Room 260 @ Ernest N. Morial Convention Center
Chair: W. Britt Zimmerman
8:00 MAJOR DEPRESSIVE ORDERS IN UROLOGIC 1:00 ANTIBIOTIC TALK
ONCOLOGY Bruce Jacobs
Nathan Hale
1:45 PROSTATE CANCER RISK STRATIFICATION IN
8:45 MICHIGAN UROLOGICAL SURGERY IMPROVE- THE ERA OF MRI
MENT COLLABORATIVE MUSIC Michael Stencel
Richard Sarle
2:45 UPDATES IN URETHRAL RECONSTRUCTION
9:30 UPDATES ON KIDNEY TUMOR MANAGEMENT W. Britt Zimmerman
Craig Rogers
3:30 ADVANCES IN KIDNEY STONE MANAGEMENT
10:15 UPDATE ON FEMALE UROLOGY ISSUES Kenneth Sands
Humphrey Atiemo
4:30 MANAGEMENT OF SMALL ADRENAL MASSES
11:00 TRANSGENDER SURGERY DETAILS FOR THE PRAC- Samuel Deem
TICING UROLOGIST: WHAT YOU NEED TO KNOW
APPROVED FOR AMA PRA CATEGORY
Richard Santucci
1 CREDITTM
11:45 LUNCH

Saturday, May 14, 2022 8:45 am – 10:00 am

Moderated Poster Session 22

TRAUMA/RECONSTRUCTION/DIVERSION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE, DIVERTICULUM) I
Room 228 @ Ernest N. Morial Convention Center
Moderators: Jennifer Anger, Kenneth Angermeier & Miroslav Djordjevic

ABSTRACT
NUMBER TITLE
MP22-01 PREDICTIVE FACTOR0S OF RECURRENCE
OF URETHRAL STRICTURES AFTER A FIRST
INTERNAL URETROTOMY
Skander Zouari*, Saadi Ahmed, Marouene
Chakroun, Selim Zaghbib, Setti Boubaker Nouha,
Hamza Boussaffa, Abderrazek Bouzouita, Amine
Derouiche, Riadh Ben Slama, Haroun Ayed,
Mohamed Chebil, Tunis, Tunisia
MP22-02 MODIFIED USS PROM FOR DVIU AND NON
TRANSECTING URETHROPLASTY FOR
SHORT BULBAR URETHRAL STRICTURES
Arun Chawla*, Suraj Jaidev Reddy, Sitaram Mum-
malaneni, Manipal, India Ramon Virasoro, Kurt McCammon, Norfolk, VA
ABSTRACT
NUMBER TITLE
MP22-03 URETHRAL CATHETER VS SUPRAPUBIC
CATHETER: WHICH DRAINS MORE
COMPLETELY AND WHY?
Aurash Naser-Tavakolian*, John Masterson, Jer-
emiah Dallmer, Catherine Bresee, Hanson Zhao,
Maurice Garcia, Los Angeles, CA
MP22-04 DOES A PREEMPTIVE QUALITY OF LIFE
CLINIC INCREASE UTILIZATION OF
TREATMENT OPTIONS FOLLOWING RADICAL
PROSTATECTOMY?
P. Walker Prillaman*, Elizabeth Roger, Franc-
esca Monn, Gregory Mansour, Jessica DeLong,

100
 MP22-05 DOES STARTING PELVIC FLOOR
PHYSICAL THERAPY PRIOR TO RADICAL
PROSTATECTOMY IMPROVE POST-
OPERATIVE CONTINENCE RATES?
P. Walker Prillaman*, Elizabeth Roger, Franc-
esca Monn, Gregory Mansour, Jessica DeLong,
Ramon Virasoro, Kurt McCammon, Norfolk, VA Zhenpeng Zhu*, Jiayu Yang, Xing Ji, Yudong
MP22-06 THE IMPACT OF PROSTATE CANCER
DISEASE PROGRESSION AND SALVAGE OR
ADJUVANT TREATMENT ON ARTIFICIAL
URINARY SPHINCTER DEVICE OUTCOMES
Shree Agrawal*, Hanson Zhao, Joao Pedro Em-
rich Accioly, Hadley Wood, Kenneth Angermeier,
Cleveland, OH OF HUMAN TISSUE ENGINEERED FETAL
MP22-07 OUTCOMES OF DORSAL ONLAY BUCCAL
MUCOSAL GRAFT URETHROPLASTY IN
PATIENTS WITH POST-PROSTATECTOMY,
POST-RADIATION ANASTOMOTIC
CONTRACTURE
Joshua Sterling*, Alex Wang, Kelly Crane,
Syracuse, NY, Javier C. Angulo, Madrid, Spain,
Wagner Franca, Sao Paulo, Brazil, Brian Flynn,
Denver, CO, Francisco Martins, Lisbon, Portu-
gal, Erick A. Ramirez, Mexico City, Mexico, Paul
Rusilko, Pittsburgh, PA, Jay Simhan, Daniel
Swerdloff, Philadelphia, PA, Dmitriy Nikolavsky,
Syracuse, NY
MP22-08 LESS IS MORE IN THE MANAGEMENT OF
PROXIMAL STRICTURE DISEASE AFTER
PROSTATE CANCER TREATMENT
Peris Castaneda*, Kai Dallas, Los Angeles, CA,
Hanson Zhao, Cleveland, OH, Jennifer Anger,
San Diego, CA
MP22-09 URETHRAL STRICTURE/STENOSIS AS
A COMPLICATION OF HIGH INTENSITY
FOCUSED ULTRASOUND OF THE
PROSTATE: WHAT IS THE OVERALL PATIENT
EXPERIENCE?
David Barham*, Orange, CA, John Barnard,
Morgantown, WV, Joel Gelman, Orange, CA
MP22-10 HOW IS HEALTH-RELATED QUALITY OF
LIFE AFFECTED BY SALVAGE CYSTECTOMY
AND URINARY DIVERSION AS A LAST-LINE
OPTION FOR BENIGN DISEASE
Yannic Volz, Lennert Eismann*, Paulo Pfitzinger,
Jan-Friedrich Jokisch, Gerald Schulz, Severin
Rodler, Alexander Buchner, Boris Schlenker,
Christian Stief, Alexander Kretschmer,
Munich, Germany
MP22-11 SUCCESSFUL TRANSURETHRAL
ENGRAFTMENT OF BUCCAL MUCOSAL
CELLS EXPANDED IN VITRO,
TRANSPLANTED IN A POLYMER SCAFFOLD
CARRIER IN A RABBIT URETHRAL
STRICTURE MODEL, AND PROVEN WITH
IMMUNOHISTOCHEMICAL BIOMARKERS
Akio Horiguchi*, Toshihiro Kushibiki, Kenichiro
Ojima, Masayuki Shinchi, Yusuke Hirano, Yoshine
Mayumi, Keiichi Ito, Kosuke Miyai, Saitama,
Japan, Ichiro Miura, Hokkaido, Japan, Masayuki
Takeda, Masaru Iwasaki, Yamanashi, Japan, Sho-
jiro Kato, Senthilkumar Rajappa, Tokyo, Japan,
Samuel JK Abraham, Yamanashi, Japan
*Presenting author
MP22-12 CLINICAL APPLICATION OF DOUBLE-
MODIFIED SULFATED BACTERIAL
CELLULOSE SCAFFOLD MATERIAL
LOADED WITH FGFR2-MODIFIED ADIPOSE
STEM CELLS IN LOWER URINARY TRACT
RECONSTRUCTION
Zheng, Jian Lin, Liqun Zhou, Beijing, China,
People’s Republic of
MP22-13 OFF THE SHELF ACELLULAR FETAL SKIN
SCAFFOLD AS A NOVEL ALTERNATIVE
TO BUCCAL MUCOSA GRAFT: THE
DEVELOPMENT AND CHARACTERIZATION
SATURDAY
DERMAL MATRIX IN RABBIT MODEL OF
HYPOSPADIASIS
Abdol-Mohammad Kajbafzadeh,
Soheila Sobhani*, Fahimeh Jafarnezhad-Ansariha,
Tehran, Islamic Republic of Iran
MP22-14 A MIXED METHODS APPROACH TO
EXPLORING PATIENT MOTIVATIONS FOR
DELAYING DEFINITIVE TREATMENT OF
URETHRAL STRICTURE DISEASE
Abimbola Ayangbesan*, George Koch, Helen
Gambrah, Rohan Bhalla, Jackson Cabo, Stephen
Hill, Niels Johnsen, Nashville, TN
MP22-15 THE EFFECT OF TOBACCO USE ON BUCCAL
MUCOSA: AN EVALUATION OF HISTOLOGIC
CHANGES
Connor Policastro*, Joshua Sterling, Daniel
Zaccarini, Baylee Porter, Guanqun Li, Gennady
Bratslavsky, Dmitriy Nikolavsky, Syracuse, NY
MP22-16 AFFIRMING LONG-TERM STRICTURE-FREE
RATES AND PATIENT SATISFACTION AFTER
URETHROPLASTY: THE NEGATIVE IMPACT
OF PANURETHRAL, LICHEN SCLEROSUS,
RADIATION AND INFECTIOUS STRICTURES
Kai Fender*, Keith Rourke, Nathan Hoy,
Edmonton, Canada
MP22-17 DEFINING THE OPTIMAL MANAGEMENT
OF LICHEN SCLEROSUS INDUCED PENILE
URETHRAL STRICTURES: A COMPARISON
OF SINGLE-STAGE URETHROPLASTY,
STAGED URETHROPLASTY AND PERINEAL
URETHROSTOMY
Alexander Hengel*, Nathan Hoy, Keith Rourke,
Edmonton, Canada
MP22-18 REVISION URETHROPLASTY AFTER FAILED
EXCISION AND PRIMARY ANASTOMOSIS
AND TISSUE TRANSFER REPAIR FOR
BULBAR URETHRAL STRICTURES:
OUTCOME ANALYSIS
David Barham*, Orange, CA, Aron Liaw, Detroit,
MI, Joel Gelman, Orange, CA
101
 MP22-19 OUTCOMES OF PRIMARY AND RE-DO
EPISPADIAS REPAIR IN PEDIATRIC AND
ADULT POPULATION
Marta Bizic*, Borko Stojanovic, Marko Bencic,
Miroslav L. Djordjevic, Belgrade, Serbia
Saturday, May 14, 2022
Moderated Poster Session 23
BLADDER CANCER: INVASIVE III
Room 225 @ Ernest N. Morial Convention Center
Moderators: Katie Murray & Alan Nieder
ABSTRACT
NUMBER TITLE
MP23-01 URETHRECTOMY AT THE TIME OF
RADICAL CYSTECTOMY FOR NON-
METASTATIC UROTHELIAL CARCINOMA
OF THE BLADDER: A COLLABORATIVE
MULTICENTER STUDY
Ekaterina Laukhtina*, Vienna, Austria, Axelle Boe-
hm, Tours, France, Benoit Peyronnet, Rennes,
France, Carlo Andrea Bravi, Milan, Italy, Jose
Batista Da Costa, Créteil, France, Francesco
Soria, Torino, Italy, David D’Andrea, Fahad Quhal,
Pawel Rajwa, Reza Sari Motlagh, Takafumi
Yanagisawa, Frederik König, Maximilian Pallauf,
Hadi Mostafaei, Tatsushi Kawada, Vienna, Aus-
tria, Dmitry Enikeev, Moscow, Russian Federa-
tion, Alexandre Ingels, Créteil, France, Gregory
Verhoest, Rennes, France, Frederiek D’Hondt,
Alexandre Mottrie, Aalst, Belgium, Hendrik Van
Poppel, Leuven, Belgium, Alexandre De La Taille,
Créteil, France, Franck Bruyère, Tours, France,
Karim Bensalah, Rennes, France, Shahrokh F.
Shariat, Benjamin Pradere, Vienna, Austria
MP23-02 EARLY ONCOLOGIC OUTCOMES OF OPEN VS
ROBOT-ASSISTED RADICAL CYSTECTOMY
WITH TOTALLY INTRACORPOREAL URINARY
DIVERSION: SINGLE CENTRE PROSPECTIVE
RANDOMISED CONTROLLED TRIAL
Riccardo Mastroianni*, Gabriele Tuderti, Umberto
Anceschi, Alfredo Maria Bove, Aldo Brassetti,
Mariaconsiglia Ferriero, Leonardo Misuraca, Sal-
vatore Guaglianone, Michele Gallucci, Giuseppe
Simone, Rome, Italy lic of, Kang Su Cho, Joo Yong Lee, Seoul, Korea,
MP23-03 INITIAL EXPERIENCE USING INDOCYANINE
GREEN IN ROBOTIC-ASSISTED
URETEROENTERIC ANASTOMOSIS
Monica Peradejordi Font*, Alba Sierra del Rio,
Claudia Mercader Barrull, Alberto Tello Delsors,
Raul Martos Calvo, Barcelona, Spain, Jaime
Durruti, Santiago de Chile, Chile, Joan Sureda
Riera, Antoni Vilaseca Cabo, Laura Izquierdo
Reyes, Maria Jose Ribal Caparros, Antonio
Alcaraz Asensio, Mireia Musquera Felip,
Barcelona, Spain
102
MP22-20 IS SUPRACRURAL REROUTING (STEP
4 ANASTOMOTIC URETHROPLASTY)
BECOMING ANECDOTICAL IN THE
MANAGEMENT OF PELVIC FRACTURE
URETHRAL INJURY?
Christian Yepes*, Marco Bandini, Pankaj Joshi,
Shreyas Bhadranavar, Sandeep Bafna, Sanjay B
Kulkarni, Pune, India
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
8:45 am – 10:00 am
ABSTRACT
NUMBER TITLE
MP23-04 BENEFIT OF NEOADJUVANT
CHEMOTHERAPY FOR INVASIVE BLADDER
CANCER PATIENTS TREATED WITH
RADIATION-BASED THERAPY: AN INVERSE
PROBABILITY TREATMENT WEIGHTED
ANALYSIS
Ronald Kool*, Alice Dragomir, Montreal, Canada,
Girish Kulkarni, Toronto, Canada, Gautier Marcq,
Montreal, Canada, Rodney Breau, Ottawa, Can-
ada, Michael Kim, Toronto, Canada, Ionut Busca,
Hamidreza Abdi, Ottawa, Canada, Mark Dawidek,
Vancouver, Canada, Michael Uy, Hamilton, Can-
ada, Gagan Fervaha, Kingston, Canada, Nimira
Alimohamed, Calgary, Canada, Jonathan Izawa,
London, Canada, Claudio Jeldres, Sherbrooke,
Canada, Ricardo Rendon, Halifax, Canada,
Bobby Shayegan, Hamilton, Canada, Robert Sie-
mens, Kingston, Canada, Peter Black, Vancouver,
Canada, Wassim Kassouf, Montreal, Canada
MP23-05 EFFECT OF NEOADJUVANT
CHEMOTHERAPY IN IMPROVING OVERALL
SURVIVAL OF T2-4AN0M0 BLADDER
CANCER PATIENTS: A SYSTEMIC REVIEW
AND META-ANALYSIS ACCORDING TO EAU
COVID-19 RECOMMENDATION
Dong Hyuk Kang*, Incheon, Korea, Republic
of, Jae Yong Jeong, Young Joon Moon, Seoul,
Korea, Republic of, Doo Yong Chung, Incheon,
Korea, Republic of, Hyun Ho Han, Seoul, Korea,
Republic of, Hae Do Jung, Gunpo, Korea, Repub-
Republic of
MP23-06 NEOADJUVANT CHEMOTHERAPY BEFORE
RADICAL CYSTECTOMY FOR MUSCLE-
INVASIVE BLADDER CANCER: PATIENT,
PROVIDER, AND CLINICAL ETIOLOGIES FOR
LACK OF UTILIZATION
Hiten D. Patel, Ushasi Naha*, Victor S. Chen,
Caitlyn Ko, Rachel Yang, Maywood, IL, Alek-
sander Druck, Tampa, FL, Goran Rac, Marcus L.
Quek, Maywood, IL
 MP23-07 PREVALENCE AND IMPACT OF FEAR OF
RECURRENCE ON BLADDER CANCER
PATIENTS AFTER RADICAL CYSTECTOMY
Justin Badal*, Brady Miller, Nora Ruel, Airybelle
Uchida, Kelly Franklin, Sumanta Pal, Bertram
Yuh, Duarte, CA CYSTECTOMY WITH URINARY DIVERSION:
MP23-08 ADVERSE PATHOLOGICAL OUTCOMES
OF PATIENTS WITH DE NOVO MUSCLE
INVASIVE BLADDER CANCER IN NORTHERN
ONTARIO
Vahid Mehrnoush, Shahrzad Keramati, Asmaa
Ismail, Ahmed Zakaria, Hazem Elmansy, Walid
Shahrour, Owen Prowse, Walid Shabana, Ahmed
Kotb*, Thunder Bay, Canada
MP23-09 ACUTE KIDNEY INJURY AND ITS DURATION
IN PATIENTS TREATED WITH RADICAL
CYSTECTOMY IN THE ENHANCED
RECOVERY AFTER SURGERY ERA:
OPTIMIZING THE SELECTION OF PATIENTS
FOR RESTRICTIVE FLUID THERAPY
Alberto Martini, Riccardo Leni*, Francesco Pel-
legrino, Giuseppe Basile, Simone Scuderi, Mario
De Angelis, Luigi Nocera, Giuseppe Rosiello,
Giorgio Gandaglia, Milan, Italy, Andrea Gallina,
Lugano, Switzerland, Francesco Montorsi, Alberto
Briganti, Marco Moschini, Milan, Italy Cox, Mia Singh, Joanne Meneses, Eila Skinner,
MP23-10 LONGITUDINAL ASSESSMENT OF 1-YR
HEALTH RELATED QUALITY OF LIFE
OUTCOMES: HEAD TO HEAD COMPARISON
BETWEEN OPEN AND ROBOT-ASSISTED
RADICAL CYSTECTOMY WITH TOTALLY
INTRACORPOREAL URINARY DIVERSION
FROM A SINGLE CENTER RANDOMISED
CONTROLLED TRIAL
Riccardo Mastroianni*, Gabriele Tuderti, Umberto
Anceschi, Alfredo Maria Bove, Aldo Brassetti,
Mariaconsiglia Ferriero, Leonardo Misuraca, Sal-
vatore Guaglianone, Michele Gallucci, Giuseppe
Simone, Rome, Italy Riccardo Schiavina, Bologne, Italy, Alberto
MP23-11 PERIOPERATIVE COMPLICATIONS
AFTER RADICAL CYSTECTOMY FOR
BLADDER CANCER: AN INTERNATIONAL
MULTICENTER COLLABORATION
Chiara Lonati*, Brescia, Italy, Luca Afferi,
Lucerne, Switzerland, Ettore Di Trapani, Milan,
Italy, Stefania Zamboni, Claudio Simeone,
Brescia, Italy, Alberto Briganti, Francesco
Montorsi, Milan, Italy, Giuseppe Simone, Rome,
Italy, Francesco Soria, Turin, Italy, M. Carmen Mir,
Valencia, Spain, Rafael Sanchez-Salas, Paris,
France, Mathieu Roumiguié, Toulouse, France,
Alessandro Antonelli, Verona, Italy, Kees Hen-
dricksen, Amsterdam, Netherlands, Agostino Mat-
tei, Christian D. Fankhauser, Roberto Carando,
Lucerne, Switzerland, Jeremy Y.C. Teoh, Hong
Kong, China, People’s Republic of, Shahrokh F.
Shariat, Vienna, Austria, Simone Albisinni,
Bruxelles, Belgium, Rodolfo Hurle, Milan, Italy,
Angelo Peroni, Brescia, Italy, Evanguelos Xylinas,
Paris, France, Wojciech Krajewski, Wroclaw,
Poland, Morgan Roupret, Paris, France, Marco
Moschini, Milan, Italy
*Presenting author
MP23-12 EMOTIONAL FUNCTION AND EARLY BODY
IMAGE ACCEPTANCE AS INDEPENDENT
PREDICTORS OF IMPROVED LONG-
TERM HEALTH-RELATED QUALITY OF
LIFE IN PATIENTS RECEIVING RADICAL
IMPLICATIONS FOR PERIOPERATIVE
COUNSELLING
Riccardo Mastroianni*, Gabriele Tuderti, Umberto
Anceschi, Alfredo Maria Bove, Aldo Brassetti,
Mariaconsiglia Ferriero, Leonardo Misuraca, Sal-
vatore Guaglianone, Michele Gallucci, Giuseppe
Simone, Rome, Italy
SATURDAY
MP23-13 ASSESSMENT OF BASELINE FUNCTIONAL
STATUS AND RECOVERY FOLLOWING
ROBOT-ASSISTED RADICAL CYSTECTOMY
WITH INTRACORPOREAL URINARY
DIVERSION
Rand Wilcox Vanden Berg*, Ashwin Ramaswamy,
Bernard Bochner, Alvin Goh, New York, NY
MP23-14 REDUCING READMISSIONS FOLLOWING
RADICAL CYSTECTOMY THROUGH QUALITY
IMPROVEMENT
Lee White*, Caleb Seufert, Stanford, CA, Bogda-
na Schmidt, Salt Lake City, UT, Peter Dy, Stacy
Stanford, CA
MP23-15 IMPACT OF PREVIOUS TREATMENTS FOR
PROSTATE CANCER ON PERIOPERATIVE
AND ONCOLOGICAL OUTCOMES IN
PATIENTS TREATED WITH RADICAL
CYSTECTOMY FOR BLADDER CANCER
Stefano Tappero*, Stefano Parodi, Guglielmo
Mantica, Marco Borghesi, Genoa, Italy, Cristian
Fiori, Matteo Manfredi, Turin, Italy, Marco Bandini,
Milan, Italy, Andrea Mari, Francesca Valastro,
Florence, Italy, Maria Angela Cerruto, Alessan-
dra Gozzo, Verona, Italy, Francesco Chessa,
Briganti, Milan, Italy, Andrea Minervini, Florence,
Italy, Alessandro Antonelli, Verona, Italy, Franc-
esco Porpiglia, Turin, Italy, Eugenio Brunocilla,
Bologne, Italy, Francesco Montorsi, Milan, Italy,
Nazareno Suardi, Carlo Terrone, Genoa, Italy
MP23-16 CIRCULATING TUMOR DNA IS A STRONG
PREDICTOR IN PATIENTS TREATED WITH
SYSTEMIC THERAPY FOR UROTHELIAL
CARCINOMA
Ekaterina Laukhtina*, Melanie R. Hassler, Benja-
min Pradere, Maximilian Pallauf, David D’An-
drea, Vienna, Austria, Dmitry Enikeev, Moscow,
Russian Federation, Shahrokh F. Shariat, Vienna,
Austria
103
 MP23-17 PROGNOSTIC AND PREDICTIVE VALUE
OF PREOPERATIVE VASCULAR CELL
ADHESION MOLECULE-1 PLASMA LEVELS IN
UROTHELIAL CARCINOMA OF THE BLADDER
TREATED WITH RADICAL CYSTECTOMY
Keiichiro Mori*, Victor Schuettfort, Satoshi Katay-
ama, Ekaterina Laukhtina, Benjamin Pradere,
Fahad Quhal, Reza Sari Motlagh, Hadi Mostafaei,
Pawel Rajwa, Vienna, Austria, Jeremy Teoh,
Hong Kong, Hong Kong, Marco Moschini, Lu-
cerne, Switzerland, David D’Andrea, Mohammad
Abufaraj, Vienna, Austria, Shin Egawa, Tokyo,
Japan, Pierre Karakiewicz, Montreal, Canada,
Yair Lotan, Dallas, TX, Douglas Scherr, New York,
NY, Eva Compérat, Shahrokh Shariat, Vienna,
Austria
MP23-18 PRELIMINARY RESULTS OF A URINE-BASED
DNA METHYLATION TEST TO MONITOR
RESPONSE TO NEOADJUVANT THERAPY IN
MUSCLE-INVASIVE BLADDER CANCER
Seyedeh Sanam Ladi Seyedian*, Los Angeles,
CA, Saum Ghodoussipour, New Brunswick, CA,
Hamed Ahmadi, Ryan Lee, Alireza Ghoreifi,
Michael Basin, Los Angeles, CA, Paolo Piatti,
Taikun Yamada, Benjamin Jara, Lucy Sanossian,
Irvine, CA, Hooman Djaladat, Anne Schuckman,
Sumeet Bhanvadia, Gangning Liang, Siamak
Daneshmand, Los Angeles, CA
Saturday, May 14, 2022
Moderated Poster Session 24
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY I
Room 222 @ Ernest N. Morial Convention Center
Moderators: Riccardo Autorino & Monish Aron
ABSTRACT
NUMBER TITLE
MP24-01 RACE BASED EQUATIONS FOR ESTIMATING
KIDNEY FUNCTION MAY CONTRIBUTE
TO RACIAL DISPARITIES IN PARTIAL
NEPHRECTOMY UTILIZATION AMONG
BLACK PATIENTS WITH KIDNEY TUMORS
Nour Abdallah*, Tarik Benidir, Martin Hofmann,
Eiftu Haile, Diego Aguilar Palacios, Venkatesh
Krishnamurthi, Samuel Haywood, Mohamed
Eltemamy, Jihad Kaouk, Robert Abouassaly,
Steven Campbell, Christopher Weight,
Cleveland, OH
MP24-02 SURVEY BASED STUDY OF EMERGING
MANAGEMENT STRATEGIES FOR VHL
Neal Patel*, Aileen Arvelo, Los Angeles, CA, Gen-
nady Bratslavsky, Syracuse, NY, Chandra Clark,
Boston, MA, Othon Iliopoulos, Charlestown, MA,
Eric Jonasch, Houston, TX, Sandy Liu, Los Ange-
les, CA, Joshua Mann, Boston, MA, Peter Muraki,
Brian Shuch, Los Angeles, CA
104
MP23-19 PROSPECTIVE VALIDATION OF THE ROL
SYSTEM IN SUBSTAGING PT1 HIGH-GRADE
BLADDER CANCER: A CONFIRMATORY
PROGRESSION RISK ANALYSIS TO EASE
DECISION MAKING
Marina Valeri, Roberto Contieri, Vittorio Fasulo,
Miriam Cieri, Grazia M Elefante, Massimo Lazzeri,
Rozzano Milan, Italy, Gianluigi Taverna, Castellan-
za Varese, Italy, Luigi M Terracciano, Rodolfo Hurle,
Piergiuseppe Colombo*, Rozzano Milan, Italy
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
8:45 am – 10:00 am
ABSTRACT
NUMBER TITLE
MP24-03 LOCAL RECURRENCE FOLLOWING PARTIAL
NEPHRECTOMY IN PATIENTS WITH RENAL
CELL CARCINOMA: A MULTICENTER STUDY
Shohei Fukuda*, Hajime Tanaka, Kenji Tanabe,
Tokyo, Japan, Takashi Tamiya, Saitama, Japan,
Masaki Kobayashi, Tokyo, Japan, Shugo Yajima,
Chiba, Japan, Yuki Nakamura, Saitama, Japan,
Motohiro Fujiwara, Tokyo, Japan, Yudai Ishikawa,
Ibaraki, Japan, Takanobu Yamamoto, Tokyo, Ja-
pan, Saori Araki, Chiba, Japan, Soichiro Yoshida,
Minato Yokoyama, Yoh Matsuoka, Yukihiro Otsu-
ka, Fumitaka Koga, Yasuhisa Fujii, Tokyo, Japan
MP24-04 C-REACTIVE PROTEIN AND RISK OF
MAJOR COMPLICATIONS AND MORTALITY
OUTCOMES IN PATIENTS UNDERGOING
SURGERY FOR RENAL CELL CARCINOMA
John Perry*, La Jolla, CA, Hajime Tanaka, Tokyo,
Japan, Arman Walia, Ava Saidian, Rekha Nar-
asimhan, Mimi Nguyen, Madison Chakoumakos,
Margaret Meagher, Juan Javier-Desloges, La
Jolla, CA, Kazutaka Saito, Yasuhisa Fujii, Tokyo,
Japan, Ithaar Derweesh, La Jolla, CA
 MP24-05 OUTCOMES OF PARTIAL NEPHRECTOMY
FOR NON-METASTATIC CT2 RENAL
TUMORS: RESULTS FROM A CANADIAN
MULTI-INSTITUTIONAL COLLABORATIVE
Rahul Bansal*, Ryan Sun, Winnipeg, Canada,
Frederic Pouliot, Quebec City, Canada, Ranjeeta
Mallick, Ottawa, Canada, Simon Tanguay, Mon-
treal, Canada, Darrel Drachenberg, Winnipeg,
Canada, Richard Rendon, Halifax, Canada, Alan
So, Vancouver, Canada, Luke Lavallee, Ottawa,
Canada, Antonio Finelli, Toronto, Canada, Lucas
Dean, Edmonton, Canada, Anil Kapoor, Hamilton,
Canada, Bimal Bhindi, Calgary, Canada, Lori
Wood, Halifax, Canada, Naveen Basappa, Ed-
monton, Canada, Rodney Breau, Ottawa, Canada
MP24-06 INCIDENCE OF BENIGN RENAL MASSES IN
A CONTEMPORARY COHORT OF PATIENTS
RECEIVING PARTIAL NEPHRECTOMY FOR
PRESUMED RENAL CELL CARCINOMA
Varun Vijay*, Dora Jericevic, James Wysock,
Samir Taneja, William Huang, New York, NY Umberto Anceschi*, Rome, Italy, Andrea Min-
MP24-07 ADVERSE RADIOLOGIC AND PATHOLOGIC
FEATURES IMPACT SURVIVAL OUTCOMES
FOR SMALL RENAL MASSES FOLLOWING
NEPHRECTOMY
Sari Khaleel*, Hong Truong, Song Jiang, Benja-
min Davelman, Jonathan Coleman, Ari Hakimi,
Paul Russo, New York, NY
MP24-08 REAL-TIME ESTIMATION OF NEPHRON
ACTIVITY WITH A LINEAR MEASUREMENT
SYSTEM (RENAL-MS) OBVIATES THE
NEED FOR NUCLEAR MEDICINE SCANS TO
PREDICT GLOMERULAR FILTRATION RATE
AFTER NEPHRECTOMY
Jared Schober*, Matthew Loecher, David Strauss,
Eric Cho, Alberto Castro Bigalli, Kevin Ginsburg,
Alexander Kutikov, Philadelphia, PA, Marshall
Strother, Portland, OR
MP24-09 RISK OF PSEUDOANEURYSM AND
COMPLICATIONS AFTER PARTIAL
NEPHRECTOMY: COMPARISON OF TUMOR
ENUCLEATION TO STANDARD MARGIN
TECHNIQUE
Nicholas Elliott, Jae Han Lee*, Hiten Patel,
Whitney Halgrimson, Keshava Gali, Nicholas
Lanzotti, Goran Rac, Marcus Quek, Gopal Gupta,
Maywood, IL
MP24-10 IMPACT OF HEMOSTATIC AGENTS ON
SURGICAL COMPLICATIONS AND HOSPITAL
COSTS IN PATIENTS UNDERGOING PARTIAL
NEPHRECTOMY IN THE UNITED STATES
Kendrick Yim*, Jose I Nolaazco, Yuzhe Tang,
Marie-Therese Valovska, Kevin R Melnick, Logan
Briggs, Boston, MA, Benjamin I Chung, Stanford,
CA, Steven L Chang, Boston, MA tini, Chicago, IL, Mutahar Ahmed, Hackensack,
*Presenting author
MP24-11 IS PATHOLOGICAL UPSTAGING TO T3 RENAL
CELL CARCINOMA ASSOCIATED WITH A
SIMILAR PROGNOSIS TO NON-UPSTAGED
PATHOLOGIC T3 DISEASE? A MULTICENTER
ANALYSIS
Ryan Nasseri*, Kevin Hakimi, Ava Saidian, San
Diego, CA, Riccardo Autorino, Richmond, VA, Bri-
an Lane, Grand Rapids, MI, Yasuha Fujii, Tokyo,
Japan, Michele Marchioni, Chieti, Italy, Hajime
Tanaka, Tokyo, Japan, Dattatraya Patil, Atlanta,
GA, Francesco Porpiglia, Torino, Italy, Sabrina
Noyes, Grand Rapids, MI, Chandru Sundaram,
Indianapolis, IN, James Porter, Seattle, WA, An-
drea Minervini, Florence, Italy, Umberto Capitia-
SATURDAY
nio, Francesco Montorsi, Milan, Italy, Viraj Master,
Atlanta, GA, Ithaar Derweesh, San Diego, CA
MP24-12 RISKS ASSESSMENT OF SIGNIFICANT
RENAL FUNCTION DETERIORATION AFTER
PARTIAL NEPHRECTOMY AND CALL FOR
RECONSIDERING THE IMPERATIVE SETTING
ervini, Andrea Mari, Antonio Andrea Grosso,
Florence, Italy, Cristian Fiori, Francesco Porpiglia,
Orbassano, Turin, Italy, Gabriele Tuderti, Alfredo
Maria Bove, Aldo Brassetti, Leonardo Misuraca,
Riccardo Mastroianni, Mariaconsiglia Ferriero,
Rome, Italy, Daniele Amparore, Orbassano,
Italy, Riccardo Autorino, Richmond, VA, Alessan-
dro Veccia, Brescia, Italy, Chandru Sundaram,
Indianapolis, IN, Daniel Eun, Philadelphia, IN,
Jennifer Lee, Philadelphia, PA, Ithaar Derweesh,
San Diego, CA, Umberto Capitanio, Alessandro
Larcher, Francesco Montorsi, Milan, Italy, Michele
Gallucci, Giuseppe Simone, Rome, Italy
MP24-13 IMPACT OF PRIMARY TUMOR SIZE ON
CANCER-SPECIFIC AND ALL-CAUSE
MORTALITY IN PATIENTS UNDERGOING
CYTOREDUCTIVE NEPHRECTOMY FOR
METASTATIC RENAL CELL CARCINOMA:
ANALYSIS FROM THE INTERNATIONAL
MARKER CONSORTIUM FOR RENAL
CANCER [INMARC]
Ryan Nasseri*, San Diego, CA, Viraj Master, At-
lanta, GA, Yasuhisa Fujii, Tokyo, Japan, Margaret
Meagher, Kevin Hakimi, Ava Saidian, San Diego,
CA, Dattatraya Patil, Atlanta, GA, Kazutaka Saito,
Tokyo, Japan, Ithaar Derweesh, San Diego, CA
MP24-14 A PROPENSITY MATCHED COMPARISON OF
THE PERIOPERATIVE OUTCOMES BETWEEN
SINGLE-PORT AND MULTI-PORT ROBOTIC
ASSISTED PARTIAL NEPHRECTOMY
Kennedy E. Okhawere*, New York City, NY, Alp
Tuna Beksac, Cleveland, OH, Michael Wilson, Ta-
lia G. Korn, Kirolos N Meilika, New York City, NY,
Robert Harrison, Hackensack, NJ, Luca Morgan-
NJ, Reza Mehrazin, New York City, NJ, Ronney
Abaza, Columbus, OH, Daniel D. Eun, Philadel-
phia, PA, Akshay Bhandari, Miami, FL, Ashok K.
Hemal, Winston-Salem, NC, James Porter, Seat-
tle, WA, Michael D. Stifelman, Hackensack, NJ,
Jihad Kaouk, Cleveland, OH, Simone Crivellaro,
Chicago, IL, Ketan K. Badani, New York City, NY
105
 MP24-15 POSITIVE SURGICAL MARGINS AFTER
ROBOT-ASSISTED PARTIAL NEPHRECTOMY
(RAPN): DOES IT REALLY MATTER?
(MARGINS STUDY – UROCCR 96)
Arnoult Morrone*, Imad Bentellis, Nice, France,
Jean-Christophe Bernhard, Bordeaux, France,
Karim Bensalah, Rennes, France, Cécile
Champy, Paris, France, Franck Bruyère, Tours,
France, Nicolas Doumerc, Toulouse, France,
Olivier Jonathan, Lille, France, François Audenet,
Bastien Parier, Martin Brenier, Paris, France,
Jean-Alexandre Long, Grenoble, France, Thomas
Charles, Poitiers, France, Evanguelos Xylinas,
Paris, France, Thibaut Waeckel, Caen, France,
Florie Gomez, Paris, France, Romain Boissier,
Marseille, France, Benjamin Rouget, Libourne,
France, Daniel Chevallier, Damien Ambrosetti,
Matthieu Durand, Nice, France
MP24-16 3D VIRTUAL MODELS ASSISTANCE DURING
LAPAROSCOPIC PARTIAL NEPHRECTOMY
WITH ICON3D TECHNOLOGY: THE
SURGEON’S INTRAOPERATIVE TOUCHLESS
INTERACTION
Daniele Amparore*, Federico Piramide, Enrico
Checcucci, Paolo Verri, Angela Pecoraro, Sabrina
De Cillis, Alberto Piana, Gabriele Volpi, Michele
Sica, Mariano Burgio, Davide Zamengo, Paolo
Alessio, Marcello Della Corte, Giovanni Busacca,
Andrea Bellin, Matteo Manfredi, Cristian Fiori,
Francesco Porpiglia, Orbassano (Turin), Italy
MP24-17 PROSPECTIVE VALIDATION AND
COMPARISON OF DIFFERENT SCORING
SYSTEMS FOR THE PREDICTION OF
SURGICAL OUTCOME OF ROBOT-ASSISTED
PARTIAL NEPHRECTOMY
Cesare Saitta*, Pietro Diana, Alessandro Uleri,
Vittorio Fasulo, Andrea Gobbo, Paola Arena,
Edoardo Beatrici, Giuseppe Chiarelli, Roberto
Contieri, Nicola Frego, Pier Paolo Avolio, Davide
Maffei, Alberto Saita, Paolo Casale, Giorgio
Guazzoni, Massimo Lazzeri, Rodolfo Hurle, Gio-
vanni Lughezzani, Nicolò Maria Buffi, Milano, Italy
106
MP24-18 THE EFFECT OF VIRTUAL 3D MODELS
ON ROBOTIC PARTIAL NEPHRECTOMY:
SECONDARY ANALYSIS OF A RANDOMIZED
CLINICAL TRIAL
Joseph Shirk*, Los Angeles, CA, David Thiel,
Jacksonville, FL, Eric Wallen, Chapel Hill, NC,
Jennifer Linehan, Santa Monica, CA, Wesley
White, Knoxville, TN, Ketan Badani, Ney York,
NY, James Porter, Seattle, WA
MP24-19 COMPARISON OF ONE-YEAR HEALTHCARE
EXPENDITURE AND UTILIZATIONS
BETWEEN ROBOTIC-ASSISTED VERSUS
LAPAROSCOPIC SURGERY AMONG
PATIENTS UNDERGOING PARTIAL AND
RADICAL NEPHRECTOMY
Kennedy Okhawere*, New York, NY, Gediwon
Milky, I-Fan Shih, Yanli Li, Sunnyvale, CA, Ketan
Badani, New York, NY
MP24-20 ANALYSIS OF PREDICTORS OF SCKD
PROGRESSION AFTER MINIMALLY-INVASIVE
IMPERATIVE PARTIAL NEPHRECTOMY IN
PATIENTS WITH PREOPERATIVE CKD STAGE
3A: RESULTS OF A MULTI-INSTITUTIONAL
COLLABORATIVE SERIES
Umberto Anceschi*, Rome, Italy, Andrea Min-
ervini, Andrea Mari, Antonio Andrea Grosso,
Florence, Italy, Cristian Fiori, Francesco Porpiglia,
Orbassano, Turin, Italy, Gabriele Tuderti, Alfredo
Maria Bove, Aldo Brassetti, Leonardo Misuraca,
Riccardo Mastroianni, Mariaconsiglia Ferriero,
Rome, Italy, Daniele Amparore, Orbassano,
Italy, Riccardo Autorino, Richmond, VA, Alessan-
dro Veccia, Brescia, Italy, Chandru Sundaram,
Indianapolis, IN, Daniel Eun, Philadelphia, IN,
Jennifer Lee, Philadelphia, PA, Ithaar Derweesh,
San Diego, CA, Umberto Capitanio, Alessandro
Larcher, Francesco Montorsi, Milan, Italy, Michele
Gallucci, Giuseppe Simone, Rome, Italy
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
Saturday, May 14, 2022
Podium Session 22
PROSTATE CANCER: LOCALIZED: RADIATION THERAPY
Room 252 @ Ernest N. Morial Convention Center
Moderators: A. Oliver Sartor, Mack Roach & John Davis
ABSTRACT
TIME NUMBER TITLE
9:30
PD22-01 ONCOLOGICAL OUTCOMES OF SENTINEL
LYMPH NODE PROCEDURE-GUIDED
RADIOTHERAPY VERSUS IMAGING-
GUIDED RADIOTHERAPY FOR CLINICALLY
LOCALIZED PROSTATE CANCER – A
MULTICENTER, RETROSPECTIVE,
PROPENSITY SCORE WEIGHTED
COMPARISON
Hilda de Barros*, Amsterdam, Netherlands, Niko-
laos Grivas, Ioannina, Greece, Jan Duin, Daan
Mulder, Vincent van der Noort, Amsterdam, Neth-
erlands, Arjen Noordzij, Hoofddorp, Netherlands,
Esther Wit, Eva Schaake, Pim van Leeuwen,
Henk van der Poel, Amsterdam, Netherlands
9:40
PD22-02 RESTAGING PROSTATE-SPECIFIC
MEMBRANE ANTIGEN POSITRON
EMISSION TOMOGRAPHY/COMPUTED
TOMOGRAPHY IS ASSOCIATED WITH
IMPROVED ONCOLOGICAL OUTCOME
IN MEN WHO UNDERWENT SALVAGE
RADIATION THERAPY FOR BIOCHEMICALLY
RECURRENT PROSTATE CANCER
Dennie Meijer*, Amsterdam, Netherlands, Wietse
Eppinga, Utrecht, Netherlands, Roos Mohede,
Amsterdam, Netherlands, Ben Vanneste, Maas-
tricht, Netherlands, Philip Meijnen, Otto Meijer,
Laurien Daniels, Amsterdam, Netherlands, Rod-
erick Van den Bergh, Nieuwegein, Netherlands,
Anne Lont, Amersfoort, Netherlands, Rosemarijn
Ettema, Amsterdam, Netherlands, Frederik
Oudshoorn, Hoofddorp, Netherlands, Pim van
Leeuwen, Henk Van der Poel, Maarten Donswijk,
Daniela Oprea-Lager, Eva Schaake, André Vis,
Amsterdam, Netherlands Magné, Saint Etienne, France, David Pasquier,
9:50
PD22-03 URINARY FUNCTION FOLLOWING
HIGH DOSE INTENSITY MODULATED
RADIOTHERAPY FOR CLINICALLY
LOCALIZED PROSTATE CANCER
Shannon McNall*, Nathan Colin Wong,
Valhalla, NY, Shawn Zimberg, John Rescigno,
Hartsdale, NY
10:00
PD22-04 IMMEDIATE RADIOTHERAPY VERSUS
OBSERVATION IN PATIENTS WITH NODE-
POSITIVE PROSTATE CANCER AFTER
RADICAL PROSTATECTOMY
Christian Schaufler*, Sumedh Kaul, Aaron
Fleishman, Ruslan Korets, Peter Chang, Andrew
Wagner, Boston, MA, Simon Kim, Aurora, CO,
Joaquim Bellmunt, Irving Kaplan, Aria F. Olumi,
Boris Gershman, Boston, MA OR CONCURRENT CHEMOTHERAPY: A
*Presenting author
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:10
PD22-05 COMPARISON OF LOW-DOSE-RATE
BRACHYTHERAPY VERSUS RADICAL
PROSTATECTOMY IN PATIENTS WITH
INTERMEDIATE-RISK PROSTATE CANCER:
A PROPENSITY-MATCHED MULTI-
SATURDAY
INSTITUTIONAL STUDY
Hideyasu Tsumura*, Sagamihara, Japan, No-
bumichi Tanaka, Kashihara, Japan, Tomohiko
Oguchi, Nagano, Japan, Takuya Owari, Yas-
ushi Nakai, Isao Asakawa, Kashihara, Japan,
Kazuyoshi Iijima, Haruaki Kato, Iwao Hashida,
Nagano, Japan, Ken-ichi Tabata, Takefumi Satoh,
Hiromichi Ishiyama, Sagamihara, Japan
10:20
PD22-06 SALVAGE RADIOTHERAPY GUIDED BY
FUNCTIONAL IMAGING FOR MACROSCOPIC
LOCAL RECURRENCE FOLLOWING RADICAL
PROSTATECTOMY: A MULTICENTRIC
RETROSPECTIVE STUDY
Nicolas Benziane*, Bordeaux, France, Thomas
Zilli, Genève, Switzerland, Antoine Giraud, Bor-
deaux, France, Gianluca Ingrosso, Perugia, Italy,
Mario Di Staso, L’Aquila, Italy, Fabio Trippa, Terni,
Italy, Emmanuel Meyer, Caen, France, Giulio
Francolini, Florence, Italy, Ulrike Schick, Brest,
France, Jean Marc Cosset, La Garenne Colombe,
France, Etienne Martin, Dijon, France, Victoria
Ferrari, Nice, France, Vérane Achard, Genève,
Switzerland, Nicolas Giraud, Bordeaux, France,
Corentin Pasquier, Toulouse, France, Inga Mihoci,
L’Aquila, Italy, Beatrice detti, Florence, Italy, Hind
Zaine, Lille, France, Pascal Pommier, Osman
Osman, Lyon, France, Tanguy Perennec, Nantes,
France, Khemara Gnep, Rennes, France, Nicolas
Lille, France, Stephane Supiot, Nantes, France,
Paul Sargos, Bordeaux, France
10:30
PD22-07 BASELINE SELF-REPORTED FATIGUE
PREDICTS OVERALL SURVIVAL AFTER
STEREOTACTIC BODY RADIATION THERAPY
FOR LOCALIZED PROSTATE CANCER
Rishabh Simhal*, Tamir Sholklapper, Washington,
DC, Anish Simhal, New York City, NY, Alan Zwart,
Malika Danner, Washington, DC, Deepak Kumar,
Durham, NC, Nima Aghdam, Boston, MA, Simeng
Suy, Ryan Hankins, Keith Kowalczyk, Sean Col-
lins, Washington, DC
10:40
PD22-08 RISK OF RADIATION-INDUCED FISTULA
IS LOW AND MAY BE INCREASED IN
PATIENTS WITH PRIOR PELVIC RADIATION
SYSTEMATIC REVIEW AND META-ANALYSIS
Michael Sadighian*, Nizar Hakam, Gregory
Amend, Nathan Shaw, Peggy Tahir, Isabel Elaine
Allen, Behnam Nabavizadeh, Jordan Holler, Wil-
liam Shibley, Kevin Li, Behzad Abbasi, Alexander
Bell, Osama Mohamad, Benjamin Breyer, San
Francisco, CA
107
10:50
PD22-09 DISTINGUISHING BETWEEN PROSTATE
SPECIFIC ANTIGEN BOUNCE AND
BIOCHEMICAL RECURRENCE FOLLOWING
STEREOTACTIC BODY RADIOTHERAPY FOR
PROSTATE CANCER
Ashley Monaco*, Glen Head, NY, Jessica
Sommer, Garden City, NY, Jordan Mendelson,
Jonathan Haas, Mineola, NY, Anthony Corcoran,
Aaron Katz, Garden City, NY
11:00
PD22-10 HIGH VOLUME BIOPSY CORE INVOLVEMENT
PREDICTS FOR ELEVATED PSA NADIR
FOLLOWING DEFINITIVE SBRT IN
INTERMEDIATE RISK PROSTATE CANCER
Jonathan Lischalk*, Astrid Sanchez, Christopher
Mendez, Todd Carpenter, Moses Tam, Anthony
Corcoran, Matthew Witten, Seth Blacksburg,
Aaron Katz, Jonathan Haas, New York, NY
11:10
PD22-11 SUBCLINICAL INFLAMMATION AS A
PREDICTOR FOR ERECTILE DYSFUNCTION
AFTER BRACHYTHERAPY FOR LOCALIZED
PROSTATE CANCER
Laurianne Rita Garabed*, Daniel Taussky, Guila
Delouya, Daniel Liberman, Montreal, Canada
11:20
PD22-12 COMPARATIVE STUDY OF RARP AND
CARBON ION RADIOTHERAPY SEXUAL
FUNCTIONAL CHANGES FOR PROSTATE
CANCER USING THE PROPENSITY SCORE
MATCHING METHOD
Yoshiyuki Miyazawa*, Daisuke Oka, Hidekazu
Koike, Hidemasa Kawamura, Yuhei Miyasaka,
Seiji Arai, Yoshitaka Sekine, Masashi Nomura, Hi-
roshi Matsui, Kazuhiro Suzuki, Maebashi, Japan
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM

Saturday, May 14, 2022 9:30 am – 11:30 am

Podium Session 23
SEXUAL FUNCTION/DYSFUNCTION: PEYRONIE’S DISEASE
Room 255 @ Ernest N. Morial Convention Center
Moderators: Gerald Brock, Gregory Broderick & Serge Carrier

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
9:30
PD23-01 IMPROVED PEYRONIE’S DISEASE 10:20
PD23-06 OUTCOMES OF PENILE PLICATION IN
CURVATURE OUTCOMES USING A MORE PEYRONIE’S DISEASE - FUNCTIONAL
AGGRESSIVE COLLAGENASE TECHNIQUE PENILE LENGTH: “EMPHA-SIZING” WHAT
Alissa Tyler*, Benjamin Green, Joshua Savage, MATTERS
Klinton Brearton, Landon Trost, Orem, UT Sarah Christianson*, Philadelphia, PA, Laura
Douglass, Laura Kidd, Matthew Loecher, Michael
9:40
PD23-02 COMPARISON OF COLLAGENASE
Metro, Philadelphia, PA
CLOSTRIDIUM HISTOLYTICUM TO SURGERY
FOR THE MANAGEMENT OF PEYRONIE’S 10:30
PD23-07 PATIENTS’ COMPLIANCE WITH SURGERY
DISEASE: A RANDOMIZED TRIAL FOR PEYRONIE DISEASE: A MULTICENTRE
Benjamin Green*, Megan Francis, Joshua Sav- EUROPEAN STUDY
age, Klinton Brearton, Alissa Tyler, Landon Trost, Paolo Capogrosso*, Varese, Italy, Luigi Can-
Orem, UT dela, Milan, Italy, Georgios Hatzichristodoulou,
Würzburg, Germany, Juan I. Martinez Sala-
9:50
PD23-03 INCREMENTAL TREATMENT RESPONSE BY
manca, Madrid, Spain, Andrea Cocci, Florence,
CYCLE WITH COLLAGENASE CLOSTRIDIUM
Italy, Marco Falcone, Turin, Italy, Edoardo Pozzi,
HISTOLYTICUM FOR PEYRONIE’S DISEASE:
Nicolò Schifano, Milan, Italy, Giorgio Ivan Russo,
A POOLED ANALYSIS OF TWO PHASE 3
Catania, Italy, Andrea Salonia, Milan, Italy
TRIALS
Matthew Ziegelmann*, Rochester, MN, Qinfang 10:40
PD23-08 POSTOPERATIVE PROGRESS OF MODIFIED
Xiang, Yiqun Hu, Malvern, PA, Landon Trost, GRID INCISION AND SEALING WITH
Rochester, MN COLLAGEN FLEECE FOR TREATMENT OF
PEYRONIE’S DISEASE; CLINICAL AND
10:00
PD23-04 EXPLORING ACTINIDIN AS A NOVEL
ULTRASONOGRAPHY OUTCOME
COLLAGENASE TO TREAT HUMAN
Sun Tae Ahn*, Sun Bum Cho, Hyun Soo Lee, Da
PEYRONIE’S DISEASE CELLS
Eun Han, Jong Wook Kim, Mi Mi Oh, Hong Seok
Kevin Feng, Wongsakorn Kiattiburut, London,
Park, Du Geon Moon, Seoul, Korea, Republic of
Canada, Duane Hickling, ottawa, Canada, Jere-
my Burton, Jeffrey Campbell*, London, Canada 10:50
PD23-09 AUXETIC EXPANSION OF THE TUNICA
ALBUGINEA FOR PENILE LENGTH AND
10:10
PD23-05 PATIENT REFERRAL TRENDS AND
GIRTH RESTORATION WITHOUT A GRAFT:
OUTCOMES OF PENILE PLICATION IN THE
A CASE SERIES
CONTEMPORARY ERA: IS XIAFLEX® DRIVING
Alexandre Miranda*, Rio de Janeiro, Brazil
PATIENTS TO SURGERY?
Sam Kusin, Shervin Badkhshan*, Samantha
Nealon, Gregory Joice, Sarah Sanders, Steven
Hudak, Allen Morey, Dallas, TX

108
11:00
PD23-10 PEYRONIE’S DISEASE: A FAMILIAL, 11:20
PD23-12 A DETAILED CHARACTERIZATION OF
HERITABLE CONDITION MEN WITH PEYRONIE’S DISEASE AND NO
Michael Christensen*, Kristy Allen-Brady, Alexan- ASSOCIATED RISK FACTORS
der Pastuszak, Salt Lake City, UT Christian Corsini*, Milan, Italy, Paolo Capogrosso,
Varese, Italy, Edoardo Pozzi, Federico Belladelli,
11:10
PD23-11 UNCOVERING THE GENETIC PATHWAYS
Giuseppe Fallara, Massimiliano Raffo, Daniele
OF PEYRONIE’S FIBROSIS: SINGLE
Cignoli, Luigi Candela, Nicolò Schifano, Alessia
CELL TRANSCRIPTOMIC ANALYSIS OF
d’Arma, Luca Boeri, Eugenio Ventimiglia, Rayan
PEYRONIE’S PLAQUE
Matloob, Milan, Italy, Federico Dehò, Varese, Italy,
Luke Witherspoon*, Reza Soltani, Meghan Rob-
Francesco Montorsi, Andrea Salonia, Milan, Italy
inson, Faraz Hach, Ryan Flannigan, Vancouver,
Canada APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM

SATURDAY
Saturday, May 14, 2022 9:30 am – 11:30 am

Podium Session 24
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: NEUROGENIC VOIDING DYSFUNCTION
Room 245 @ Ernest N. Morial Convention Center
Moderator: E. Ann Gormley

ABSTRACT
TIME NUMBER TITLE
9:30
PD24-01 DIFFERENTIAL TRANSCRIPTOMIC CHANGES
IN THE CENTRAL NERVOUS SYSTEM
AND NEUROGENIC BLADDERS OF MICE
INFECTED WITH A CORONAVIRUS
Taylor Clarkson, Alison Xie, Naoko Iguchi, Anna
Malykhina*, Aurora, CO
9:40
PD24-02 NEUROGENIC BLADDER MANAGEMENT IN
AWAKE CHRONIC SPINAL CORD INJURED
CATS BY AN IMPLANTABLE PUDENDAL
NERVE STIMULATOR
Jialiang Chen, Guangzhou, China, People’s Re-
public of, Yihua Zhong, Beijing, China, People’s
Republic of, Jun Zhao, Xian, China, People’s
Republic of, Anand Mohapatra*, Bing Shen,
Jicheng Wang, William de Groat, Changfeng Tai,
Pittsburgh, PA A Ginsberg, Los Angeles, CA, Natalia Hernan-
9:50
PD24-03 PATIENTS WITH SEVERE POST-STROKE
LOWER URINARY TRACT SYMPTOMS
EXHIBIT INCREASED CORTICAL ACTIVATION
DURING URGENCY AND VOIDING INITIATION
Aref Sayegh*, Evgeniy Kreydin, Rita Jen, Laura
Perez, Enanyeli Rangel, Aidin Abedi, Charles Liu,
David Ginsberg, Kay Jann, Los Angeles, CA PATIENTS: PRELIMINARY RESULTS
10:00
PD24-04 DETECTION OF PELVIC FLOOR MUSCLE
ACTIVITY AND QUANTIFICATION OF OXYGEN
KINETICS IN WOMEN WITH SPINAL CORD
INJURY AND NEUROGENIC LOWER URINARY
TRACT DYSFUNCTION
Lynn Stothers*, Andrew Macnab,
Vancouver, Canada
10:10
PD24-05 BLADDER MANAGEMENT AND QUALITY
OF LIFE BY GENDER AFTER SPINAL CORD
INJURY: RESULTS FROM 40 YEARS OF
FOLLOW-UP
Paige Nichols*, Rochester, MN, Brian Goh,
Boston, MA, Elizabeth Bearrick, Rochester, MN,
Stuart Hershman, Boston, MA, Katherine Ander-
son, Rochester, MN
ABSTRACT
TIME NUMBER TITLE
10:20
PD24-06 BLADDER RELATED QUALITY OF LIFE IN
WOMEN WITH SPINAL CORD INJURY
Ann Dekalo*, London, Canada, Jeremy Myers,
Salt Lake City, UT, Michael Kennelly, Charlotte,
NC, Blayne Welk, London, Canada
10:30
PD24-07 FAILURE RATES OF BLADDER OUTLET
SURGERIES FOR STRESS URINARY
INCONTINENCE IN WOMEN WITH
NEUROGENIC LOWER URINARY TRACT
DYSFUNCTION: A MULTICENTER
NEUROGENIC BLADDER RESEARCH GROUP
STUDY DYSFUNCTION (NLUTD)
Javier Santiago*, Ann Arbor, MI, Min Soo Choo,
Seoul, Korea, Republic of, Anne Cameron, Ann
Arbor, MI, Richard Mora, Evgeniy Kreydin, David
dez, Paola Bustillos, Rose Khavari, Houston, TX,
Stephanie Daignault-Newton, John Stoffel, Ann
Arbor, MI
10:40
PD24-08 ROBOT ASSISTED BLADDER NECK
ARTIFICIAL URINARY SPHINCTER
IMPLANTATION IN NEUROLOGICAL MALE
Benoit Peyronnet*, Rennes, France, Thibault
Tricard, Strasbourg, France, Thibaut Brierre, Tou-
louse, France, Juliette Hascoet, Rennes, France,
Thomas Prudhomme, Toulouse, France, Baptiste
Poussot, Strasbourg, France, Andrea Manunta,
Rennes, France, Evelyne Castel-Lacanal, Tou-
louse, France, Christian Saussine, Strasbourg,
France, Xavier Gamé, Toulouse, France
10:50
PD24-09 INITIAL TRAINING OF AN AI INTEGRATED
INTRA URETHRAL CATHETER PUMP
PROSTHESIS
William Hendricks, Sylvie M Kalikoff, Hannah A
McKenney, Patricia Thai, Musa Ozturk, Alexis
Hoyos, Alex Arevalos, Houston, TX, Kunj Sheth*,
Palo Alto, CA

*Presenting author 109

11:00
PD24-10 FAILURE OF COST CONTAINMENT IN 11:20
PD24-12 PATIENTS WITH ALZHEIMER’S DISEASE
NEUROGENIC BLADDER CARE: UPDATED AND NEUROGENIC BLADDER DYSFUNCTION
ANALYSIS OF THE NATIONAL EMERGENCY HAVE ALTERED URINE HEPATOCYTE
DEPARTMENT SAMPLE 2012-2017 GROWTH FACTOR
Deepansh Dalela*, Detroit, MI, Hei-Kit Chan, Yao-Chi Chuang*, Kaohsiung, Taiwan, Sarah
Matthew Davis, Argyrios Stampas, Houston, TX, Bartolone, Elijah Ward, Royal Oak, MI, Tsu-Kung
Humphrey Atiemo, Detroit, MI Lin, Chinug-Chih Chang, Kaohsiung, Taiwan,
Bernadette Zwaans, Michael Chancellor, Royal
11:10
PD24-11 NATIONAL TRENDS IN READMISSIONS
Oak, MI
OF NEUROGENIC BLADDER PATIENTS
UNDERGOING URINARY DIVERSION IN THE APPROVED FOR AMA PRA CATEGORY 2
UNITED STATES 2016-2017: AN ANALYSIS CREDITSTM
USING THE NATIONAL READMISSIONS
DATABASE
Jazzmyne Montgomery*, Tiffany Damm, M.
Francesca Monn, Springfield, IL

Saturday, May 14, 2022 9:30 am – 11:30 am

Podium Session 25
HEALTH SERVICES RESEARCH: PRACTICE PATTERNS, QUALITY OF LIFE AND SHARED DECISION MAKING II
Room 244 @ Ernest N. Morial Convention Center
Moderators: Jonathan Bergman & David Penson

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
9:30
PD25-01 SOCIAL DETERMINANTS OF HEALTH 10:20
PD25-06 VARIATION IN COMMUNICATION OF
AND OVERACTIVE BLADDER IN A LARGE COMPETING RISKS OF MORTALITY
NATIONWIDE CROSS-SECTIONAL STUDY IN PROSTATE CANCER TREATMENT
Elisabeth Sebesta*, Stephanie Gleicher, Melissa CONSULTATIONS
Kaufman, Roger Dmochowski, W. Stuart Reynolds, Aurash Naser-Tavakolian*, Rebecca Gale,
Nashville, TN Michael Luu, Abhishek Venkataramana, Los An-
geles, CA, Dmitry Khodyakov, Santa Monica, CA,
9:40
PD25-02 UTILIZATION OF ECONSULT AND CLINICAL
Jennifer Anger, Edwin Posadas, Howard Sandler,
INTEGRATION TO MAXIMIZE ACCESS TO
Brennan Spiegel, Stephen Freedland, Timothy
UROLOGIC CARE IN THE SAFETY NET:
Daskivich, Los Angeles, CA
OUTCOMES FROM THE LARGEST ECONSULT
EXPERIENCE IN THE UNITED STATES 10:30
PD25-07 RACIAL DISPARITIES IN SURGICAL
Jonathan Bergman*, Katherine Fero, Jamal Nab- TREATMENT OF RENAL MASSES: INITIAL
hani, Jeremy Blumberg, Kiran Gollapudi, Stanley ANALYSIS OF A STATEWIDE REGISTRY
Frencher, Paul Giboney, Los Angeles, CA Mohit Butaney*, Detroit, MI, Ji Qi, Stephanie
Daignault-Newton, Randy Vince, Anna Johnson,
9:50
PD25-03 ASSOCIATION BETWEEN FINANCIAL
Ann Arbor, MI, Amit Patel, Detroit, MI, Susan
BURDEN AND TREATMENT REGRET IN MEN
Linsell, Simpa Salami, Ann Arbor, MI, Firas
WITH LOCALIZED PROSTATE CANCER
Abdollah, Detroit, MI, Khurshid Ghani, Ann Arbor,
Daniel D. Joyce*, Rochester, MN, Christopher
MI, Humphrey Atiemo, Detroit, MI, Brian Lane,
J.D. Wallis, Toronto, Canada, Li-Ching Huang,
Grand Rapids, MI, Craig Rogers, Detroit, MI, for
Nashville, TN, Karen E. Hoffman, Houston, TX,
the Michigan Urological Surgery Improvement
Zhiguo Zhao, Tatsuki Koyama, Ralph Conwill,
Collaborative, Ann Arbor, MI
David F. Penson, Daniel A. Barocas, Nashville, TN
10:40
PD25-08 ADVANCED PRACTICE PROVIDERS AND
10:00
PD25-04 PERCEPTIONS OF GENDER EQUITY BY
UROLOGIC PROCEDURES: AN ANALYSIS OF
UROLOGIC SUBSPECIALTY
MEDICARE AND COMMERCIAL CLAIMS
Roxanne Haslam*, Rebecca Agnor, Austin
Max Hyman, Parth Modi*, Chicago, IL
Collins, Leigh Martin, Solange Bassale, Casey
Seideman, Portland, OR 10:50
PD25-09 18-YEAR POPULATION TRENDS DEPICT
UROLOGIST ACCESS WORSENING FOR
10:10
PD25-05 CHANGES IN HEALTH BEHAVIORS AMONG
RURAL MALES AND IMPROVING FOR
LOW-INCOME UNINSURED MEN WITH
METROPOLITAN FEMALES
PROSTATE CANCER
Stephen Pittman*, Shachi Patel,
Allen E. D. Siapno*, Megha D. Tandel, Lorna
Jeffrey Thompson, Ajay Nangia, Kansas City, KS
Kwan, Mark S. Litwin, Los Angeles, CA

110
11:00
PD25-10 EVALUATION OF UROLOGIC PATIENT 11:20
PD25-12 URBAN FAMILIES AMELIORATE RURAL
REPORTED PERI-OPERATIVE FINANCIAL GENITOURINARY CANCER DISPARITIES
TOXICITY Jeffrey Vehawn*, Mouneeb Choudry, Trevor Hunt,
Daniel Au*, Jared Starkey, Jeffery Thompson, Christopher Martin, Jacob Ambrose, Benjamin
William Parker, Kansas City, KS Haaland, Jonathan Chipman, Heidi A. Hanson,
Brock O’Neil, Salt Lake City, UT
11:10
PD25-11 EVALUATING WHY PATIENTS SELECT
TELEPHONE VISITS OVER VIDEO VISITS IN APPROVED FOR AMA PRA CATEGORY 2
AN OUTPATIENT UROLOGY PRACTICE CREDITSTM
Daniel Jacobs*, Denzel Zhu, Kara Watts, Bronx, NY

SATURDAY
Saturday, May 14, 2022 10:00 am – 12:00 pm

Forums
YOUNG UROLOGISTS FORUM
Room 278 @ Ernest N. Morial Convention Center
10:00 INTRODUCTION NUTS & BOLTS OF PODCASTS, DEFINING SUC-
Chair: Sammy Elsamra CESS WITH SOCIAL MEDIA, PASSION PROJECT
Aditya Bagrodia
10:05 YU of the Year Awards
WHY YOU SHOULD UTILIZE SOCIAL MEDIA,
10:15 PANEL DISCUSSION
EXPERIENCE WITH TWITTER, PASSION PROJECT
GLOBAL PERSPECTIVE: PROMISE AND TO AVOID BURNOUT
PITFALLS OF SOCIAL MEDIA Justin Dubin
Stacy Loeb
11:15 Q&A SESSION WITH AUDIENCE
CHOOSING A PLATFORM (INSTAGRAM,
11:30 FUJIFILM SPONSORSHIP TALK AND LUNCH
YOUTUBE, TIKTOK): WHAT PLATFORM IS A
RIGHT FIT? DILEMAS ON SOCIAL MEDIA
Rena Malik

Saturday, May 14, 2022 10:30 am – 11:45 am

Moderated Poster Session 25

TRAUMA/RECONSTRUCTION/DIVERSION: URETER (INCLUDING PYELOPLASTY) AND BLADDER RECONSTRUCTION (INCLUDING
FISTULA), AUGMENTATION, SUBSTITUTION, DIVERSION
Room 228 @ Ernest N. Morial Convention Center
Moderators: Ronak Gor, Judith Hagedorn & Arnulf Stenzl

ABSTRACT
NUMBER TITLE
MP25-01 INTRACORPOREAL URETEROCUTANEOUS
URINARY DIVERSION AFTER ROBOT-
ASSISTED RADICAL CYSTECTOMY:
OUTCOMES AND COMPLICATIONS
Serena Tolani*, Etienne Lavallee, John Sfakianos,
Reza Mehrazin, Nikhil Waingankar, New York,
NY, Sebastian Edeling, Hanover, Germany, Carl
Wijburg, Velp, Netherlands, Karel Decaesteck-
er, Ghent, Belgium, Alberto Martini, Francesco
Montorsi, Milan, Italy, Abolfazl Hosseini, Peter
Wiklund, Stockholm, Sweden
MP25-02 RADICAL CYSTECTOMY AND URINARY
DIVERSION OUTCOMES IN PATIENTS
WITH SINGLE VS. DOUBLE KIDNEY: A 2:1
MATCHED-PAIR ANALYSIS
Alireza Ghoreifi*, Richard Mora Jr, Sanam La-
di-Seyedian, Farshad Sheybaee Moghaddam, Jie
Cai, Gus Miranda, Monish Aron, Anne Schuck-
man, Mihir Desai, Inderbir Gill, Siamak Danesh-
mand, Hooman Djaladat, Los Angeles, CA
ABSTRACT
NUMBER TITLE
MP25-03 ORTHOTOPIC NEOBLADDER IN FEMALE
PATIENTS WITH BLADDER CANCER: LONG-
TERM FUNCTIONAL OUTCOMES AND THE
ROLE OF SURGICAL TECHNIQUE
Seyedeh Sanam Ladi Seyedian*, Mitchell Gold-
enburg, Muhannad Alsyouf, Sumeet Bhanvadia,
Hooman Djaladat, Anne Schuckman, David Gins-
berg, Siamak Daneshmand, Los Angeles, CA
MP25-04 IMPACT OF SELF-CLEAN INTERMITTENT
CATHETERIZATION IN ORTHOTOPIC ILAEL
NEOBLADDER: FUNCTIONAL OUTCOMES,
CONTINENCE STATUS AND URINARY TRACT
INFECTIONS
Antonio Luigi Pastore*, Andrea Fuschi, Yazan Al
Salhi, Alessia Martoccia, Lorenzo Capone, Silvio
Scalzo, Paolo Pietro Suraci, Onofrio Antonio
Rera, Fabio Maria Valenzi, Alice Antonioni, Anto-
nio Carbone, Latina, Italy

*Presenting author 111

 MP25-05 URINARY DIVERSION WITH OR WITHOUT MP25-12 ROBOTIC BUCCAL GRAFT URETEROPLASTY
CONCOMITANT BENIGN CYSTECTOMY WITHOUT URETERAL REST
FOR RADIOGENIC AND NON-RADIOGENIC Shellee Ogawa*, Wesley Baas, Kushan Radad-
CONDITIONS: A COMPARATIVE ia, Alexander Parker, Kefu Du, Eric Kim, Robert
MORBIDITY ASSESSMENT ACCORDING Figenshau, Gregory Murphy, St Louis, MO
TO THE UPDATED EAU GUIDELINES ON
MP25-13 TRANSURETHRAL VESICAL FISTULA
STANDARDIZED COMPLICATION REPORTING
REPAIR, NATURAL ORIFICE TRANSLUMINAL
Malte W. Vetterlein*, Hang Yu, Hamburg, Ger-
ENDOSCOPIC SURGERY (NOTES): A NOVEL
many, Maria Buhné, Lübeck, Germany, Philipp
TECHNIQUE CASE SERIES
Gild, Mara Kölker, Armin Soave, Roland Dahlem,
Alexandra Mendoza*, Laura Cuello, Oriana Arias,
Margit Fisch, Michael Rink, Hamburg, Germany
Manuel Duque, Cali, Colombia
MP25-06 LONG-TERM FOLLOW UP OF PATIENTS
MP25-14 A MULTI-INSTITUTIONAL EXPERIENCE
WITH CEREBRAL PALSY UNDERGOING
UTILIZING BOARI FLAP IN ROBOTIC
CATHETERIZABLE CHANNEL CREATION
URINARY RECONSTRUCTION
WITHOUT CONCURRENT BLADDER
Kunj Jain, Kevin Alter, Nathan Cheng, Hacken-
AUGMENTATION
sack, NJ, Tanner Corse*, Nutley, NJ, Naveen
Molly DeWitt-Foy*, Rachael Gotlieb, Sean Elliott,
Krishnan, Matthew Lee, Randall Lee, Philadel-
Minneapolis, MN
phia, PA, Kirtishri Mishra, New York, NY, David
MP25-07 INCIDENCE OF HIGH GRADE Strauss, Daniel Eun, Philadelphia, PA, Lee Zhao,
COMPLICATIONS AND ASSOCIATED New York, NY, Michael Stifelman, Nutley, NJ
READMISSION RATES FOLLOWING COLON
MP25-15 NATIONAL TRENDS AND OUTCOMES IN
CONDUIT URINARY DIVERSION
THE USE OF INTRAVESICAL BOTULINUM
Kevin Hebert*, Ryan Anderson, Rano Matta,
TOXIN AND ENTEROCYSTOPLASTY AMONG
Benjamin McCormick, Jeremy Myers,
PATIENTS WITH SPINA BIFIDA
Salt Lake City, UT
Rano Matta*, Salt Lake City, UT, Joshua Horns,
MP25-08 URINARY TRACT RECONSTRUCTION WITH Salt Lake City, UT, Deborah Jacobson, Anthony
ENTEROCYSTOPLASTY AFTER RADIATION Schaeffer, M. Chad Wallis, Glen Lau, Salt Lake
FOR PELVIC CANCER City, UT
Sender Herschorn*, Jenn Locke, Toronto, Canada
MP25-16 CLINICAL IMPLICATIONS OF THE URINARY
MP25-09 MULTI-INSTITUTIONAL COMPARISON OF DIVERSION MICROBIOME AFTER RADICAL
NON-TRANSECTING VERSUS TRANSECTING CYSTECTOMY
PRIMARY ROBOTIC PYELOPLASTY FOR Saum Ghodoussipour, New Brunswick, CA, Seye-
URETEROPELVIC JUNCTION OBSTRUCTION: deh Sanam Ladi Seyedian*, David Nusbaum,
THE COLLABORATIVE OF RECONSTRUCTIVE Shane Pearce, Los Angeles, CA, Hiren Patel,
ROBOTIC URETERAL SURGERY (CORRUS) Aishani Prem, Wendy Ullmer, Irvine, CA, Sumeet
EXPERIENCE Bhanvadia, Hooman Djaladat, Anne Schuckman,
David Strauss*, Matthew Lee, Philadelphia, PA, Gangning Liang, Siamak Daneshmand, Los
Ziho Lee, Chicago, IL, Aeen Asghar, Randall Angeles, CA
Lee, Philadelphia, PA, Lee Zhao, New York, NY,
MP25-17 PELVIC INSUFFICIENCY FRACTURE—AN
Michael Stifelman, Hackensack, NJ, Daniel Eun,
UNDERRECOGNIZED CAUSE OF PAIN AFTER
Philadelphia, PA
PUBECTOMY
MP25-10 PREVENTION AND DETECTION OF Molly DeWitt-Foy*, Ranveer Vasdev, Sean Elliott,
IATROGENIC URETERAL INJURY DURING Minneapolis, MN
ABDOMINAL OR PELVIC SURGERY: A
MP25-18 SEPARATE ABDOMINAL CLOSURE TRAYS
SYSTEMATIC REVIEW AND META-ANALYSIS
SIGNIFICANTLY IMPROVE CYSTECTOMY
Takafumi Yanagisawa*, Vienna, Austria, Keiichiro
SURGICAL SITE INFECTION; OUTCOMES
Mori, Tokyo, Japan, Reza Sari Motlagh, Tatsushi
FROM A PRE-POST IMPLEMENTATION
Kawada, Hadi Mostafaei, Fahad Quhal, Ekaterina
NATIONAL SURGICAL QUALITY INPATIENT
Laukhtina, Pawel Rajwa, Frederik König, Maximil-
PROGRAM (NSQIP) PROJECT
ian Pallauf, Benjamin Pradere, Vienna, Austria,
Kevin Krughoff*, Christopher Mantyh, Charles D
Jun Miki, Takahiro Kimura, Shin Egawa, Tokyo,
Scales, Andrew C. Peterson, Durham, NC
Japan, Shahrokh F. Shariat, Vienna, Austria
MP25-11 PREDICTORS OF SURGICAL SUCCESS FOR
ROBOTIC URETERAL RECONSTRUCTION
OF PROXIMAL AND MIDDLE URETERAL
STRICTURES
Matthew Lee*, Philadelphia, PA, Ziho Lee,
Chicago, IL, Randall Lee, David Strauss, Rohit
Reddy, Philadelphia, PA, Lee C Zhao, New York,
NY, Michael D Stifelman, Hackensack, NJ, Daniel
Eun, Philadelphia, PA

112
 MP25-19 COMPARISON OF COMPLICATIONS, MP25-20 DEMUSOCALIZED DETRUSOR MUSCLE
OPERATING TIME AND COSTS IN DOUBLE- FLAPS FOR COMPLEX URETHRAL FISTULA
LAYERED HAND-SEWN VS. MECHANICAL Matthew Loecher*, Ramphis Morales-Lopez,
STAPLED ILEO-ILEAL ANASTOMOSIS Michael Metro, Philadelphia, PA
DURING RADICAL CYSTECTOMY
APPROVED FOR AMA PRA CATEGORY 1.25
Gabriele Tulone*, Palermo, Italy, Nicola Pavan,
CREDITSTM
Trieste, Italy, Sofia Giannone, Palermo, Italy,
Giuseppe Alario, Messina, Italy, Alberto Abrate,
Sondrio, Italy, Mirko Pinelli, Piero Mannone,
Palermo, Italy, Francesco Claps, Trieste, Italy,
Davide Baiamonte, Rosa Giaimo, Marco Vella,
Carlo Pavone, Palermo, Italy, Vincenzo Ficarra,
Messina, Italy, Alchiede Simonato, Palermo, Italy

SATURDAY
Saturday, May 14, 2022 10:30 am – 11:45 am

Moderated Poster Session 26

STONE DISEASE: EPIDEMIOLOGY & EVALUATION I
Room 225 @ Ernest N. Morial Convention Center
Moderators: Casey Dauw & Glenn Preminger

ABSTRACT
NUMBER TITLE
MP26-01 COMPLETENESS OF 24-HOUR URINE
TESTING AMONG US VETERANS WITH
URINARY STONE DISEASE
Ryan Hsi*, Nashville, TN, Autumn Valicevic,
Sanjeevkumar Patel, John Hollingsworth, Vahakn
Shahinian, Ann Arbor, MI Chen, Ana Ricardo, Chicago, IL, Robert Burk,
MP26-02 PREVALENCE OF 24-HOUR URINE
ABNORMALITIES AMONG OLDER ADULTS
WITH URINARY STONE DISEASE
Ryan Hsi*, Nashville, TN, Mary Oerline, Ann Ar-
bor, MI, Joseph Crivelli, Birmingham, AL, Vahakn
Shahinian, John Hollingsworth, Ann Arbor, MI STATES - EXPERIENCE OVER LAST
MP26-03 24-HOUR URINE TEST CONTRIBUTES TO
THE DECREASED RISK OF RECURRENT
STONE EVENTS
Rei Unno*, Xavier Cortez, Leslie Charondo, Kevin
Chang, Nizar Hakam, Carter Chan, Heiko Yang,
Gregory Hosier, Fadl Hamouche, David Bayne,
Marshall Stoller, Thomas Chi, San Francisco, CA
MP26-04 24-HOUR URINE COLLECTIONS PERFORMED
IN THE IMMEDIATE POST-OPERATIVE
PERIOD ARE ACCURATE FOR METABOLIC
STONE EVALUATION
Emily Serrell*, Margaret Knoedler, Shuang Li,
Sean Hedican, Sara Best, Kristina Penniston,
Stephen Nakada, Madison, WI IDENTIFY PRIMARY HYPEROXALURIA
MP26-05 CHARACTERISTICS OF PATIENTS WITH AND
WITHOUT MALABSORPTION ACCORDING TO
24-HOUR URINE OXALATE EXCRETION
Kyle Wood*, Birmingham, AL, Marja Puurunen,
Kyra Mulder, Cambridge, MA, James MacDou-
gall, Haverhill, MA, Caroline Kurtz, Aoife Brennan,
Gary Curhan, Cambridge, MA
ABSTRACT
NUMBER TITLE
MP26-06 PREVALENCE OF KIDNEY STONE DISEASE
IN U.S. HISPANIC/LATINO ADULTS: FINDINGS
FROM THE HISPANIC COMMUNITY HEALTH
STUDY/STUDY OF LATINOS (HCHS/SOL)
Marcelino Rivera*, Indianapolis, IN, Jinsong
Bronx, NY, Jianwen Cai, Chapel Hill, NC, Martha
Daviglus, James Lash, Chicago, IL
MP26-07 PREVALENCE OF SYMPTOMATIC PEDIATRIC
NEPHROLITHIASIS AT AN EMERGENCY
DEPARTMENT IN SOUTH-EASTERN UNITED
15 YEARS
Shirley Zhang*, Birmingham, AL, Joshua Colling-
wood, Dothan, AL, Ayaka Fujihashi, Kai He,
Lauren Oliver, Pankaj Dangle, Birmingham, AL
MP26-08 PREVALENCE OF SYMPTOMATIC PEDIATRIC
STONE DISEASE AT THE EMERGENCY
DEPARTMENT – A REVIEW OF NATIONAL
PHIS DATABASE
Joshua Collingwood, Cole Arnold*, Dothan, AL,
Shelby Mize, Kalamazoo, MI, Pankaj Dangle,
Birmingham, AL
MP26-09 ACCURACY OF DIAGNOSTIC CODES IN
A CLINICAL RESEARCH NETWORK TO
PATIENTS
Christina Ching, Columbus, OH, Kim Dickinson*,
Hanieh Razzaghi, Nicole Marchesani, Brian
Augelli, Levon Utidjian, Philadelphia, PA, Lisa Mu-
cha, Nuno Antunes, John Karafilidis, Cambridge,
MA, Karyn Yonekawa, Seattle, WA, Doug Coplen,
St. Louis, MO, Samina Muneeruddin, Wilmington,
DE, Bob DeFoor, Cincinnati, OH, Kyle Rove,
Denver, CO, Christopher Forrest, Gregory Tasian,
Philadelphia, PA

*Presenting author 113

 MP26-10 CLINICAL AND METABOLIC FACTORS
AFFECTING RELATIVE PROPORTION OF
CALCIUM OXALATE MONOHYDRATE AND
DIHYDRATE IN PURE CALCIUM OXALATE
STONES
Mohammad Hout*, Vedant Acharya, Madhumita
Parmar, Ruben Blachman Braun, Jonathan Katz,
Robert Marcovich, Hemendra Shah, Miami, FL
MP26-11 CALCIUM PHOSPHATE STONE
COMPOSITION VARIES BASED ON WHETHER
STONE ANALYSES ARE WHOLE STONES
VERSUS STONE FRAGMENTS
Margaret Knoedler*, Shuang Li, Stephen Nakada,
Sara Best, Sean Hedican, Kristina Penniston,
Madison, WI
MP26-12 CHANGING NATIONAL TRENDS IN OPIOID
PRESCRIPTIONS FOR PAIN MANAGEMENT
IN ACUTE KIDNEY STONE DISEASE
Chinmayee Katragadda, Alexis Steinmetz*, Alex-
ander Cranwell, Rajat Jain, Rochester, NY
MP26-13 INCIDENCE AND TRENDS IN THE
TREATMENT OF KIDNEY STONES IN
CANADA: A POPULATION-BASED COHORT
STUDY
Michael Ordon*, Toronto, Canada, Andrea Lantz
Powers, Halifax, Canada, Ben Chew, Vancouver,
Canada, Jason Lee, Michael Kogon, Toronto,
Canada, Sri Sivalingam, Cleveland, OH, Shubha
De, Edmonton, Canada, Naeem Bhojani, Sero
Andonian, Montreal, Canada
MP26-14 ASSOCIATIONS OF FOOD ACCESS AND
NEIGHBORHOOD WALKABILITY WITH
URINARY RISK FACTORS FOR KIDNEY
STONE DISEASE
Joseph Crivelli*, David Redden, Birmingham,
AL, Naim Maalouf, Dallas, TX, Kyle Wood, Dean
Assimos, Gabriela Oates, Birmingham, AL
MP26-15 RURAL HOSPITAL LOCATION IS
ASSOCIATED WITH HIGHER REPORTED
PRICES FOR URETEROSCOPY WITH LASER
LITHOTRIPSY AMONG COMMERCIALLY
INSURED PATIENTS
Ian Berger*, Vishnukamal Golla, Marcelo Cerullo,
Yuqi Zhang, Michael E. Lipkin, Gary J. Faerber,
Deborah R. Kaye, Charles D. Scales Jr.,
Durham, NC
114
MP26-16 THE FINANCIAL BURDEN OF PATIENTS WITH
KIDNEY STONES AND ASSOCIATION WITH
HEALTH-RELATED QUALITY OF LIFE
Jackson Cabo*, Ryan Hsi, Nashville, TN
MP26-17 FINANCIAL TOXICITY OF NEPHROLITHIASIS:
AN ASSESSMENT OF THE ECONOMIC
BURDEN OF STONE DISEASE TREATMENT IN
A DIVERSE, URBAN POPULATION
Benjamin Green*, Nathan Feiertag, Kavita Gupta,
Jillian Donnelly, Kara Watts, Alexander Small,
Bronx, NY
MP26-18 UNDERINSURANCE IS ASSOCIATED
WITH INCREASED RISK OF MULTIPLE
PROCEDURES FOR KIDNEY STONES
Cameron Hicks*, David Bayne, San Francisco,
CA, Sudarshan Srirangapatanam, Orlando, FL,
Manuel Armas-Phan, Atlanta, GA, Efstathios
Gennatas, Johsias Maru, San Francisco, CA
MP26-19 THE SMALL ACUTE URETERAL STONE
PROTOCOL: LONGITUDINAL OUTCOMES
Conrad Bayley*, Tim Wollin, Shubha De, Sentil
Senthilselvan, Trevor Schuler, Edmonton, Canada
MP26-20 IMPACT OF COVID-19 ON THE MANAGEMENT
OF URETERIC STONES IN THE UK: THE
COVID STONES STUDY
Matthew Byrne*, Oxford, United Kingdom,
Fanourios Georgiades, Cambridge, United
Kingdom, Catherine Lovegrove, Oxford, United
Kingdom, Tobias Klatte, Berlin, Germany, Kasra
Saeb-Parsy, Cambridge, United Kingdom, Rajeev
Kumar, Oxford, United Kingdom, Alexander Light,
Cambridge, United Kingdom, Josephine Rahman,
Bristol, United Kingdom, Catherine Dominic,
London, United Kingdom, Senthooran Kathi-
ravelupillai, Cambridge, United Kingdom, Sarah
Howles, Oxford, United Kingdom, Grant Stewart,
Cambridge, United Kingdom, Ben Turney, Oxford,
United Kingdom, Oliver Wiseman, Cambridge,
United Kingdom,. COVID Stones Collaborative,
Oxford, United Kingdom
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
 Saturday, May 14, 2022
Moderated Poster Session 27
PROSTATE CANCER: ADVANCED (INCLUDING DRUG THERAPY) I
Room 222 @ Ernest N. Morial Convention Center
Moderators: R. Jeffrey Karnes, Daniel Petrylak & Neal Shore
ABSTRACT
NUMBER TITLE
MP27-01 TIME ON TREATMENT WITH ABIRATERONE
IN MEN WITH DE NOVO METASTATIC
CASTRATION SENSITIVE PROSTATE
CANCER
Pär Stattin*, Hans Garmo, Uppsala, Sweden,
Camilla Thellenberg-Karlsson, Umeå, Sweden,
Giuseppe Fallara, Milan, Italy, Johan Styrke,
Umeå, Sweden, Ingela Franck Lissbrant,
Gothenburg, Sweden, Rolf Gedeborg,
Uppsala, Sweden Ortiz, Whippany, NJ, Anja Schmall, Berlin, Ger-
MP27-02 NOT ALL ADVERSE PATHOLOGY
FEATURES ARE EQUAL: IDENTIFYING
OPTIMAL CANDIDATES FOR ADJUVANT
RADIOTHERAPY AMONG PATIENTS WITH
ADVERSE PATHOLOGY AT RADICAL
PROSTATECTOMY
Elio Mazzone*, Giorgio Gandaglia, Armando
Stabile, Milan, Italy, Nicola Fossati, Andrea
Gallina, Lugano, Switzerland, Emanuele Zaffuto,
Marta Picozzi, Francesco Barletta, Simone
Scuderi, Riccardo Leni, Luigi Nocera, Gabriele
Sorce, Francesco Pellegrino, Giuseppe Rosiello,
Umberto Capitanio, Alessandro Larcher, Milan,
Italy, Roberta Lucianò, Milano, Italy, Alessia Ci-
madamore, Ancona, Italy, Federico Dehò, Varese,
Italy, Rodolfo Montironi, Ancona, Italy, Pierre I.
Karakiewicz, Montreal, Canada, Shahrokh F. Sha-
riat, Vienna, Austria, Francesco Montorsi, Alberto
Briganti, Milano, Italy
MP27-03 DELAYING POST-OPERATIVE
RADIATION THERAPY AFTER RADICAL
PROSTATECTOMY IS ASSOCIATED WITH
INCREASED FUNCTIONAL OUTCOMES:
RESULTS FROM A LARGE SINGLE,
REFERRAL CENTER SERIES
Mario de Angelis*, Elio Mazzone, Milano, Italy,
Giorgio Gandaglia, Armando Stabile, Milan, Italy,
Simone Scuderi, Francesco Barletta, Daniele
Robesti, Milano, Italy, Luigi Nocera, Milan, Italy,
Riccardo Leni, Milano, Italy, Vito Cucchiara, Mi-
lan, Italy, Marco Bandini, Milano, Italy, Emanuele
Zaffuto, Milan, Italy, Nazareno Suardi, Genoa,
Italy, Andrea Necchi, Milano, Italy, Shahrokh F.
Shariat, Vienna, Austria, Francesco Montorsi,
Alberto Briganti, Milano, Italy MP27-09 IMPACT OF TROUGH CONCENTRATIONS OF
MP27-04 ONCOLOGIC OUTCOMES IN MEN WITH
ADVERSE PATHOLOGY AND BIOCHEMICAL
PERSISTENCE AFTER RADICAL
PROSTATECTOMY
Marlon Perera, Amy Tin, Benjamin Beech*, Daniel
Sjoberg, Nicole Benfante, Jaspreet Sandhu, Vin-
cent Laudone, Behfar Ehdaie, James Eastham,
Peter Scardino, Karim Touijer, New York, NY
*Presenting author
10:30 am – 11:45 am
ABSTRACT
NUMBER TITLE
MP27-05 EFFICACY AND SAFETY OF DAROLUTAMIDE
IN NONMETASTATIC CASTRATION-
RESISTANT PROSTATE CANCER PATIENTS
WITH AND WITHOUT PRIOR LOCAL
THERAPY WITH RADICAL PROSTATECTOMY
SATURDAY
OR RADIOTHERAPY
David Robert Siemens*, Kingston, Canada, Karim
Fizazi, Villejuif, France, Neal D. Shore, Myrtle
Beach, SC, Matthew R. Smith, Boston, MA, Jorge
many, Shankar Srinivasan, Whippany, NJ, Frank
Verholen, Basel, Switzerland, Matthias Saar,
Aachen, Germany
MP27-06 CHARACTERISTICS AND PROGRESSION-
FREESURVIVAL OF AFRO-CARIBBEAN MEN
WITH METASTATIC HORMONE-SENSITIVE
PROSTATE CANCER (MHSPC) AT THE TIME
OF DIAGNOSIS
Laurent Brureau*, Pointe-A-Pitre, France, Thiba-
ult Rossignol, Yvane Sadreux, Gilles Gourtaud,
Cédric Senechal, Virginie Roux, Pascal Blanchet,
Pointe-À-Pitre, Guadeloupe
MP27-07 COMPARISON OF CLINICAL OUTCOMES
BETWEEN ANDROGEN DEPRIVATION
THERAPY WITH UP-FRONT ABIRATERONE
AND BICALUTAMIDE FOR JAPANESE
PATIENTS WITH LATITUDE HIGH-RISK
PROSTATE CANCER IN A REAL-WORLD
MULTICENTER ANALYSIS
Taku Naiki*, Kiyoshi Takahara, Nagoya, Japan,
Toshiki Ito, Hamamatsu, Japan, Keita Nakane,
Gifu, Japan, Yosuke Sugiyama, Nagoya, Japan,
Takuya Koie, Gifu, Japan, Ryoichi Shiroki, Nago-
ya, Japan, Hideaki Miyake, Hamamatsu, Japan,
Takahiro Yasui, Nagoya, Japan
MP27-08 EVALUATING THE EFFICACY OF A NOVEL
AKR1C3 INHIBITOR IN PATIENT-DERIVED
PROSTATE CANCER CELL LINE AND
XENOGRAFT MODELS
Joy C. Yang, Shu Ning, Sacramento, CA, Hans
Adomat, Martin Gleave, Vancouver, Canada, Al-
len C. Gao, Christopher P. Evans, Chengfei Liu*,
Sacramento, CA
ABIRATERONE AND D4A ON THE CLINICAL
OUTCOMES OF PATIENTS WITH METASTATIC
CASTRATION-SENSITIVE AND CASTRATION-
RESISTANT PROSTATE CANCER
Yoshiko Takahashi*, Shintaro Narita, Akita,
Japan, Masaki Shiota, Fukuoka, Japan, Soki
Kashima, Ryohei Yamamoto, Atsushi Koizumi,
Kazuyuki Numakura, Mitsuru Saito, Akita, Japan,
Masatoshi Eto, Fukuoka, Japan, Masatomo
Miura, Tomonori Habuchi, Akita, Japan
115
 MP27-10 CLINICAL UTILITY OF NEXT-GENERATION
SEQUENCING FOR PROSTATE CANCER IN
THE CONTEXT OF A CHANGING TREATMENT
LANDSCAPE
Jacqueline R. Griffin, MS, PhD*, Tomi Jun, MD,
Sunny Guin, PhD, Stamford, CT, Bobby Chi-Hung
Liaw, MD, Vaibhav G. Patel, MD, Brooklyn, NY,
Che-Kai Tsao, MD, Astoria, NY, Michael R. Rossi,
PhD, Rong Chen, PhD, Xiang Zhou, PhD, Feras
Hantash, MD, MS, PhD, Stamford, CT, William K.
Oh, MD, New York, NY Saltzstein, San Antonio, TX, Emmanuel Antonar-
MP27-11 INCREASED CYTOKINE GENE
EXPRESSION AND INFLAMMATORY
MARKERS ASSOCIATED WITH ANDROGEN
DEPRIVATION THERAPY
Shiv Verma, Vaibhav Singh, Eswar Shankar,
Sanjay Gupta*, Cleveland, OH 3 HERO STUDY
MP27-12 DEVELOPMENT OF EXOSOME-BASED
PLASMA RNA BIOMARKERS FOR HIGH-RISK
PROSTATE CANCER
Sandra Gaston*, Benjamin Spieler, Alan Dal Pra,
Radka Stoyanova, Miami, FL, Yevgenia Khodor,
Sudipto Chakrabortty, Vasisht Tadigotla, Seth Yu,
Grannum Sant, Waltham, MA, Christian Fischer,
Martinsried, Germany, Sanoj Punnen, Miami, FL,
Johan Skog, Waltham, MA, Alan Pollack, Miami, FL
MP27-13 LONG-TERM SAFETY OF DAROLUTAMIDE
AMONG PATIENTS WITH METASTATIC
CASTRATION-RESISTANT PROSTATE
CANCER WHO RECEIVED MORE THAN 4
YEARS OF THERAPY
Robert Hugh Jones*, Cardiff, United Kingdom,
Karim Fizazi, Villejuif, France, Nicholas D. James,
Birmingham, United Kingdom, Teuvo L. Tam-
mela, Tampere, Finland, Nobuaki Matsubara,
Chiba, Japan, Frank Priou, La Roche-Sur-Yon,
France, Phillipe Beuzeboc, Paris, France, Thierry
Lesimple, Rennes, France, Petri Bono, Helsinki,
Finland, Vesa Kataja, Kuopio, Finland, Jorge
A. Garcia, Cleveland, OH, Andrew Protheroe,
Oxford, United Kingdom, John Aspegren, Heikki
Joensuu, Espoo, Finland, Iris Kuss, Silke Thiele,
Berlin, Germany, Sabine Fiala-Buskies, Wupper-
tal, Germany, Eglis Vjaters, Riga, Latvia PROSTATE CANCER
MP27-14 OVERALL SURVIVAL IN PATIENTS WITH
METASTATIC HORMONE-SENSITIVE
PROSTATE CANCER TREATED WITH
ENZALUTAMIDE OR PLACEBO PLUS
ANDROGEN DEPRIVATION THERAPY WHO
HAD PRIOR LOCAL THERAPY: POST HOC
ANALYSIS OF THE PHASE 3 ARCHES TRIAL
Taro Iguchi*, Ishikawa, Japan, Arnauld Villers, Lil-
le, France, Neal D Shore, Myrtle Beach, SC, Arun
A Azad, Melbourne, Australia, Russell Z Szmule-
witz, Chicago, IL, Jeffrey Holzbeierlein, Kansas
City, KS, Antonio Alcaraz, Barcelona, Spain,
Boris Alekseev, Moscow, Russian Federation,
Francisco Gomez-Veiga, Salamanca, Spain, Brad
Rosbrook, San Diego, CA, Ho-Jin Lee, Gabriel
P Haas, Northbrook, IL, Andrew J Armstrong,
Durham, NC, Arnulf Stenzl, Tübingen, Germany
116
MP27-15 SABIZABULIN HAS BOTH CYTOTOXIC AND
CYTOSTATIC ACTIVITY IN PHASE 1B/2
CLINICAL OF MEN WITH METASTATIC
CASTRATION RESISTANT PROSTATE
CANCER WHO PROGRESSED ON ANDROGEN
RECEPTOR TARGETING AGENTS
Mark Markowski*, Mario Eisenberger, Baltimore,
MD, Christopher Pieczonka, Syracuse, NY,
Robert Getzenberg, Domingo Rodriguez, K. Gary
Barnette, MItchell Steiner, Miami, FL, Daniel
akis, Baltimore, MD, Ronald Tutrone, Towson, MD
MP27-16 ORAL RELUGOLIX FOR ANDROGEN
DEPRIVATION THERAPY IN ADVANCED
PROSTATE CANCER: DETAILED SAFETY
ANALYSIS FROM THE RANDOMIZED PHASE
Bryan Mehlhaff*, Springfield, OR, Neal D. Shore,
Myrtle Beach, SC, Daniel J. George, Durham,
NC, Michael S. Cookson, Oklahoma City, OK,
Daniel R. Saltzstein, San Antonio, TX, Ronald
Tutrone, Towson, MD, James L. Bailen, Jefferson-
ville, IN, Bruce Brown, Andria G.M. Langenberg,
Mark Fallick, Sophia Lu, Brisbane, CA, Sarah
Hanson, New York, NY, Bertrand Tombal, Brus-
sels, Belgium, Fred Saad, Montreal, Canada
MP27-17 NIRAPARIB WITH ABIRATERONE ACETATE
AND PREDNISONE FOR METASTATIC
CASTRATION-RESISTANT PROSTATE
CANCER: RESULTS FROM THE PHASE 2
QUEST STUDY
Kim Chi*, Vancouver, Canada, Neil Fleshner,
Toronto, Canada, Vincenzo Emanuele Chiuri, Scar-
anos, Lecce, Italy, Siska Van Bruwaene, Kortrijk,
Belgium, Jason Hafron, West Bloomfield Township,
MI, Douglas G. McNeel, Madison, WI, Peter De
Porre, Beerse, Belgium, R. Scott Maul, Los An-
geles, CA, Mahesh Daksh, Raritan, NJ, Xiaogang
Zhong, College Park, MD, Gary E. Mason, Spring
House, PA, Ronald Tutrone, Towson, MD
MP27-18 PRACTICE PATTERNS IN MANAGEMENT OF
HORMONE SENSITIVE METASTATIC AND
CASTRATE-RESISTANT NON-METASTATIC
Daniel D. Joyce*, Vidit Sharma, Andrew Zganjar,
Eugene D. Kwon, R. Jeffrey Karnes, Rochester, MN
MP27-19 COMPARATIVE OUT-OF-POCKET COSTS
OF TREATMENT OPTIONS IN PRIVATELY
INSURED PATIENTS WITH ADVANCED
PROSTATE CANCER
Daniel D. Joyce*, Vidit Sharma, David H. Jiang,
Holly K. Van Houten, Lindsey R. Sangaraling-
ham, Eugene D. Kwon, Rochester, MN, David F.
Penson, Stacie B. Dusetzina, Nashville, TN, Jon
C. Tilburt, Scottsdale, AZ, Stephen A. Boorjian,
Rochester, MN
MP27-20 ANALYZING MEDICAL MARIJUANA’S EFFECT
ON NARCOTIC PAIN MEDICATION CONSUMPTION
IN PATIENTS WITH PROSTATE CANCER
Young Son*, Benjamin Fink, Katelyn Klimowich,
Stratford, NJ, Ian Madison, Philadelphia, PA, Julia
Scali, Dayna DeVincentz, Paul Chialastri, Thomas
Mueller, Gordon Brown, Stratford, NJ
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
Saturday, May 14, 2022 12:25 pm – 5:05 pm
Society of Urologic Oncology (SUO)
LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention Center
12:25 WELCOME AND INTRODUCTION 3:15 PROSTATE CANCER
Chairs: Brian Cross, Stacy Loeb Moderator: Kelvin Moses
12:30 SUO AWARDS DE-INTENSIFYING ACTIVE SURVEILLANCE FOR
Society President: Jeffrey Holzbeierlein PROSTATE CANCER
Daniel Lin
12:40 INTRODUCTION TO THE WHITMORE LECTURE
Jeffrey Holzbeierlein IMPLEMENTATION OF GERMLINE TESTING IN
PROSTATE CANCER
12:45 WHITMORE LECTURE
Veda Giri
Keynote Speaker: Eila Skinner
UPDATE ON CLINICAL TRIALS IN PROSTATE

SATURDAY
1:10 KIDNEY CANCER
CANCER
Moderator: Jose Karam
A. Oliver Sartor
TIPS AND TRICKS IN IVC THROMBECTOMY
THREE PAPERS IN THE PAST YEAR THAT
Stephen Boorjian
INFLUENCED MY PRACTICE
IS CYTOREDUCTIVE NEPHRECTOMY DEAD OR Andres Correa
ALIVE IN 2022?
4:00 TECHNOLOGY IN UROLOGIC ONCOLOGY PANEL
E. Jason Abel
Moderator: Prokar Dasgupta
SHOULD EVERYONE RECEIVE ADJUVANT THER-
ARTIFICIAL INTELLIGENCE IN UROLOGIC
APY AFTER RESECTION OF HIGH-RISK RCC?
ONCOLOGY
Viraj Master
Andrew Hung
THREE PAPERS IN THE PAST YEAR THAT INFLU-
SIMULATION AND 3D PRINTING IN UROLOGIC
ENCED MY PRACTICE
ONCOLOGY
Kara Babaian
Ahmed Ghazi
2:05 UROTHELIAL CANCER
SOCIAL MEDIA IN UROLOGIC ONCOLOGY
Moderator: Katie Murray
Kara Watts
ONCOLYTIC VIROTHERAPY IN THE TREATMENT
4:35 HEALTH SERVICES
OF BLADDER CANCER
Moderator: Bruce Trock
Roger Li
PITFALLS & BEST PRACTICES IN REPORTING
RESCUE THERAPY AND BCG ALTERNATIVES IN
UROLOGIC ONCOLOGY RESEARCH
NON-MUSCLE INVASIVE BLADDER CANCER
Melissa Assel
Max Kates
REGISTRIES AND DASHBOARDS IN UROLOGIC
ADJUVANT THERAPY AFTER NEPHROURE-
ONCOLOGY
TERECTOMY FOR HIGH-RISK UPPER TRACT
David Robinson
UROTHELIAL CARCINOMA
Sima Porten INFORMED CONSENT FOR CLINICAL TRIALS
Andrew Vickers
THREE PAPERS IN THE PAST YEAR THAT
INFLUENCED MY PRACTICE APPROVED FOR AMA PRA CATEGORY 1
LaMont Barlow CREDITTM
2:45 BREAK
2:55 ADDRESSING RACIAL DISPARITIES IN UROLOGIC
CANCER
Randy Vince

*Presenting author 117

Saturday, May 14, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 28

HEALTH SERVICES RESEARCH: PRACTICE PATTERNS, QUALITY OF LIFE AND SHARED DECISION MAKING III
Room 228 @ Ernest N. Morial Convention Center
Moderators: Amanda North, Kevan Sternberg & John Wei

ABSTRACT ABSTRACT
NUMBER TITLE NUMBER TITLE
MP28-01 SMOKING CESSATION COUNSELING MP28-07 ASSOCIATION BETWEEN BASELINE BONE
IN PATIENTS PRESENTING WITH MINERAL DENSITY TESTING AND THE
ASYMPTOMATIC HEMATURIA: ARE RISK OF FRACTURES IN MEN INITIATING
UROLOGISTS DOING ENOUGH? ANDROGEN DEPRIVATION THERAPY:
Michael Goedde*, Thomas Barefoot, POPULATION-BASED STUDY
Kellen Choi, Louisville, KY Jason Hu*, Armen Aprikian, Alice Dragomir,
Montreal, Canada
MP28-02 MEASURING THE IMPACT OF THE
VETERANS CHOICE LEGISLATION MP28-08 BURDEN OF DEPRESSION AND ANXIETY IN
ON PROSTATE CANCER CARE FOR MEN WITH HIGH-RISK, INTERMEDIATE-RISK
RURAL VETERANS IN THE VETERANS OR LOW-RISK PROSTATE CANCER
ADMINISTRATION HEALTHCARE SYSTEM Sumedha Chhatre*, S Bruce Malkowicz, Ravis-
Bradley Erickson*, Richard Hoffman, Jason hankar Jayadevappa, Philadelphia, PA
Wachsmuth, Hayden Warner, Mary Vaughan-
MP28-09 IMPACT OF SPIRITUALITY ON QUALITY OF
Sarrazin, Iowa City, IA
LIFE IN LOW-INCOME MEN WITH PROSTATE
MP28-03 EVALUATING AN INFORMED/SHARED CANCER
DECISION-MAKING PROGRAM FOR Thomas Gaither*, Mark Litwin, Los Angeles, CA
PROSTATE CANCER SCREENING AMONG
MP28-10 10-YEAR OUTCOMES IN WORK LOSS,
MEMBERS OF THE WORLD TRADE CENTER
PHYSICAL FUNCTION, AND MENTAL HEALTH
HEALTH PROGRAM: RESULTS FROM AN
OF 6,693 MEN UNDERGOING PRIMARY
IMPLEMENTATION STUDY
TREATMENT FOR PROSTATE CANCER
Michael Diefenbach*, Thomas Mistretta, Manhas-
Samuel Washington*, San Francisco, CA, Peter
sett, NY, Simon Hall, Manish Vira, New Hyde
Lonergan, Dublin, Ireland, Janet Cowan, Shoujun
Park, NY, Allison Marzilliano, Manhassett, NY, An-
Zhao, Scott Greenberg, Jenny Broering, Nynikka
drea Yacoub, Manhasset, NY, Mayer Bellehsen,
Palmer, Robert Parker, Alexander Bell, Matthew
Manhassett, NY, Jason Kornrich, New Hyde Park,
Cooperberg, Peter Carroll, San Francisco, CA
NY, Jacqueline Moline, Manhasset, NY
MP28-11 IMPLICIT BIAS IN COMMUNICATION OF
MP28-04 VALIDATION OF A SURGICAL DECISION AID
RISK IN PROSTATE CANCER TREATMENT
FOR PATIENTS WITH NEPHROLITHIASIS:
CONSULTATIONS
SHOCKWAVE LITHOTRIPSY VERSUS
Aurash Naser-Tavakolian*, Rebecca Gale,
URETEROSCOPY
Michael Luu, Abhishek Venkataramana, Los An-
John Michael DiBianco*, Stephanie Daig-
geles, CA, Dmitry Khodyakov, Santa Monica, CA,
nault-Newton, Bronson Conrado, Sarah T.
Edwin Posadas, Howard Sandler, Jennifer Anger,
Hawley, Giulia Lane, Khurshid R. Ghani, Casey
Stephen Freedland, Brennan Spiegel, Timothy
A. Dauw, for the Michigan Urological Surgery
Daskivich, Los Angeles, CA
Improvement Collaborative, Ann Arbor, MI
MP28-12 PROLIFERATION OF PHYSICIAN DISPENSING
MP28-05 STONE SURGERY TRENDS FROM 2012-
AMONG LARGE SINGLE-SPECIALTY
2019 WITHIN THE MEDICARE UTILIZATION
MEDICAL ONCOLOGY AND UROLOGY
AND PAYMENT DATA: SHARP GROWTH
PRACTICES
IN URETEROSCOPY UTILIZATION WITH
Lillian Lai*, Samuel Kaufman, Mary Oerline,
DIMINISHING SWL UTILIZATION
Megan Caram, Avinash Maganty,
Christopher Haas*, Margaret Knoedler, Kristina L.
Chad Ellimoottil, Vahakn Shahinian,
Penniston, Stephen Y. Nakada, Madison, WI
Brent Hollenbeck, Ann Arbor, MI
MP28-06 NATIONAL TRENDS IN THE PRESCRIPTION
MP28-13 LARGE VARIATIONS IN INSURANCE
OF NARCOTICS IN THE EMERGENCY
CHARGES AND CASH FEES FOR COMMON
DEPARTMENT IN PATIENTS WITH
UROLOGICAL PROCEDURES
NEPHROLITHIASIS
Cailey Guercio*, Danielle Sharbaugh, Daniel
Spencer Liem*, Timothy Demus, Miami Beach,
Pelzman, Emily Hacker, Levi Bowers, Ifunanya
FL, Alexandra Perez, Fort Lauderdale, FL, Crystal
Anyaeche, Ashti Shah, Michael Stencel, Bruce
Lee, Philadelphia, PA, Kevin George, Miami, FL,
Jacobs, Benjamin Davies, Pittsburgh, PA
Alejandra Perez, Miami Beach, FL, Luigi Cubed-
du, Fort Lauderdale, FL, Jorge Pereira, Miami MP28-14 UTILITY OF RENAL MASS BIOPSY IN
Beach, FL SHARED DECISION MAKING FOR RENAL
MASS TREATMENT
Jane Kurtzman*, Connie Wang, New York, NY,
Luis Pina Martina, Bronx, NY, Rainjade Chung,
Christopher Anderson, New York, NY

118
 MP28-15 DECISION MAKING FACTORS MP28-19 CONTEMPORARY TREND ANALYSIS OF
IN TRANSMASCULINE GENITAL INTRA-DETRUSOR BOTOX INJECTION
RECONSTRUCTION SURGERY: A MIXED AND AUGMENT CYSTOPLASTY FOR SPINA
METHODS STUDY BIFIDA POPULATION IN US FREE-STANDING
Rebecca Butcher, Kaylee Luck*, Lebanon, NH, CHILDRENS HOSPITALS
Gaines Blasdel, New York, NY, Linda Kinney, Hsin-Hsiao Wang, Kenneth Softness*, John Pa-
Benjamin Boh, Karen Schifferdecker, Lebanon, nagides, Dylan Cahill, Rachel Saunders, Boston,
NH, Jeremy Myers, Salt Lake City, UT, Rachel MA, Ranveer Vasdev, Minneapolis, MN, Tanya
Moses, Lebanon, NH Logvinenko, Carlos Estrada, Boston, MA
MP28-16 HEALTH CARE DISPARITIES IN THE MP28-20 STATEWIDE OPIOID STEWARDSHIP
TRANSGENDER POPULATION POLICIES ASSOCIATED WITH MINIMAL
Niki Parikh*, Patricio Gargollo, CHANGES IN OPIOID PRESCRIBING
Candace Granberg, Rochester, MN FOLLOWING UROLOGIC SURGERY

SATURDAY
Tudor Borza, Jeremy Goodman*, Manasa
MP28-17 CHARACTERIZING THE CHALLENGES
Venkatesh, Emi Serrell, Elise Lawson, Sudha
TRANSFEMININE INDIVIDUALS FACE IN
Quamme, Kyle Richards, E. Jason Abel, David
SEEKING UROLOGICAL CARE
Jarrard, Caprice Greenberg, Corrine Voils, Jessi-
Andrew Denisenko*, Andrew Salib,
ca Schumacher, Madison, WI
Jessica Bulafka, Sabina Spigner,
Vishal Swaminathan, Peyton Stauffer, Cassra B. APPROVED FOR AMA PRA CATEGORY 1.25
Clark, Andrew Shumaker, Rosemary Frasso, CREDITSTM
Paul H. Chung, Philadelphia, PA
MP28-18 RELATIONSHIP BETWEEN INSURANCE
STATUS AND PENILE SQUAMOUS
CELL CARCINOMA SURVIVORSHIP: A
POPULATION BASED STUDY
Yousef Rafati*, Daniel Millian, Laith Alzweri,
Galveston, TX

Saturday, May 14, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 29

BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY III
Room 225 @ Ernest N. Morial Convention Center
Moderators: Alexis Te, Thomas Lynch & Mario Gonzalez

ABSTRACT
NUMBER TITLE
MP29-01 COMPARISON OF POSTOPERATIVE
OUTCOMES OF TRANSURETHRAL
RESECTION OF THE PROSTATE, LASER
VAPORIZATION OR LASER ENUCLEATION
FOR BENIGN PROSTATIC HYPERPLASIA
TREATMENT USING THE AMERICAN
COLLEGE OF SURGEONS NATIONAL
SURGICAL QUALITY IMPROVEMENT
PROGRAM (ACS-NSQIP) DATASET
Christian Ayoub*, Rachelle Haber, Reem Amine,
Diana Mikati, Albert El Hajj, Beirut, Lebanon
MP29-02 SALVAGE VERSUS PRIMARY HOLMIUM
LASER ENUCLEATION FOR BPH: AN
OUTCOMES AND SAFETY ANALYSIS
Adri Durant*, Sandeep Voleti, Sarah Wu, Phoenix,
AZ, Jonathan Moore, Davis, CA, Gopal Narang,
Scott Cheney, Mitchell Humphreys, Phoenix, AZ Karim Bensalah, Benoit Peyronnet, Romain
MP29-03 IS SIMPLE PROSTATECTOMY AFTER PRIOR
MINIMALLY INVASIVE SURGICAL THERAPIES
FOR BENIGN PROSTATIC HYPERPLASIA
AS EFFICACIOUS AS PRIMARY SIMPLE
PROSTATECTOMY
Ram Pathak, Bridget Krol*, Nikhil Crain, Ashok
Hemal, Winston-Salem, NC
ABSTRACT
NUMBER TITLE
MP29-04 EFFECT OF SURGEON VOLUME AND
FACILITY VOLUME ON OUTCOMES OF
BENIGN PROSTATIC HYPERPLASIA
SURGERY
David-Dan Nguyen*, David Bouhadana, Montreal,
Canada, Michelina Stoddard, Xinyan Zheng, Jialin
Mao, New York, NY, Naeem Bhojani, Montreal,
Canada, Bilal Chughtai, New York, NY
MP29-05 PROPENSITY-SCORE ANALYSIS COMPARING
PERIOPERATIVE AND FUNCTIONAL
OUTCOMES BETWEEN XPS 180 W
PHOTOVAPORIZATION AND GREENLIGHT
LASER ENUCLEATION OF THE PROSTATE:
REASONS TO DISCARD VAPORIZATION AND
MOVE TO ENUCLEATION
Anis Gasmi*, Zine-Eddine Khene, Sonia Guérin,
Mathieu, Rennes, France, Morgan Rouprêt, Paris,
France, Enrique Rijo, Barcelona, Spain, Benja-
min Pradère, Rennes, France, Vincent Misrai,
Toulouse, France

*Presenting author 119

 MP29-06 INITIAL COMPARISON OF TECHNIQUE
CHANGE FROM THREE LOBE TO EARLY
APICAL RELEASE IN HOLMIUM LASER
ENUCLEATION OF THE PROSTATE IN A
HIGH-VOLUME CENTER
Christian Ericson*, Bryce Baird, Chandler Dora,
Jacksonville, FL Bilal Ahmed Khan, Hackensack, NJ, Tanner
MP29-07 FIVE-YEAR OUTCOMES AFTER
AQUABLATION COMPARED TO TURP:
THE FINAL WATER STUDY RESULTS
Peter Gilling*, Tauranga, New Zealand
MP29-08 AQUABLATION FOR BENIGN PROSTATIC
HYPERPLASIA IN LARGE PROSTATES
(80-150CC): 4-YEAR RESULTS
Naeem Bhojani*, Montreal, Canada
MP29-09 AQUABLATION: MULTI-PASS IMPACT
Thorsten Bach*, Hamburg, Germany, Steven
Kaplan, New York, NY Krystal DePorto*, Trevor Cesar, Los Angeles,
MP29-10 AQUABLATION IN VERY LARGE PROSTATES
(>150ML): TECHNIQUE AND MULTICENTER
CASE SERIES
Alexander Glaser*, Brian Helfand, Glenview, IL,
Ali Kasraeian, Jacksonville, FL, Steve Sterious,
Philadelphia, PA, Pooja Talaty, Glenview, IL,
Miguel Alcantara, Kaitlyn Alcantara, Jacksonville,
FL, Andrew Higgins, Eric Ghiraldi, Philadelphia,
PA, Dean Elterman, Toronto, Canada Gregory Jack, Melbourne, Australia
MP29-11 HOLMIUM LASER ENUCLEATION OF
PROSTATE VERSUS MINIMALLY INVASIVE
SIMPLE PROSTATECTOMY FOR LARGE
VOLUME (≥ 120 ML) PROSTATE GLANDS:
A PROSPECTIVE MULTICENTER
RANDOMIZED STUDY
Andrea Fuschi*, Yazan Al Salhi, Alessia Martoc-
cia, Lorenzo Capone, Silvio Scalzo, Paolo Pietro
Suraci, Onofrio Antonio Rera, Fabio Maria Valen-
zi, Alice Antonioni, Latina, Italy, Filippo Annino,
Arezzo, Italy, Mario Falsaperla, Catania, Italy,
Antonio Carbone, Antonio Luigi Pastore,
Latina, Italy
MP29-12 TRANSURETHRAL BIPOLAR ENUCLEATION
(TUBE): IMPROVED OUTCOMES VERSUS
STANDARD BIPOLAR TRANSURETHRAL
PROSTATE RESECTION (TURIS) WITHOUT A
SIGNIFICANT LEARNING CURVE MAY EASE
ADOPTION OF ENUCLEATION TECHNIQUES
INTO CLINICAL PRACTICE
Zachary Tully*, Brian Barnes, Ryan Steinberg,
Bradley Erickson, Iowa City, IA
MP29-13 OVERCOMING THE LEARNING CURVE: A
SINGLE INSTITUTION REVIEW OF HOLEP
COMPLICATIONS AND HOW TO
MANAGE THEM
Cassra Clark*, Jared Raikin, Anthony Tokarski,
Abhay Singh, Patrick Shenot, Akhil Das, Philadel-
phia, PA
MP29-14 OFFICE VERSUS OPERATING ROOM
REZÜM PROSTATE ABLATION: PATIENTS’
SELECTION AND POSTOPERATIVE
OUTCOMES
Engy Habashy*, Ajay Gopalakrishna, Sevann
Helo, Matthew Ziegelmann, Tobias Kohler,
Rochester, MN
120
MP29-15 COMPARISON OF PERIOPERATIVE
OUTCOMES BETWEEN TRANSVESICAL
SINGLE PORT AND INTRAVESICAL
MULTIPORT ROBOTIC ASSISTED SIMPLE
PROSTATECTOMY: A SINGLE CENTER
STUDY
Corse, Jay Zaifman, Nutley, NJ, Ruth Sanchez De
La Rosa, Sarah Brink*, Janmejay Hingu, Suzan-
nah Sorin, Hackensack, NJ, Ravi Munver, Michael
Stifelman, Mutahar Ahmed, Nutley, NJ
MP29-16 SAME-DAY HOME RECOVERY
TRANSURETHRAL RESECTION OF THE
PROSTATE IS NOT ASSOCIATED WITH
INCREASED URGENT CARE OR EMERGENCY
DEPARTMENT RETURN RATES IN AN
INTEGRATED HEALTH CARE DELIVERY
SYSTEM
CA, Eugene Rhee, San Diego, CA, Steven Crain,
Woodland Hills, CA, Gary Chien, Polina Reyblat,
Christopher Tenggardjaja, Los Angeles, CA
MP29-17 RECOVERY ROOM TIME AND LENGTH-OF-
STAY ARE SIMILAR AFTER SPINAL AND
GENERAL ANAESTHESIA FOR
BPH SURGERY
Kirby R. Qin*, William Wang, Damien Bolton,
MP29-18 POST-OPERATIVE BLADDER PRESSURE
MONITORING FOR SAME DAY CATHETER
REMOVAL AFTER HOLEP
Gopal Narang*, Charlotte Pougnier, Lanyu Mi,
Kevin Wymer, Mitchell Humphreys, Scott Cheney,
Phoenix, AZ
MP29-19 PROSPECTIVE RANDOMIZED TRIAL
ASSESSING THE SEVERITY OF IRRITATIVE
SYMPTOMS AFTER HOLMIUM LASER
ENUCLEATION OF THE PROSTATE
(HOLEP) VERSUS THULIUM FIBER LASER
ENUCLEATION OF THE PROSTATE
(THUFLEP)
Dmitry Enikeev*, Mark Taratkin, Diana Babae-
vskaya, Vladislav Petov, Mikhail Enikeev, Roman
Sukhanov, Evgeny Shpot, Denis Chinenov,
Moscow, Russian Federation, Thomas Herrmann,
Hannover, Germany
MP29-20 BLADDER NECK AND URETHRAL STENOSIS
AFTER THULIUM LASER ENUCLEATION OF
THE PROSTATE: A MULTICENTRIC COHORT
STUDY
Michele Antonucci, Rome, Italy, Daniele Castel-
lani, Ancona, Italy, Marta Signoretti, Marco Carilli,
Matteo Vittori, Francesco Maiorino, Chiara Cip-
riani, Valerio Iacovelli, Riccardo Bertolo*, Rome,
Italy, Marco Dellabella, Ancona, Italy, Pierluigi
Bove, Rome, Italy
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
Saturday, May 14, 2022
Moderated Poster Session 30
GLOBAL HEALTH/HUMANITARIAN
Room 222 @ Ernest N. Morial Convention Center
Moderators: John Lynch, Gopal Badlani & Graham Watson
ABSTRACT
NUMBER TITLE
MP30-01 IMPACT AT 20 YEARS: IVUMED BY THE
NUMBERS
Jacob Knorr*, Cleveland, OH, Danielle Sweeney,
Christina Ching, Ashley Westrum, Frank Burks,
Heidi Stephany, Eric Richter, Joseph Costa, Scott
Eggener, Maahum Haider, Benjamin Davies, Jo-
seph Smith, Kurt McCammon, Francis Schneck,
Ian Metzler, Salt Lake City, UT Laudano, New York, NY, Christopher Smith, Hou-
MP30-02 THE IVU VIRTUAL VISITING
PROFESSORSHIP PROGRAM: YOUTUBE
AND ITS IMPACT ON GLOBAL HEALTH
EDUCATION
Dzhuliyan (Jay) Vasilev*, Scottsdale, AZ, Danielle
D Sweeney, Ashley M Westrum, Austin, TX,
Christina B. Ching, Columbus, OH, Francis X
Schneck, Pittsburg, PA, Ian S. Metzler, Portland,
OR jita, Hirosaki, Japan, Hayato Yamamoto, Hirosaki,
MP30-03 EVALUATION OF AUGMENTED REALITY
TECHNOLOGY IN GLOBAL UROLOGIC
SURGERY
Georgina Dominique*, Inglewood, CA, Kevin
Kunitsky, Kansas City, MO, Gilles Natchagande,
Michel Michaël Agounkpe, Fred D. Hodonou,
Dodji Magloire Ines Yevi, Josué D. G. Avakoudjo,
Cotonou, Benin, Kurt McCammon, Norfolk, VA,
Graham Watson, East Sussex, United Kingdom,
Kymora Scotland, Los Angeles, CA Okita, Sakae Konishi, Takuma Narita,
MP30-04 REINTEGRATING A GLOBAL HEALTH
PROGRAM TO ON-SITE VISITS DURING THE
COVID-19 PANDEMIC
Christina B Ching*, Columbus, OH, Danielle D
Sweeney, Ashley M Westrum, Austin, TX, Janelle
Fox, Pittsburgh, PA, Maahum A Haider, Seattle,
WA, Kurt A McCammon, Virginia Beach, VA, Ian
S Metzler, Portland, OR, Francis X Schneck,
Pittsburgh, PA COVIDSurg Cancer Collaborators, Birmingham,
MP30-05 THE PROJECTED IMPACT OF COVID-19 ON
GLOBAL HEALTH SERVICES: TAXING AN
ALREADY CRITICALLY LIMITED RESOURCE
Christina B Ching*, Columbus, OH, Danielle D
Sweeney, Ashley M Westrum, Austin, TX, Frank
N Burks, Royal Oak, MI, Patricia Christensen,
Salt Lake City, UT, Joseph A Costa, Jacksonville,
FL, Benjamin Davies, Pittsburgh, PA, Scott E
Eggener, Chicago, IL, Maahum A Haider, Seattle,
WA, Kurt A McCammon, Virginia Beach, VA, Ian
S Metzler, Portland, OR, Eric R Richter, Pueb-
lo, CO, Joseph A Smith, Nashville, TN, Heidi A
Stephany, Irvine, CA, Francis X Schneck, Pitts-
burgh, PA
MP30-06 FINANCIAL IMPACT OF UROLOGIC
CONDITIONS IN MEN AND WOMEN IN
BELIZE
Clinton Yeaman*, Devang Sharma,
Raj Desai, Rajesh Balkrishnan, David Rapp,
Charlottesville, VA
*Presenting author
1:00 pm – 2:15 pm
ABSTRACT
NUMBER TITLE
MP30-07 CONDUCTING UROLOGY RESEARCH
DURING COVID-19: SOCIAL MEDIA-BASED
CROWDSOURCING OF URINE SAMPLES FOR
BIOMARKER DEVELOPMENT
Elijah Ward*, Sarah Bartolone, Alexander Varab-
SATURDAY
ulea, Joseph Janicki, Hannah Peters, Kenneth
Peters, Royal Oak, MI, Nitya Abraham, Melissa
ston, TX, Bernadette Zwaans, Michael Chancel-
lor, Royal Oak, MI, Laura Lamb, Ann Arbor, MI
MP30-08 ANTIBODY RESPONSES TO BNT162B2
MRNA COVID-19 VACCINE IN HEALTHCARE
WORKERS AND PATIENTS WITH
UROLOGICAL DISEASES IN JAPAN
Shingo Hatakeyama*, Tohru Yoneyama, Tomoko
Hamaya, Kyo Togashi, Takuma Narita, Naoki Fu-
Japan, Takahiro Yoneyama, Yasuhiro Hashimoto,
Chikara Ohyama, Hirosaki, Japan
MP30-09 DEVELOPMENT OF A NOVEL DIAGNOSTIC
MODEL FOR UROLOGICAL CANCERS USING
COMPREHENSIVE N-GLYCAN SIGNATURES
OF SERUM IMMUNOGLOBULINS WITH A
MACHINE LEARNING APPROACH
Hiromichi Iwamura*, Tohru Yoneyama, Hirotake
Kodama, Kai Ozaki, Yusuke Ozaki, Kazutaka
Naoki Fujita, Yuta Kojima, Teppei Okamoto,
Yuki Tobisawa, Hayato Yamamoto, Shingo
Hatakeyama, Takahiro Yoneyama, Yasuhiro
Hashimoto, Chikara Ohyama, Hirosaki, Japan
MP30-10 UROLOGICAL CANCERS DURING COVID-19:
ANALYSES OF SHORT-TERM OUTCOMES
FROM THE COVIDSURG-CANCER STUDY
Vinson Wai-Shun Chan*, Leeds, United Kingdom,
United Kingdom, British Urology Researchers in
Surgical Training (BURST) Collaborators, London,
United Kingdom
MP30-11 COVID-19 VACCINATION IN AN INNER-CITY
UROLOGY POPULATION FROM SEPTEMBER -
OCTOBER 2021
Meher Pandher*, Courtney Berg, Gabriel Fer-
nandez, Chrystal Chang, Amjad Alwaal, Robert
Weiss, Newark, NJ
MP30-12 VALIDATION OF MOBILE APPLICATION
MEASURING VOIDED VOLUME: A PILOT
PROSPECTIVE STUDY
Hwanik Kim, Jin Hyuck Kim, Changhee Ye*,
Gyoohwan Jung, Jung Kwon Kim, Hakmin Lee,
Seong Jin Jeong, Sangchul Lee, Seongnam,
Korea, Republic of
121
 MP30-13 TRAINING AND IMPLEMENTATION OF
HANDHELD ULTRASOUND TECHNOLOGY
AT GEORGETOWN PUBLIC HOSPITAL
CORPORATION: A LOW-COST
INTERVENTION TO IMPROVE DIAGNOSTIC
EVALUATION IN A RESOURCE-LIMITED
UROLOGY CLINIC
Michelle Bui*, Adrian Fernandez, San Francis-
co, CA, Budheshwar Ramsukh, Georgetown,
Guyana, Onika Noel, Sacramento, CA, Chris
Prashad, Georgetown, Guyana, David Bayne,
San Francisco, CA
MP30-14 ENVIRONMENTAL IMPACT OF
TRANSRECTAL ULTRASOUND GUIDED
PROSTATE BIOPSY
Michael Leapman*, NEW HAVEN, CT, Cassandra
Thiel, New York, NY, Ilyssa Gordon, Cleveland,
OH, Adam Nolte, Miami, FL, Aaron Perecman,
Burlington, MA, Michael Overcash, Wichita, KS,
Jodi Sherman, New Haven, CT
MP30-15 ASSOCIATION BETWEEN BODY MASS
INDEX, METABOLIC SYNDROME, AND
UROLOGIC CONDITIONS: RESULTS FROM
A MULTI-INSTITUTIONAL DATABASE FROM
THE UNITED STATES
Maxwell Towe*, Sirpi Nackeeran, Mohammad
Hout, Abhishek Bhat, Ranjith Ramasamy,
Hemendra Shah, Miami, FL
MP30-16 THE BURDEN OF BLADDER OUTLET
OBSTRUCTION IN MEN IN RURAL UGANDA:
A CROSS SECTIONAL SURVEY AND
FURTHER VALIDATION OF THE VISUAL
PROSTATE SYMPTOM SCORE (VPSS)
Lynn Stothers*, Andrew Macnab, Vancouver,
Canada
Saturday, May 14, 2022
Podium Session 26
BLADDER CANCER: NON-INVASIVE I
Room 252 @ Ernest N. Morial Convention Center
Moderators: Ashish Kamat & Rajeev T.P.
ABSTRACT
TIME NUMBER TITLE
1:00
PD26-01 EN-BLOC VERSUS CONVENTIONAL
TRANSURETHRAL RESECTION OF BLADDER
TUMORS: SINGLE-CENTER PROSPECTIVE
RANDOMIZED TRIAL
Andrea Gallioli*, Pietro Diana, Matteo Fontana,
Angelo Territo, Alberto Piana, Ferran Algaba,
Óscar Rodriguez-Faba, Asier Marcadé, Alejandra
Bravo, Antonio Rosales, Josep Maria Gaya, Joan
Palou, Alberto Breda, Barcelona, Spain
1:10
PD26-02 REAL-TIME BLADDER TUMOR DETECTION
AT CLINICS IN FLEXIBLE CYSTOSCOPY
WITH WHITE LIGHT AND NARROW BAND
IMAGING USING DEEP LEARNING
Atsushi Ikeda*, Shogo Takaoka, Hirokazu Nosato,
Hiromitsu Negoro, Hidenori Sakanashi, Masahiro
Murakawa, Hiroyuki Nishiyama, Tsukuba, Japan Umesh Sharma, Anurag Singla, New Delhi, India
122
MP30-17 ASSOCIATIONS BETWEEN TOILET AND
SANITATION INSECURITY, PSYCHOSOCIAL
BURDEN, AND LOWER URINARY TRACT
SYMPTOMS IN A SAMPLE OF U.S. ADULTS
Elisabeth Sebesta*, LeChey Hibbler, Stephanie
Gleicher, Roger Dmochowski, Lindsey McKernan,
W. Stuart Reynolds, Nashville, TN
MP30-18 COMPARING OUTCOMES OF PELVIC
FRACTURE URETHRAL INJURY REPAIR IN
THIRD WORLD COUNTRIES VERSUS UNITED
STATES
Jacob Stephens*, Frank Burks, Royal Oak, MI
MP30-19 THE RAKAI SCORE: A NOVEL TOOL FOR
PAIN MEASUREMENT DURING EARLY
INFANT MALE CIRCUMCISION WITH THE
SHANGRING
Aaron Brant, Christina Sze, Jeffrey Johnson*,
Spyridon Basourakos, Quincy Nang, New York,
NY, Stephen Kiboneka, Joseph Kagayi, Kali-
sizo, Uganda, Alice Christensen, Dar Es Alaam,
Tanzania-United Republic, Mark Barone, Marc
Goldstein, Kaylee Ho, Karla Ballman, Philip Li,
New York, NY, Godfrey Kigozi, Kalisizo, Uganda,
Richard Lee, New York, NY
MP30-20 SHANGRING USE BY NON-PHYSICIAN
PROVIDERS IN MALE INFANTS: SAFETY AND
EFFICACY FROM A LARGE FIELD STUDY
Aaron Brant, Christina Sze, Jeffrey Johnson*,
Spyridon Basourakos, Quincy Nang, Kaylee Ho,
New York, NY, Stephen Kiboneka, Joseph Kagayi,
Kalisizo, Uganda, Alice Christensen, Dar Es
Alaam, Tanzania-United Republic, Godfrey Kigozi,
Kalisizo, Uganda, Mark Barone, Karla Ballman,
Marc Goldstein, Philip Li, Richard Lee,
New York, NY
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
1:00 pm – 3:00 pm
ABSTRACT
TIME NUMBER TITLE
1:20
PD26-03 SEQUENTIAL INTRAVESICAL GEMCITABINE
AND DOCETAXEL FOR BCG-NAÏVE HIGH-
RISK NON-MUSCLE INVASIVE BLADDER
CANCER
Ian M. McElree*, Ryan L. Steinberg, Alexander C.
Martin, Jordan Richards, Sarah L. Mott, Paul T.
Gellhaus, Kenneth G. Nepple, Michael A. O’Don-
nell, Vignesh T. Packiam, Iowa City, IA
1:30
PD26-04 A RANDOMIZED STUDY TO COMPARE
OUTCOMES OF INTRAVESICAL
CHEMOHYPERTHERMIA WITH MITOMYCIN C
VS INTRAVESICAL BCG FOR INTERMEDIATE
AND HIGH RISK NON-MUSCLE INVASIVE
BLADDER CANCER(NMIBC)
Karandeep Guleria*, Rajeev Sood, Hemant Goel,
1:40
PD26-05 HOW LONG SHOULD WE FOLLOW LOW
GRADE TA NON-MUSCLE INVASIVE
BLADDER CANCER (NMIBC)? A LARGE
RETROSPECTIVE SINGLE INSTITUTION
ANALYSIS
Eunice Villegas, Christian Vitug, Katherine La-
jkosz, Cynthia Kuk, Bruce Gao, Otto Hemminiki,
Dhiral Kot, Shayan Din, Jimmy Misurka, Girish S.
Kulkarni, Michael Jewett, Neil E. Fleshner, The-
odorus H. van der Kwast, Alexandre R. Zlotta*,
Toronto, Canada Lotan, Dallas, TX, Gary Steinberg, New York, NY,
1:50
PD26-06 ADJUVANT CHEMOTHERAPY PLUS
RADIOTHERAPY VERSUS CHEMOTHERAPY
ALONE FOR LOCALLY ADVANCED BLADDER
CANCER AFTER RADICAL CYSTECTOMY
John Ernandez*, Sumedh Kaul, Aaron Fleishman,
Ruslan Korets, Peter Chang, Andrew Wagner,
Boston, MA, Simon Kim, Aurora, CO, Joaquim
Bellmunt, Irving Kaplan, Aria Olumi, Boris Gersh-
man, Boston, MA Yasser Osman*, Mansoura, Egypt, M Elbaset,
2:00
PD26-07 SEQUENTIAL ENDOLUMINAL CABAZITAXEL
AND GEMCITABINE WITH PEMBROLIZUMAB
FOR DOCETAXEL-UNRESPONSIVE
NON-MUSCLE INVASIVE UROTHELIAL
CARCINOMA OF THE UPPER AND LOWER
URINARY TRACTS
Vignesh T. Packiam*, Ian McElree, Ryan L.
Steinberg, Adam Prescott, Rohan Garje, Yousef
Zakharia, Michael A. O’Donnell, Iowa City, IA COMBAT BRS HIVEC SYSTEM
2:10
PD26-08 LOW-GRADE UROTHELIAL CARCINOMA
RECURS AT A TEMPO THAT NATURALLY
ACCELERATES FROM ADAGIO TO ALLEGRO
Alex Sankin*, Bronx, NY, Louise-Rae Cherrill, Re-
becca H. Boucher, Birmingham, United Kingdom,
Maurice P. Zeegers, Maastricht, Netherlands, K.
K. Cheng, Birmingham, United Kingdom, Nich-
olas D. James, London, United Kingdom, Mark
Schoenberg, Ilir Agalliu, Bronx, NY, Richard T.
Bryan, Birmingham, United Kingdom
2:20
PD26-09 PRIMARY TA HIGH GRADE BLADDER
TUMORS: DETERMINATION OF THE RISK OF
PROGRESSION
Fahad Quhal*, Keiichiro Mori, Ekaterina Laukhti-
na, Benjamin Pradere, Vienna, Austria, Franc-
esco Soria, Turin, Italy, Marco Moschini, Luzern,
Switzerland, Alberto Briganti, Milan, Italy, Pierre
I. Karakiewicz, Montreal, Canada, Shahrokh F.
Shariat, Vienna, Austria
*Presenting author
2:30
PD26-10 COMPARISON OF INTRAVESICAL THERAPY
AND SURGERY AS TREATMENT OPTIONS
FOR RECURRENT BLADDER CANCER
(CISTO): UPDATE ON AN ONGOING
MULTICENTER PRAGMATIC STUDY
John Gore*, Erika Wolff, Bryan Comstock,
Kristin Follmer, Michael Nash, On Ho, Seattle,
WA, Stephanie Chisolm, Bethesda, MD, Doug
MacLean, Jenney Lee, Sarah Lawrence, Seattle,
WA, Danielle Lavallee, Vancouver, Canada, Yair
Sima Porten, San Francisco, CA, Larry Kessler,
Seattle, WA, Angela Smith, Chapel Hill, NC, CIS-
TO Collaborative, Seattle, WA
SATURDAY
2:40
PD26-11 DOES SURGEON’S OPINION DURING THE
PRIMARY TRANSURETHRAL RESECTION
OF BLADDER TUMOR SURROGATE THE
NEED FOR REPEATED RESECTION? A
PRELIMINARY RESULTS
Cairo, Egypt, Ahmed Harraz, Mohamed Ramez,
Islam M Hawash, Abdullah A Sobh, Ahmed
Elghareeb, Ahmed Elhussein Abolazm, R.F.
Elbaz, Ahmed Elkarta, Ahmed Lashin, Rasha T
Abouelkheir, Ahmed Mosbah, Mansoura, Egypt
2:50
PD26-12 HIVEC-E: SPANISH MULTICENTER
PROSPECTIVE EXPERIENCE WITH
RECIRCULANT HYPERTHERMIC MMC WITH
Ana Plata Bello*, La Laguna-Santa Cruz de
Tenerife, Spain, Felix Guerrero-Ramos, Madrid,
Spain, Carlos García, La Laguna-Santa Cruz
de Tenerife, Spain, Alejandro González Diaz,
Ignacio González-Valcárcel, Jose Manuel De la
Morena-Gallego, Francisco Javier Diaz Goizueta,
Madrid, Spain, Julio Fernández-Alamo, Torrejon
de Ardoz, Spain, Victoria Gonzalo, Javier Mon-
tero, Burgos, Spain, Alejandro Sousa-Escandon,
Juan Leon, Monforte de Lemos, Spain, Jose Luis
Pontones, Francisco Delgado, Valencia, Spain,
Miguel Adriazola, Angela Pascual, Palencia,
Spain, Jesus Calleja, Ana Ruano, Valladolid,
Spain, Luis Martinez-Piñeiro, Javier Angulo-Cues-
ta, Madrid, Spain
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
123
Saturday, May 14, 2022 1:00 pm – 3:00 pm

Podium Session 27
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY II
Room 255 @ Ernest N. Morial Convention Center
Moderators: Sanoj Punnen & Andreas Gross

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
1:00
PD27-01 PREDICTING EXTRA-PROSTATIC EXTENSION 1:50
PD27-06 INCREASED AWARENESS OF SURGICAL
(EPE) FOR SURGICAL GUIDANCE IN OUTCOMES IMPROVES LONG-TERM
PROSTATE CANCER: A COMPARISON OF FUNCTIONAL OUTCOMES AFTER ROBOT-
BIOPSY PATHOLOGY, MULTIPARAMETRIC ASSISTED RADICAL PROSTATECTOMY. A
MRI, AND PSMA-PET PROSPECTIVE ASSESSMENT FOLLOWING
Clinton Bahler*, Mark Green, Mark Tann, Katrina IMPLEMENTATION OF PROSPECTIVE DATA
Collins, Jordan Swensson, Eric Brocken, Liang COLLECTION
Cheng, Carla Mathias, Indianapolis, IN, David Giuseppe Cirulli*, Milan, Italy, Giuseppe Rosiel-
Alexoff, Hank Kung, Philadelphia, PA, Gary lo, Elio Mazzone, Milano, Italy, Nicola Fossati,
Hutchins, Michael Koch, Indianapolis, IN Lugano, Switzerland, Francesco Barletta, Simone
Scuderi, Daniele Robesti, Milano, Italy, Gior-
1:10
PD27-02 IS CAPSULAR ABUTMENT ON MRI A
gio Gandaglia, Milan, Italy, Lorenzo Toneatto,
PREDICTOR OF EXTRAPROSTATIC
Gianmarco Colandrea, Riccardo Leni, Lucia
EXTENSION (EPE) ON RADICAL
D’Ambrosio, Antony Pellegrino, Leonardo Quarta,
PROSTATECTOMY?
Milano, Italy, Andrea Gallina, Lugano, Switzer-
Mohammad Siddiqui*, Jonathan Aguiar, Eric Li,
land, Vito Cucchiara, Milan, Italy, Alberto Martini,
Brandon Ansbro, Moataz Soliman, Mary-Kate
Milano, Italy, Sabrina Comana, Milan, Italy,
Keeter, Quan Mai, Edward Schaeffer, Ashley
Armando Stabile, Milano, Italy, Enrico Camisassa,
Ross, Chicago, IL
Milan, Italy, Federico Dehò, Varese, Italy, Franc-
1:20
PD27-03 FEASIBILITY OF NONLINEAR MICROSCOPY esco Montorsi, Alberto Briganti, Milano, Italy
TECHNIQUE FOR EVALUATING
2:00
PD27-07 PROSTATE VOLUME, BASELINE URINARY
PROSTATECTOMY MARGINS IN REAL TIME
SYMPTOMS, AND THEIR ASSOCIATION WITH
May Jean Counsilman*, Yuchen Liu, Yue Sun,
POST-TREATMENT URINARY FUNCTION IN
Seymour Rosen, Boston, MA, Lucas Cahill,
MEN TREATED FOR LOCALIZED
Tadayuki Yoshitake, James Fujimoto, Cam-
PROSTATE CANCER
bridge, MA, Yubo Wu, Allison Kleeman, Jeffrey
Jacob Tallman*, Christopher Wallis, Li-Ching
Sun, Boston, MA, Timothy Weber, Sagar Doshi,
Huang, Zhiguo Zhao, David Penson, Tatsuki
Cambridge, MA, Peter Chang, Andrew Wagner,
Koyama, Ralph Conwill, Nashville, TN, Michael
Boston, MA
Goodman, Atlanta, GA, Ann Hamilton, Los Ange-
1:30
PD27-04 ROBOT-ASSISTED PSMA-RADIOGUIDED les, CA, Xiao-Cheng Wu, New Orleans, LA, Lisa
SALVAGE SURGERY IN RECURRENT Paddock, Antoinette Stroup, New Brunswick, NJ,
PROSTATE CANCER USING A DROP- Matthew Cooperberg, San Francisco, CA, Mia
IN GAMMA PROBE - A PROSPECTIVE Hashibe, Brock O’Neil, Salt Lake City, UT, Sherrie
FEASIBILITY STUDY Kaplan, Sheldon Greenfield, Irvine, CA, Karen
Hilda de Barros*, Amsterdam, Netherlands, Hoffman, Houston, TX, Daniel Barocas,
Matthias van Oosterom, Leiden, Netherlands, Nashville, TN
Maarten Donswijk, Jeroen Hendrikx, André Vis,
2:10
PD27-08 PREDICTORS AND TRENDS OF OPIOID-
Amsterdam, Netherlands, Tobias Maurer, Ham-
SPARING RADICAL PROSTATECTOMY FROM
burg, Germany, Fijs van Leeuwen, Leiden, Neth-
A LARGE NATIONAL COHORT
erlands, Henk van der Poel, Pim van Leeuwen,
Aaron Brant*, Patrick Lewicki, Alec Zhu, Christina
Amsterdam, Netherlands
Sze, Jeffrey Johnson, Christopher Gaffney,
1:40
PD27-05 RELIABILITY OF 68GA-PSMA PET/CT New York, NY, Ilon Weinstein, Anise Bowman,
IN ASSESSING REAL NODAL BURDEN Jonathan Shoag, Cleveland, OH
IN MEN WITH CN1 DISEASE: CLINICAL
2:20
PD27-09 PRELIMINARY FINDINGS OF A
IMPLICATIONS FOR PATIENT COUNSELLING
PROSPECTIVE, RANDOMIZED CONTROLLED
AND MULTI-MODAL TREATMENTS
PILOT STUDY EVALUATING THE RECOVERY
Daniele Robesti*, Elio Mazzone, Milano, Italy,
OF POTENCY AND CONTINENCE
Giorgio Gandaglia, Armando Stabile, Milan, Italy,
FOLLOWING ROBOTIC PROSTATECTOMY
Carlo Andrea Bravi, Andrea Necchi, Daniele
WITH AND WITHOUT UMBILICAL CORD
Raggi, Laura Marandino, Milano, Italy, Giuseppe
ALLOGRAFT
Cirulli, Milan, Italy, Nazareno Suardi, Genoa,
Tanner Corse*, Mutahar Ahmed, Linda Dayan,
Italy, Eleonora Balestrazzi, Stefano Fanti, Andrea
Jay Zaifman, Nutley, NJ, Michael Degen,
Farolfi, Lorenzo Bianchi, Bologna, Italy, Shahrokh
Hackensack, NJ, Ravi Munver, Michael Stifelman,
F. Shariat, Vienna, Austria, Riccardo Schiavina,
Nutley, NJ
Bologna, Italy, Francesco Montorsi, Alberto Brig-
anti, Milano, Italy

124
2:30
PD27-10 ORGASMIC DYSFUNCTION FOLLOWING
ROBOT-ASSISTED RADICAL
PROSTATECTOMY: A SINGLE CENTER
PREVALENCE STUDY
Masashi Honda*, Ryutaro Shimizu, Shogo Terao-
ka, Tetsuya Yumioka, Noriya Yamaguchi, Hideto
Iwamoto, Shuichi Morizane, Katsuya Hikita,
Atsushi Takenaka, Yonago, Japan Gandaglia, Elio Mazzone, Francesco Barletta,
2:40
PD27-11 PREREHABILITATION CAN IMPROVE
URINARY CONTINENCE IN PATIENTS AFTER
LAPAROSCOPIC RADICAL PROSTATECTOMY
Aleksandra Juszczak*, Tomasz Konecki, Piotr Ku-
twin, Łowicki Roman, Marcin Cichocki, Zbigniew
Jabłonowski, Łódź, Poland
Saturday, May 14, 2022
Podium Session 28
SEXUAL FUNCTION/DYSFUNCTION: SURGICAL THERAPY I
Room 245 @ Ernest N. Morial Convention Center
Moderators: Wayne Hellstrom, David Ralph & Tobias Kohler
ABSTRACT
TIME NUMBER TITLE
1:00
PD28-01 HOW ACCURATE ARE WE WHEN PLACING
SUBMUSCULAR RESERVOIRS DURING
MULTI-COMPONENT PENILE IMPLANT
SURGERY
Bruce Kava*, Amanda Levine, Thomas Master-
son, Nicholas Hauser, Ranjith Ramasamy,
Miami, FL
1:10
PD28-02 MULTICENTER COMPARISON OF SINGLE
DILATION VERSUS SEQUENTIAL DILATION
IN PRIMARY INFLATABLE PENILE
PROSTHESIS PLACEMENT
Daniel Swerdloff*, Zafardjan Dalimov, Phila-
delphia, PA, David Barham, Irvine, CA, Joshua
Ghoulian, Glendale, AZ, Robert Andrianne, Thom-
as Deprez, Liege, Belgium, Zachary Dionise, Dur-
ham, NC, Martin Gross, Lebanon, NH, Georgios
Hatzichristodolou, Nuremberg, Germany, Hossein
Sadeghi-Nejad, Hackensack, NJ, Sherry Huang,
Los Angeles, CA, Aaron Lentz, Durham, NC,
Jeffrey Loh-Doyle, Los Angeles, CA, Jake Miller,
Irvine, CA, Koenraad van Renterghem, Leuven,
Belgium, Sung Hun Park, Seoul, Korea, Republic
of, Maxime Sempels, Liege, Belgium, Jonathan N
Warner, Rochester, MN, Faysal A Yafi, Irvine, CA,
Jay Simhan, Philadelphia, PA 2:00
1:20
PD28-03 THE PENOSCROTAL APPROACH TO PENILE
IMPLANTATION RESULTS IN INCREASED
PENILE, NOT SCROTAL PAIN: IMPORTANT
CONSIDERATIONS FOR PROSTHETIC
UROLOGISTS
Avery Braun*, Daniel Swerdloff, Hira Chaudry,
Alice Xiang, Michelle Chen, Philadelphia, PA,
Martin Gross, Lebanon, NH, Jay Simhan,
Philadelphia, PA
*Presenting author
2:50
PD27-12 ASSESSING THE ROLE OF FRAILTY
STATUS ON ONCOLOGIC AND FUNCTIONAL
OUTCOMES IN PATIENTS TREATED
WITH ROBOT-ASSISTED RADICAL
PROSTATECTOMY FOR LOCALIZED
PROSTATE CANCER
Giuseppe Rosiello*, Simone Scuderi, Giorgio
Daniele Robesti, Riccardo Leni, Lorenzo Toneat-
to, Antony Pellegrino, Leonardo Quarta, Armando
Stabile, Milano, Italy, Vito Cucchiara, Milan, Italy,
Gianmarco Colandrea, Milano, Italy, Sabrina
Comana, Enrico Camisassa, Milan, Italy, Nicola
Fossati, Lugano, Switzerland, Federico Dehò, Va-
SATURDAY
rese, Italy, Francesco Montorsi, Alberto Briganti,
Milano, Italy
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
1:00 pm – 3:00 pm
ABSTRACT
TIME NUMBER TITLE
1:30
PD28-04 RESERVOIR DISTANCE FROM CRITICAL
PELVIC STRUCTURES: RADIOGRAPHIC
COMPARISON OF HIGH SUBMUSCULAR AND
SPACE OF RETZIUS INFLATABLE PENILE
PROSTHESIS PLACEMENT TECHNIQUES
Mehraban Kavoussi*, Grayden Cook, Shaun
Nordeck, Shervin Badkhshan, Samantha Nealon,
Benjamin Dropkin, Gregory Joice, Sarah Sand-
ers, Jeffrey Pruitt, Steven Hudak, Allen Morey,
Dallas, TX
1:40
PD28-05 3-PIECE INFLATABLE PENILE IMPLANT
PUMP MALFUNCTION: MANAGEMENT USING
PUMP REPLACEMENT ALONE
Hisanori Taniguchi*, John Sullivan, Jose Flores,
Carolyn Salter, Helen Bernie, Lawrence Jenkins,
John Mulhall, New York, NY
1:50
PD28-06 COMPLICATION PROFILE OF 3-PIECE
(3P) INFLATABLE PENILE IMPLANT
(IPP) SURGERY AFTER RADICAL
CYSTOPROSTATECTOMY (RC)
John Sullivan*, Jose Flores, Serkan Deveci,
Josep Torremade, Nicole Benfante, Pat Guhring,
Marilyn Parker, John Mulhall, New York, NY
PD28-07 UROLOGY RESIDENT AUTONOMY IN
PERFORMING PENILE PROSTHESES IN THE
VETERANS AFFAIRS (VA) HOSPITALS
Anh Nguyen*, Jacob Veliky, John Fastenau,
Newark, NJ, Devashish Anjaria, Joseph Oliver,
Hossein Sadeghi-Nejad, East Orange, NJ
2:10
PD28-08 BACK TO THE FUTURE: TWO NOVEL
TECHNIQUES FOR LOW SUBMUSCULAR
RESERVOIR PLACEMENT
Mohamed Ahmed*, Rochester, MN, Mohit Khera,
Houston, TX, Matthew (Matt) Ziegelmann,
Sevann Helo, Tobias Köhler, Rochester, MN
125
2:20
PD28-09 SINGLE PERINEAL INCISION IN
SIMULTANEOUSLY PLACED PENILE
IMPLANT AND ARTIFICIAL SPHINCTER: A
COMPARISON OF COMPLICATIONS AND
DEVICE LONGEVITY
Kirema Macharia, Kyle Blum*, Travis Green,
Justin Mehr, Leyla Akhverdiyeva, Alex Leonard,
Run Wang, Houston, TX
2:30
PD28-10 CONCOMITANT UROLOGIC PROCEDURES
DURING PENILE PROSTHESIS SURGERY
Jason Levy*, Ridwan Alam, Baltimore, MD, Wil-
liam Ducomb, Detroit, MI, Arthur Burnett,
Baltimore, MD
Saturday, May 14, 2022
Podium Session 29
TRAUMA/RECONSTRUCTION/DIVERSION: EXTERNAL GENITALIA RECONSTRUCTION AND UROTRAUMA
(INCLUDING TRANSGENDER SURGERY) II
Room 244 @ Ernest N. Morial Convention Center
Moderators: Richard Santucci, Frank Burks & Andre van der Merwe
ABSTRACT
TIME NUMBER TITLE
1:00
PD29-01 SELECTIVE ANGIOEMBOLIZATION
IS ASSOCIATED WITH NEED FOR
HEMODIALYSIS AFTER HIGH-GRADE
RENAL TRAUMA
Stephen Hill*, George Koch, Jackson Cabo,
Rohan Bhalla, Abimbola Ayangbesan, Helen
Gambrah, Niels Johnsen, Nashville, TN Gurnee, IL, Joshua Broghammer, Kansas City,
1:10
PD29-02 RISK OF HYPERTENSION AFTER RENAL
TRAUMA
Matthew S Swallow*, Odinachi I Moghalu, Joshua
J Horns, Benjamin J McCormick, Jeremy B My-
ers, Salt Lake City, UT
1:20
PD29-03 IMPACT OF HOSPITAL VOLUME ON
THE OUTCOMES OF RENAL TRAUMA
MANAGEMENT
Paul Baloche, Nicolas Szabla, Caen, France, Lu-
cas Freton, Rennes, France, Marine Hutin, Mont-
pellier, France, Marina Ruggiero, Paris, France,
Inès Dominique, Lyon, France, Clémentine Millet,
Clermont Ferrand, France, Sébastien Berger-
at, Strasbourg, France, Paul Panayotopoulos,
Angers, France, Reem Betari, Amiens, France,
Xavier Matillon, Lyon, France, Ala Chebbi, Rouen,
France, Thomas Caes, Lille, France, Pierre-Ma-
rie Patard, Toulouse, France, Nicolas Brichart,
Orléans, France, Laura Sabourin, Clermont
Ferrand, France, Charles Dariane, Paris, France,
Michael Baboudjian, Bastien Gondran-Tellier,
Nantes, France, Cédric Lebacle, Paris, France,
François-Xavier Madec, Nantes, France,
François-Xavier Nouhaud, Rouen, France, Xavier
Rod, Nantes, France, Gaelle Fiard, Grenoble,
France, Benjamin Pradere, Tours, France, Benoit
Peyronnet*, Rennes, France
126
2:40
PD28-11 VALUE OF ROUTINE PRE-OPERATIVE
CYSTOSCOPY PRIOR TO INSERTION OF
PENILE PROSTHESIS
Leonid Aksenov*, Zachary Dionise, Durham, NC,
Faysal Yafi, Newport Beach, CA, Aaron Lentz,
Durham, NC
2:50
PD28-12 MODIFIED TEP: A NOVEL WAY TO OPTIMIZE
PENILE GIRTH AND LENGTH ENHANCEMENT
POST IPP
Shirin Razdan*, Ariel Zisman, Robert Valenzuela,
New York, NY
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
1:00 pm – 3:00 pm
ABSTRACT
TIME NUMBER TITLE
1:30
PD29-04 COMPARISON OF STRICTURE
CHARACTERISTICS AND URETHROPLASTY
SUCCESS RATES CAUSED BY EXTERNAL
VERSUS INTERNAL URETHRAL TRAUMA
Faizan Khawaja*, Kevin Flynn, Iowa City, IA,
Shawn Grove, Minneapolis, MN, Nejd Alsikafi,
KS, Jill Buckley, San Diego, CA, Sean Elliott, Min-
neapolis, MN, Jeremy Myers, Salt Lake City, UT,
Andrew Peterson, Durham, NC, Keith Rourke,
Edmonton, Canada, Thomas Smith III, Houston,
TX, Alex Vanni, Burlington, MA, Lee Zhao, New
York City, NY, Bradley Erickson, Iowa City, IA
1:40
PD29-05 THE EFFECT OF BIKE SEAT MODELS ON
PERINEAL PRESSURE DURING CYCLING:
IMPLICATIONS FOR PATIENTS AFTER
URETHRAL SURGERY
Behnam Nabavizadeh*, San Francisco, CA,
Gregory Amend, New York, NY, Anthony Enri-
quez, Nizar Hakam, Jason Lui, Kevin Li, Patrick
Low, Behzad Abbasi, Nathan Shaw, Benjamin
Breyer, San Francisco, CA
1:50
PD29-06 AN ANALYSIS OF COMBAT-RELATED
UROLOGIC INJURIES
Shane Kronstedt*, Piscataway, NJ, Andrew Fish-
er, Albuquerque, NM, Joseph Boyle, Piscataway,
NJ, Daniel Grabo, Morgantown, WV, Michael
April, Fort Carson, CO, Steven Schauer, San
Antonio, TX
2:00
PD29-07 THE MANAGEMENT AND OUTCOMES OF
VESICOVAGINAL FISTULA REPAIR
Rachel Barratt*, Alejandro Mercado Campero,
Jeremy Ockrim, Tamsin Greenwell, London,
United Kingdom
2:10
PD29-08 PENUMA© IMPLANT SURGERY - A SAFETY
AND EFFICACY TRIAL
Ariel Zisman*, Alexandra Siegal, Shirin Razdan,
Robert Valenzuela, New York, NY
2:20
PD29-09 PRIMARY CLOSURE IS SUPERIOR TO 2:40
PD29-11 INTRA-ABDOMINAL COMPLICATIONS
SECONDARY INTENTION FOR TREATING FOLLOWING PERITONEAL FLAP
FOURNIER GANGRENE VAGINOPLASTY
Peter Sam*, Andrew Zilavy, Carolyn Ice, Maxx Isabel Robinson*, Rachel Bluebond-Langner, Lee
Gallegos, Albuquerque, NM Zhao, New York, NY
2:30
PD29-10 RETROSPECTIVE ANALYSIS OF 2:50
PD29-12 IS A BMI CUTOFF FOR GENDER
PHALLOPLASTY BY A SPECIALIZED AFFIRMATION SURGERY SCIENTIFICALLY
TRANSGENDER SURGERY CENTER SUPPORTED?
Brenna Briles*, Houston, TX, Jessica Gondran, Erin Carter*, Salt Lake City, UT, Michael Safir,
Austin, TX, Emma R. Linder, Chicago, IL, Michael San Francisco, CA, Ashley DeLeon, Curtis Crane,
Safir, Curtis Crane, Richard Santucci, Austin, TX Richard Santucci, Austin, TX
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM

SATURDAY
Saturday, May 14, 2022 1:00 pm – 3:00 pm
Podium Session 30
EDUCATION RESEARCH III
Room 243 @ Ernest N. Morial Convention Center
Moderators: Simone Thavaseelan & Kirsten Greene

ABSTRACT
TIME NUMBER TITLE
1:00
PD30-01 OBSERVED DIFFERENCES IN UROLOGY
RESIDENT OPERATIVE AUTONOMY
ASSOCIATED WITH PATIENT RACE
Anh Nguyen*, Jacob Veliky, John Fastenau,
Newark, NJ, Devashish Anjaria, Joseph Oliver,
Anastasia Kunac, Hossein Sadeghi-Nejad, East
Orange, NJ Houston, TX, Ruslan Korets, Brian H. Eisner,
1:10
PD30-02 ASSESSING THE PERCEIVED IMPORTANCE
OF SELECTION CRITERIA FOR UROLOGY
RESIDENCY BY UNDER-REPRESENTED IN
MEDICINE APPLICANTS
Efe Chantal Ghanney Simons*, Parris A. Diaz,
Los Angeles, CA, Rebecca Takele, Blacksburg,
VA, Serena Does, Utrecht, Netherlands, Nicholas
J. Jackson, Los Angeles, CA, Samuel L. Wash-
ington III, San Francisco, CA, Benjamin N. Breyer,
San Francisco, CA, Tracy M. Downs, Charlottes-
ville, VA, Christopher Saigal, Los Angeles, CA San Francisco, CA, Tracy M. Downs, Charlottes-
1:20
PD30-03 TOTAL FINANCIAL BURDEN OF INCREASING
UROLOGY RESIDENCY APPLICATIONS ON
APPLICANTS AND PROGRAMS
Kevin Koo*, Elizabeth Bearrick, Bridget Findlay,
Candace Granberg, Rochester, MN Lauren Conroy*, Kyle Blum, Hannah Slovacek,
1:30
PD30-04 THE FATE OF THE UNMATCHED UROLOGY
APPLICANT
Rebecca Takele*, Annandale, VA, Nishant Patel,
Charlottesville, VA, Ryan Dobbs, Chicago, IL TRAINING
1:40
PD30-05 INTERNATIONAL MEDICAL GRADUATES IN
UROLOGY: TRACKING SUCCESS THROUGH
RESEARCH EXPERIENCE
David E. Hinojosa-Gonzalez*, Anton Wintner,
Dimitar V. Zlatev, Boston, MA, Wesley A. Mayer,
Houston, TX, Ruslan Korets, Brian H. Eisner,
Boston, MA
ABSTRACT
TIME NUMBER TITLE
1:50
PD30-06 TRENDS IN PUBMED-INDEXED RESEARCH IN
MATCHED UROLOGY APPLICANTS: YEARLY
ANALYSIS OF THE 2017-2021 MATCH
CYCLES
David E. Hinojosa-Gonzalez*, Dimitar V. Zlatev,
Anton Wintner, Boston, MA, Wesley A. Mayer,
Boston, MA
2:00
PD30-07 THE USE OF USMLE STEP 1 AND USMLE
STEP 2 REQUIRED MINIMUM SCORES
IN SCREENING UROLOGY RESIDENCY
APPLICANTS FOR INTERVIEW OFFERS
Efe Chantal Ghanney Simons*, Parris A. Diaz,
Los Angeles, CA, Rebecca Takele, Blacksburg,
VA, Serena Does, Utrecht, Netherlands, Nicholas
J. Jackson, Los Angeles, CA, Samuel L. Wash-
ington III, San Francisco, CA, Benjamin N. Breyer,
ville, VA, Christopher Saigal, Los Angeles, CA
2:10
PD30-08 UROLOGIC TRAINEE SURGICAL
ASSESSMENT TOOLS: SEEKING
STANDARDIZATION
Phillip Mann, Steven Canfield, Houston, TX
2:20
PD30-09 IMPACT AND IMPLICATIONS OF THE
COVID-19 PANDEMIC ON UROLOGIC
Brandon Piyevsky, Dayton, OH, John Maclean*,
Anqing Li, Stephen Rhodes, Megan Prunty, Erin
Jesse, Anood Alfahmy, Ramy Abou-Ghayda,
Michael Zell, Michael Callegari, Cleveland, OH

*Presenting author 127

2:30
PD30-10 ARE ACADEMIC MEDICINE SOCIAL MEDIA 2:50
PD30-12 COMPARISON OF UROGYNECOLOGICAL
INFLUENCERS ACTUALLY INFLUENCING TRAINING AMONG US UROLOGY AND
CITATION RATES? OBSTETRICS AND GYNECOLOGY
Shirley Wang*, Baltimore, MD, Christopher RESIDENTS AND THE IMPACT FPMRS
Meilchen, Galveston, TX, Pranjal Agrawal, Mary FELLOWSHIP AND DEDICATED ROTATION
Rostom, Gaurish Agrawal, Baltimore, MD, Justin TIME HAVE ON TRAINING
M Dubin, Chicago, IL, Andrew T Gabrielson, Michael Hung*, Ashley Huber, Rosen Jeong,
Taylor P Kohn, Baltimore, MD Jason Kim, Stony Brook, NY
2:40
PD30-11 CHARACTERIZATION OF GENDER APPROVED FOR AMA PRA CATEGORY 2
DIFFERENCES IN H-INDEX WITHIN CREDITSTM
UROLOGIC SUBSPECIALTIES
Bridget Findlay*, Rochester, MN, Timothy Lyon,
Jacksonville, FL, Maraika Robinson, Elizabeth
Bearrick, Boyd Viers, Rochester, MN, Colleen
Ball, Jacksonville, FL, Katherine Anderson,
Rochester, MN

Saturday, May 14, 2022 1:00 pm – 3:00 pm

Video Session 5
MISC. BENIGN/TRANSPLANT/RENOVASCULAR
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Marc Bjurlin, Ronald Boris & Sero Andonian

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
1:00
V05-01 3D AUGMENTED REALITY-GUIDED ROBOTIC- 1:40
V05-05 REPAIR OF ENTERO-CONDUIT FISTULA
ASSISTED KIDNEY TRANSPLANTATION: USING ROBOT-ASSISTED LAPAROSCOPY
REVEALING THE CONCEALED Aeen Asghar*, David Strauss, Daniel Eun, Phila-
Alberto Piana*, Gallioli Andrea, Pietro Diana, delphia, PA
Angelo Territo, Josep Maria Gaya, Pavel Gavrilov,
1:50
V05-06 ROBOTIC BILATERAL PELVIC URETERAL
Óscar Rodriguez Faba, Jordi Huguet, Lluis Guira-
SUBSTITUTION AND AUGMENTATION
do, Carme Facundo, Barcelona, Spain, Riccardo
CYSTOPLASTY WITH ILEAL LOOP FOR
Campi, Florence, Italy, Andrea Bellin, Daniele
DISTAL URETERAL STRICTURE AND
Amparore, Turin, Italy, Sergio Serni, Florence, Ita-
RADIATION CYSTITIS: RESULTS AFTER
ly, Joan Palou, Alberto Breda, Barcelona, Spain
1-YEAR FOLLOW UP
1:10
V05-02 SINGLE PORT ROBOT-ASSISTED  Francesca Ambrosini*, Nicolò Testino, Enrico
EXTRAPERITONEAL KIDNEY Vecchio, Flavia Carlini, Marco Borghesi, Naza-
TRANSPLANTATION: TIPS AND TRICKS reno Suardi, Giovanni Camerini, Carlo Terrone,
Aaron Kaviani*, Jihad Kaouk, Mahmoud Abou Genova, Italy
Zeinab, Alp Tuna Beksac, Ethan Ferguson,
2:00
V05-07 ROBOTIC-ASSISTED LAPAROSCOPIC
Yi-Chia Lin, Alvin Wee, Mohamed Eltemamy,
LEFT RENAL VEIN TRANSPOSITION FOR
Cleveland, OH
TREATMENT OF NUTCRACKER SYNDROME
1:20
V05-03 NEAR MISS IN UROLOGICAL SURGERY: Robert Harrison*, Tanner Corse, Michael Stifel-
DEFINITION AND TIPS FOR PREVENTING man, Hackensack, NJ
UNEXPECTED COMPLICATIONS
2:10
V05-08 ROBOTIC-ASSISTED LAPAROSCOPIC LEFT
Stefano Parodi, Stefano Tappero*, Giovanni
SEMINAL VESICULECTOMY AND DISTAL
Guano, Andrea Pacchetti, Francesco Chierigo,
LEFT URETERECTOMY FOR A PATIENT WITH
Guglielmo Mantica, Marco Borghesi, Nazareno
ZINNER SYNDROME
Suardi, Carlo Terrone, Genoa, Italy
Safiya-Hana Belbina*, Scott Spivey-Provencio,
1:30
V05-04 ROBOTIC MANAGEMENT OF SURGICAL Rachel Wallace, Aaron Laviana, Austin, TX
COMPLICATIONS AFTER ROBOT-
2:20
V05-09 VIRTUAL LEARNING AND COLLABORATIVE
ASSISTED RADICAL CYSTECTOMY WITH
WORKING IN A PANDEMIC - HOW TO
INTRACORPOREAL DIVERSION
CHANGE A SUPRAPUBIC CATHETER
Leonardo Misuraca*, Riccardo Mastroianni, Ga-
Damiete Harry*, Barking, United Kingdom
briele Tuderti, Umberto Anceschi, Aldo Brassetti,
Mariaconsiglia Ferriero, Alfredo Maria Bove, Sal-
vatore Guaglianone, Michele Gallucci, Giuseppe
Simone, Rome, Italy

128
2:30
V05-10 ACTIVSIGHT LASER SPECKLE CONTRAST 2:50
V05-12 ROBOTIC-ASSISTED LAPAROSCOPIC
IMAGING COMPARED TO INDOCYANINE EXCISION OF RETROPERITONEAL
GREEN IN RENAL PERFUSION OF AN GANGLIONEUROMA
ANIMAL MODEL Jeffery Lin*, David Ortega, Edward Forsyth,
Jonathan Noël, Celebration, FL, Anya Mascar- Inderbir Gill, Los Angeles, CA
enhas, Boston, MA, Chibueze Nwaiwu, Yao Liu,
APPROVED FOR AMA PRA CATEGORY 2
Providence, RI, Vasiliy Buharin, John Oberlin,
CREDITSTM
Alyson Dechert, Boston, MA, Marcio Moschovas*,
Celebration, FL, Peter Kim, Providence, RI, Vipul
Patel, Celebration, FL
2:40
V05-11 LAPAROSCOPIC MANAGEMENT
OF XANTHOGRANULOMATOUS
PYELONEPHRITIS – COMPARISON OF TWO
DIFFERENT YET SIMILAR CASES

SATURDAY
Catarina Laranjo Tinoco*, Andreia Cardoso,
Ricardo Matos Rodrigues, Sara Anacleto, Ana
Sofia Araújo, Mário Cerqueira Alves, Emanuel
Carvalho-Dias, Braga, Portugal

Saturday, May 14, 2022 1:00 pm – 3:00 pm

ASOCIACIÓN ESPAÑOLA DE UROLOGÍA (AEU)
Room 214 @ Ernest N. Morial Convention Center
1:00 WELCOME MESSAGE 1:45 RECENT ADVANCES IN CRPC
AUA Secretary: John Denstedt Moderator: Alfredo Rodríguez Antolín
Society President: José Luis Álvarez-Ossorio Eric Small
1:05 CURRENT STATUS IN MHSPC 2:05 IMMUNOTHERAPY IN UROLOGY
Moderator: Ana Plata Moderator: José Manuel Cózar
Neal Shore José Antonio Karam
1:25 URODYNAMIC NEWS 2:30 ARE THERE LIMITS TO ROBOTIC SURGERY?
Moderator: Luis Prieto Moderator: Joan Palou
Victor Nitti René Sotelo

Saturday, May 14, 2022 1:00 pm – 4:00 pm

SOCIETY FOR BASIC UROLOGIC RESEARCH (SBUR)
Marlborough Room @ Hilton New Orleans Riverside
Chair: William Ricke
1:00 WELCOME AND INTRODUCTORY REMARKS 2:25 BREAK
Chair: William Ricke
2:35 NONCANONICAL AR FUNCTION IN THE
1:05 MITOCHONDRIAL DYSFUNCTION IN THE AGED DEVELOPMENT OF CASTRATION RESISTANCE
PROSTATE AND LOWER URINARY TRACT Haojie Huang
DYSFUNCTION
2:55 MECHANISMS AND MODELS OF CASTRATION
Teresa Liu
RESISTANCE
1:25 AGING AND INFLAMMATION: MECHANISMS IN Petra Popovics
BLADDER DYSFUNCTION
3:15 5ARI-INDUCED LINEAGE PLASTICITY IN HUMAN
Indira Mysorekar
BPH
1:45 IMPACT OF PNPASE DYSREGULATION IN THE Douglas Strand
AGING LOWER URINARY TRACT
3:35 NEW MECHANISMS INVOLVED IN THE DEVELOP-
Lori Birder
MENT OF CASTRATION RESISTANT PROSTATE
2:05 THE EFFECT OF RADIATION ON AGING CANCER
HALLMARKS, INFLAMMATION AND FIBROSIS, Scott Dehm
IN BLADDER FUNCTION
APPROVED FOR AMA PRA CATEGORY 1 CREDITTM
Bernadette Zwaans

*Presenting author 129

Saturday, May 14, 2022 1:00 pm – 5:00 pm
BRAZILIAN/PORTUGUESE UROLOGY PROGRAM (BPUP)
Room 345 @ Ernest N. Morial Convention Center
Chair: Fernando Kim
1:00 WELCOME AND INTRODUCTIONS DISCUSSION WITH BRAZILIAN PANEL
Panelists: Marcello Gava, Luiz Otavio Torres
1:05 INTRODUCTION OF AUA-SBU SCHOLARS AND
SBU LEADERSHIP BPH
Alfredo Canalini, Fernando Kim Steven Kaplan
1:10 SESSION I: URO-ONCOLOGY DISCUSSION WITH PANEL
Panelists: Thiago Hota, Daniel Moser
PROSTATE CANCER
Angela Smith 3:50 SESSION III: UROLOGIC RECONSTRUCTION
DISCUSSION WITH BRAZILIAN PANEL ERECTILE DYSFUNCTION POST PROSTATECTO-
Panelists: Gustavo Carvalhal, Marcus Sadi MY UPDATE
Arthur Burnett
BLADDER CANCER
Raj Pruthi DISCUSSION WITH PANEL
Panelists: Leonardo Seligra Lopes, Alexandre Miranda
DISCUSSION WITH PANEL
Panelists: Rafael Coelho, Felipe Lott 4:30 CLOSING REMARKS
2:30 SESSION II: MEN’S HEALTH OR BPH/LUTS APPROVED FOR AMA PRA CATEGORY 1 CREDITTM
MEN’S HEALTH
Jesse Mills

Saturday, May 14, 2022 1:00 pm – 5:00 pm

KOREAN WORLD UROLOGIC CONGRESS (KWUC)
St. James Ballroom @ Hilton New Orleans Riverside
Chair: Sung Kyu Hong
1:00 WELCOME ADDRESS BY KUA PRESIDENT & AUA THE ROLE OF BETA-3 ADRENOCEPTOR AGONIST
Society President: Sang Don Lee FOR THE TREATMENT OF BLADDER DYSFUNC-
TION IN CHILDREN
1:10 PROSTATE CANCER
Joan Ko
Moderators: Jun Hyuk Hong, Isaac Kim
DISCUSSION
GENETIC TESTING IN ADVANCED PROSTATE
Panelists: Byunghoon Kim, Joan Ko, Robert Kovell,
CANCER: WHEN? HOW? AND WHOM?
Hwancheol Son
Seok-Soo Byun
2:55 BREAK
ROBOTIC RADICAL PROSTATECTOMY USING
HUGO SYSTEM: TECHNIQUES AND TIPS 3:00 KIDNEY CANCER
James Porter Moderator: Seongil Seo
EVOLVING ROLE OF PSMA PET/CT IN LOCALIZED PREDICTING AGGRESSIVE BEHAVIOR IN SMALL
PROSTATE CANCER RENAL MASSES BEFORE THE TREATMENT:
Ji Youl Lee RADIOMICS APPLICATION
Ashok Hemal
DISCUSSION
Panelists: Hong Koo Ha, Taek Won Kang, Brian McNeill, CURRENT AND FUTURE OF ADJUVANT
James Porter THERAPY IN ADVANCED RCC?
2:00 BREAK WHICH APPROACH IS BETTER FOR 1ST LINE
THERAPY IN METASTATIC RCC? IO+IO VS IO+TKI
2:05 ANDROLOGY & PEDIATRICS
Chan Ho Lee
Moderators: Sang Don Lee, Chester Koh
3:30 DISCUSSION
IS PENILE REHABILITATION STILL VALUABLE
Panelists: Ashok Hemal, Sung-Hoo Hong, Jung Ki Jo
FOR PATIENTS AFTER PROSTATECTOMY?
Robert Kovell
POST-FINASTERIDE SYNDROME & SEXUAL
HEALTH IN YOUNG MEN; IS IT REALLY
DANGEROUS?
Min Chul Cho

130
Saturday, May 14, 2022
Moderated Poster Session 31
HEALTH SERVICES RESEARCH: QUALITY IMPROVEMENT & PATIENT SAFETY II
Room 228 @ Ernest N. Morial Convention Center
Moderators: Timothy Daskivich & Ted Skolarus
ABSTRACT
TIME NUMBER TITLE
MP31-01 MINIMIZING NARCOTICS: A RANDOMIZED-
CONTROLLED TRIAL COMPARING
PERCOCET TO KETOROLAC AFTER KIDNEY
STONE SURGERY
Mathew Demasi, Cleveland, OH, Michal Segall*,
Nathan Feiertag, Amanda Mengotto, Pablo Cuar-
tas, Justin Loloi, Bronx, NY, Jordan Ahn, Boston,
MA, Josh Stern, Melissa Laudano, Kara Watts,
Bronx, NY
MP31-02 DECREASED OPIOID USE & EQUIVALENT
PAIN SCORE OUTCOMES AFTER UROLOGIC
ROBOTIC SURGERY USING A SIMPLIFIED
OPIOID MINIMIZATION PROTOCOL: A
PROSPECTIVE, NON-INFERIORITY STUDY
Sofia Gereta*, Safiya-Hana Belbina, Elizabeth
Blankenship, J. Stuart Wolf Jr., E. Charles
Osterberg, Aaron A. Laviana, Austin, TX
MP31-03 A PROSPECTIVE INTERVENTION OF NO
OPIOIDS PRESCRIPTIONS AT DISCHARGE
AFTER SURGERY (NOPIODS) IN UROLOGIC
ONCOLOGY
Zorawar Singh*, Kevin Carnes, Leanne Lorenz,
Paul Feustel, Hugh Fisher, Ronald Kaufman,
Theodore Cangero, Badar Mian, Albany, NY
MP31-04 PASSIVE OPIOID STEWARDSHIP INITIATIVES
ASSOCIATED WITH SIGNIFICANT CHANGE
IN OPIOID PRESCRIBING FOLLOWING
UROLOGIC SURGERY
Tudor Borza, Emily Serrell*, Manasa Ven-
katesh, Jeremy Goodman, Elise Lawson, Sudha
Quamme, Kyle Richards, David Jarrard, Madison,
WI, Caprice Greenberg, Augusta, GA, Corrine
Voils, Jessica Schumacher, Madison, WI
MP31-05 LARGE SCALE IMPLEMENTATION OF
OPIOID PRESCRIPTION REDUCTION AFTER
ROBOTIC PROSTATECTOMY – 2 YEAR
EVALUATION FROM THE PENNSYLVANIA
UROLOGIC REGIONAL COLLABORATIVE
(PURC)
Thenappan Chandrasekar*, Philadelphia, PA, Ne-
cole Streeper, Charles Keith, Hershey, PA, Andrea
Quin, Kaynaat Syed, Alexander Kutikov, Phila-
delphia, PA, John Danella, Danville, PA, Thomas
Lanchoney, Paoli, PA, Jeffrey Tomaszewski,
Camden, NJ, Edouard Trabulsi, Adam Reese,
Marc Smaldone, Robert Uzzo, Thomas Guzzo,
Philadelphia, PA, Jay Raman, Hershey, PA, Adrien
Bernstein, Daniel Lee, Philadelphia, PA
MP31-06 REAL-TIME MEASUREMENT OF PATIENT
REPORTED OUTCOMES AND OPIOID USE
FOLLOWING UROLOGIC PROCEDURES
USING AUTOMATED TEXT MESSAGING
Daniel Lee*, Anish Agarwal, Zarina Ali, Ruiying
Xiong, Evan Spencer, Jessica Hemmons, Kit
Delgado, Philadelphia, PA
*Presenting author
2:45 pm – 4:00 pm
ABSTRACT
TIME NUMBER TITLE
MP31-07 ATTITUDES TOWARDS THE USE OF
MEDICAL MARIJUANA AMONG HEALTH
CARE WORKERS: A PILOT STUDY
Leah Beland*, Darius Paduch, New Hyde Park, NY
SATURDAY
MP31-08 USE OF SMOKING CESSATION
PHARMACOTHERAPY FOLLOWING
CYSTECTOMY AMONG SMOKERS WITH
BLADDER CANCER
Eli Rapoport*, New York, NY, Marc Bjurlin,
Chapel Hill, NC, Helena Furberg,
Timothy Donahue, Bernard Bochner,
Jamie Ostroff, Richard Matulewicz,
New York, NY
MP31-09 DECREASED URETERAL STENT DURATION
AFTER RADICAL CYSTECTOMY AND
ILEAL CONDUIT URINARY DIVERSION IS
ASSOCIATED WITH DECREASED RATE OF 30
AND 90-DAY COMPLICATIONS
David Miller*, Danielle Sharbaugh, Cameron
Jones, John Myrga, Jennifer Mihalo, Michelle
Yu, Tatum Tarin, Robert Turner, Bishoy Gayed,
Benjamin Davies, Bruce Jacobs, Pittsburgh, PA
MP31-10 SYSTEMATIC REVIEW AND META-ANALYSIS
OF FRAILTY INDICES IN UROLOGIC
SURGERY: RISK PREDICTION
OF POSTOPERATIVE COMPLICATIONS
Jane Kurtzman*, Preston Kerr, Rashed Kosber,
Steven Brandes, New York, NY
MP31-11 THE GERIATRIC NUTRITIONAL RISK
INDEX PREDICTS POSTOPERATIVE
COMPLICATIONS IN PATIENTS UNDERGOING
RADICAL NEPHRECTOMY FOR RENAL
CANCER: A PROPENSITY SCORE-MATCHED
ANALYSIS
Carlos Riveros*, Victor Chalfant, Ahmed Elshafei,
KC Balaji, Jacksonville, FL
MP31-12 HIGH LEVELS OF HIDDEN SEGREGATION
EXIST FOR BLACK AND WHITE PATIENTS
UNDERGOING CANCER SURGERY WITHIN
THE SAME HOSPITAL
Lillian Lai*, Addison Shay, Sitara Murali, Phyllis
Yan, John Hollingsworth, Ann Arbor, MI
MP31-13 DISPARITIES IN RACE AND ETHNICITY
REPORTING IN CONTEMPORARY CLINICAL
TRIALS LEADING TO NEW
DRUG APPROVALS IN UROLOGY
Andres Guillen Lozoya*, Vidit Sharma, Bradley
Leibovich, Candace Granberg, Patricio Gargollo,
Kevin Koo, Rochester, MN
131
 MP31-14 VARIATION IN COMMUNICATION OF
SIDE EFFECTS IN PROSTATE CANCER
TREATMENT CONSULTATIONS
Aurash Naser-Tavakolian*, Rebecca Gale,
Michael Luu, Abhishek Venkataramana, Los An-
geles, CA, Dmitry Khodyakov, Santa Monica, CA,
Edwin Posadas, Howard Sandler, Jennifer Anger,
Brennan Spiegel, Stephen Freedland, Timothy
Daskivich, Los Angeles, CA
MP31-15 TELEUROLOGY: EXPANDING HORIZONS TO
INPATIENT ECONSULTS
Nathan Feiertag*, Benjamin Green, Justin Loloi,
Brendon Hopgood, Farzaan Kassam, Olsjon
Shperdheja, Priya Dave, Jubin Matloubieh, Jen-
nifer Nauheim, Mustufa Babar, Max Abramson,
Alex Sankin, Nitya Abraham, Ahmed Aboumo-
hamed, Alexander Small, Jillian Donnelly, Frank
Lowe, Melissa Laudano, Kara Watts, Bronx, NY
MP31-16 FEASIBILITY AND ACCEPTABILITY OF
SHARED MEDICAL APPOINTMENTS
UTILIZING TELEHEALTH MEDICINE FOR
KIDNEY STONE PREVENTION
Necole Streeper*, Rachael Smith, Megan Beyer,
Hershey, PA
Saturday, May 14, 2022
Moderated Poster Session 32
SURGICAL TECHNOLOGY & SIMULATION: INSTRUMENTATION & TECHNOLOGY I
Room 225 @ Ernest N. Morial Convention Center
Moderators: William Roberts, Prokar Dasgupta & D. Duane Baldwin
ABSTRACT
NUMBER TITLE
MP32-01 COMPARISON OF 1.9MM TRILOGY PROBE
AND MOSES HOLMIUM LASER IN MINI-
PERCUTANEOUS NEPHROLITHOTOMY
Daniel Rosen*, Hanover, MD, Max Drescher,
Baltimore, MD, Julio Davalos, Hanover, MD STONE DUSTING MODEL
MP32-02 DEVELOPMENT OF AN AUTOMATED
IRRIGATION SYSTEM SYNCHRONIZED
WITH AN ULTRA‑MINIATURE FIBER‑OPTIC
PRESSURE SENSOR FOR REGULATING
INTRAPELVIC PRESSURE DURING
URETEROSCOPY: AN EX VIVO PRECLINICAL
STUDY
Takashi Yoshida*, Osaka, Japan, Tadao Matsu-
naga, Tottori, Japan, Noriko Tsuruoka, Sendai,
Japan, Hidefumi Kinoshita, Osaka, Japan, Youichi
Haga, Sendai, Japan
MP32-03 AUTOMATED SEGMENTATION OF KIDNEY
STONES DURING URETEROSCOPY USING
COMPUTER VISION TECHNIQUES
Shaan Setia*, Zachary Stoebner, Daiwei Lu, Ipek
Oguz, Nicholas Kavoussi, Nashville, TN Republic of, Hae Do Jung, Gunpo, Korea, Repub-
132
MP31-17 THE COVID-19 EXPERIENCE WITH
TELEHEALTH FOR MALE HYPOGONADISM: A
CAUTIONARY TALE
John Fisher*, Jorge Rivera-Mirabal, Hudson
Pierece, Kenny Kim, Larry Lipshultz, Houston, TX
MP31-18 MOBILISING THE CLINIC: PERFORMING
TRIALS WITHOUT CATHETERS WITHIN THE
COMMUNITY
Anne Hong*, Cheryl Yeo, Henry Yao, Damien
Bolton, Melbourne, Australia
MP31-19 REDUCING CATHETER ASSOCIATED-
URINARY TRACT INFECTIONS WITH
STERILE, CONTINUOUSLY CLOSED
DRAINAGE SYSTEMS DOES NOT HAVE TO
BE COSTLY
Janelle Fox*, Suffolk, VA, Christina Jockel, Leslie
Konyk, Shaina Thomas, Omar Ayyash, Rajeev
Chaudhry, Glenn Cannon, Francis Schneck, Dan-
iel Pelzman, Lindsay Montoya, Pittsburgh, PA
MP31-20 REPROCESSING EFFECTIVENESS FOR
FLEXIBLE URETEROSCOPES: A LOOK AT
THE EVIDENCE
Seth Bechis*, San Diego, CA, Krystina Hopkins,
Cori Ofstead, St Paul, MN
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
2:45 pm - 4:00 pm
ABSTRACT
NUMBER TITLE
MP32-04 ANOTHER ONE BITES THE DUST:
EVALUATING THE EFFICACY OF THE
EXTENDED FREQUENCY RANGE OF THE
MOSES 2.0 LASER SYSTEM IN AN IN VITRO
Patrick Whelan, Christopher Kim,
Christian Tabib*, Pei Zhong, Glenn Preminger,
Michael Lipkin, Durham, NC
MP32-05 BENCHTOP EVALUATION OF MINIATURE
PERCUTANEOUS NEPHROLITHITOMY
LITHOTRITES
Patrick Whelan, Christopher Kim, Christian Ta-
bib*, Durham, NC, Russell Terry, Gainesville, FL,
Glenn Preminger, Michael Lipkin, Durham, NC
MP32-06 FEASIBILITY OF LASER LITHOTRIPSY USING
ROBOTIC RETROGRADE INTRARENAL
SURGERY SYSTEM EASYURETERO AND
AURIGA XL HOLMIUM LASER IN PORCINE
MODEL
Hyun Ho Han*, Young Joon Moon, Seoul, Korea,
lic of, Joonhwan Kim, Byungsik Cheon, Jungmin
Han, Daejeon, Korea, Republic of, Sung Yong
Cho, Seoul, Korea, Republic of, Dong-Soo Kwon,
Daejeon, Korea, Republic of, Joo Yong Lee,
Seoul, Korea, Republic of
 MP32-07 THERMAL EFFECTS OF THE SUPER-PULSE
THULIUM FIBER LASER DURING URETERAL
STONE LASER LITHOTRIPSY: AN IN-VIVO
PORCINE STUDY
Kalon L. Morgan*, Pengbo Jiang, Akhil Peta,
Maged Ayad, Rohit Bhatt, Andrew Brevik, Krista
Larson, Zhamshid Okhunov, Ted Farzeneh, Ros-
han M. Patel, Jaime Landman, Ralph V. Clayman,
Orange, CA
MP32-08 DEVELOPMENT OF A SAFE ALTERNATIVE TO
FOLEY CATHETER (SAFECATH) TO REDUCE
CATHETER-INDUCED TRAUMA
Hersh Bendre*, Graham Lieberman, Jonathan
Kusner, Amy Hao, Francis McGovern, Boston,
MA
MP32-09 PATIENT CONTROLLED URETHRAL
HYDRODISTENTION REDUCES PAIN DURING
MALE FLEXIBLE CYSTOSCOPY
Daniel Wagner*, Chicgo, IL, William Lin,
Chicago, IL
MP32-10 SINGLE PORT ROBOTIC UROLOGIC
SURGERY: FEWER PORTS, HIGHER COSTS
Mark Biebel*, St. Louis, MO, Brijesh Patel,
Ramakrishna Venkatesh, St. Loius, MO, Robert
Figenshau, St. Louis, MO RENAL CRYOABLATION: INSIGHTS FROM
MP32-11 FREE-HAND VERSUS GRID-ASSISTED
TRANSPERINEAL ULTRASOUND MRI-FUSION
PROSTATE BIOPSY: AN INITIAL EXPERIENCE
Jacob Enders*, Nicole Varble, Michael Rothberg,
Zach Kozel, Sheng Xu, Patrick Gomella,
Michael Daneshvar, Reza Seifabadi,
Maria Merino, Baris Turkbey, Bradford Wood,
Peter Pinto, Bethesda, MD
MP32-12 LAPAROSCOPIC RENAL SURGERY
USING MULTI DEGREE-OF-FREEDOM
ARTICULATING LAPAROSCOPIC
INSTRUMENTS IN A PORCINE MODEL
Jong Keun Kim*, Hwaseong, Korea, Republic of,
Bosik Kang, Yu Seon Kim, Yujin Yun, Myoung
Jin Jang, Seoul, Korea, Republic of, Donghwan
Bae, Seongnam, Korea, Republic of, Dalsan You,
Seoul, Korea, Republic of ANALGESIA AFTER RADICAL
MP32-13 TRANSPERITONEAL RADICAL
PROSTATECTOMY USING THE SENHANCE
ROBOTIC SYSTEM: INITIAL CASE SERIES,
LEARNING CURVE AND COST ANALYSIS
Yen-Chun Lin*, Lun-Hsiang Yuan, Shi-Wei
Huang, Yu-Wen Huang, Yunlin, Taiwan,
Chao-Yuan Huang, Taipei, Taiwan
MP32-14 IN VITRO TESTING OF UNTETHERED
THERMAL-ACTUATED MICROGRIPPERS AS A
NOVEL DIAGNOSTIC TOOL FOR UROTHELIAL
TISSUE
Ridwan Alam*, Wangqu Liu, Ezra Baraban, Brian
Matlaga, Andres Matoso, David Gracias, Balti-
more, MD, Jared Winoker, New York City, NY
*Presenting author
MP32-15 MORTALITY RELATED TO THE USE OF
STAPLER DEVICES AND CLIP APPLIERS:
ANALYSIS OF THE FDA MAUDE DATABASE
Balaji Reddy*, Miami, FL, Shirin Razdan, New
York, NY, Sanjay Razdan, Miami, FL
MP32-16 COMPARISON OF PERIOPERATIVE
OUTCOMES OF SINGLE-PORT DA VINCI
SP AND MULTIPORT DA VINCI XI ROBOTIC
SYSTEMS IN ROBOTIC-ASSISTED UROLOGIC
SURGERIES
Christopher Dennis*, Luca Morgantini, Marcin Zu-
berek, Simone Francavilla, Ryan Trippel, Simone
SATURDAY
Crivellaro, Chicago, IL
MP32-17 EFFECTIVITY OF A NOVEL IMPLANTABLE
DEVICE (STIMROUTER) FOR THE
TREATMENT OF OVERACTIVE BLADDER
SYNDROME: 30 MONTHS RESULTS OF A
MULTI-CENTRE STUDY
Mohammad Khaneshi*, Heerlen, Netherlands,
Mohammad Sajjad Rahnama’i, Aachen,
Germany, Sakineh Haj Ebrahimi, Tabriz, Islamic
Republic of Iran
MP32-18 DEVICE-RELATED COMPLICATIONS DURING
THE MANUFACTURER AND USER FACILITY
DEVICE EXPERIENCE (MAUDE) DATABASE
Srinath Kotamarti*, Zoe Michael, Durham, NC,
David Silver, Ervin Teper, Brooklyn, NY, Alireza
Aminsharifi, Hershey, PA, Thomas Polascik, Dur-
ham, NC, Ariel Schulman, Brooklyn, NY
MP32-19 BRIDGING THE GAP – BUILDING SURGICAL
SUBSPECIALTY TELEMEDICINE CLINICS IN
THE RURAL SETTING
Chris Ferrari, Indianapolis, IN, Katharina Mitchell*,
Chad Crigger, Shirley Zupper, Amy Wildasin,
Michael Ost, Brian Hendricks, Osama Al-Omar,
Morgantown, WV
MP32-20 LAPAROSCOPIC VERSUS ULTRASOUND
GUIDED TRANSVERSUS ABDOMINIS
PLANE (TAP) BLOCK FOR POSTOPERATIVE
PROSTATECTOMY: A RANDOMIZED
CONTROLLED TRIAL
Angelo Civitella*, Francesco Prata, Piergiorgio
Tuzzolo, Luca Romei, Vito Giuseppe Crimi,
Francesco Tedesco, Alberto Ragusa, Noemi
Deanesi, Antonio Testa, Loris Cacciatore,
Gerardo Paolo Flammia, Antonio Alcini,
Annamaria Salerno, Rome, Italy, Salvatore Mario
Prata, Sora, Italy, Francesco Esperto, Roberto
Mario Scarpa, Rocco Papalia, Rome, Italy
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
133
Saturday, May 14, 2022 3:00 pm – 5:00 pm

Forums
AUA ROBOTICS THEATER SPONSORED BY INTUITIVE: MULTIPORT BENIGN INNOVATION AND
SURGICAL PROCEDURES - RECONSTRUCTION AND BLADDER CANCER
S&T Hall C: Booth 311 @ Ernest N. Morial Convention Center
Chair: Ashutosh Tewari
AUA ROBOTICS THEATER: MULTIPORT BENIGN
INNOVATION AND SURGICAL PROCEDURES –
RECONSTRUCTION AND BLADDER CANCER
Program Leaders: Craig Rogers, Chandru Sundaram
Panelists: Rajesh Alhawat, Dipen Parikh, James Porter

Saturday, May 14, 2022 3:00 pm – 5:00 pm

SOCIEDAD COLOMBIANA DE UROLOGÍA
St. Charles Ballroom @ Hilton New Orleans Riverside
3:00 INAUGURATION 4:15 NEOADJUVANT PROSTATE CANCER: PRESENT
Society President: Jaime Cajigas AND FUTURE PERSPECTIVES
Adriana Pedraza
3:05 A NEW PROPOSAL IN FENO AND GENO TIPIFICA-
TION IN HIPOSPADIAS AND ITS IMPACT IN THE 4:30 Q&A
SURGERY TECNICHS: USE OF NEW TECHNOLO-
4:35 ROBOTIC SURGERY IN FEMALE UROLOGY FOR
GIES AND ARTFICIAL INTELIGENCE
PROLAPSES, VESICOVAGINAL FISTULAS, VESI-
Nicolas Fernandez
CO URETERAL REIMPLANTATION AND INCONTI-
3:25 MODERN TREATMENT FOR VESICO URETERIC NENCE (ARTIFICIAL SPHINCTER FOR WOMEN)
REFLUX Natalia Hernandez
Pablo Gomez
4:50 Q&A
3:40 SCROTAL APPROACH FOR NO DESCENDED
4:55 FINAL REMARKS
TESTIS: EXPERIENCE AFTER 1,000 CASES
William Quiroga
Juan Carlos Prieto
4:01 MOLECULAR SUBTIPIFICATION OF MUSCLE
INVASIVE BLADDER CANCER; CLINIC
PERSPECTIVES AND LIMITATIONS
Jorge Daza

Saturday, May 14, 2022 3:00 pm - 5:00 pm

Forums
CLINICAL CONTROVERSIES IN MEN’S HEALTH
Room 267 @ Ernest N. Morial Convention Center
Chairs: Michael Eisenberg & Larry Lipshultz
3:00 ARE SPERM COUNTS DECLINING? 4:20 EMERGING OPTIONS FOR THE ORAL
Debater-Pro: Kevin Campbell TREATMENT OF MALE HYPOGONADISM:
Debater-Con: Dolores Lamb PANEL DISCUSSION
DISCUSSION PRO: ORAL PREPARATIONS ARE NEEDED AND
THE NEW ORALS APPEAR TO BE JUST WHAT
3:40 THE FUTURE OF MALE PENILE PROSTHESES:
THE DOCTOR ORDERED
WHAT IS NEEDED AND WHAT LIES AHEAD
Adrian Dobs
WHAT IS NEEDED
CON: THE NEW ORALS MAY BE DIFFICULT TO
Tobias Kohler
TITRATE AND MAY NOT GIVE PATIENTS WHAT
WHAT IS PLANNED THEY WANT: LIMITATIONS AND CONCERNS
Dean Knoll John Mulhall
DISCUSSION APPROVED FOR AMA PRA CATEGORY 1
CREDITTM

134
Saturday, May 14, 2022 3:30 pm - 5:30 pm

Podium Session 31
TRAUMA/RECONSTRUCTION/DIVERSION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE, DIVERTICULUM) II
Room 252 @ Ernest N. Morial Convention Center
Moderators: Sean Elliott, Sanjay Kulkarni & Jerilyn Latini

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
3:30
PD31-01 TRANSURETHRAL CATHETERISATION 4:20
PD31-06 EXPRESSION AND LOCALIZATION OF MIR-
SAFETY VALVE (TUCSV©) FOR THE 146A-5P AND MIR-142-3P IN URETHRAL
PREVENTION OF CATHETER BALLOON SUBMUCOSA OF PATIENTS WITH LICHEN
INFLATION INJURY OF THE URETHRA - A SCLEROSUS-INDUCED URETHRAL
PROSPECTIVE MULTI-INSTITUTIONAL STRICTURE DISEASE

SATURDAY
STUDY Aaron Perecman*, Harjivan Kohli, Brandon
Eabhann O’Connor, Stefanie Croghan*, Dublin, Childs, Travis Sullivan, Burlington, MA, Myrtha
Ireland, Olivia Baird, John Fallon, Peter Lough- Constant, Eric Burks, Boston, MA, Kimberly Rieg-
man, Jibraan Esoof, Limerick, Ireland, Robert er-Christ, Alex Vanni, Burlington, MA
Keenan, James Ryan, Dublin, Ireland, Subhasis
4:30
PD31-07 DOES ORAL HEALTH AND GRAFT
Giri, Limerick, Ireland
HISTOLOGY PREDICT POSTOPERATIVE
3:40
PD31-02 MULTI-CENTERED ASSESSMENT OUTCOMES FOLLOWING ORAL GRAFT
OF FACTORS ASSOCIATED WITH URETHROPLASTY?
EXPLANTATION OF 3RD GENERATION Jane Kurtzman*, Preston Kerr, Rashed Kosber,
ADJUSTABLE TRANSOBTURATOR MALE Carlos Pagan, Mahveesh Chowdhury, Steven
SYSTEM (ATOMS) Brandes, New York, NY
Elizabeth Naud*, Edmonton, Canada, Genevieve
4:40
PD31-08 LONG-TERM OUTCOMES OF URETHRAL
Nadeau, Quebec, Canada, Le-Mai Tu, Sher-
STRICTURE TREATMENT WITH THE
brooke, Canada, Christopher Doiron, Stephen
OPTILUME PACLITAXEL-COATED BALLOON:
Steele, Kingston, Canada, Sender Herschorn,
4-YEAR RESULTS FROM THE ROBUST I
Jennifer Locke, Toronto, Canada, Conrad Macie-
STUDY
jewski, Ottawa, Canada, Neil Dwyer, Moncton,
Sean Elliott*, Minneapolis, MN, Ramon Vira-
Canada, Lysanne Campeau, Montreal, Canada,
soro, Norfolk, VA, Rafael Estrella, Santiago de
Kevin Carlson, Calgary, Canada, Keith Rourke,
los Caballeros, Dominican Republic, Merycarla
Edmonton, Canada
Pichardo, Santo Domingo, Dominican Republic,
3:50
PD31-03 BLADDER OUTLET SURGERIES FOR MEN Ramon Rodríguez Lay, Gustavo Espino, Panama
WITH STRESS URINARY INCONTINENCE City, Panama, Jessica DeLong, Norfolk, VA
AND NEUROGENIC LOWER URINARY
4:50
PD31-09 PROSPECTIVE ASSESSMENT OF GENITAL
TRACT DYSFUNCTION: A MULTICENTER
PAIN IN PATIENTS UNDERGOING
NEUROGENIC BLADDER RESEARCH GROUP
URETHROPLASTY: INCIDENCE,
STUDY
ASSOCIATIONS AND IMPACT OF SURGERY
Javier Santiago*, Ann Arbor, MI, Min Soo Choo,
Declan Rourke*, Jordan Bekkema, Keith Rourke,
Seoul, Korea, Republic of, Richard Mora, Evgeniy
Edmonton, Canada
Kreydin, David A Ginsberg, Los Angeles, CA, Na-
talia Hernandez, Paola Bustillos, Rose Khavari, 5:00
PD31-10 PATIENT AND STRICTURE VARIABLES
Houston, TX, Stephanie Daignault-Newton, John ASSOCIATED WITH FAILURE AFTER
Stoffel, Ann Arbor, MI URETHROPLASTY FOR BULBAR URETHRAL
STRICTURES
4:00
PD31-04 LOWER URINARY TRACT MICROBIOTA
Kevin Flynn*, Iowa City, IA, Shawn Grove, Min-
DYSBIOSIS IS ASSOCIATED WITH URETHRAL
neapolis, MN, Nejd Alsikafi, Gurnee, IL, Joshua
FIBROSIS
Broghammer, Kansas City, KS, Jill Buckley, San
Michael Witthaus*, Valmik Bhargava, Jill Buckley,
Diego, CA, Sean Elliott, Minneapolis, MN, Jeremy
Mahadevan Rajasekaran, San Diego, CA
Myers, Salt Lake City, UT, Andrew Peterson,
4:10
PD31-05 REPEATED TRANSURETHRAL Durham, NC, Keith Rourke, Edmonton, Canada,
INTERVENTIONS INCREASE ELASTIN Thomas Smith III, Houston, TX, Alex Vanni, Burl-
DEGRADATION AND STRICTURE SEVERITY ington, MA, Lee Zhao, New York City, NY, Bradley
Michael Witthaus*, San Diego, CA, Jathin Erickson, Iowa City, IA
Bandari, Rochester, NY, Thomas Will Fuller,
Seattle, WA, Valmik Bhargava, Jill Buckley, Ma-
hadevan Rajasekaran, San Diego, CA

*Presenting author 135

5:10
PD31-11 PATIENT, STRICTURE, AND
URETHROPLASTY PREDICTORS OF
ERECTILE DYSFUNCTION AFTER
URETHROPLASTY FOR BULBAR URETHRAL
STRICTURES
Justin Drobish*, Iowa City, IA, Shawn Grove, Min-
neapolis, MN, Nejd Alsikafi, Gurnee, IL, Joshua
Broghammer, Kansas City, KS, Jill Buckley, San
Diego, CA, Sean Elliott, Minneapolis, MN, Jeremy
Myers, Salt Lake City, UT, Andrew Peterson,
Durham, NC, Keith Rourke, Edmonton, Canada,
Thomas Smith III, Houston, TX, Alex Vanni, Burl-
ington, MA, Lee Zhao, New York City, NY, Bradley
Erickson, Iowa City, IA
Saturday, May 14, 2022
Podium Session 32
INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: KIDNEY & BLADDER III
Room 255 @ Ernest N. Morial Convention Center
Moderators: Kymora Scotland & Michel Pontari
ABSTRACT
TIME NUMBER TITLE
3:30
PD32-01 CARBAPENEM-RESISTANT
ENTEROBACTERIACAE ISOLATES
FROM DUKE UNIVERSITY HOSPITAL
CHARACTERIZED VIA WHOLE GENOME
SEQUENCING
Lauren Elam, Chae Hee Lim, Krishnan Chittur,
Huntsville, AL, Rachel Addison, Sarah S. Lewis,
Becky A. Smith, Deverick Anderson, Durham, NC,
Tatyana Sysoeva*, Huntsville, AL
3:40
PD32-02 POPULATION BASED STUDY ON THE
INCIDENCE AND RISKS OF MULTIDRUG-
RESISTANT ORGANISMS IN PATIENTS WITH
URETERIC STENTS
Runhan Ren*, Zoe Hsu, Erik Youngson, Shubha
De, Edmonton, Canada Griffith, Minneapolis, MN
3:50
PD32-03 TEBIPENEM IN VITRO ACTIVITY AGAINST A
COLLECTION OF PATHOGENS RESPONSIBLE
FOR URINARY TRACT INFECTIONS IN THE
UNITED STATES
S.J. Ryan Arends*, North Liberty, IA, Ian Critch-
ley, Nicole Cotroneo, Cambridge, MA, Jennifer
Streit, Helio Sader, Mariana Castanheira, Rodrigo
Mendes, North Liberty, IA
4:00
PD32-04 D-MANNOSURIA LEVELS MEASURED ONE
HOUR AFTER D-MANNOSE INTAKE SELECT
OUT FAVORABLE RESPONDERS
Ethan Fan*, Jorge Fuentes, Dallas, TX, Marjan
Ganjali Dashti, Larry Reitzer, Richardson, TX,
Alana L. Christie, Philippe E. Zimmern, Dallas, TX
4:10
PD32-05 RATE OF PROGRESSION TO SEPSIS
FOLLOWING PRESENTATION FOR
ACUTE CYSTITIS
Daniela Kaefer*, Jeffrey Chiang,
A. Lenore Ackerman, Los Angeles, CA PERCUTANEOUS NEPHROLITHOTOMY
136
5:20
PD31-12 EVALUATING PREDICTIVE TOOLS FOR
ANTERIOR URETHROPLASTY OUTCOMES: A
COMPARISON OF THE TURNS LSE SYSTEM
AND U-SCORE
Jane Kurtzman*, Rashed Kosber, Preston Kerr,
Steven Brandes, New York, NY
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
3:30 pm - 5:30 pm
ABSTRACT
TIME NUMBER TITLE
4:20
PD32-06 THE ROLE OF PRESEPSIN AS PREDICTIVE
FACTOR FOR SEPSIS IN PATIENTS WITH
URINARY TRACT INFECTION ASSOCIATED
WITH URINARY CALCULI
Yeong Uk Kim*, Jong Gyun Ha, Jae Youn Jang,
Jae Young Choi, Young Hwii Ko, Phil Hyun Song,
Ki Hak Moon, Hee Chang Jung, Daegu, Korea,
Republic of
4:30
PD32-07 MICROBIAL EXPOSURE REDUCES
SUSCEPTIBILITY TO UROPATHOGENIC
E. COLI (UPEC)-INDUCED UROSEPSIS
Matthew Martin*, Whitney Swanson, Tamara Ku-
caba, Minneapolis, MN, Vladimir Badovinac, Iowa
City, IA, Molly Ingersoll, Paris, France, Thomas
4:40
PD32-08 ELEVATED THROMBIN-ANTITHROMBIN
COMPLEX IS A RISK FACTOR OF SEVERE
ACUTE KIDNEY INJURY IN PATIENTS
WITH UROLOGICAL SEPSIS
Masaki Momota*, Hirosaki, Japan
4:50
PD32-09 COMPARISON OF GUIDANCE UTI® AND
STANDARD URINE CULTURE FOR RATES
OF SEPSIS, HOSPITALIZATION AND OTHER
ADVERSE OUTCOMES IN COMPLICATED
URINARY TRACT INFECTIONS
Aparna Ashok*, Dicken Ko, Providence, RI, Emily
Lukacz, La Jolla, CA, Annah Vollstedt, Iowa City,
IA, Iver Juster, San Rafael, CA, Timothy Niecko,
Tierra Verde, FL, David Baunoch, Trabuco Can-
yon, CA, Mohit Mathur, Irvine, CA
5:00
PD32-10 KIDNEY STONE ENDOTOXIN
CONCENTRATION CORRELATES WITH
POST-OPERATIVE SEPSIS FOLLOWING
David T. Tzou*, Farhan Anwar, Ava C. Wong,
David T. Harris, Tucson, AZ, Thomas Chi, San
Francisco, CA, Gayatri Vedantam, Tucson, AZ
5:10
PD32-11 RENAL PELVIS URINE SAMPLING IN
PATIENTS WITH INFECTED, OBSTRUCTING
STONES – A NEW STANDARD PRACTICE?
Majid Mirzazadeh*, Parth Udayan Thakker,
Raymond Xu, Winston Salem, NC Alberto Piana*, Jordi Huguet, Antoni Sanchez-
Saturday, May 14, 2022
Podium Session 33
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY II
Room 245 @ Ernest N. Morial Convention Center
Moderators: Jeffrey Campbell & Alberto Briganti
ABSTRACT
TIME NUMBER TITLE
3:30
PD33-01 COMPREHENSIVE MANAGEMENT OF RENAL
MASSES IN SOLITARY KIDNEYS
Yosuke Yasuda*, JJ Zhang, Nityam Rathi,
Gustavo Roversi, Ao Zhang, Diego Palacios,
Jihad Kaouk, Georges-Pascal Haber, Venkatesh
Krishnamurthi, Robert Abouassaly, Christopher
Weight, Steven Campbell, Cleveland, OH Schiefelbein, Andreas Schneller, Wuerzburg,
3:40
PD33-02 EVALUATION OF AN UNCOMPLICATED
RECOVERY AFTER NEPHRECTOMY: MUSIC-
KIDNEY NOTES (NOTABLE OUTCOMES AND
TRACKABLE EVENTS AFTER SURGERY)
Mohit Butaney*, Detroit, MI, Anna Johnson, Ji Qi,
Ann Arbor, MI, Amit Patel, Detroit, MI, Sabrina
Noyes, Christopher Brede, Grand Rapids, MI,
Brian Seifman, West Bloomfield, MI, Thomas
Maatman, Wyoming, MI, Craig Rogers, Detroit,
MI, Brian Lane, Grand Rapids, MI, for the Michi-
gan Urological Surgery Improvement Collabora-
tive, Ann Arbor, MI 4:10
3:50
PD33-03 IS ANGIOTENSIN SYSTEM INHIBITOR USE
ASSOCIATED WITH IMPROVED OUTCOMES
IN PATIENTS WITH LOCALIZED CLEAR CELL
RCC?
Paige Nichols*, Andrew Zganjar, Christine Lohse,
Sounak Gupta, John Cheville, Cameron Britton,
Aaron Potretzke, Stephen Boorjian, Houston
Thompson, Bradley Leibovich, Vidit Sharma,
Rochester, MN
*Presenting author
5:20
PD32-12 RADICAL CYSTECTOMY FOR THE
TREATMENT OF PELVIC RADIATION
CYSTITIS: A SINGLE HIGH-EXPERIENCE
CENTER STUDY
Puy, Angelo Territo, Pietro Diana, Andrea Gallioli,
Francesco Sanguedolce, Alejandra Bravo, Anto-
nio Rosales, Ruben Parada, Joan Palou, Alberto
Breda, Barcelona, Spain
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
SATURDAY
3:30 pm - 5:30 pm
ABSTRACT
TIME NUMBER TITLE
4:00
PD33-04 PRIOR SURGICAL EXPERIENCE AND THE
IMPACT ON PERIOPERATIVE OUTCOMES IN
ROBOT-ASSISTED PARTIAL NEPHRECTOMY:
A MULTICENTER ANALYSIS WITH 2,500
PATIENTS
Nina N. Harke*, Hannover, Germany, Frank
Germany, Georg Schoen, Munich, Germany,
Clemens G. Wiesinger, Jacob Pfuner, Wels,
Austria, Boris A. Hadaschik, Jan Philipp Radt-
ke, Mulham Al Nader, Essen, Germany, Daniar
Osmonov, Ahmed Eraky, Kiel, Germany, Burkhard
Ubrig, Simon Gloger, Bochum, Germany, Jorn H.
Witt, Nikolaos Liakos, Christian Wagner, Gronau,
Germany, Florian Imkamp, Stephan Huusmann,
Markus A. Kuczyk, Hannover, Germany, Stefan
Siemer, Michael Stoeckle, Philip Zeuschner,
Homburg/Saar, Germany
PD33-05 INCIDENCE AND SIGNIFICANCE OF
20% DECREASE FROM NEW BASELINE
ESTIMATED GLOMERULAR FILTRATION
RATE AFTER RADICAL AND PARTIAL
NEPHRECTOMY
Bo Fan*, Minato Yokoyama, Yosuke Yasuda, Yuki
Nakamura, Yusuke Uchida, Shohei Fukuda, Sho
Uehara, Hajime Tanaka, Soichiro Yoshida, Yoh
Matsuoka, Yasuhisa Fujii, Tokyo, Japan
4:20
PD33-06 SPLIT RENAL FUNCTION IMPROVES
PREDICTION OF GFR AFTER RADICAL
NEPHRECTOMY
Nityam Rathi*, Yosuke Yasuda, Diego Aguilar
Palacios, Cleveland, OH, Hajime Tanaka, Tokyo,
Japan, Yunlin Ye, Guangzhou, China, People’s
Republic of, Jianbo Li, Cleveland, OH, Bimal
Bhindi, Calgary, Canada, Robert Houston, Roch-
ester, MN, Michael Liss, San Antonio, TX, Ithaar
Derweesh, La Jolla, CA, Christopher Weight,
Mohammed Eltemamy, Robert Abouassaly,
Steven Campbell, Cleveland, OH
137
4:30
PD33-07 IMPACT OF AGE ON FUNCTIONAL DECLINE 5:10
PD33-11 IMPACT OF ADHESIVE PERINEPHRIC FAT ON
FOLLOWING RADICAL NEPHRECTOMY: SURGICAL PLANNING AND PERIOPERATIVE
ANALYSIS OF THE INTERNATIONAL MARKER OUTCOMES IN PARTIAL NEPHRECTOMY
CONSORTIUM FOR RENAL CANCER Nina N. Harke*, Hannover, Germany, Frank
(INMARC) Schiefelbein, Andreas Schneller, Wuerzburg,
Mimi Nguyen*, Arman Walia, Ava Saidian, Germany, Georg Schoen, Munich, Germany, Olga
Margaret Meagher, John Matthew Perry, Rekha Katzendorn, Christoph A.J. von Klot, Hannover,
Narasimhan, Madison Chakoumakos, La Jolla, Germany, Julia K. Mühlbauer, Philipp Nuhn,
CA, Viraj Master, Atlanta, GA, Kazutaka Saito, Maximilian C. Kriegmair, Margarete T. Walach,
Tokyo, Japan, Dattatraya Patil, Atlanta, GA, Juan Mannheim, Germany
Javier-DesLoges, La Jolla, CA, Yasuhisa Fujii,
5:20
PD33-12 PRE-OPERATIVE RISK CALCULATOR OF THE
Tokyo, Japan, Ithaar Derweesh, La Jolla, CA
PROBABILITY OF COMPLETING NEPHRON-
4:40
PD33-08 COMPARISON OF PERIOPERATIVE SPARING SURGERY FOR KIDNEY CANCER
OUTCOMES BETWEEN SINGLE-PORT AND BASED ON TUMOUR COMPLEXITY AND
MULTIPORT RETROPERITONEAL ROBOT- SURGICAL APPROACH
ASSISTED PARTIAL NEPHRECTOMIES Alessandro Larcher, Francesco Cei, Giuseppe
Arnold Palacios*, Luca Morgantini, Ryan Trippel, Rosiello, Giacomo Musso, Giuseppe Fallara,
Simone Crivellaro, Chicago, IL, Michael Abern, Chiara Re, Daniele Cignoli, Giuseppe Basile*,
Durham, NC Gianmarco Colandrea, Gianfranco Baiamonte,
Isaline Rowe, Daniela Canibus, Milan, Italy, Fed-
4:50
PD33-09 MULTI-INSTITUTIONAL REPORT OF PATIENT
erico Dehò, Varese, Italy, Andrea Gallina, Milan,
CHARACTERISTICS AND ONCOLOGIC
Italy, Alexandre Mottrie, Aalst, Belgium, Cristina
OUTCOMES FOLLOWING MICROWAVE
Giancristofaro, Francesco De Cobelli, Giorgio
ABLATION OF BIOPSY-PROVEN RENAL
Brembilla, Alberto Briganti, Roberto Bertini,
CELL CARCINOMA
Francesco Montorsi, Andrea Salonia, Umberto
Leo Dreyfuss*, New York, NY, Arighno Das, Mad-
Capitanio, Milan, Italy
ison, WI, Kimberly Maciolek, Charlottesville, VA,
Rand Wilcox Vanden Berg, New York, NY, Glenn APPROVED FOR AMA PRA CATEGORY 2
Allen, Madison, WI, Jonathan Fainberg, New CREDITSTM
York, NY, Tudor Borza, Shane Wells, Madison,
WI, Stephen Culp, Charlottesville, VA, E. Jason
Abel, Madison, WI, Timothy McClure,
New York, NY
5:00
PD33-10 NEPHROMETRY AND CUMULATIVE
MORBIDITY AFTER PARTIAL
NEPHRECTOMY: A STANDARDIZED
ASSESSMENT OF COMPLICATIONS IN
THE CONTEXT OF R.E.N.A.L. AND PADUA
SCORES
Dejan K. Filipas*, Hang Yu, Clemens Spink,
Michael Rink, Silke Riechardt, Philipp Gild, Phillip
Marks, Margit Fisch, Roland Dahlem, Hamburg,
Germany, Christian P. Meyer, Herford, Germany,
Malte W. Vetterlein, Hamburg, Germany

Saturday, May 14, 2022 3:30 pm - 5:30 pm

Podium Session 34
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: FEMALE INCONTINENCE: THERAPY II
Room 244 @ Ernest N. Morial Convention Center
Moderators: Anne Cameron, Karyn Eilber & Priyanka Gupta

ABSTRACT
TIME NUMBER TITLE
3:30
PD34-01 SACRAL NEUROMODULATION DEVICES
CONSISTENTLY HARBOR BACTERIA
AND POSSESS A UNIQUE MICROBE AND
METABOLITE PROFILE
Glenn T. Werneburg*, Ava Adler, Daniel Hettel,
Sandip Vasavada, Raymond Rackley, Howard
Goldman, Jacqueline Zillioux, Bradley Gill, Daniel
Shoskes, Aaron Miller, Cleveland, OH
ABSTRACT
TIME NUMBER TITLE
3:40
PD34-02 CHEMOKINE THERAPY FOR ANAL
SPHINCTER INJURY: DEVELOPMENT OF A
RAT MODEL OF CHRONIC INJURY
Amr El Haraki*, Shannon Lankford, Wencheng Li,
Catherine Matthews, Koudy Williams,
Winston-Salem, NC, Gopal Badlani, Winston
Salem, NC

138
3:50
PD34-03 MACHINE LEARNING ALGORITHMS ARE
ACCURATE AND NON-INFERIOR TO HUMAN
EXPERTS IN PREDICTING MEDICALLY-
REFRACTORY OVERACTIVE BLADDER
TREATMENT OUTCOMES
Glenn Werneburg*, Cleveland, OH, Eric Wer-
neburg, Stony Brook, NY, Howard Goldman,
Cleveland, OH, Andrew Mullhaupt, Stony Brook,
NY, Sandip Vasavada, Cleveland, OH
4:00
PD34-04 IMPACT OF COGNITIVE FUNCTION IN
OLDER PATIENTS UNDERGOING SACRAL
NEUROMODULATION FOR OVERACTIVE
BLADDER: A PROSPECTIVE STUDY
Jacqueline Zillioux*, Sarah Martin, Lauren Gleich,
Glenn T. Werneburg, Emily Slopnick, Raymond R.
Rackley, Sandip Vasavada, Bradley Gill, Howard
B. Goldman, Cleveland, OH
4:10
PD34-05 DOES COGNITIVE IMPAIRMENT IMPACT
SACRAL NEUROMODULATION IN OLDER
PATIENTS WITH OVERACTIVE BLADDER?
Jacqueline Zillioux*, Kevin Lewis, Daniel Hettel,
Sarah Martin, Lauren Gleich, Howard B. Gold-
man, Bradley Gill, Cleveland, OH
4:20
PD34-06 ROBOT-ASSISTED ARTIFICIAL URINARY
SPHINCTER IMPLANTATION IN FEMALE
PATIENTS: AN INTERNATIONAL
MULTICENTER SERIES OF 182 PATIENTS
Benoit Peyronnet*, Rennes, France, Jean-Nicolas
Cornu, Rouen, France, Olivier Belas, Le Mans,
France, Grégoire Capon, Bordeaux, France,
Xavier Biardeau, Lille, France, Pierre Lecoanet,
Nancy, France, Luis Castro-Sader, Barcelona,
Spain, Shahed Borojeni, Paris, France, Rainer
Hein, Magdeburg, Germany, Juliette Hascoet,
Rennes, France, Frederic Thibault, Metz, France,
Frederic Dubois, Rennes, France, Vincent Cardot,
Paris, France, Adrien Vidart, Suresnes, France,
Aurélien Descazeaud, Limoges, France, Georges
Fournier, Brest, France, Frank van der Aa,
Leuven, Belgium
Saturday, May 14, 2022
Video Session 6
FEMALE VOIDING DYSFUNCTION/PELVIC FLOOR DISORDERS/INCONTINENCE/NEURO-UROLOGY
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Ryan Krlin, Ajay Singla & Sender Herschorn
ABSTRACT
TIME NUMBER TITLE
3:30
V06-01 SURGICAL TECHNIQUE AND OUTCOMES OF
MALONE ANTEGRADE CONTINENCE ENEMA
Natalia Hernandez*, Hunter Flores, Julie N Stew-
art, Rose Khavari, Houston, TX Colby P. Souders*, Ramy Goueli, Hersh Trivedi,
3:40
V06-02 SINGLE PORT ROBOTIC ASSISTED
LAPAROSCOPIC SACROCOLPOPEXY:
NEW FRONTIER IN MINIMALLY INVASIVE
ABDOMINAL REPAIR OF PELVIC ORGAN
PROLAPSE
David Ali*, Paterson, NJ, Mubashir Billah, Muta-
har Ahmed, Hackensack, NJ
*Presenting author 139
4:30
PD34-07 PREDICTORS OF SLINGS AFTER URETHRAL
DIVERTICULECTOMY: A 5-YEAR LARGE
POPULATION ANALYSIS
Allison Sih*, Seth Cohen, Fornati Bedell, Duarte,
CA, Karyn Eilber, Victoria Scott, Los Angeles, CA,
Kai Dallas, Duarte, CA
4:40
PD34-08 PIVOTAL STUDY OF A LEADLESS TIBIAL
NERVE STIMULATOR FOR URGENCY
URINARY INCONTINENCE (UUI): 2-YEAR
OUTCOMES FROM A SINGLE SITE
Alexandra Rogers*, Santa Barbara, CA
4:50
PD34-09 VESICO-VAGINAL FISTULA PREVALENCE
AND REPAIR PATTERNS: A LARGE
SATURDAY
RETROSPECTIVE POPULATION-BASED
COHORT ANALYSIS
Sarah Neu*, Jennifer Locke, Bo Zhang, Refik
Saskin, Sender Herschorn, Toronto, Canada
5:00
PD34-10 DO MEDICAID PATIENTS HAVE ACCESS TO
THIRD LINE THERAPIES IN OAB? A STATE-
BY-STATE ANALYSIS
Kelly Ieong*, Stony Brook, NY, Wai Lee, Lake
Success, NY, Jason Kim, Stony Brook, NY
5:10
PD34-11 EFFECTS OF AGE AND MULTIPLE VAGINAL
BIRTHS ON URINARY BLADDER, SPHINCTER
STRUCTURE, FUNCTION AND PELVIC
SUPPORT IN NONHUMAN PRIMATES
J. Koudy Williams*, Shannon Lankford, Gopal
Badlani, Winston-Salem, NC
5:20
PD34-12 STRESS URINARY INCONTINENCE
RECOVERY AFTER A SIMULATED DUAL
INJURY CHILDBIRTH MODEL IS DEPENDENT
ON BRAIN-DERIVED NEUROTROPHIC
FACTOR
Brian Balog, Kangli Deng, Tessa Askew, Brett
Hanzlicek, Margot Damaser*, Cleveland, OH
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
3:30 pm - 5:30 pm
ABSTRACT
TIME NUMBER TITLE
3:50
V06-03 VARIATIONS IN PROMONTORY
ANATOMY COMPLICATING ROBOTIC
SACROCOLPOPEXY
Gaurav Khatri, Philippe E. Zimmern, Dallas, TX
4:00
V06-04 EXCISION OF ERODED VAGINAL
MESH SLING WITH OBLITERATION OF
URETHRA REQUIRING CONCURRENT
URETHROPLASTY
Matthew Mikula*, Justin Han, Wai Lee, New Hyde
Park, NY
4:10
V06-05 OFFICE REMOVAL OF SACRAL 5:00
V06-10 ROBOTIC UTEROSACRAL LIGAMENT
NEUROMODULATION- WELL TOLERATED, PLICATION AT TIME OF BENIGN
SAFE AND EFFECTIVE CYSTECTOMY
Sarah Martin*, Cleveland Heights, OH, Jacque- Jacqueline Zillioux*, Emily Slopnick, Nima Almas-
line Zillioux, Lauren Gleich, Howard Goldman, si, Sandip Vasavada, Cleveland, OH
Cleveland, OH
5:10
V06-11 ROBOT-ASSISTED MITROFANOFF
4:20
V06-06 ROBOTIC ARTIFICIAL URINARY SPHINCTER APPENDICOVESICOSTOMY
EXPLANTATION AND CONCOMITANT Camille Haudebert*, Juliette Hascoet, Lucas Fre-
FASCIAL SING INSERTION IN CASE OF ton, Claire Richard, Caroline Voiry, Emmanuelle
BLADDER NECK CUFF EXTRUSION FOR Samson, Karim Bensalah, Gregory Verhoest,
FEMALE PATIENTS Zine Eddine Khene, Romain Mathieu, Rennes,
Camille Haudebert*, Juliette Hascoet, Lucas France, Emmanuelle Bryckaert, Le Mans, France,
Freton, Claire Richard, Karim Bensalah, Gregory Benoit Peyronnet, Rennes, France
Verhoest, Zine Eddine Khene, Romain Mathieu,
5:20
V06-12 LAPAROSCOPIC MITROFANOFF
Andrea Manunta, Benoit Peyronnet, Rennes,
APPENDICOVESICOSTOMY: AN OPTION
France
IN COMPLEX ADULT PATIENT TO ACCESS
4:30
V06-07 MANAGEMENT OF VAULT PROLAPSE TO THE BLADDER
INCLUDING A BOWEL OBSTRUCTION: Roberto Hugo Martinez Rodriguez*, Cristina
EXPANDING THE ROLE OF TRANSVAGINAL Gutierrez Ruiz, Leire Portilla Maediavilla, Fatima
SURGERY Castroviejo, Jose H. Amon Sesmero, Valladolid,
Elizabeth J. Olive*, Rochester, MN, Cassandra Spain
K. Kisby, Durham, NC, Scott R. Kelley, Brian J.
APPROVED FOR AMA PRA CATEGORY 2
Linder, Rochester, MN
CREDITSTM
4:40 V06-08 MODIFIED MARTIUS FLAP URETHROPLASTY
Jacob Rust, MD*, Christian Twiss, MD, FACS,
Tucson, AZ
4:50
V06-09 DORSAL ONLAY LINGUAL MUCOSA GRAFT
URETHROPLASTY FOR FEMALE URETHRAL
STRICTURE
Claire Richard*, Benoit Peyronnet, RENNES,
France, Alice Drain, New York, NY, Juliette
Hascoet, Rennes, France, Nirit Rosenblum, New
York, NY, Rachael Sussman, Washington, DC,
Lucas Freton, Rennes, France, Lee C Zhao, New
York, NY, Victor W Nitti, Los Angeles, CA, Benja-
min Brucker, New York, NY

Saturday, May 14, 2022 4:00 pm - 6:00 pm

Forums
MEDICAL STUDENT FORUM
Room 353 @ Ernest N. Morial Convention Center

140
Saturday, May 14, 2022
Moderated Poster Session 33
URORADIOLOGY I
Room 228 @ Ernest N. Morial Convention Center
Moderators: Christopher Porter, Edouard Trabulsi & Craig Smith
ABSTRACT
NUMBER TITLE
MP33-01 “THAT CAN’T BE A STONE!”:
PREDICTORS OF FALSE POSITIVITY FOR
NEPHROLITHIASIS ON RADIOLOGIC
REPORTS OF RENAL SONOGRAMS
Dylan Z. Taylor*, Garrett E. Smith, Scott V.
Wiener, Syracuse, NY (KISSS)
MP33-02 AUTOMATED STONE VOLUME
DETERMINATION: TRAINING AN
ARTIFICIALLY INTELLIGENT ALGORITHM
TO SEGMENT KIDNEY STONES ON CT AND
CALCULATE 3D VOLUME
Kalon L. Morgan*, Rohit Bhatt, Sina Soltanzadeh
Zarandi, Kelvin Vo, Minh-Chau Vu, Paul Piedras,
Akhil Peta, Andrew Brevik, Rajiv Karani, Lillian
Xie, Pengbo Jiang, Sohrab Ali, Roshan M. Patel,
Jaime Landman, Ralph V. Clayman,
Orange, CA Nikhil Gopal, Zach Kozel, Mina Dehghani Firou-
MP33-03 DIAGNOSTIC PERFORMANCE OF UPPER
TRACT IMAGING PERFORMED FOR
HEMATURIA SCREENING: REAL-WORLD
RESULTS FROM A NATIONAL PRIVATELY
INSURED COHORT
Alex Hannemann*, Simon Kim, Aurora, CO, Peter
Clark, Charlotte, NC, Michael Bronsert, Aurora,
CO, Boris Gershman, Boston, MA, Granville
Lloyd, Rodrigo Rodrigues Pessoa, Jeffrey Morri-
son, Aurora, CO, Marc Smaldone, Philadelphia,
PA, Eric Ballon-Landa, Aurora, CO Potretzke, R. Houston Thompson, Stephen A.
MP33-04 CONTRAST-ENHANCED
ULTRASONOGRAPHY FOR THE EVALUATION
OF COMPLEX RENAL CYSTS
Cassra Clark*, Corinne Wessner, Shuo Wang,
Andrew Denisenko, Andrew Shumaker, Joonyau
Leong, Andrea Quinn, Erica Mann, Lydia Glick,
Timothy Han, Kibo Nam, Katherine Smentkowski,
John Eisenbrey, Leonard Gomella, Edouard
Trabulsi, Costas Lallas, Mark Mann, James Mark,
Flemming Forsberg, Andrej Lyshchik,
Ethan Halpern, Thenappan Chandrasekar,
Philadelphia, PA
MP33-05 DIAGNOSTIC PARAMETERS OF 99MTC-
SESTAMIBI SPECT/CT FOR RENAL
ONCOCYTOMAS AND HYBRID ONCOCYTIC/
CHROMOPHOBE TUMORS: COMBINED
PROSPECTIVE TRIAL DATA
Alexa Meyer*, Hiten Patel, Lilja Solnes, Reema
Goel, Mehrbod Javadi, Phillip Pierorazio, Chris-
tian Pavlovich, Mohamad Allaf, Michael Gorin,
Steven Rowe, Baltimore, MD
*Presenting author
4:30 pm - 5:45 pm
ABSTRACT
NUMBER TITLE
MP33-06 PREDICTING RENAL TUMOR GROWTH IN
VON HIPPEL-LINDAU (VHL) PATIENTS FROM
MAGNETIC RESONANCE IMAGING (MRI)
FEATURES: A PILOT STUDY OF THE KIDNEY
IMAGING SURVEILLANCE SCORING SYSTEM
SATURDAY
Nikhil Gopal*, Pouria Yazdian, Aditi Chaurasia,
Maria Antony, Safa Samimi, Rabindra Gautam,
Elizabeth Jones, Mark Ball, W. Marston Linehan,
Evrim Turkbey, Ashkan Malayeri, Bethesda, MD
MP33-07 MRI-BASED SEGMENTATION OF
PREOPERATIVE RENAL PARENCHYMA IN
VON HIPPEL LINDAU DISEASE TO PREDICT
POSTOPERATIVE RENAL FUNCTIONAL
DECLINE
Maria Antony*, Pouria Yazdian, Aditi Chaurasia,
zabadi, Maryam Homayounieh, Safa Samimi,
Rabindra Gautam, Sandeep Gurram, Ashkan
Malayeri, Marston Linehan, Mark Ball, Bethesda,
MD
MP33-08 DEEP LEARNING RENAL VOLUME
ANALYSIS TO PREDICT LONG-TERM RENAL
FUNCTION AFTER PARTIAL AND RADICAL
NEPHRECTOMY
Abhinav Khanna*, Vidit Sharma, Adriana Gregory,
Christine Lohse, Harrison C. Gottlich, Theodora
Boorjian, Bradley Leibovich, Timothy Kline, Aaron
Potretzke, Rochester, MN
MP33-09 RADIOGENOMIC CORRELATES OF
CLINICALLY RELEVANT CLEAR CELL
RENAL CELL CANCER BIOMARKERS
Derek Liu, Bino Varghese, Darryl Hwang,
Xiaomeng Lei, Afshin Azadikhah, Komal Dani,
Alex Raman, Steven Cen, Manju Aron, Harris
Zahoor, Imran Siddiqi, Inderbir Gill, Vinay Duddal-
war*, Los Angeles, CA
MP33-10 EVALUATION OF BLADDER SHAPE
COMPLIANCE USING ABDOMINAL
COMPRESSIONS DURING URODYNAMICS
Adam Vossenberg, Richmond, VA, Sarah Koda-
ma, Richmond, WV, Ria Khandpur, Jared Dunlap,
Abraham Alattar, William Visser, Christopher Bed-
narz*, Linda Burkett, Lauren Siff, Adam Klausner,
John Speich, Richmond, VA
MP33-11 DEVELOPMENT OF A URINARY TRACT
ATLAS USING CONVOLUTIONAL NEURAL
NETWORKS
Katherine Fischer*, Yuemeng Li, Benjamin Schur-
hamer, Justin Ziemba, Yong Fan, Gregory Tasian,
Philadelphia, PA
141
 MP33-12 DYNAMIC COMPRESSION OF THE URETHRA- MP33-18 ASSOCIATION OF PATIENT AND IMAGING-
MECHANISM OF ACTION OF A MALE RELATED FACTORS WITH FALSE NEGATIVE
TRANSOBTURATOR SLING WITH 5-YEAR FUSION BIOPSIES OF PI-RADS 4 AND 5
IMAGING FOLLOW-UP LESIONS ON MRI
Joshua Makary*, Thomas Jarvis, Vincent Tse, Miyad Movassaghi*, Firas Ahmed, Hanisha Patel,
Lewis Chan, Sydney, Australia Lyndon Luk, New York, NY, Elias Hyams, Prov-
idence, RI, Sven Wenske, Hiram Shaish, New
MP33-13 IMPACT OF PROSTATIC URETHRAL LIFT
York, NY
DEVICE ON PROSTATE MR IMAGE QUALITY
Tarik Benidir*, Ryan Ward, Justin Ream, Ethan MP33-19 INTRADUCTAL CARCINOMA OF THE
Austhof, Eric Klein, Cleveland, OH, Ismail Turkbey, PROSTATE IN THE ERA OF MPMRI-
Bethesda, MD, Andrei Purysko, Cleveland, OH TARGETED PROSTATE BIOPSIES: CLINICAL,
PATHOLOGIC AND MRI CHARACTERISTICS
MP33-14 EXAMINATION OF SCROTAL ULTRASOUND
Jonathan Fainberg*, Christine Chen, Johnson
INDICATIONS IN THE UNITED STATES
Chen, Adithya Balasubramanian, Christopher
Joey Fougerousse*, Gerald McGwin, Jr., Peter
Barbieri, Leo Dreyfus, Beerinder Karir, Francesca
Kolettis, Birmingham, AL
Khani, Daniel Margolis, Timothy McClure, Himan-
MP33-15 A STUDY OF PROGNOSTIC VALUE OF shu Nagar, Brian Robinson, New York, NY
SERUM ALKALINE PHOSPHATASE AND
MP33-20 UTILITY OF ADDITIONAL TARGETED AND
ITS CORRELATION WITH BONE SCAN IN
SYSTEMIC BIOPSIES IN THE PRESENCE OF
UROLOGICAL MALIGNANCIES
AN INDEX PI-RADS 5 LESION
Rohit Ranjan*, Shivcharan Navriya, Ankur Mittal,
Ahmad Alzubaidi*, Hershey, PA, Michael Maidaa,
Arup Kumar Mandal, Rishikesh, India
Gainesville, FL, Mohammad Said, Iowa City,
MP33-16 BIPARAMETRIC QUANTITATIVE MRI FOR IA, Grant Owens, Max Yudovich, Hershey, PA,
PROSTATE CANCER DETECTION R.Scott Grant, Camphill, PA, Thomas F. Stringer,
Hari Vigneswaran*, Meltem Uyanik, Karen Xie, Gainesville, FL, Chad Tracy, Iowa City, IA, Jay D.
Virgilia Macias, Andre Balla, Richard Magin, Kejia Raman, Hershey, PA
Cai, Fred Damen, Xiaohong Zhou, Peter Gann,
APPROVED FOR AMA PRA CATEGORY 1.25
Michael Abern, Chicago, IL
CREDITSTM
MP33-17 TRANSPERINEAL FUSION BIOPSIES WITH
SOFTWARE REGISTRATION: CANCER
DETECTION BY PIRADS V2
Eusebio Luna*, Gloria Egui-Benatuil, Alberto
Lopez-Prieto, Edward Gheiler, Kaufman Ariel,
Miami, FL, Farshad Shafizadeh, New York, NY,
Luis Avila, Barrios Dailianys, Miami, FL, Juan
Martinez-Salamanca, Madrid, Spain, Fernando
Bianco, Miami, FL

Saturday, May 14, 2022 4:30 pm – 5:45 pm

Moderated Poster Session 34

INFERTILITY: THERAPY
Room 225 @ Ernest N. Morial Convention Center
Moderators: Jay Sandlow, Christopher Deibert & William J. Huang

ABSTRACT
NUMBER TITLE
MP34-01 IS TESTIS SPARING SURGERY A SAFE
APPROACH IN PATIENTS WITH SMALL
TESTICULAR LESIONS REFERRING TO A
FERTILITY CENTER? A RETROSPECTIVE
ANALYSIS REPORTING LONG-TERM
ONCOLOGICAL OUTCOMES AND FACTORS
ASSOCIATED WITH MALIGNANCY
Andrea Gobbo*, Vittorio Fasulo, Cesare Saitta,
Pietro Diana, Paola Arena, Giuseppe Chiarelli,
Roberto Contieri, Nicola Frego, Davide Maffei,
Alberto Saita, Paolo Casale, Giorgio Guazzoni,
Massimo Lazzeri, Pier Paolo Avolio, Giovanni
Lughezzani, Rodolfo Hurle, Nicolò Maria Buffi,
Renzo Benaglia, Paolo Levi, Luciano Negri,
Milano, Italy
ABSTRACT
NUMBER TITLE
MP34-02 OPIOID PRESCRIBING FOLLOWING MALE
INFERTILITY SURGERY IS ASSOCIATED
WITH PERSISTENT OPIOID USE - ANALYSIS
OF A U.S. CLAIMS DATABASE
Corey Able*, Galveston, TX, Andrew T Gabri-
elson, Baltimore, MD, Christopher Meilchen,
Galveston, TX, Jaden R Kohn, Taylor P Kohn,
Baltimore, MD
MP34-03 VASECTOMY IN CHILDLESS MEN: IS
REGRET MORE LIKELY?
David Charles*, Danyon Anderson, Peter Dietrich,
Jay Sandlow, Milwaukee, WI

142
 MP34-04 SYSTEMATIC EVALUATION OF YOUTUBE
CONTENT ON TESTOSTERONE THERAPY:
THE PROLIFERATION OF BRO-SCIENCE
Zhenyue Huang*, Heng Ruan, Rosen Jeong,
Eileen Zhou, Tal Meir Cohen, Jason Kim, William
T. Berg, Stony Brook, NY Figueiredo, Thais Feitosa, Rafaella Medugno,
MP34-05 IMPACT OF NASAL, INTRAMUSCULAR, AND
SUBCUTANEOUS TESTOSTERONE PELLETS
ON INTRATESTICULAR TESTOSTERONE:
EVALUATION OF DATA FROM TWO
RANDOMIZED CLINICAL TRIALS
Parris Diaz*, Rohit Reddy, Ruben Blach-
man-Braun, Alexandra Dullea, Isaac J. Zucker,
Daniel C. Gonzalez, Eliyahu Kresch, Ranjith
Ramasamy, Miami, FL
MP34-06 PREDICTORS OF SUCCESS AFTER
BILATERAL VASOEPIDIDYMOSTOMY
PERFORMED DURING VASECTOMY
REVERSAL: A MULTI-INSTITUTIONAL
ANALYSIS
Joshua White*, Jesse Ory, Halifax, Canada, Sirpi
Nackeeran, Miami, FL, Udi Blankstein, Hamilton,
Canada, Justin Dubin, Chicago, MI, Aditya Sathe,
Memphis, TN, Ethan Grober, Toronto, Canada,
Sheldon Marks, Tuscon, AZ, Ranjith Ramasamy,
Miami, FL
MP34-07 VASECTOMY REVERSAL OUTCOMES
AND MANAGEMENT OF PATIENTS ON
TESTOSTERONE REPLACEMENT THERAPY
Jasper C Bash*, Akash Kapadia, Malachi Mason,
Jason C Hedges, Portland, OR
MP34-08 TWO-LAYER VASOVASOTOMY TECHNIQUE IS
ASSOCIATED WITH IMPROVED PREGNANCY
RATES AS COMPARED TO MODIFIED ONE-
LAYER TECHNIQUE
Matt Kasson*, Ashley Pittman, David Charles,
Jacqueline Sehring, Peter Dietrich, Jay Sandlow,
Milwaukee, WI
MP34-09 VASECTOMY REVERSAL FOLLOWING
PERCUTANEOUS EPIDIDYMAL SPERM
ASPIRATION (PESA): OPERATIVE
IMPLICATIONS AND POST-OPERATIVE
OUTCOMES
Udi Blankstein*, Hamilton, Canada, Joseph Mory-
ousef, Montreal, Canada, Ethan Grober, Toronto,
Canada
MP34-10 MALE AGE IN IN VITRO FERTILIZATION
RESULTS: DOES IT MATTER?
Mariangela Badalotti, Isadora Badalotti-Teloken,
Victória Campos Dornelles, Marta Ribeiro
Hentschke, Fernando Badalotti, Natalia Vascon-
celos, Alvaro Petracco, Claudio Teloken*, Porto
Alegre, Brazil
MP34-11 EFFECT OF ANASTROZOLE ON SPERM
CONCENTRATION IN MALE PATIENTS WITH
IDIOPATHIC INFERTILITY
Bryan Naelitz*, Carlos Munoz-Lopez, Neel
Parekh, Scott Lundy, Sarah Vij, Cleveland, OH
*Presenting author
MP34-12 OPEN TESTICULAR MAPPING TECHNIQUE
FOR SPERM RETRIEVAL IN MEN WITH
NON-OBSTRUCTIVE AZOOSPERMIA
Leonardo Lopes*, Rodrigo Silva, Santo Andre,
Brazil, Joaquim Lorenzetti, Parana, Brazil, Winter
Ivan Yoshida, Caio Barbosa, Roberto Juliano,
Sidney Glina, Santo Andre, Brazil
MP34-13 THE OUTCOMES OF EX-VIVO TESTIS
SPERM EXTRACTION AT THE TIME OF
RADICAL ORCHIECTOMY IN TESTIS
CANCER PATIENTS
Jose M Flores*, Joshua Jue, Nicole Benfante,
SATURDAY
John P Mulhall, New York, NY
MP34-14 EFFECTS OF RADIATION THERAPY ON
MICROSURGICAL TESTICULAR SPERM
EXTRACTION FOR MEN WITH NON-
OBSTRUCTIVE AZOOSPERMIA
Aaron Brant*, Nahid Punjani, Peter Schlegel,
New York, NY
MP34-15 DISCORDANT TESTICULAR PATHOLOGY IS
COMMON IN MEN WITH NON-OBSTRUCTIVE
AZOOSPERMIA UNDERGOING BILATERAL
MTESE
Scott Lundy*, Sarah Vij, Cleveland, OH
MP34-16 ARTIFICIAL INTELLIGENCE BASED
MACHINE LEARNING MODELS PREDICT
SPERM PARAMETER UPGRADING AFTER
MICROSURGICAL VARICOCELE REPAIR: A
MULTI-INSTITUTIONAL ANALYSIS
Jesse Ory*, Halifax, Canada, Michael B
Tradewell, Miami, FL, Udi Blankstein, Hamilton,
Canada, Thiago Lima, Sirpi Nackeeran, Daniel C
Gonzales, Elie Nwefo, Vinayak Madhusoodanan,
Miami, FL, Susan Lau, Keith Jarvi, Toronto,
Canada, Ranjith Ramasamy, Miami, FL
MP34-17 INSTANTANEOUS TRACKING OF POST-
VARICOCELECTOMY RECOVERY DYNAMICS
USING THE HOME-BASED SEMEN QUALITY
MONITORING DEVICE LENSHOOKE® X1
Cheng-Han Tsai*, Taipei, Taiwan, George C. Hsu,
Han-Ching Tsai, Cheng-Teng Hsu, Taichung,
Taiwan, William J. Huang, Taipei, Taiwan
MP34-18 PRE-OPERATIVE IMAGING IS NOT
NECESSARY WHEN OFFERING
VARICOCELECTOMY FOR SCROTAL PAIN
Muhammad Alkazemi, Joel Vetter, Alethea
Paradis, Marjorie Hosto, Dane Johnson*,
St Louis, MO
MP34-19 EFFECT OF SURGICAL AND RADIOLOGICAL
MANAGEMENT OF RECURRENT
VARICOCELE ON FERTILITY POTENTIAL: A
RETROSPECTIVE STUDY AND METANALYSIS
Mohammed Mahdi*, Haitham Elbardisi, Ahmad
Majzoub, Mohamed Arafa, Doha, Qatar
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
143
Saturday, May 14, 2022
Moderated Poster Session 35
SEXUAL FUNCTION/DYSFUNCTION: MEDICAL, HORMONAL & NON-SURGICAL THERAPY I
Room 222 @ Ernest N. Morial Convention Center
Moderator: Amy Pearlman
ABSTRACT
NUMBER TITLE
MP35-01 PREVALENCE OF SECONDARY
ERYTHROCYTOSIS IN MEN RECEIVING
TESTOSTERONE THERAPY: A MATCHED
COHORT ANALYSIS OF INJECTIONS,
INTRANASAL GEL, AND PELLETS
Rohit Reddy*, Parris Diaz, Ruben Blach-
man-Braun, Isaac J. Zucker, Alexandra Dullea,
Eliyahu Kresch, Daniel Gonzalez, Ranjith
Ramasamy, Miami, FL
MP35-02 COMPARISON OF PREVALENCE OF
POLYCYTHEMIA BETWEEN NASAL
TESTOSTERONE GEL VS INTRAMUSCULAR
TESTOSTERONE CYPIONATE: EVALUATION
OF DATA FROM AN ONGOING PHASE IV,
OPEN-LABEL, RANDOMIZED CLINICAL TRIAL
Parris Diaz*, Daniel C. Gonzalez, Miami, FL,
Jesse Ory, Halifax, Canada, Navin C. Balaji,
Rohit Reddy, Manuel Molina, Ranjith Ramasamy,
Miami, FL LaGrange, IL, Robert Dudley, Northbrook, IL
MP35-03 THE BROAD REACH OF SOCIAL MEDIA AS A
HEALTH RESOURCE FOR TESTOSTERONE
INFORMATION
Justin Dubin*, Daniel Greenberg, Chicago, IL,
Richard Fantus, Evanston, IL, Minh Pham, Mat-
thew Hudnall, Nelson Bennett, Robert Brannigan,
Joshua Halpern, Chicago, IL
MP35-04 TESTOSTERONE REPLACEMENT THERAPY:
PATIENT REPORTED PREFERENCES
Charles Loeb*, Jake Miller, Douglas Schneider,
Faysal Yafi, Orange, CA haven, Germany, Gheorghe Doros, Abdulmaged
MP35-05 COST ANALYSIS OF DIRECT-TO-CONSUMER
TELEHEALTH PLATFORMS OFFERING
TESTOSTERONE THERAPY
Erin Jesse, Nicholas Sellke*, Wade Muncey,
Ramy Abou Ghayda, Aram Loeb, Nannan Thiru-
mavalavan, Cleveland, OH DIABETES
MP35-06 SIGNIFICANT DECREASE IN SEX HORMONE
BINDING GLOBULIN WITH USE OF
TESTOSTERONE UNDECANOATE CAPSULES
(JATENZO) IN MEN WITH HYPOGONADISM
Alyssa Yee*, Maria Uloko, Irwin Goldstein, San
Diego, CA
MP35-07 COMPARISON OF THREE DIFFERENT
TADALAFIL REGIMES FOR THE
TREATMENT OF ERECTILE DYSFUNCTION
IN DIABETES MELLITUS PATIENTS WITH
MICROVASCULAR COMPLICATIONS
Goksel Bayar*, Hatay, Turkey, Caglar Yildirim,
Mardin, Turkey
144
4:30 pm – 5:45 pm
ABSTRACT
NUMBER TITLE
MP35-08 INVESTIGATION OF GROWTH FACTORS
CONCENTRATION IN PLATELET RICH
PLASMA (PRP) OBTAINED FROM MEN WITH
ERECTILE DYSFUNCTION
Kajal Khodamoradi*, Miami, FL, Alexandra
Dullea, Spokane, WA, Roei Golan, Tallahassee,
FL, Manuel Leyba Molina, Thomas Masterson,
Himanshu Arora, Ranjith Ramasamy, Miami, FL
MP35-09 LINEAR RELATIONSHIP BETWEEN
THE TIME OF DOSING AND 24-HOUR
AVERAGE CONCENTRATION OF TOTAL
TESTOSTERONE IN MEN TREATED WITH
AN ORAL TESTOSTERONE UNDECANOATE
CAPSULE (JATENZO®)
Ronald Swerdloff, Torrance, CA, Jason Kovac*,
Indianapolis, IN, Christina Wang, Torrance, CA,
Marc Gittelman, Aventura, FL, B. Woun Seo,
Jay Newmark, Northbrook, IL, Nestor Rohowsky,
MP35-10 THE IMPACT OF PAP THERAPY ON
HEMATOCRIT IN OSA AND POLYCYTHEMIA:
A PILOT STUDY
Mustafa Jafri*, Gabrielle Rosa-Acosta, Jose
Flores Martinez, Elizabeth Schofield, Cy Wilkins,
John Mulhall, Miranda Tan, New York, NY
MP35-11 LUTS, ED, AND QOL IMPROVE UNDER LONG-
TERM TESTOSTERONE THERAPY IN OBESE
MEN WITH FUNCTIONAL HYPOGONADISM
Ahmad Haider*, Karim Sultan Haider, Bremer-
Traish, Boston, MA
MP35-12 LOWER URINARY TRACT SYMPTOMS
AND QUALITY OF LIFE IMPROVE UNDER
LONG-TERM TESTOSTERONE THERAPY
IN HYPOGONADAL MEN WITH TYPE 2
Karim Sultan Haider*, Ahmad Haider, Bremer-
haven, Germany, Gheorghe Doros, Abdulmaged
Traish, Boston, MA
MP35-13 ANABOLIC-ANDROGENIC STEROID USE
IS ASSOCIATED WITH DEPRESSION AND
SUICIDALITY: ANALYSIS OF A NATIONAL
FEDERATED DATABASE
Sirpi Nackeeran, Mehul Patel*, Devi Nallakumar,
Miami, FL, Jesse Ory, Halifax, Canada, Taylor
Kohn, Baltimore, MD, Christopher Deibert, Oma-
ha, NE, Ranjith Ramasamy, Miami, FL
MP35-14 PATIENT SATISFACTION AFTER SWITCHING
TO ORAL TESTOSTERONE UNDECANOATE
IN MEN CURRENTLY RECEIVING
TESTOSTERONE THERAPY: AN OPEN-LABEL
SINGLE-CENTER PHASE IV CLINICAL TRIAL
Rohit Reddy, Mehul Patel*, Ranjith Ramasamy,
Miami, FL
 MP35-15 DO STATINS CAUSE TESTOSTERONE
DEFICIENCY IN MEN? SYSTEMATIC REVIEW
AND META ANALYSIS
Felipe Glina, Leonardo Seligra Lopes*, Rodrigo
Spinola e Silva, Eduardo Augusto Correa Barros,
Santo André, São Paulo, Brazil, Bruno Biselli,
São Paulo, Brazil, Sidney Glina, Santo André,
São Paulo, Brazil
MP35-16 IMPROVING QUALITY OF LIFE FOR PATIENTS
WITH CHRONIC PELVIC AND GENITAL PAIN
THROUGH AN INTERDISCIPLINARY PAIN
REHABILITATION PROGRAM
Kevin Hanna, M.D.*, Matthew Ziegelmann, M.D.,
Hannah Betcher, M.D., Sevann Helo, M.D.,
Elizabeth Kacel, Ph.D., Wesley Gilliam, Ph.D.,
Rochester, MN
MP35-17 ONLINE USER TRENDS FOR TESTICULAR
AND PELVIC PAIN
Garrick Greear*, Sarah Holt, Tristan Nicholson,
Hunter Wessells, Thomas Walsh, Marah Hehe-
mann, Seattle, WA
*Presenting author
MP35-18 CHARACTERISTICS OF SYSTEMIC
TESTOSTERONE THERAPY FOR FEMALE
HYPOACTIVE SEXUAL DESIRE DISORDER -
A CLAIMS DATABASE ANALYSIS
Pranjal Agrawal*, Kathryn Dumas, Taylor P Kohn,
Jaden R Kohn, Marisa Clifton, Baltimore, MD
MP35-19 EFFECTS OF BALLOON ANGIOPLASTY FOR
PATIENTS WITH ARTERIOGENIC ERECTILE
DYSFUNCTION
Cheng-Han Tsai*, Shu-Huei Shen, Hsien-Tzu Liu,
William J. Huang, Taipei, Taiwan
MP35-20 ANDROGEN REPLACEMENT THERAPY FOR
CANCER-RELATED SYMPTOMS IN MALE
SATURDAY
ADVANCED CANCER PATIENTS
Kouji Izumi*, Atshushi Mizokami, Kanazawa,
Japan
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
145
NOTES
NOTES
NOTES
 MP = Moderated Poster Session, PD = Podium Session

Sunday, May 15, 2022 Plenary: Prime Time Sunday Morning Session 7:30 am – 11:30 am
Great Hall A @ Ernest N. Morial Convention Center
7:30 PANEL DISCUSSION: REGENERATIVE MEDICINE IN PEDIATRICS
Moderator: Walid Farhat
Panelists: Roger De Filippo, Carlos Estrada
7:50
EUROPEAN ASSOCIATION OF UROLOGY (EAU) LECTURE: IS ENDOCRINE TREATMENT FOR
UNDESCENDED TESTIS OF ANY BENEFIT AT ALL?
Presenter: Christian Radmayr
8:05 PANEL DISCUSSION: RENAL AND URETERAL DUPLICATIONS
Moderator: Douglas Coplen
Panelists: Mohan Gundeti, Luis Guerra
8:25 SECOND OPINION CASES: URETEROCELES
Moderator: Rosalia Misseri
Panelists: Miguel Castellan, Melise Keays, Sang Don Lee
8:45 JOHN DUCKETT MEMORIAL LECTURE: LIFELONG LEARNING, WHAT’S IN IT FOR ME?
Presenter: David Joseph
9:05 SOCIÉTÉ INTERNATIONALE D’UROLOGIE (SIU) LECTURE: RESEARCH IN COST CONSTRAINT ENVIRONMENTS

SUNDAY
Presenter: Andre van der Merwe
9:25
STATE-OF-THE-ART LECTURE: SHOCKWAVE THERAPY FOR ERECTILE DYSFUNCTION AND PEYRONIE’S DISEASE:
LEGITIMACY, EFFICACY, AND REGULATORY COMMENTARY
Presenter: Ranjith Ramasamy
9:40
PANEL DISCUSSION: HEALTH RISKS NO PROVIDER SHOULD MISS IN MEN PRESENTING WITH SEXUAL
DYSFUNCTION OR INFERTILITY
Moderator: Landon Trost
Panelists: Mohit Khera, Serge Carrier, Alan Shindel
10:00 PANEL DISCUSSION: THE IMPACT OF THE INTERNET ON SEXUAL MEDICINE
Moderator: Gregory Broderick
Panelists: Hossein Sadeghi-Nejad, Irwin Goldstein, Christian Nelson
10:20 PANEL DISCUSSION: PEYRONIE’S DISEASE MANAGEMENT: TIPS AND TRICKS
Moderator: Lawrence Hakim
Panelists: Matthew Ziegelmann, Wayne Hellstrom, Laurence Levine, Run Wang, Faysal Yafi
10:40
CROSSFIRE: CLINICAL CONTROVERSIES IN UROLOGY DEBATE: TELEMEDICINE IS GOOD FOR PATIENTS AND
PROVIDERS IN SEXUAL MEDICINE
Moderator: Nelson Bennett
Debaters: John Mulhall, Gerald Brock
11:10 AUA GUIDELINES: PRIAPISM
Presenter: Trinity Bivalacqua

Sunday, May 15, 2022 Plenary: Prime Time Sunday Afternoon Session 1:00 pm – 4:30 pm
Great Hall A @ Ernest N. Morial Convention Center
1:00 PANEL DISCUSSION: MOLECULAR URINARY TRACT INFECTION TESTING
Moderator: Una Lee
Panelists: Duane Hickling, A. Ackerman, Sonali Advani
1:20
PANEL DISCUSSION: CARE FOR TRANSGENDER/NON-BINARY PATIENT: WHAT EVERY UROLOGIST NEEDS TO
KNOW IN 2022
Moderator: Polina Reyblat
Panelists: Kamran Sajadi, Geolani Dy
1:40 PANEL DISCUSSION: FEMALE URETHRA: SHORT BUT NOT SIMPLE
Moderator: Eric Rovner
Panelists: Anne Pelletier Cameron, Nitya Abraham, Melissa Kaufman
2:00 POINT-COUNTERPOINT DEBATE: SHOULD WE BE USING ANTICHOLINERGICS IN 2022?
Panelists: Yahir Santiago-Lastra, Anne Suskind, Blayne Welk
2:20 PANEL DISCUSSION: UROLOGIC PAIN MANAGEMENT IN THE NON-NARCOTIC ERA
Moderator: Jennifer Robles
Panelists: Casey Duaw, Larissa Rodriguez, Greg Auffenberg

*Presenting author 149

2:50
STATE-OF-THE-ART LECTURE: THE ROLE OF NEUTRACEUTICALS IN THE MANAGEMENT OF LUTS
IN GERIATRIC PATIENTS
Presenter: Claus Roehrborn
3:05 STATE-OF-THE-ART LECTURE: ECONOMICS OF OFFICE-BASED BPH TREATMENTS
Presenter: Richard Levin
3:20 SEMI-LIVE SURGERIES/SURGICAL TECHNIQUES: BPH
Surgeon: Bilal Chughtai
4:20 CROSSFIRE: CONTROVERSIES IN UROLOGY: SUI IN THE OBESE PATIENT
Moderator: Tracey Wilson
Panelists: Tamsin Greenwell, Ekene Enemchukwu

Sunday, May 15, 2022 7:00 am – 11:30 am

Forums
RESIDENTS FORUM
Room 262 @ Ernest N. Morial Convention Center
RESIDENTS FORUM SPONSORED BY INTUITIVE
7:00 REGISTRATION AND BREAKFAST
7:15 WELCOME
Chairs: Michael Ernst, Ruchika Talwar
7:20 BREAKFAST & TALK SPONSORED BY INTUITIVE
7:50 ABU UPDATE
J. Brantley Thrasher
8:00 EQIPS UPDATE
Justin Ziemba
8:10 FINANCIAL TALK
Dave Canes
8:55 RFC ESSAY CONTEST PRIZE WINNERS (2021 AND 2022)
9:05 RFC TEACHING AWARD WINNERS (2021 AND 2022)
9:15 AUA EDUCATION COUNCIL UPDATE
Jay Raman
9:25 SOCIAL MEDIA: DOS AND DONT’S
Justin Dubin, Matt Nielsen, Courtney Rowe, Ashley Winter
9:55 YOUNG UROLOGISTS COMMITTEE UPDATE
Sammy Elsamra
10:05 BREAK
10:15 BEYOND WELLNESS: SUSTAINABLE SOLUTIONS TO AVOID BURNOUT
Moderator: Rachel Mann
Panelists: Chris Jaeger, Betsy Kohne, Amanda North, Phil Pierorazio, Angie Smith
10:45 GRANT WRITING 101
Panelists: Trinity Bivalacqua,Todd Morgan, Yaw Nyame, Anne Suskind, Greg Tasian

150
Sunday, May 15, 2022
Moderated Poster Session 36
RENAL TRANSPLANTATION & VASCULAR SURGERY
Room 228 @ Ernest N. Morial Convention Center
Moderator: Nicholas Cowan
ABSTRACT
NUMBER TITLE
MP36-01 KIDNEY TRANSPLANTATION WITH COVID-19
POSITIVE DONORS: A SERIES OF 55 CASES
Yi-Chia Lin*, Mazhar Kahlil, Mohamed Eltemamy,
Hannah Kerr, Venkatech Krishnamurthi, David
Goldfarb, Alvin Wee, Cleveland, OH
MP36-02 SINGLE PORT ROBOTIC VERSUS
OPEN KIDNEY TRANSPLANTATION: A
COMPARISON OF OUTCOMES
Aaron Kaviani*, Mohamed Eltemamy, Yi-Chia Lin,
Mahmoud Abou Zeinab, Alp Tuna Beksac,
Ethan Ferguson, Alvin Wee, Jihad Kaouk,
Cleveland, OH
MP36-03 ERECTILE FUNCTION 5-YEARS FOLLOWING
SUCCESSFUL PENIS TRANSPLANTATION
Meredith Wasserman*, Gabriella Avellino, Priyan-
ka Bearelly, Providence, RI, Rachel Goldstein,
Houston, TX, Rachel Greenberg, Mark Sigman,
Providence, RI, Branko Bojovic, Curtis Cetrulo,
Jr., Boston, MA, Dicken Ko, Providence, RI
MP36-04 THE “CANNIBALIZATION” OF ALTRUISTIC
KIDNEY DONATION BY VOUCHER-BASED
KIDNEY TRANSPLANTATION
Nima Nassiri*, Torey Averick, Jeffrey Veale,
Los Angeles, CA
MP36-05 A NOVEL METHOD OF CD31 COMBINED ABO
CARBOHYDRATE ANTIGEN MICROARRAY
PREDICTS ACUTE ANTIBODY MEDIATED
REJECTION IN ABO-INCOMPATIBLE KIDNEY
TRANSPLANTATION
Masayuki Tasaki*, Niigata, Japan, Hiroaki Tateno,
Takashi Sato, Azusa Tomioka, Hiroyuki Kaji,
Hisashi Narimatsu, Tsukuba, Japan, Kazuhide
Saito, Toshinari Aoki, Masami Kamimura, Takashi
Ushiki, Yutaka Yoshida, Niigata, Japan, Kota
Takahashi, Tokyo, Japan, Yoshihiko Tomita,
Niigata, Japan
MP36-06 CHARACTERISTICS AND OUTCOMES OF DE
NOVO PROSTATE CANCER IN THE SOLID
ORGAN TRANSPLANT POPULATION AT THE
UNIVERSITY OF MINNESOTA
Brent Cleveland*, Andrew Gardeck, Matthew
Holten, Scott Jackson, Timothy Pruett, Christo-
pher Warlick, Minneapolis, MN
MP36-07 MAG-3 SCAN REVEALS SIMULTANEOUS
LIVER-KIDNEY TRANSPLANTATION IS
ACCOMPANIED BY SIGNIFICANT RETURN
OF NATIVE RENAL FUNCTION
Glenn T. Werneburg, David Goldfarb, Daniel
Hettel*, Alvin Wee, Cleveland, OH
MP36-08 RCC IN KIDNEY TRANSPLANT RECIPIENTS:
INCIDENCE, TRENDS, CLINICAL
MANAGEMENT AND OUTCOMES
Jason Lee*, Michelle Minkovich, Rebecca Wong,
Olusegun Famure, Yanhong Li, Joseph Kim,
Toronto, Canada
*Presenting author
7:00 am – 8:15 am
ABSTRACT
NUMBER TITLE
MP36-09 VALIDATION OF A URINARY EXOSOME
MRNA SIGNATURE FOR THE DIAGNOSIS OF
HUMAN KIDNEY TRANSPLANT REJECTION
Rania El Fekih*, Boston, MA, Kurt Franzen, Brian
Cole, James Hurley, Sonia Kumar, Johan Skog,
Waltham, MA, Jamil Azzi, Boston, MA
MP36-10 COMPARATIVE ANALYSIS OF
PERIOPERATIVE COMPLICATIONS IN
KIDNEY TRANSPLANT PATIENTS WITH
CORONARY ARTERY DISEASE ON DUAL
ANTIPLATELET DRUGS
SUNDAY
Amit Bansal, Pratik Garg, Pawan Kandhari, Ruchir
Maheshwari, Samit Chaturvedi, Harshit Garg,
Ayush Singh, ANANT KUMAR*, New Delhi, India
MP36-11 INDUCTION OF IMMUNE TOLERANCE AFTER
HAPLOIDENTICAL LIVING DONOR KIDNEY
TRANSPLANT
Nima Nassiri*, Erik Lum, Monica Mead, Gabriel
Danovitch, H. Albin Gritsch, Neil Kogut, Jeffrey
Veale, Los Angeles, CA
MP36-12 AN IMMUNOSUPPRESSIVE REGIMEN
CONTAINING EVEROLIMUS DECREASES
THE INTERSTITIAL FIBROSIS FORMATION
OF KIDNEY ALLOGRAFT BY SUPPRESSING
MTOR-RELATED PROTEIN EXPRESSION
Takuro Saito*, Mitsuru Saito, Yu Aoyama, Ryuichi-
ro Sagehashi, Ryohei Yamamoto, Soki Kashima,
Atsushi Koizumi, Taketoshi Nara, Kazuyuki Nu-
makura, Shintaro Narita, Shigeru Satoh, Tomonori
Habuchi, Akita, Japan
MP36-13 ANALYSIS OF PRIMARY NON-FUNCTION,
DELAYED GRAFT FUNCTION AND OVERALL
GRAFT SURVIVAL FOR EXPANDED CRITERIA
DONORS’ KIDNEYS
Monica Peradejordi Font*, Antoni Vilaseca Cabo,
Lluis Peri Cusi, Mireia Musquera Felip, Tarek
Ajami Fardoun, Claudia Mercader Barrull, Angel
Ruiz Arranz, David Paredes Zapata, Fritz Diek-
mann, Antonio Alcaraz Asensio, Barcelona, Spain
MP36-14 THE EFFECT OF RENAL TRANSPLANTATION
ON ERECTILE FUNCTIONS IN PATIENTS
WITH END-STAGE RENAL DISEASE
Serdar Karadag*, Istanbul, Turkey
MP36-15 ROBOTIC SINGLE-PORT VERSUS
LAPAROSCOPIC DONOR NEPHRECTOMY: AN
INSTITUTIONAL ANALYSIS
Chih Peng Chin*, Evan Garden, Micah Levy, Kr-
ishna Ravivarapu, Osama Al-Alao, Joseph Sewell
Araya, Sander Florman, Antonios Arvelakis,
Daniel Herron, Edward Chin, Michael Palese,
New York, NY
151
 MP36-16 VIRTUAL IMAGING 3D ANATOMICAL
MODELING CAN FACILITATE LAPAROSCOPIC
OR ROBOTIC DONOR NEPHRECTOMY IN
PATIENTS WITH COMPLEX RENAL ANATOMY
THAT WERE PRECLUDED FROM DONATION
BASED ON COMPUTED TOMOGRAPHY
ANGIOGRAPHY OR MAGNETIC RESONANCE
IMAGING
Ravi Munver*, Jennifer Kuo, Michael Degen,
Hackensack, NJ
MP36-17 ROBOTIC BILATERAL NEPHRECTOMY FOR
LARGE KIDNEYS WITH ADULT POLYCYSTIC
KIDNEY DISEASE WITH DA VINCI XI AND DA
VINCI SP
Hanson Zhao, Lior Taich, John M. Masterson*,
Aurash Naser-Tavakolian, Hayley Johnson, Reiad
Najjar, Irene Kim, Amit Gupta, Los Angeles, CA
MP36-18 ADVANCED TERTIARY LYMPHOID TISSUES
ARE ASSOCIATED WITH PROGRESSIVE
GRAFT DYSFUNCTION IN KIDNEY
TRANSPLANT RECIPIENTS
Mitsuru Saito*, Akita, Japan, Yu Ho Lee, Yuki
Sato, Kyoto, Japan, Nobuhiro Fujiyama, Shigeru
Satoh, Akita, Japan, Motoko Yanagita, Kyoto,
Japan, Tomonori Habuchi, Akita, Japan
Sunday, May 15, 2022
Moderated Poster Session 37
INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: PROSTATE & GENITALIA
Room 225 @ Ernest N. Morial Convention Center
Moderators: Robert Moldwin, J. Curtis Nickel & Claire Yang
ABSTRACT
NUMBER TITLE
MP37-01 PILOT TRIAL FOR PIVOT: PREVENTION OF
RECURRENT URINARY TRACT INFECTION
USING VAGINAL TESTOSTERONE
Mariela Martinez*, Arshia Sandozi, Jeffrey Lee,
Liliya Vafina, Brooklyn, NY, Cassandra Pond,
Robert Adelson, Manhasset, NY, Elie Kaplan-Ma-
rans, Katiana Vazquez-Rivera, Brooklyn, NY,
Annette Lee, Manhasset, NY, Allison Polland,
Brooklyn, NY
MP37-02 HYPERTENSION AND LOW CHOLESTEROL
AS RISK FACTORS FOR INFECTION AFTER
PENILE PROSTHESIS SURGERY IN A
DIVERSE, URBAN ACADEMIC CENTER
Justin Loloi*, Jubin Matloubieh, Bronx, NY, Catie
Riley, Waterville, ME, David Melendez, Kara
Watts, Pedro Maria, Bronx, NY
MP37-03 EXTRACORPOREAL SHOCKWAVE THERAPY
IMPROVES CP/CPPS BY DOWN-REGULATING
NLPR3 INFLAMMASOME IN A PROSTATITIS
RAT MODEL
Dongho Shin*, Chang Eil Yoon, Hyeok Jae Kwon,
Hyong Woo Moon, Yong Hyun Park, Hyuk Jin
Cho, U-syn Ha, Sung-Hoo Hong, Sae Woong
Kim, Ji Youl Lee, Woong Jin Bae, Seoul, Korea,
Republic of
152
MP36-19 PROSTACYCLIN (TREPROSTINIL) THERAPY
IMPROVES RENAL HEMODYNAMICS DURING
RAT RENAL ISCHEMIA-REPERFUSION
INJURY
Frances Kazal*, Providence, RI, Meiwen Ding,
Kingston, RI, Dicken Ko, Reginald Gohh, Provi-
dence, RI, Nisanne Ghonem, Kingston, RI
MP36-20 MULTI-PHOTON MICROSCOPY FOR THE
EVALUATION OF INTERSTITIAL FIBROSIS IN
EXTENDED CRITERIA DONOR KIDNEYS: A
PROOF-OF-CONCEPT PILOT STUDY
Wei Zheng So*, Jirong Lu, Benjamin Yen Seow
Goh, Rachel Zui Chih Teo, Anantharaman Vathsa-
la, Ho Yee Tiong, Kent Ridge, Singapore
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
7:00 am – 8:15 am
ABSTRACT
NUMBER TITLE
MP37-04 PROSTATE ABSCESS: CLINICAL FEATURES,
MANAGEMENT, AND OUTCOMES OF A
“MASKED” INFECTION IN COVID 19 PERIOD:
A CASE SERIES
Harmanmeet Singh*, JVS Prakash, PV Thiruvarul,
Vetrichandar S, Arasi KV, Natarajan V, ArunKumar
Paranjothi, Chennai, India
MP37-05 A SYSTEMATIC REVIEW AND META-
REGRESSION OF PLACEBO EFFECT IN
CHRONIC PROSTATITIS/CHRONIC PELVIC
PAIN SYNDROME
Andrey Morozov*, Andrey Bazarkin, Diana Babae-
vskaya, Mark Taratkin, Vasiliy Kozlov, Aleksandr
Suvorov, Leonid Spivak, Jonathan Mcfarland,
Moscow, Russian Federation, Giorgio Russo,
Catania, Italy, Dmitry Enikeev, Moscow, Russian
Federation
MP37-06 ANTIMICROBIAL RESISTANCE AND
MICROBIAL PATTERNS WITHIN THE
CHRONIC PROSTATITIS UROBIOME
COMPARED TO ASYMPTOMATIC HEALTHY
CONTROLS
J. Curtis Nickel*, Kingston, Canada, Niccole Diaz,
Craig D. Tipton, Lubbock, TX, E. David Crawford,
San Diego, CA, Rick Martin, Caleb D. Phillips,
Lubbock, TX
 MP37-07 DOES VASECTOMY INDUCE SEMEN
MICROBIOME DYSBIOSIS?
Maria Camila Suarez*, Joseph M. Israeli, Kajal
Khodamoradi, Ranjith Ramasamy, Miami, FL
MP37-08 URINARY MICROBIOME AS A BIOMARKER
FOR PROSTATE CANCER
Michael Liss*, John Lee, San Antonio, TX, James
White, Baltimore, MD, Teresa Johnson-Pais, Zhao
Lai, San Antonio, TX, Dean Troyer, Norfolk, VA,
Robin Leach, Brian Wickes, San Antonio, TX
MP37-09 PROSTATE BIOPSY TISSUE CORES OBTAINED
FROM THE TRANSPERINEAL APPROACH
HARBOR FEWER MICROBIAL SPECIES AND
LOWER MICROBIAL RESEMBLANCE TO
THE RECTAL FLORA RELATIVE TO THOSE
OBTAINED TRANSRECTALLY
Glenn T. Werneburg*, Aaron Miller, Ava Adler,
Samuel Haywood, Eric A. Klein, Cleveland, OH
MP37-10 ETIOLOGY OF ACUTE EPIDIDYMITIS (AE) IN
MP37-15 A MULTICENTER RETROSPECTIVE STUDY
ASSESSING RISK OF COMPLICATIONS IN
HYDROCELE SURGERY
Lauri Mäki-Lohiluoma*, Tuomas P. Kilpeläinen,
Petrus Järvinen, Henna K. Söderström, Kari A.O.
Tikkinen, Jukka Sairanen, Helsinki, Finland
MP37-16 HYDROCELE ASPIRATION AND SCLEROSIS;
IS SODIUM TETRADECYL SULPHATE
SUPERIOR?
Jacob Nelson*, Matthew Kasson, Peter Dietrich,
Jay Sandlow, Milwaukee, WI
MP37-17 PREVALENCE OF HPV AWARENESS AMONG
YOUNG SEXUALLY ACTIVE MALE
Francesco Esperto, Francesco Prata*, Francesco
Tedesco, Alberto Ragusa, Noemi Deanesi, Anto-
nio Testa, Angelo Civitella, Piergiorgio Tuzzolo,
Luca Romei, Vito Giuseppe Crimi, Loris Cac-
ciatore, Gerardo Paolo Flammia, Antonio Alcini,
Annamaria Salerno, Rome, Italy, Salvatore Mario

SUNDAY
Prata, Sora, Italy, Roberto Mario Scarpa, Rocco
YOUNG PATIENTS UNDER 35 YEARS
Papalia, Rome, Italy
Anan Hussein*, Michael Cohen, Michael gross,
Genady Zlitschinko, Arnon Lavi, Bishara Ibrahim, MP37-18 NO RELATIONSHIP BETWEEN HPV AND
Rashad Abu leil, Afula, Israel, Tarek Taha, Safed, PROSTATE CANCER
Israel, Yanovskay Anna, Chazan Bibiana, Afula, Israel Cristina Minasola*, Marco Vella, Gabriele Tulone,
Mirko Pinelli, Palermo, Italy, Alberto Abrate,
MP37-11 WHOLE EXOME SEQUENCING IDENTIFIES A
Sondrio, Italy, Gianpaolo Di Gregorio, Sonia
RARE MUTATION IN NACAD AS A POSSIBLE
Maria Agiato, Rosellina Giaimo, Carlo Pavone,
CAUSE OF COVID ORCHITIS IN BROTHERS
Giuseppina Capra, Chiara Mascarella, Alchiede
Rohit Reddy*, Efimenko Iakov, Kajal Khodamora-
Simonato, Palermo, Italy
di, Willy Chertman, Himanshu Arora, Parris Diaz,
Ranjith Ramasamy, Miami, FL MP37-19 RATE AND PROGNOSTIC VALUE OF
NEW DIAGNOSES OF DIABETES WITH
MP37-12 COVID-19 VACCINATION IS ASSOCIATED
FOURNIER’S GANGRENE
WITH A DECREASED RISK OF ORCHITIS
Christopher Staniorski*, Michael Pintauro, Emily
AND/OR EPIDIDYMITIS IN MEN
Hacker, Jen Mihalo, Benjamin Davies, Bruce
Chase Carto*, Sirpi Nackeeran, Ranjith
Jacobs, Michelle Yu, Paul Rusilko, Pittsburgh, PA
Ramasamy, Miami, FL
MP37-20 OUTCOMES AND HEALTH-RELATED
MP37-13 MEAN PLATELET VOLUME IS THE MOST
QUALITY OF LIFE (HRQOL) IN LONG-TERM
VALUABLE HEMATOLOGIC PARAMETER IN
SURVIVORS OF FOURNIER’S GANGRENE
DIFFERENTIATING TESTICULAR TORSION
Laila Schneidewind*, Vanessa Roßberg, Desiree
FROM EPIDIDYMITIS WITHIN THE GOLDEN
L. Dräger, Rostock, Germany, Joachim Steffens,
TIME
Eschweiler, Germany, Oliver W. Hakenberg, Ros-
Chung Ho Seok*, Yu Seong Hyeon, Hwang Eu
tock, Germany, Jennifer Kranz, Aachen, Germany
Chang, Kim Sun-Ouck, Oh Kyung Jin, Jung
Seung Il, Kang Taek Won, Kwon Dongdeuk, Park APPROVED FOR AMA PRA CATEGORY 1.25
Kwangsung, Gwangju, Korea, Republic of CREDITSTM
MP37-14 A DOSE-ESCALATING PHASE I STUDY OF
AN INJECTION OF LIDOCAINE PASTE FOR
PROLONGED SPERMATIC CORD BLOCK IN
MEN WITH CHRONIC SCROTAL CONTENT
PAIN
Luke Witherspoon*, Claudia Kesch, Veronika
Schmitt, Graeme Boniface, Colin Lundeen,
Vancouver, Canada, J. Curtis Nickel, Kingston,
Canada, Ryan Paterson, Martin Gleave, Ryan
Flannigan, Vancouver, Canada

*Presenting author 153

Sunday, May 15, 2022
Moderated Poster Session 38
SEXUAL FUNCTION/DYSFUNCTION: BASIC RESEARCH & PATHOPHYSIOLOGY
Room 222 @ Ernest N. Morial Convention Center
Moderators: Trinity Bivalacqua & Jeffrey Campbell
ABSTRACT
NUMBER TITLE
MP38-01 BIOACTIVE FIBROUS MEMBRANE
CONTAINING ENDOGENOUS NERVE
GROWTH FACTOR PROMOTES CELLULAR
AND FUNCTIONAL RECUPERATION OF
IMPAIRED CAVERNOUS NERVE: AN IN VIVO
ANIMAL STUDY
Paulo Mota, Cabeceiras de Basto, Portugal, Marta
Casanova, Braga, Portugal, Helena Vala, Carmen
Nóbrega, Vila Real, Portugal, Alain Morais, Braga,
Portugal, Catarina Silva, Guimarães, Portugal,
Sara Anacleto*, Braga, Portugal, Alexandre
Barros, Guimarães, Portugal, Rui Reis, Braga,
Portugal, Estêvão Lima, Cabeceiras de Basto,
Portugal, Albino Martins, Nuno Neves, Braga,
Portugal
MP38-02 IMPAIRED NICOTINAMIDE ADENINE
DINUCLEOTIDE (NAD+) MEDIATING
ENDOTHELIUM-INDEPENDENT RELAXATION
WITH AGING ON HUMAN CORPUS
CAVERNOSUM
Serap Gur*, Ankara, Turkey, Suresh C. Sikka,
Sudha Talwar, New Orleans, LA, Didem Yil-
maz-Oral, Adana, Turkey, Asim Abdel-Mageed,
Wayne JG Hellstrom, New Orleans, LA
MP38-03 COMBINATION TREATMENT WITH A
JNK INHIBITOR AND HEPATOCYTE
GROWTH FACTOR FOR RESTORATION OF
ERECTILE FUNCTION IN A RAT MODEL OF
CAVERNOSAL NERVE INJURY: COMPARISON
WITH A JNK INHIBITOR ALONE OR
HEPATOCYTE GROWTH FACTOR ALONE
Junghoon Lee*, Sangjun Yoo, Min Soo Choo,
Hwancheol Son, Hyeon Jeong, Soo Woong Kim,
Min Chul Cho, Seoul, Korea, Republic of
MP38-04 TUMOR NECROSIS FACTOR ALPHA (TNF- α)
AND RHO-KINASE 2 (ROCK2) INHIBITORS
IMPROVE ERECTILE FUNCTION IN A
BILATERAL CAVERNOUS NERVE INJURY
RAT MODEL
James Liu*, Kara Lombardo, Alok Singh, Monali
Praharaj, Serkan Karakus, Arthur Burnett, Balti-
more, MD, Trinity Bivalacqua, Philadelphia, PA
MP38-05 TARGETED LIQUID CHROMATOGRAPHY
MASS SPECTROMETRY QUANTIFICATION
OF EXCRETED URINARY ESTROGENS
AMONG POSTMENOPAUSAL WOMEN
USING DIFFERENT ESTROGEN HORMONE
THERAPY MODALITIES
Michael L. Neugent*, Neha Hulyalkar, Richardson,
TX, Vladimir Shulaev, Denton, TX, Philippe E.
Zimmern, Dallas, TX, Nicole J. De Nisco,
Richardson, TX
154
7:00 am – 8:15 am
ABSTRACT
NUMBER TITLE
MP38-06 SONIC HEDGEHOG SIGNALING IN
CORPORA CAVERNOSAL CELLS
FROM PROSTATECTOMY, DIABETIC,
HYPERTENSION AND PEYRONIE’S PATIENTS
WITH ERECTILE DYSFUNCTION
Sarah Martin, Timothy Searl, Samuel Ohlander,
Chicago, IL, Kevin McVary, Maywood, IL, Carol
Podlasek*, Chicago, IL
MP38-07 VASCULAR, NEUROLOGIC AND HORMONAL
ABNORMALITIES IN MEN WITH
PERSISTENT SEXUAL DYSFUNCTION AFTER
DISCONTINUATION OF FINASTERIDE
Marvin Carlisle*, Maria Uloko, Alyssa Yee, Sue
Goldstein, Irwin Goldstein, San Diego, CA
MP38-08 HUMAN UMBILICAL CORD MESENCHYMAL
STEM CELLS AMELIORATE ERECTILE
DYSFUNCTION IN TYPE I AND TYPE II
DIABETES MELLITUS RATS THROUGH
THE ATTENUATION OF FERROPTOSIS BY
SLC7A11/GPX4/ACSL4 PATHWAY
Huan Feng*, Tao Wang, Jihong Liu, Wuhan,
China, People’s Republic of
MP38-09 MAGNETIC INDUCTION WAND DESIGN FOR
NOVEL PENILE PROSTHESIS
Shannon Roney, Michael Mendoza, Maya McKen-
zie, Gail Baura, Chicago, IL, Brian Le, Madison,
WI, Kevin McVary, Alberto Colombo*, Chicago, IL
MP38-10 TENSILE STRENGTH OF PENILE TUNICA
ALBUGINEA IN A HUMAN MODEL
Alexander M. Kandabarow*, Eric Chuang, May-
wood, IL, Kevin McKenna, Chicago, IL, Brian Le,
Madison, WI, Kevin McVary, Alberto Colombo,
Maywood, IL
MP38-11 GENERATION OF LEYDIG CELLS DERIVED
FROM HUMAN IPS CELLS
Katsuya Sato*, Masato Fujisawa, Takashi Aoi,
Kobe, Japan
MP38-12 EFFECT OF LI-ESWT ON TESTICULAR
TISSUE AND FUNCTION IN AGING RATS
Dongho Shin*, Seung Hwan Jeon, Hyuk Jin Cho,
U-syn Ha, Sung-Hoo Hong, Ji Youl Lee, Wen Jie
Tian, Jun Jie Piao, Sae Woong Kim, Woong Jin
Bae, Seoul, Korea, Republic of, Mahadevan Raj
Rajasekaran, San Diego, CA
MP38-13 DATA MINING AND BIOINFORMATIC
ANALYSIS REVEAL DYSREGULATION OF
ANDROGEN BIOSYNTHESIS AND SIGNALING
PATHWAYS IN TESTIS OF SARS-COV-2
INFECTED MEN
Manesh Kumar Panner Selvam*, Saradha Bas-
karan, New Orleans, LA, Peter Natesan Push-
paraj, Jeddah, Saudi Arabia, Suresh Sikka, New
Orleans, LA
 MP38-14 GUT MICROBIOME ASSOCIATED WITH
BLOOD TESTOSTERONE LEVELS IN
ELDERLY MEN
Kazutoshi Fujita*, Osakasayama, Japan, Makoto
Matsushita, Koji Hatano, Suita, Japan, Mitsu-
hisa Nishimoto, Osakasayama, Japan, Daisuke
Motooka, Suita, Japan, Eri Banno, Osakasayama,
Japan, Junya Hata, Fukushima, Japan, Takafumi
Minami, Masahiro Nozawa, Osakasayama, Japan,
Shota Nakamura, Suita, Japan, Akira Tsujimu-
ra, Urayasu, Japan, Wataru Obara, Morioka,
Japan, Kazuhiro Yoshimura, Hirotsugu Uemura,
Osakasayama, Japan, Norio Nonomura, Suita,
Japan
MP38-15 LEPTIN INDUCED LEYDIG CELL
DIFFERENTIATION AND TESTOSTERONE
PRODUCTION IS INFLUENCED
DIFFERENTIALLY WITH RESPECT TO BMI
Deepa Seetharam*, Kajal Khodamoradi, Alexan-
dra Dullea, Issa Isabelle Catherine, Natoli Farber,
Himanshu Arora, Ranjith Ramasamy, Maimi, FL
MP38-16 IS IT TIME FOR FPMRS TO PRESCRIBE
VIBRATORS?
Alexandra Dubinskaya*, Beverly Hills, CA, Rainey
Horrwitz, St Louis, MO, Poone Shoureshi, Beverly
Hills, CA, Jennife Anger, La Jolla, CA, Victoria
Scott, Karyn Eilber, Beverly Hills, CA
MP38-17 CURRENT CLINICAL RESEARCH IN
ERECTILE DYSFUNCTION
Arshia Sandozi*, Benjamin Shpeen, Ariel Schul-
man, Brooklyn, NY
Sunday, May 15, 2022
Podium Session 35
PROSTATE CANCER: ADVANCED (INCLUDING DRUG THERAPY) II
Room 252 @ Ernest N. Morial Convention Center
Moderators: Sam Chang, Stephen Freedland & Judd Moul
ABSTRACT
TIME NUMBER TITLE
7:00 PD35-01 WHICH PATIENTS WITH CN1 DISEASE AT
PET/CT ARE AFFECTED BY SYSTEMIC
DISEASE? IMPLICATIONS FOR TAILORED
TREATMENT APPROACHES BASED ON A
LARGE MULTI-INSTITUTIONAL SERIES
Elio Mazzone*, Milano, Italy, Giorgio Gandaglia,
Armando Stabile, Milan, Italy, Daniele Robesti,
Antony Pellegrino, Andrea Necchi, Daniele Raggi,
Laura Marandino, Simone Scuderi, Francesco
Barletta, Milano, Italy, Vito Cucchiara, Emanuele
Zaffuto, Milan, Italy, Nazareno Suardi, Genoa,
Italy, Shahrokh F. Shariat, Vienna, Austria, Franc-
esco Montorsi, Alberto Briganti, Milano, Italy
*Presenting author
MP38-18 ANDROGEN RECEPTOR SIGNALING IN
CORPUS CAVERNOSUM IS SIMILAR IN MEN
WITH SERUM TESTOSTERONE LEVELS
ABOVE 200 NG/DL
Kajal Khodamoradi, Alexandra Dullea*, Miami, FL,
Roei Golan, Tallahassee, FL, Jesse Ory, Halifax,
Canada, Himanshu Arora, Ranjith Ramasamy,
Miami, FL
MP38-19 PREVALENCE OF TESTOSTERONE
DEFICIENCY AND SECONDARY
POLYCYTHEMIA IN MEN WITH OBSTRUCTIVE
SLEEP APNEA
Chase Carto*, Sirpi Nackeeran, Ranjith
Ramasamy, Miami, FL
MP38-20 SEXUAL DYSFUNCTION ISSUES AMONG
MEN WITH PSYCHIATRIC COMORBIDITIES:
A MANAGEMENT CHALLENGE?
Nicolò Schifano*, Milan, Italy, Paolo Capogrosso,
Varese, Italy, Giuseppe Fallara, Edoardo Pozzi,
SUNDAY
Federico Belladelli, Luigi Candela, Christian Cors-
ini, Massimiliano Raffo, Antonio Costa, Daniele
Cignoli, Alessia d’Arma, Luca Boeri, Eugenio
Ventimiglia, Rayan Matloob, Milan, Italy, Vincenzo
Mirone, Naples, Italy, Federico Dehò, Varese,
Italy, Francesco Montorsi, Andrea Salonia,
Milan, Italy
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
7:10 PD35-02 WHEN IS NEOADJUVANT ANDROGEN
DEPRIVATION THERAPY BENEFICIAL
FOR HIGHLY AGGRESSIVE PROSTATE
CANCER CANDIDATES TO RADICAL
PROSTATECTOMY? IMPLICATIONS FOR
MULTI-MODAL TAILORED APPROACHES AND
TRIALS DESIGN
Francesco Barletta*, Giorgio Gandaglia, Simone
Scuderi, Giuseppe Ottone Cirulli, Elio Mazzone,
Milano, Italy, Armando Stabile, Milan, Italy, Andrea
Necchi, Laura Marandino, Daniele Raggi, Milano,
Italy, Vito Cucchiara, Milan, Italy, Daniele Robesti,
Milano, Italy, Emanuele Zaffuto, Luigi Nocera, Mi-
lan, Italy, Donato Cannoletta, Milano, Italy, Mario
De Angelis, Milan, Italy, Pierre I. Karakiewicz,
Montreal, Canada, Francesco Montorsi, Alberto
Briganti, Milano, Italy
155
7:20 PD35-03 THE SIGNIFICANCE OF DE-RITIS RATIO IN
PATIENTS WITH RADIATION-RECURRENT
PROSTATE CANCER UNDERGOING SALVAGE
RADICAL PROSTATECTOMY
Fahad Quhal*, Ekaterina Laukhtina, Benjamin
Pradere, Pawel Rajwa, Vienna, Austria, Axel
Heidenreich, Cologne, Germany, Shahrokh F.
Shariat, Vienna, Austria
7:30 PD35-04 QUANTITATIVE PIFLUFOLASTAT F18 (PSMA)
SCAN INDICES AS A RESPONSE IMAGING-
BIOMARKER TO ANDROGEN DEPRIVATION
THERAPY IN VETERANS WITH NEWLY
DIAGNOSED METASTATIC PROSTATE CANCER
Nicholas Nickols*, Gholam Berenji, Nathanael
Kane, Los Angeles, CA, Karl Sjöstrand, Aseem
Anand, Lund, Sweden, Clayton Smith, Jeremie
Calais, Matthew Rettig, Los Angeles, CA
7:40 PD35-05 INITIAL EXPERIENCE OF [177LU]
LUDOTADIPEP TREATMENT IN PATIENTS
WITH [18F]PSMA PET CT POSITIVE
METASTATIC CASTRATION-RESISTANT
PROSTATE CANCER: PRELIMINARY STUDY
Dongho Shin*, Chang Eil Yoon, Hyeok Jae Kwon,
Hyong Woo Moon, Yong Hyun Park, Woong Jin
Bae, Hyuk Jin Cho, U-syn Ha, Sung-Hoo Hong,
Sae Woong Kim, Ji Youl Lee, Seoul, Korea,
Republic of
7:50 PD35-06 HEALTH-RELATED QUALITY OF LIFE IN
LOW-INCOME MEN AFTER SURGICAL
CASTRATION FOR METASTATIC PROSTATE
CANCER
Thomas Gaither*, Mark Litwin, Los Angeles, CA
8:00 PD35-07 ANALYSIS OF DISCONTINUATION RATES
AND CAUSES OF EARLY DISCONTINUATION
OF NOVEL ORAL HORMONE THERAPY IN
MEN WITH ADVANCED PROSTATE CANCER
David Gangwish*, Bernadette Zwaans, Royal
Oak, MI, Paul Miriani, Wesley Dejoie, Andrina Ajo,
Connor Ervin, Jeff Sarazin, Jason Hafron, Troy, MI
8:10 PD35-08 ORAL RELUGOLIX FOR ANDROGEN
DEPRIVATION THERAPY IN ADVANCED
PROSTATE CANCER: POOLED SAFETY
ANALYSES FROM RANDOMIZED
CONTROLLED STUDIES
James L. Bailen*, Jeffersonville, IN, Fred Saad,
Montreal, Canada, Daniel J. George, Durham,
NC, Bryan Mehlhaff, Springfield, OR, Michael
S. Cookson, Oklahoma City, OK, Daniel R.
Saltzstein, San Antonio, TX, Ronald Tutrone, Tow-
son, MD, Bruce Brown, Andria G.M. Langenberg,
Sophia Lu, Jina Lee, Brisbane, CA, Sarah Han-
son, New York, NY, Bertrand Tombal, Brussels,
Belgium, Neal D. Shore, Myrtle Beach, SC
156
8:20 PD35-09 HOMOLOGOUS RECOMBINATION
DEFICIENCY (HRD) SCORE IN
CHINESE AGGRESSIVE PROSTATIC
ADENOCARCINOMA WITH OR WITHOUT
INTRADUCTAL CARCINOMA OF THE
PROSTATE
Sha Zhu*, Hao Zeng, Chengdu, China, People’s
Republic of
8:30 PD35-10 PROGNOSTIC SIGNIFICANCE OF RISK
STRATIFICATION IN CHAARTED AND
LATITUDE STUDIES AMONG JAPANESE MEN
WITH CASTRATION-RESISTANT PROSTATE
CANCER
Masaki Shiota*, Sotaro Chikamatsu, Leandro
Blas, Takashi Matsumoto, Eiji Kashiwagi, Junichi
Inokuchi, Ken-ichiro Shiga, Akira Yokomizo, Ma-
satoshi Eto, Fukuoka, Japan
8:40 PD35-11 THE IMPACT OF OLDER AGE ON THE
ONCOLOGICAL OUTCOMES FOR HIGH-
RISK METASTATIC HORMONE-SENSITIVE
PROSTATE CANCER TREATED WITH
UPFRONT INTENSIVE THERAPY
Shingo Hatakeyama*, Hirosaki, Japan, Shintaro
Narita, Akita, Japan, Takahiro Kimura, Kenichi
Hata, Takafumi Yanagisawa, Tokyo, Japan,
Norihiko Tsuchiya, Senji Hoshi, Yamagata, Japan,
Shigeto Ishidoya, Sendai, Japan, Sadafumi Kawa-
mura, Natori, Japan, Akihiro Ito, Sendai, Japan,
Shin Egawa, Tokyo, Japan, Tomonri Habuchi,
Akita, Japan, Chikara Ohyama, Hirosaki, Japan
8:50 PD35-12 ASSOCIATION BETWEEN USE OF SECOND-
GENERATION ANTIANDROGENS AND
OVERALL SURVIVAL IN PATIENTS WITH
METASTATIC PROSTATE CANCER – A
POPULATION-BASED STUDY
Isaac Kim Jr.*, Providence, RI, Nikita Nikita,
Joshua Banks, Scott Keith, Philadelphia, PA,
Isaac Kim, New Haven, CT, Grace Lu-Yao,
Philadelphia, PA
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
Sunday, May 15, 2022 7:00 am – 9:00 am

Podium Session 36
INFERTILITY: BASIC RESEARCH & PATHOPHYSIOLOGY
Room 255 @ Ernest N. Morial Convention Center
Moderators: Peter Schlegel & Kathleen Hwang

ABSTRACT
TIME NUMBER TITLE
7:00 PD36-01 BIOINFORMATIC ANALYSIS OF RNA
SEQUENCING DATA OF TESTIS FROM
SARS-COV-2 INFECTED MEN REVEALS
MOLECULAR ALTERATION OF GERM CELL-
SERTOLI CELL JUNCTION SIGNALING
PATHWAY
Manesh Kumar Panner Selvam*, New Orleans,
LA, Peter Natesan Pushparaj, Jeddah, Saudi
Arabia, Saradha Baskaran, Suresh Sikka, New
Orleans, LA
7:10 PD36-02 HISTOLOGICAL EVIDENCE OF
ABSTRACT
TIME NUMBER TITLE
8:00 PD36-07 DISCOVERY OF A EPIGENETIC BIOMARKER
PREDICTIVE OF MALE INFERTILITY
Chad Pollard, Provo, UT, Ryan Miller, Salt Lake
City, UT, Tim Jenkins, Provo, UT, Kristin Bro-
gaard*, Salt Lake City, UT
8:10 PD36-08 BLOOD TESTIS BARRIER-MIMETIC DROPLET
INTERFACE BILAYERS (DIBS) FOR PASSIVE
PERMEABILITY PREDICTION
Jaime Korner*, Victoria, Canada, Meghan Robin-
son, Vancouver, Canada, Katherine Elvira, Victo-
ria, Canada, Ryan Flannigan, Vancouver, Canada,

SUNDAY
SPERMATOGENIC FAILURE IN MEN WITH Stephanie Willerth, Victoria, Canada
HIGH SPERM DNA FRAGMENTATION INDEX
8:20 PD36-09 DIFFERENTIAL EXPRESSION OF SEMINAL
Taras Shatylko*, Inessa Telezhnikova, Safar
PLASMA PROTEINS IN RESPONDERS
Gamidov, Alikhan Tambiev, Alina Popova, Vlada
AND NON-RESPONDERS TO VARICOCELE
Kometova, Moscow, Russian Federation
TREATMENT
7:20 PD36-03 CHRONIC MARIJUANA USE IMPACTS Timur Bitsoev, Vitaliy Chagovets, Taras Shatylko*,
TESTICULAR VOLUME AND MALE Alisa Tokareva, Safar Gamidov, Natalia Starodubt-
REPRODUCTIVE HEALTH IN RHESUS seva, Alina Popova, Vladimir Frankevich, Moscow,
MACAQUES Russian Federation
Jasper C. Bash*, Jason C. Hedges, Emily R.
8:30 PD36-10 THE MAMMALIAN REPRODUCTIVE
Boniface, Victoria HJ Roberts, Carol B. Hannah,
GENETICS DATABASE, VERSION 2 (MRGDV2)
Jamie O. Lo, Portland, OR
Ricardo Deras, Vivek Ramanathan, Xingquan Lu,
7:30 PD36-04 AROMATIZATION OF ENDOGENOUS Uma Ramamurthy, Martin Matzuk, Larry Lipshultz,
TESTOSTERONE OCCURS PRIMARILY IN Thomas Garcia*, Houston, TX
TESTICULAR LEYDIG CELLS
8:40 PD36-11 MUTATION AND MICRODELETIONS IN
Caroline Kang*, Nahid Punjani, Jessica Marinaro,
PRSS50 AFFECT MALE FERTILITY
Peter Schlegel, New York, NY
Hunter Flores*, Abhishek Seth, Juan Bournat,
7:40 PD36-05 LOSS-OF-FUNCTION IN PHF7 CAUSE MALE Carolina Jorgez, Houston, TX
INFERTILITY BY IMPAIRING HISTONE-
8:50 PD36-12 ABNORMALITIES IN BOTH SOMATIC AND
TO-PROTAMINE EXCHANGE DURING
GERM CELLS DIFFERENTIATE NOA TESTES
SPERMIOGENESIS
FROM NORMAL CONTROLS USING SINGLE
Jianxing Cheng*, Mengyang Cao, Zhongjie
CELL RNA SEQUENCING
Zheng, Haocheng Lin, Beijing, China, People’s
Arina Piechka*, Ghazal Ebrahimi, Meghan Robin-
Republic of
son, Anton Afanassiev, Geoffrey Schiebinger, Eric
7:50 PD36-06 PROSPECTIVE TWO-ARM STUDY OF Belanger, Faraz Hach, Ryan Flannigan, Vancou-
FERTILITY IN MEN WITH COVID-19 ver, Canada
Dmitry Enikeev*, Mark Taratkin, Andrey Morozov,
Vladislav Petov, Dmitry Korolev, Anastasia Shpiki-
APPROVED FOR AMA PRA CATEGORY 2
na, Leonid Spivak, Svetlana Kharlamova, Shched-
CREDITSTM
rina Irina, Oleg Mestnikov, Dmitry Fiev, Timur
Ganzha, Marina Geladze, Aichurok Mambetova,
Evgenia Kogan, Nikolay Zharkov, Gregoriy Demy-
ashkin, Moscow, Russian Federation, Shahrokh
Shariat, Vienna, Austria, Petr Glybochko, Moscow,
Russian Federation

*Presenting author 157

Sunday, May 15, 2022
Podium Session 37
SURGICAL TECHNOLOGY & SIMULATION: INSTRUMENTATION & TECHNOLOGY II
Room 245 @ Ernest N. Morial Convention Center
Moderators: Stephen Nakada, Robert Sweet & Ahmed Ghazi
ABSTRACT
TIME NUMBER TITLE
7:00 PD37-01 A RANDOMIZED, SINGLE-CENTER,
CLINICAL TRIAL COMPARING ROBOTIC-
ASSISTED FLUOROSCOPIC-GUIDED WITH
ULTRASOUND-GUIDED RENAL ACCESS FOR
PERCUTANEOUS NEPHROLITHOTOMY
Kazumi Taguchi*, Shuzo Hamamoto, Takahiro
Yanase, Yasuhito Sue, Tatsuya Hattori, Teruaki
Sugino, Teruaki Sugino, Atsushi Okada, Takahiro
Yasui, Nagoya, Japan
7:10 PD37-02 ROBOTIC-ASSISTED PERCUTANEOUS
NEPHROLITHOTOMY AND URETEROSCOPY
WITH THE MONARCH® PLATFORM,
UROLOGY COMPARES FAVORABLY AGAINST
CONVENTIONAL TECHNIQUES
Thomas Chi*, San Francisco, CA,
Lauren Hathaway, Rachel Chok, Redwood City,
CA, Marshall Stoller, San Francisco, CA
7:20 PD37-03 DETERMINING THE THRESHOLD OF SAFETY
FOR INTRARENAL PRESSURE DURING
FLEXIBLE URETEROSCOPY USING AN IN
VIVO PIG MODEL
Matthew Lee*, Chicago, IL, Deepak Agarwal,
Minneapolis, MN, Bret Connors, Indianapolis, IN,
Mark Assmus, Chicago, IL, James Williams,
Tim Large, Indianapolis, IN, Amy Krambeck,
Chicago, IL
7:30 PD37-04 MOSES 2.0 OR MASTERPULSE? AN
IN-VITRO COMPARISON OF TWO NOVEL
LASER SYSTEMS FOR DUSTING AND
FRAGMENTING IN A BENCHTOP MODEL
Harmenjit Brar*, Glenn Werneburg, Sriharan
Sivalingam, Cleveland, OH
7:40 PD37-05 NOVEL SYPHON URETERIC ACCESS
SHEATH HAS THE POTENTIAL TO IMPROVE
RENAL PRESSURES AND IRRIGANT FLOW
John Lazarus*, Lisa Kaestner, Cape Town, South
Africa
7:50 PD37-06 COMPARISON OF COMPUTATIONAL
SIMULATION AND HYDROGEL KIDNEY
PHANTOMS FOR IN VIVO ASSESSMENT OF
INTRARENAL PRESSURE (IRP) DYNAMICS
DURING URETEROSCOPY UNDER VARIOUS
EXPERIMENTAL CONDITIONS
Ahmed Ghazi*, Rachel Melnyk, Andrew Cook,
Nitin Sharma, Hana Kalco, Tran Phuc, David
Foster, Rochester, NY
8:00 PD37-07 THULIUM FIBER VS THULIUM YAG LASER
EFFECT ON UPPER URINARY TRACT SOFT
TISSUE: AN EX VIVO STUDY
Luis Rico*, Silvia Proietti, Maria Pia Pavia, Milan,
Italy, Leandro Blas, Buenos Aires, Argentina,
Roberta Lucianò, Nazario Pio Tenace, Milan, Italy,
Pablo Contreras, Buenos Aires, Argentina, Andrea
Benedetto Galosi, Ancona, Italy, Franco Gaboardi,
Guido Giusti, Milan, Italy
158
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
8:10 PD37-08 3D MODELING OF RENAL TUMORS FOR
PLANNING AND GUIDANCE OF SELECTIVE
CLAMPING AND UCS SUTURE
Riccardo Schiavina*, Lorenzo Bianchi, Laura
Cercenelli, Barbara Bortolani, Pietro Piazza, Sara
Boschi, Matteo Droghetti, Angelo Mottaran, Franc-
esco Costa, Francesco Chessa, Amelio Ercolino,
Andrea Angiolini, Simone Lodi, Alessandro Pis-
savini, Luca Fontanella, Luca Spinozzi, Riccardo
Melloni, Federico Bevilacqua, Danilo Cangemi,
Caterina Gaudiano, Beniamino Corcioni, Rita
Golfieri, Emanuala Marcelli, Eugenio Brunocilla,
Bologna, Italy
8:20 PD37-09 PREDICTIVE VALIDITY OF IRISTM 3D
ANATOMICAL MODELS DURING ROBOT
ASSISTED PARTIAL NEPHRECTOMY
Nitin Sharma*, Thomas Osinski, Thomas Frye,
William Tabayoyong, Jonathan Bloom, Hani
Rashid, Ahmed Ghazi, Jean Joseph, Rochester,
NY
8:30 PD37-10 COMPARATIVE ANALYSIS OF FUNCTIONAL
OUTCOMES OF OPEN, LAPAROSCOPIC
AND ROBOTIC PARTIAL NEPHRECTOMY
STRATIFIED BY TUMOR COMPLEXITY: A
MULTI-CENTER STUDY
Ava Saidian*, Arman Walia, Juan Javier-De-
sloges, Ithaar Derweesh, La Jolla, CA
8:40 PD37-11 INTERIM RESULTS FROM A MULTICENTER
CLINICAL TRIAL EVALUATING A DROP-IN
GAMMA PROBE FOR SENTINEL LYMPH
NODE DISSECTION IN PROSTATE CANCER
Jose Maria Abascal Junquera, Nuria Juanpere,
Marta Corcoy, Maria Yolanda Aguilar, Barcelona,
Spain, Jochen Christoph Walz, Marseille, France,
Wouter Everaerts, Karolien Goffin, Leuven,
Belgium, Maarten Ruben Grootendorst, Amster-
dam, Netherlands, Francesca Oldfield, Chesham,
United Kingdom, Antoni Mestre Fusco, Girona,
Spain, Sergi Vidal-Sicart, Lluis Fumado*, Barce-
lona, Spain
8:50 PD37-12 MUTLICENTER DEVELOPMENT AND
VALIDATION OF A CONSENSUS BASED NON-
BIOHAZARDOUS SIMULATION MODEL FOR
HOLMIUM LASER ENUCLEATION OF THE
PROSTATE (HOLEP)
Rachel Melnyk, Christopher Wanderling, Rajat
Jain, Scott Quarrier, Rochester, NY, Amy Kram-
beck, Chicago, IL, Nicole Miller, Nashville, TN,
Gopal Narang, Mitchell Humphreys, Phoenix, AZ,
Ahmed Ghazi*, Rochester, NY
Sunday, May 15, 2022
Podium Session 38
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: NON-NEUROGENIC
VOIDING DYSFUNCTION II
Room 244 @ Ernest N. Morial Convention Center
Moderators: Gary Lemack, Eric Rovner & Priya Padmanabhan
ABSTRACT
TIME NUMBER TITLE
7:00 PD38-01 FEASIBILITY, SAFETY AND EFFICACY
RESULTS OF THE SUFU FOUNDATION OPEN
LABEL CLINICAL TRIAL OF ULTRASOUND
CONFIRMED TRANSVAGINAL BOTULINUM
TOXIN A (BTA) FOR REFRACTORY
OVERACTIVE BLADDER (OAB)
Sean W. Berquist*, Stanford, CA, Chen Shenhar,
Tikva, Israel, Stefanie van Uem, Ashu Moham-
mad, Abdelrahman S. Abdalla, Craig V. Comiter,
Stanford, CA, Raveen Syan, Miami, FL, Eboo
Versi, New Brunswick, NJ, Amy D. Dobberfuhl,
Stanford, CA
7:10 PD38-02 10-YEAR FOLLOW-UP OBSERVATION OF
IDIOPATHIC DETRUSOR UNDERACTIVITY
IN THE ELDERLY LIVING IN COMMUNITY:
TREATMENT AND URODYNAMIC CHANGES
Seong Jin Jeong*, Seongnam, Korea, Republic of,
Ji Seok Kim, Seoul, Korea, Republic of, Sang Hun
Song, Hakju Kim, Jin Hyuck Kim, Changhee Ye,
Seongnam, Korea, Republic of, Sang Wook Lee,
Jeong Hyun Kim, Chuncheon, Korea, Republic of,
Hwanik Kim, Seongnam, Korea, Republic of
7:20 PD38-03 ROLE OF POST-VOIDED RESIDUAL
RATIO IN PATIENTS WITH DETRUSOR
UNDERACTIVITY: A PRESSURE-FLOW STUDY
ANALYSIS
Cosimo De Nunzio, Riccardo Lombardo, Rome,
Italy, Antonio Nacchia*, Rionero in Vulture,
Italy, Antonio Maria Cicione, Rome, Italy, Simon
Carter, London, United Kingdom, Carlo Vicentini,
L’Aquila, Italy, Beatrice Turchi, Carmen Gravina,
Jordi Stira, Alessandro Guercio, Giacomo Gallo,
Valeria Baldassarri, Olivia Alessandra Voglino,
Antonio Franco, Lorenzo Maria Rivesti, Sara
Riolo, Simone D’Annunzio, Elisa Mancini, Giorgio
Guarnotta, Andrea Tubaro, Rome, Italy
7:30 PD38-04 A COMMUNITY-BASED EDUCATION
PROGRAM FOR OVERACTIVE BLADDER IN A
PREDOMINANTLY MINORITY OLDER FEMALE
POPULATION: A PILOT STUDY
Susana Martinez Diaz*, Hudson Pierce, John
Lee, Tirsit Asfaw, Andrew Abram, New York,
NY, Naeem Bhojani, Montreal, Canada, Dean
Elterman, Toronto, Canada, Kevin Zorn, Montreal,
Canada, Bilal Chughtai, New York, NY
7:40 PD38-05 EXCESSIVE VISCERAL FAT IN MEN IS
ASSOCIATED WITH THE PRESENCE AND
SEVERITY OF OVERACTIVE BLADDER
Tomohiro Matsuo*, Yasuyoshi Miyata, Hidenori
Ito, Hiroki Kurata, Masahito Masato, Kensuke
Mitsunari, Kojiro Ohba, Hideki Sakai, Nagasaki,
Japan
*Presenting author
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
7:50 PD38-06 TURPUDU TRIAL- A PROSPECTIVE
STUDY EVALUATING THE EFFECT OF
TRANSURETHRAL RESECTION OF
PROSTATE ON URODYNAMIC PARAMETERS
IN PATIENTS OF BENIGN ENLARGEMENT OF
PROSTATE WITH UPPER URINARY TRACTS
DILATATION
Shantanu Tyagi*, Kalpesh Parmar, Shrawan Sin-
gh, Chandigarh, India
8:00 PD38-07 HIGH FLOW BLADDER OUTLET
SUNDAY
OBSTRUCTION IN MEN
Aaron Huang*, Brooklyn, NY, Kevin Rychik, Tel-
Aviv, Israel, Max Edeson, Nutley, NJ, Wade Bush-
man, Madison, WI, Jerry Blaivas, New York, NY
8:10 PD38-08 EFFICACY OF LOW-INTENSITY SHOCK
WAVE THERAPY ON PERSISTENT STORAGE
SYMPTOMS AFTER TRANSURETHRAL
SURGERY FOR BENIGN PROSTATIC
OBSTRUCTION: PRELIMINARY RESULTS OF
A RANDOMIZED CONTROLLED TRIAL
Mohammed Hegazy*, Khaled Zaky Sheir,
Mohamed Ahmed Gaballah, Ahmed Mohamed
Elshal, Mansoura, Egypt
8:20 PD38-09 AUA-SYMPTOM SCALE IS NOT RELIABLE
FOR USE IN MEASURING STORAGE PHASE
DYSFUNCTION
Taylor Y. Sadun*, Nicholas J. Jackson, A. Lenore
Ackerman, Los Angeles, CA
8:30 PD38-10 UPRIGHT OPEN MRI WITH STANDING
YOGA POSES INDICATES THAT POSTURAL
EFFECTS ON THE BLADDER NECK AND
URETHRA OCCUR RELEVANT TO FEMALE
URINARY INCONTINENCE
Lynn Stothers*, Andrew MacNab, Vancouver,
Canada
8:40 PD38-11 LONG-TERM EFFICACY AND SAFETY OF
VIBEGRON FOR OVERACTIVE BLADDER IN
PATIENTS ≥65 YEARS OLD: ANALYSIS FROM
THE EMPOWUR EXTENSION TRIAL
Jeffrey Frankel*, Burien, WA, Susann Varano,
Milford, CT, Heather Greene, Elizabeth Thomas,
Irvine, CA, David Staskin, Boston, MA
8:50 PD38-12 LONG-TERM PATIENT-REPORTED
OUTCOMES OF VIBEGRON FOR
OVERACTIVE BLADDER: ANALYSES FROM
THE EMPOWUR EXTENSION TRIAL
David Staskin*, Boston, MA, Susann Varano,
Milford, CT, Heather Greene, Elizabeth Thomas,
Irvine, CA, Jeffrey Frankel, Burien, WA
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
159
Sunday, May 15, 2022
Podium Session 39
BENIGN PROSTATIC HYPERPLASIA: EPIDEMIOLOGY, EVALUATION & MEDICAL NON-SURGICAL THERAPY
Room 243 @ Ernest N. Morial Convention Center
Moderators: Bilal Chughtai & Zeph Okeke
ABSTRACT
TIME NUMBER TITLE
7:00 PD39-01 PSA DENSITY IS CORRELATED WITH BPH
CELLULAR COMPOSITION
Liwei Jia, Douglas Strand, Claus Roehrborn,
Ryan Mauck*, Dallas, TX
7:10 PD39-02 DOES RACE INFLUENCE THE SURGICAL
TREATMENT FOR BENIGN PROSTATIC
HYPERPLASIA? - AN ANALYSIS OF 30,000
MEDICARE LIVES
Gopal L. Narang*, Scottsdale, AZ,
Sirikan Rojanasarot, Michael Murphy,
Ben Cutone, Marlborough, MA,
Mitchell R. Humphreys, Scottsdale, AZ
7:20 PD39-03 POST-VOIDED RESIDUAL URINE
RATIO IS A PREDICTOR OF BLADDER
OUTLET OBSTRUCTION IN MEN WITH
LOWER URINARY TRACT SYMPTOMS:
DEVELOPMENT OF A CLINICAL NOMOGRAM
Cosimo De Nunzio*, Riccardo Lombardo, Rome,
Italy, Antonio Nacchia, Rionero in Vulture, Italy,
Antonio Cicione, Beatrice Turchi, Giacomo Gallo,
Carmen Gravina, Alessandro Guercio, Jordi Stira,
Lorenzo Maria Rivesti, Antonio Franco, Giorgio
Guarnotta, Elisa Mancini, Olivia Alessandra Vogli-
no, Valeria Baldassarri, Simone D’Annunzio, Sara
Riolo, Rome, Italy, Simon Carter, London, United
Kingdom, Carlo Vicentini, L’Aquila, Italy, Andrea
Tubaro, Rome, Italy
7:30 PD39-04 COMPREHENSIVE ANALYSIS OF CLINICAL
RISK FACTORS ASSOCIATED WITH BENIGN
PROSTATIC HYPERPLASIA IN THE UK
BIOBANK
Steven A Sidelsky*, Chicago, IL, Alexander P.
Glaser, Richard J. Fantus, Jun Wei, Shi Zhuqing,
Brian T. Helfand, Jianfeng Xu, Evanston, IL
7:40 PD39-05 PROSTATE MEASUREMENT ON COMPUTED
TOMOGRAPHY: VARIANCE DECREASES AS
PROSTATE VOLUME INCREASES
Anastasija Useva, Bethany Regan, Michael
Iorga*, Alexandr Pinkhasov, Timothy Byler, Scott
Wiener, Syracuse, NY
7:50 PD39-06 FACTORS ASSOCIATED WITH NON-
ELECTIVE TURPS: PATIENTS, PAYORS, AND
HOSPITALS
Zafardjan Dalimov*, Philadelphia, PA, Nicole
Alavi-Dunn, Ellen Lutnick, Ali Houjaij, Oussama
M. Darwish, K. Kent Chevli, Buffalo, NY
160
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
8:00 PD39-07 MEDICARE NATIONAL AND REGIONAL
TRENDS IN BPH SURGERY, 2013–2019
Alan Paniagua Cruz*, Tammer Yamany,
New York, NY
8:10 PD39-08 IMPLEMENTATION OF A SIMPLE CLINICAL
PATHWAY INCREASES RELEVANCE OF
INPATIENT CONSULTS FOR URINARY
RETENTION
Luke Griffiths*, Darian Andreas, Shannon Smith,
Aaron Smith, Hollie Brown, Jessica Kreshover,
Justin Han, New Hyde Park, NY
8:20 PD39-09 PREDICTORS OF EXTENDED LENGTH
OF STAY FOLLOWING HOMIUM LASER
PROSTATE SURGERY FOR BENIGN
PROSTATIC HYPERPLASIA
Victor Chalfant*, Carlos Riveros, Ahmed Elshafei,
K.C. Balaji, Jacksonville, FL
8:30 PD39-10 SOCIODEMOGRAPHIC DISPARITIES IN
ACCESS TO HIGH-VOLUME PROVIDERS AND
FACILITIES FOR SIMPLE PROSTATECTOMY:
A NEW YORK STATEWIDE ANALYSIS
Krishna Ravivarapu*, Olamide Omidele, Evan
Garden, Chih Peng Chin, Micah Levy, Alexander
Small, Joseph Sewell Araya, Michael Palese, New
York, NY
8:40 PD39-11 EVALUATING FACTORS THAT INFLUENCE
HEALTHCARE RESOURCE UTILIZATION
IN TRANSURETHRAL RESECTION OF
PROSTATE
Rebecca Edwins*, Amber Bettis, Andrew Harris,
MD, Lexington, KY
8:50 PD39-12 A PROSPECTIVE TRIAL OF
MULTIPARAMETRIC MAGNETIC RESONANCE
OF THE PROSTATE USE TO AVOID BIOPSIES
IN PATIENTS WITH ELEVATED PROSTATE
SPECIFIC ANTIGEN AND SURGICAL
INDICATION FOR BENIGN PROSTATIC
HYPERPLASIA
Marcelo Wroclawski, Lucas Takemura*, Felipe
Gushiken, Breno Amaral, Paulo Kayano, Ronaldo
Baroni, Bianca Bianco, Arie Carneiro, Gustavo
Lemos, Sao Paulo, Brazil
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
Sunday, May 15, 2022
Video Session 7
PROSTATE, PENILE, TESTIS & MISC. ONCOLOGY I
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: David Chen, Francesco Montorsi & Clinton Bahler
ABSTRACT
TIME NUMBER TITLE
7:00 V07-01 SINGLE-PORT TRANSVESICAL ROBOTIC
RADICAL PROSTATECTOMY: DESCRIPTION
OF TECHNIQUE
Alp T. Beksac*, Mahmoud Abou Zeinab, Aaron
Kaviani, Ethan Ferguson, Jihad Kaouk, Cleveland,
OH
7:10 V07-02 SINGLE PORT ROBOTIC ASSISTED
LAPAROSCOPIC RADICAL PROSTATECTOMY:
INITIAL EXPERIENCE AND TECHNIQUE AT
NORTHWELL HEALTH
Alexa Meyer*, Leon Telis, Bertie Zhang, Jared
Winoker, Michael Feuerstein, New York, NY, Jay
Bishoff, Michael Schwartz, Manish Vira, Louis
Kavoussi, New Hyde Park, NY, Lee Richstone,
New York, NY
7:20 V07-03 SOLVING CLINICAL CHALLENGES IN
PROSTATECTOMY USING SINGLE-PORT
ROBOT SYSTEM: A CASE SERIES
Alison Levy*, Mohit Butaney, Wooju Jeong, Craig
Rogers, Detroit, MI
7:30 V07-04 SINGLE PORT TRANSVESICAL PARTIAL
PROSTATECTOMY FOR LOCALIZED
PROSTATE CANCER
Ethan Ferguson*, Mahmoud Abou Zeinab, Alp
Tuna Beksac, Aaron Kaviani, Christopher Weight,
Eric Klein, Jihad Kaouk, Cleveland, OH
7:40 V07-05 HOW WE SURVIVED OUR FIRST 50 RETZIUS
SPARING PROSTATECTOMIES: TIPS AND
PITFALLS OF ROUNDING THE LEARNING
CURVE
Ben Schurhamer*, Daniel Lee, Phil Mucksavage,
Philadelphia, PA
7:50 V07-06 RETZIUS-SPARING ROBOT-ASSISTED
RADICAL PROSTATECTOMY IN HIGH-RISK
PROSTATE CANCER PATIENTS
Paolo Dell’Oglio*, Milan, Italy, Stefano Tappero,
Genova, Italy, Mattia Longoni, Carlo Buratto, Piet-
ro Scilipoti, Silvia Secco, Alberto Olivero, Michele
Barbieri, Erika Palagonia, Giancarlo Napoli,
Elena Strada, Giovanni Petralia, Dario Di Trapani,
Angelo Vanzulli, Aldo Massimo Bocciardi, Antonio
Galfano, Milan, Italy
*Presenting author
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
8:00 V07-07 ANATOMICAL ROBOTIC-ASSISTED RADICAL
PROSTATECTOMY: STEP-BY-STEP NERVE-
SPARING TECHNIQUE FOR DIFFERENT
GRADES OF PRESERVATION
Marcio Covas Moschovas*, Travis Rogers,
Jonathan Noel, Jaber Abdel, Seetharam Bhat,
Vipul Patel, Celebration, FL
8:10 V07-08 FEASIBILITY AND CLINICAL OUTCOMES
OF ROBOT-ASSISTED RADICAL
PROSTATECTOMY BY LATERAL APPROACH
Javier Reinoso Elbers*, Moises Rodríguez
SUNDAY
Socarras, Luis Llanes González, Juan Gómez
Rivas, Diego Carrion Monsalve, Julio Fernán-
dez del Álamo, Madrid, Spain, Richard Gaston,
Bourdeaux, France, Fernando Gómez Sancha,
Madrid, Spain
8:20 V07-09 ROBOTIC-ASSISTED LAPAROSCOPIC
PROSTATECTOMY AND URETHRAL PULL
THROUGH OF MEMBRANOUS URETHRA TO
BLADDER
Safiya-Hana Belbina*, Scott Spivey-Provencio,
Pegah Taheri, E. Charles Osterberg, Aaron A.
Laviana, Austin, TX
8:30 V07-10 FULL URETHRAL PRESERVATION DURING
LAPAROSCOPIC RADICAL PROSTATECTOMY
(FUP-LRP)
Catarina Tinoco*, Andreia Cardoso, Ricardo Ma-
tos Rodrigues, Sara Anacleto, Ana Sofia Araújo,
Mário Cerqueira Alves, Emanuel Carvalho-Dias,
Braga, Portugal
8:40 V07-11 VARYING APPROACHES TO THE PROSTATE
APEX TO OPTIMIZE URETHRAL STABILITY
AND EARLY CONTINENCE RECOVERY
AFTER ROBOTIC RADICAL PROSTATECTOMY
Claudia Mercader*, J. Francisco Lopez, Nitesh
Ranasinha, Mutie Raslan, Ruth McPherson,
Richard Bell, Tom Leslie, Richard Bryant, Freddie
Hamdy, Alastair Lamb, Oxford, United Kingdom
8:50 V07-12 ROBOTIC PROSTATECTOMY WITH WIDE
EXCISION FOR LOCALLY ADVANCED
PROSTATE CANCER
Jeffrey Vehawn*, Mouneeb Choudry, Austen
Slade, Jacob Ambrose, Alejandro Sanchez,
Christopher Dechet, Salt Lake City, UT
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
161
Sunday, May 15, 2022 7:30 am – 10:00 am
SOCIETY OF WOMEN IN UROLOGY (SWIU)
Jefferson Ballroom @ Hilton New Orleans Riverside
7:30 BREAKFAST OPENS 8:30 R. FRANK JONES UROLOGICAL SOCIETY
UPDATE
7:45 SWIU 2022 ANNUAL BUSINESS MEETING (SWIU
Linda McIntire
MEMBERS ONLY)
8:45 SWIU AWARD PRESENTATIONS
PRESIDENT’S WELCOME
Anne P. Cameron 9:30 NETWORKING WITH COLLEAGUES
8:15 AUA UPDATE
AUA President-Elect: Edward Messing

Sunday, May 15, 2022 7:30 am – 11:30 am

Forums
CHALLENGES FOR UROLOGIC RESEARCH SYMPOSIUM
Rivergate Room @ Ernest N. Morial Convention Center
CHALLENGES FOR UROLOGIC RESEARCH 9:30
SESSION THREE: HEALTH SERVICES AND
SYMPOSIUM: TRACKING OUTCOMES FOR PATIENT-CENTERED RESEARCH IN GENDER-
GENDER-AFFIRMING AFFIRMING SURGERY
SURGERY IN TRANSGENDER & GENDER NON- Moderator: Gaines Blasdel
BINARY PATIENTS
DECISION MAKING IN MASCULINIZING GENDER-
Chairs: Geolani Dy, Dmitriy Nikolavsky, Lee Zhao
AFFIRMING GENITAL SURGERY
7:30 WELCOME AND OPENING REMARKS Rachel Moses
Chair: Lee Zhao
STUDYING THE TRANS POPULATION AND GEN-
7:40
SESSION ONE: CURRENT OUTCOMES IN DER-AFFIRMING HEALTHCARE UTILIZATION IN
GENDER-AFFIRMING SURGERY ADMINISTRATIVE DATASETS
Moderator: Polina Reyblat Jae Downing
SEXUAL DIVERSITY AND SEXUAL HEALTH BUILDING A NEW CULTURE OF GENDER-AF-
NEEDS IN TRANS/NON-BINARY INDIVIDUALS FIRMING SURGERY RESEARCH: COMMUNITY
Maurice Garcia ENGAGEMENT AND PATIENT-CENTERED
OUTCOMES RESEARCH
ERECTILE DEVICES IN TRANSMASCULINE
Gaines Blasdel, Geolani Dy
INDIVIDUALS AFTER PHALLOPLASTY
Mang Chen PATIENT-REPORTED OUTCOMES IN GENDER-
AFFIRMING SURGERY
URETHRAL COMPLICATIONS AFTER MASCULIN-
Nnenaya Mmonu
IZING GENITAL SURGERY
Dmitriy Nikolavsky Q&A AND DISCUSSION WITH SESSION
SPEAKERS
CREATION OF THE TRANSGENDER AND NON-
BINARY SURGERY (TRANS) REGISTRY 10:30
SESSION FOUR: SURGICAL AND TECHNICAL
Geolani Dy INNOVATIONS
Moderator: Joseph Pariser
Q&A AND DISCUSSION WITH SESSION
SPEAKERS ERECTILE DEVICE DEVELOPMENT FOR
PHALLOPLASTY
8:35 SESSION TWO: LIFELONG UROLOGIC NEEDS
Curtis Crane, Bryan Kansas
OF TRANSGENDER PATIENTS
Moderator: Miriam Hadj-Moussa PENILE TRANSPLANTATION IN TRANSGENDER
INDIVIDUALS
FERTILITY PRESERVATION IN THE
Arthur Burnett
TRANSGENDER POPULATION
James Hotaling ROBOTICS IN GENDER-AFFIRMING SURGERY
Lee Zhao
PROSTATE CANCER IN TRANSGENDER
WOMEN/NON-BINARY INDIVIDUALS Q&A AND DISCUSSION WITH SESSION
Amanda Chi SPEAKERS
GURS FELLOWSHIP: TRAINING THE NEXT 11:20 CLOSING REMARKS
GENERATION OF UROLOGISTS IN GENDER- Chair: Lee Zhao
AFFIRMING SURGERY
APPROVED FOR AMA PRA CATEGORY 1
Daniel Dugi
CREDITTM
Q&A AND DISCUSSION WITH SESSION
SPEAKERS

162
Sunday, May 15, 2022
ENGINEERING AND UROLOGY SECTION OF THE ENDOUROLOGY SOCIETY (EUS)
Grand Ballroom A @ Hilton New Orleans Riverside
7:50 WELCOME
Chair: Lee Richstone
8:00 AUTONOMOUS ROBOTIC SURGERY (ARS):
FUTURE OR FANTASY?
DOMO ARIGATO MR ROBOTO: WHY STRIVE
TOWARDS AUTOMOUS ROBOTIC SURGERY?
Louis Kavoussi
DEAR DR. FANTASY: AUTONOMOUS ROBOTIC
SURGERY IS A FOOL’S ERRAND!
Jaime Landman
CLASSIFICATION SYSTEMS, LEVELS OF AUTON-
OMY AND MEANINGFUL HUMAN CONTROL
Duke Herrell, III
PARANOID ANDROID: ETHICAL, REGULATORY
AND LEGAL CONSIDERATIONS OF AUTONO-
MOUS ROBOTICS AND ARTIFICIAL INTELLI-
GENCE
Sammy Elsamra
Q&A FOR PANEL
9:15 AUTONOMOUS ROBOTIC SURGERY (ARS):
BUILDING BRICKS IN THE WALL
ACHIEVEMENTS IN ARS: FROM INDUSTRY TO
SURGERY, FROM RIGID TO SOFT TISSUE
Pete C.W. Kim
AUTONOMOUS SURGICAL ROBOTS: WILL FU-
TURE SURGEONS NEED CAFFEINE OR 120V?
Axel Krieger
MINIATURIZATION: MICROBOTS, NANOBOTS,
AND MEMS
Sijo Parekattil
Q&A FOR PANEL
Sunday, May 15, 2022
AMERICAN SOCIETY FOR MEN’S HEALTH (ASMH)
Grand Ballroom B @ Hilton New Orleans Riverside
8:00 INTRODUCTION
Society President: Joel Heidelbaugh
8:05 THE MEN’S HEALTH CHECKLIST: IS THERE RE-
ALLY A NEED TO UPDATE IT AT THIS TIME?
Martin Miner
8:15 RACIAL DISPARITIES IN MEN’S HEALTH
Kelvin Moses
8:40 IS THERE A TRUE PREVENTION STRATEGY IN
MEN’S HEALTH AND HOW DO WE GET YOUNGER
MALE PATIENTS TO SEE US EARLIER?
Jesse Mills
8:55 CANCER SCREENINGS DECADE BY DECADE:
WHAT UROLOGISTS AND MEN’S HEALTH EX-
PERTS NEED TO KNOW
Bruce Kava
9:20 RECOGNIZING HYPERTENSION AND DYSLIPI-
DEMIA: WHAT UROLOGISTS NEED TO KNOW
Stephen Kopecky
*Presenting author
7:50 am – 12:15 pm
10:15 AUTONOMOUS ROBOTIC SURGERY (ARS):
MYSTERIOUS ACHIEVEMENTS
PLANNING AND SKILL MODELING
INTELLIGENT CONTROL: FROM NEURAL
NETWORKS TO FUZZY LOGIC
Andrew Hung
REAL TIME TRACKING AND NAVIGATION
Bradford Wood
IMAGING AND REGISTRATION (RIGID AND
SOFT TISSUE)
Tom Calef
DEFINING PROPERTIES OF NORMAL AND
ABNORMAL TISSUE
Lauren Poniatowski
SUNDAY
END EFFECTORS NOW AND IN THE FUTURE
Danyal Fer
Q&A FOR PANEL
12:00 AWARDS PRESENTATION
Presenter: Dan Stoianovici
1:00 EUS POSTER SESSION
Location: Grand Salon Ballroom
POSTER SESSION 1
Moderators: Zhamshid Okhunov, Arun Rai
POSTER SESSION 2
Moderator: Alexa Meyer
8:00 am – 11:50 am
9:40 ADULT IMMUNIZATIONS: WHAT MEN’S HEALTH
EXPERTS SHOULD KNOW IN 2022
10:00 MENTAL HEALTH UPDATE: WHY ARE SUICIDE
AND DEPRESSION INCREASING DISPROPOR-
TIONATELY IN MEN - WHAT CAN WE DO TO
IDENTIFY AND ALTER THIS?
Penny Jensen
10:15 COVID-19 UPDATE
David Mushatt
10:30 BREAK
10:45 SEXUALITY UPDATE 2021: CURRENT TRENDS
IN THE MANAGEMENT OF ERECTILE
DYSFUNCTION, PREMATURE EJACULATION,
AND PEYRONIE’S DISEASE
Faysal Yafi
11:05 DEVELOPING A PERSONALIZED BPH STRATEGY
Steven Kaplan
11:15 PSA SCREENING
163
 PRO: DON’T ASK DON’T TELL A REASONABLE 11:35 ANNUAL BUSINESS MEETING
APPROACH
APPROVED FOR AMA PRA CATEGORY 1
CON: DON’T ASK DON’T TELL IS A COPOUT CREDITTM
Matthew Cooperberg

Sunday, May 15, 2022 8:30 am – 3:45 pm

Forums
UROLOGIC CARE FOR THE ADVANCED PRACTICE PROVIDER
Room 271 @ Ernest N. Morial Convention Center
9:00 WELCOME/INTRODUCTION 1:10
BILLING & CODING FOR APPS; IMPLICATIONS
Co-Course Directors: Anne Lizardi-Calvaresi, James Kovarik FOR TELEMEDICINE
Faculty: Mark Painter
9:10 PRE-TEST #3
Co-Course Directors: Anne Lizardi-Calvaresi, James Kovarik 1:50
UAPA LECTURE: PEARLS FOR A SUCCESSFUL
PHYSICIAN/PA TEAM
9:15 THE PRE-TRANSPLANT UROLOGIC EVALUATION
Faculty: Adam Mogil
Faculty: Gwendolyn Zilinskas
2:10
SUNA LECTURE: ONBOARDING AND ROLE CON-
9:55
RATIONALE AND STRATEGIES FOR REDUCING
SIDERATIONS FOR THE UROLOGY APP
POST-OPERATIVE OPIOD PRESCRIBING (WHITE
Faculty: Susanne Quallich
PAPER)
Faculty: Jennifer Robles 2:35
PANEL DISCUSSION: BREAKING DOWN BAR-
RIERS IN ADULT AND PEDIATRIC UROLOGY IN
10:50 RADIOLOGY 101
PRIVATE AND ACADEMIC UROLOGY PRACTICES
Faculty: Daniel Costa
Faculty: Benjamin Dillon, Diane Newman,
11:30 POST-TEST #3 Gwendolyn Zilinskas, Kaity Colon-Sanchez,
Co-Course Directors: Anne Lizardi-Calvaresi, James Kovarik Pamela Ellsworth
11:40 APP OF THE YEAR AWARD 4:05 POST-TEST #4
Speaker: Tricia Zubert Co-Course Directors: Anne Lizardi-Calvaresi, James
Kovarik
11:50 NON-CME LUNCHTIME SYMPOSIUM
4:15 CLOSING REMARKS/COURSE ADJOURNS
1:05 PRE-TEST #4
Co-Course Directors: Anne Lizardi-Calvaresi, James
Co-Course Directors: Anne Lizardi-Calvaresi, James
Kovarik
Kovarik

Sunday, May 15, 2022 8:45 am – 10:00 am

Moderated Poster Session 39

HEALTH SERVICES RESEARCH: VALUE OF CARE: COST AND OUTCOMES MEASURES
Room 228 @ Ernest N. Morial Convention Center
Moderators: Yair Lotan, Mark Edney & Danil Makarov

ABSTRACT
NUMBER TITLE
MP39-01 TELEMEDICINE SATISFACTION AND
OUTCOMES FOR ADULT UROLOGICAL
POSTOPERATIVE CARE: RESULTS FROM
THE RANDOMIZED EVALUATION AND
METRICS OBSERVING TELEMEDICINE
EFFICACY (REMOTE) TRIAL
Mustufa Babar*, Denzel Zhu, Justin Loloi, Melissa
Laudano, Erin Ohmann, Nitya Abraham, Alexan-
der Small, Kara Watts, Bronx, NY
MP39-02 LONG TERM COST COMPARISONS OF
RADICAL CYSTECTOMY VERSUS TRIMODAL
THERAPY FOR MUSCLE-INVASIVE BLADDER
CANCER
Vishnukamal Golla*, Durham, NC, Yong Shan,
Elias Farran, Courtney Stewart, Kevin Vu, Alexan-
der Yu, Galveston, TX, Ali Raza Khaki, Stanford,
CA, Kirk Keegan, Nashville, TN, Ashish Kamat,
Houston, TX, Douglas S. Tyler, Galveston, TX,
Stephen J. Freedland, Los Angeles, CA, Stephen
B. Williams, Galveston, TX
ABSTRACT
NUMBER TITLE
MP39-03 A COST AND TIME ANALYSIS OF
PARTICIPANT RECRUITMENT AND URINE
SAMPLE COLLECTION THROUGH SOCIAL
MEDIA OPTIMIZATION
Prasun Sharma*, Sarah Bartolone, Elijah Ward,
Alexander Varabulea, kenneth Peters, Joseph
Janicki, Royal Oak, MI, Nitya Abraham, Melissa
Laudano, New York, NY, Christopher Smith, Hou-
ston, TX, Bernadette Zwaans, Michael Chancellor,
Royal Oak, MI, Laura Lamb, Ann Arbor, MI
MP39-04 COMPARISON OF ONE-YEAR HEALTHCARE
EXPENDITURE AND UTILIZATIONS
BETWEEN MINIMALLY INVASIVE AND OPEN
SURGICAL APPROACHES AMONG PATIENTS
UNDERGOING NEPHRECTOMY
Kennedy Okhawere*, New York, NY, Gediwon
Milky, I-Fan Shih, Yanli Li, Sunnyvale, CA, Ketan
Badani, New York, NY

164
 MP39-05 UROLOGY ADVANCED PRACTICE
PROVIDERS IN RURAL AMERICA: AN
OPPORTUNITY TO PROVIDE CARE
Jennifer Nauheim*, Bronx, NY, Raymond Fang,
William Meeks, Keonna Confesor, Linthicum, MD,
Amanda North, Bronx, NY
MP39-06 EVALUATING THE REAL-WORLD PAYER
AND PATIENT COSTS OF BPH SURGICAL
MANAGEMENT
Kevin Wymer*, Gopal Narang, Phoenix, AZ,
Austen Slade, Indianapolis, IN, Vidit Sharma,
Viengneesee Thao, Bijan Borah, Rochester, MN,
Marcelino Rivera, Indianapolis, IN, Scott Cheney,
Mitchell Humphreys, Phoenix, AZ
MP39-07 THE IMPACT OF PATIENT AND PROVIDER
DEMOGRAPHICS ON PRESS GANEY® RATINGS
IN UROLOGY: WHO IS AT RISK OF BIAS?
Jane Kurtzman, Connie Wang*, Edwin Melendez,
Julia Finkelstein, Christina Carpenter, New York, NY
MP39-08 IMPACT OF SARS-COV-2 PANDEMIC ON THE
DIAGNOSIS AND SURGICAL INTERVENTION
OF COMMON UROLOGICAL CONDITIONS:
RESULTS FROM A MULTI-INSTITUTIONAL
DATABASE FROM THE UNITED STATES
Maxwell Towe*, Sirpi Nackeeran, Mohammad
Hout, Abhishek Bhat, Ranjith Ramasamy, Hemen-
dra Shah, Miami, FL
MP39-09 COMPARISON OF ALVIMOPAN VERSUS
NALOXEGOL FOR ENHANCING POSTOPERATIVE
RECOVERY FOLLOWING RADICAL
CYSTECTOMY FOR BLADDER CANCER
Peter Kirk*, Austin Wang, Dima Raskolnikov,
Sarah Psutka, George Schade, John Gore, Yaw
Nyame, Janet Kelly, Jonathan Wright, Seattle, WA
MP39-10 MANAGEMENT, SURVEILLANCE PATTERNS,
AND COSTS ASSOCIATED WITH LOW-GRADE
TA NON-MUSCLE INVASIVE BLADDER CANCER
Kelly Bree*, Houston, TX, Yong Shan, Galveston,
TX, Patrick Hensley, Niyati Lobo, Houston, TX,
Chengrui Hu, Douglas Tyler, Galveston, TX, Karim
Chamie, Los Angeles, CA, Ashish Kamat, Hou-
ston, TX, Stephen Williams, Galveston, TX
MP39-11 COST-EFFECTIVENESS OF HOLMIUM LASER
ENUCLEATION OF THE PROSTATE: INSIGHTS
FROM A MARKOV MODEL COMPARING BPH
SURGICAL OPTIONS FOR GLANDS <80 G
Kevin Wymer*, Gopal Narang, Phoenix, AZ, Aus-
ten Slade, Indianapolis, IN, Vidit Sharma, Viengn-
eesee Thao, Bijan Borah, Bijan Borah, Rochester,
MN, Marcelino Rivera, Indianapolis, IN, Scott
Cheney, Mitchell Humphreys, Phoenix, AZ
MP39-12 REDUCING POST-OPERATIVE EMERGENCY
DEPARTMENT VISITS AND READMISSIONS
AFTER NEPHRECTOMY: AN INITIAL
EVALUATION OF THE MUSIC-KIDNEY
REGISTRY
Mohit Butaney*, Detroit, MI, Anna Johnson, Asha
Bulusu, David Gandham, Ji Qi, Ann Arbor, MI, Mar-
cus Jamil, Amit Patel, Detroit, MI, Sabrina Noyes,
John Anema, Grand Rapids, MI, Michael Levin,
Mt Clemens, MI, Bradley Rosenberg, Royal Oak,
MI, Brian Lane, Grand Rapids, MI, Craig Rogers,
Detroit, MI, for the Michigan Urological Surgery
Improvement Collaborative, Ann Arbor, MI
*Presenting author
MP39-13 COST-EFFECTIVENESS OF NEOADJUVANT
CHEMOTHERAPY REGIMENS PRIOR TO
RADICAL CYSTECTOMY FOR MUSCLE-
INVASIVE BLADDER CANCER
Daniel D. Joyce*, Rochester, MN, Kevin M.
Wymer, Scottsdale, AZ, Vidit Sharma, James P.
Moriarty, Bijan J. Borah, Rochester, MN, Daniel M.
Geynisman, Elizabeth R. Plimack, Philadelphia,
PA, Brian A. Costello, Lance C. Pagliaro, Stephen
A. Boorjian, Rochester, MN
MP39-14 COMPARING HEALTHCARE UTILIZATION
AND COSTS ACCORDING TO RENAL
PRESERVATION VERSUS RADICAL
NEPHROURETERECTOMY MANAGEMENT
FOR PATIENTS WITH NON-METASTATIC
UPPER TRACT UROTHELIAL CARCINOMA
Kathryn Fero, Los Angeles, CA, Yong Shan,
Giri Movva, Jacques Baillargeon, Douglas Tyler,
Galveston, TX, Karim Chamie, Los Angeles, CA,
Stephen Williams*, Galveston, TX
SUNDAY
MP39-15 RESTORATIVE THERAPY CLINICAL TRIALS
FOR ERECTILE DYSFUNCTION: A SCOPING
REVIEW OF ENDPOINT MEASURES
Russell Saltzman, Miami, FL, Roei Golan*,
Tallahassee, FL, Thomas Masterson, Ranjith
Ramasamy, Miami, FL
MP39-16 IMPACT OF HIGH-GRADE RADIATION
INJURY FOLLOWING PROSTATE CANCER
RADIATION ON HEALTHCARE COST AND
UTILIZATION
Kevin Hebert*, Joshua Horns, Nathan Driggs,
Rupam Das, Rano Matta, Benjamin McCormick,
Salt Lake City, UT, James Hotaling, Salt Lake City,
UT, Jeremy Myers, Salt Lake City, UT
MP39-17 ADVANCED PRACTICE PROVIDERS AND
PATIENT ACCESS IN ACADEMIC MEDICAL
CENTERS: A SECRET SHOPPER STUDY
Armaan Singh*, Jared Lassner, Ashley Diaz,
Marc Sleiman, Parth Modi, CHICAGO, IL
MP39-18 SAME DAY DISCHARGE AFTER ROBOTIC
PARTIAL NEPHRECTOMY: IS IT WORTH IT?
Andrew Wood, Eitan Katlowitz*, Elie Kaplan-
Marans, Marc Lubin, Ervin Teper, David Silver,
Ariel Schulman, Brooklyn, NY
MP39-19 INTERSTATE TELEMEDICINE FOR UROLOGIC
ONCOLOGY CARE DURING THE COVID-19
PANDEMIC
Jason Reynolds*, Adam Gadzinski, Erin Dwyer,
Blair Stewart, Isabelle Abarro, Sarah Holt,
John Gore, Seattle, WA
MP39-20 ACCESS TO DEFINITIVE TREATMENT
AND SURVIVAL FOR INTERMEDIATE-RISK
AND HIGH-RISK PROSTATE CANCER AT
HOSPITALS SYSTEMS SERVING HEALTH
DISPARITY POPULATIONS (HSDPS)
David-Dan Nguyen*, Muhieddine Labban, Logan
Briggs, Alexander P. Cole, Stuart R. Lipsitz, Hari
S. Iyer, Timothy R. Rebbeck, Joel S. Weissman,
Quoc-Dien Trinh, Boston, MA
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
165
Sunday, May 15, 2022 8:45 am – 10:00 am

Moderated Poster Session 40

BLADDER CANCER: UPPER TRACT TRANSITIONAL CELL CARCINOMA I
Room 225 @ Ernest N. Morial Convention Center
Moderators: Mario Fernandez, Michael Grasso & Mantu Gupta

ABSTRACT
NUMBER TITLE
MP40-01 COST AND DIAGNOSTIC YIELD OF
UPPER TRACT IMAGING IN HIGH RISK
MICROHEMATURIA; ARE WE STILL DOING
TOO MUCH?
Clay Martin*, Eric Macdonald, Ella Taubenfeld,
Simon Hall, New Hyde Park, NY
MP40-02 CAN THE PRESENTATION OF UPPER TRACT
UROTHELIAL CANCER GUIDE US ON HOW
TO IMAGE NON-VISIBLE HAEMATURIA?: A
REVIEW OF 10 YEARS
Kirolos Michael*, Navin Ravindranath,
Thomas Riley, Annette German, Andreas
Bourdoumis, Raveendra Surange, Rochdale,
United Kingdom
MP40-03 THE ADDED VALUE OF SYSTEMATIC
BIOPSIES IN THE DIAGNOSIS AND
CHARACTERIZATION OF UPPER TRACT
UROTHELIAL CANCER
Andrea Gallioli*, Pietro Diana, Angelo Terri-
to, Josep Maria Gaya, Alberto Piana, Pavel
Gavrilov, Francesco Sanguedolce, Julio Francis-
co Calderón, Antoni Sánchez-Puy, Joan Palou,
Alberto Breda, Barcelona, Spain
MP40-04 PREDICTIVE RISK FACTORS FOR
EARLY RECURRENCE AFTER RADICAL
NEPHROURETERECTOMY FOR LOW-
GRADE UPPER TRACT UROTHELIAL
CARCINOMA
Heather Huelster*, Alyssa Bilotta, Jacob Britt,
Nicholas Russo, Wade Sexton, Michael Poch,
Scott Gilbert, Alice Yu, Philippe Spiess, Roger Li,
Tampa, FL
MP40-05 RISK FACTORS OF SUBSEQUENT
UPPER URINARY TRACT CARCINOMA
TREATED WITH INTRAVESICAL BACILLUS
CALMETTE-GUERIN THERAPY FOR
NON-MUSCLE-INVASIVE BLADDER
CANCER: FROM MULTIPLE JAPANESE
HOSPITALS
Kazuyuki Numakura*, Akita, Japan, Makito
Miyake, Nara, Japan, Yuya Sekine, Yumina Muto,
Mizuki Kobayashi, Akita, Japan, Rikiya Taoka,
Kagawa, Japan, Takashi Kobayasi, Kyoto, Japan,
Takahiro Kojima, Tsukuba, Japan, Hiroshi Kitamu-
ra, Toyama, Japan, Hiroyuki Nishiyama, Tsukuba,
Japan, Kiyohide Fujimoto, Nara, Japan, Tomonori
Habuchi, Akita, Japan
ABSTRACT
NUMBER TITLE
MP40-06 ROLE OF NEOADJUVANT CHEMOTHERAPY
IN PATHOLOGICAL DOWNSTAGING DURING
RADICAL NEPHROURETERECTOMY FOR
UPPER TRACT UROTHELIAL CARCINOMA
(ROBUUST COLLABORATIVE GROUP)
Nicholas Corsi*, Marcus Jamil, Sohrab Arora,
Deepansh Dalela, Detroit, MI, Riccardo Auturino,
Richmond, VA, Chandru Sundaram, Indianapolis,
IN, Robert Uzzo, Philadelphia, PA, Alex Mottrie,
Aalst, Belgium, James Porter, Seattle, WA, Daniel
Eun, Philadelphia, PA, Koon Rha, Seoul, Korea,
Republic of, Amit Satish Bhattu, Miami, FL,
Zhenjue Wu, Shanghai, China, People’s Republic
of, Andrea Minervini, Florence, Italy, Matteo Ferro,
Milan, Italy, Giuseppe Simone, Rome, Italy, Ithaar
Derweesh, La Jolla, CA, Vitaly Margulis, Dallas,
TX, Hooman Djaladat, Los Angeles, CA, Andrew
Katims, New York, NY, Firas Abdollah, Detroit, MI
MP40-07 THE EFFECTS OF ADJUVANT CHEMOTHERAPY
FOR UPPER URINARY TRACT UROTHELIAL
CARCINOMA FOR JAPANESE PATIENTS IN
REAL WORLD IN MULTICENTER
Tetsuya Yumioka*, Masashi Honda, Ryutaro
Shimizu, Shogo Teraoka, Noriya Yamaguchi, Bun-
ya Kawamoto, Shuichi Morizane, Katsuya Hikita,
Atsushi Takenaka, Yonago, Japan
MP40-08 NOVEL ENDOSCOPIC MANAGEMENT
FOR LOCALIZED UPPER URINARY TRACT
CARCINOMA USING A PHOTODYNAMIC
DIAGNOSIS-GUIDED DUAL LASER ABLATION
TECHNIQUE: 3-YEAR FOLLOW-UP RESULTS
Takashi Yoshida*, Tadashi Matsuda, Chisato Ohe,
Hidefumi Kinoshita, Osaka, Japan
MP40-09 THE SYSTEMIC IMMUNE–INFLAMMATION
INDEX (SII) AS PREDICTOR FACTOR OF
SURVIVAL IN PATIENTS UNDERGOING
RADICAL NEPHROURETERECTOMY FOR
UPPER TRACT UROTHELIAL CARCINOMA
Skander Zouari*, Saadi Ahmed, Setti Boubak-
er Nouha, Bilel Saidani, Marouene Chakroun,
Khadija Medddeb, Mouna Ayadi, Meriem Ksontini,
Ahlem Blel, Hamza Boussaffa, Abderrazek
Bouzouita, Amine Derouiche, Riadh Ben Slama,
Ksontini Feriel, Amel Mezlini, Soumaya Rammeh,
Haroun Ayed, Mohamed Chebil, Tunis, Tunisia
MP40-10 SURVIVAL OUTCOMES OF UPPER TRACT
UROTHELIAL CARCINOMA PATIENTS
TREATED WITH THERAPEUTIC ENDOSCOPIC
MANAGEMENT
Wesley Yip*, Peter Reisz, Amy Tin, Nicole Ben-
fante, Eugene Cha, Eugene Pietzak, Ari Hakimi,
Jonathan Coleman, New York, NY

166
 MP40-11 RENAL FUNCTION VARIATION AFTER
NEPHROURETERECTOMY FOR UPPER
URINARY TRACT CARCINOMA: EVALUATION
IN A LARGE MULTICENTER COHORT
(RADICAL NEPHROURETERECTOMY
OUTCOMES (RANEO) RESEARCH
CONSORTIUM)
Alessandro Tafuri, Lecce, Italy, Michele Marchioni,
Chieti, Italy, Clara Cerrato*, Katia Ododrizzi, Ve-
rona, Italy, Andrea Mari, Riccardo Tellini, Firenze,
MP40-16 EXPRESSION ANALYSIS AND
Italy, Alessandro Veccia, Mantova, Italy, Daniele
Amparore, Orbassano, Torino, Italy, Federica Di
Cosmo, Lecce, Italy, Umberto Carbonara, Bari, It-
aly, Federica Trovato, Catania, Italy, Michele Cas-
tellani, Letizia M. I. Janello, Milano, Italy, Lorenzo
Bianchi, Bologna, Italy, Giacomo Novara, Fabrizio
Dal Moro, Padova, Italy, Riccardo Schiavina,
Bologna, Italy, Elisa De Lorenzis, Milano, Italy,
Paolo Parma, Mantova, Italy, Sebastiano Cimino,
Catania, Italy, Ottavio De Cobelli, Milano, Italy,
MP40-15 ASSOCIATION BETWEEN DAILY
BEHAVIORAL HABITS OF FLUID-INTAKING
AND URINATION AND THE RISK OF UPPER
TRACT UROTHELIAL CARCINOMA: A CASE-
CONTROL STUDY
Chunru Xu*, Zhihua Li, Ying Liu, Hua Guan,
Xinyan Che, Meng Zhang, Yanbo Huang, Liqun
Zhou, Xuesong Li, Chunde Li, Beijing, China,
People’s Republic of
MUTATIONAL STATUS OF HISTONE
METHYLTRANSFERASE KMT2D IN UPPER
TRACT UROTHELIAL CARCINOMA
Ekaterina Laukhtina*, Ursula Lemberger, Andreas
Bruchbacher, Dafina Ilijazi, David D’Andrea,
Martin Susani, Vienna, Austria, Dmitry Enikeev,
Moscow, Russian Federation, Eva Compérat,
Shahrokh F. Shariat, Melanie R. Hassler, Vienna,
Austria

SUNDAY
Francesco Maiorino, Pierluigi Bove, Roma, Italy, MP40-17 LNCRNA SNHG16 MEDIATE CISPLATIN
Fabio Crocerossa, Francesco Cantiello, Catanza- AND GEMCITABINE RESISTANCE IN UPPER
ro, Italy, David D’Andrea, Vienna, Austria, Franc- TRACT UROTHELIAL CARCINOMA CELLS BY
esco Porpiglia, Orbassano, Torino, Italy, Pasquale SPONGING OF MIR-31-5P
Ditonno, Bari, Italy, Emanuele Montanari, Milano, Wei-Chi Hsu*, Wei-Ming Li, A-Mei Huang, Lin-Li
Italy, Francesco Soria, Paolo Gontero, Torino, Chang, Hui-Hui Lin, Wen-Jeng Wu, Ching-Chia Li,
Italy, Giovanni Liguori, Carlo Trombetta, Trieste, Hung-Lung Ke*, Kaohsiung City, Taiwan
Italy, Marco Borghesi, Carlo Terrone, Genova,
MP40-18 OFFICE-BASED FLEXIBLE URETEROSCOPY
Italy, Luigi Schips, Chieti, Italy, Francesco Del
FOR ACTIVE SURVEILLANCE FOR UPPER
Giudice, Alessandro Sciarra, Roma, Italy, Andrea
TRACT UROTHELIAL CARCINOMA
Galosi, Ancona, Italy, Marco Moschini, Matteo
FOLLOWING NEPHRON-SPARING SURGERY
Ferro, Milano, Italy, Shahrokh F. Shariat, Vienna,
Nathan Colin Wong*, Sameh Naim, Jonathan
Austria, Marta Di Nicola, Marta Di Nicola, Chieti,
Wagmeister, Ariel Schulman, Bertie Zhang, John
Italy, Michele Battaglie, Bari, Italy, Andrea Minerv-
Phillips, Muhammad Choudhury, Majid Eshghi,
ini, Firenze, Italy, Maria Angela Cerruto, Verona,
Valhalla, NY
Italy, Vincenzo Pagliarulo, Lecce, Italy, Alessandro
Antonelli, Verona, Italy MP40-19 HOW TO IDENTIFY PATIENTS SUITABLE FOR
CONSERVATIVE MANAGEMENT OF UPPER
MP40-12 THE KEYHOLE TECHNIQUE FOR RESECTION
TRACT UROTHELIAL CARCINOMA (UTUC)
OF THE DISTAL URETER AND BLADDER
ACCORDING TO TUMOR SIZE: IMPLICATIONS
CUFF DURING ROBOTIC RADICAL
FOR CLINICAL GUIDELINES
NEPHROURETERECTOMY
Eugenio Ventimiglia*, Christian Corsini, Margher-
Luis G. Medina*, Muhannad Alsyouf, Alireza
ita Fantin, Mario de Angelis, Pietro Dioni, Marco
Ghoreifi, Aref S. Sayegh, Kailyn Koh, Wenhao Yu,
Moschini, Daniele Raggi, Maurilio Ponzoni, Um-
Sina Sobhani, Antoin Douglawi, Hooman Djaladat,
berto Capitanio, Andrea Necchi, Roberta Lucianò,
Los Angeles, CA
Milan, Italy, Olivier Traxer, Paris, France, Alberto
MP40-13 ARE METACHRONOUS BLADDER TUMORS Briganti, Francesco Montorsi, Luca Villa, Andrea
PREDICTIVE OF UPPER TRACT UROTHELIAL Salonia, Milan, Italy
CARCINOMA RECURRENCE IN PATIENTS
APPROVED FOR AMA PRA CATEGORY 1.25
TREATED WITH RADICAL OR ENDOSCOPIC
CREDITSTM
SURGERY
Christian Ericson*, Anthony Compton, Bryce
Baird, Raymond Pak, Jacksonville, FL
MP40-14 OVERALL SURVIVAL AMONG ELDERLY
PATIENTS WITH LOCALIZED UPPER TRACT
UROTHELIAL CARCINOMA RECEIVING
OBSERVATION VERSUS DEFINITIVE
TREATMENT
Syed Rahman*, Jamil Syed, Soum Lokesh-
war, Benjamin Press, New Haven, CT, Thomas
Monaghan, Dallas, TX, Michael Leapman, New
Haven, CT

*Presenting author 167

ºSunday, May 15, 2022 9:30 am – 11:30 am

Podium Session 40
URORADIOLOGY II
Room 252 @ Ernest N. Morial Convention Center
Moderators: Pat Fulgham & Daniel Rukstalis

ABSTRACT
TIME NUMBER TITLE
9:30 PD40-01 ACCURACY OF CYSTOGRAPHY IN CHILDREN
UNDER GENERAL ANESTHESIA WITH
SUSPECTED VESICOURETERAL REFLUX
Michael Frumer*, Bezalel Sivan, Tal May, Roy
Morag, Dmitry Khunovich, David Ben Meir, Petah
Tikva, Israel
9:40 PD40-02 A RANDOMIZED STUDY USING
COMBINATION OF STATIN AND ASCORBIC
ACID FOR PREVENTION OF CONTRAST-
INDUCED NEPHROPATHY (NCT03391830)
Abdelwahab Hashem*, Mahmoud Laymon,
Mostafa Elgamal, Ahmed M. Lashin, Mohamed
Ramez, Refaie Huda, Yasser Osman, Mansoura,
Egypt
9:50 PD40-03 DIGITAL PATHOLOGY LABELS PERFORM
BETTER THAN RADIOLOGIST LABELS FOR
TRAINING DEEP LEARNING MODELS TO
DETECT PROSTATE CANCER ON MRI
Indrani Bhattacharya*, David Lim, Christian
Kunder, Han Lin Aung, Xingchen Liu, Wei
Shao, Simon Soerensen, Richard Fan, Pejman
Ghanouni, Katherine To’o, James Brooks, Mirabe-
la Rusu, Geoffrey Sonn, Palo Alto, CA
10:00 PD40-04 HOW DOES MAGNETIC FIELD STRENGTH IN
MULTIPARAMETRIC MAGNETIC RESONANCE
IMAGING AFFECT SIGNIFICANT PROSTATE
CANCER DETECTION?: A MULTICENTER
PROPENSITY SCORE–MATCHED ANALYSIS
Sunao Shoji*, Kumpei Takahashi, Soichiro Yuzuri-
ha, Tatsuo Kano, Izumi Hanada, Takahiro Ogawa,
Tatsuya Umemoto, Mayura Nakano, Masayoshi
Kawakami, Masahiro Nitta, Masanori Hasegawa,
Akira Miyajima, Isehara, Japan
10:10 PD40-05 DEEP LEARNING BASED ASSESSMENT
OF PROSTATE LESION DYNAMICS ON
MULTIPARAMETRIC MRI DURING ACTIVE
SURVEILLANCE
Michael Daneshvar*, Stephanie Harmon, Tim
Phelps, Michael Rothberg, Jacob Enders, Nitin
Yerram, Luke O’Connor, Alex Wang, Sherif
Mehralivand, Samira Masoudi, Bethesda, MD,
Dong Yang, Ziyue Xu, Daguang Xu, Santa Clara,
CA, Maria Merino, Bradford Wood, Peter Choyke,
Peter Pinto, Baris Turkbey, Bethesda, MD
ABSTRACT
TIME NUMBER TITLE
10:20 PD40-06 USEFULNESS OF PROSTATE SPECIFIC
ANTIGEN–GLYCOSYLATION ISOMER FOR
SIGNIFICANT CANCER DETECTION AND
PATHOLOGICAL FINDINGS OF INDEX
PROSTATE CANCERS ON MAGNETIC
RESONANCE IMAGING–TRANSRECTAL
ULTRASOUND FUSION IMAGE-GUIDED
BIOPSY: A PROSPECTIVE MULTICENTER
STUDY
Sunao Shoji*, Mayura Nakano, Isehara, Japan,
Kohei Uemura, Bunkyo-Ku, Japan, Kumpei
Takahashi, Tatsuo Kano, Soichiro Yuzuriha, Izumi
Hanada, Takahiro Ogawa, Tatsuya Umemoto,
Masayoshi Kawakami, Masahiro Nitta, Masanori
Hasegawa, Isehara, Japan, Terumitsu Hasebe,
Hachioji, Japan, Akira Miyajima, Isehara, Japan
10:30 PD40-07 CLINICAL DECISION ALGORITHM USING
RESTRICTION SPECTRUM IMAGING AND
BIOMARKERS TO PREDICT UPGRADING IN
ACTIVE SURVEILLANCE
Stefan Eng, Los Angeles, CA, Benjamin Basasie,
San Antonio, TX, Alfonso Lam, Los Angeles,
CA, John Semmes, Dean Troyer, Norfolk, VA,
Geoffrey Clarke, Abhijit Sunnapwar, Robin Leach,
Teresa Johnson-Pais, San Antonio, TX, Lori
Sokoll, Daniel Chan, Baltimore, MD, Jeffrey To-
soian, Javed Siddiqui, Arul Chinnaiyan, Ann Arbor,
MI, Paul Boutros, Los Angeles, CA, Michael Liss*,
San Antonio, TX
10:40 PD40-08 RENAL COLIC IMAGING PRACTICE
PATTERNS IN ONTARIO: A POPULATION-
BASED STUDY
Danielle Jenkins*, Kingston, Canada, Greg
Hosier, San Franscisco, CA, Marlo Whitehead,
Rebecca Griffiths, Thomas McGregor, D. Robert
Siemens, Kingston, Canada
10:50 PD40-09 EVOLUTION OF BIIF RENAL CYSTS AND
THE IMPACT OF THE 2019 BOSNIAK
CLASSIFICATION
Félix Couture*, Montreal, Canada, Sarah Hadj-Mi-
moune, Sherbrooke, Canada, Stéphane Michael,
Quebec City, Canada, Maxime Noël-Lamy, Patrick
Richard, Sherbrooke, Canada

168
11:00 PD40-10 FORMAL VALIDATION AT FINAL PATHOLOGY
AFTER RADICAL NEHRECTOMY OF
NEPHROMETRY SCORES: DISCORDANCE
RATES AND OVERTREATMENT RISK
Francesco Cei*, Giacomo Musso, Giuseppe Rosiel-
lo, Giuseppe Fallara, Daniele Cignoli, Giuseppe Ba-
sile, Gianmarco Colandrea, Gianfranco Baiamonte,
Federico Belladelli, Isaline Rowe, Daniela Canibus,
Chiara Re, Roberta Lucianò, Maurizio Colecchia,
Francesco De Cobelli, Giorgio Brembilla, Milan, It-
aly, Federico Dehò, Varese, Italy, Vincenzo Mirone,
Naples, Italy, Alberto Briganti, Roberto Bertini,
Francesco Montorsi, Andrea Salonia, Alessandro
Larcher, Umberto Capitanio, Milan, Italy
11:10 PD40-11 COMPARING RADIATION DOSE AND IMAGE
QUALITY IN THREE DIFFERENT FLAT-PANEL
DETECTOR C-ARMS DURING SIMULATED
PCNL
Daniel R. Peverini, Akin S. Amasyali*, Avi Assi-
don, Ricky Chen, John C. Hartman, Eun Hye Joo,
Catalina Baas, Cayde Ritchie, Joshua D. Belle,
Elizabeth Baldwin, D. Duane Baldwin, Loma
Linda, CA
Sunday, May 15, 2022
Podium Session 41
PROSTATE CANCER: DETECTION & SCREENING IV
Room 255 @ Ernest N. Morial Convention Center
Moderators: Armando Stabile, Karim Touijer & Fred Saad
ABSTRACT
TIME NUMBER TITLE
9:30 PD41-01 DETECTION OF OCCULT PROSTATE
ADENOCARCINOMA USING STEREOTACTIC
TRANSPERINEAL BIOPSY FOLLOWING
NEGATIVE TRANSRECTAL ULTRASOUND-
GUIDED BIOPSIES
Russell Maxwell*, Philadelphia, PA, Roksana
Tech, Westmont, IL, Manuj Agarwal, Philadelphia,
PA, Brian Moran, Westmont, IL
9:40 PD41-02 DIAGNOSIS OF PROSTATE CANCER IN
MEN TREATED WITH 5-ALPHA-REDUCATES
INHIBITORS WITH MULTIPARAMETRIC
MRI: RESULTS OF A MULTICENTER
INTERNATIONAL COLLABORATION
Ugo Falagario*, Foggia, Italy, Anna Lantz, Stock-
holm, Sweden, Ivan Jambor, Turku, Finland, Luca
Carmignani, Emanuele Montanari, Milan, Italy,
Pierluigi Bove, Rome, Italy, Paolo Gontero, Turin,
Italy, Alessandro Sciarra, Rome, Italy, Pasquale
Di Tonno, bari, Italy, Carlo Trombetta, trieste, Italy,
Pierfrancesco Bassi, Giuseppe Simone, Rome,
Italy, vincenzo Mirone, Naples, Italy, Alessandro
Antonelli, Verona, Italy, Luigi Schips, Chieti, Italy,
Gian Maria Busetto, Foggia, Italy, Matteo Ferro,
Milan, Italy, Peter Bostrom, Turku, Finland, Tobias
Nordström, Stockholm, Sweden, Ottavio de Co-
belli, Milan, Italy, Luigi Cormio, Giuseppe Carrieri,
Foggia, Italy
*Presenting author 169
11:20 PD40-12 ROBOTIC-ASSISTED ELECTROMAGNETIC
GUIDANCE MINIMIZES RADIATION
EXPOSURE IN GAINING PERCUTANEOUS
ACCESS FOR NEPHROLITHOTOMY: A
CADAVERIC STUDY WITH NOVICES
Mitchell Humphreys*, Kevin Wymer, Phoenix, AZ,
Ben Chew, Vancouver, Canada, Janet Zhen, Red-
wood City, CA, Fuad Elkhoury, Los Angelas, CA,
Sri Sivalingam, Cleveland, OH, Matthew Dunn,
Santa Monica, CA, Michael Borofsky, Minneapo-
lis, MN
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
SUNDAY
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
9:50 PD41-03 ANTIBIOTIC-FREE TRANSPERINEAL
PROSTATE BIOPSY: UROLOGY’S
CONTRIBUTION TO RESPONSIBLE
ANTIMICROBIAL STEWARDSHIP
Kevin B. Ginsburg, Johnathan Drevik, Jared
P. Schober, Alberto A. Castro Bigalli, Jeffrey L.
Ellis*, Avery Braun, Kaynaat Syed, Philadelphia,
PA, John Danella, Danville, PA, Serge Ginzburg,
Philadelphia, PA, Laurence Belkoff, Bala Cynwyd,
PA, Adam C. Reese, Philadelphia, PA, Jeffrey
Tomaszewski, Camden, NJ, Edouard Trabulsi,
Phiadelphia, PA, Eric A. Singer, New Brunswick,
NJ, Bruce Jacobs, Pittsburgh, PA, Jay D. Raman,
Hershey, PA, Thomas Guzzo, Robert G. Uzzo,
Marc C. Smaldone, Andres F. Correa, Philadel-
phia, PA
10:00 PD41-04 DISTRIBUTION OF NATIONAL
COMPREHENSIVE CANCER NETWORK
RISK CLASSIFICATIONS USING MAGNETIC
RESONANCE IMAGING-ULTRASOUND
FUSION VERSUS SYSTEMIC 12 CORE
BIOPSIES
Ghazal Khajir*, Benjamin Press, Preston
Sprenkle, New Haven, CT, Samuel Washington,
Matthew Cooperberg, San Francisco, CA, Michael
Leapman, New Haven, CT
10:10 PD41-05 BIOPSY TECHNIQUE (TRANSPERINEAL
VS. TRANSRECTAL) IS NOT ASSOCIATED
WITH POSITIVE SURGICAL MARGINS OR
PERIOPERATIVE MORBIDITY FOLLOWING
RADICAL PROSTATECTOMY
Kevin Ginsburg, Johnathan Drevik*, Alberto
Andres Castro Bigalli, Jeffrey Ellis, Avery Braun,
Kaynaat Syed, Philadelphia, PA, John Danella,
Danville, PA, Serge Ginzburg, Laurence Belkoff,
Adam Reese, Philadelphia, PA, Jeffrey Tomasze-
wski, Camden, NJ, Edouard Trabulsi, Philadel-
phia, PA, Eric Singer, New Brunswick, NJ, Bruce
Jacobs, Pittsburg, PA, Jay Raman, Hershey, PA,
Thomas Guzzo, Robert Uzzo, Marc Smaldone,
Andres Correa, Philadelphia, PA
10:20 PD41-06 TRANSPERINEAL PROSTATE BIOPSIES
USING MICRO-ULTRASOUND, MRI-GUIDED
AND SYSTEMATIC BIOPSIES (MADRID
PROTOCOL), AN UPDATE WITH 482 PATIENTS
Moises Elias Socarras*, Javier Reinoso Elbers,
Fabio Esposito, Isabella Greco, Julio Fernandez
del Alamo, Vanesa Cuadros Rivera, Diego Carrion
Monsalve, Juan Gomez Rivas, Luis Llanes Gon-
zalez, Luis Llanes Gonzalez, Fernando Gomez
Sancha, Madrid, Spain
10:30 PD41-07 LEARNING CURVE FOR TRANSPERINEAL
ULTRASOUND/MRI FUSION BIOPSY FOR THE
DETECTION OF PROSTATE CANCER
Yuval Elkun*, Henry Dumke, Vincent Wong, Dan-
iel Bassily, Nathan Wong, Valhalla, NY, Christo-
pher Dixon, Suffern, NY
10:40 PD41-08 THE ROLE OF MICRO-ULTRASOUND AMONG
PATIENTS WITH A PIRADS 5 LESION AT
MULTIPARAMETRIC MAGNETIC RESONANCE
IMAGING
Marco Paciotti*, Milan, Italy, Davide Maffei, Pier
Paolo Avolio, Cesare Saitta, Vittorio Fasulo,
Nicola Frego, Roberto Contieri, Alessandro Uleri,
Alberto Saita, Rodolfo Hurle, Massimo Lazzeri,
Paolo Casale, Rozzano, Milan, Italy, Giorgio
Guazzoni, Nicolò Buffi, Giovanni Lughezzani,
Milan, Italy
10:50 PD41-09 MOVING BEYOND PSA: IDENTIFYING THE
OPTIMAL DIAGNOSTIC STRATEGY TO
ASSESS PROSTATE CANCER RISK
Douglas Cheung*, Diana Magee, Toronto, Can-
ada, Thomas Stonier, London, United Kingdom,
Andrew Briggs, Bart Ferket, New York, NY,
Antonio Finelli, Girish Kulkarni, Toronto, Canada,
Andrew Vickers, Sigrid Carlsson, James Eastham,
New York, NY
170
11:00 PD41-10 THE UTILITY OF PSA DENSITY IN PATIENTS
WITH PI-RADS 3 LESIONS ACROSS A LARGE
MULTI-INSTITUTIONAL COLLABORATIVE
Johnathan Drevik*, Zafardjan Dalimov, Kaynaat
Syed, Philadelphia, PA, John Danella, Danville,
PA, Laurence Belkoff, Adam Reese, Philadelphia,
PA, Jeffrey Tomaszewski, Camden, NJ, Edouard
Trabulsi, Philadelphia, PA, Eric Singer, New
Brunswick, NJ, Bruce Jacobs, Pittsburg, PA, Jay
Raman, Hershey, PA, Thomas Guzzo, Andres
Correa, Marc Smaldone, Robert Uzzo, Serge
Ginzburg, Philadelphia, PA
11:10 PD41-11 UPDATE FROM THE PEDAL TRIAL: A
PROSPECTIVE SINGLE ARM PAIRED
COMPARISON OF ABILITY TO DIAGNOSE
AND LOCATE PROSTATE CANCER
BETWEEN MULTIPARAMETRIC MRI AND
18F-PSMA-PET/CT
Vy Tran*, Thomas Sutherland, Kim Taubman,
Su-Faye Lee, Daniel Lenaghan, Niall Corcoran,
Nathan Lawrentschuk, Melbourne, Australia,
Henry Woo, Lisa Tarlinton, Sydney, Australia,
Tim Spelman, Lauren Thomas, Russell Booth,
Melbourne, Australia, Elisa Perry, Justin Hegar-
ty, Christchurch, New Zealand, Lih-Ming Wong,
Melbourne, Australia
11:20 PD41-12 FROM BIOPSY TO DIAGNOSIS IN 30 MIN:
REMOTE INSTANT PROSTATE PATHOLOGY
BASED ON ARTIFICIAL INTELLIGENCE
ENHANCED ULTRASOUND (AI-US)
Hamza Aljabali, Jakob Heidborn, Turkan Hajili,
Kristina Greimelmaier, Jeremias Wohlschläger,
Flensburg, Germany, Stephan Kruck, Pforzheim,
Germany, Gerd Reis, Kaiserslautern, Germany,
Tillmann Loch, Flensburg, Germany
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
Sunday, May 15, 2022
Podium Session 42
BLADDER CANCER: INVASIVE IV
Room 245 @ Ernest N. Morial Convention Center
Moderators: Khurshid Guru & D. Robert Siemens
ABSTRACT
TIME NUMBER TITLE
9:30 PD42-01 PROPENSITY MATCHED COMPARISON OF
RADICAL CYSTECTOMY WITH TRIMODALITY
THERAPY FOR MUSCLE INVASIVE BLADDER
CANCER (MIBC): A MULTI-INSTITUTIONAL
STUDY
Alexandre R. Zlotta*, Toronto, Canada, Leslie K.
Ballas, Los Angeles, CA, Andrzej Niemierko, Bos-
ton, MA, Katherine Lajkosz, Cynthia Kuk, Toronto,
Canada, Gus Miranda, Los Angeles, CA, Michael
Drumm, Boston, MA, Andrea Mari, Florence, Italy,
Ethan Thio, Los Angeles, CA, Neil E. Fleshner,
Girish S. Kulkarni, Peter Chung, Toronto, Canada,
Robert Bristow, Manchester, United Kingdom, Ale-
jandro Berlin, Srikala S. Sridhar, Toronto, Canada,
Adam S. Feldman, Matthew Wszolek, Richard
Lee, Anthony Zietman, William Shipley, Philip
Saylor, Boston, MA, Siamak Daneshmand, Los
Angeles, CA, Jason A. Efstathiou, Boston, MA
9:40 PD42-02 RESULTS OF THE INTRACORPOREAL
ROBOTIC VS OPEN CYSTECTOMY (IROC)
MULTI-CENTRE RANDOMISED TRIAL
Pramit Khetrapal*, London, United Kingdom,
James Catto, Sheffield, United Kingdom, Gareth
Ambler, Frederico Ricciardi, Shamim Khan, An-
drew Feber, London, United Kingdom, Simon Dix-
on, Sheffield, United Kingdom, Norman Williams,
London, United Kingdom, Imran Ahmed, Glasgow,
United Kingdom, Philip Charlesworth, Reading,
United Kingdom, Marcus Cumberbatch, Syed
Hussain, Aidan Noon, Sheffield, United King-
dom, Sanjeev Kotwal, Leeds, United Kingdom,
Edward Rowe, Anthony Koupparis, Bristol, United
Kingdom, John McGrath, Exeter, United Kingdom,
Nikhil Vasdev, Stevenage, United Kingdom, Chris
Brew-Graves, Daryl Hagan, John Kelly, iROC Trial
Study Group, London, United Kingdom
9:50 PD42-03 ONCOLOGIC SURVEILLANCE INTENSITY
FOR VARIANT HISTOLOGY VERSUS PURE
UROTHELIAL CARCINOMA OF THE BLADDER
AFTER RADICAL CYSTECTOMY
Alberto Martini, Riccardo Leni, Giuseppe Basile*,
Simone Scuderi, Mario De Angelis, Luigi Nocera,
Giuseppe Rosiello, Giorgio Gandaglia, Milan, Italy,
Chiara Lonati, Luca Afferi, Lucerne, Switzerland,
Vincenzo Mirone, Naples, Italy, Andrea Gallina,
Lugano, Switzerland, Francesco Montorsi, Alberto
Briganti, Marco Moschini, Milan, Italy
10:00 PD42-04 PREDICTIVE VALUE OF SERUM LEVELS OF
SQUAMOUS CELL CARCINOMA ASSOCIATED
ANTIGEN, CARCINOEMBRYONIC ANTIGEN,
AND CARBOHYDRATE ANTIGEN 19-9 IN
UROTHELIAL CANCER OF THE URINARY
BLADDER
Yasuyoshi Miyata*, Yuta Mukae, Yuichiro Na-
kamura, Kensuke Mitsunari, Tomohiro Matsuo,
Kojiro Ohba, Hideki Sakai, Nagasaki, Japan
*Presenting author
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:10 PD42-05 EXPANDING THE USE OF TARGETED
THERAPY FOR UROTHELIAL BLADDER
CANCER (UBC): NON-FGFR3 RECEPTOR
TYROSINE KINASE (RTK) GENE
REARRANGEMENTS (REAR) AND
FUSIONS (FUS)
Andrea Necchi*, Milan, Italy, Dean Pavlick, Cam-
bridge, MA, Gennady Bratslavsky, Joseph Jacob,
Oleksandr Kravtsov, New York, NY, Philippe
Spiess, Tampa, FL, Petros Grivas, Seattle, WA,
Vamsi Parini, Brennan Decker, Lin Douglas,
SUNDAY
Danziger Natalie, Levy Mia Alyce, Jeffrey Ross,
Cambridge, MA
10:20 PD42-06 THE ACCURACY OF VESICAL IMAGING-
REPORTING AND DATA SYSTEM (VI-
RADS): AN UPDATED COMPREHENSIVE
MULTI-INSTITUTIONAL, MULTI-READERS
SYSTEMATIC REVIEW AND META-ANALYSIS
FROM DIAGNOSTIC EVIDENCE INTO FUTURE
CLINICAL RECOMMENDATIONS
Francesco Del Giudice*, Rocco Simone Flammia,
Martina Pecoraro, Rome, Italy, Marco Moschini,
Milan, Italy, David D’Andrea, Vienna, Austria,
Benjamin I. Chung, Stanford, CA, Lucia Martina
Pisciotti, Alessandro Sciarra, Ettore De Berardinis,
Valeria Panebianco, Rome, Italy
10:30 PD42-07 RADICAL VS PARTIAL CYSTECTOMY FOR
URACHAL CARCINOMA: A POPULATION-
BASED ANALYSIS
Rocco Simone Flammia*, Rome, Italy, Francesco
Chierigo, Genova, Italy, Benedikt Hoeh, Frankfurt,
Germany, Gabriele Sorce, Milan, Italy, Christoph
Würnschimmel, Hamburg, Germany, Zhe Tian,
Montreal, Canada, Costantino Leonardo, Rome,
Italy, Derya Tilki, Hamburg, Germany, Felix Chun,
Frankfurt, Germany, Carlo Terrone, Genova, Italy,
Francesco Montorsi, Milan, Italy, Shahrokh Sha-
riat, Wien, Austria, Michele Gallucci, Rome, Italy,
Pierre karakiewicz, Montreal, Canada
10:40 PD42-08 REAL-WORLD PERFORMANCE OF MRI
AFTER TURBT IN PREDICTING FINAL
PATHOLOGIC OUTCOMES IN BLADDER
CANCER
Michael Chandra*, Fort Worth, TX, Thomas
Gerald, Suzanne Cole, Liwei Jia, Jeffrey Howard,
Dallas, TX, Aditya Bagrodia, San Diego, CA, Xia-
osong Meng, Vitaly Margulis, Yair Lotan, Alberto
Diaz de Leon, Solomon Woldu, Dallas, TX
10:50 PD42-09 DO PROPHYLACTIC ANTIBIOTICS REDUCE
URINARY TRACT INFECTIONS FOLLOWING
ROBOT-ASSISTED RADICAL CYSTECTOMY?
A RANDOMIZED CONTROL TRIAL
Holly Houenstein, Yousuf Ramahi, Ayat A. Shah*,
Philippa Doherty, Kristopher Attwood, Zhe Jing,
Qiang Li, Ahmed A. Hussein, Khurshid A. Guru,
Buffalo, NY
171
11:00 PD42-10 INDEPENDENT PREDICTORS AND PATTERNS 11:20 PD42-12 MODELING THE CONTRIBUTION OF
OF EARLY AND LATE RECURRENCE AFTER PREOPERATIVE VI-RADS SCORE TO
RADICAL CYSTECTOMY FOR BLADDER PREDICT FINAL PATHOLOGIC LYMPH-NODES
CANCER: A MULTICENTER COLLABORATION INVOLVEMENT IN PATIENTS WITH MIBC
Chiara Lonati*, Brescia, Italy, Roberto Carando, UNDERGONE RADICAL CYSTECTOMY
Lucerne, Switzerland, Alberto Martini, Milan, Italy, Francesco Del Giudice*, Martina Pecoraro,
Claudio Simeone, Stefania Zamboni, Bres- Maurizio Del Monte, Marco Bicchetti, Emanuele
cia, Italy, Giuseppe Simone, Rome, Italy, Luca Messina, Ailin Dehghanpour, Rome, Italy, Benja-
Afferi, Christian D. Fankhauser, Agostino Mattei, min I. Chung, Stanford, CA, Ettore De Berardinis,
Lucerne, Switzerland, Mario Álvarez-Maestro, Ma- Alessandro Sciarra, Carlo Catalano, Valeria
drid, Spain, Alberto Briganti, Francesco Montorsi, Panebianco, Rome, Italy
Marco Moschini, Milan, Italy
APPROVED FOR AMA PRA CATEGORY 2
11:10 PD42-11 COMPARISON OF COMPREHENSIVE CREDITSTM
COMPLICATION INDEX AND CLAVIEN-
DINDO CLASSIFICATION TO ESTIMATE
PERIOPERATIVE MORBIDITY IN BLADDER
CANCER PATIENTS WITH COMPLETE
INTRACORPOREAL ROBOT-ASSISTED
RADICAL CYSTECTOMY
Mikolaj Mendrek*, Jorn H. Witt, Gronau, Germany,
Sergey Sarychev, Frauenfeld, Switzerland, Nikolaos
Liakos, Gronau, Germany, Mustapha Addali,
Siegen, Germany, Christian Wagner, Theodoros
Karagiotis, Andreas Schuette, Gronau, Germany,
Armin Soave, Margit Fisch, Hamburg, Germany,
Julian Reinisch, Thomas Herrmann, Frauenfeld,
Switzerland, Malte W. Vetterlein, Hamburg, Germa-
ny, Sami-Ramzi Leyh-Bannurah, Gronau, Germany

Sunday, May 15, 2022 9:30 am – 11:30 am

Podium Session 43
KIDNEY CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY II
Room 244 @ Ernest N. Morial Convention Center
Moderators: Jodi Maranchie & Simon Tanguay

ABSTRACT
TIME NUMBER TITLE
9:30 PD43-01 PEVONEDISTAT SENSITIZES RENAL
MEDULLARY CARCINOMA CELLS TO
CARBOPLATIN BY DISRUPTING DNA
DAMAGE REPAIR MECHANISMS
Daniel Shapiro*, Madison, WI, Niki Millward Zach-
arias, Durga Tripathi, Jean-Philippe Bertocchio,
Melinda Soeung, Rong He, Jianjun Gao, Priya
Rao, Truong Lam, Luigi Perelli, Alessandro Caru-
go, Timothy Heffernan, Cheryl Walker, Giannicola
Genovese, Nizar Tannir, Christopher Wood, Jose
Karam, Pavlos Msaouel, Houston, TX
9:40 PD43-02 THERAPEUTIC EFFICACY OF YM155 TO
REPRESS AN EPIGENETIC ENZYME AND
EVEROLIMUS RESISTANCE IN RCC
Seong Hwi Hong*, Hyun Ji Hwang, Na Gyeong
Ha, Sung Yul Park, Hong Sang Moon, Young Eun
Yoon, Seoul, Korea, Republic of
9:50 PD43-03 MCT INHIBITION SYNERGIZES WITH
TYROSINE KINASE AND MTOR INHIBITOR
TREATMENT IN RENAL CELL CARCINOMA
Bhaghyasree Jambunathan, Abdo Dergham,
Sayani Bhattacharjee, Rebecca Wynn, Puneet
Sindhwani, Firas Petros, Nagalakshmi Nadiminty*,
Toledo, OH
ABSTRACT
TIME NUMBER TITLE
10:00 PD43-04 PD-L1 LOCALIZATION WITHIN EXOSOMES:
A PRE-CLINICAL STUDY ON EXOSOME
TARGETING THERAPIES TO COMBAT DRUG
RESISTANCE IN RENAL CELL CARCINOMA
Jacob W. Greenberg*, Hogyoung Kim, Ahmed
A. Moustafa, Asim B. Abdel-Mageed, L. Spencer
Krane, New Orleans, LA
10:10 PD43-05 A NOVEL SIRNA-BASED NANOTHERAPY
AGAINST METASTATIC CLEAR CELL RENAL
CELL CARCINOMA
Jan Rudzinski*, Houston, TX, Natasha Govin-
dasamy, Konstantin Stoletov, Katia Carmine-Sim-
men, Arun Raturi, John Lewis, Edmonton, Canada
10:20 PD43-06 EZH2 INHIBITION AS THERAPEUTIC
STRATEGY TO DYSREGULATE LATS1 IN RCC
Seong Hwi Hong*, Hyun Ji Hwang, Na Gyeong
Ha, Sung Yul Park, Hong Sang Moon, Young Eun
Yoon, Seoul, Korea, Republic of
10:30 PD43-07 TKI-INDUCED TREATMENT RESISTANCE OF
RCC VIA MODULATING THE LONG NON-
CODING RNA-ECVSR/ERβ/HIF2-α SIGNALING
Yixi Hu*, Miao He, Huan Yang, Rochester, NY,
Minfeng Chen, Changsha, China, People’s
Republic of, Chawnshang Chang, Jean Joseph,
Edward M Messing, Shuyuan Yeh, Rochester, NY

172
10:40 PD43-08 DEVELOPMENT OF PATIENT-DERIVED
KIDNEY CANCER ORGANOID; APPLICATION
TO DRUG SCREENING MODELS AND ITS
CHALLENGES
Akira Kazama*, Vladimir Bilim, Yoshihiko Tomita,
Niigata, Japan
10:50 PD43-09 PHENOTYPICAL SCREENING ONMETASTATIC
PRCC-TFE3 FUSIONTRANSLOCATION
RENAL CELL CARCINOMA ORGANOIDS
REVEALSPOTENTIAL THERAPEUTIC AGENTS
Chuanzhen Cao*, Xiaomei Lan, Weixing Jiang,
Lei Guo, Xingang Bi, Shan Zheng, Aiping Zhou,
Zhijian Sun, Jianzhong Shou, Beijing, China,
People’s Republic of
11:00 PD43-10 CANCER-ASSOCIATED ADIPOSE-DERIVED
MESENCHYMAL STEM CELLS PROMOTE
MIGRATION AND INVASION IN KIDNEY
CANCER
Yumina Muto*, Kazuyuki Numakura, Yuya Se-
kine, Mizuki Kobayashi, Soki Kashima, Ryohei
Yamamoto, Atsushi Koizumi, Taketoshi Nara,
Mitsuru Saito, Shintaro Narita, Yasufumi Omori,
Tomonori Habuchi, Akita, Japan
Sunday, May 15, 2022
Podium Session 44
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: PELVIC PROLAPSE
Room 243 @ Ernest N. Morial Convention Center
Moderators: O. Lenaine Westney & Sandip Vasavada
ABSTRACT
TIME NUMBER TITLE
9:30 PD44-01 IS THERE AN ADDED VALUE FOR DYNAMIC
MRI OF THE PELVIC FLOOR, TO THE
CLINICAL POP-Q EXAMINATION BEFORE
MANAGEMENT OF PELVIC ORGAN
PROLAPSE IN FEMALES: A DOUBLE
BLINDED PROSPECTIVE STUDY IN A
TERTIARY CARE CENTER
Ahmed Fathy Hussein*, Ranya Farouk Elsayed,
Noha Mahfouz, Ahmed Yehya Abdelziz, Amr
Mostafa Zahran, Hussein Ali Hussein, Mohamed
Salah Abdel Azim, Cairo, Egypt
9:40 PD44-02 CHANGES TO THE UPPER URINARY TRACT
IN PELVIC ORGAN PROLAPSE
Olesya Snurnitsyna*, Alexandr Nikitin, Mikhail
Lobanov, Leonid Rapoport, Dmitry Enikeev,
Mikhail Enikeev, Moscow, Russian Federation
9:50 PD44-03 TO HYST OR NOT: CONCURRENT VAGINAL
HYSTERECTOMY AT TIME OF COLPOCLEISIS
Oluwarotimi Nettey*, Kai Dallas, Anne Lenore
Ackerman, Los Angeles, CA
10:00 PD44-04 NATIVE TISSUE REPAIR OF ANTERIOR
COMPARTMENT PROLAPSE FROM MULTIPLE
INSTITUTIONS IS DURABLE OVER 3 YEARS
Ramzy Burns*, Leo Song, Indianapolis, IN, Feras
Alhalabi, Dallas, TX, Lauren Snodgrass, Indianap-
olis, IN, Philippe Zimmern, Dallas, TX, CR Powell,
Indianapolis, IN
*Presenting author
11:10 PD43-11 METHYLATION HETEROGENEITY IN CCRCC
OFFERS INSIGHTS INTO TUMORIGENESIS
AND BIOMARKER DEVELOPMENT
Sabrina Rossi*, Cambridge, United Kingdom,
Victoria Dombrowe, Berlin, Germany, Sara Pita,
Christopher Smith, Grant Stewart, Cambridge,
United Kingdom, Roland Schwarz, Berlin, Germa-
ny, Charlie Massie, Cambridge, United Kingdom
11:20 PD43-12 BIOMARKS FOR KIDNEY CANCER
DIFFERENTIATION
Melanie von Brandenstein, Jan Herden, Barbara
Köditz*, Manuel Huerta, Tim Nestler, Jochen
Fries, Axel Heidenreich, Cologne, Germany
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
SUNDAY
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:10 PD44-05 ROBOT ASSISTED SACROCOLPOPEXY: PRE-
AND PERIOPERATIVE FACTORS ASSOCIATED
WITH A SHORTER LENGTH OF STAY
Chris Du*, Kuemin Hwang, John Hill, Kelly Ieong,
Kerry Adler, Igor Inoyatov, Steven Weissbart,
Jason Kim, Stony Brook, NY
10:20 PD44-06 PUDENDAL BLOCK ANALGESIA WITH
VAGINAL SURGERY: A RANDOMIZED,
DOUBLE-BLIND, PLACEBO CONTROLLED
TRIAL
Emily Slopnick*, Graham Chapman, David D
Sheyn, Sarah Sears, Megan Abrams, Kasey M
Roberts, Robert Pollard, Jeffrey Mangel, Cleve-
land, OH
10:30 PD44-07 EVALUATING THE LONG-TERM IMPACT
OF IMPLEMENTING STANDARDIZED
POSTOPERATIVE OPIOID PRESCRIBING
GUIDELINES FOLLOWING PELVIC ORGAN
PROLAPSE SURGERY
Elizabeth J. Olive*, Amy E. Glasgow, Elizabeth B.
Habermann, John B. Gebhart, John A. Occhino,
Emanuel C. Trabuco, Brian J. Linder, Rochester, MN
10:40 PD44-08 POSTOPERATIVE OUTCOMES AFTER
ROBOTIC SACROCOLPOPEXY WITH
CONCURRENT RECTOPEXY IN WOMEN
WITH MULTICOMPARTMENT PELVIC ORGAN
PROLAPSE
Shivani Gaitonde*, Jessie Chen, Craig Olson,
Philippe Zimmern, Maude Carmel, Dallas, TX
173
10:50 PD44-09 RATES AND RISK FACTORS FOR PELVIC
ORGAN PROLAPSE RECURRENCE
REQUIRING RE-OPERATION AFTER ROBOTIC
SACROCOLPOPEXY
Paige Kuhlmann*, Los Angeles, CA, Lisa Ro-
go-Gupta, Stanford, CA, Karyn Eilber, Los Ange-
les, CA, Jennifer Anger, San Diego, CA, Victoria
Scott, Los Angeles, CA, Kai Dallas, Duarte, CA
11:00 PD44-10 URODYNAMIC PROFILE OF VOIDING IN
PELVIC ORGAN PROLAPSE PATIENTS AFTER
SURGERY: A SYSTEMATIC REVIEW WITH
META-ANALYSIS
Hugo Santos*, Danilo Lourenço, Alexandre
Partezani, Saulo Teles, Lucas Takemura, Felipe
Gushiken, Guilherme Andrade, Bianca Bianco,
Luis Rios, Gustavo Lemos, Arie Carneiro, São
Paulo, Brazil
Sunday, May 15, 2022
Video Session 8
PEDIATRICS
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderator: Mohan Gundeti
ABSTRACT
TIME NUMBER TITLE
9:30 V08-01 LEVERAGING ROBOTICS, IRIS, AND
SELECTIVE CLAMPING TO MANAGE
COMPLEX ENDOPHYTIC LESIONS IN A
PEDIATRIC PATIENT WITH WILMS TUMORS
Robert Harrison*, Tanner Corse, Michael Stifel-
man, Hackensack, NJ
9:40 V08-02 PEDIATRIC ROBOT-ASSISTED
HEMINEPHRECTOMY UTILIZING
INDOCYANINE GREEN
Akhil Saji*, Ashley Dixon, Miriam Harel, Richard
Schlussel, Valhalla, NY
9:50 V08-03 COMPLEX RIGHT POST-CHEMOTHERAPY
LAPAROSCOPIC RETROPERITONEAL LYMPH
NODE DISSECTION
Sebastiano Nazzani*, Stefano Chiaravalli, Monica
Terenziani, Luigi Piva, Mario Catanzaro, Nicola
Nicolai, Davide Biasoni, Milan, Italy
10:00 V08-04 PARTIAL ORCHIECTOMY FOR TESTICULAR
MASS IN A PEDIATRIC PATIENT: TECHNIQUE
AND OUTCOMES
Katherine Fischer*, Ruchika Talwar, Karl God-
lewski, Alice Xiang, Aseem Shukla, Arun Srini-
vasan, Christopher Long, Thomas Kolon, Sameer
Mittal, Philadelphia, PA
10:10 V08-05 THE ANATOMIC BLADDER NECK TAILORING
IN CPRE: THE PATH TO NORMAL ANATOMY
Dana Weiss*, Philadelphia, PA, Elizabeth Roth,
Travis Groth, John Kryger, Milwaukee, WI, Richard
Lee, Boston, MA, Aseem Shukla, Philadelphia, PA,
Joseph G, Boston, MA, Michael Mitchell, Milwau-
kee, WI, Douglas Canning, Philadelphia, PA
10:20 V08-06 REDO ROBOTIC LEFT URETERAL
REIMPLANT USING THE EXTRAVESICAL
LUAA TECHNIQUE
Clark Judge*, Anastasia Gliatis, Amrita Mohanty,
Mohan Gundeti, Chicago, IL
174
11:10 PD44-11 UNDERSTANDING PATIENT PELVIC ORGAN
EXPERIENCE COMPARING DIGITAL
ETHNOGRAPHY AND FOCUS GROUPS—
WHICH ONE DOES BETTER?
Gabriela Gonzalez*, Sacramento, CA, Kristina
Vaculik, Beverly Hills, CA, Corey Arnold, Los An-
geles, CA, Christopher Almario, Brennan Spiegel,
Beverly Hills, CA, Jennifer Anger, La Jolla, CA
11:20 PD44-12 VAGINAL ESTROGEN THERAPY FOR
GENITOURINARY SYNDROME OF
MENOPAUSE (GSM) IN WOMEN WITH A
PERSONAL HISTORY OF BREAST CANCER-
A CLAIMS DATABASE ANALYSIS
Kathryn Dumas*, Sajya Singh, Jaden R Kohn,
Taylor P Kohn, Marisa Clifton, Baltimore, MD
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:30 V08-07 ROBOTIC PYELOPLASTY OF LOWER POLE
MOIETY IN A 2 MONTH OLD INFANT WITH
CUTANEOUS PYELOURETERAL (CPU) STENT
Amrtia Mohanty*, Clark Judge, Anastasia Gliatis,
Tony Da Lomba, Mohan Gundeti, Chicago, IL
10:40 V08-08 MANAGEMENT OF URETHRAL DUPLICATION
Patrick Curtin*, Yu Zheng, Jessica Connor,
Shumyle Alam, Charleston, SC
10:50 V08-09 SERIES OF MISSED FIBROEPITHELIAL
POLYPS IN THE PEDIATRIC POPULATION
Aznive Aghababian*, John Weaver, Sahar Eft-
ekharzadeh, Sonam Saxena, Iqra Nadeem, Pooja
Unadkat, Katherine Fischer, Karl Godlewski,
Sameer Mittal, Christopher Long, Dana Weiss,
Arun Srinivasan, Aseem Shukla, Philadelphia, PA
11:00 V08-10 ROBOTIC ASSISTED LAPAROSCOPIC
CALYCEAL DIVERTICULECTOMY: A SAFE
AND FEASIBLE TECHNIQUE
Alejandra Guevara*, Miami Beach, FL, Cinthia S.
Galvez, Daniel Nassau, Andrew Labbie, Miguel
Castellan, Miami, FL
11:10 V08-11 ROBOTIC EXCISION OF A MASSIVE
CALYCEAL DIVERTICULUM
Jennifer M. Lovin*, Andrew J. Kirsch, Atlanta, GA
11:20 V08-12 ROBOTIC-ASSISTED LAPAROSCOPIC BLADDER
AUGMENTATION ILEOCYSTOPLASTY AND
MITROFANOFF APPENDICOVESICOSTOMY
(RALIMA) WITH CONCURRENT BLADDER
NECK RECONSTRUCTION AND CECAL
FLAP ANTEGRADE COLONIC ENEMA (ACE)
CHANNEL CREATION
Steven A Sidelsky*, Chicago, IL, Ankita Nallani,
Columbia, MO, Mohan S Gundeti, Chicago, IL
APPROVED FOR AMA PRA CATEGORY
2 CREDITSTM
Sunday, May 15, 2022 8:00 am – 1:00 pm

Forums
INTERNATIONAL PROSTATE FORUM
LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention Center
Chairs: John Davis & Neal Shore
1:00 IPF INTRODUCTIONS RARP MODIFICATIONS THAT ENHANCE CONTI-
Chairs: John Davis, Neal Shore NENCE RETURN
Kirsten Greene
8:05 SESSION I: EARLY DISEASE
Moderators: John Davis, Badar Mian, Rick Popert Q&A: MODERATORS/AUDIENCE WITH DR.
GREENE
PROSTATE CANCER PREVENTION AND EARLY
DISEASE NON-PROGRESSION: UPDATE AND NEWER ROBOTS, SMALLER ROBOTS, CHEAPER
DIET, EXERCISE, SUPPLEMENTS ROBOTS—WHERE IS THE TECHNOLOGY HEAD-
Justin Gregg ED?
Isaac Kim
Q&A: MODERATORS/AUDIENCE WITH DR. GREGG
PANEL DISCUSSION: SOLVING EXTREME INDICA-
TESTOSTERONE REPLACEMENT: UPDATE ON
TIONS FOR ROBOTICS
MANAGEMENT FOR PCA SCREENING, SURVEIL-
Panelists: Vip Patel, Jean Joseph, Matthew Tollefson
LANCE, AND TREATED PATIENTS

SUNDAY
Run Wang 11:45 SESSION IV: RECURRENT/ADVANCED DISEASE
Moderators: Alicia Morgans, Neal Shore
Q&A: MODERATORS/AUDIENCE WITH DR. WANG
SALVAGE BRACHYTHERAPY: AN ALTERNATIVE
PANEL DISCUSSION: CHALLENGING CASES IN
TO SALVAGE RP
PROSTATE CANCER SCREENING
Panelists: Stacey Loeb, Kelly Stratton Q&A: MODERATORS/AUDIENCE
9:15 SESSION II: ADVANCES IN DIAGNOSTICS ADVANCED PROSTATE CANCER TREATMENTS:
Moderators: Brian Chapin, , Brusabhanu Nayak, Weranja THE LARGE UROLOGY GROUP PRACTICE MODEL
Ranasinghe Jason Hafron
MRI UTILIZATION: EVIDENCE REVIEW, GUIDE- ADVANCED PROSTATE CANCER TREATMENTS:
LINES STATEMENTS, AND HOW I USE IT THE ACADEMIC MODEL
Behfar Ehdaie Pedro Barata
Q&A: MODERATORS/AUDIENCE WITH DR. EH- Q&A: MODERATORS/AUDIENCE WITH DRS. HA-
DAIE FRON AND BARATA
PSMA IS HERE IN THE U.S. - NOW WHAT? PANEL DISCUSSION WITH 5 MINUTE UPDATES:
Yam Nyame OPTIMIZED TESTING AND THERAPEUTICS IN
ADVANCED PROSTATE CANCER
Q&A: MODERATORS/AUDIENCE WITH DR. NYAME
Panelists: Pedro Barata, Alicia Morgans, Oliver Sartor
PANEL DISCUSSION: CASES WHERE IMAGING
UPDATE: GENOMIC PROFILING
CHANGED EVERYTHING…
Oliver Sartor
Panelists: Tharak Bathala, Arvin George, Rob Reiter
UPDATE: METASTATIC CASTRATE SENSITIVE
10:25 BREAK
DISEASE
10:40
SESSION III: LOCALIZED DISEASE—SURGICAL Pedro Barata
FORUM
UPDATE:METASTATIC CASTRATE RESISTANT
Moderators: Prokar Dasgupta, Katie Murray
DISEASE
Derya Tilki
Alicia Morgan
APPROVED FOR AMA PRA CATEGORY 1
CREDITTM

*Presenting author 175

Sunday, May 15, 2022
Moderated Poster Session 41
SURGICAL TECHNOLOGY & SIMULATION: TRAINING & SKILLS ASSESSMENT
Room 228 @ Ernest N. Morial Convention Center
Moderators: Jaime Landman, Khurshid Ghani & Michael Borofsky
ABSTRACT
NUMBER TITLE
MP41-01 DISSECTION ASSESSMENT FOR ROBOTIC
TECHNIQUE (DART) TO EVALUATE NERVE-
SPARE OF ROBOT-ASSISTED RADICAL
PROSTATECTOMY
Runzhuo Ma*, Alvin Hui, Jiashu Xu, Aditya Desai,
Los Angeles, CA, Michael Tzeng, Emily Cheng,
New York, NY, Loc Trinh, Jessica H Nguyen, Los
Angeles, CA, Anima Anandkumar, Pasadena, CA,
Jim C. Hu, New York, NY, Andrew J. Hung, Los
Angeles, CA
MP41-02 NOVEL ROBOTIC-ASSISTED
ELECTROMAGNETIC GUIDANCE FOR
PRECISION PERCUTANEOUS ACCESS: A
CADAVERIC STUDY OF NOVICES VERSUS
AN EXPERT
Mitchell Humphreys*, Kevin Wymer, Phoenix,
AZ, Ben Chew, Vancouver, Canada, Janet Zhen,
Redwood City, CA, Fuad Elkhoury, Los Angelas,
CA, Sri Sivalingam, Cleveland, OH, Matthew
Dunn, Santa Monica, CA, Michael Borofsky,
Minneapolis, MN
MP41-03 COMPUTER VISION FOR SURGICAL ERRORS
DETECTION DURING ROBOTIC TISSUE
DISSECTION
Rafal Kocielnik*, Inhoo Lee, Pasadena, CA, Jas-
per Laca, Sidney I. Roberts, Jessica H. Nguyen,
Los Angeles, CA, Idris O. Sunmola, Evanston,
IL, De-An Huang, Santa Clara, CA, Sandra P.
Marshall, Solana Beach, CA, Anima Anandkumar,
Pasadena, CA, Andrew J. Hung, Los Angeles, CA
MP41-04 MOTION METRICS AND MACHINE
LEARNING-BASED FEEDBACK IN WET-LAB
LAPAROSCOPIC SURGICAL TRAINING
Takashige Abe*, Koki Ebina, Kiyohiko Hotta,
Madoka Higuchi, Jun Furumido, Naoya Iwaha-
ra, Masafumi Kon, Kou Miyaji, Sayaka Shibuya,
Yan Lingbo, Suhnsuke Komizunai, Yo Kurashi-
ma, Hiroshi Kikuchi, Ryuji Matsumoto, Takahiro
Osawa, Sachiyo Murai, Sapporo, Japan, Teppei
Tsujita, Yokosuka, Japan, Kazuya Sase, Taga-
jo, Japan, Xiaoshuai Chen, Hirosaki, Japan,
Atsushi Konno, Nobuo Shinohara, Sapporo,
Japan
MP41-05 EVALUATING THE EFFICACY OF TISSUE
DISSECTION GESTURES DURING ROBOTIC
SIMULATION TASK
Daniel Inouye*, Runzhuo Ma, Jessica H. Nguyen,
Jasper Laca, Los Angeles, CA, Rafal Kocielnik,
Anima Anandkumar, Pasadena, CA, Andrew J.
Hung, Los Angeles, CA
176
10:30 am – 11:45 am
ABSTRACT
NUMBER TITLE
MP41-06 A PROSPECTIVE, RANDOMIZED, MULTI-
CENTRE TRIAL ON THE EFFICIENCY AND
EFFECTIVENESS OF PROFICIENCY BASED
PROGRESSION ROBOTIC SURGICAL SKILLS
TRAINING
Stefano Puliatti*, Marco Amato, Modena, Italy, Rui
Farinha, Ghent, Belgium, Artur paludo, Porto Alegre,
Brazil, Giuseppe Rosiello, Milan, Italy, Ruben De
Groote, Aalst, Belgium, Laura Langhendries, Maxime
Lassel, Leuven, Belgium, Andrea Mari, Florence,
Italy, Lorenzo Bianchi, Pietro Piazza, Bologna,
Italy, Ben Van Cleynenbreugel, Leuven, Belgium,
Elio Mazzone, Milan, Italy, Kobe Van Hove, Simon
Meganck, Léonore Maertens, Louis-Philippe Boret,
Ghent, Belgium, Filippo Migliorini, Verona, Italy,
Saverio Forte, Bari, Italy, Bernardo Rocco, Milan, Ita-
ly, Salvatore Micali, Modena, Italy, Alexandre Mottrie,
Aalst, Belgium, Anthony Gallagher, Melle, Belgium
MP41-07 PRESENTATION SKILLS IN THE VIRTUAL
MEETING ERA – AN ANALYSIS OF #EAU21
Kenneth Chen, Jonathan O’Brien*, Pocharapong
Jenjitranant, Omar Alghazo, Brian Kelly, Renu
Eapen, Daniel Moon, Nathan Lawrentschuk,
Declan Murphy, Melbourne, Australia
MP41-08 ADVANCED TECHNIQUES TO IMPROVE
VIDEO-BASED AUTOMATION OF SUTURING
SKILLS ASSESSMENT
Andrew J Hung*, Los Angeles, CA, Richard Bao,
Pasadena, CA, Idris O Sunmola, Evanston,
IL, De-An Huang, Santa Clara, CA, Jessica H.
Nguyen, Los Angeles, CA, Anima Anandkumar,
Pasadena, CA
MP41-09 COMBINING VIDEO AND FORCE SENSOR
DATA WITHIN A MULTILABEL MULTIMODAL
DEEP LEARNING ALGORITHM TO PROVIDE
AUTOMATED FEEDBACK FOR ROBOT
ASSISTED RADICAL PROSTATECTOMY
SIMULATIONS
Patrick Saba*, Beilei Xu, Rachel Melnyk, Christo-
pher Wanderling, Ahmed Ghazi, Rochester, NY
MP41-10 USING CUSTOMIZED FEEDBACK TO
EXPEDITE THE ACQUISITION OF ROBOTIC
SUTURING SKILLS
Runzhuo Ma*, Jessica H. Nguyen, Andrew Cow-
an, Ryan S. Lee, Taseen Haque, Jonathan You,
Sidney I. Roberts, Steven Cen, Los Angeles, CA,
Anthony Jarc, Norcross, GA, Andrew J. Hung, Los
Angeles, CA
MP41-11 ANALYSIS OF FLEXIBLE URETEROSCOPIC
MOTION AND KINEMATIC EFFICIENCY-A
SIMULATION-BASED PILOT STUDY
Marie-Therese Valovska*, Gricelda Gomez,
Boston, MA, Richard Fineman, William Woltmann,
Cambridge, MA, Leia Stirling, Ann Arbor, MI,
Daniel Wollin, Boston, MA
 MP41-12 EFFECTIVENESS OF VIRTUAL REALITY
SIMULATION OF RENAL PUNCTURE FOR
ENDOSCOPIC-COMBINED INTRARENAL
SURGERY
Atsushi Okada*, Kazuya Ohashi, Yusuke Noda,
Tomoki Okada, Ryosuke Chaya, Kengo Kawase,
Taiki Kato, Kazumi Taguchi, Shuzo Hamamoto,
Keiichi Tozawa, Kenjiro Kohri, Takahiro Yasui,
Nagoya, Japan
MP41-13 DOES QUALITY ASSURED ELEARNING
PROVIDE ADEQUATE PREPARATION
FOR ROBOTIC SURGICAL SKILLS; A
PROSPECTIVE, RANDOMIZED AND MULTI-
CENTER STUDY
Stefano Puliatti*, Marco Amato, Modena, Italy,
Rui Farinha, Ghent, Belgium, Artur paludo, Porto
Alegre, Brazil, Giuseppe Rosiello, Milan, Italy,
Ruben De Groote, Aalst, Belgium, Andrea Mari,
Florence, Italy, Lorenzo Bianchi, Pietro Piazza,
Bologna, Italy, Ben Van Cleynenbreugel, Leuven,
Belgium, Elio Mazzone, Milan, Italy, Simon Meg-
anck, Léonore Maertens, Louise Callens, Ghent,
Belgium, Filippo Migliorini, Verona, Italy, Saverio
Forte, Bari, Italy, Bernardo Rocco, Milan, Italy,
Salvatore Micali, Modena, Italy, Alexandre Mottrie,
Aalst, Belgium, Anthony Gallagher, Melle, Belgium
MP41-14 THE LEARNING CURVE OF RADICAL
NEPHRECTOMY FOR KIDNEY CANCER:
IMPLICATIONS FOR SURGICAL TRAINING
Federico Belladelli*, Giuseppe Fallara, Giuseppe
Rosiello, Daniele Cignoli, Giuseppe Basile,
Gianmarco Colandrea, Giacomo Musso, Franc-
esco Cei, Daniela Canibus, Walter Cazzaniga,
Gianfranco Baiamonte, Chiara Re, Andrea Ieva,
Milan, Italy, Pierre I. Karakiewicz, Montreal, Can-
ada, Federico Dehò, Varese, Italy, Patrizio Rigatti,
Giorgio Guazzoni, Milan, Italy, Andrea Gallina,
Lugano, Switzerland, Alexandre Mottrie, Aalst,
Belgium, Francesco Montorsi, Roberto Bertini, An-
drea Salonia, Alberto Briganti, Umberto Capitanio,
Alessandro Larcher, Milan, Italy
MP41-15 PCNL ACCESS PLANNING USING A NOVEL
OPTIMIZATION ALGORITHM
Moiz Khan, Boston, MA, Filipe De Carvalho
Pedrosa, Lexuan Wang, London, Canada,
Borna Dabiri, Boston, MA, Rajni Patel, London,
Canada, Jayender Jagadeesan, Dianne Sacco*,
Boston, MA
*Presenting author
MP41-16 EVALUATION OF MIXED REALITY (MR)
TECHNOLOGIES FOR REMOTE GUIDANCE
DURING TRANSRECTAL ULTRASOUND
BIOPSY (TRUS-BX) SIMULATION: A
PROSPECTIVE, RANDOMIZED
COMPARATIVE TRIAL
Rachel Melnyk, John Melnyk, Christopher
Wanderling, Scott Quarrier, Hani Rashid, Ahmed
Ghazi*, Rochester, NY
MP41-17 USING A MULTI-TASK CONVOLUTIONAL
NEURAL NETWORK TO PREDICT SURGEON
SKILL IN ROBOT-ASSISTED PARTIAL
NEPHRECTOMY
Hal Kominsky*, Yihao Wang, Jessica Dai, Tara
Morgan, Alaina Garbens, Jeffrey Gahan, Eric
Larson, Dallas, TX
MP41-18 DIFFICULT FOLEY? A LOOK INTO DIFFICULT
FOLEY CONSULTS
Katharina Mitchell*, Amr Elbakry, Caitlyn Patton,
SUNDAY
John Barnard, Morgantown, WV, Chad Morley,
Morgantown, WV
MP41-19 PHASE I NCT03738488. FEASIBLE 3D
PRINTED MODELS OF RENAL CELL
CARCINOMA WITH VENOUS THROMBUS
EXTENSION FOR SURGICAL PLANNING AND
SIMULATION
Ines Rivero Belenchon*, Carmen Belen Congre-
gado Ruiz, Gorka Gomez Ciriza, Seville, Spain,
Victoria Gomez Dos Santos, Madrid, Spain,
Cristina Asensio, Seville, Spain, Cristina Gonzalez
Gordaliza, Madrid, Spain, Ignacio Osman Garcia,
Jose Manuel Conde Sanchez, Seville, Spain,
Francisco Javier Burgos Revilla, Madrid, Spain,
Rafael Antonio Medina Lopez, Seville, Spain
MP41-20 COST-EFFECTIVE AND READILY
REPLICABLE SURGICAL SIMULATION
MODEL IMPROVES TRAINEE PERFORMANCE
IN URETHROVESICAL ANASTOMOSIS
Stacy Jeong*, Cleveland Heights, OH, Maxx
Caveney, Jacob Knorr, Rebecca Campbell, Daniel
Santana, Christopher Weight, Nima Almassi,
Steven Campbell, Cleveland, OH
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
177
Sunday, May 15, 2022
Moderated Poster Session 42
BLADDER CANCER: EPIDEMIOLOGY & EVALUATION II
Room 225 @ Ernest N. Morial Convention Center
Moderators: Karim Chamie, John Gore & Eila Skinner
ABSTRACT
NUMBER TITLE
MP42-01 COMPARISON OF MICROSCOPIC
HEMATURIA INCIDENCE AND GRADE
BETWEEN MICROSCOPIC AND IRIS™
AUTOMATED URINALYSIS METHODS
Aleem Khan*, Jani Alkesh, Mark Sawyer,
Denver, CO
MP42-02 URINARY HUMAN PAPILLOMA VIRUS
INFECTION AND BLADDER CANCER RISK:
A SYSTEMATIC REVIEW AND A PRISMA-
COMPLIANT META-ANALYSIS
Dario Garcia-Rojo*, Jesus Muñoz-Rodriguez,
Clara Centeno, Angel Prera, Carlos Abad, Edu-
ardo Vicente, Jose Luis Gonzalez-Sala, Naim
Hannaoui, Arturo Dominguez-Garcia, Marta
Capdevila, Leticia de Verdonces, Anna Ferran,
Carmina Pla, Paula Azuara, Silvia Cuadrench,
Maria Eugenia Zegri, Juan Prats, Sabadell, Spain
MP42-03 5α-REDUCTASE INHIBITORS AND THE
RISK OF BLADDER CANCER IN A LARGE,
POPULATION-BASED COHORT
Snir Dekalo*, Eric McArthur, Jeff Campbell,
Michael Ordon, Nicholas Power, Blayne Welk,
London, Canada
MP42-04 FINANCIAL BURDEN OF BLADDER CANCER
CARE: CDC NATIONAL HEALTH SURVEY
ANALYSIS
Laura Bukavina*, Alberto Castro Bigalli, Philadel-
phia, PA, Thomas Cwalina, Caleb Curry, Michael
Callegari, Megan Prunty, Ilaha Isali, Cleveland,
OH, Mohit Sindhani, New Delhi, India, Adam
Calaway, Lee Ponsky, Cleveland, OH, Andres
Correa, Alexander Kutikov, Philadelphia, PA,
Sarah Psutka, Seattle, WA
MP42-05 USE OF INTRAVESICAL CHEMOTHERAPY
IN THE UNITED STATES FOLLOWING
PUBLICATION OF A RANDOMIZED TRIAL
Alec Zhu*, Patrick Lewicki, New York, NY, Camilo
Arenas-Gallo, Cleveland, OH, Aaron Brant,
Spyridon Basourakos, Yuqing Qiu, New York, NY,
Megan Prunty, Cleveland, OH, Douglas Scherr,
New York, NY, Jonathan Shoag, Cleveland, OH
MP42-06 IMPACT OF EXERCISE ON PHYSICAL
HEALTH STATUS IN BLADDER CANCER
PATIENTS
Mara Koelker*, Khalid Alkhatib, Muhieddine Lab-
ban, Mark A. Preston, Timothy N. Clinton, Steven
L. Chang, Quoc-Dien Trinh, Matthew Mossanen,
Boston, MA
MP42-07 EFFECTS OF LIFESTYLE AND
ENVIRONMENTAL FACTORS ON STAGE
OF BLADDER CANCER AT INITIAL
PRESENTATION
Ayat A. Shah*, Nighat Sofi, Holly Houenstein,
Yousuf Ramahi, Zhe Jing, Ahmed A. Hussein,
Khurshid A. Guru, Buffalo, NY
178
10:30 am – 11:45 am
ABSTRACT
NUMBER TITLE
MP42-08 CAN VESICAL IMAGING-REPORTING AND
DATA SYSTEM DIFFERENTIATE T1 AND T2
BLADDER TUMORS? A META-ANALYSIS
Seyed Behzad Jazayeri*, Hojat Dehghanbanada-
ki, Seyed Behnam Jazayeri, Mahdie Hosseini,
Pourya Taghipour, Muhammad Umar Alam, KC
Balaji, Mark Bandyk, Jacksonville, FL
MP42-09 NEIGHBORHOOD DISADVANTAGE
CORRELATES WITH OUTCOMES IN MUSCLE
INVASIVE BLADDER CANCER
Devon Langston*, Sarah Beebe, Tasha Posid,
Victor Heh, Kamal Pohar, Columbus, OH
MP42-10 TREATMENT AND ASSOCIATED SURVIVAL
TRENDS FOR LOCALIZED SMALL CELL
CARCINOMA OF THE BLADDER
Woodson Smelser*, Wilson Sui, Nashville, TN,
Christopher Wallis, Toronto, Canada, Sam Chang,
Nashville, TN
MP42-11 THE IMPACT OF PSYCHIATRIC DIAGNOSES
ON PERIOPERATIVE OUTCOMES
FOLLOWING RADICAL CYSTECTOMY IN THE
STATE OF FLORIDA
Bryce Baird*, Tiara Taylor, Shalmali Borkar, Laura
Geldmaker, Christian Ericson, Emily Brennan,
Jacksonville, FL, Augustus Anderson, New
Orleans, LA, Stephen Boorjian, Rochester, MN,
Shehzad Niazi, Dorin Colibaseanu, Aaron Spauld-
ing, Timothy Lyon, Jacksonville, FL
MP42-12 HIGHER PREOPERATIVE EGFR IS A
PREDICTOR OF WORSE RENAL FUNCTION
DECLINE AFTER ROBOTIC ASSISTED
RADICAL CYSTECTOMY
Shirin Razdan*, Benjamin Eilender, John Pfail,
Mariely Garcia, Daniel Ranti, Shoshana Rosen-
zweig, New York, NY, Abolfazl Hosseini, Jari
Radros, Stockholm, Sweden, Reza Mehrazin,
Peter Wiklund, John Sfakianos, New York, NY
MP42-13 PELVIC LYMPHADENECTOMY FOR BLADDER
CANCER: DOES A THOROUGH DISSECTION
STILL MATTER?
Arnav Srivastava*, Hiren Patel, Kevin Chua,
Sai Krishnaraya Doppalapudi, Akshay Thaper,
Sammy Elsamra, New Brunswick, NJ, Isaac Kim,
New Haven, CT, Eric Singer, Thomas Jang, Saum
Ghodoussipour, New Brunswick, NJ
MP42-14 CHARACTERISTICS CONTRIBUTING TO
SURVIVAL DIFFERENCES BETWEEN BLACK
AND WHITE PATIENTS FOLLOWING RADICAL
CYSTECTOMY
Shoshana Rosenzweig*, John Sfakianos, Reza
Mehrazin, Peter Wiklund, Nikhil Waingankar, New
York, NY
 MP42-15 UROTHELIAL CARCINOMA OF THE BLADDER MP42-18 SOCIAL AND ENVIRONMENTAL RISK
WITH ISOLATED LYMPH NODE METASTASIS: FACTORS FOR UNDERGOING RADICAL
NATURAL HISTORY AND OUTCOMES CYSTECTOMY FOR UROTHELIAL
FOLLOWING SURGICAL RESECTION CARCINOMA IN RHODE ISLAND: 2000-2020
Ernest Morton*, Grand Rapids, MI, Sumedh Kaul, Borivoj Golijanin*, Sarah Andrea, Justin Bessette,
Aaron Fleishman, Ruslan Korets, Peter Chang, Rebecca Ortiz, Philip Caffery, Timothy O’Rourke,
Andrew Wagner, Boston, MA, Simon Kim, Aurora, Christopher Tucci, Ali Amin, Dragan Golijanin,
CO, Joaquim Bellmunt, Irving Kaplan, Aria Olumi, Providence, RI
Boris Gershman, Boston, MA
APPROVED FOR AMA PRA CATEGORY 1.25
MP42-16 VARIOUS INCIDENCE RISKS OF CREDITSTM
SUBSEQUENT MALIGNANCIES IN URINARY
TRACT AFTER INITIAL BLADDER CANCER
DIAGNOSIS STRATIFIED BY LATENCIES
Shu Wang*, Ryan Russell, Michael Phelan, M.
Minhaj Siddiqui, Baltimore, MD
MP42-17 CONDITIONAL SURVIVAL FOLLOWING
RADICAL CYSTECTOMY FOR UROTHELIAL
CARCINOMA OF THE BLADDER
Maria F. Moreno*, Sumedh Kaul, Aaron Fleish-

SUNDAY
man, Ruslan Korets, Peter Chang, Andrew
Wagner, Boston, MA, Simon Kim, Aurora, CO,
Joaquim Bellmunt, Irving Kaplan, Aria F. Olumi,
Boris Gershman, Boston, MA

Sunday, May 15, 2022 10:30 am – 11:45 am

Moderated Poster Session 43

PROSTATE CANCER: LOCALIZED: ACTIVE SURVEILLANCE
Room 222 @ Ernest N. Morial Convention Center
Moderators: Joseph Smith, Sung Kyu Hong & Peter Carroll

ABSTRACT
NUMBER TITLE
MP43-01 CLINICAL SIGNIFICANCE OF DETECTION OF
PERINEURAL INVASION IN LOW-RISK MEN
ON ACTIVE SURVEILLANCE
Claire de la Calle*, Mufaddal Mamawala, Patricia
Landis, Jonathan Epstein, Bruce Trock, Ballentine
Carter, Christian Pavlovich, Baltimore, MD
MP43-02 PREFERENCE ELICITATION AND
TREATMENT DECISION MAKING AMONG
MEN DIAGNOSED WITH LOCALIZED
PROSTATE CANCER: RESULTS FROM THE
HEALIUM TRIAL
Michael Diefenbach*, Simon Hall, Manish Vira, Mi-
chael Schwartz, New Hyde Park, NY, Erin Tagai,
Alexander Kutikov, Andres Correa, Philadelphia,
PA, Halie Pfister, Andrea Yacoub, Manhasset, NY,
Suzanne Miller, Philadelphia, PA
MP43-03 ACTIVE SURVEILLANCE FOR LOW-RISK
PROSTATE CANCER: TIME TRENDS AND
VARIATION IN THE AUA QUALITY (AQUA)
REGISTRY
Matthew Cooperberg*, San Francisco, CA,
William Meeks, Raymond Fang, Baltimore, MD,
Franklin Gaylis, San Diego, CA, William Catalona,
Chicago, IL, Danil Makarov, New York, NY
MP43-04 COMPARISON OF 4K SCORE, PROSTATE
HEALTH INDEX, AND PSA DENSITY IN
ACTIVE SURVEILLANCE
Bruce Trock*, Mufaddal Mamawala, Patricia Lan-
dis, Yasin Bhanji, Baltimore, MD, Andrew Vickers,
New York, NY, Christian Pavlovich, Baltimore, MD
ABSTRACT
NUMBER TITLE
MP43-05 UPFRONT MRI IS THE NEW STANDARD,
HAVE CONFIRMATORY BIOPSIES BECOME
OBSOLETE?
Henk Luiting, Ivo Izaak de Vos*, Sebastiaan Rem-
mers, Egbert Boevé, Chris Bangma, Rotterdam,
Netherlands, Riccardo Valdagni, Milan, Italy, Peter
Chiu, Hong Kong, Hong Kong, Axel Semjonow,
Münster, Germany, Viktor Berge, Oslo, Norway,
Karl Tully, Herne, Germany, Antti Rannikko, Hel-
sinki, Finland, Frédéric Staerman, Reims, France,
Monique Roobol, Rotterdam, Netherlands
MP43-06 COMPARING MRI/US FUSION TO STANDARD
PROSTATE BIOPSY IN DETERMINING GRADE
RECLASSIFICATION AT CONFIRMATORY
BIOPSY IN A MULTI-INSTITUTIONAL ACTIVE
SURVEILLANCE COHORT: A PENNSYLVANIA
UROLOGY REGIONAL COLLABORATIVE
(PURC) ANALYSIS
David Strauss*, Rohit Reddy, Matthew Loecher,
Philadelphia, PA, Kaynaat Syed, Philadelphia,
PA, John Danella, Danville, PA, Serge Ginzburg,
Philadelphia, PA, Laurence Belkoff, Bala Cynwyd,
PA, Jeffrey Tomaszewski, Camden, NJ, Edouard
Trabulsi, Philadelphia, PA, Eric Singer, New
Brunswick, NJ, Bruce Jacobs, Pittsburgh, PA, Jay
Raman, Hershey, PA, Thomas Guzzo, Robert
Uzzo, Adam Reese, Philadelphia, PA

*Presenting author 179

 MP43-07 NEGATIVE PROSTATE MRI AS A PREDICTOR
OF DISEASE STABILITY IN PATIENTS ON
ACTIVE SURVEILLANCE
Jacob Enders*, Michael Rothberg, Zach Kozel,
Michael Daneshvar, Luke O’Connor, Alex Wang,
Cheyenne Williams, Nitin Yerram, Sandeep Gur-
ram, Maria Merino, Baris Turkbey, Bradford Wood,
Peter Pinto, Bethesda, MD
MP43-08 ACTIVE SURVEILLANCE FOR PROSTATE
CANCER: UPTAKE OVER TIME AND THE
IMPACT OF AN ORGANIZED PROTOCOL
Sebastiaan Remmers*, Monique Roobol, ERSPC
Rotterdam Study Group, Rotterdam, Netherlands
MP43-09 RISK OF ADVERSE PATHOLOGY AFTER
MP43-15 A 5-YEAR PROSPECTIVE STUDY OF
DEFERRED PROSTATECTOMY FOR GRADE
GROUP 1 AND 2 PROSTATE CANCER BEING
MANAGED BY ACTIVE SURVEILLANCE
Cheyenne Williams*, Philadelphia, PA, Michael
Daneshvar, Patrick Gomella, Luke O’Connor,
Sandeep Gurram, Peter Choyke, Bradford Wood,
Baris Turkbey, Maria Merino, Peter Pinto, Bethes-
da, MD
MP43-16 RACIAL DISPARITIES IN RATES OF GLEASON
MP43-10 IMPACT OF FAMILY HISTORY AND GERMLINE
GENETIC RISK VARIANTS ON LONG-TERM
OUTCOMES OF ACTIVE SURVEILLANCE-
ELIGIBLE PROSTATE CANCER
Florian Rumpf, Anna Plym, Jane Vaselkiv, Mark
Preston, Adam Kibel, Lorelei Mucci, Keyan Sala-
ri*, Boston, MA
MP43-11 THE USE AND OUTCOMES OF MEN WITH
NCCN FAVORABLE INTERMEDIATE RISK
PROSTATE CANCER MANAGED WITH
ACTIVE SURVEILLANCE
Roshan Paudel*, Ann Arbor, MI, Raghav Madan,
Detroit, MI, Ji Qi, Ann Arbor, MI, Michael Cher,
Detroit, MI, Brian Lane, Grand Rapids, MI, Arvin
George, Alice Semerjian, Ann Arbor, MI, Kevin
MP43-17 PREDICTING TRUE PATHOLOGIC GLEASON
Ginsburg, Detroit, MI, for the Michigan Urolog-
ical Surgery Improvement Collaborative, Ann
Arbor, MI
MP43-12 IMPACT OF NCCN-COMPLIANT
MULTIDISCIPLINARY CONFERENCE ON THE
UTILIZATION OF ACTIVE SURVEILLANCE
FOR PATIENTS WITH LOCALIZED PROSTATE
CANCER
Ayat A. Shah*, Holly Houenstein, Yousuf Ramahi,
Philippa Doherty, Zhe Jing, Umar Iqbal, Caleb
J. Eun, Grace E. Harrington, Mohammad Khan,
Thomas Schwaab, Qiang Li, Eric C. Kauffman,
James L. Mohler, Michael Kuettel, Khurshid A.
Guru, Ahmed A. Hussein, Buffalo, NY
MP43-18 PROSTATE CANCER MORTALITY RATES
MP43-13 INTERLABORATORY GLEASON GRADING
VARIATION AFFECTS TREATMENT: A
DUTCH HISTORIC COHORT STUDY IN 30,509
PROSTATE CANCER PATIENTS
Rachel Flach*, Carmen van Dooijeweert, Katja
Aben, Britt Suelmann, Peter-Paul Willemse, Paul
van Diest, Richard Meijer, Utrecht, Netherlands
180
MP43-14 EXTERNAL VALIDATION OF A MODEL
PREDICTING INCREASE IN GLEASON GRADE
FOR MEN ON ACTIVE SURVEILLANCE IN
THE GAP3 CONSORTIUM DATABASE
Daan Nieboer*, Ivo de Vos, Rotterdam, Nether-
lands, Lui Shiong Lee, Singapore, Singapore,
Phillip Stricker, Darlinghurst, Australia, Mark
Frydenburg, Melbourne, Australia, Anders Bjartell,
Malmö, Sweden, Jose Rubio-Briones, Valencia,
Spain, Axel Semjonow, Muenster, Germany, Antti
Rannikko, Helsinki, Finland, Mieke van Hemelri-
jck, London, United Kingdom, Christian Pavlovich,
Baltimore, MD, Peter Carroll, San Fransisco, CA,
Monique Roobol, Rotterdam, Netherlands
AFRICAN AMERICAN MEN ON PROSTATE
CANCER ACTIVE SURVEILLANCE: DOES
RACE PREDICT UPGRADING?
Joshua Pincus*, Jacob W. Greenberg, Christo-
pher Koller, New Orleans, LA, Jonathan Sil-
berstein, Aventura, FL, L. Spencer Krane, New
Orleans, LA
GRADE RECLASSIFICATION IN A MULTI-
INSTITUTIONAL PROSTATE CANCER ACTIVE
SURVEILLANCE COHORT: A PENNSYLVANIA
UROLOGY REGIONAL COLLABORATIVE
(PURC) ANALYSIS
Rohit Reddy*, David Strauss, Matthew Loecher,
Kaynaat Syed, Philadelphia, PA, John Danella,
Danville, PA, Serge Ginzburg, Philadelphia, PA,
Laurence Belkoff, Bala Cynwyd, PA, Jeffrey
Tomaszewski, Camden, NJ, Edouard Trabulsi,
Philadelphia, PA, Eric A Singer, New Brunswick,
NJ, Bruce L. Jacobs, Pittsburgh, PA, Jay Raman,
Hershey, PA, Thomas Guzzo, Thomas Guzzo,
Robert Uzzo, Adam C. Reese, Philadelphia, PA
GRADE DURING ACTIVE SURVEILLANCE
FOR PROSTATE CANCER: CALIBRATION OF
THE JOHNS HOPKINS ACTIVECARE MODEL
IN FIVE LARGE ACTIVE SURVEILLANCE
COHORTS
Christian Pavlovich*, Baltimore, MD, Daan Niebo-
er, Rotterdam, Netherlands, Mufaddal Mamawala,
Akihiko Nishimura, Patricia Landis, Katarzyna
Macura, Jonathan Epstein, Baltimore, MD, Jozien
Helleman, Rotterdam, Netherlands, Bruce Trock,
Baltimore, MD, Movember Foundation’s Global
Action Plan Prostate Cancer Active Surveillance
(GAP3) consortium, Rotterdam, Netherlands
IN LOW AND FAVORABLE INTERMEDIATE
RISK ACTIVE SURVEILLANCE PATIENTS: A
POPULATION-BASED COMPETING RISKS
ANALYSIS
Rashid Sayyid*, John Benton, William Reed, Mer-
ry Ma, Phillip Woodruff, Martha Terris, Augusta,
GA, Christopher Wallis, Toronto, Canada, Zachary
Klaassen, Augusta, GA
 MP43-19 DROP-OUT RATES FROM ACTIVE MP43-20 LONG TERM HEALTH-RELATED QUALITY OF
SURVEILLANCE FOR DISEASE LIFE (HRQOL) OUTCOMES AFTER SURGERY,
PROGRESSION REMAIN CONSISTENT AND RADIOTHERAPY, OR ACTIVE SURVEILLANCE
NOT NEGLIGIBLE OVER TIME. A PLEA FOR FOR LOCALIZED PROSTATE CANCER
LONG-TERM ASSESSMENT BASED ON Eyal Kord*, Nathan Jung, Seattle, WA, Jiji Jiang,
A LARGE, PROSPECTIVELY COLLECTED Bethesda, MD, Natasza Posielski, On Ho, Seattle,
ACTIVE SURVEILLANCE COHORT WA, Sally Elsamanoudi, Gregory T. Chesnut,
Luigi Nocera*, Milan, Italy, Riccardo Leni, Milano, Bethesda, MD, Ryan Speir, Tacoma, WA, Sean
Italy, Armando Stabile, Milan, Italy, Giorgio Stroup, San diego, CA, John Musser, Honolulu,
Gandaglia, Elio Mazzone, Milano, Italy, Gabri- HI, Alexander Ernest, Houston, TX, Timothy
ele Sorce, Francesco Pellegrino, Milan, Italy, Tausch, Bethesda, MD, John Paul Flores, Christo-
Francesco Barletta, Simone Scuderi, Milano, pher Porter, Seattle, WA
Italy, Andrea Gallina, Nicola Fossati, Lugano,
APPROVED FOR AMA PRA CATEGORY 1.25
Switzerland, Emanuele Zaffuto, Milan, Italy, Marco
CREDITSTM
Moschini, Lucerne, Switzerland, Nazareno Suardi,
Genoa, Italy, Shahrokh F. Shariat, Vienna, Austria,
Francesco Montorsi, Alberto Briganti, Milano, Italy

Sunday, May 15, 2022 10:30 am – 2:30 pm

SUNDAY
UROLOGICAL SOCIETY FOR AMERICAN VETERANS (USAV)
St. Charles Ballroom @ Hilton New Orleans Riverside
Chair: Arvin George
10:30 WELCOME/USAV UPDATE 12:20 VISIT EXHIBITS - LUNCH BREAK - VIEW POSTERS
Society President: Robert Grubb
12:50 INDUSTRY SUPPORTED TALK BY EXACT
Chair: Arvin George
SCIENCES
10:40 CONDUCTING RESEARCH AT THE VA-NAVREF
1:10 ADDRESSING NEEDS OF FEMALE VETS AT THE VA
Julia Houston
Rachel Rubin
10:55 MODERATED POSTER SESSION
1:25 PSMA PET - INDICATIONS AND OUTCOMES
11:40 KEYNOTE TALKS: BALLOON DEBATE Kevin Ginsberg
ENUCLEATION 1:40 INDUSTRY SUPPORTED TALK
John DiBianco
2:00 NOVEL LASERS IN ENDOUROLOGY
TURP Khurshid Ghani
L. Spencer Krane
2:15 POSTERS AWARDS CEREMONY
UROLIFT
2:25 CONCLUDING REMARKS
Amin Herati
Society President: Robert Grubb
–
REZUM™ Chair: Arvin George
Arvin George
AQUABLATION
Gopal Badlani

Sunday, May 15, 2022 12:00 pm – 6:00 pm

SOCIETY OF UROLOGIC ROBOTIC SURGERY (SURS)
Grand Ballroom A @ Hilton New Orleans Riverside
12:00 INVITED VIDEO SESSION 1:00 WELCOME AND SURS UPDATE
Moderator: Ashok Hemal Ashutosh Tewari
ROBOTIC SINGLE PORT RADICAL CYSTECTOMY 1:05 SESSION 1
Jeffery Nix Moderators: Ashok Hemal, Ashutosh Tewari
ROBOTIC TRANSVESICAL RADICAL ADVANCING LANDSCAPE OF ROBOTIC SURGERY
PROSTATECTOMY USING MULTIPORT Prokar Dasgupta
Vinayak Wagaskar
ADVANCING FIELD OF ROBOTIC URO-
ROBOTIC SINGLE PORT PARTIAL NEPHRECTOMY ONCOLOGIC SURGERY
Inderbir Gill
ROBOTIC VEIL TECHNIQUE FOR LYMPH NODES
DISSECTION ESTABLISHING STRUCTURED ORSI ROBOTIC
Sudhir Rawal TRAINING PROGRAM
Alex Mottrie
HYDRO DISSECTION
Adriana Pedraza 1:45 SESSION 2: DEBATE SESSION
Moderators: Prokar Dasgupta, Kirsten Greene,
Chandru Sundaram

*Presenting author 181

 SINGLE PORT ROBOTIC RADICAL ROBOTIC PARTIAL NEPHRECTOMY: COMPLEX,
PROSTATECTOMY T1B & BEYOND
Debater-Pro: Jihad Kaouk Ketan Badani
Debater-Con: Jim Porter
INDIVIDUALIZED APPROACH TO HIGH-RISK
SINGLE PORT ROBOTIC PARTIAL NEPHRECTOMY UTUC: WHEN IS SEGMENTAL RESECTION VS.
Debater-Pro: Simone Crivellaro DISTAL URETERECTOMY VS. RADICAL NEPHRO-
Debater-Con: Inderbir Gill URETERECTOMY PREFERRED?
Ram Pathak
SINGLE PORT ROBOTIC RADICAL CYSTECTOMY
Debater-Pro: Mutahar Ahmed ROBOTIC RECONSTRUCTIVE UPPER TRACT
Debater-Con: Mihir Desai URETERAL SURGERY
Lee Zhao
MALE WITH UNFAVORABLE INTERMEDIATE-RISK
PROSTATE CANCER ROBOTIC RECONSTRUCTIVE LOWER TRACT
Debaters: John Davis, Avi Reddy URETERAL SURGERY
Raju Thomas
3:05 SESSION 3: PROSTATE
Moderators: Peter Carroll, Li-Ming Su, ROBOTIC RENAL TRANSPLANT
Aneesh Shrivastava Alberto Breda
ROBOTIC RADICAL PROSTATECTOMY: ADVANC- ROBOTIC SURGERY IN CHILDREN
ES IN NERVE SPARING PROSTATECTOMY Aseem Shukla
Ashutosh Tewari
4:50 SESSION 5: BLADDER & TESTIS
ROBOTIC RADICAL PROSTATECTOMY IN HIGH- Moderators: Ali Reza Kural, Reza Mehrazin,
GRADE HIGH-RISK PROSTATE CANCER Raj Pruthi
3:30
SESSION 4: KIDNEY & RECONSTRUCTIVE ROBOTIC RADICAL CYSTECTOMY: IS IT WAY TO
SURGERY GO?
Moderators: Rajesh Ahlawat, Mo Allaf, Khurshid Guru
Francesco Porpiglia, Casey Seideman
INTRACORPOREAL URINARY DIVERSION
ROBOTIC PARTIAL NEPHRECTOMY: ENDOPHYT- Peter Wiklund
IC & HILAR
ROBOTIC RETROPERITONEAL LYMPHADENEC-
Craig Rogers
TOMY
John Sfakianos
5:30 SURS BUSINESS MEETING
APPROVED FOR AMA PRA CATEGORY 1
CREDIT™

Sunday, May 15, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 44

STONE DISEASE: SURGICAL THERAPY (INCLUDING ESWL) III
Room 228 @ Ernest N. Morial Convention Center
Moderators: Ojas Shah & Michael Bailey

ABSTRACT ABSTRACT
NUMBER TITLE NUMBER TITLE
MP44-01 WHAT IS THE IDEAL FOLLOW UP
MP44-02 FAVORABLE OUTCOMES OF
AFTER KIDNEY STONE TREATMENT?
CONTEMPORARY PERCUTANEOUS
A SYSTEMATIC REVIEW AND FOLLOW-
NEPHROLITHOTOMY VERSUS RETROGRADE
UP ALGORITHM FROM THE EUROPEAN
INTRARENAL SURGERY FOR TREATMENT
ASSOCIATION OF UROLOGY UROLITHIASIS
OF RENAL STONES IN ADULT PATIENTS: A
PANEL
COCHRANE REVIEW
Riccardo Lombardo*, Rome, Italy, Lazaros
Leah Soderberg, Rochester, MN, Maylynn Ding,
Tzelves, Athens, Greece, Robert Geraghty, New-
Hamilton, Canada, Vernon Pais, Lebanon, NH, Mi-
castle-upon-Tyne, United Kingdom, Niall F. Davis,
chael S Borofsky, Minneapolis, MN, Robin Parker,
Dublin, Ireland, Andreas Neisius, Trier, Germany,
Halifax, Canada, Philipp Dahm*, Minneapolis, MN
Ales Petřík, Prague, Czech Republic, Giovanni
MP44-03 ULTRASOUND-ONLY PERCUTANEOUS
Gambaro, Verona, Italy, Christian Türk, Vienna,
NEPHROLITHOTOMY IS SAFE AND
Austria, Bhaskar Somani, Southampton, United
EFFECTIVE COMPARED TO FLUOROSCOPY-
Kingdom, Andreas Skolarikos, Athens, Greece,
DIRECTED PCNL
Kay Thomas, London, United Kingdom
Nizar Hakam*, Gregory Hosier, Xavier Cortez,
Fadl Hamouche, Leslie Charondo, Heiko Yang,
Carter Chan, Kevin Chang, David Bayne, Marshall
Stoller, Thomas Chi, San Francisco, CA

182
 MP44-04 REAL-WORLD PRACTICE STONE-FREE
RATES AFTER URETEROSCOPY FROM A
SURGICAL COLLABORATIVE: MUCH TO
IMPROVE
Hyung Joon Kim*, Stephanie Daignault-Newton,
John M. DiBianco, Ann Arbor, MI, S. Mohammad
Jafri, Royal Oak, MI, Brian Seifman, Royal Oak,
Troy, MI, Eduardo Kleer, Ypsilanti, MI, Casey
A. Dauw, Khurshid R. Ghani, for the Michigan
Urological Surgery Improvement Collaborative,
Ann Arbor, MI
MP44-05 TREATMENT OF URETERIC STONES WITH
LITHOEVO DEVICE AND VAPOR TUNNEL
TOOL
Matteo Maltagliati, Lorenzo Berti, Umberto Besa-
na, Carlo Buizza, Busto Arsizio, Italy, Davide Per-
ri, Novara, Italy, Salvatore Micali, Modena, Italy,
Bernardo Rocco, Maria Chiara Sighinolfi, Milano,
Italy, Carmine Sciorio, Lecco, Italy, Antonio Luigi
Pastore, Latina, Italy, Dymitry Pushkar, Alexander
Govorov, Moscow, Russian Federation, Javier
Romero Otero, Madrid, Spain, Giorgio Bozzini*,
Como, Italy
MP44-06 MORBIDLY OBESE PATIENTS MAY
SAFELY UNDERGO PERCUTANEOUS
NEPHROLITHOTOMY AT AN AMBULATORY
SURGERY CENTER
Max Drescher*, Baltimore, MD, Daniel Rosen,
Hanover, MD, Joel Abbott, Las Vegas, NV, Julio
Davalos, Hanover, MD
MP44-07 RELATIONSHIP BETWEEN RENAL PELVIS
PRESSURE AND POST-URETEROSCOPY
INFECTION IN A LIVE SWINE MODEL
David Hinojosa-Gonzalez, Christina Kottooran,
Boston, MA, Jennifer Saunders, Marle Franco,
Marlborough, MA, Brian Eisner*, Boston, MA
MP44-08 A NOVEL SCORE TO PREDICT SEPSIS
IN PATIENTS UNDERGOING URETERAL
STENT PLACEMENT FOR OBSTRUCTING
STONE AND PRESUMED URINARY TRACT
INFECTION
David E. Hinojosa-Gonzalez*, Jason J. Lee,
Christina S Kottooran, Alan J. Yaghoubian,
Boston, MA, Nikil R. Uppaluri, Kate A. Hanson,
Micheal S. Borofsky, Minneapolis, MN, Brian H.
Eisner, Boston, MA
MP44-09 A PROSPECTIVE, RANDOMIZED, SINGLE-
BLIND STUDY OF URETERAL STENT
BIOMATERIAL ENCRUSTATION AFTER
URETEROSCOPIC LITHOTROPISY
Shuzo Hamamoto*, Ryosuke Chaya, Kazumi
Taguchi, Kengo Kawase, Tomoki Okada, Tatsuya
Hattori, Terukaki Sugino, Rei Unno,
Atsushi Okada, Takahiro Yasui, Nagoya, Japan
MP44-10 A COMPARISON AMONG RIRS AND
MINIPERC FOR RENAL STONES BETWEEN 1
AND 2 CM USING FIBER DUST: A RCT
Lorenzo Berti, Matteo Maltagliati, Umberto Be-
sana, Carlo Buizza, Busto Arsizio, Italy, Andrea
Pacchetti, Genova, Italy, Salvatore Micali, Mode-
na, Italy, Maria Chiara Sighinolfi, Bernardo Rocco,
Milano, Italy, Giorgio Bozzini*, Como, Italy
*Presenting author
MP44-11 URETEROSCOPY VS. SHOCKWAVE
LITHOTRIPSY FOR LOWER POLE RENAL
STONES: TREATMENT VARIATION
AND OUTCOMES IN A SURGICAL
COLLABORATIVE
John Michael DiBianco*, Stephanie Daig-
nault-Newton, Ann Arbor, MI, Eric Stockall,
Lansing, MI, Spencer Hiller, Hyung Joon Kim,
Ann Arbor, MI, Hector Pimentel, Grand Rapids,
MI, Casey A. Dauw, Khurshid R. Ghani, for the
Michigan Urological Surgery Improvement Collab-
orative, Ann Arbor, MI
MP44-12 VACUUM-ASSISTED MINI PERCUTANEOUS
NEPHROLITHOTOMY ALLOWS OUTPATIENT
MANAGEMENT OF LARGE KIDNEY STONES,
A STUDY FROM RESKU
Fadl Hamouche, Kevin Chang*, Rei Unno, Greg
Hosier, Heiko Yang, Justin Ahn, David Bayne, San
Francisco, CA, Marshall Stoller, San Francisco,
CA, Thomas Chi, San Francisco, CA
SUNDAY
MP44-13 STONE CULTURES FOR URETEROSCOPY:
ARE THEY NECESSARY AND WHO
NEEDS THEM? RESULTS FROM A SINGLE
INSTITUTION SERIES
Daniel Wong*, Kenneth Sands, Alana Desai, Saint
Louis, MO
MP44-14 MINI-PNL FACILITATES SAME DAY
DISCHARGE WITHOUT AFFECTING
OUTCOMES COMPARED TO STANDARD
SIZED PCNL
Fadl Hamouche*, Kevin Chang, Rei Unno, Greg
Hosier, Heiko Yang, Justin Ahn, David Bayne, San
Francisco, CA, Marshall Stoller, San Francisco,
CA, Thomas Chi, San Francisco, CA
MP44-15 EARLY EXPERIENCE WITH VACUUM
ASSISTED URETERAL ACCESS SHEATHS
Daniel Wong*, Alana Desai, Saint Louis, MO
MP44-16 ESTIMATED DOSES OF RADIATION
RECEIVED BY THE EYE LENS DURING
ENDOUROLOGICAL PROCEDURES: ARE
WE BEING CAREFUL ENOUGH? ESUT-YAU
ENDOUROLOGY GROUP COLLABORATION
Alejandra Bravo-Balado*, Sofía Fontanet,
Barcelona, Spain, Andreas Skolarikos, Athens,
Greece, Ali Serdar Gozen, Heilbronn, Germany,
Bhaskar Somani, Southampton, United Kingdom,
Olivier Traxer, Paris, France, Michele Talso, Luca
Villa, Milan, Italy, Athanasios Papatsoris, Athens,
Greece, Amelia Pietropaolo, Southampton, United
Kingdom, Senol Tonyali, Istanbul, Turkey, Etienne
Xavier Keller, Zurich, Switzerland, Thomas Tailly,
Ghent, Belgium, Panagiotis Kallidonis, Patras,
Greece, Emre Sener, Istanbul, Turkey, Udo
Nagele, Hall in Tirol, Austria, Esteban Emiliani,
Barcelona, Spain
183
 MP44-17 COMPARISON OF OPERATIVE EFFICIENCY MP44-19 PCNL USING ZEEGO ROBOTIC HYBRID
AND EFFECTIVENESS BETWEEN A SYSTEM HAS LOWER EFFECTIVE RADIATION
DUAL LUMEN AND SINGLE LUMEN DOSE THAN PCNL USING STANDARD
URETEROSCOPE FOR URETEROSCOPIC FLUOROSCOPY
STONE REMOVAL Mark Sawyer, Xavier Glover*, Eric Ballon-Landa,
Andrew Brevik, Rohit Bhatt*, Kalon Morgan, Sohr- Denver, CO
ab Ali, Akhil Peta, Sina Zarandi, Luke Limfueco,
MP44-20 COMPARISON OF ULTRA-MINI
Rajiv Karani, Lillian Xie, Raphael Arada, John
PERCUTANEOUS NEPHROLITHOTOMY AND
Sung, Francis Jefferson, Egor Parkhomenko,
RETROGRADE INTRARENAL SURGERY FOR
Daniel Lama, Shoaib Safiullah, Pengbo Jiang,
RENAL STONES: A SYSTEMATIC REVIEW AND
Roshan Patel, Ralph Clayman, Jaime Landman,
META-ANALYSIS FROM KSER UPDATE SERIES
Orange, CA
Hae Do Jung*, Gunpo, Korea, Republic of, Doo
MP44-18 PROLONGED ENDOUROLOGICAL TRAINING Yong Chung, Incheon, Korea, Republic of, Min Ho
IS THE KEY TO IMPROVE SURGICAL Lee, Changwon, Korea, Republic of, Do Kyung
OUTCOMES OF STONE PATIENTS TREATED Kim, Sin Woo Lee, Sunghyun Paick, Seung Hyun
WITH FLEXIBLE URETEROSCOPY Jeon, Joo Yong Lee, Seoul, Korea, Republic of
Luca Villa*, Pietro Dioni, Margherita Fantin, Mario
APPROVED FOR AMA PRA CATEGORY 1.25
de Angelis, Christian Corsini, Milan, Italy, Olivier
CREDITSTM
Traxer, Paris, France, Alberto Briganti, Francesco
Montorsi, Eugenio Ventimiglia, Andrea Salonia,
Milan, Italy

Sunday, May 15, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 45

PROSTATE CANCER: MARKERS
Room 225 @ Ernest N. Morial Convention Center
Moderators: Daniel Lin, Ketan Badani & Jose Luis Alvarez Ossorio

ABSTRACT
NUMBER TITLE
MP45-01 A NEW SERUM BIOMARKER TO PREDICT
THE RISK OF PROSTATE CANCER AT
BIOPSY: PENTRAXIN-3
Gian Maria Busetto*, Ugo Giovanni Falagario, Gi-
useppe Stefano Netti, Oscar Selvaggio, Frances-
ca Sanguedolce, Elena Ranieri, Carlo Bettocchi,
Giuseppe Carrieri, Luigi Cormio, Foggia, Italy
MP45-02 A PROSPECTIVE STUDY OF THE
PROSTATE HEALTH INDEX DENSITY AND
MULTIPARAMETRIC MAGNETIC RESONANCE
IMAGING IN DIAGNOSING CLINICALLY
SIGNIFICANT PROSTATE CANCER
Gang Song*, Yuanchong Chen, Beijing, China,
People’s Republic of
MP45-03 URINARY EXOSOME MICRORNA SIGNATURES
AS A NONINVASIVE PROGNOSTIC
BIOMARKER FOR PROSTATE CANCER
Hyeok Jae Kwon*, Chang Eil Yoon, Dongho Shin,
Sun Shin, Hyong Woo Moon, Hyuk Jin Cho,
U-Syn Ha, Sung-Hoo Hong, Ji Youl Lee, Yeun–
Jun Chung, Sae Woong Kim, Yong Hyun Park,
Seoul, Korea, Republic of
MP45-04 SELECTMDX URINE TEST DIAGNOSE MEN
WITH HIGH-GRADE PROSTATE CANCER
Whitney Stanton, Aurora, CO, E David Crawford*,
La Jolla, CA, Paul Arangua, Joshua Romero,
Francisco G. La Rosa, Adrie van Bokhoven, M.
Scott Lucia, Paul Maroni, Aurora, CO, Wendy Po-
age, Centennial, CO, Jack Schalken, Nijmegen,
Netherlands, Fernando Kim, Denver, CO, Jack
Groskopf, Irvine, CA, Priya Werahera, Aurora, CO
ABSTRACT
NUMBER TITLE
MP45-05 MICRORNA 185-5P IS A NOVEL BIOMARKER
ASSOCIATED WITH HIGH-RISK PATHOLOGY
AT RADICAL PROSTATECTOMY IN PATIENTS
WITH LOW-RISK DISEASE AT DIAGNOSIS
Kevin Shee*, Cassandra Belair, John Neuhaus,
Janet Cowen, Robert Blelloch, Matthew Cooper-
berg, San Francisco, CA
MP45-06 CLINICAL SIGNIFICANCE OF α2,3-
SIALYLATED PROSTATE-SPECIFIC ANTIGEN
DENSITY AND MRI FOR HIGH-GRADE
PROSTATE CANCER IN BIOPSY-NAÏVE MEN
WITH ELEVATED PSA LEVEL
Tohru Yoneyama*, Shingo Hatakeyama, Mihoko
Sutoh Yoneyama, Yuki Tobisawa, Takuma Nari-
ta, Hirotake Kodama, Masaki Momota, Hirosaki,
Japan, Hiroyuki Ito, Aomori, Japan, Shintaro
Narita, Akita, Japan, Fumiyasu Tsushima,
Hirosaki, Japan, Koji Mitsuzuka, Sendai, Japan,
Takahiro Yoneyama, Yasuhiro Hashimoto,
Hirosaki, Japan, Wilhelmina Duivenvoorden, Je-
honathan H. Pinthus, Hamilton, Canada, Shingo
Kakeda, Hirosaki, Japan, Akihiro Ito, Sendai,
Japan, Norihiko Tsuchiya, Yamagata, Japan, To-
monori Habuchi, Akita, Japan, Chikara Ohyama,
Hirosaki, Japan
MP45-07 ONCOLOGIC OUTCOMES OF TOTAL
LENGTH GLEASON PATTERN 4 ON BIOPSY
IN MEN WITH GRADE GROUP 2 PROSTATE
CANCER
Marlon Perera*, Melissa Assel, Nicole Benfante,
Andrew Vickers, Victor Reuter, Sigrid Carlsson,
Vincent Laudone, Karim Touijer, James Eastham,
Peter Scardino, Samson Fine, Behfar Ehdaie,
New York, NY

184
 MP45-08 A COMPARISON OF BIOPSY GENOMIC
TEST TO PREDICT ADVERSE DISEASE ON
PROSTATECTOMY
Joon Yau Leong, Alex Uhr*, Benjamin Rudnick,
Andrea Quinn, Brian Calio, Edouard Trabulsi,
Tingting Zhan, Leonard Gomella, Mark Mann,
Collaborators of PURC, Philadelphia, PA
MP45-09 DISCRIMINATIVE SIGNIFICANCE OF
PROSTATE BIOPSY DECIPHER SCORE
TO PREDICT ADVERSE PATHOLOGY AND
PATHOLOGICAL DISCORDANCE AT RADICAL
PROSTATECTOMY
Ghazal Khajir*, Deepika Kumar, Syed Rahman,
Michael Leapman, Angelique Levi, Peter Hum-
phrey, Preston Sprenkle, New Haven, CT
MP45-10 DOES PERIOPERATIVE TESTOSTERONE
PREDICT POST-PROSTATECTOMY GENOMIC
RISK SCORE?
Mohammed Shahait*, Amman, Jordan, Joseph
G. Cheaib, Baltimore, MD, Elai Davicioni, Yang
Liu, San Francisco, CA, Ibrahim Abu Ghaida, Abu
Dhabi, United Arab Emirates, Ryan Dobbs, Chica-
go, IL, Priti Lal, Daniel Lee, Philadelphia, PA, PA,
David Lee, Irvine, CA
MP45-11 METABOLOMICS OF BLACK-WHITE
DIFFERENCES IN RISK OF PROSTATE
CANCER BIOCHEMICAL RECURRENCE
Bruce Trock*, Yuezhou Jing, Tracy Jones, Angelo
De Marzo, Baltimore, MD
MP45-12 PTEN LOSS AND DIFFUSIVE KI67 PREDICT
BIOCHEMICAL RECURRENCE OF LOCALIZED
PROSTATE CANCER AFTER RADICAL
PROSTATECTOMY: A VALIDATION COHORT
STUDY
Che Hsueh Yang*, Yi Sheng Lin, Wei Chun Weng,
Chin Heng Lu, Chung Hsiao Chin, Tang Yi Tsao,
Chao Yu Hsu, Min Che Tung, Yen Chuan Ou,
Taichung, Taiwan
MP45-13 ASSOCIATION BETWEEN POLYMORPHISMS
OF HOMOLOGOUS RECOMBINATION
RAD51B AND DISEASE RECURRENCE IN
A PROSPECTIVE COHORT OF PROSTATE
CANCER PATIENTS UNDERGOING RADICAL
PROSTATECTOMY
Vito Cucchiara*, Luigi Nocera, Dejan Lazarevic,
Davide Cittaro, Matteo Zoccolillo, Milan, Italy,
Giorgio Gandaglia, Elio Mazzone, Armando Stabile,
Francesco Barletta, Simone Scuderi, Daniele
Robesti, Andrea Necchi, Milano, Italy, Vincenzo
Mirone, Napoli, Italy, Pierre I. Karakiewicz, Montreal,
Canada, Francesco Montorsi, Milano, Italy, Giovanni
Tonon, Milan, Italy, Alberto Briganti, Milano, Italy
*Presenting author
MP45-14 THE SPATIAL LANDSCAPE OF CLONAL
SOMATIC MUTATIONS IN BENIGN AND
MALIGNANT PROSTATE EPITHELIA
Andrew Erickson*, Oxford, United Kingdom, Eme-
lie Berglund, Mengxiao He, Maja Marklund, Reza
Mirzazadeh, Niklas Schultz, Ludvig Bergenstråhle,
Linda Kvastad, Alma Andersson, Joseph Ber-
genstråhle, Ludvig Larsson, Solna, Sweden, Alia
Shamikh, Elisa Basmaci, Teresita Diaz De Ståhl,
Stockholm, Sweden, Timothy Rajakumar, Oxford,
United Kingdom, Kim Thrane, Solna, Sweden, An-
drew Ji, Paul Khavari, Stanford, CA, Firaz Tarish,
Solna, Sweden, Anna Tanoglidi, Uppsala, Swe-
den, Jonas Maaskola, Solna, Sweden, Richard
Colling, Oxford, United Kingdom, Tuomas Mirtti,
Helsinki, Finland, Freddie C Hamdy, Dan Wood-
cock, Oxford, United Kingdom, Thomas Helleday,
Solna, Sweden, Ian Mills, Oxford, United Arab
Emirates, Alastair Lamb, Oxford, United Kingdom,
Joakim Lundeberg, Solna, Sweden
SUNDAY
MP45-15 PTEN LOSS AND DIFFUSIVE KI67 ARE
RELATED TO CASTRATION-RESISTANT
PROSTATE CANCER: A VALIDATION COHORT
STUDY
Che Hsueh Yang*, Yi Sheng Lin, Wei Chun Weng,
Chin Heng Lu, Chung Hsiao Chin, Tang Yi Tsao,
Chao Yu Hsu, Min Che Tung, Yen Chuan Ou,
Taichung, Taiwan
MP45-16 CRISRP SCREENS REVEAL DETERMINANTS
OF PARP INHIBITOR RESPONSE IN
PROSTATE CANCER
Takuya Tsujino*, Chenkui Miao, Boston, MA, Har-
uhito Azuma, Osaka, Japan, Li Jia, Boston, MA
MP45-17 CORRELATION BETWEEN CTC COUNTS
AND RADIOMIC METRICS FROM MULTIPLE
OSSEOUS METASTATIC LESIONS IN
METASTATIC PROSTATE CANCER
Bino Varghese, Steven Cen, Gareth Morrison,
Jonathan Buckley, Dejerianne Ostrow, David
Quinn, Timothy Triche, Amir Goldkorn, Vinay
Duddalwar*, Los Angeles, CA
MP45-18 IDENTIFICATION OF DNA DAMAGE REPAIR-
ASSOCIATED PROGNOSTIC BIOMARKERS
FOR PROSTATE CANCER USING
TRANSCRIPTOMIC DATA ANALYSIS
Shu-Pin Huang*, Kaohsiung, Taiwan, Pai-Chi
Teng, Taipei, Taiwan, Chia-Hsin Liu, Taichung,
Taiwan, Ting-Yi Lin, Taipei, Taiwan, Yi-Chun
Cho, Yo-Liang Lai, Taichung, Taiwan, Shu-Chi
Wang, Hsin-Chih Yeh, Kaohsiung, Taiwan, Chih-
Pin Chuu, Miaoli, Taiwan, Deng-Neng Chen,
Pingtung, Taiwan, Wei-Chung Cheng, Taichung,
Taiwan, Chia-Yang Li, Kaohsiung, Taiwan
MP45-19 COMPARISON OF PREDICTIVE MARKERS
OF EFFECTIVENESS OF PARP INHIBITORS
VS IMMUNOTHERAPY FOR TREATMENT OF
CLINICALLY ADVANCED PROSTATE CANCER
(CAPC) BASED ON TMPRSS2:ERG FUSION
STATUS
Aleksandar Popovic*, Anastasija Useva, Alex
Wang, Michael Basin, Rebecca Sager, Jeffrey
Ross, Gennady Bratslavsky, Syracuse, NY
185
 MP45-20 VARIABILITY IN TESTOSTERONE
MEASUREMENT BETWEEN
RADIOIMMUNOASSAY (RIA),
CHEMILUMINESCENCE ASSAY(CLIA) AND
LIQUID CHROMATOGRAPHY-TANDEM MASS
SPECTROMETRY(MS) AMONG PROSTATE
CANCER PATIENTS ON ANDROGEN
DEPRIVATION THERAPY (ADT)
Sunday, May 15, 2022
Moderated Poster Session 46
PENILE & TESTICULAR CANCER I
Room 222 @ Ernest N. Morial Convention Center
Moderator: Curtis Pettaway
ABSTRACT
NUMBER TITLE
MP46-01 COLLABORATIVE RESILIENCE PROGRAM
TO ENHANCE QUALITY OF LIFE FOR POST-
PENECTOMY PATIENTS: DYADIC COPING
PERSPECTIVE
George Soko*, Lusaka, Zambia, Mwila Mulubwa,
Cape Town, South Africa, Tepwanji Mpetemoya,
Lusaka, Zambia
MP46-02 REFINEMENT OF THE SERUM MIR-
371A-3P TEST FOR THE DETECTION OF
CHEMOTHERAPY-NAIVE MINIMAL RESIDUAL
TESTICULAR CANCER
John T. Lafin, Armon Amini, Bendu Konneh, Anna
Savelyeva, Dallas, TX, Jin Piao, Michelle Nuno,
Monrovia, CA, Cinzia G. Scarpini, Cambridge,
United Kingdom, Jeffrey M. Howard, Thomas
Gerald, Dallas, TX, Nicholas Coleman, Matthew J.
Murray, Cambridge, United Kingdom, A. Lindsay
Frazier, Boston, MA, James F. Amatruda, Los
Angeles, CA, Aditya Bagrodia*, La Jolla, CA
MP46-03 OUTCOMES OF PENILE CANCER STRATIFIED
BY NODAL STAGING: IMPORTANCE OF
PELVIC NODAL INVOLVEMENT
Uday Chandankhede*, Amandeep Arora, Gagan
Prakash, Mahendra Pal, Manoj Tummala, Anand
Mohan, Ganesh Bakshi, Mumbai, India
MP46-04 10-YEAR EXPERIENCE WITH MIDLINE
EXTRAPERITONEAL RETROPERITONEAL
LYMPH NODE DISSECTION
Muhannad Alsyouf*, Sanam Ladi Seyedian,
Arman Ashrafi, Hamed Ahmadi, Madeleine
Burg, Alireza Ghoreifi, Antoin Douglawi, Sumeet
Bhanvadia, Anne Schuckman, Hooman Djaladat,
Siamak Daneshmand, Los Angeles, CA
MP46-05 CHARACTERIZING ONLINE TESTICULAR
CANCER DISCUSSIONS WITH QUANTITATIVE
THEMATIC ANALYSIS
Krishna Ravivarapu*, Alexander Small, Micah
Levy, Chih Peng Chin, Evan Garden, Osama Al-
Alao, Joseph Sewell Araya, Michael Palese, New
York, NY
186
Raj Tiwari*, Katherine Lajkosz, MohamedBaker
Berjaoui, Yazan Qaoud, Toronto, Canada, Clive
Woffendin, Portland, OR, Patrick Caron, Chantal
Guillemette, Quebec City, Canada, Neil Fleshner,
Toronto, Canada
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
1:00 pm – 2:15 pm
ABSTRACT
NUMBER TITLE
MP46-06 TRENDS IN PERIOPERATIVE OUTCOMES
FOLLOWING MIDLINE EXTRAPERITONEAL
RETROPERITONEAL LYMPH NODE
DISSECTION: SINGLE TERTIARY CENTER
EXPERIENCE
Hamed Ahmadi, Muhannad Alsyouf*, Madeleine
Burg, Arman Ashrafi, Sidney Roberts, Sanam Ladi
Seyedian, Alireza Ghoreifi, Antoin Douglawi, Sumeet
Bhanvadia, Hooman Djaladat, Anne Schuckman,
Siamak Daneshmand, Los Angeles, CA
MP46-07 THE PROGNOSTIC SIGNIFICANCE OF
TIM-3 EXPRESSING TUMOR-INFILTRATING
LYMPHOCYTES IN TESTICULAR GERM CELL
TUMORS
Ki Hong Kim*, Hee Jo Yang, Si Hyun Kim, Doo
Sang Kim, Chang Ho Lee, Cheonan, Korea,
Republic of, Soon Auck Hong, Byung Hoon Chi,
Seoul, Korea, Republic of, Ji-Hye Lee, Youn Soo
Jeon, Cheonan, Korea, Republic of
MP46-08 COST AND UTILIZATION OF CONCURRENT
VS STAGED TESTICULAR IMPLANT FOR
RADICAL ORCHIECTOMY
Arman Walia*, San Diego, CA, Joshua Horns,
Niraj Paudel, Salt Lake City, UT, Aditya Bagrodia,
San Diego, CA, Jim Hotaling, Salt Lake City, UT,
Tung-Chin Hsieh, San Diego, CA
MP46-09 DOES TIME TO DYNAMIC SENTINEL LYMPH
NODE BIOPSY AFFECT RECURRENCE-FREE
SURVIVAL IN PENILE SQUAMOUS CELL
CARCINOMA?
James A. Churchill*, Ashwin Sachdeva, Allaudin
Issa, Craig Jones, Noel W. Clarke, Maurice W.
Lau, Arie S. Parnham, Vijay K. Sangar, Manches-
ter, United Kingdom
MP46-10 ELUCIDATING THERAPEUTIC OPTIONS
FOR TREATMENT-NAÏVE AND CISPLATIN-
RESISTANT TESTICULAR CANCER
Julie-Ann Cavallo, Daniel Ranti*, Elliot Merritt,
Anna Tocheva, John P. Sfakianos, Benjamin Hop-
kins, New York, NY
 MP46-11 BILATERAL INGUINAL LYMPHNODE
DISSECTION VERSUS INGUINAL LYMPHNODE
DISSECTION AND DYNAMIC SENTINEL NODE
BIOPSY IN CLINICAL N1 SQUAMOUS CELL
CARCINOMA OF THE PENIS
Sebastiano Nazzani*, Mario Achille Catanzaro,
Alberto Macchi, Tullio Torelli, Silvia Stagni, Antonio
Tesone, Alice Lorenzoni, Mauro Maccauro, Rodolfo
Lanocita, Tommaso Cascella, Davide Biasoni, Luigi
Piva, Roberto Salvioni, Nicola Nicolai, Milan, Italy
MP46-12 DECLINES IN SKELETAL MUSCLE MASS
AND QUALITY DURING CYTOTOXIC
CHEMOTHERAPY PREDICT INCREASED RISK
OF CHEMOTHERAPY-ASSOCIATED ADVERSE
EVENTS IN MEN WITH TESTIS CANCER
Anthea Phuong*, Seattle, WA, J. Peter Marquardt,
Florian J. Fintelmann, Boston, MA, Ryan O’Mal-
ley, Grace Laidlaw, Zachary Eagle, Steven Ngo,
Sarah Holt, Delaney Orcutt, George R. Schade,
Daniel W. Lin, Michael T. Schweizer, Todd
Yezefski, Evan Y. Yu, Bruce Montgomery, Petros
Grivas, Sarah Psutka, Seattle, WA
MP46-13 TEX11 SUPPRESS THE MIGRATION AND
INVASION IN TESTICULAR GERM CELL
TUMOR BY DOWN-REGULATED ITGB2
Wenjun Zhou*, Changsha, China, People’s
Republic of
MP46-14 INGUINAL LYMPHADENECTOMY FOR
PENILE CANCER USING A FASCIAL
SPARING TECHNIQUE - OUTCOMES FROM
A SINGLE CENTRE
Nicolo’ Schifano*, Milan, Italy, Castiglione Fabio,
Matthew Rewhorn, Paul Hadway, Rees Rowland,
Raj Nigam, Hussain M. Alnajjar, Asif Muneer,
London, United Kingdom
MP46-15 POST-OPERATIVE MORBIDITY AND
COMPLICATIONS OF INGUINAL
LYMPHADENECTOMY FOR PENILE CANCER:
A SYSTEMATIC REVIEW
Giacomo Rebez*, Carmelo Morreale, Ottavia
Runti, Trieste, Italy, Tommaso Cai, Rovereto, Italy,
Michele Rizzo, Carlo Trombetta, Giovanni Liguori,
Trieste, Italy
MP46-16 INGUINAL LYMPH NODE DISSECTION
FOR PENILE CANCER: RESULTS OF A
MINIMALLY INVASIVE APPROACH FROM A
MULTICENTER DATABASE
Aldo Brassetti*, Alfredo Bove, Umberto Anceschi,
Maria Consiglia Ferriero, Salvatore Guaglianone,
Riccardo Mastroianni, Leonardo Misuraca, Gabri-
ele Tuderti, Rome, Italy, Gabriele Cozzi, Milan,
Italy, Pavel Gavrilov, Barcelona, Spain, Julian
Andres Chavarriaga, Bogota, Colombia, Gennaro
Musi, Ottavio de Cobelli, Milan, Italy, Alberto
Breda, Josep Maria Gaya Sopena, Barcelona,
Spain, Diego Camacho, Rodolfo Varela, Bogota,
Colombia, Giuseppe Simone, Rome, Italy
*Presenting author
MP46-17 HEALTH-RELATED QUALITY OF LIFE AND
TREATMENT-RELATED SIDE-EFFECTS IN
PATIENTS WHO HAVE BEEN IN REMISSION
FROM TESTICULAR CANCER FOR
12–24 MONTHS
Walter Cazzaniga*, London, United Kingdom,
Adam Pearce, Brisbane, Australia, Chandran
Tanabalan, Prabhakar Rajan, Netty Kinsella,
Alison Reid, Robert Huddart, David Nicol, London,
United Kingdom
MP46-18 HUMAN PAPILLOMAVIRUS MEDIATED
PENILE CANCER OVEREXPRESS NOTCH2
AND JAG1
Carlos Rivera-López*, San Juan, Puerto Rico,
María Sánchez-Vázquez, San Juan, Puerto Rico,
Andrés Hernández-González, San Juan, Puerto
Rico, María Marcos-Martínez, Jasmine Figueroa-
Díaz, Josue Pérez-Santiago, San Juan, Puerto
Rico, Xin Lu, Notre Dame, IN, Jad Chahoud,
Tampa, FL, Niki Zacharias, Houston, TX, Antonio
SUNDAY
Puras-Baez, San Juan, Puerto Rico, Curtis Petta-
way, Houston, TX, Magaly Martínez-Ferrer, San
Juan, Puerto Rico
MP46-19 COMBINED REPORTING OF SURGICAL
QUALITY AND CANCER CONTROL
AFTER SURGICAL TREATMENT FOR
PENILE TUMORS: THE TETRAFECTA
ACHIEVEMENT
Aldo Brassetti*, Alfredo Bove, Umberto An-
ceschi, Maria Consiglia Ferriero, Salvatore
Guaglianone, Riccardo Mastroianni, Leonardo
Misuraca, Gabriele Tuderti, Rome, Italy, Gabri-
ele Cozzi, Milan, Italy, Pavel Gavrilov, Barcelo-
na, Spain, Julian Andres Chavarriaga, Bogota,
Colombia, Gennaro Musi, Ottavio de Cobelli,
Milan, Italy, Alberto Breda, Josep Maria Gaya
Sopena, Barcelona, Spain, Diego Camacho,
Rodolfo Varela, Bogota, Colombia, Giuseppe
Simone, Rome, Italy
MP46-20 INFLUENCE OF RESISTANCE TO CISPLATIN
AND OSIMERTINIB ON PATTERNS OF
METASTATIC BEHAVIOR OF PENILE CANCER
Anita Thomas*, Shirine Huck, Kimberly Slade,
Olesya Vakhrusheva, Mainz, Germany, Martin
Michaelis, Kent, United Kingdom, Jaroslav Jinatl,
Florian Rothweiler, Frankfurt, Germany, Axel Haf-
erkamp, Eva Juengel, Mainz, Germany, Jindrich
Cinatl, Frankfurt, Germany, Igor Tsaur, Mainz,
Germany
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
187
Sunday, May 15, 2022 1:00 pm – 3:00 pm

Forums
AUA ROBOTICS THEATER SPONSORED BY INTUITIVE: SINGLE PORT ROBOTIC PROCEDURES
S&T Hall C: Booth 311 @ Ernest N. Morial Convention Center
Chair: Ashutosh Tewari
AUA ROBOTICS THEATER: SINGLE PORT
ROBOTIC PROCEDURES
Program Leaders: Simone Crivellaro, Jihad Kaouk
Panelists: Ronney Abaza, Mihit Desai Porpiglia Francesco

Sunday, May 15, 2022 1:00 pm – 3:00 pm

Podium Session 45
BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY IV
Room 252 @ Ernest N. Morial Convention Center
Moderators: Ricardo Gonzalez, Steven Kaplan & Kevin Zorn

ABSTRACT
TIME NUMBER TITLE
1:00 PD45-01 SHORT-TERM POSTOPERATIVE FUNCTIONAL
OUTCOMES OF REZÜM VS. GREENLIGHT
PVP 180W XPS: A PROPENSITY MATCH
SCORE STUDY
Iman Sadri*, David-Dan Nguyen,
Adel Arezki, Naeem Bhojani, Montreal,
Canada, Bilal Chughtai, New York, NY, Dean
Elterman, Toronto, Canada, Kevin C. Zorn,
Montreal, Canada
1:10 PD45-02 UROLIFT VERSUS REZUM FOR BENIGN
PROSTATIC HYPERPLASIA: A REAL-WORLD
SINGLE-INSTITUTION ANALYSIS
Chih Peng Chin*, Evan Garden, Krishna Ravi-
varapu, Devki Shukla, Olamide Omidele, Micah
Levy, Joseph Sewell Araya, New York, NY, Alex-
ander Small, Bronx, NY, Steven Kaplan, Robert
Valenzuela, Avinash Reddy, Susan Marshall,
Jay Motola, Craig Nobert, Mantu Gupta, Michael
Palese, New York, NY
1:20 PD45-03 THE MORBIDITY OF PROSTATIC URETHRAL
LIFTS IN THE MANAGEMENT OF BLADDER
OUTLET OBSTRUCTION FOLLOWING
RADIOTHERAPY
Monika Tedeschi*, Lauren Keenan, Gregg Eure,
Kurt McCammon, Norfolk, VA
1:30 PD45-04 CHANGE IN PROSTATE VOLUME REDUCTION
AND SYMPTOMATIC IMPROVEMENT IN
MEN TREATED WITH REZUM CONVECTIVE
WATER VAPOUR THERMAL THERAPY
Dean Elterman*, Katherine Lajkosz, Toronto,
Canada, Kevin C. Zorn, Montreal, Canada, Bilal
Chughtai, New York, NY, Naeem Bhojani,
Montreal, Canada
1:40 PD45-05 FUNCTIONAL IMPROVEMENT AND
PRESERVATION OF SEXUAL FUNCTION
3 YEARS AFTER TREATMENT WITH THE
OPTILUME BPH CATHETER SYSTEM
Steven Kaplan*, New York, NY, Merycarla Pichar-
do, Santo Domingo, Dominican Republic, Edwin
Rijo, La Romana, Dominican Republic, Ramon
Rodriguez Lay, Gustavo Espino, Panama City,
Panama, Rafael Estrella, Santiago de los Caballe-
ros, Dominican Republic
ABSTRACT
TIME NUMBER TITLE
1:50 PD45-06 URINARY AND SEXUAL OUTCOMES AFTER
AQUABLATION IN MEN WITH BENIGN
PROSTATE HYPERPLASIA: A SYSTEMATIC
REVIEW AND META-ANALYSIS
David Chen, Liang Qu, Howard Webb, Michael
Harvey, Kirby Qin, Melbourne, Australia, Sari
Khaleel, New York City, NY, Ahmed Adam, Jo-
hannesburg, South Africa, Damien Bolton, Marlon
Perera*, Melbourne, Australia
2:00 PD45-07 PROSPECTIVE COMPARISON OF
FUNCTIONAL OUTCOMES AFTER
ENDOSCOPIC SURGICAL INTERVENTIONS
FOR BENIGN PROSTATIC HYPERPLASIA: THE
ROLE OF EJACULATION-SPARING ANATOMIC
PHOTOSELECTIVE VAPORIZATION OF THE
PROSTATE (ESA-PVP)
Mattia Sibona*, Paolo Destefanis, Federico Vitiel-
lo, Eugenia Vercelli, Gabriele Montefusco, Ales-
sandro Mara, Andrea Bosio, Alessandro Bisconti,
Paolo Gontero, Turin, Italy
2:10 PD45-08 SELECTIVE MEDIAN LOBE LASER
ENUCLEATION OF THE PROSTATE:
PRESERVING SEXUAL FUNCTION WITHOUT
COMPROMISING URINARY OUTCOMES
Benjamin Press*, David Kim, New Haven, CT, Eric
Ghiraldi, Philadelphia, PA, Michael Siev, Daniel
Kellner, New Haven, CT
2:20 PD45-09 LONG TERM OUTCOME OF A RANDOMIZED
CLINICAL TRIAL COMPARING THULIUM
VAPORIZATION OF THE PROSTATE VERSUS
MONOPOLAR TURP, THE TEST OF TIME
Osama Ezzat*, Ahmed M. Elshal, Mahmoud Lay-
mon, Ahmed El-Assmy, Ahmed Shoma, Mansou-
ra, Egypt
2:30 PD45-10 OUTCOMES AFTER HOLMIUM LASER
ENUCLEATION OF THE PROSTATE, OPEN
SIMPLE PROSTATECTOMY, AND ROBOTIC
SIMPLE PROSTATECTOMY: EXPERIENCE
FROM A LARGE ACADEMIC MEDICAL
CENTER
Matthew Lee*, Meera Ganesh, Joshua Han, Quan
Mai, Mark Assmus, Jessica Helon, Chicago, IL,
Briana Kaplunov, Philadelphia, PA, Amy Kram-
beck, Chicago, IL

188
2:40 PD45-11 PERI-OPERATIVE OUTCOMES OF OPEN
VERSUS ROBOT-ASSISTED SIMPLE
PROSTATECTOMY: RESULTS FROM TWO
HIGH-VOLUME CENTRES
Simone Scarcella*, Ancona, Italy, Angelo Mot-
taran, Bologna, Italy, Carlo Andrea Bravi, Milan,
Italy, Luca Sarchi, Modena, Italy, Pietro Piazza,
Bologna, Italy, Marco Paciotti, Milan, Italy, Marco
Amato, Stefano Puliatti, Modena, Italy, Paolo
Umari, Padova, Italy, Carlo Giuloni, Giulio Milan-
ese, Lucio Dell’Atti, Daniele Castellani, Ancona, It-
aly, Edward Lambert, Jonathan Vollemaere, Dries
Develtere, Ralf Veys, Marijn Goossens, Jolien
Van der Jeugt, Ghent, Belgium, Andrea Galosi,
Ancona, Italy, Alexandre Mottrie, Aalst, Belgium
Sunday, May 15, 2022
Podium Session 46
PROSTATE CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY II
Room 255 @ Ernest N. Morial Convention Center
Moderators: James Brooks, Christopher Evans & Bal Lokeshwar
ABSTRACT
TIME NUMBER TITLE
1:00 PD46-01 THE EXPRESSION OF ANDROGEN
RECEPTOR SPLICE VARIANT 7 AT RADICAL
PROSTATECTOMY PREDICTS THE RISK
OF PROGRESSION IN UNTREATED NON-
METASTATIC PROSTATE CANCER PATIENTS
Martina Maggi*, Alessandro Sciarra, Stefano Sal-
ciccia, Alice Nicolai, Elisabetta Tortorella, Sabrina
Giantulli, Fabio Massimo Magliocca, Ida Silvestri,
Ludovica Taglieri, Susanna Cattarino, Susanna
Scarpa, Rome, Italy
1:10 PD46-02 OPTICAL GENOME MAPPING IDENTIFIES
CLINICALLY RELEVANT GENOMIC
REARRANGEMENTS IN PROSTATE CANCER
BIOPSY SAMPLE
Jong Su Lee, Yeeun Shim, Jieun Seo, Hyun-
ho Han*, Young Deuk Choi, Cheol Keun Park,
Saeam Shin, Seung-Tae Lee, Jong Rak Choi,
Seoul, Korea, Republic of
1:20 PD46-03 METASTASIS PRONE GENES IN PROSTATE
CANCER REVEALED BY TARGETED
SEQUENCING
Seung-Hwan Jeong*, Jang Hee Han, Hyeo-
ng-Dong Yuk, Chang-Wook Jeong, Hyeon-Hoe
Kim, Ja-Hyeon Ku, Cheol Kwak, Seoul, Korea,
Republic of
1:30 PD46-04 BRCA1/2 AND ATM MUTATED METASTATIC
PROSTATE CANCERS MAY PRESENT WITH
LOW SERUM PSA
Hyunho Han*, Cheol Keun Park, Nam Hoon Cho,
Jong Su Lee, Won Sik Ham, Woong Kyu Han,
Young Deuk Choi, Seoul, Korea, Republic of
1:40 PD46-05 NOVEL CYCLIN-DEPENDENT KINASE 12
(CDK12) AND PROTEIN KINASE D1 (PRKD1)
INTERACTION IN CASTRATION RESISTANT
PROSTATE CANCER CELL LINES
Victor Chalfant*, Carlos Riveros, Sanjeev Shukla,
Teruko Osumi, K.C. Balaji, Jacksonville, FL
*Presenting author
2:50 PD45-12 SEXUAL AND FUNCTIONAL OUTCOMES
AFTER TRANS-URETHRAL INCISION OF
THE PROSTATE: A LONG TERM FOLLOW UP
ANALYSIS
Riccardo Lombardo*, Antonio Maria Cicione,
Rome, Italy, Antonio Nacchia, Rionero in Vulture,
Italy, Carmen Gravina, Beatrice Turchi, Jordi
Stira, Simone D’Annunzio, Lorenzo Maria Rivesti,
Alessandro Guercio, Giorgio Guarnotta, Antonio
Franco, Giacomo Gallo, Elisa Mancini, Olivia Ales-
sandra Voglino, Valeria Baldassarri, Sara Riolo,
Andrea Tubaro, Cosimo De Nunzio, Rome, Italy
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
1:00 pm – 3:00 pm
SUNDAY
ABSTRACT
TIME NUMBER TITLE
1:50 PD46-06 SYMPTOMATIC BENIGN PROSTATIC
HYPERPLASIA WITH IMMUNE-ENRICHED
LANDSCAPES SHOW LOWER INCIDENCE
OF PROSTATE CANCER DEVELOPMENT
Nimrod Barashi Gozal*, Tiandao Li, Bo Zhang,
Charles Nottingham, Gerald Andriole, Kiran Maha-
jan, Eric Kim, Saint Louis, MO
2:00 PD46-07 THE ROLE OF B7-H4/AR MEDIATED IMMUNE
ESCAPE IN CASTRATION RESISTANCE OF
PROSTATE CANCER
Bintao Hu*, Yue Wu, Xian Wei, Huan Feng,
Jihong Liu, Tao Wang, Wuhan, China, People’s
Republic of
2:10 PD46-08 COMBINED TREATMENT WITH ULTRASOUND
AND IMMUNE CHECKPOINT INHIBITORS
FOR PROSTATE CANCER
Fuuka Hayashi*, Katsumi Shigemura, Koichi
Kitagawa, Noriaki Maeshige, Koki Maeda, Masato
Fujisawa, Kobe, Japan
2:20 PD46-09 LIPOPOLYSACCHARIDE FROM DYSBIOTIC
GUT MICROBIOTA PROMOTES
INFLAMMATORY PROSTATE CANCER
GROWTH THROUGH HISTAMINE H1
RECEPTOR SIGNALING
Makoto Matsushita*, Suita, Japan, Kazutoshi
Fujita, Osakasayama, Japan, Takuji Hayashi,
Hisako Kayama, Daisuke Motooka, Hiroaki
Hase, Toshihiko Uemura, Akinaru Yamamoto,
Gaku Yamamichi, Eisuke Tomiyama, Yoko Koh,
Taigo Kato, Koji Hatano, Atsunari Kawashima,
Motohide Uemura, Satoshi Nojima, Ryoichi Ima-
mura, Kazutake Tsujikawa, Shota Nakamura,
Kiyoshi Takeda, Eiichi Morii, Norio Nonomura,
Suita, Japan
189
2:30 PD46-10 SATURATED FATTY ACID PROMOTES
PROSTATE CANCER DEVELOPMENT WITH
TUMOR INFILTRATING REGULATORY T CELL
ALTERATION IN A PTEN-DEFICIENT MOUSE
MODEL
Hiromi Sato*, Shintaro Narita, Yoshiko Takahashi,
Masanori Ishida, Soki Kasima, Ryohei Yamamoto,
Atsushi Koizumi, Taketoshi Nara, Mingguo Huang,
Kazuyuki Numakura, Mitsuru Saito, Toshiaki
Yoshioka, Tomonori Habuchi, Akita, Japan
2:40 PD46-11 IMMUNE TRANSCRIPTOMIC REPERTOIRE
EVALUATION IN PROSTATE CANCER
PROGRESSION
Derek Van Booven*, Anastasia Vedenko, Ra-
ghuram Reddy, Himanshu Arora, Miami, FL
Sunday, May 15, 2022
Podium Session 47
SEXUAL FUNCTION/DYSFUNCTION: EVALUATION II
Room 245 @ Ernest N. Morial Convention Center
Moderators: Hossein Sadeghi-Nejad, Rachel Rubin & Nelson Bennett
ABSTRACT
TIME NUMBER TITLE
1:00 PD47-01 LOW SOCIOECONOMIC STATUS IS A RISK
FACTOR FOR ERECTILE DYSFUNCTION: AN
ANALYSIS OF NHANES DATA
Eric Macdonald*, Lake Success, NY, Joseph Kim,
Bronx, NY, Darius A. Paduch, Lake Success, NY
1:10 PD47-02 ASSOCIATION OF LOW TESTOSTERONE AND
FRAILTY AMONG VETERANS UNDERGOING
CANCER SURGERY
Matthew Hudnall*, Neil Mistry, David Bentrem, Justin
Dubin, Robert Brannigan, Joshua Halpern, Chicago, IL
1:20 PD47-03 LOW TESTOSTERONE LEVELS AND THE
RISK OF ANEMIA IN MIDDLE-AGED MEN: A
PROPENSITY SCORE–MATCHED ANALYSIS
Jun Ho Lee*, Dong-Gi Lee, Seoul, Korea, Republic of
1:30 PD47-04 ANALYZING THE IMPACT OF
TESTOSTERONE ON BONE DENSITY LOSS
Jose M. Flores*, Nicole Benfante, Elizabeth Schof-
ield, John P. Mulhall, New York, NY
1:40 PD47-05 SERUM PREDICTORS OF PITUITARY TUMOR
PRESENCE ON MRI
Jose M. Flores*, Nicole Benfante, John P. Mulhall,
New York, NY
1:50 PD47-06 DIFFERENCES IN SEXUAL ADVERSE
EFFECTS OF PREMATURE EJACULATION
MEDICATIONS RECOMMENDED BY THE
AMERICAN UROLOGICAL ASSOCIATION
IN THE FEDERAL ADVERSE EVENTS
REPORTING SYSTEM DATABASE
Michael Tram*, Brian Meyerson, Charles Welliver,
Brian Inouye, Albany, NY
190
2:50 PD46-12 PRECLINICAL STUDIES USING CISPLATIN/
CARBOPLATIN TO RESTORE THE
ENZALUTAMIDE SENSITIVITY VIA
DEGRADING THE ANDROGEN RECEPTOR
SPLICING VARIANT 7 (ARV7) TO FURTHER
SUPPRESS ENZALUTAMIDE RESISTANT
PROSTATE CANCER
Fu-Ju Chou, Yixi Hu*, ChangYi Lin, Hao Tian,
Deepak Sahasrabudhe, Jean Joseph, Edward
M. Messing, Shuyuan Yeh, Chawnshang Chang,
Rochester, NY
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
1:00 pm – 3:00 pm
ABSTRACT
TIME NUMBER TITLE
2:00 PD47-07 RATE OF PRIOR INVASIVE PELVIC
PROCEDURES, CO-DIAGNOSES, AND
TREATMENT CHOICES IN WOMEN
PRESENTING WITH DYSPAREUNIA-A UNITED
STATES CLAIMS DATABASE ANALYSIS
Kathryn Dumas*, Baltimore, MD, Corey Able,
Galveston, TX, Jaden R. Kohn, Taylor P. Kohn,
Marisa Clifton, Baltimore, MD
2:10 PD47-08 ASSOCIATION OF SEXUAL DYSFUNCTION
AND DEPRESSION IN WOMEN FOLLOWING
TRAUMATIC PELVIC FRACTURE
Helen Gambrah*, Niels Vass Johnsen, MD, MPH,
Nashville, TN
2:20 PD47-09 ANALYZING THE IMPACT OF CIRCUMCISION
ON PENILE SENSATION
Serkan Deveci*, ·Istanbul, Turkey, Jose Torre-
made, Patricia Guhring, Marilyn Parker, John P.
Mulhall, New York, NY
2:30 PD47-10 THE ATHEROSCLEROTIC CARDIOVASCULAR
DISEASE RISK SCORE IS A RELIABLE
TOOL TO IDENTIFY PATIENTS WITH
ARTERIOGENIC ERECTILE DYSFUNCTION AT
DYNAMIC PENILE COLOR DOPPLER DUPLEX
ULTRASOUND–FINDINGS FROM A REAL-LIFE
CROSS-SECTIONAL STUDY
Edoardo Pozzi*, Massimiliano Raffo, Milan,
Italy, Paolo Capogrosso, Varese, Italy, Giuseppe
Fallara, Federico Belladelli, Christian Corsini,
Daniele Cignoli, Luigi Candela, Nicolò Schifano,
Alessia d’Arma, Luca Boeri, Eugenio Ventimiglia,
Rayan Matloob, Milan, Italy, Vincenzo Mirone,
Naples, Italy, Francesco Montorsi, Andrea Salo-
nia, Milan, Italy
2:40 PD47-11 YOUNG MEN WITH REFRACTORY ERECTILE
DYSFUNCTION SHOULD UNDERGO A PENILE
DUPLEX ULTRASOUND
Aaron Smith*, Bruce Gilbert, New Hyde Park, NY
Sunday, May 15, 2022
Podium Session 48
PEDIATRIC UROLOGY: GENITALIA, UPPER & LOWER URINARY TRACT
Room 244 @ Ernest N. Morial Convention Center
Moderators: Briony Varda & Pankaj Dangle
ABSTRACT
TIME NUMBER TITLE
1:00 PD48-01 SAFETY AND EFFICACY OF FLUOXETINE,
SELECTIVE SEROTONIN REUPTAKE
INHIBITOR, FOR THE TREATMENT
OF REFRACTORY PRIMARY
MONOSYMPTOMATIC NOCTURNAL
ENURESIS IN CHILDREN: A RANDOMIZED
PLACEBO-CONTROLLED STUDY
Mohamed Hussiny*, Ahmed Abdelhalim, Abdel-
wahab Hashem, Mohamed A. Soltan, Mahmoud
R.El-Kenawy, Tamer Helmy, Mansoura, Egypt
1:10 PD48-02 IS THE THULIUM FIBER LASER SUPERIOR
TO THE LOW-POWER HO:YAG LASER FOR
URETEROSCOPY IN CHILDREN?
Christopher Jaeger*, Caleb Nelson, Bartley Cilen-
to, Tanya Logvinenko, Michael Kurtz, Boston, MA
1:20 PD48-03 HOW FAR SHOULD WE EXPLORE
HYPOSPADIAS? NEXT-GENERATION
SEQUENCING APPLIED TO A LARGE
COHORT OF HYPOSPADIAC PATIENTS
Nicolas Kalfa*, Anne Bergougnoux, Pascal
Philibert, Nadège Servant-Fauconnet, Montpell-
ier, France, Alice Faure, Marseille, France, Jean
Breaud, Nice, France, Laura Gaspari, Charles
Sultan, Françoise Paris, Vuthy Ea, Montpellier,
France
1:30 PD48-04 RECURRENT CURVATURE AFTER
CORPOROPLASTY WITH TUNICA
VAGINALIS FLAP: AN ANALYSIS OF
BOYS WHO UNDERWENT VENTRAL
PENILE LENGTHENING FOR PROXIMAL
HYPOSPADIAS
Kathy Huen*, Amanda Macaraeg, Carol Da-
vis-Dao, Sarah Holzman, Timothy Boswell, Zayn
Suhale, Kai-Wen Chuang, Heidi Stephany, Elias
Wehbi, Antoine Khoury, Orange, CA
1:40 PD48-05 SHORT- AND LONG-TERM OUTCOMES OF
SMALL INTESTINAL SUBMUCOSA FOR
CORPOREAL BODY GRAFTING IN PATIENTS
WITH PROXIMAL HYPOSPADIAS AND
SEVERE CHORDEE
Maria Camila Suarez*, Christian Guevara, Daniel
Nassau, Andrew Labbie, Andrew Ransford,
Alireza Alam, Miguel Castellan, Rafael Gosalbez,
Miami, FL
*Presenting author
2:50 PD47-12 PREDICTING MAJOR ISCHEMIC PRIAPISM:
A NOVEL DYNAMIC NOMOGRAM BASED
ON RECURRENT ISCHEMIC PRIAPISM RISK
FACTORS
Laurence Hou*, Hackensack, NJ, Yuezhou Jing,
Bruce Trock, Arthur Burnett, Baltimore, MD
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
1:00 pm – 3:00 pm
ABSTRACT
SUNDAY
TIME NUMBER TITLE
1:50 PD48-06 MEAN TRANSIT TIME: A NOVEL MARKER
TO IDENTIFY OBSTRUCTIVE UROPATHY IN
THE SETTING HYDRONEPHROSIS USING
FUNCTIONAL MAGNETIC RESONANCE
UROGRAPHY
Karmon Janssen, Richard Jones, Damien
Grattan-Smith, Andrew Kirsch, Jennifer Lovin*,
Atlanta, GA
2:00 PD48-07 PEDIATRIC PYELOPLASTY AND
PERIOPERATIVE URETHRAL CATHETER:
WHAT ARE THE BENEFITS?
Maria Camila Suarez*, Sirpi Nackeeran, Daniel E.
Nassau, Alireza Alam, Rafael Gosalbez, Miguel
Castellan, Miami, FL
2:10 PD48-08 PREDICTORS OF RESOLUTION OF
HYDRONEPHROSIS AFTER PYELOPLASTY IN
CHILDREN. WILL IT GO AWAY?
Mohamed Soltan*, Ahmed Abdelhalim, Mohamed
Edwan, Ahmed Elkashef, Ahmed Atwa, Mohamed
Abou-El Ghar, Tamer Helmy, Ashraf Tarek,
Mohamed Dawaba, Ahmed Shokier, Mansoura,
Egypt
2:20 PD48-09 IS THERE AN OPTIMAL WAY TO MEASURE
RENAL FUNCTION IN PRUNE BELLY
SYNDROME?
Shane Batie*, Samuel Gold, Shaheer Ali, Daniel
Wong, Niccolo Passoni, Steven Harrison, Nida
Karra, Nathalia Amado, Jyothsna Gattineni, Linda
Baker, Dallas, TX
2:30 PD48-10 TESTICULAR TRANSCRIPTOME ANALYSIS
REVEALS POTENTIAL GENES ASSOCIATED
WITH ENDOCRINE SYSTEM IN A MOUSE
MODEL OF COMPENSATED TESTICULAR
HYPERTROPHY
Daniel E. Nassau*, Alexandra Dullea, Eliyahu
Kresch, Vinayak Madhusoodanan, Shathiyah
Kulandavelu, Miguel Castellan, Himanshu Arora,
Ranjith Ramasamy, Miami, FL
2:40 PD48-11 DECISIONAL CONFLICT IN PARENTS
REGARDING NEWBORN CIRCUMCISION
Hannah Botkin*, Denise Juhr, Douglas Storm,
Christopher Cooper, Gina Lockwood, Iowa City, IA
191
2:50 PD48-12 NEWBORN CIRCUMCISIONS BY APPROVED FOR AMA PRA CATEGORY 2
NON-UROLOGIST: CIRCUMCISION CREDITSTM
COMPLICATIONS REQUIRING SURGICAL
REVISION
Abdul Qadar*, Michael Anderson, Oklahoma City,
OK, Oren Miller, Tulsa, OK, Bahar Iranpour Brou-
jeni, Adam Rensing, Bhalajee Meenakshi Sundar-
am, Dominic Frimberger, Oklahoma City, OK

Sunday, May 15, 2022 1:00 pm – 3:00 pm

Video Session 9
BLADDER & UROTHELIAL UPPER TRACT ONCOLOGY
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Richard Matulewicz & Matthew Kaag

ABSTRACT
TIME NUMBER TITLE
1:00 V09-01 THULIUM FIBER LASER EN BLOC
RESECTION FOR BLADDER TUMOUR. TIPS
AND TRICKS
Dmitry Enikeev*, Andrey Morozov, Mark Taratkin,
Diana Babaevskaya, Roman Sukhanov, Petr
Glybochko, Moscow, Russian Federation
1:10 V09-02 THULIUM FIBER LASER FOR BLADDER
LEIOMYOMA TREATMENT
Alim Dymov*, Evgeny Shpot, Alexandra Proskura,
Roman Sukhanov, Vladimir Lekarev, Temirlan
Karakotov, Yuliya Lee, Leonid Rapoport, Moscow,
Russian Federation
1:20 V09-03 A NOVEL APPLICATION OF THE HOLMIUM
LASER: EN BLOC RESECTION OF
INTRAURETERAL UROTHELIAL CARCINOMA
Tavya Benjamin*, New Hyde Park, NY, Zachary
Kozel, Bethesda, MD, Ryan Margolin, New York,
NY, Daniel Sagalovich, Staten Island, NY
1:30 V09-04 URETERAL STRICTURE PREVENTION
THROUGH A MULTI-MODAL INTERVENTION
FOR ROBOTIC INTRACORPOREAL ILEAL
CONDUIT URINARY DIVERSION
Shu Wang*, Ryan Russell, Michael Phelan, M.
Minhaj Siddiqui, Baltimore, MD
1:40 V09-05 NOVEL TECHNIQUE FOR INJECTION OF
LIPIODOL AS FIDUCIAL MARKER FOR
RADIOTHERAPY TREATMENT IN BLADDER
CANCER
Aoife McVey*, Elvira Polo Alonso, Olivia Fraser,
Daryl Lim Joon, Gregory Jack, Melbourne, Aus-
tralia
1:50 V09-06 PROSTATE-CAPSULE SPARING
RADICAL CYSTECTOMY WITH MODIFIED
W-POUCH ORTHOTOPIC NEOBLADDER
RECONSTRUCTION
Christopher Dall*, Charlotte Goldman, James
Mason, Lisa Chuong, Keith Kowalczyk, Lambros
Stamatakis, Ross Krasnow, Washington, DC
2:00 V09-07 ROBOTIC PROSTATE-SPARING CYSTECTOMY
Sharon White*, Denver, CO, Xavier Glover, Janet
Kukreja, Aurora, CO
ABSTRACT
TIME NUMBER TITLE
2:10 V09-08 IMPLEMENTATION OF ROBOTIC RADICAL
CYSTECTOMY WITH INTRACORPOREAL
NEOBLADDER RECONSTRUCTION: STEP-BY-
STEP TECHNIQUE
Maria Sighinolfi*, Simone Assumma, Elena Morini,
Modena, Italy, Alberto Del Nero, Igor Piacentini,
Barbara Mangiarotti, Matteo Maggioni, Stefano
Picozzi, Milano, Italy, Giorgio Bozzini, Como, Italy,
Stefano Puliatti, Salvatore Micali, Modena, Italy,
Bernardo Rocco, Milano, Italy
2:20 V09-09 ROBOTIC RADICAL CYSTECTOMY WITH
INTRACORPOREAL ILEAL CONDUIT:
SURGICAL TECHNIQUE, PERIOPERATIVE,
FUNCTIONAL AND ONCOLOGIC OUTCOMES
Leonardo Misuraca*, Gabriele Tuderti, Umberto
Anceschi, Riccardo Mastroianni, Aldo Brassetti,
Mariaconsiglia Ferriero, Alfredo Maria Bove, Sal-
vatore Guaglianone, Michele Gallucci, Giuseppe
Simone, Rome, Italy
2:30 V09-10 NEWLY ESTABLISHED APPROACH OF AN
ENTIRELY RETROPERITONEAL ROBOTIC
NEPHROURETERECTOMY
Peter Sparwasser*, Stefan Epple, Anita Thomas,
Robert Dotzauer, Katharina Böhm, Maximilian
Peter Brandt, Kamal Gheith, Rene Mager, Martin
Kurosch, Hendrik Borgmann, Thomas Höfner,
Axel Haferkamp, Igor Tsaur, Mainz, Germany
2:40 V09-11 NOVEL USE OF THE DAVINCI SINGLE PORT
ROBOT IN NEPHROURETERECTOMY OF A
HORSESHOE KIDNEY
John Sheng*, Chrystal Chang, Newark, NJ, Mi-
chael Stifelman, Mutahar Ahmed, Hackensack, NJ
2:50 V09-12 SINGLE PORT MODIFIED PARTIAL
NEPHRECTOMY: NOVEL TECHNIQUE FOR
SIMULTANEOUS ACCESS TO PERITONEAL
AND RETROPERITONEAL PARTIAL
NEPHRECTOMY
Mubashir Billah, Fahad Sheckley*, Tanner Corse,
Nathan Cheng, Hackensack, NJ, David Ali,
Newark, NJ, Michael Stifelman, Gregory Lovallo,
Mutahar Ahmed, Hackensack, NJ
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM

192
Sunday, May 15, 2022 1:00 pm – 3:00 pm
LATE-BREAKING ABSTRACT I – CANCER & BPH
Room 243 @ Ernest N. Morial Convention Center

ABSTRACT
TIME NUMBER TITLE
1:00 LBA01-01 HARM-TO-BENEFIT OF THREE
DECADES OF PROSTATE CANCER
SCREENING IN BLACK MEN
Spyridon Basourakos, Roman Gulati, Randy
Vince, Daniel Spratt, Patrick Lewicki, Alexander
Hill, Yaw Nyame, Jennifer Cullen, Sarah Markt,
Christopher Barbieri, Jim Hu, Jonathan Shoag
1:10 LBA01-02 EFFICACY OF LOW-POWER THULIUM LASER
ENUCLEATION OF PROSTATE LARGER THAN
80 GRAMS
Samer Morsy, Islam Kamal, Alaa Meshref, Ahmed
Yehia, Mahmoud Abdel-Hakim
1:20 LBA01-03 A PROSPECTIVE STUDY OF SINGLE-PORT
ABSTRACT
TIME NUMBER TITLE
2:00 LBA01-07 OVERALL SAFETY AND INCIDENCES OF
ADVERSE EVENTS BY TIME INTERVAL
WITH DAROLUTAMIDE PLUS ANDROGEN-
DEPRIVATION THERAPY AND DOCETAXEL IN
THE PHASE 3 ARASENS TRIAL
E. David Crawford, Matthew R. Smith, Bertrand
Tombal, Karim Fizazi, Maha Hussain, Cora N.
Sternberg, Arash Rezazadeh Kalebasty, Ronald
Tutrone, Neal D. Shore, Laurence Belkoff, Silke
Thiele, Rui Li, Iris Kuss, Heikki Joensuu, Fred
Saad
2:10 LBA01-08 INTERIM ANALYSIS OF PADRES (PRIOR
AXITINIB AS A DETERMINANT OF OUTCOME

SUNDAY
OF RENAL SURGERY NCT03438708)
VERSUS MULTI-PORT PATIENT REPORTED
CLINICAL TRIAL
SURGICAL OUTCOMES
Kevin Hakimi, Steven Campbell, Mimi Nguyen,
Luca Morgantini, Matthew Del Pino, Arthi Bharad-
Nityam Rathi, Luke Wang, Brian Rini, Moshe
waj, Erin Egan, Ashwin Ganesh, Ahmad Alzein,
Ornstein, Rana McKay, Ithaar Derweesh
Simone Crivellaro
2:20 LBA01-09 INTERIM ANALYSIS NCT04046094: IV
1:30 LBA01-04 ARTIFICIAL INTELLIGENCE PET
VITAMIN C WITH CHEMOTHERAPY FOR
INTERPRETATION VS HUMAN SPECIALISTS.
CISPLATIN INELIGIBLE BLADDER CANCER
LATAM STUDY
PATIENTS (CI-MIBC)
Danny Mena, Diego Barreiro, Federico Losco,
John Taylor, Rahul Parikh, Qi Chen, Benjamin
Andres Lopez-Cortes, Juan Pablo Sade
Woolbright, Ping Chen, Elizabeth Wulff-Burch-
1:40 LBA01-05 SURGICAL TREATMENT OF LOWER URINARY field, Jeff Holzbeierlein, Jane Ledesma, Roy
TRACT SYMPTOMS DUE TO BENIGN Jensen, Jeanne Drisko
PROSTATIC ENLARGEMENT BY HOLMIUM
2:30 LBA01-10 INTERIM RESULTS FROM A PHASE 1B CLINICAL
LASER ENUCLEATION OF THE PROSTATE
TRIAL EVALUATING TOLERABILITY AND ACTIVITY
VERSUS TRANSURETHRAL RESECTION OF
OF FGFR INHIBITION IN LOCALIZED UPPER TRACT
THE PROSTATE AND OPEN ADENOMECTOMY
UROTHELIAL CARCINOMA (UTUC)
Miguel Beltran, Yoni Pallas , Ivan Povo, Sara
Surena Matin, Mehrad Adibi, Amishi Shah,
Mitjana, Kevin Rechi, Marta Diranzo, Fernando
Omar Alhalabi, Paul Corn, Charles Guo,
Martinez, Rosa Gras, Emilio Lopez
Rhenita Amirtharaj, Marisa Lozano, Lianchun
Xiao, Sumanta Pal, Matthew Campbell
1:50 LBA01-06 LONG TERM FOLLOW-UP OF AN
INTERNATIONAL MULTICENTER
PROSPECTIVE STUDY IN APPLICATION
OF TEMPORARY IMPLANTABLE NITINOL
DEVICE (ITIND) IN MEN WITH LOWER
URINARY TRACT SYMPTOMS FOR BPH
Daniele A, Sabrina De Cillis, Cristian Fiori, Gregor
Kadner, Claude Schulman, Francesco Porpiglia

Sunday, May 15, 2022 1:00 pm – 3:00 pm

Forums
RESEARCH FORUM: EARLY CAREER INVESTIGATORS SHOWCASE
Room 344 @ Ernest N. Morial Convention Center

Sunday, May 15, 2022 1:00 pm – 3:00 pm

GERIATRIC UROLOGICAL SOCIETY (GUS)
Room 353 @ Ernest N. Morial Convention Center
1:00 WELCOME AND INTRODUCTIONS 1:05
AGING AND BLADDER HEALTH: A CLINICAL
Society President: Tomas Griebling CASE-BASED DISCUSSION
Moderator: Alexander Gomelsky
Panelists: Ryan Krlin, Elizabeth Rourke, J. Christian Winters

*Presenting author 193

1:45 PARKINSON’S DISEASE AND THE IMPACT ON 2:45 RESEARCH ROUNDTABLE
UROLOGIC HEALTH IN OLDER ADULTS Moderator: Ananias Diokno
E.Camille Vaughan
CHEMODENERVATION WITH INTRAVESICAL
2:00 AGING-ASSOCIATED LOWER URINARY TRACT INJECTION IN OLDER ADULTS
(LUT) DYSFUNCTION INVOLVES ALTERED PU- Michael Basin
RINE METABOLISM
IMPROVEMENT IN OVERACTIVE BLADDER SYMP-
Lori Birder
TOMS FOLLOWING DIFFERENT PROSTATEC-
2:15 CANCER SURVIVORSHIP IN OLDER UROLOGIC TOMY PROCEDURES: COMPARISON BETWEEN
PATIENTS: ISSUES AFTER PELVIC RADIATION HOLEP, PVP AND TURP
Bernadette Zwaans Mostafa Mostafa
2:30 TESTOSTERONE TREATMENT FOR Q&A
HYPOGONADISM AND AGING-RELATED
APPROVED FOR AMA PRA CATEGORY 1
PROSTATE GLAND DISEASES: EVIDENCE-BASED
CREDIT™
NEW APPROACH
Ananias Diokno

Sunday, May 15, 2022 1:00 pm – 3:30 pm

ENGINEERING AND UROLOGY SECTION OF THE ENDOUROLOGY SOCIETY (EUS) POSTER SESSION
Grand Salon @ Hilton New Orleans Riverside
1:00 EUS POSTER SESSION 1 2:30 EUS POSTER SESSION 2
Moderators: Zhamshid Okhunov, Arun Rai Moderators: Alexa Meyer, TBD

Sunday, May 15, 2022 1:00 pm – 3:30 pm

SOCIETY FOR INFECTION AND INFLAMMATION (SIIU)
Rivergate Room @ Ernest N. Morial Convention Center
Chairs: Michel Pontari & Kymora Scotland
1:00 OVERVIEW OF MAPP HIGHLIGHTS 2:20 NIH OVERVIEW OF FUTURE PELVIC
PAIN STUDIES
OVERVIEW
Chris Mullins
Quentin Clemens
DISCUSSION
REVIEW MAJOR NEURO FINDINGS
Jason Kutch 2:45 ABSTRACT PRESENTATIONS
FOCUS ON BIOMARKER STUDIES 3:15 BUSINESS MEETING
2:00
DISCUSSION: WHERE THE FIELD OF PELVIC PAIN
NEEDS TO GO
Discussants: A. Ackerman, Karl Kreder, J. Curtis Nickel
Larissa Rodriguez

Sunday, May 15, 2022 1:00 pm – 5:00 pm

R. FRANK JONES UROLOGICAL SOCIETY (RFJUS)
Jackson Room @ Hilton New Orleans Riverside
1:00 WELCOME
Society President: Linda McIntire
AUA President: Raju Thomas
1:15 AUA UPDATE ON DIVERSITY AND INCLUSION
Efe Ghanney Simons
1:25 MENTORSHIP IN UROLOGY FOR BLACK WOMEN
Shenelle Wilson
1:35 KEYNOTE: RECONCILING WORK-LIFE BALANCE
WITH PROMOTION AND GENDER PAY EQUITY
IN ACADEMIC LEADERSHIP ROLES: WHAT ARE
THE UNIQUE CHALLENGES BLACK WOMEN FACE
AND HOW TO OVERCOME THEM?
Keynote Speaker: O. Lenaine Westney
1:55 ROUND TABLE DISCUSSION
Moderator: Emilie Johnson
Panelists: Elodi Dielubanza, Cheryl Lee,
O. Lenaine Westney, Tracey Wilson
2:45 JOURNAL CLUB
Moderators: Denise Asafu-Adjei, J. Curtis Nickel
Kymora Scotland
THE FUTURE IS FEMALE: UROLOGY WORK-
FORCE PROJECTION FROM 2020 TO 2060
Ashanda Esdaille
RISING TIDES: CHALLENGES AND
OPPORTUNITIES FOR WOMEN IN THE
UROLOGIC WORKFORCE
Onika Noel
THE GENDER PAY GAP IN UROLOGY
Oluwarotimi Nettey

194
 GENDER AND RACIAL DISPARITIES IN EAR- Moderators: Denise Asafu-Adjei, Kymora Scotland
LY UROLOGY EXPOSURES DURING MEDICAL Panelists: Kirsten Greene, Kate Kraft, Amanda North,
SCHOOL Simone Thavaseelan, Hadley Wood
Efe Ghanney Simons
APPROVED FOR AMA PRA CATEGORY 1
3:30 ROUND TABLE DISCUSSION OF JOURNAL CREDITTM
ARTICLES

Sunday, May 15, 2022 1:00 pm – 5:00 pm

SOCIETY FOR THE STUDY OF MALE REPRODUCTION (SSMR)
LaNouvelle Orleans Ballroom B @ Ernest N. Morial Convention Center
1:00 INTRODUCTION 3:00 SESSION 3: KEYNOTE SPEAKER – THE IMPACT
James Smith OF SYSTEMIC RACISM ON MALE INFERTILITY
PATIENTS AND PRACTICES
1:10 SESSION 1: STARTING WITH THE PATIENT
Moderator: David Shin
Moderator: James Smith
KEYNOTE LECTURE
A PATIENT’S PERSPECTIVE ON HAVING INFER-
Keynote Speaker: Tracy Downs
TILITY NOW AND WHAT’S NEEDED FOR THE
FUTURE BUILDING MALE INFERTILITY PRACTICES THAT

SUNDAY
Jacob Anderson-Bialis SUPPORT OUR MULTICULTURAL PATIENTS
Tolulope Bakare
Q&A
Q&A
1:25 SESSION 2: DEBATE-THE IMPACT OF COVID-19
ON MALE REPRODUCTIVE HEALTH AND OUR 4:00 SESSION 4: MALE INFERTILITY CARE IN 2026
PRACTICES AND BEYOND: WHERE DO WE NEED TO GO AND
Moderator: James Dupree HOW DO WE GET THERE?
Moderator: Christopher Deibert
DEBATE #1: THE SARS-COV-2 VIRUS HAS A NEG-
ATIVE IMPACT ON SPERMATOGENESIS, MALE ADVANCED DIAGNOSTICS: WHAT’S COMING AND
REPRODUCTIVE HEALTH, AND OFFSPRING WHAT’S NEEDED?
Debater-Pro: Ranjith Ramasamy Dolores Lamb
Debater-Con: James Hotaling
ADVANCED THERAPEUTICS: WHAT’S COMING
DEBATE #2: TELEMEDICINE CAN REPLACE AND WHAT’S NEEDED?
IN-PERSON CLINIC VISITS BECAUSE MALE IN- Kathleen Hwang
FERTILITY CARE DOES NOT REQUIRE A PHYSI-
SSMR/SMRU WHITE PAPER: PRODUCTIVITY
CAL EXAM
METRICS AND THREATS TO SOCIETY
Debater-Pro: Akanksha Mehta
James Dupree
Debater-Con: Sarah Vij
PANEL DISCUSSION AND Q & A
PANEL DISCUSSION AND Q & A
APPROVED FOR AMA PRA CATEGORY 1
2:45 BREAK
CREDITTM

Sunday, May 15, 2022 1:00 pm – 5:00 pm

UROLOGIC SOCIETY FOR TRANSPLANTATION & RENAL SURGERY (USTRS)
Room 355 @ Ernest N. Morial Convention Center
1:00 RECEPTION WITH EXHIBITORS - VIEWING AND
JUDGING OF POSTERS (NON-CME)
1:20 PRESIDENT WELCOME - ANNOUNCEMENT OF
BARRY INAUGURAL TRAVELING FELLOWSHIP
1:25 ROBOTIC AUTOTRANSPLANTATION: ‘THE NO
INCISION TRANSPLANT’
Alberto Breda
1:45 ROBOTIC PROSTATECTOMY/CYSTECTOMY
FOLLOWING RENAL TRANSPLANTATION
Obi Ekwenna
2:05 TRUE MIRACLES: TRANSPLANTING KIDNEYS IN
THE THIRD WORLD
Kamrul Islam
2:25 POSTER PRESENTATIONS
2:55 BREAK WITH EXHIBITORS–POSTER
PRESENTATION AWARDS
3:15 GIVING OUT ‘VOUCHERS’ FOR FUTURE KIDNEY
TRANSPLANTATIONS
Jeffrey Veale
3:55 NOVICK RESIDENT PRESENTATIONS
 SE OF RIGHT KIDNEYS VERSUS LEFT KIDNEYS
U
IN LIVING-DONOR ROBOT-ASSISTED KIDNEY
TRANSPLANTATION: A COMPARATIVE ANALYSIS
Arnau Abella
ROBOTIC SURGERY TO SOLVE URINARY TRACT
COMPLICATIONS AFTER KIDNEY TRANSPLANTA-
TION
Pol Sanz-Serra

*Presenting author 195

 RECIPIENTS WITH ABNORMAL URINARY TRACT: 4:30 NOVICK WINNER AWARD – BUSINESS MEETING
EXPERIENCE IN OUR TERTIARY CARE CENTER
APPROVED FOR AMA PRA CATEGORY 1
Victor Javier Tames Chacon
CREDITTM
CAN WE PREDICT DELAYED GRAFT FUNCTION
AND GRAFT SURVIVAL RATE USING HYPOTHER-
MIC MACHINE PERFUSION PARAMETERS FROM
DONORS AFTER CARDIAC DEATH?
Juliano Offerni

Sunday, May 15, 2022 1:00 pm – 5:00 pm

Forums
QUALITY IMPROVEMENT SUMMIT
Room 349 @ Ernest N. Morial Convention Center

QUALITY IMPROVEMENT SUMMIT: LAYING THE 2:40 BREAK
FOUNDATION FOR PRIMARY PALLIATIVE CARE
2:50 WHAT CLINICAL INNOVATIONS AND OTHER IN-
IN UROLOGY
TERVENTIONS ARE NEEDED?
Chairs: Jonathan Bergman, John Gore,
Moderators: Joshua Hauser, Karl Lorenz
Matthew Nielsen
Panelists: icheal Darson, Jaime Goldberg, Kevin Koo,
1:00 WELCOME AND INTRODUCTION Kelvin Moses, Desiree Sanchez
Chairs: John Gore, Jonathan Bergman,
DISCUSSION/Q & A
Matthew Nielsen
3:30 BREAK
1:25 GROWING PERIOPERATIVE PALLIATIVE CARE IN
THE VETERANS AFFAIRS HEALTH CARE SYSTEM 3:40 WHAT OUTCOMES SHOULD WE TRACK?
Scott Shreve, Karleen Giannitrapani Moderators: Pauline Filippou, John Gore,
Panelists: Lee Hugar, John Leppert, Karl Lorenz,
1:55 OPTIMAL STATE OF PALLIATIVE CARE IN UROLO-
Charles Scales, Anne Suskind
GY & HOW CAN WE OPERATIONALIZE A PRIMA-
RY PALLIATIVE CARE MODEL? DISCUSSION/Q & A
Moderators: Jonathan Bergman, Martha Terris
4:45 CONCLUSION
Panelists: Katherine Fero, Scott Gilbert, Jaime Goldberg,
Jonathan Bergman, John Gore
Bruce Jacobs, Farnoosh Nik-Ahd
APPROVED FOR AMA PRA CATEGORY 1
DISCUSSION/Q & A
CREDITTM

Sunday, May 15, 2022 2:00 pm – 5:00 pm

Forums
BLADDER CANCER FORUM
LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention Center
2:00 INTRODUCTION 3:00 CASE-BASED DEBATE: DO I NEED TO DO REPEAT
Chairs: Ashish Kamat, Sima Porten TUR FOR ALL HIGH GRADE NMIBC PATIENTS?
Moderator: Neal Shore
2:05
CASE-BASED DEBATE: IS ACTIVE SURVEIL-
Debater-Pro: Trinity Bivalacqua
LANCE VALID OPTION FOR 57 YEAR OLD PA-
Debater-Con: Fred J. Witjes
TIENT WITH RECURRENT TALG TUMORS, SMALL
SIZE, NEGATIVE CYTOLOGY? 3:20 STATE-OF-THE-ART LECTURES
Moderator: Mark Soloway
BCG UNRESPONSIVE DISEASE
Debater-Pro: Wes Kassouf
Seth Lerner
Debater-Con: Juan Palou
TIMING OF RADICAL CYSTECTOMY IN BCG UN-
2:25
CASE-BASED DEBATE: SHOULD VARIANT
RESPONSIVE DISEASE
HISTOLOGY CHANGE THE MANAGEMENT OF
Patrick Hensley
BLADDER CANCER?
Moderator: Peter Black DISCUSSANT
Debater-Pro: Mario Fernandez Roger Li
Debater-Con: Michael O’Donnell
3:35 STATE-OF-THE-ART LECTURE: SYSTEMIC THER-
2:45 STATE-OF-THE-ART LECTURE: IBCG MASTER APY FOR MUSCLE INVASIVE BLADDER CANCER
CLASS ON TURBT (NON METASTATIC)
Arnulf Stenzl Matthew Galsky
DISCUSSANT DISCUSSANT
Sarah Psutka Stephen B. Williams

196
3:50
CASE-BASED DEBATE: IN PATIENT WITH PURE 4:30
CASE PRESENTATION: IS THERE A ROLE OF
T2 UC, PDL1-HIGH, GFR 60 DO I NEED NEOADJU- RADICAL CYSTECTOMY IN CN1-2 DISEASE?
VANT THERAPY? Moderator: Kamal Pohar
Moderator: Siamak Daneshmand Debater-Po: Brant Inman
Debater-Pro: Shilpa Gupta Debater-Con: Yair Lotan
Debater-Con: Arlene Siefker-Radtke
4:50 CLOSING REMARKS
4:10
CASE PRESENTATION: DO WE NEED TO PER- Chairs: Ashish Kamat, Sima Porten
FORM RADICAL CYSTECTOMY FOR PATIENT
APPROVED FOR AMA PRA CATEGORY 1
WHO IS CT0 AFTER NEOADJUVANT CHEMO-
CREDITTM
THERAPY?
Moderator: Angela Smith
Debater-Pro: Gary Steinberg
Debater-Con: John Taylor

Sunday, May 15, 2022 2:00 pm – 5:00 pm

BRITISH ASSOCIATION OF UROLOGICAL SURGEONS/BJU INTERNATIONAL/UROLOGICAL SOCIETY OF AUSTRALIA

SUNDAY
AND NEW ZEALAND/SCANDINAVIAN ASSOCIATION OF UROLOGY (BAUS/BJUI/USANZ/SCAUR)
Jefferson Ballroom @ Hilton New Orleans Riverside
2:00
NEXT GENERATION SCREENING FOR PROSTATE SESSION INTRODUCTION
CANCER
3:45 NATURAL HISTORY OF SMALL ASYMPTOMATIC
Chair: Alastair Lamb
KIDNEY AND RESIDUAL STONES (BJUI
SESSION INTRODUCTION SPONSORED USANZ SPEAKER)
Nadya York
2:05 A COMBINATION OF BIOMARKERS AND MRI:
TARGETED OR STANDARD BIOPSY IN PROSTATE 4:10 TOWARD IMPROVED ENDOSCOPIC EXAMINA-
CANCER SCREENING TION OF URINARY STONES: A CONCORDANCE
STUDY BETWEEN ENDOSCOPIC DIGITAL
2:30 PROSTAGRAM MRI: THE FUTURE OF PROSTATE
PICTURES VS MICROSCOPY (BJUI SPONSORED
CANCER SCREENING
SPEAKER)
Hashim Ahmed
Olivier Traxer
2:55 SMARTER SCREENING: LIQUID MARKERS FIRST,
4:35 UTILITY OF BLOOD TESTS IN SCREENING FOR
IMAGING SECOND
METABOLIC DISORDERS IN KIDNEY STONE
Matthew Cooperberg
DISEASE (BJUI SPONSORED BAUS SPEAKER)
3:20 AFTERNOON TEA Sarah Howles
3:40 THE STONY WAY TO SUCCESS 4:55 BJUI AMERICAS AWARD
Chair: Palle Osther
APPROVED FOR AMA PRA CATEGORY 1
CREDITTM

Sunday, May 15, 2022 2:00 pm – 6:00 pm

SOCIEDAD ARGENTINA DE UROLOGÍA (SAU)
Room 345 @ Ernest N. Morial Convention Center
Chairs: Miguel Costa & Carlos Scorticati
Moderators: Gerardo Perazzo & Antonio Villamil
2:00 APERTURA (OPENING) 2:50 NOVEDADES EN TERAPIA INTRACAVERNOSA
PARA DISFUNCIÓN SEXUAL (NEWS IN INTRA-
2:10 EL CAMINO HACIA LA CIRUGÍA PERCUTÁNEA
CAVERNOUS THERAPY FOR SEXUAL
IDEAL (THE ROAD TO THE IDEAL
DYSFUNCTION)
PERCUTANEOUS SURGERY)
Adrián Momesso
Norberto Bernardo
3:10 MANEJO CONSERVADOR DEL CARCINOMA DEL
2:30 ENUCLEACIÓN PROSTÁTICA AMBULATORIA:
TRACTO URINARIO SUPERIOR (CONSERVATIVE
¿ES POSIBLE? (AMBULATORY PROSTATIC
MANAGEMENT OF UPPER URINARY TRACT
ENUCLEATION: IS IT POSSIBLE?)
CARCINOMA)
Mariano González
Pablo Contreras
3:30 BREAK

*Presenting author 197

4:00 SITUACIONES COMPLEJAS EN CIRUGÍA 5:00 ACTUALIZACIÓN EPIDEMIOLÓGICA EN CÁNCER
RECONSTRUCTIVA GENITAL (COMPLEX DE PENE (UPDATE ON EPIDEMIOLOGY IN
SITUATIONS IN GENITAL RECONSTRUCTIVE PENILE CANCER)
SURGERY) Carlos Palazzo
Javier Belinky
5:20 PRTU COMO TRATAMIENTO FOCAL PARA EL
4:20 ESTRECHEZ PANURETRAL: UN DESAFÍO PARA CÁNCER DE PRÓSTATA (TURP AS FOCAL
EL URÓLOGO-CUÁNDO EMBARCARSE EN TREATMENT FOR PROSTATE CANCER)
CIRUGÍAS COMPLEJAS (PAN-URETHRAL Diego Barreiro
STRICTURES: A CHALLENGE FOR THE
5:40 CONCLUSIONES Y CIERRE DEL SIMPOSIO
UROLOGIST-WHEN TO EMBARK IN COMPLEX
(CONCLUSIONS AND CLOSING OF THE
SURGERIES)
SYMPOSIUM)
Leandro Capiel
4:40 MANEJO CONSERVADOR DE LESIONES
RENALES PEQUEÑAS (CONSERVATIVE
MANAGEMENT OF SMALL RENAL LESIONS)
Gabriel Moncalvo

Sunday, May 15, 2022 2:25 pm – 5:30 pm

SOCIETÀ ITALIANA DI UROLOGIA (SIU)
Commerce Room @ Hilton New Orleans Riverside
2:25 WELCOME AND INTRODUCTION 3:55 SESSION II
Society Secretary: Giuseppe Carrieri Moderator: Andrea Salonia
2:30 SESSION I ROBOT-ASSISTED RADICAL CYSTECTOMY:
Moderator: Vincenzo Ficarra A RIGOROUS ANALYSIS OF POSTOPERATIVE
COMPLICATIONS
HOW TO “BETTER” DETECT AN INSIDIOUS
Debater: Peter Wiklund
BLADDER CANCER?
Gianluca Giannarini ROBOT-ASSISTED RADICAL CYSTECTOMY:
A CRITICAL REAPPRAISAL OF FUNCTIONAL
PRECISION MEDICINE IN ONCOLOGY: THE CASE
OUTCOMES
FOR PERSONALIZED NEOADJUVANT THERAPY
Marco Moschini
FOR BLADDER CANCER
Roger Li ROBOT-ASSISTED RADICAL CYSTECTOMY:
LONG-TERM ONCOLOGIC OUTCOMES
ADJUVANT CHEMOTHERAPY FOR MUSCLE-IN-
Khurshid Guru
VASIVE BLADDER CANCER: WHERE WE ARE?
WHERE DO WE GO? 4:55 TAKE HOME MESSAGE AND GUIDELINES
Cora Sternberg UPDATE
Sam Chang
ROBOT-ASSISTED RADICAL CYSTECTOMY: A
CRITICAL REAPPRAISAL OF INTRACORPOREAL 5:15 DEBATE
NEOBLADDER RECONSTRUCTION TECHNIQUES
5:25 AWARD: BEST ITALIAN ABSTRACT PRESENTED
Riccardo Autorino
AT THE 2022 AUA ANNUAL MEETING
3:45 DEBATE Giuseppe Carrieri

198
Sunday, May 15, 2022
Moderated Poster Session 47
KIDNEY CANCER: EPIDEMIOLOGY & EVALUATION/STAGING/SURVEILLANCE III
Room 228 @ Ernest N. Morial Convention Center
Moderators: Allan Pantuck, Stephen Savage & John Pattaras
ABSTRACT
NUMBER TITLE
MP47-01 DEVELOPMENT OF INDIVIDUAL LEVEL
INFERENCE AVAILABLE EXPLAINABLE
ARTIFICIAL INTELLIGENCE MODEL
FOR CANCER-SPECIFIC SURVIVAL
AFTER NEPHRECTOMY IN RENAL CELL
CARCINOMA PATIENTS
Jungyo Suh*, Dongwon Kim, Bumjin Lim, Cheryn
Song, Dalsan You, In Gab Jeong, Jun Hyuk Hong,
Bumsik Hong, Hanjong Ahn, Choung-Soo Kim,
Seoul, Korea, Republic of
MP47-02 MACHINE LEARNING APPROACH TO
PREDICT PT3A UPSTAGING OF CLINICALLY
LOCALIZED RENAL CELL CARCINOMA
AND ONCOLOGICAL OUTCOMES AFTER
SURGERY (UROCCR 15 STUDY)
Astrid Boulenger de Hauteclocque*, Loïc Ferrer,
Bordeaux, France, Damien Ambrosetti, Nice, France,
Solène Ricard, Bordeaux, France, Pierre Bigot, An-
gers, France, Karim Bensalah, Rennes, France, Ar-
nauld Villers, François Henon, Lille, France, Nicolas
Doumerc, Toulouse, France, Arnaud Méjean, Virginie
Verkarre, Charles Dariane, Paris, France, Stéphane
Larré, Reims, France, Cécile Champy, Alexandre
de La Taille, Créteil, France, Franck Bruyère, Tours,
France, Morgan Rouprêt, Paris, France, Philippe
Paparel, Lyon, France, Stéphane Droupy, Alexis
Fontenil, Nîmes, France, Jean-Jacques Patard, Mont
de Marsan, France, Romain Boissier, Marseille,
France, Mokrane Yacoub, Thierry Colin, Jean-Chris-
tophe Bernhard, Bordeaux, France
MP47-03 MAYO CLINIC VALIDATION OF THE
AMERICAN UROLOGIC ASSOCIATION
RISK GROUPS FOR LOCALIZED RENAL
CANCER
Andrew Zganjar*, Abhinav Khanna, Dan Joyce,
Paige Nichols, Christine Lohse, John Cheville,
Sounak Gupta, Aaron Potretzke, R. Houston
Thompson, Bradley Leibovich, Stephen Boorjian,
Vidit Sharma, Rochester, MN
MP47-04 VALIDATION OF A 22-GENE EPITHELIAL-
MESENCHYMAL TRANSITION (EMT)
PROGNOSTIC SIGNATURE IN CLEAR CELL
RENAL CELL CARCINOMA
Brittney Cotta*, Srinivas Nallandhighal, Ann Arbor,
MI, Judith Stangl-Kremser, Vienna, Austria, Trinh
Pham, Ann Arbor, MI, Jeffrey Tosoian, Nashville,
TN, Kathryn Marchetti, Joel Berends, Mahir Maruf,
Scott Tomlins, Todd Morgan, Ganesh Palapattu,
Eman Abdulfatah, Aaron Udager, Simpa Salami,
Ann Arbor, MI
*Presenting author
2:45 pm – 4:00 pm
ABSTRACT
NUMBER TITLE
MP47-05 STIMULATED RAMAN HISTOLOGY ALLOWS
FOR REAL TIME DETERMINATION OF THE
ADEQUACY OF RENAL MASS BIOPSY AND
IDENTIFY MALIGNANT SUBTYPES OF
RENAL CELL CARCINOMA
Miles P. Mannas*, Fang-Ming Deng, Derek Jones,
William Huang, Daniel Orringer, Samir S Taneja,
New York, NY
MP47-06 ASSESSING RENAL MASS MANAGEMENT
OF PATIENTS WITH INCREASED
COMORBIDITIES: RESULTS FROM A
SUNDAY
STATEWIDE REGISTRY
Mohit Butaney*, Amit Patel, Detroit, MI, Ji Qi,
Karandeep Singh, Anna Johnson, Ann Arbor, MI,
Alison Levy, Detroit, MI, Sabrina Noyes, Grand
Rapids, MI, Khurshid Ghani, Ann Arbor, MI, Craig
Rogers, Detroit, MI, Brian Lane, Grand Rapids,
MI, for the Michigan Urological Surgery Improve-
ment Collaborative, Ann Arbor, MI
MP47-07 DEFINING THE IMPACT OF PERCUTANEOUS
RENAL BIOPSY ON RISK OF INTERVENTION
FOR PATIENTS ON ACTIVE SURVEILLANCE
FOR SMALL RENAL MASSES
Song Jiang*, Dan Sjoberg, Sari Khaleel, Nicole
Benfante, Paul Russo, Abraham Hakimi, Jonathan
Coleman, New York, NY
MP47-08 SURGICAL DELAY AFTER BIOPSY AND RISK
OF UPSTAGING FOR CLINICAL T1A RENAL
CELL CARCINOMA
Leilei Xia*, Ruchika Talwar, Raju Chelluri, Daniel
Lee, Thomas Guzzo, Philadelphia, PA
MP47-09 THE ADDED VALUE OF HISTOLOGICAL
SUBTYPE IN THE PREDICTION OF
ONCOLOGIC OUTCOMES IN PATIENTS WITH
NON-METASTATIC PAPILLARY RENAL CELL
CARCINOMA
Giuseppe Rosiello, Gianfranco Baiamonte*,
Giuseppe Fallara, Giuseppe Basile, Roberta
Lucianò, Maurizio Colecchia, Alberto Martini,
Daniele Cignoli, Luigi Nocera, Federico Belladelli,
Gianmarco Colandrea, Daniela Canibus, Chiara
Re, Giacomo Musso, Francesco Cei, Alberto
Briganti, Roberto Bertini, Andrea Necchi, Daniele
Raggi, Milan, Italy, Pierre I. Karakiewicz, Montreal,
Canada, Francesco Montorsi, Andrea Salonia,
Alessandro Larcher, Umberto Capitanio,
Milan, Italy
199
 MP47-10 DIFFERENCES IN PREDICTIVE ABILITY OF
CRP AND DE RITIS RATIO FOR OUTCOMES
IN RENAL CELL CARCINOMA
John Perry*, La Jolla, CA, Viraj Master, Atlanta,
GA, Hajime Tanaka, Tokyo, Japan, Arman Walia,
Ava Saidian, Rekha Narasimhan, Mimi Nguyen,
Madison Chakoumakos, Margaret Meagher, Juan
Javier-Desloges, La Jolla, CA, Dattatraya Patil,
Atlanta, GA, Kazutaka Saito, Yasuhisa Fujii, To-
kyo, Japan, Ithaar Derweesh, La Jolla, CA
MP47-11 DIFFERENTIAL ASSOCIATION OF BODY
MASS INDEX ON SURVIVAL OUTCOMES
IN RENAL CELL CARCINOMA: IMPACT OF
TUMOR HISTOLOGY
Arman Walia*, San Diego, CA, Yasuhisa Fujii, To-
kyo, Japan, Viraj Master, Atlanta, GA, Ava Saidi-
an, Rekha Narasimhan, Mimi Nguyen, John Perry,
Margaret Meagher, Madison Chakoumakos, Kevin
Hakimi, San Diego, CA, Dattatraya Patil, Atlanta,
GA, Yosuke Yasuda, Hajime Tanaka, Tokyo,
Japan, Ithaar Derweesh, San Diego, CA
MP47-12 FRAILTY STATUS PREDICTS WORSE
POSTOPERATIVE AND LONG-TERM
ONCOLOGIC OUTCOMES IN PATIENTS
TREATED WITH PARTIAL NEPHRECTOMY
FOR SMALL RENAL MASSES
Giuseppe Rosiello*, Giuseppe Fallara, Daniele
Cignoli, Giuseppe Basile, Gianmarco Colandrea,
Gianfranco Baiamonte, Isaline Rowe, Daniela
Canibus, Giacomo Musso, Federico Belladelli,
Francesco Cei, Cristina Giancristofaro, Milan,
Italy, Pierre I. Karakiewicz, Montreal, Canada,
Alberto Briganti, Roberto Bertini, Francesco
Montorsi, Andrea Salonia, Alessandro Larcher,
Umberto Capitanio, Milan, Italy
MP47-13 MUSCLE MASS CHANGE USING LINEAR
MEASUREMENT ANALYSIS AFTER
NEPHRECTOMY FOR PT3 RENAL CELL
CARCINOMA IS ASSOCIATED WITH
MORTALITY
Alexandra Medline*, Eric Midenberg, Dattatraya
Patil, Sean Evans, Fatima Kamal, Kenneth Ogan,
Atlanta, GA, Sarah Psutka, Seattle, WA, Mehmet
Asim Bilen, Viraj Master, Atlanta, GA
MP47-14 THE ROLE OF COMBINED SARCOPENIA
AND ALBUMIN IN THE SURGICAL
PROGNOSTICATION OF LOCALLY ADVANCED
RENAL CELL CARCINOMA WITH VENOUS
TUMOR THROMBUS
Eric Midenberg*, Dattatraya Patil, Alexandra Med-
line, Atlanta, GA, Michelle Higgins, Baltimore, MD,
Milton Williams, Birmingham, AL, Sarah P. Psutka,
Seattle, WA, Kenneth Ogan, Mehmet A. Bilen,
Viraj A. Master, Atlanta, GA
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
200
MP47-15 IMPACT OF DIABETES MELLITUS ON
FUNCTIONAL DECLINE AND NON-CANCER
MORTALITY IN RENAL CELL CARCINOMA:
ANALYSIS OF THE INTERNATIONAL MARKER
CONSORTIUM (INMARC)
Ava Saidian*, Arman Walia, Rekha Narashimhan,
John Perry, La Jolla, CA, Hajime Tanaka, Tokyo,
Japan, Kevin Hakimi, Margaret Meagher, La Jolla,
CA, Dattatraya Patil, Atlanta, GA, Yosuke Yasuda,
Kazutaka Saito, Yasuhisa Fujii, Tokyo, Japan,
Viraj Master, Atlanta, GA, Ithaar Derweesh, La
Jolla, CA
MP47-16 DECLINE TO “SEVERE” CKD-S IS A
PREDICTIVE MARKER FOR ALL-CAUSE
AND NON-CANCER MORTALITY IN RENAL
CELL CARCINOMA: ANALYSIS OF THE
INTERNATIONAL MARKER CONSORTIUM
FOR RENAL CANCER (INMARC)
Mimi Nguyen*, Arman Walia, Rekha Narasimhan,
Ava Saidian, John Matthew Perry, La Jolla, CA,
Hajime Tanaka, Tokyo, Japan, Kevin Hakimi,
Margaret Meagher, La Jolla, CA, Dattatraya Patil,
Atlanta, GA, Yosuke Yasuda, Kazutaka Saito,
Yasuhisa Fujii, Tokyo, Japan, Viraj Master, Atlan-
ta, GA, Ithaar Derweesh, La Jolla, CA
MP47-17 IMPACT OF PATIENT AND LIFESTYLE
FACTORS IN PATIENTS WITH STAGE III & IV
RENAL CANCER: A DANISH NATIONWIDE
STUDY
Freja Ebbestad*, Copenhagen, Denmark, Louise
Geertsen, Odense, Denmark, Naomi Nadler,
Roskilde, Denmark, Sofie Axelsen, Hjørring, Den-
mark, Trine Horsbøll, Odense, Denmark, Susanne
Dalton, Copenhagen, Denmark, Jane Chris-
tensen, Copenhagen, Denmark, Frede Donskov,
Aarhus, Denmark, Lars Lund, Odense, Denmark,
Nessn Azawi, Roskilde, Denmark
MP47-18 SUSTAINABLE MULTIDISCIPLINARY TEAM
REFERRAL FOR NON-METASTATIC RENAL
CELL CARCINOMA: A SURVIVAL-BASED
RECOMMENDATION
Giuseppe Basile*, Alberto Martini, Giuseppe Fal-
lara, Antony Pellegrino, Alessandro Larcher, Dan-
iele Raggi, Milan, Italy, Riccardo Campi, Florence,
Italy, Sumanta Pal, Duarte, CA, Philippe Spiess,
Tampa, FL, Francesco Montorsi, Milan, Italy, Toni
K. Choueiri, Boston, MA, Andrea Necchi, Umberto
Capitanio, Milan, Italy
MP47-19 UNDERREPRESENTATION OF HISPANICS
AND AMERICAN INDIAN/ALASKA NATIVES
IN THE NATIONAL CANCER DATABASE
Juan Javier-DesLoges*, Arman Walia, Margaret
Meagher, John Perry, Mimi Nguyen, Rekha Nar-
asimhan, Madison Chakoumakos, Ava Saidian,
Ithaar Derweesh, San Diego, CA
MP47-20 UNIVERSAL GERMLINE GENETIC TESTING
OF PATIENTS WITH NEWLY DIAGNOSED
UPPER TRACT UROTHELIAL CARCINOMA:
AN INTERIM ANALYSIS
Craig Labbate*, Donika Saporito, Maureen Mork,
Eduardo Vilar Sanchez, Eric Jonasch, Mehrad
Adibi, Surena Matin, Houston, TX
Sunday, May 15, 2022
Moderated Poster Session 48
PROSTATE CANCER: ADVANCED (INCLUDING DRUG THERAPY) III
Room 225 @ Ernest N. Morial Convention Center
Moderators: Todd Morgan, Brian Chapin & Chengfei Liu
ABSTRACT
NUMBER TITLE
MP48-01 HOW TO OPTIMIZE PATIENT SELECTION
BEFORE SALVAGE LYMPH NODE
DISSECTION FOR NODAL RECURRENT
PROSTATE CANCER: A NOVEL RISK
STRATIFICATION TOOL
Nicola Fossati*, Lugano, Switzerland, Jeffrey R.
Karnes, Rochester, MN, David Pfister, Munich,
Germany, Axel Heidenreich, Cologne, Germa-
ny, Alexander Kretschmer, Alexander Buchner,
Christian Stief, Munich, Germany, Steven Joniau,
Hendrik van Poppel, Leuven, Belgium, Daniar
Osmonov, Klaus-Peter Juenemann, Kiel, Germa-
ny, Shahrokh Shariat, Vienna, Austria, Andreas
Hiester, Peter Albers, Düsseldorf, Germany,
Derya Tilki, Markus Graefen, Hamburg, Germany,
Inderbir S. Gill, Los Angeles, CA, Elio Mazzone,
Armando Stabile, Milan, Italy, Alexander Mottrie,
Melle, Belgium, Giorgio Gandaglia, Milan, Italy,
Andrea Gallina, Lugano, Switzerland, Francesco
Montorsi, Alberto Briganti, Milano, Italy
MP48-02 PERSISTENT TESTOSTERONE
SUPPRESSION AFTER CESSATION OF
ANDROGEN DEPRIVATION THERAPY FOR
LOCALIZED PROSTATE CANCER
Jessica Delgado*, Miami, FL, Jesse Ory, Nova
Scotia, Canada, Joshua Bitran, Ruben Blachman
Braun, Sirpi Nackeeran, Ranjith Ramasamy,
Miami, FL
MP48-03 PREVALENCE AND NATURAL HISTORY OF
NON-METASTATIC CASTRATE RESISTANT
PROSTATE CANCER: A POPULATION-BASED
ANALYSIS
Amanda Hird*, Erind Dvorani, Refik Saskin, Send-
er Herschorn, Ronald Kodama, Girish Kulkarni,
Robert Nam, Toronto, Canada
MP48-04 EVALUATING CARDIOVASCULAR RISK IN
MEN STARTING ANDROGEN DEPRIVATION
THERAPY FOR PROSTATE CANCER
Benjamin Lowentritt*, Towson, MD, Mark Fallick,
Robert Dufour, Janis Pruett, Brisbane, CA, Tao
Jiang, Boston, MA, Esmond Nwokeji, New York,
NY, Mitch Nagao, Brisbane, CA
MP48-05 CHANGES IN PITUITARY–GONADAL
HORMONES AFTER ENZALUTAMIDE OR
ABIRATERONE PLUS PREDNISONE IN MEN
WITH CASTRATION-RESISTANT PROSTATE
CANCER (HEAT): RESULTS FROM A
RANDOMISED CLINICAL TRIAL
Klara Ternov*, Jens Sønksen, Mikkel Fode,
Henriette Lindberg, Herlev, Denmark, Caroline
Kistorp, copenhagen, Denmark, Rasmus Bisbjerg,
Jens Faber, Herlev, Denmark, Ganesh Palapattu,
Ann Arbor, MI, Peter Busch Østergren, Herlev,
Denmark
*Presenting author
2:45 pm – 4:00 pm
ABSTRACT
NUMBER TITLE
MP48-06 ADVERSE EVENTS RELATED TO
DAROLUTAMIDE TREATMENT: ANALYSIS OF
“REAL LIFE” DATA FROM EUDRAVIGILANCE
(EV) AND THE FOOD AND DRUG
ADMINISTRATION (FDA) DATABASE ENTRIES
Antonio Cicione*, Rome, Italy, Antonio Nacchia,
Rionero in Vulture, Italy, Beatrice Turchi, Carmen
Gravina, Giacomo Gallo, Alessandro Guercio,
Lorenzo Maria Rovesti, Giorgio Guarnotta, Elisa
Mancini, Jordi Stira, Sara Riolo, Antonio Franco,
Olivia Alessandra Voglino, Valeria Baldassarri,
SUNDAY
Simone D’Annunzio, Rome, Italy, Ferdinando Di
Giacomo, Giuseppe Disabato, Alfredo Tartarone,
Rionero in Vulture, Italy, Cosimo De Nunzio,
Andrea Tubaro, Rome, Italy
MP48-07 THE NEUROTOXICITY OF ANDROGEN
DEPRIVATION THERAPY: A
PHARMACOVIGILANCE STUDY
Logan Briggs*, Stephen Reese, Peter Herzog, Da-
vid-Dan Nguyen, Muhieddine Labban, Khalid Alkhat-
ib, Quoc-Dien Trinh, Alicia K Morgans, Boston, MA
MP48-08 RESPONSE RATES AND SURVIVAL
OUTCOMES OF METASTASIS DIRECTED
THERAPIES IN SOLITARY OLIGO-
RECURRENT PROSTATE CANCER
Mohamed Ahmed*, Jack Andrews, Vidit Sharma,
Cameron Britton, Vidhu Joshi, Bradley Stish,
Ryan Phillips, R. Jeffrey Karnes, Eugene Kwon,
Rochester, MN
MP48-09 TOXICITY PROFILE OF IMMEDIATE POST-
PROSTATECTOMY RADIATION THERAPY:
RESULTS FROM A LARGE MULTI-
INSTITUTIONAL SERIES
Nicola Fossati*, Lugano, Switzerland, Jeffrey R.
Karnes, Stephen A. Boorjian, Alberto Bossi, Roches-
ter, MN, Nadia Di Muzio, Cesare Cozzarini, Barbara
Noris Chiorda, Giorgio Gandaglia, Milano, Italy, Detlef
Bartkowiak, Ulm, Germany, Shahrokh Shariat, Vien-
na, Austria, Gregor Goldner, Department of Radiation
Oncology, Austria, Charlien Berghen, Steven Joniau,
Gert De Meerleer, Leuven, Belgium, Elio Mazzone,
Armando Stabile, Milano, Italy, Hendrik van Poppel,
Leuven, Belgium, Andrea Gallina, Lugano, Swit-
zerland, Francesco Montorsi, Milano, Italy, Thomas
Wiegel, Ulm, Germany, Alberto Briganti, Milano, Italy
MP48-10 ANDROGEN DEPRIVATION THERAPY FOR
NODE-POSITIVE PROSTATE CANCER AT
RADICAL PROSTATECTOMY AND PELVIC
LYMPH NODE DISSECTION: CONTEMPORARY
PRACTICE PATTERNS AND ASSOCIATED
FACTORS
Leilei Xia, Ruchika Talwar, Raju Chelluri*, Daniel
Lee, Thomas Guzzo, Philadelphia, PA
201
 MP48-11 CARDIOVASCULAR ADVERSE EVENTS-
RELATED TO GNRH AGONISTS AND GNRH
ANTAGONISTS: ANALYSIS OF REAL-LIFE
DATA FROM EUDRA-VIGILANCE DATABASE
Cosimo De Nunzio, Rome, Italy, Antonio Nacchia*,
Rionero in Vulture, Italy, Antonio Cicione, Beatrice
Turchi, Giacomo Gallo, Carmen Gravina, Alessandro
MP48-16
Guercio, Jordi Stira, Lorenzo Maria Rivesti, Antonio
Franco, Elisa Mancini, Olivia Alessandra Voglino,
Valeria Baldassarri, Giorgio Guarnotta, Rome, Italy,
Ferdinando Di Giacomo, Giuseppe Disabato, Rione-
ro in Vulture, Italy, Andrea Tubaro, Rome, Italy
MP48-12 OPTIMIZING TIMING AND INDICATIONS
FOR 68GA-PSMA PET/CT IN PATIENTS WITH
BIOCHEMICAL RECURRENT PROSTATE
CANCER AFTER RADICAL PROSTATECTOMY
Daniele Robesti*, Elio Mazzone, Milano, Italy,
Giorgio Gandaglia, Armando Stabile, Milan, Italy,
Carlo Andrea Bravi, Andrea Necchi, Daniele
Raggi, Laura Marandino, Milano, Italy, Giuseppe
Cirulli, Milan, Italy, Francesco Barletta, Simone
Scuderi, Riccardo Leni, Milano, Italy, Luigi
Nocera, Milan, Italy, Eleonora Balestrazzi, Stefano
Fanti, Andrea Farolfi, Lorenzo Bianchi, Riccardo
Schiavina, Bologna, Italy, Francesco Montorsi,
Alberto Briganti, Milano, Italy
MP48-13 THE KEY ROLE OF CONCOMITANT
ANDROGEN-DEPRIVATION THERAPY
ON THE EFFICACY OF IMAGING GUIDED
TREATMENTS IN MEN WITH BIOCHEMICAL
RECURRENT PROSTATE CANCER AFTER
RADICAL PROSTATECTOMY AND POSITIVE
68GA-PSMA PET/CT SCAN
Daniele Robesti*, Milano, Italy, Elio Mazzone,
Milan, Italy, Giorgio Gandaglia, Armando Stabile,
Giuseppe Rosiello, Alberto Martini, Carlo Andrea
Bravi, Milano, Italy, Giuseppe Cirulli, Antony
Pellegrino, Riccardo Leni, Milan, Italy, Francesco
Barletta, Milano, Italy, Mario De Angelis, Milan,
Italy, Simone Scuderi, Milano, Italy, Luigi Nocera,
Milan, Italy, Daniele Raggi, Milano, Italy, Vito Cuc-
chiara, Milan, Italy, Nazareno Suardi, Genoa, Italy,
Andrea Necchi, Milano, Italy, Shahrokh F. Shariat,
Vienna, Austria, Francesco Montorsi, Alberto
Briganti, Milano, Italy
MP48-14 WHEN NODE-POSITIVE PROSTATE CANCER
SHOULD BE CONSIDERED A SYSTEMIC
DISEASE? ASSESSING THE PROGNOSTIC
ROLE OF PREOPERATIVE 68GA-PSMA PET/
CT RESULTS IN PATIENTS WITH LYMPH
NODE INVASION AT FINAL PATHOLOGY
Daniele Robesti*, Elio Mazzone, Milano, Italy,
Giorgio Gandaglia, Armando Stabile, Milan, Italy,
Carlo Andrea Bravi, Andrea Necchi, Daniele
Raggi, Laura Marandino, Milano, Italy, Giuseppe
Cirulli, Milan, Italy, Francesco Barletta, Simone
Scuderi, Riccardo Leni, Milano, Italy, Mario de
Angelis, Vito Cucchiara, Milan, Italy, Eleonora
Balestrazzi, Stefano Fanti, Andrea Farolfi, Loren-
zo Bianchi, Riccardo Schiavina, Bologna, Italy,
Francesco Montorsi, Alberto Briganti, Milano, Italy
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
MP48-15 CORRELATION BETWEEN 18F-DCFPYL
PET DETECTED LOCAL RECURRENCE
AND RADICAL PROSTATECTOMY
HISTOPATHOLOGY: A PILOT STUDY
Sophie Tissot*, Jessica Wynn, Lih-Ming Wong,
Michael Ng, Fitzroy, Australia
18
F-DCFPYL PSMA PET IMAGING IMPROVES
DETECTION OF NODAL METASTASES IN
COMPARISON TO CONVENTIONAL IMAGING
IN PATIENTS WITH LOCALLY ADVANCED OR
OLIGOMETASTATIC PROSTATE CANCER
Ashanda Esdaille*, Edward Lawrence, Chris-
tos Kyriakopoulos, Brian Johnson, Alejandro
Roldan-Alzate, Wei Huang, David Beebe, Hamid
Emamekhoo, Shane Wells, Joshua Lang, Steve
Cho, David Jarrard, Madison, WI
MP48-17 ONCOLOGICAL OUTCOMES IN PATIENTS
WITH RECURRENT PROSTATE CANCER
STAGED WITH PSMA PET/CT: RESULTS
FROM 3 EUROPEAN TERTIARY CENTERS
Matteo Droghetti*, Lorenzo Bianchi, Francesco
Costa, Eleonora Balestrazzi, Francesco Chessa,
Bologna, Italy, Francesco Ceci, milano, Italy, Ric-
cardo Mei, Andrea Farolfi, Paolo Castellucci, Pietro
Piazza, Bologna, Italy, Stefano Puliatti, Modena,
Italy, Alessandro Larcher, Giorgio Gandaglia, Milano,
Italy, Alexandre Mottrie, Aalst, Belgium, Alberto
Briganti, Milano, Italy, Stefano Fanti, Bologna, Italy,
Francesco Montorsi, Milano, Italy, Riccardo Schiavi-
na, Eugenio Brunocilla, Bologna, Italy
MP48-18 THE IMPACT OF LOCOREGIONAL
TREATMENTS FOR METASTATIC CASTRATION
RESISTANT PROSTATE CANCER ON DISEASE
PROGRESSION: REAL LIFE EXPERIENCE
FROM A MULTICENTER COHORT
Mariaconsiglia Ferriero*, Gabriele Tuderti, Umber-
to Anceschi, Alfredo Maria Bove, Aldo Brassetti,
Leonardo Misuraca, Salvatore Guaglianone,
Riccardo Mastroianni, Cosimo De Nunzio, Silvana
Giacinti, Giorgia Tema, Rome, Italy, Luca Cindolo,
Vasto, Italy, Andrea Tubaro, Michele Gallucci,
Rome, Italy, Luigi Schips, Vasto, Italy, Fabio Cal-
abrò, Giuseppe Simone, Rome, Italy
MP48-19 RISK OF METABOLIC AND
CARDIOVASCULAR ADVERSE EVENTS WITH
ABIRATERONE OR ENZALUTAMIDE AMONG
MEN WITH ADVANCED PROSTATE CANCER
Lillian Lai*, Mary Oerline, Megan Caram, Phoebe
Tsao, Samuel Kaufman, Brent Hollenbeck, Va-
hakn Shahinian, Ann Arbor, MI
MP48-20 PROTECTIVE EFFECTS OF METFORMIN
AGAINST BIOCHEMICAL FAILURE
FOLLOWING RADICAL PROSTATECTOMY
OR RADIATION THERAPY IN LOCALIZED
PROSTATE CANCER
Linda My Huynh*, Orange, CA, Emily Keit,
Omaha, NE, Erica Huang, Raymond Ceja Carrillo,
Thomas Ahlering, Orange, CA, Shawna Boyle,
Charles Enke, Michael J. Baine, Omaha, NE

202
Sunday, May 15, 2022 3:30 pm – 5:30 pm

Podium Session 49
SEXUAL FUNCTION/DYSFUNCTION: MEDICAL, HORMONAL & NON-SURGICAL THERAPY II
Room 252 @ Ernest N. Morial Convention Center
Moderators: Mohit Khera, Ingrid Perscky & Joseph Alukal

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
3:30 PD49-01 SECONDARY POLYCYTHEMIA WHILE ON
4:30 PD49-07 SEXUAL FUNCTION RECOVERY
TESTOSTERONE THERAPY INCREASES RISK
FOLLOWING OPEN AND ROBOTIC RADICAL
OF MAJOR ADVERSE CARDIOVASCULAR
PROSTATECTOMY: RESULTS OF AN
EVENTS AND VENOUS THROMBOEMBOLISM
ACADEMIC PENILE REHABILITATION
IN MEN: INSIGHTS FROM A GLOBAL HEALTH
PROGRAM
RESEARCH NETWORK
Ugo Falagario*, Michele Di Nauta, Andrea
Jesse Ory*, Halifax, Canada, Sirpi Nackeeran,
Checchia, Marco Recchia, Anna Ricapito, Nicola
Navin Balaji, Joshua Hare, Ranjith Ramasamy,
D’Altilia, Pasquale Annese, Gian Maria Busetto,
Miami, FL
Luigi Cormio, Giuseppe Carrieri, Carlo Bettocchi,
3:40 PD49-02 MEDICATIONS MOST COMMONLY Foggia, Italy
ASSOCIATED WITH ERECTILE

DYSFUNCTION: EVALUATION OF THE FOOD
AND DRUG ADMINISTRATION NATIONAL
PHARMACOVIGILANCE DATABASE
Elie Kaplan-Marans*, Mariela Martinez, Arshia
Sandozi, Jeffrey Lee, Jacob Khurgin,
Ariel Schulman, New York, NY
3:50 PD49-03 IS TADALAFIL ASSOCIATED WITH
DECREASED RISK OF MAJOR ADVERSE
CARDIAC EVENTS OR VENOUS
THROMBOEMBOLISM IN MEN WITH LOWER
URINARY TRACT SYMPTOMS?
Ruben Blachman-Braun*, Miami, FL, Sankalp
Goberdhan, Orlando, FL, Sirpi Nackeeran,
Thomas Masterson, Ranjith Ramasamy,
Miami, FL
4:00 PD49-04 5 YEARS FOLLOW-UP OUTCOMES OF PELVIC
FLOOR REHABILITATION PROTOCOL IN
SUBJECTS WITH LIFELONG PREMATURE
EJACULATION: THE DEFINITIVE LONG-TERM
EVALUATION
Antonio Luigi Pastore*, Andrea Fuschi, Yazan Al
Salhi, Alessia Martoccia, Lorenzo Capone, Silvio
Scalzo, Paolo Pietro Suraci, Gennaro Velotti,
Latina, Italy, Ester Illiano, Terni, Italy, Giorgio
Bozzini, Milan, Italy, Serena Maruccia, Monza,
Italy, Alessandro Zucchi, Pisa, Italy, Elisabetta
Costantini, Terni, Italy, Antonio Carbone,
Latina, Italy
4:10 PD49-05 ERECTILE DYSFUNCTION IS AN
INDEPENDENT RISK FACTOR FOR MAJOR
ADVERSE CARDIOVASCULAR EVENTS
Uday Mann*, Ranveer Brar, Premal Patel,
Winnipeg, Canada
4:20 PD49-06 EFFICACY OF RESTOREX PENILE
TRACTION THERAPY IN IMPROVING PENILE
LENGTH AND ERECTILE FUNCTION POST
PROSTATECTOMY
Andrew Zganjar*, Amir Toussi,
Matthew Ziegelmann, David Yang, Madeleine
Manka, Tobias Kohler, Sevann Helo, Landon
Trost, Rochester, MN
SUNDAY
4:40 PD49-08 INCREASED RISK OF MAJOR ADVERSE
CARDIOVASCULAR EVENTS IN MEN
RECEIVING TESTOSTERONE REPLACEMENT
THERAPY
Uday Mann*, Ranveer Brar, Premal Patel, Winni-
peg, Canada
4:50 PD49-09 TESTOSTERONE THERAPY IN MEN ON
ACTIVE SURVEILLANCE FOR PROSTATE
CANCER
Jose M Flores*, Carolyn A Salter, Nicole Benfan-
te, Lawrence Jenkins, Behfar Ehdaie, Vincent
Laudone, James Eastham, John P. Mulhall, New
York, NY
5:00 PD49-10 SLEEP DISORDERS AND CIRCADIAN
RHYTHM SLEEP DISORDERS ARE
ASSOCIATED WITH SIGNIFICANTLY HIGHER
RATES OF HYPOGONADISM AND ERECTILE
DYSFUNCTION - A U.S. CLAIMS DATABASE
ANALYSIS
Pranjal Agrawal*, Sajya Singh, Baltimore, MD,
Corey Able, Galveston, TX, Taylor P. Kohn, Amin
S Herati, Baltimore, MD
5:10 PD49-11 THREE YEARS AFTER FINISHING PENILE
REHABILITATION STUDY PROGRAMS AND
5 YEARS AFTER NERVE-SPARING RADICAL
PROSTATECTOMY: WHAT`S UP WITH OUR
PATIENTS?
Andreas Bannowsky*, Rendsburg, Germany,
Daniar Osmonov, Kiel, Germany, Viktoria Märker,
Hamburg, Germany, Stefan Ückert, Hannover,
Germany
5:20 PD49-12 AWARENESS OF VTE RISK IN KLINEFELTER
SYNDROME AND TESTOSTERONE THERAPY
Frederick Melling*, Sophie Birch, Tet Yap, Paul
Carrol, Awatul El-Shirif, Leila Frodsham, Paula
Allchrone, Karen Briggs, London, United Kingdom
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM

*Presenting author 203

Sunday, May 15, 2022
Podium Session 50
STONE DISEASE: EPIDEMIOLOGY & EVALUATION II
Room 255 @ Ernest N. Morial Convention Center
Moderators: Charles Scales & Shuba De
ABSTRACT
TIME NUMBER TITLE
3:30 PD50-01 DURATION OF FOLLOW-UP AND TIMING
OF DISCHARGE IN ADULT PATIENTS WITH
UROLITHIASIS AFTER SURGICAL OR
MEDICAL INTERVENTION: A SYSTEMATIC
REVIEW AND META-ANALYSIS FROM THE
EUROPEAN ASSOCIATION OF UROLOGY
GUIDELINE PANEL ON UROLITHIASIS
Lazaros Tzelves*, Athens, Greece, Robert Ger-
aghty, Newcastle, United Kingdom, Riccardo Lom-
bardo, Rome, Italy, Niall D. Davis, Dublin, Ireland,
Andreas Neisius, Trier, Germany, Ales Petřík,
Prague, Czech Republic, Giovanni Gambaro,
Verona, Italy, Christian Türk, Vienna, Austria,
Kay Thomas, London, United Kingdom, Bhaskar
Somani, Southampton, United Kingdom, Andreas
Skolarikos, Athens, Greece
3:40 PD50-02 DO SEQUENTIAL 24-HOUR URINE
COLLECTIONS IN AN INDIVIDUAL
PATIENT RESULT IN IMPROVED URINARY
PARAMETERS?
Akin S. Amasyali*, Jason Groegler, Hyukje Sung,
Daniel Jhang, Joshua D. Belle, Mohammad
Hajiha, D.Duane Baldwin, Loma Linda, CA
3:50 PD50-03 NO ASSOCIATION BETWEEN STATINS AND
INCREASED NEPHROLITHIASIS RISK
Wilson Sui, Christina J. Peterson*, Naren Nim-
magadda, Nicholas L Kavoussi, Nicole L Miller, S.
Duke Herrell, Ryan S. Hsi, Nashville, TN
ABSTRACT
TIME NUMBER TITLE
4:00 PD50-04 ELECTRONIC HEALTH RECORD-BASED
RISK STRATIFICATION FOR RECURRENCE
OF KIDNEY STONES: A FEASIBILITY
IMPLEMENTATION
Ryan Hsi*, Tatsuki Koyama, Allison McCoy,
Nashville, TN
4:10 PD50-05 A NOVEL PREDICTION OF URIC ACID
COMPONENT IN NEPHROLITHIASIS USING
SIMPLE CLINICAL INFORMATION: A
MACHINE LEARNING-BASED MODEL
Hao-Wei Chen*, Yu-Chen Chen, Jung-Ting Lee,
Chung-Yao Kao, Wen-Jeng Wu, Yung-Shun Juan,
Kaohsiung, Taiwan
4:20 PD50-06 EXAMINING RISKS OF COMPOSITION
CONVERSION IN RECURRENT STONE
FORMERS
Hari Nair*, Tinika Montgomery, Michael Siev, New
Haven, CT, Erin Murphy, North Haven, CT, Kath-
ryn Simmons, Piruz Motamedinia, Neera Dahl,
Dinesh Singh, New Haven, CT
204
3:30 pm – 5:30 pm
4:30 PD50-07 DEFINING STONE PASSAGE IN A CLINICAL
TRIAL: ADJUDICATION IN THE PREVENTION
OF URINARY STONES WITH HYDRATION
(PUSH) STUDY
Hunter Wessells, Seattle, WA, Henry Lai, St.
Louis, MO, John Lieske*, Rochester, MN, Brian
Matlaga, Baltimore, MD, Sharon Settles, Hongqiu
Yang, Durham, NC, Jonathan Harper, Seattle,
WA, Charles Scales Jr, Durham, NC, Alana Desai,
St. Louis, MO, Naim Maalouf, Dallas, TX, Peter
Reese, Sri Sivalingam, Durham, NC, Gregory
Tasian, Philadelphia, PA, Hussein Al-Khalidi,
Durham, NC, Ziya Kirkali, Bethesda, MD
4:40 PD50-08 PRACTICE PATTERNS IN THE SURGICAL
MANAGEMENT OF UROLITHIASIS: DATA
FROM THE AUA QUALITY (AQUA) REGISTRY
Amy Showen*, Justin Ahn, San Francisco, CA,
Raymond Fang, Cody Weiss, William Meeks, Lin-
thicum, MD, Matthew Cooperberg, David Bayne,
Tom Chi, San Francisco, CA
4:50 PD50-09 CLINICAL IMPLICATIONS OF ULTRASOUND
SHEAR WAVE ELASTOGRAPHY OF URINARY
STONES IN PATIENT CANDIDATE FOR
URETEROSCOPY
Enrico De Marzo*, Chiara Lonati, Stefania Zambo-
ni, Brescia, Italy, Giuseppe Pezzotti, Desenzano,
Italy, Claudio Simeone, Brescia, Italy
5:00 PD50-10 EVALUATING THE ENCRUSTATION
FEATURES DUE TO THE SHORT-TERM
URETERAL STENT PLACEMENT USING
MICRO-COMPUTED TOMOGRAPHY: THE
RESULTS FROM A PROSPECTIVE STUDY
Shinji Fukui*, Takashi Yoshida, Kuniko Takemoto,
Hidefumi Kinoshita, Hirakata, Japan
5:10 PD50-11 THE PATIENT VOICE: EXPERIENCES WITH
URETERAL STENT REMOVAL–A URINARY
STONE DISEASE RESEARCH NETWORK
(USDRN) STUDY
Carrie Dombeck, Charles Scales Jr*, Kevin
McKenna, Teresa Swezey, Durham, NC, Jodi
Antonelli, Dallas, TX, Alana Desai, St. Louis, MO,
Jonathan Harper, Michele Curatolo, Seattle, WA,
Naim Maalouf, Dallas, TX, Peter Reese, Rebecca
McCune, Philadelphia, PA, Hussein Al-Khalidi,
Durham, NC, Ziya Kirkali, Bethesda, MD, Amy
Corneli, Durham, NC
5:20 PD50-12 PRELIMINARY VALIDATION OF THE 6-ITEM
SHORT FORM OF THE WISCONSIN STONE
QUALITY OF LIFE QUESTIONNAIRE
(WISQOL)
Shuang Li*, Christopher Haas, Margaret Knoedler,
Stephen Nakada, Kristina Penniston, Madison, WI
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
Sunday, May 15, 2022
Podium Session 51
PENILE & TESTICULAR CANCER II
Room 245 @ Ernest N. Morial Convention Center
Moderators: Jeffrey Holzbeierlein & Philippe Spiess
ABSTRACT
TIME NUMBER TITLE
3:30 PD51-01 CONTEMPORARY SURGICAL OUTCOMES
OF RETROPERITONEAL LYMPH NODE
DISSECTION FROM THE SEMS TRIAL
Brian Hu*, Loma Linda, CA, Muhannad Alsyouf,
Los Angeles, CA, Clint Cary, Timothy A. Mas-
terson, Lawrence Einhorn, Indianapolis, IN,
Stephen A. Boorjian, Rochester, MN, Christian
K. Kollmannsberger, Vancouver, Canada, Anne
K. Schuckman, Los Angeles, CA, Alan So, Peter
C. Black, Vancouver, Canada, Aditya Bagro-
dia, Dallas, TX, Eila C. Skinner, Palo Alto, CA,
Mehrdad Alemozaffar, Atlanta, GA, Timothy C.
Brand, Tacoma, WA, Scott E. Eggener, Chicago,
IL, Phillip M. Pierorazio, Baltimore, MD, Kelly Lynn
Stratton, Oklahoma, OK, Lucia Nappi, Vancouver,
Canada, Craig R. Nichols, Seattle, WA, Siamak
Daneshmand, Los Angeles, CA
3:40 PD51-02 ONCOLOGIC OUTCOMES OF PRIMARY
RETROPERITONEAL LYMPH NODE
DISSECTION FOR STAGE II SEMINOMA:
INDIANA UNIVERSITY EXPERIENCE
Isamu Tachibana*, Andre Alabd, Sean Kern,
Mohammad Mahmoud, Timothy Masterson, Nabil
Adra, Richard Foster, Lawrence Einhorn, Clint
Cary, Indianapolis, IN
ABSTRACT
TIME NUMBER TITLE
3:50 PD51-03 MOLECULAR CHARACTERISTICS OF
METASTATIC TERATOMAS AND MATCHED
PRIMARY TESTICULAR GERM CELL TUMORS
Anna Savelyeva*, Feng Wang, Lei Guo, John
Lafin, Liwei Jia, Kirill Medvedev, Cheryl Lewis,
Payal Kapur, Vitaly Margulis, Solomon Woldu,
Xiaosong Meng, Nick Grishin, Dallas, TX, James
Amatruda, Los Angeles, CA, Lin Xu, Dallas, TX,
Aditya Bagrodia, San Diego, CA
4:00 PD51-04 MEDIUM TO LONG TERM HEALTH-RELATED
QUALITY OF LIFE AND TREATMENT-
RELATED SIDE-EFFECTS IN PATIENTS
TREATED WITH A SINGLE DOSE OF
ADJUVANT CARBOPLATIN FOR HIGH-RISK
SEMINOMA – RESULTS FROM A PILOT
STUDY
Walter Cazzaniga*, London, United Kingdom,
Adam Pearce, Brisbane, Australia, Chandran
Tanabalan, Prabhakar Rajan, Netty Kinsella,
Alison Reid, Robert Huddart, David Nicol,
London, United Kingdom
4:10 PD51-05 FEASIBILITY OF OMITTING CT PELVIS
IN PATIENTS WITH STAGE I GERM CELL
TUMOR (GCT) ON ACTIVE SURVEILLANCE: A
MULTI-INSTITUTIONAL STUDY
*Presenting author
3:30 pm – 5:30 pm
Hamed Ahmadi*, Minneapolis, MN, Tarik Benidir,
Cleveland, OH, Ragheed Saoud, New Jersey, NJ,
Lynn Anson-Cartwright, Martin O’Malley, Toronto,
Canada, Scott E. Eggener, Chicago, IL, Robert J
Hamilton, Toronto, Canada, Siamak Daneshmand,
Los Angeles, CA
4:20 PD51-06 EVALUATION OF MIR-371A-3P
PERFORMANCE IN DETECTING
SEMINOMATOUS TESTICULAR CANCER
METASTASES
Bendu Konneh*, John T Lafin, Anna Savelyeva,
Solomon L. Woldu, Cheryl Lewis, Vitaly Margulis,
Dallas, TX, Lindsay Frazier, Boston, MA, Nicholas
SUNDAY
Coleman, Matthew Murray, Cambridge, United
Kingdom, Armon Amini, Dallas, TX, James F. Am-
atruda, Boston, MA, Cinzia Scarpini, Cambridge,
United Kingdom, Aditya Bagrodia, San Diego, CA
4:30 PD51-07 PREDICTING THE HISTOPATHOLOGY
RESULT OF POST-CHEMO
RETROPERITONEAL LYMPH NODE
DISSECTION (PC-RPLND)
Axel Gerdtsson, Malmö, Sweden, Anna Thor*,
Stockholm, Sweden, Anna Grenabo Bergdahl,
Göteborg, Sweden, Helene Negaard, Oslo,
Norway, Bjarte Almås, Bergen, Norway, Ingrid
Glimelius, Uppsala, Sweden, Åsa Karlsdottir, Ber-
gen, Norway, Dag Halvorsen, Trondheim, Norway,
Kristine Engen Andreassen, Signe Melsen Larsen,
Rolf Wahlqvist, Oslo, Norway, Hege Saagstuen
Haugnes, Tromsö, Norway, Torgrim Tandstad,
Trondheim, Norway, Göran Holmberg, Göteborg,
Sweden, Gabriella Cohn Cedermark, Stockholm,
Sweden, Olof Ståhl, Lund, Sweden, Gustav
Thorison, Malmö, Sweden, Anders Kjellman,
Stockholm, Sweden
4:40 PD51-08 NERVE SPARING RETROPERITONEAL
LYMPH NODE DISSECTION IN LOW VOLUME
METASTATIC SEMINOMA
Axel Heidenreich*, Pia Paffenholz, Tim Nestler,
David Pfister, Cologne, Germany
4:50 PD51-09 SURVIVAL IN N3 PENILE CANCER: DOES
PELVIC LYMPHADENOPATHY PREDICT
A WORSE PROGNOSIS THAN INGUINAL
EXTRA-NODAL EXTENSION?
James A. Churchill*, Ashwin Sachdeva, Allaudin
Issa, Craig Jones, Fowz Azhar, Ikenna Aneke,
Noel W. Clarke, Maurice W. Lau, Vijay K. Sangar,
Arie S. Parnham, Manchester, United Kingdom
5:00 PD51-10 PERINEURAL INVASION AS A PROGNOSTIC
INDICATOR FOR EARLY METASTATIC
SPREAD IN PENILE CANCER
Titus Murphy*, Luis Ribeiro, Marta Skrodzka,
Eleni Anastasiadis, Sylvia Yan, Benjamin Ayres,
Nicholas Watkin, London, United Kingdom
205
5:10 PD51-11 CONCOMITANT VS STAGED 5:20 PD51-12 PATTERNS OF RECURRENCE IN
LYMPHADENECTOMY IN CLINICALLY PENILE CANCER: IMPLICATIONS FOR
NODE-POSITIVE PENILE SQUAMOUS CELL SURVEILLANCE STRATEGIES
CARCINOMA: RECURRENCE PATTERNS AND Amandeep Arora*, Gagan Prakash, Mahendra
SURVIVAL OUTCOMES Pal, Uday Chandankhede, Manoj Tummala,
Heather Huelster*, Tampa, FL, Marco Band- Anand Mohan, Ganesh Bakshi, Mumbai, India
ini, Milan, Italy, Oscar Brouwer, Amsterdam,
APPROVED FOR AMA PRA CATEGORY 2
Netherlands, Maarten Albersen, Eduard Roussel,
CREDITSTM
Leuven, Belgium, Hielke de Vries, Amsterdam,
Netherlands, Juan Chipollini, Mounsif Azizi, Tam-
pa, FL, Yao Zhu, Ding-Wei Ye, Shanghai, China,
People’s Republic of, Antonio Ornellas, Rio de Ja-
neiro, Brazil, Mario Catanzaro, Laura Marandino,
Milan, Italy, Oliver Hakenberg, Rostock, Germany,
Axel Heidenreich, Friederike Haidl, Köln, Germa-
ny, Nick Watkin, Michael Ager, London, United
Kingdom, Mohamed Ahmed, Jeffrey Karnes,
Rochester, MN, Alberto Briganti, Roberto Salvioni,
Francesco Montorsi, Andrea Necchi, Milan, Italy,
Philippe Spiess, Tampa, FL

Sunday, May 15, 2022 3:30 pm – 5:30 pm

Video Session 10
ADRENAL & RENAL ONCOLOGY I
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Robert Figenshau, Kristen Scarpato & Michael Staehler

ABSTRACT
TIME NUMBER TITLE
3:30 V10-01 ROBOTIC PARTIAL NEPHRECTOMY IN
TRANSPLANTED KIDNEY: LANDMARKS
AND STEPS
Aaron Kaviani*, Mahmoud Abou Zeinab, Mark
Noble, Alvin Wee, Jihad Kaouk, Mohamed
Eltemamy, Cleveland, OH
3:40 V10-02 ROBOTIC PARTIAL NEPHRECTOMY
WITH REVERSIBLE SELECTIVE ARTERY
ENDOLUMINAL BALLOON OCCLUSION ON A
KIDNEY GRAFT
Patrick-Julien Treacy*, Nice, France, Severine
Lagarde, Al Emadi Ibrahim, Thomas Prudhomme,
Marine Lesourd, Toulouse, France, Rayan Atme,
Matthieu Durand, Imad Bentellis, Nice, France,
Michel Soulié, Nicolas Doumerc, Toulouse, France
3:50 V10-03 3D VIRTUAL MODELS APPLICATION FOR
AN ANATOMIC-FUNCTIONAL APPROACH TO
HIGHLY COMPLEX RENAL TUMORS WITH
IMPERATIVE INDICATIONS TO NEPHRON
SPARING SURGERY
Daniele Amparore*, Angela Pecoraro, Federico Pi-
ramide, Paolo Verri, Enrico Checcucci, Sabrina De
Cillis, Alberto Piana, Matteo Manfredi, Cristian Fiori,
Francesco Porpiglia, Orbassano (Turin), Italy
4:00 V10-04 MINIMALLY-INVASIVE PARTIAL
NEPHRECTOMY EMPLOYING 4K
VISUALIZATION SYSTEM WITH OPAL 1
NEAR-INFRARED AND INDOCYANINE GREEN
TECHNOLOGY
Pietro Diana*, Andrea Gallioli, Alberto Piana,
Angelo Territo, Julia Aumatell, Alejandra Bra-
vo, Josep Maria Gaya, Jordi Huguet, Antonio
Rosales, Francesco Sanguedolce, Pavel Gavrilov,
Joan Palou, Alberto Breda, Barcelona, Spain
ABSTRACT
TIME NUMBER TITLE
4:10 V10-05 UTILIZATION OF A 3D MODEL FOR
REHEARSAL TUMOR RESECTION PRIOR TO
ROBOT ASSISTED LAPAROSCOPIC PARTIAL
NEPHRECTOMY
Pratik Kanabur*, Sagar Patel, Richard E. Link,
Wesley A. Mayer, Houston, TX
4:20 V10-06 ROBOTIZED 3D LAPAROSCOPIC PARTIAL
NEPHRECTOMY FOR RIGHT RENAL
MIDPOLE MASS LESION
Krishna Mohan Ramaswami*, Pankaj Bhirud,
Harigovind Podiyedath, Calicut, India
4:30 V10-07 NEAR-INFRARED FLUORESCENCE IMAGING
TECHNOLOGY APPLICATIONS IN UROLOGIC
SURGERY
Riccardo Mastroianni*, Gabriele Tuderti, Umberto
Anceschi, Alfredo Maria Bove, Aldo Brassetti,
Mariaconsiglia Ferriero, Leonardo Misuraca,
Giuseppe Simone, Rome, Italy
4:40 V10-08 ROBOT-ASSISTED PARTIAL NEPHRECTOMY
OF A RIGHT PELVIC KIDNEY
Nicholas Elliott*, Gaurav Pahouja, Samantha
Jakuboski, Marcus Quek, Maywood, IL
4:50 V10-09 SUTURELESS PURELY OFF-CLAMP ROBOTIC
PARTIAL NEPHRECTOMY: TECHNIQUE AND
PERIOPERATIVE OUTCOMES
Leonardo Misuraca*, Riccardo Mastroianni,
Gabriele Tuderti, Umberto Anceschi, Alfredo Maria
Bove, Aldo Brassetti, Mariaconsiglia Ferriero, Sal-
vatore Guaglianone, Michele Gallucci, Giuseppe
Simone, Rome, Italy

206
5:00 V10-10 ROBOTIC PARTIAL NEPHRECTOMY
FOR COMPLEX RENAL TUMORS; OUR
EXPERIENCE AND TIPS AND TRICKS
Burak Ucpinar*, Shirin Razdan, New York, NY,
Kennedy Okhawere, Indu Saini, New York City,
NY, Tara Tomy, New York, NY, Ketan K. Badani,
New York City, NY
Sunday, May 15, 2022
LATE-BREAKING ABSTRACT II – BENIGN DISEASE
Room 243 @ Ernest N. Morial Convention Center
ABSTRACT
TIME NUMBER TITLE
3:30 LBA02-01 EFFECT OF CANNABIDIOL OIL ON POST-
URETEROSCOPY PAIN FOR URINARY
CALCULI: A RANDOMIZED DOUBLE-BLIND
PLACEBO CONTROLLED TRIAL
Gopal Narang, Olufunmilola Adeleye, Kevin
Wymer, Mitchell Humphreys, Karen Stern
3:40 LBA02-02 DEVELOPMENT OF A MULTIPHASIC
BLADDER PATCH COMPOSED OF
COLLAGEN, AMNIOTIC MEMBRANE, AND
PATIENT-DERIVED EPITHELIAL CELLS
Ilaha Isali, Phillip McClellan, Thomas Wong, Ozan
Akkus, Rachel Pope, Shubham Gupta, Adonis
Hijaz
3:50 LBA02-03 MARKED REDUCTION OF URINARY
EXCRETION OF OSTEOPONTIN IN CHILDREN
WITH UROLITHIASIS AND HYPOCITRATURIA
Larisa Kovacevic, Yegappan Lakshmanan
4:00 LBA02-04 EFFECT OF EXTRACORPOREAL SHOCK
WAVE LITHOTRIPSY COMBINED WITH
EXTRACORPOREAL PHYSICAL VIBRATION
LITHOTRIPSY IN THE TREATMENT OF
PATIENTS WITH URETERAL CALCULI
Han Yang, Xueyu Li, Ke Wang
4:10 LBA02-05 OASIS PIVOTAL TRIAL TO EVALUATE THE
SAFETY AND EFFICACY OF THE RENOVA
ISTIM SYSTEM™ FOR THE TREATMENT OF
WOMEN WITH OAB
Suzette Sutherland, Osvaldo Padron, Kevin
Benson, Rebecca McCrery, Kevin Cline, Philip
Toozs-Hobson, Alessandro Digesu, John Hee-
sakkers
4:20 LBA02-06 AN OPEN SOURCE, NON-INVASIVE, AND
INEXPENSIVE ASSEMBLY FOR AUTOMATIC
HEMATURIA MONITORING IN CONTINUOUS
BLADDER IRRIGATION.
Rohit Malyala, Alireza Habibi, Drew Phillips, Ryan
Yan, Christopher Nguan
*Presenting author
5:10 V10-11 PARTIAL NEPHRECTOMY IN COMPLEX
KIDNEY MASSES-TWO APPROACHES WITH
THE DAVINCI SINGLE PORT ROBOT
John Sheng*, Chrystal Chang, Newark, NJ,
Michael Stifelman, Mutahar Ahmed,
Hackensack, NJ
5:20 V10-12 COMPLEX PARTIAL NEPHRECTOMY IN
SOLITARY KIDNEY
Nimrod Barashi Gozal*, Brijesh Patel, Mark
Biebel, Joseph Ippolito, Robert Figenshau, Saint
Louis, MO
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
3:30 pm – 5:30 pm
SUNDAY
ABSTRACT
TIME NUMBER TITLE
4:30 LBA02-07 DELINEATING THE FAILURE MECHANISM
FOR PHOTONIC LITHOTRIPSY
Ian Houlihan, Prajakatta Mulay, Smitha De, Vijay
Krishna
4:40 LBA02-08 RISK FACTORS FOR INCREASED STENT-
ASSOCIATED SYMPTOMS FOLLOWING
URETEROSCOPY FOR URINARY STONES:
RESULTS FROM THE URINARY STONE DISEASE
RESEARCH NETWORK (USDRN) STENTS STUDY
Jonathan Harper, Hongqiu Yang, Naim Maalouf,
Jodi Antonelli, Alana Desai, Henry Lai, Peter
Reese, Gregory Tasian, Hunter Wessells, Hussein
Al-Khalidi, Ziya Kirkali, Charles Scales
4:50 LBA02-09 INTRACELLULAR SARS-COV-2 FOUND IN
THE SPERMATOZOA OF CONVALESCENT
MEN WITH NEGATIVE PCR SEMEN SAMPLES
REVEALED BY ELECTRON MICROSCOPY
Jorge Hallak, Elia Tamaso Espin Garcia Caldini,
Maria Cássia Jacintho Mendes Corrêa, Marisa
Dolhnikoff, Paulo Hilario Nascimento Saldiva, Es-
per Georges Kallas, Amaro Nunes Duarte Neto,
Raul Segundo Sanchez Gutierrez, Joel R Drevet,
Thiago Afonso Carvalho Celestino Teixeira, Felipe
Saraiva Bernardes, Heloisa Faquineti
5:00 LBA02-10 ASSESSING THE RISKS OF A POSITIVE
URINE CULTURE IN UNCOMPLICATED
RENAL COLIC PATIENTS
Nikhile Mookerji, Matthew Mancuso, Vardhil Gan-
dhi, Efrem Violato, Stacey Broomfield, Tim Wollin,
Trevor Schuler, Shubha De
5:10 LBA02-11 NOVEL ON-DEMAND TREATMENT FOR
LIFELONG PREMATURE EJACULATION
USING TRANSCUTANEOUS PERINEAL MINI-
PATCH STIMULATOR
Ariki Shechter, Nicola Mondaini, Ege Can Serefo-
glu, Tal Gollan, Boaz Appel, Ilan Gruenwald
5:20 LBA02-12 RBFOX2 COPY NUMBER VARIATION
VITIATES URETHRAL CLOSURE CAUSING
HYPOSPADIAS
Victor Ruthig, Fredi Ruiz Rojano, Jeffrey White,
Marisol O’Neill, Dolores Lamb
207
Sunday, May 15, 2022
Moderated Poster Session 49
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: BASIC RESEARCH & PATHOPHYSIOLOGY
Room 228 @ Ernest N. Morial Convention Center
Moderators: Toby Chai & Marcio Averbeck
ABSTRACT
NUMBER TITLE
MP49-01 HUNNER’S LESIONS CORRELATE WITH
A DECREASE AND REDISTRIBUTION
OF MUCOSAL COLLAGEN CONTENT IN
PATIENTS WITH INTERSTITIAL CYSTITIS
Raymond Xu*, Harrison Martin, Dylan T. Wolff,
Wencheng Li, Robert J. Evans, Gopal Badlani,
Catherine A. Matthews, Stephen J. Walker,
Winston-Salem, NC
MP49-02 MODULATION OF SENSORY GLIA GQ-
GPCR SIGNALING IN VIVO AFFECTS
SPONTANEOUS VOIDING AND BLADDER
FUNCTION IN AN ANIMAL MODEL OF
CHRONIC PELVIC PAIN
Alison Xiaoqiao Xie*, Randall Meacham,
Anna Malykhina, Aurora, CO
MP49-03 PANNEXIN 1 CHANNELS PLAY AN
IMPORTANT ROLE IN MECHANISMS OF
DIABETIC BLADDER DYSFUNCTION
Nicole Roselli*, Yi Wang, Marcia Urban-Maldona-
do, Melissa Laudano, Sylvia Suadicani, Bronx, NY
MP49-04 MATRIX METALLOPROTEINASE-9 CONTROLS
SECRETION OF NERVE GROWTH FACTOR
FROM BLADDER CELLS IN VITRO
Aya Hajj, Aalya Hamouda, Stephanie Sir-
makesyan, Philippe Cammisotto, Lysanne Cam-
peau*, Montreal, Canada
MP49-05 INTRAVESICAL NERVE GROWTH
FACTOR-TARGETING THERAPY USING
LIPOSOME-CONJUGATED ANTISENSE IN
RATS WITH STRESS-INDUCED BLADDER
HYPERSENSITIVITY
Tetsuichi Saito*, Matsumoto, Japan, Pradeep Tya-
gi, Taro Igarashi, Pittsburgh, PA, Tomonori Minaga-
wa, Teruyuki Ogawa, Osamu Ishizuka, Matsumoto,
Japan, Naoki Yoshimura, Pittsburgh, PA
MP49-06 SIGNIFICANT DIFFERENCES IN UROTHELIAL
GENE EXPRESSION AMONG WOMEN WITH
UUI
Gabrielle McNary*, Joseph Prinz, Carole Grenier,
Cindy Amundsen, Susan Murphy, Nazema Sid-
diqui, Durham, NC
MP49-07 AUTONOMIC SYMPTOM SCORE IS GREATER
IN INTERSTITIAL CYSTITIS PATIENTS
EXHIBITING A NON-BLADDER-CENTRIC
PHENOTYPE
Dylan T. Wolff*, Peyton Lee, Robert J. Evans,
Gopal Badlani, Catherine A. Matthews, Stephen J.
Walker, Winston-Salem, NC
MP49-08 PRE-CLINICAL APPLICATIONS OF HIGH-
DEFINITION MANOMETRY (HDM) SYSTEM
TO INVESTIGATE PELVIC FLOOR MUSCLE
CONTRIBUTION TO URETHRAL CLOSURE
PRESSURE IN A RABBIT MODEL
Samuel Sorkhi*, Valmik Bhargava, Youngjin Seo,
Kyoko Sakamoto, Mahadevan Rajasekaran, San
Diego, CA
208
4:30 pm – 5:45 pm
ABSTRACT
NUMBER TITLE
MP49-09 OXIDATIVE STRESS DRIVES NOCTURNAL
POLYURIA VIA INTRARENAL SPAK-NCC
PATHWAY: A THERAPEUTIC POTENTIAL
OF A NOVEL ANTIOXIDANT, SILICON
COMPONENT AGENTS
Yosuke Sekii*, Hiroshi Kiuchi, Takahiro Imana-
ka, Sohei Kuribayashi, Koichi Okada, Kentaro
Takezawa, Shinichiro Fukuhara, Norio Nonomura,
Suita, Japan
MP49-10 EFFECTS OF CONSTANT ILLUMINATION ON
MOUSE VOIDING BEHAVIOR
Whitney Clearwater*, Yi Wang, Marcia Urban-Mal-
donado, Sylvia Suadicani, Bronx, NY
MP49-11 FIDGETIN-LIKE 2 (FL2) DEPLETION AT THE
SITE AND TIME OF CAVERNOUS NERVE
INJURY IMPROVES BLADDER FUNCTIONAL
OUTCOMES
Yi Wang, Moses Tar, Marcia Urban-Maldonado,
Lisa Baker, David Sharp, Sylvia Suadicani, Kelvin
Davies*, Bronx, NY
MP49-12 A NOVEL BLADDER FIBROSIS PATHWAY
THROUGH PDGFRα+ CELLS ASSOCIATED
WITH ESTROGEN DEFICIENCY AND
REPLACEMENT
Ken Lee*, Masatoshi Eto, Fukuoka, Japan, Ken-
ton Sanders, Sang don Koh, Reno, NV
MP49-13 BLADDER-CENTRIC INTERSTITIAL CYSTITIS/
BLADDER PAIN SYNDROME PATIENTS
EXHIBIT A VARIABLE BLADDER MUCOSAL
FIBROSIS-RELATED GENE EXPRESSION
PROFILE BASED ON HUNNER’S LESION
STATUS
Dylan T. Wolff*, Raymond Xu, Sarah Wachtman,
Robert J. Evans, Gopal Badlani, Catherine A.
Matthews, Stephen J. Walker, Winston-Salem, NC
MP49-14 NEW TECHNIQUE FOR VIDEO
URODYNAMICS IN MICE ALLOWS NEW
INSIGHTS INTO THE ROLE OF ION CHANNEL
TRPV4 IN THE MURINE LOWER URINARY
TRACT
Helene De Bruyn*, Noémie Luyts, Thomas Voets,
Wouter Everaerts, Leuven, Belgium
MP49-15 OVERACTIVE BLADDER MEDICATION;
HOW LONG SHOULD IT BE CONTINUED? -
MIRABEGRON INTERFERES WITH CENTRAL
SENSITIZATION IN A MOUSE MODEL OF
OVERACTIVE BLADDER
Joonbeom Kwon*, Eun-Ju Lee, Hye-Ri Park,
Hyun-Jung Cho, Ji-Ae Jang, Daegu, Korea, Re-
public of, Donghwi Park, Ulsan, Korea, Republic
of, Naoki Yoshimura, Pittsburgh, PA
 MP49-16 IMPAIRED UROTHELIAL BARRIER FUNCTION
INDUCED LOWER URINARY TRACT
DYSFUNCTION BY PROTEASE-ACTIVATED
RECEPTER 2 ACTIVATION
Hidenori Akaihata*, Yusuke Hakozaki, Hiroki Nat-
suya, Tomoyuki Kumekawa, Shunsuke Yoshioka,
Hitomi Imai, Akifumi Onagi, Kanako Matsuoka,
Tomoyuki Koguchi, Junya Hata, Yuichi Sato,
Masao Kataoka, Yoshiyuki Kojima, Fukushima,
Japan
MP49-17 PUDENDAL NERVE MAPPING AND
THE USE OF URODYNAMICS TO
EXAMINE THE EFFECTS OF PUDENDAL
NEUROMODULATION
Priyanka Gupta*, Po-Ju Chen, Amador Lagunas,
Luis C. Ruiz, Anagha Kotkar, Gaurang Shah,
Scott F. Lempka, Tim M. Bruns, Ann Arbor, MI
MP49-18 NITRIC OXIDE CONTROLS NGF SECRETION
IN BLADDER CELLS IN VITRO THROUGH
MATRIX METALLOPROTEINASES
Stephanie Sirmakesyan, Aya Hajj, Aalya Ham-
ouda, Philippe Cammisotto, Lysanne Campeau*,
Montreal, Canada
Sunday, May 15, 2022
Moderated Poster Session 50
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY III
Room 225 @ Ernest N. Morial Convention Center
Moderators: R. Houston Thompson, David Duchene & Jeffrey Cadeddu
ABSTRACT
NUMBER TITLE
MP50-01 PROGNOSTIC IMPACT OF PATHOLOGICAL
RENAL PARENCHYMAL INFILTRATION IN
NON-METASTATIC CLEAR CELL RENAL CELL
CARCINOMA
Hajime Tanaka*, Yuki Fukawa, Kouhei Yamamoto,
Shohei Fukuda, Sho Uehara, Soichiro Yoshida,
Minato Yokoyama, Yoh Matsuoka, Tokyo, Japan,
Steven C. Campbell, Cleveland, OH, Yasuhisa
Fujii, Tokyo, Japan
MP50-02 HOW IMPORTANT ARE MORPHOLOGIC
SUBTYPES ON THE PROGNOSIS OF
SURGICALLY TREATED NON-METASTATIC
PAPILLARY RENAL CELL CARCINOMA? AN
ANALYSIS FROM A CONTEMPORARY MULTI-
INSTITUTIONAL DATABASE
Selcuk Erdem*, Istanbul, Turkey, Umberto Cap-
itanio, Milan, Italy, Riccardo Campi, Florence,
Italy, Daniele Amparore, Turin, Italy, Maria Carme
Mir, Valencia, Spain, Eduard Roussel, Leuven,
Belgium, Nicola Pavan, Trieste, Italy, Onder Kara,
Kocaeli, Turkey, Tobias Klatte, Berlin, Germany,
Enes Degirmenci, Resat Aydin, Istanbul, Turkey,
Andrea Minervini, Sergio Serni, Alessandro Berni,
Florence, Italy, Giacomo Rebez, Trieste, Italy,
Faruk Ozcan, Istanbul, Turkey
*Presenting author
MP49-19 TIME COURSE CHANGES IN VOIDING
INTERVAL IN RATS WITH FOCAL
CEREBRAL INFARCTION INDUCED BY
PHOTOCHEMICALLY-INDUCED THROMBOSIS
Yuya Ota*, Yasue Kubota, Yuji Hotta, Mami Mat-
sumoto, Nayuka Matsuyama, Taiki Kato, Takashi
Hamakawa, Tomoya Kataoka, Kazunori Kimura,
Kazunobu Sawamoto, Takahiro Yasui, Nagoya,
Japan
MP49-20 UROTYPES IN YOUNG WOMEN WITH PELVIC
PAIN: A PILOT ANALYSIS OF CLINICAL
URINARY MICROBIOME CLASSIFICATION
James M. Weinberger*, L. Marcella Henao,
Crystal Cisneros, James E. Ackerman, A. Lenore
Ackerman, Los Angeles, CA
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
SUNDAY
4:30 pm – 5:45 pm
ABSTRACT
NUMBER TITLE
MP50-03 SYSTEMATIC DEFINITION OF TREATMENT
MODALITY AND CLINICAL OUTCOMES
REPORTING SYSTEM IN CASE OF SURGICAL
TREATMENT FOR VON HIPPEL-LINDAU
RENAL CELL CARCINOMA
Alessandro Larcher, Federico Belladelli*, Andrea
Ieva, Isaline Rowe, Giuseppe Fallara, Daniele
Cignoli, Gianmarco Colandrea, Miriam Santan-
gelo, Roberta Lucianò, Claudio Doglioni, Stefano
Clerici, Laura Castellino, Anna Damascelli, Giorgia
Guazzarotti, Francesco De Cobelli, Andrea Necchi,
Daniele Raggi, Roberto Bertini, Francesco Montor-
si, Umberto Capitanio, Andrea Salonia, Milan, Italy
MP50-04 MULTIMODAL IMAGE-GUIDED ABLATION
ON MANAGEMENT OF RENAL CANCER IN
VON-HIPPEL-LINDAU (VHL) SYNDROME
PATIENTS FROM 2004 TO 2021 AT A
SPECIALIST CENTRE: A LONGITUDINAL
OBSERVATIONAL STUDY
Vinson Wai-Shun Chan*, James Lenton, Jonathan
Smith, Satinder Jagdev, Christy Ralph, Naveen
Vasudev, Selina Bhattarai, Andrew Lewington, Mi-
chael Kimuli, Jon Cartledge, Tze Min Wah, Leeds,
United Kingdom
MP50-05 ORDER OF THROMBECTOMY FOR
MANAGEMENT OF RENAL CELL
CARCINOMA WITH INFERIOR VENA
CAVA THROMBUS
Yudai Ishiyama*, Tsunenori Kondo, Arakawa,
Japan, Kazuhiko Yoshida, Junpei Iizuka, Kazunari
Tanabe, Toshio Takagi, Tokyo, Japan
209
 MP50-06 RADICAL NEPHRECTOMY AND CAVAL
THROMBECTOMY WITH HEART BEATING
TECHNIQUE FOR RENAL CELL CANCER
WITH TUMOR THROMBUS EXTENSION INTO
INFERIOR VENA CAVA AND RIGHT ATRIUM:
A LESS INVASIVE MULTIDISCIPLINARY
APPROACH
Sonia Guzzo, Sebastiano Nazzani*, Chiara
Vaccaro, Roberto Di Benedetto, Claudia Signorini,
Damiano Vizziello, Andrea Conti, Elisabetta Fin-
kelberg, Giacomo Bortolussi, Pietro Acquati, Carlo
De Vincentiis, Luca Carmignani, Milan, Italy
MP50-07 IMPLICATIONS OF POSITIVE SURGICAL
MARGINS FOLLOWING ROBOTIC PARTIAL
NEPHRECTOMY
Sij Hemal*, Mahmoud Abou Zeinab, Alp Tuna
Beksac, Jayram Krishnan, Cleveland, OH, Amr
Fergany, Sebastian, FL, Robert Stein, Georg-
es-Pascal Haber, Jihad Kaouk, Cleveland, OH
MP50-08 THE PROGNOSTIC SIGNIFICANCE OF
LYMPH NODE DISSECTION IN PATIENTS
WITH NON-METASTATIC RENAL CELL
CARCINOMA WHO UNDERWENT CURATIVE
NEPHRECTOMY: A RETROSPECTIVE, LONG-
TERM FOLLOW-UP, MULTICENTER STUDY
CARCINOMA (NMRCC) WHO UNDERWENT
CURATIVE NEPHRECTOMY
Sung Han Kim*, Jinsoo Chung, Hyung Ho Lee,
Boram Park, Goyangsi, Korea, Republic of, Seok
Soo Byun, Seongnamsi, Korea, Republic of,
Chang Wook Chung, Sung Hoo Hong, Seoul,
Korea, Republic of, Eu Chang Hwang, Hwasun,
Korea, Republic of, Cheol Kwack, Seoul, Korea,
Republic of
MP50-09 IMAGING INTENSITY AFTER SURGERY FOR
CLEAR CELL RENAL CELL CARCINOMA
Alberto Martini*, Federico Belladelli, Daniele
Cignoli, Giuseppe Rosiello, Giuseppe Fallara,
Giuseppe Basile, Luigi Nocera, Gianmarco
Colandrea, Daniela Canibus, Chiara Re, Giacomo
Musso, Francesco Cei, Francesco De Cobel-
li, Giorgio Brembilla, Alberto Briganti, Roberto
Bertini, Daniele Raggi, Andrea Necchi, Francesco
Montorsi, Andrea Salonia, Alessandro Larcher,
Umberto Capitanio, Milan, Italy
MP50-10 RISKS AND BENEFITS OF PARTIAL
NEPHRECTOMY WITH LIMITED OR WITHOUT
ISCHEMIA TIME
Alessandro Larcher, Daniele Cignoli*, Giuseppe
Fallara, Giuseppe Rosiello, Giuseppe Basile,
Gianmarco Colandrea, Gianfranco Baiamon-
te, Francesco Cei, Giacomo Musso, Daniela
Canibus, Roberto Bertini, Milan, Italy, Pierre
I. Karakiewicz, Montreal, Canada, Alexandre
Mottrie, Aalst, Belgium, Federico Dehò, Varese,
Italy, Andrea Gallina, Francesco Montorsi, Andrea
Salonia, Umberto Capitanio, Milan, Italy
210
MP50-11 HEAD TO HEAD COMPARISON BETWEEN
OFF-CLAMP VS ON-CLAMP RAPN IN HIGH-
RISK RENAL SCORE KIDNEY TUMORS
Rocco Simone Flammia*, Umberto Anceschi,
Antonio Tufano, Gabriele Tuderti, Rome, Italy,
Alexander Kutikov, Robert G. Uzzo, Philadelphia,
Philippines, Francesco Porpiglia, Cristian Fiori,
Turin, Italy, Andrea Minervini, Florence, Italy,
Umberto Capitanio, Milan, Italy, Riccardo Autori-
no, Richmond, VA, Michele Gallucci, Costantino
Leonardo, Giuseppe Simone, Rome, Italy
MP50-12 BODY MASS INDEX, OBESITY AND ACUTE
KIDNEY INJURY AFTER ROBOT-ASSISTED
PARTIAL NEPHRECTOMY: RESULTS FROM A
HIGH-VOLUME ROBOTIC CENTER
Marco Paciotti*, Carlo Andrea Bravi, Milan, Italy,
Luca Sarchi, Modena, Italy, Angelo Mottaran, Pi-
etro Piazza, Bologna, Italy, Alberto Martini, Milan,
Italy, Fernando Gonzalez Meza, Marco Corsetti,
Ghent, Belgium, Sophie Knipper, Hamburg, Ger-
many, Marco Amato, Modena, Italy, Rui Farinha,
Ghent, Belgium, Stefano Puliatti, Modena, Italy,
Simone Scarcella, Celine Sinatti, Ghent, Belgium,
Geert De Naeyer, Ruben De Groote, Alexandre
Mottrie, Aalst, Belgium
MP50-13 FEASIBILITY AND OPTIMAL SETTING OF
ROBOT-ASSISTED PARTIAL NEPHRECTOMY
USING A NOVEL MULTI-ARM, MODULAR
ROBOTIC PLATFORM
Carlo Andrea Bravi*, Milan, Italy, Luca Sarchi,
Modena, Italy, Angelo Mottaran, Pietro Piaz-
za, Bologna, Italy, Fernando Gonzalez Meza,
Marco Corsetti, Ghent, Belgium, Sophie Knipper,
Hamburg, Germany, Marco Paciotti, Milan, Italy,
Marco Amato, Modena, Italy, Rui Farinha, Ghent,
Belgium, Stefano Puliatti, Modena, Italy, Simone
Scarcella, Ghent, Belgium, Geert De Naeyer, Ru-
ben De Groote, Alexandre Mottrie, Aalst, Belgium
MP50-14 SINGLE PORT VS MULTI PORT ROBOTIC RENAL
SURGERY: ANALYSIS OF PERIOPERATIVE
OUTCOMES FOR EXCISION OF HIGH AND LOW
COMPLEXITY RENAL MASSES
Grant Henning*, Joel Vetter, Nicholas Pickersgill,
Arjun Sivaraman, R. Sherburne Figenshau, Eric
Kim, St. Louis, MO
MP50-15 DEVELOPMENT AND VALIDATION OF AN
OBJECTIVE SCORING TOOL FOR ROBOT
ASSISTED PARTIAL NEPHRECTOMY:
SCORING FOR PARTIAL NEPHRECTOMY
(SPAN)
Umar Iqbal, Philippa Doherty, Ahmed S. Elsayed,
Zhe Jing, Buffalo, NY, Craig Rogers, Detroit, MI,
Ronald Boris, Indianapolis, IN, James Porter,
Seattle, WA, Mohammad Allaf, Baltimore, MD,
Ketan K. Badani, New York, NY, Michael Stifel-
man, Hackensack, NJ, Jihad Kaouk, Cleveland,
OH, Tomoaki Terakawa, Nobuyuki Hinata, Kobe,
Japan, Ahmed A. Aboumohamed, Bronx, NY,
Eric C. Kauffman, Qiang Li, Buffalo, NY, Ronney
Abaza, Columbus, OH, Khurshid A. Guru, Ahmed
A. Hussein, Buffalo, NY, Daniel Eun, Philadelphia,
PA, Ayat Shah*, Buffalo, NY
 MP50-16 ASSESSING THE ROLE OF OFF-CLAMP
ROBOTIC PARTIAL NEPHRECTOMY IN THE
SETTING OF LOW COMPLEXITY RENAL
TUMORS: PROPENSITY SCORE-MATCHED
ANALYSIS OF A MULTICENTER DATABASE
Gabriele Tuderti*, Riccardo Mastroianni, Umberto
Anceschi, Alfredo Maria Bove, Aldo Brassetti,
Mariaconsiglia Ferriero, Leonardo Misuraca,
Salvatore Guaglianone, Rome, Italy, Riccardo
Autorino, Richmond, VA, Ava Saidian, Ithaar
Derweesh, John Perry, San Diego, La Jolla, CA,
Andrea Mari, Andrea Minervini, Florence, Italy,
Manuela Costantini, Michele Gallucci, Giuseppe
Simone, Roma, Italy
MP50-17 PROSPECTIVE COMPARATIVE STUDY TO
EVALUATE THE CLINICAL UTILITY OF IRIS
3-D ANATOMICAL MODELING SOFTWARE
FOR PREOPERATIVE SURGICAL PLANNING
AND INTRA-OPERATIVE NAVIGATION FOR
ROBOT ASSISTED PARTIAL NEPHRECTOMY
(RAPN): A PRELIMINARY ANALYSIS
Ahmed Ghazi*, Rochester, NY, Tanner Corse,
Hackensack, NJ, Thomas Osinski, Thomas Frye,
William Tabayoyong, Rochester, NY, Linda Dayan,
Ravi Munver, Hackensack, NJ, Hani Rashid,
Jean Joseph, Rochester, NY, Michael Stifelman,
Hackensack, NJ
Sunday, May 15, 2022
Moderated Poster Session 51
PROSTATE CANCER: STAGING
Room 222 @ Ernest N. Morial Convention Center
Moderator: Chad Ritch
ABSTRACT
NUMBER TITLE
MP51-01 HOW MANY LYMPH NODES COULD WE
SAVE IN PROSTATE CANCER STAGING
LYMPHADENECTOMY?
Javier Pérez Ardavín*, Manuel Martínez-Sarmien-
to, Juan José Monserrat-Monfort, Jose Vicente
Sanchez-Gonzalez, Victor Vera-Pinto, Valencia,
Spain, Pilar Bello-Arqués, València, Spain, Fran-
cisco Boronat-Tormo, César David Vera Donoso,
Valencia, Spain
MP51-02 PROSPECTIVE STUDY TO EVALUATE THE
PROGNOSTIC VALUE OF NODAL DISEASE IN
PROSTATE CANCER?
Javier Pérez Ardavín*, Manuel Martínez-Sarmien-
to, Juan José Monserrat-Monfort, Jose Vicente
Sanchez-Gonzalez, Victor Vera-Pinto, Valencia,
Spain, Pilar Bello-Arqués, València, Spain, Fran-
cisco Boronat-Tormo, César David Vera Donoso,
Valencia, Spain
*Presenting author
MP50-18 EFFICACY AND FEASIBILITY OF ROBOT-
ASSISTED PARTIAL NEPHRECTOMY FOR
OCTOGENARIANS: COMPARISON WITH
YOUNGER COUNTERPARTS
Yudai Ishiyama*, Tsunenori Kondo, Arakawa,
Japan, Kazuhiko Yoshida, Junpei Iizuka, Kazunari
Tanabe, Toshio Takagi, Tokyo, Japan
MP50-19 PREDICTORS OF EMERGENCY
NEPHRECTOMY FOR RENAL CELL
CARCINOMA
Emily Ellmann*, Oussama Darwish, Ali Houjaij,
Zafar Dalimov, Buffalo, NY, Mohamad Shahait,
Amman, Jordan, Nader Nader, Buffalo, NY
MP50-20 SURGICAL MANAGEMENT AND OUTCOMES
OF NATIVE UPPER URINARY TRACT
UROTHELIAL CARCINOMA AFTER KIDNEY
TRANSPLANTATION
Shi-Jie Tsai*, Eric Yi-Hsiu Huang, Tzu-Hao
Huang, Tzu-Chun Wei, Chih-Chieh Lin, Tzu-Ping
SUNDAY
Lin, Hsiao-Jen Chung, William J.S. Huang, Yen-
Hwa Chang, Taipei, Taiwan
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
4:30 pm – 5:45 pm
ABSTRACT
NUMBER TITLE
MP51-03 DEVELOPMENT OF A NOVEL NOMOGRAM TO
IDENTIFY CANDIDATES FOR EXTENDED PELVIC
LYMPH-NODE DISSECTION IN PROSTATE
CANCER USING MRI AND PSMA PET
Dennie Meijer*, André Vis, Amsterdam, Neth-
erlands, Matthew Roberts, Amila Siriwardana,
Andrew Morton, John Yaxley, Hemamali Sa-
maratunga, Brisbane, Australia, Louise Emmett,
Darlinghurst, Australia, Peter van de Ven, Martijn
Heijmans, Henk Van der Poel, Maarten Donswijk,
Thierry Boellaard, Ivo Schoots, Daniela Oprea-La-
ger, Amsterdam, Netherlands, Geoffrey Coughlin,
Brisbane, Australia, Pim van Leeuwen, Amster-
dam, Netherlands
MP51-04 P-SCORE IN PREOPERATIVE BIOPSIES
ACCURATELY PREDICTS P-SCORE IN FINAL
PATHOLOGY AT RADICAL PROSTATECTOMY
Pontus Röbeck*, Uppsala, Sweden, Li-Di Xu, Dil-
ruba Ahmed, Stockholm, Sweden, Anca Dragomir,
Pär Dahlman, Sam Ladjevardi, Michael Häggman,
Uppsala, Sweden
211
 MP51-05 IMPACT OF CLINICAL STAGING BASED MP51-10 ONCOLOGIC OUTCOMES AFTER RADICAL
ON DRE VS IMAGING (TRUS/MRI) IN A PROSTATECTOMY FOR LOCALIZED
LOCALIZED PROSTATE CANCER RISK PROSTATE CANCER: CLASSIFICATION
ASSESSMENT NOMOGRAM ACCORDING TO PROSTATE MAGNETIC
Kevin Chang*, Scott Greenberg, Janet Cowan, RESONANCE IMAGING FINDINGS
Katsuto Shinohara, Hao Nguyen, Matthew Coop- Jin Hyuck Kim, Gyoohwan Jung*, Hwanik Kim,
erberg, Peter Carroll, San Francisco, CA Jung Kwon Kim, Hakmin Lee, Jong Jin Oh,
MP51-06 PIRADS SCORE COMBINED WITH POSITIVE Sangchul Lee, Seong Jin Jeong, Seok-Soo Byun,
CORE NUMBER ON MRI-ULTRASOUND Sung Kyu Hong, Seongnam, Korea, Republic of
FUSION TARGETED PROSTATE BIOPSY CAN
MP51-11 HAS THE INTRODUCTION OF MPMRI
PREDICT THE ABSENCE OF PATHOLOGICAL
IN THE DIAGNOSTIC PATHWAY OF
EXTRAPROSTATIC EXTENSION
PROSTATE CANCER LED TO IMPROVED
Masaki Kobayashi*, Yoh Matsuoka, Sho Uehara,
ONCOLOGICAL OUTCOMES AFTER RADICAL
Hiroshi Tanaka, Yuki Nakamura, Yusuke Uchida,
PROSTATECTOMY? RESULT FROM A LARGE
Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida,
SINGLE-INSTITUTIONAL SERIES
Minato Yokoyama, Yasuhisa Fujii, Tokyo, Japan
Armando Stabile*, Elio Mazzone, Gabriele Sorce,
MP51-07 THE PROGNOSTIC VALUE OF THE NUMBER Francesco Barletta, Luigi Nocera, Vito Cucchiara,
OF POSITIVE TARGETED CORES IN MEN Milan, Italy, Emanuele Zaffuto, Federico Dehò,
WITH POSITIVE MULTIPARAMETRIC Varese, Italy, Donato Cannoletta, Mario De
MAGNETIC RESONANCE IMAGING OF THE Angelis, Simone Scuderi, Giorgio Gandaglia,
PROSTATE. RESULTS FROM A LARGE, Milan, Italy, Giuseppe Rosiello, Antony Pellegrino,
MULTI-INSTITUTIONAL SERIES Milano, Italy, Nicola Fossati, Lugano, Switzerland,
Armando Stabile*, Elio Mazzone, Giorgio Nazareno Suardi, Genoa, Italy, Francesco De
Gandaglia, Milan, Italy, Guillaume Ploussard, Raz- Cobelli, Antonio Esposito, Giorgio Brembilla,
van-George Rahota, Toulouse, France, Massimo Milan, Italy, Shahrokh Shariat, Vienna, Austria,
Valerio, Lausanne, Switzerland, Riccardo Campi, Francesco Montorsi, Alberto Briganti, Milan, Italy
Andrea Mari, Florence, Italy, Agostino Mattei,
MP51-12 THE ADDED VALUE OF MICROUS FOR THE
Lucerne, Switzerland, Giancarlo Marra, Turin,
PREOPERATIVE STAGING OF PROSTATE
Italy, Jean Baptiste Beauval, Mathieu Roumiguiè,
CANCER: AN UPDATE OF A SINGLE-
Toulouse, France, Luca Afferi, Lucerne, Italy,
INSTITUTIONAL PROSPECTIVE SERIES
Marco Moschini, Lucerne, Switzerland, Paolo
Vittorio Fasulo*, Edoardo Beatrici, Luca Disconzi,
Gontero, Turin, Italy, Roderick van den Bergh,
Pier Paolo Avolio, Nicola Frego, Pietro Diana,
Utrecht, Netherlands, Junlong Zhuang, Hongqian
Marco Paciotti, Davide Maffei, Alessandro Uleri,
Tuo, Jiangsu, China, People’s Republic of, Nicola
Cesare Saitta, Paola Arena, Giuseppe Chiarelli,
Fossati, Lugano, Switzerland, Francesco Montor-
Andrea Gobbo, Milan, Italy, Alberto Saita, Rodolfo
si, Alberto Briganti, Milan, Italy
Hurle, Massimo Lazzeri, Milano, Italy, Giorgio
MP51-08 DOES A POSITIVE MULTI-PARAMETRIC MRI Guazzoni, Milan, Italy, Paolo Casale, Milano, Italy,
ALWAYS WARRANT PROSTATE BIOPSY? THE Nicolò Maria Buffi, Giovanni Lughezzani,
IMPORTANCE OF INTEGRATING CLINICAL Milan, Italy
AND IMAGING DATA BASED ON A LARGE,
MP51-13 FLUORINE-18 (18F) PROSTATE-SPECIFIC
MULTI-INSTITUTIONAL SERIES
MEMBRANE ANTIGEN (PSMA) POSITRON
Armando Stabile*, Giorgio Gandaglia, Elio
EMISSION TOMOGRAPHY (PET) AND THE
Mazzone, Francesco Barletta, Simone Scu-
DIAGNOSIS AND STAGING OF PRIMARY
deri, Daniele Robesti, Giuseppe Cirulli, Donato
PROSTATE CANCER (PCA)
Cannoletta, Francesco Pellegrino, Luigi Nocera,
Matthew Byrne*, Nithesh Ranasinha, Claudia
Gabriele Sorce, Mario De Angelis, Carlo Andrea
Mercader, Mutie Raslan, Francesca Lewis,
Bravi, Milan, Italy, Alberto Martini, Milano, Italy,
Stefanos Gorgoraptis, Ganesh Sathanapally, Ana
Thomas Seisen, Morgan Roupret, Paris, France
Catarina Lopes Vieira, Golebka Jedrzej, Bryony
- Metropolitan, Jeffrey R. Karnes, Rochester,
Peiris, Mark Tuthill, Andrew Protheroe, Philip
MN, Nicola Fossati, Lugano, Switzerland,
Camilleri, Phil Turner, Gerard Andrade, Saiful
Francesco De Cobelli, Antonio Esposito, Giorgio
Miah, Tom Leslie, Richard Bryant, Freddie Hamdy,
Brembilla, Francesco Montorsi, Alberto Briganti,
Ruth MacPherson, Fergus Gleeson, Alastair D.
Milan, Italy
Lamb, Oxford, United Kingdom
MP51-09 THE UTILITY OF NOVEL QUANTIFICATION
USING IMAGING SOFTWARE FOR
ANALYZING WHOLE-BODY MAGNETIC
RESONANCE IMAGING OF PATIENTS WITH
METASTATIC PROSTATE CANCER
Yuki Kohada*, Nozomi Satani, Yasuhiro Kaiho,
Sendai, Japan, Hiromichi Iwamura, Hirosaki,
Japan, Takashi Kukimoto, Masaaki Oikawa, Jun
Ito, Tomonori Matsuura, Sendai, Japan, Nobuyuki
Hinata, Hiroshima, Japan, Kaneki Koyama, Mako-
to Sato, Sendai, Japan

212
 MP51-14 IMPACT OF 68GA-PSMA PET/CT AND
METASTASIS-DIRECTED THERAPY ON
CLINICAL RECURRENCE IN PATIENTS
WITH BIOCHEMICAL RECURRENCE AFTER
RADICAL PROSTATECTOMY. RESULTS FROM
A SINGLE CENTER SERIES
Elio Mazzone*, Daniele Robesti, Giorgio
Gandaglia, Armando Stabile, Simone Scuderi,
Alberto Martini, Carlo Andrea Bravi, Milano, Italy,
Gabriele Sorce, Francesco Pellegrino, Luigi
MP51-18 TRENDS OF PRIMARY STAGING FOR
Nocera, Milan, Italy, Giuseppe Rosiello, Lucia
D’Ambrosio, Milano, Italy, Giuseppe Cirulli, Milan,
Italy, Laura Marandino, Daniele Raggi, Andrea
Necchi, Milano, Italy, Vincenzo Mirone, Napoli,
Italy, Francesco Montorsi, Alberto Briganti,
Milano, Italy
MP51-15 THE ROLE OF 68GA-PSMA- AND 68GA-DOTA-
RM2 PET/MRI IN THE PRIMARY STAGING OF
HIGH-RISK PROSTATE CANCER PATIENTS
MP51-19 PATHOLOGIC GLEASON GRADE GROUP
UNDERGOING RADICAL PROSTATECTOMY.
MP51-17 DEMOGRAPHICS AND SOCIOECONOMIC
DESCRIPTION OF PATIENTS WITH
PROSTATE CANCER IN WHOM A PROSTATE-
SPECIFIC MEMBRANE ANTIGEN PET WAS
PERFORMED: A SINGLE-INSTITUTION,
RETROSPECTIVE ANALYSIS IN NYC
Juana Martinez*, Kritika Subramanian, Mu-
hammad Niaz, Ted Getz, Amie Patel, Joseph
Osborne, Scott Tagawa, NY, NY
NEWLY DIAGNOSED PROSTATE CANCER
– ASSESSING THE UPTAKE OF PROSTATE
SPECIFIC MEMBRANE ANTIGEN POSITRON
EMISSION TOMOGRAPHY: A POPULATION
BASED ANALYSIS
Marlon Perera*, Nathan Papa, Declan Murphy,
Nathan Lawrentschuk, Melanie Evans, Jeremy
Millar, Damien Bolton, Melbourne, Australia

SUNDAY
1 IN BLACK MEN IMPLICATIONS FOR
PRELIMINARY RESULTS OF A PROSPECTIVE,
RENAMING IT “NOT CANCER” IN HIGH-RISK
SINGLE CENTER STUDY
POPULATIONS
Vito Cucchiara, Paola Mapelli*, Samuele Ghezzo,
Courtney Berg*, Newark, NJ, Matthew DeMasi,
Ana Maria Samanes Gajate, Enrico Camisassa,
Bronx, NY, Amjad Alwaal, Robert Weiss, Evan
Sabrina Comana, Erik Preza, Giorgio Brembilla,
Kovac, Newark, NJ
Naghia Ahmed, Carolina Bezzi, Luca Presot-
to, Valentino Bettinardi, Annarita Savi, Patrizia MP51-20 THE ASSOCIATION OF TYPE AND NUMBER
Magnani, Raffaele Menichini, Angela Coliva, OF D’AMICO HIGH-RISK CRITERIA WITH
Ilaria Neri, Ettore Di Gaeta, Luigi Gianolli, Giorgio RATES OF PATHOLOGICALLY NON ORGAN
Gandaglia, Francesco Montorsi, Alberto Briganti, CONFINED PROSTATE CANCER
Francesco De Cobelli, Paola Scifo, Maria Picchio, Francesco Chierigo*, Genova, Italy, Rocco
Milan, Italy Simone Flammia, Rome, Italy, Gabriele Sorce,
Milan, Italy, Benedikt Hoeh, Frankfurt, Germany,
MP51-16 THE RISK OF RECURRENCE IN CN1
Lukas Hohenhorst, Hamburg, Germany, Zhe
PROSTATE CANCER PATIENTS TREATED
Tian, Fred Saad, Montreal, Canada, Markus
WITH RADICAL PROSTATECTOMY VARIES
Graefen, Hamburg, Germany, Michele Gallucci,
ACCORDING TO THE TYPE PREOPERATIVE
Rome, Italy, Alberto Briganti, Francesco Montorsi,
STAGING. A COMPARISON BETWEEN
Milan, Italy, Felix K.H. Chun, Frankfurt, Germany,
68GA-PSMA-PET VERSUS CONVENTIONAL
Shahrokh F. Shariat, Vienna, Austria, Guglielmo
IMAGING IN A LARGE, MULTI-
Mantica, Maro Borghesi, Nazareno Suardi, Carlo
INSTITUTIONAL STUDY
Terrone, Genova, Italy, Pierre I Karakiewicz,
Gabriele Sorce*, Milan, Italy, Giuseppe Rosiel-
Montreal, Canada
lo, Milano, Italy, Giorgio Gandaglia, Milan, Italy,
Simone Scuderi, Milano, Italy, Lorenzo Bianchi, APPROVED FOR AMA PRA CATEGORY 1.25
Riccardo Schiavina, Bologna, Italy, Bram Vansev- CREDITSTM
enant, Gaëtan Devos, Leuven, Belgium, Armando
Stabile, Riccardo Leni, Daniele Robesti, Elio
Mazzone, Antony Pellegrino, Milano, Italy, Nicola
Fossati, Lugano, Switzerland, Lucia D’Ambrosio,
Milano, Italy, Andrea Gallina, Lugano, Switzer-
land, Marta Picozzi, Milan, Italy, Manuela Tutolo,
Alberto Martini, Milano, Italy, Steven Joniau, Leu-
ven, Belgium, Jeffrey R. Karnes, Rochester, MN,
Francesco Montorsi, Alberto Briganti, Milano, Italy

*Presenting author 213

NOTES
NOTES
NOTES
 MP = Moderated Poster Session, PD = Podium Session

Monday, May 16, 2022 Plenary: Prime Time Monday Morning Session 7:30 am – 11:30 am
Great Hall A @ Ernest N. Morial Convention Center
7:30 PANEL DISCUSSION: RENAL TRAUMA MANAGEMENT
Moderator: Judith Hagedorn
Panelists: Steven Hudak, Benjamin Breyer, Rachel Moses
7:50
PANEL DISCUSSION: BULBAR URETHRAL STRICTURES 101: A REVIEW OF THE GUIDELINES AND BASIC
MANAGEMENT OPTIONS FOR BULBAR
Moderator: Dmitriy Nikolavsky
Panelists: Amanda Chung, Matthias Hofer, Lindsay Hampson, Cooper Benson
8:15 SURGICAL TECHNIQUES: ARTIFICIAL URINARY SPHINCTER PLACEMENT
Moderator: Brian Flynn
Panelists: Keith Rourke, Sean Elliott
9:05 LAPAROSCOPIC ROBOTIC SURGICAL SYSTEMS – EMERGING SYSTEMS IN UROLOGY USE
Moderator: Duke Herrell
Panelists: Prokar Dasgupta, Kevin de Laet, Ryoichi Joe Shiroki, Liqun Zhou, Koon Ho Rha, Alexandre Mottrie,
Simone Crivellaro, Ashok Hemal
10:10 PANEL DISCUSSION: INTRA-OPERATIVE NAVIGATION TOOLS FOR ROBOT-ASSISTED SURGERY
Moderator: Chandru Sundaram
Panelists: Ahmed Ghazi
10:35
PANEL DISCUSSION: USES OF APPS IN UROLOGY: CLINIC VISITS, INPATIENT, OFFICE-BASED PROCEDURES,
INDEPENDENT PRACTICE
Moderator: Kyle Richards
Panelists: Stacy Loeb, Matthew Resnick

MONDAY
11:05
STATE-OF-THE-ART LECTURE: DIGITAL HEALTH INNOVATION IN UROLOGY: USE OF HEALTH-INFORMATION
TECHNOLOGY TO REDUCE MORBIDITY, READMISSIONS, AND IMPROVE PATIENT CARE
Presenter: Raj Pruthi

Monday, May 16, 2022 Plenary: Prime Time Monday Afternoon Session 1:00 pm – 4:00 pm
Great Hall A @ Ernest N. Morial Convention Center
1:00 PANEL DISCUSSION: NOVEL METHODS TO BOOST KIDNEY TRANSPLANTATION GLOBALLY
Moderator: Alp Sener
Panelists: Jeffrey Veale
1:20 PANEL DISCUSSION: MALE INFERTILITY AS A MARKER FOR OVERALL MALE HEALTH
Panelists: Michael Eisenberg, Andrea Salonia
1:45 POINT-COUNTERPOINT DEBATE: TELEMEDICINE IN REPRODUCTIVE UROLOGY
Moderator: Jay Sandlow
Debaters: James Smith, James Dupree
2:15
CROSSFIRE: CONTROVERSIES IN UROLOGY DEBATE: DOES EXERCISE, DIET MODIFICATION OR ANTIOXIDANTS
HELP IMPROVE MALE FERTILITY?
Moderator: Cigdem Tanrikut
Debaters-Con: Robert Coward, Akanksha Mehta
Debaters-Pro: David Shin, Ryan Smith
2:45 SECOND OPINION CASES: ALTERNATIVES TO TESTOSTERONE SUPPLEMENTATION THERAPY
3:05 FERTILITY SAFETY EVALUATIONS POST COVID-19 VACCINATION
Presenter: Jordan Dimitrakoff

Monday, May 16, 2022 6:55 am – 7:55 am

RESEARCH ON CALCULUS KINETICS SOCIETY (ROCK) NON-CME INDUSTRY SPONSORED BREAKFAST PROGRAM
Room 265 @ Ernest N. Morial Convention Center

*Presenting author 217

Monday, May 16, 2022 7:55 am – 12:00 pm
RESEARCH ON CALCULUS KINETICS SOCIETY (ROCK)
Room 262 @ Ernest N. Morial Convention Center
7:55 INTRODUCTION REDUCING PERIOPERATIVE INFECTIOUS
Society President: Vernon Pais COMPLICATIONS
Moderator: Nicole Miller
8:00 SESSION I: EPIDEMIOLOGY; PEDIATRIC AND
PREGNANT STONE DISEASE GROUP DISCUSSION
Moderator: Necole Streeper
10:00 BREAK
DISPARITIES IN STONE EPIDEMIOLOGY AND
10:30 SESSION 3: SURGICAL MANAGEMENT
STONE CARE
Kelly Healy
Karen Stern
SELECTING A LASER: HOLMIUM VS THULLIUM
CONSIDERATIONS FOR SURGICAL MANAGE-
Bodo Knudsen
MENT OF STONES IN CHILDREN
Gregory Tasian OPTIMIZING MINIPCNL
Seth Bechis
WHAT “NOT TO MISS” IN EVALUATION OF PEDI-
ATRIC STONE FORMERS UPDATES ON BURST WAVE LITHOTRIPSY
Michelle Baum Jonathan Harper
STRATEGIES FOR DIAGNOSIS AND MANAGE- GROUP DISCUSSION
MENT OF SUSPECTED RENAL COLIC DURING
11:15 SESSION 4: MEDICAL MANAGEMENT
PREGNANCY
Moderator: Sara Best
Amy Krambeck
URINARY AMMONIUM: AN UNSUNG DIAGNOSTIC
GROUP DISCUSSION
HERO
9:00 SESSION II: PERIOPERATIVE Ryan Hsi
Moderator: Michael Lipkin
EXPLORING OPTIONS FOR URINARY ALKALINI-
PERIOPERATIVE ANALGESIA STRATEGIES FOR ZATION
STONE SURGERY Justin Friedlander
Kevan Sternberg
BREAKTHROUGHS IN MANAGEMENT OF HYPER-
ASSESSING AND OPTIMIZING STENT-RELATED OXALURIA
QUALITY OF LIFE Kyle Wood
Sero Andonian
GROUP DISCUSSION
SAFETY FOR THE UROLOGIST DURING
11:55 CLOSING REMARKS
ENDOUROLOGIC SURGERY
Society President:Vernon Pais
Michelle Semins
APPROVED FOR AMA PRA CATEGORY
1 CREDITTM

Monday, May 16, 2022 12:00 pm – 12:30 pm

AUA ANNUAL BUSINESS MEETING
Rivergate Room @ Ernest N. Morial Convention Center

Monday, May 16, 2022 12:00 pm – 1:00 pm

RESEARCH ON CALCULUS KINETICS SOCIETY (ROCK) NON-CME INDUSTRY SPONSORED LUNCH PROGRAM
Room 265 @ Ernest N. Morial Convention Center

218
Monday, May 16, 2022
Moderated Poster Session 52
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: MALE INCONTINENCE: THERAPY
Room 228 @ Ernest N. Morial Convention Center
Moderators: Jaspreet Sandhu & Craig Comiter
ABSTRACT
NUMBER TITLE
MP52-01 ANALYZING OUTCOMES OF THE ADJUSTABLE
TRANSOBTURATOR MALE SYSTEM (ATOMS)
FOR POST-PROSTATECTOMY INCONTINENCE:
RESULTS OF A SINGLE-CENTER STUDY
Samuel Farag*, Joanie Pelletier, Salima Ismail, Le
Mai Tu, Sherbrooke, Canada
MP52-02 ADJUSTABLE ARTIFICIAL URINARY
SPHINCTER (VICTO): EXPERIENCE AFTER
110 CASES OF MALE STRESS URINARY
INCONTINENCE
Ghazal Ameli*, Peter Weibl, Michael Rutkowski,
Wilhelm Huebner, Korneuburg, Austria
MP52-03 PRECLINICAL EVALUATION OF A NOVEL
ARTIFICIAL URINARY SPHINCTER IN A
WETHER MODEL
Aurelien Beaugerie, Florence Poinard, Juliette
Cotte, Anne Denormandie, Paris, France, Chris-
tine Reus, Stockholm, Sweden, Pierre Mozer,
Emmanuel Chartier-Kastler*, Paris, France
MP52-04 COMPARATIVE URODYNAMIC STUDY
IN CADAVER OF URETHRAL PRESSURE
PROFILOMETRY BETWEEN THE UROMEMS
ARTIFICIAL URINARY SPHINCTER AND THE
AMS80TM
Aurelien Beaugerie, Florence Poinard,
Anne Denormandie, Juliette Cotte, Paris, France,
Christine Reus, Stockholm, Sweden, Pierre Moz-
er, Emmanuel Chartier-Kastler*, Paris, France
MP52-05 PRE-EXISTING DETRUSOR OVERACTIVITY
LEADS TO EARLIER ARTIFICIAL URINARY
SPHINCTER FAILURE AND NEED FOR
REVISION
Kevin Krughoff*, Andrew C. Peterson,
Durham, NC
MP52-06 LONGITUDINAL CHANGES IN LOWER
URINARY TRACT SYMPTOMS AFTER
ARTIFICIAL URETHRAL SPHINCTER
IMPLANTATION IN PATIENTS UNDERGOING
PRIOR RADIOTHERAPY
Minato Yokoyama*, Madoka Kataoka, Yusuke
Uchida, Yuki Nakamura, Shohei Fukuda, Sho
Uehara, Hajime Tanaka, Soichiro Yoshida, Yoh
Matsuoka, Yasuhisa Fujii, Tokyo, Japan
MP52-07 IMPACT OF FRAILTY ON ADVERSE
COMPLICATIONS FOLLOWING ARTIFICIAL
URINARY SPHINCTER IMPLANTATION
Rohan Bhalla*, Jackson Cabo, Tanya Marvi,
Abimbola Ayangbesan, George Koch, Stephen
Hill, Douglas Milam, Melissa Kaufman, Niels
Johnsen, Nashville, TN
*Presenting author
7:00 am – 8:15 am
ABSTRACT
NUMBER TITLE
MP52-08 ARTIFICIAL URINARY SPHINCTER CUFF
DOWNSIZING IMPROVES CONTINENCE AND
PATIENT SATISFACTION IN CASES OF
SUB-CUFF ATROPHY
Kevin Krughoff*, Brent D Nosé,
Andrew C. Peterson, Durham, NC
MP52-09 SAFETY OF TRANSURETHRAL
ENDOSCOPIC TREATMENT IN MEN WITH
AN ARTIFICIAL URINARY SPHINCTER:
A 15 YEAR ANALYSIS
Corey Weinstein*, Brooklyn, NY,
Jaspreet Sandhu, New York, NY
MP52-10 EARLY ARTIFICIAL URINARY SPHINCTER
PLACEMENT AND DEVICE SURVIVAL
AFTER BLADDER NECK CONTRACTURE
TREATMENT: WHAT IS THE EVIDENCE?
MONDAY
Samantha Nealon*, Raj Bhanvadia, Shervin
Bhadkhshan, Sarah Sanders, Steve Hudak,
Allen Morey, Dallas, TX
MP52-11 BLADDER NECK CONTRACTURES STABILIZE
AFTER ARTIFICIAL URINARY SPHINCTER
PLACEMENT
Kevin Krughoff*, Hayley Premo,
Andrew C. Peterson, Durham, NC
MP52-12 RISK FACTORS ASSOCIATED WITH VENOUS
THROMBOEMBOLISM AFTER ARTIFICIAL
URINARY SPHINCTER SURGERY? AN
ASSESSMENT OF 4,870 PATIENTS
Kevin Hebert*, Niraj Paudel, Rupam Das, Rano
Matta, Joshua Calvert, Benjamin McCormick, Josh-
ua Horns, Salt Lake City, UT, James Hotaling, Salt
Lake City, UT, Jeremy Myers, Salt Lake City, UT
MP52-13 PRESENTING SIGNS AND SYMPTOMS OF
ARTIFICIAL URINARY SPHINCTER CUFF
EROSION
Linley Diao*, Samantha Nealon,
Shervin Badkhshan, Avery Wolfe, Gianpaolo
Carpinito, Benjamin Dropkin, Sarah Sanders,
Steven Hudak, Allen Morey, Dallas, TX
MP52-14 ESTIMATED GLOMERULAR FILTRATION RATE
PREDICTS ADVERSE OUTCOMES AMONG
MEN UNDERGOING ARTIFICIAL URINARY
SPHINCTER SURGERY
Carlos Riveros*, Victor Chalfant, Ahmed Elshafei,
KC Balaji, Jacksonville, FL
219
 MP52-15 ABDOMINAL SUBCUTANEOUS FAT
THICKENING IS THE USEFUL MARKER
TO PREDICT LOWER URINARY TRACT
DYSFUNCTION AFTER ROBOT-ASSISTED
RADICAL PROSTATECTOMY
Shunta Makabe*, Yusuke Kirihana, Tomoyuki
Kumekawa, Hiroki Natsuya, Yusuke Hakozaki,
Shunsuke Yoshioka, Yu Endo, Akihisa Hasegawa,
Yuki Harigane, Kei Yaginuma, Hitomi Imai, Akifumi
Onagi, Kanako Matsuoka, Tomoyuki Koguchi, Jun-
ya Hata, Yuichi Sato, Hidenori Akaihata, Masao
Kataoka, Yoshiyuki Kojima, Fukushima, Japan
MP52-16 ELUCIDATION OF URINARY INCONTINENCE
MECHANISM AFTER ROBOT-ASSISTED
RADICAL PROSTATECTOMY FOCUSING ON
THE SLING MECHANISM BY THE LEVATOR
ANI MUSCLE
Masao Kataoka*, Tomoyuki Koguchi, Junya Sato,
Yuichi Sato, Hidenori Akaihata, Yoshiyuki Kojima,
Fukushima, Japan
Monday, May 16, 2022
Moderated Poster Session 53
PROSTATE CANCER: DETECTION & SCREENING V
Room 225 @ Ernest N. Morial Convention Center
Moderators: Andre Abreu, James McKiernan & Ryan Berglund
ABSTRACT
NUMBER TITLE
MP53-01 DETECTION OF CLINICALLY SIGNIFICANT
PROSTATE CANCER IN MPMRI VISIBLE
LESIONS: SIZE MATTERS. RESULTS FROM A
LARGE, TWO-INSTITUTIONAL SERIES
Armando Stabile*, Giorgio Gandaglia, Elio
Mazzone, Francesco Barletta, Daniele Robesti,
Giuseppe Cirulli, Donato Cannoletta, Francesco
Pellegrino, Luigi Nocera, Gabriele Sorce, Mario De
Angelis, Carlo Andrea Bravi, Milan, Italy, Alberto
Martini, Milano, Italy, Thomas Seisen, Morgan
Roupret, Paris, France - Metropolitan, Jeffrey R.
Karnes, Rochester, MN, Vito Cucchiara, Milan, Italy,
Nicola Fossati, Lugano, Switzerland, Francesco De
Cobelli, Antonio Esposito, Giorgio Brembilla, Franc-
esco Montorsi, Alberto Briganti, Milan, Italy
MP53-02 COMPARISON OF HIGHEST-GRADE TUMOR
PERCENTAGE IN CORE SAMPLES FROM
MRI-TARGETED BIOPSY AND SYSTEMATIC
BIOPSY FOR PROSTATE CANCER
DIAGNOSIS
Shu Wang*, Ryan Russell, Ashley Park, Alexa
Van Besien, Adrianna Lee, Linhan Xu, Ankur
Choksi, M. Adil Afzal, Amelia Wnorowski, Michael
Naslund, M. Minhaj Siddiqui, Baltimore, MD
MP53-03 EFFECT OF TARGETED CORES ON RISK
STRATIFICATION IN THE ERA OF IMAGE-
GUIDED PROSTATE BIOPSY
Samuel Washington*, Janet Cowan, San Francis-
co, CA, Peter Lonergan, Dublin, Ireland, Alexan-
der Bell, Robert Parker, Katsuto Shinohara, Hao
Nguyen, Peter Carroll, Matthew Cooperberg, San
Francisco, CA
220
MP52-17 RACIAL AND REGIONAL DISPARITIES AND
SURGICAL INTERVENTION FOR URINARY
INCONTINENCE AFTER PROSTATE CANCER
THERAPY: A SEER-MEDICARE STUDY
Nishant Garg*, Alexandra Muise, Michael Pan,
Michael Witthaus, Brent Rose, Jill Buckley,
San Diego, CA
MP52-18 QUALITY OF INFORMATION FOR POST-
PROSTATECTOMY INCONTINENCE
TREATMENTS ON YOUTUBE
Daniel Bockelman*, Aaron Huang, Lakshay
Khosla, So Yeon Pak, Jacob Bamberger, Corey
Weinstein, Abdo Kabarriti, Brooklyn, NY
MP52-19 COMPARISON OF IN-PERSON FPMRS-
DIRECTED PELVIC FLOOR THERAPY
PROGRAM VERSUS UNSUPERVISED
PELVIC FLOOR EXERCISES FOLLOWING
PROSTATECTOMY
Jacques Farhi*, Anthony DeNovio, David Barquin,
David Rapp, Charlottesville, VA
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
7:00 am – 8:15 am
ABSTRACT
NUMBER TITLE
MP53-04 RATES OF UPGRADING AND UPSTAGING IN
PROSTATE CANCER PATIENTS WITH SINGLE
GGG1 POSITIVE BIOPSY CORE
Benedikt Hoeh*, Frankfurt am Main, Germany,
Rocco Flammia, Rome, Italy, Mike Wenzel, Frank-
furt am Main, Germany, Sorce Gabriele, Milan,
Italy, Francesco Chierigo, Genova, Italy, Zhe Tian,
Fred Saad, Montreal, Canada, Markus Graefen,
Hamburg, Germany, Michele Gallucci, Rome,
Italy, Alberto Briganti, Milan, Italy, Carlo Terrone,
Genova, Italy, Shahrokh Shariat, Vienna, Austria,
Derya Tilki, Luis Kluth, Hamburg, Germany,
Philipp Mandel, Felix Chun, Frankfurt am Main,
Germany, Pierre Karakiewicz, Montreal, Canada
MP53-05 CLINICALLY SIGNIFICANT PROSTATE
CANCER DETECTION RATE OF PROSTATE
IMAGING REPORTING AND DATA SYSTEM
SCORE 4 IN THE PERIPHERAL ZONE
Gang Song*, Zhoujie Sun, Beijing, China, Peo-
ple’s Republic of
MP53-06 MRI AND MRI-TARGETED BIOPSY CAN
DETECT CRIBRIFORM CANCER OF THE
PROSTATE
Sho Uehara*, Yoh Matsuoka, Kurara Yamamoto,
Yuki Nakamura, Yusuke Uchida, Shohei Fuku-
da, Hajime Tanaka, Soichiro Yoshida, Minato
Yokoyama, Kenichi Ohashi, Yasuhisa Fujii, Tokyo,
Japan
 MP53-07 HISTOLOGICAL VARIANTS OF PROSTATE
CANCER ARE UNDER-REPORTED IN
PROSTATE BIOPSIES ASSESSED OUTSIDE
TERTIARY REFERRAL CENTERS. A PLEA
FOR BIOPSY REVIEW FOR OPTIMAL PATIENT
MANAGEMENT
Simone Scuderi*, Francesco Pellegrino, Roberta
Lucianò, Nazario Tenace, Milan, Italy, Francesca
Paparesta, Laura Pepi, Ancona, Italy, Leonar-
do Quarta, Lorenzo Toneatto, Elio Mazzone,
Francesco Barletta, De Angelis Mario, Daniele
Robesti, Donato Cannoletta, Antony Pellegrino,
Vito Cucchiara, Riccardo Leni, Giorgio Gandaglia,
Armando Stabile, Milan, Italy, Alessia Cimada-
more, Rodolfo Montironi, Ancona, Italy, Francesco
Montorsi, Alberto Briganti, Milan, Italy
MP53-08 EFFECT OF NEARNESS TO CANCER CENTRE
ON PROSTATE CANCER OUTCOMES AND
PATIENT’S CHOICE FOR THE TYPE OF
INTERVENTION
Waleed Shabana*, Vahid Mehrnoush, Neda
Ghaffari-Marandi, Kristi Dolcetti, Hazem Elmansy,
Kevin Ramchandar, Edwin Long, Ahmed Zakaria,
Ahmed Kotb, Walid Shahrour, Thunder Bay,
Canada
MP53-09 MACHINE LEARNING MODELS TO PERFORM
ACTIVE SURVEILLANCE ON PROSTATE
CANCER
Derek Van Booven*, Miami, FL, Victor Sandoval,
Guadalajara, Mexico, Farhan Ismael, Ahmed
Norman, Karachi, Pakistan, Oleksandr Kryvenko,
Sanoj Punnen, Himanshu Arora, Miami, FL
MP53-10 THE ROLE OF SELECTMDX IN MEN
UNDERGOING PRIMARY PROSTATE BIOPSY:
A PROSPECTIVE MULTI-INSTITUTIONAL
STUDY
Martina Maggi*, Francesco Del Giudice, Rome, It-
aly, Ugo G Falagario, Foggia, Italy, Andrea Cocci,
Florence, Italy, Giorgio I. Russo, Marina Di Mauro,
Catania, Italy, Giuseppe Salvatore Sepe, Mon-
dragone, Italy, Fabio Galasso, Eboli, Italy, Rosario
Leonardi, Gravina di Catania, Italy, Gabriele Iaco-
na, Acireale, Italy, Peter R. Carroll, Matthew R.
Cooperberg, San Francisco, CA, Angelo Porreca,
Padua, Italy, Matteo Ferro, Milan, Italy, Giuseppe
Lucarelli, Bari, Italy, Daniela Terracciano, Naples,
Italy, Luigi Cormio, Giuseppe Carrieri, Foggia,
Italy, Ettore De Berardinis, Alessandro Sciarra,
Rome, Italy, Gian Maria Busetto, Foggia, Italy
MP53-11 FOUR KALLIKREIN PANEL TESTING AMONG
MEDICARE BENEFICIARIES UNDERGOING
PROSTATE CANCER SCREENING
Michael Leapman*, Jessica Long, Rong Wang,
Preston Sprenkle, Xiaomei Ma, Cary Gross, New
Haven, CT
MP53-12 HOW DO PSA-BASED MARKERS PREDICT
CLINICALLY SIGNIFICANT PROSTATE
CANCER (CSPCA) ON PROSTATE BIOPSY
INDEPENDENT OF PROSTATE SIZE
Max Kuster*, Michelle Ou, Jacob Gaines, Eric
Macdonald, Simon Hall, Lake Success, NY
*Presenting author
MP53-13 TRANSITION OF PROSTATE CANCER
PRIMARY DIAGNOSTICS: TAKEOVER OF MRI-
GUIDED TARGETED- VERSUS SYSTEMATIC
BIOPSY
Mykyta Kachanov*, Hamburg, Germany,
Sami-Ramzi Leyh-Bannurah, Gronau, Germany,
Christoph Würnschimmel, Dirk Beyersdorff, Fa-
bian Falkenbach, Tobias Maurer, Hendrik Isbarn,
Thomas Steuber, Markus Graefen, Lars Budäus,
Hamburg, Germany
MP53-14 FEASIBILITY OF TRANSPERINEAL
PROSTATE BIOPSIES UNDER LOCAL
ANESTHESIA: A COMPARATIVE STUDY WITH
THE TRANSRECTAL APPROACH
Camille Berquin*, Dries Develtere, Hannah Van
Puyvelde, Elisabeth Pauwels, Ruben De Groote,
Frederiek D’Hondt, Peter Schatteman, Alex Mot-
trie, Geert De Naeyer, Aalst, Belgium
MP53-15 MRI-DIRECTED BIOPSY FOR PRIMARY
DETECTION OF PROSTATE CANCER: MRI IN-
BORE VS MRI-TRANSRECTAL ULTRASOUND
FUSION-TARGETED TECHNIQUES
Francesco Del Giudice*, Maurizio Del Monte, Ste-
fano Cipollari, Martina Pecoraro, Marco Bicchetti,
Emanuele Messina, Ailin Dehghanpour, Alessan-
MONDAY
dro Sciarra, Ettore De Berardinis, Rome, Italy,
Benjamin I. Chung, Stanford, CA, Carlo Catalano,
Valeria Panebianco, Rome, Italy
MP53-16 THE TRENDS OF COMPLICATION RATES
AND THE ROLE OF AZTREONAM AS A
PROPHYLACTIC ANTIBIOTIC AFTER
PROSTATE BIOPSY
Sung Jin Kim*, Han Kyu Chae, Wook Nam, Kim
Han Gwun, Park Jong Yeon, Gangneung-si,
Korea, Republic of
MP53-17 CULTURE-DIRECTED ANTIMICROBIAL
PROPHYLAXIS IN TRANSRECTAL
ULTRASOUND-GUIDED PROSTATE BIOPSIES:
CONTEMPORARY 7-YEAR EXPERIENCE
Steven A Sidelsky*, Chicago, IL, Pooja Talaty,
Pranvera Sulejmani, Mira Suseno, Sandra Naege-
le, Kristian Novakovic, Brian T Helfand, Alexander
P Glaser, Evanston, IL
MP53-18 CONTINUED PSA SCREENING IN MEN AGED
60 YEARS AND OLDER WITH VERY LOW
SERUM PROSTATE SPECIFIC ANTIGEN IN A
LARGE, INTEGRATED HEALTHCARE SYSTEM
James Kearns*, Erin Donahue, Rupali Bose,
Jason Zhu, Claud Grigg, Earle Burgess, Kris Gas-
ton, Stephen Riggs, Justin Matulay, Peter Clark,
Charlotte, NC
MP53-19 PROSTATE SPECIFIC ANTIGEN SCREENING
UTILIZATION IN MEN WITH A FAMILY
HISTORY OF PROSTATE CANCER AND
EXTENDED LIFE EXPECTANCY
Taylor Malchow*, Dayton, OH, Deepansh Dalela,
Sami Majdalany, Austin Piontkowski, Nicholas
Corsi, Ivan Rakic, Marcus Jamil, Detroit, MI,
Akshay Sood, Houston, TX, Sohrab Arora, Craig
Rogers, Detroit, MI, Mara Schonberg, Boston,
MA, Firas Abdollah, Detroit, MI
221
 MP53-20 ADDED VALUE OF MPMRI IN THE
APPROVED FOR AMA PRA CATEGORY 1.25
STRATIFICATION OF PATIENTS WITH CREDITSTM
HIGH-RISK PATIENTS PROSTATE CANCER
TREATED WITH RADICAL PROSTATECTOMY:
IMPLICATIONS FOR TAILORED MULTI-MODAL
STRATEGIES
Giuseppe Cirulli*, Milan, Italy, Elio Mazzone,
Milano, Italy, Giorgio Gandaglia, Milan, Italy,
Razvan-George Rahota, Toulouse, France,
Giancarlo Marra, Turin, Italy, Massimo Valerio,
Lausanne, Switzerland, Riccardo Campi, Andrea
Mari, Florence, Italy, Agostino Mattei, Marco
Moschini, Lucerne, Switzerland, Jean Baptiste
Beauval, Mathieu Roumiguiè, Toulouse, France,
Luca Afferi, Lucerne, Italy, Paolo Gontero, Turin,
Italy, Armando Stabile, Milan, Italy, Nicola Fossati,
Lugano, Switzerland, Vito Cucchiara, Giuseppe
Rosiello, Francesco Montorsi, Alberto Briganti,
Milan, Italy

Monday, May 16, 2022 7:00 am – 9:00 am

Podium Session 52
SEXUAL FUNCTION/DYSFUNCTION: SURGICAL THERAPY II
Room 252 @ Ernest N. Morial Convention Center
Moderator: Joshua Halpern

ABSTRACT
TIME NUMBER TITLE
7:00 PD52-01 COMPLICATIONS OF THE PENUMA PENILE
IMPLANT FOR GENITAL ENHANCEMENT
David Barham*, Orange, CA, John Barnard, Mor-
gantown, WV, Joel Gelman, Orange, CA
7:10 PD52-02 EXTENDED CORPORAL DILATION (ECD) OF
MEN WITH PEYRONIE’S DISEASE (PD) AT
THE TIME OF INFLATABLE PENILE IMPLANT
SURGERY (IPP)
Hisanori Taniguchi*, Jose Flores, Carolyn Salter,
Helen Bernie, John Mulhall, New York, NY
7:20 PD52-03 EVALUATION OF PROTECTION AGAINST
GRAM-POSITIVE AND GRAM-NEGATIVE
BACTERIA IN A NOVEL IN VITRO BIOFILM
MODEL OF PENILE PROSTHESIS
Manish Narasimman*, Gregory Plano, Miami,
FL, Jesse Ory, Halifax, Canada, Sara Schesser
Bartra, Ranjith Ramasamy, Miami, FL
7:30 PD52-04 OUTCOMES OF PENILE PROSTHESIS
IMPLANTATION IN TRANSGENDER
NEOPHALLUS: A SINGLE CENTER
EXPERIENCE
Jesse Persily*, New York, NY, Begoña Etchev-
erry, Barcelona, Spain, Kirtishri Mishra, Gaines
Blasdel, Rachel Bluebond-Langner, Lee Zhao,
New York, NY
7:40 PD52-05 UNINFECTED INFLATABLE PENILE
PROSTHESES UNIFORMLY DEMONSTRATE
RICH DYNAMIC BACTERIAL BIOFILMS
WITH COMPLEX UNDERLYING MICROBE-
METABOLITE INTERACTION NETWORKS
Glenn T. Werneburg, Daniel Hettel*, Bradley Gill,
Ava Adler, Hadley Wood, Petar Bajic, Kenneth
Angermeier, Scott Lundy, Daniel Shoskes, Aaron
Miller, Cleveland, OH
ABSTRACT
TIME NUMBER TITLE
7:50 PD52-06 PENILE IMPLANT BACTERIAL BIOFILM
PROFILES VARY BY SURGICAL INDICATION:
AN OPPORTUNITY TO MODIFY PERI-
OPERATIVE CARE?
Paul H. Chung, Joon Yau Leong*, Philadelphia,
PA, Caleb D. Phillips, Lubbock, TX, Gerard D.
Henry, Bossier City, LA
8:00 PD52-07 OUTCOMES AND SATISFACTION AFTER
PENILE SILICONE IMPLANT SURGERY
Morgan Salkowski*, Kevin Alter, Laurence Levine,
Chicago, IL
8:10 PD52-08 SINGLE CENTER EXPERIENCE WITH
ZSI FTM PENILE IMPLANTS FOR
PHALLOPLASTY
Garry Pigot*, Joost van Leeuwen, Freek de Rooij,
Brechje Ronkes, Wouter van der Sluis, Mark
Bram Bouman, Amsterdam, Netherlands
8:20 PD52-09 LOW CONCENTRATION CHLORHEXIDINE
GLUCONATE (CHG) IN STERILE WATER
SOLUTION ADHERENCE DIP TIME, EFFECT
ON THE HYDROPHILIC INFLATABLE PENILE
PROSTHESIS (HIPP) COATING, AND PATIENT
TOLERANCE
Ryan Griggs*, Bossier City, LA, Edward Karpman,
Mountainview, CA, Wei Zhang, Eden Prairie, MN,
Gerard Henry, Bossier City, LA
8:30 PD52-10 COMPLETE VESTIBULECTOMY IN
WOMEN WITH PERSISTENT ENTRANCE
DYSPAREUNIA FOLLOWING PARTIAL
POSTERIOR VESTIBULECTOMY
Alyssa Yee*, Maria Uloko, Sue Goldstein, Irwin
Goldstein, San Diego, CA

222
8:40 PD52-11 COMPARISON OF SURGICAL OUTCOMES
AFTER INSERTION OF PENILE IMPLANTS
IN PHALLOPLASTY WITH AND WITHOUT
URETHRAL LENGTHENING
Sterre Mokke, Freek de Rooij, Joost van Leeuw-
en, Brechje Ronkes, Pip Roijer, Wouter van der
Sluis, Mark Bram Bouman, Garry Pigot*, Amster-
dam, Netherlands
Monday, May 16, 2022
Podium Session 53
BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY III
Room 255 @ Ernest N. Morial Convention Center
Moderators: Debasish Sundi, Joshua Meeks & Vinata Lokeshwar
ABSTRACT
TIME NUMBER TITLE
7:00 PD53-01 MOLECULAR SUBTYPING OF N-METHYL-
N-NITROSOUREA (MNU) RAT MODEL OF
UROTHELIAL CARCINOMA REVEALS BOTH
LUMINAL AND BASAL SIGNATURES
Kara Lombardo*, Takahiro Yoshida, Kate Fitzger-
ald, Kate Johnson, David McConkey, Alok Singh,
Ridwan Alam, Max Kates, Alex Baras, Baltimore,
MD, Trinity Bivalacqua, Philadelphia, PA
7:10 PD53-02 CYTOTOXICITY CAUSED BY CISPLATIN,
VENETOCLAX, AND S63845 TO UROTHELIAL
CARCINOMA CELLS EXPANDED IN 3D
ORGANOIDS DIFFERS CLEARLY FROM
CYTOTOXICITY TO AUTOLOGOUS 2D
ADHERENT CELLS
Yi Wei, Bastian Amend, Wilhelm K. Aicher*, Arnulf
Stenzl, Niklas Harland, Tuebingen, Germany
7:20 PD53-03
SCHISTOSOMA HAEMATOBIUM MAY
PROMOTE BLADDER CARCINOGENESIS
THROUGH DNA BINDING OF ITS HOMOLOG
OF THE INTERLEUKIN-4-INDUCING
PRINCIPLE FROM SCHISTOSOMA MANSONI
EGGS
Derick Osakunor*, Washington, DC, Trevor Sig-
gers, Boston, MA, Olivia Lamanna, Kenji Ishida,
Washington, DC, Heather Hook, Boston, MA,
Michael Hsieh, Washington, DC
7:30 PD53-04 BIODEGRADABLE DEVICE FOR
CONTROLLED RELEASE OF CISPLATIN AS
LOCAL CHEMOTHERAPY FOR BLADDER
CANCER
Gilad Amiel*, Alexandra Bukchin-Tihomirov,
Ahmed Kabha, Azik Hoffman, Eyal Zussman,
Haifa, Israel
7:40 PD53-05 BLADDER CANCER TUMOROIDS AND
NORMAL UROTHELIAL ORGANOIDS
AS NEAR-PATIENT MODELS TO STUDY
BLADDER CANCER TUMORIGENESIS AND
PREDICT TREATMENT RESPONSE
Maryam Akbarzadeh, Mathijs Scholtes*, Ameneh
Bazrafshan, Tokameh Mahmoudi, Tahlita Zuiver-
loon, Rotterdam, Netherlands
*Presenting author
8:50 PD52-12 ASSESSMENT OF WORK-RELATED
MUSCULOSKELETAL PAIN IN UROLOGIC
MICROSURGEONS
Douglas Schneider*, Charles Loeb, Orange, CA,
R. Matthew Coward, Chapel Hill, NC, Lawrence
Jenkins, Tucson, AZ, Faysal Yafi, Orange, CA
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
7:50 PD53-06 CHANGES IN MOUSE STOOL
MICROBIOME WITH EXPOSURE TO
BLADDER CARCINOGEN N-BUTYL-N-
(4-HYDROXYBUYTL) NITROSAMINE (BBN):
LONGITUDINAL ANALYSIS
Rashida Ginwala, Laura Bukavina*, Alexander
MONDAY
Kutikov, Philadelphia, PA, Ilaha Isali, Cleveland,
OH, Mohit Sindhani, Delhi, India, Megan Prunty,
Cleveland, OH, Philip Abbosh, Philadelphia, PA
8:00 PD53-07 DETECTION OF EARLY-STAGE BLADDER
CANCER USING PLASMA EXTRACELLULAR
VESICLE PROTEIN BIOMARKERS
Juan Hinestrosa*, Jean Lewis, Gregor Schroder,
Heath Balcer, Rajaram Krishnan, San Diego, CA
8:10 PD53-08 E-CIGARETTE EXPOSURE IN MICE
PROMOTES CHANGES IN DNA
METHYLATION OF THE BLADDER
UROTHELIUM
Ibardo Zambrano*, Ujjawal Manocha, Weida
Gong, Yi-Hsuan Tsai, Manhua Zhu, Melissa Her-
man, Marc Bjurlin, William Kim, Chapel Hill, NC
8:20 PD53-09 ANTIBODY DRUG CONJUGATES AND
VARIANT HISTOLOGY MUSCLE-INVASIVE
BLADDER CANCER: ARE THE TARGETS
PRESENT IN PRIMARY AND/OR METASTATIC
TUMORS?
Fady Ghali*, Martine Roudier, Funda Vakar-
Lopez, Jose Garcia, Yan Wang, Gavin Ha, Petros
Grivas, John Lee, Evan Yu, Bruce Montgomery,
Andrew Hsieh, Jonathan Wright, Hung-Ming Lam,
Seattle, WA
8:30 PD53-10 IDENTIFYING BLADDER UROTHELIAL
CARCINOMAS USING FLUORESCENT
SIGNAL INTENSITY OF PH LOW INSERTING
PEPTIDES
Borivoj Golijanin*, Providence, RI, Michael Du-
Pont, Kingston, RI, Ali Amin, Providence, RI, Anna
Moshnikova, Kingston, RI, Ohad Kott, Providence,
RI, Yana Reshetnyak, Oleg Andreev, Kingston, RI,
Dragan Golijanin, Providence, RI
223
8:40 PD53-11 DIVERGENT THERAPEUTIC OUTCOMES
OF STING AGONIST ADU-S100 IN
INTRATUMORAL AND INTRAVESICAL
TREATMENT REGIMENS IN SYNGENEIC
MURINE MB49 AND IN THE N-METHYL-
N-NITROSOUREA (MNU) RAT MODEL OF
UROTHELIAL CARCINOMA
Alok Kumar Singh*, Kara Lombardo, Monali
Praharaj, James Liu, Russel Becker, Kelly Harris,
Max Kates, David McConkey, Andres Matoso,
William R Bishai, Baltimore, MD, Trinity Jude
Bivalacqua, Philadelphia, PA
Monday, May 16, 2022
Podium Session 54
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY III
Room 245 @ Ernest N. Morial Convention Center
Moderators: Ali Kural & Panagiotis Mourmouris
ABSTRACT
TIME NUMBER TITLE
7:00 PD54-01 REDEFINING OPIOID USE AFTER
PROSTATECTOMY: RESULTS FROM THE
IMPLEMENTATION OF A STATEWIDE
OPIOID-FREE PAIN OPTIMIZATION
PATHWAY
Udit Singhal*, Ji Qi, Ann Arbor, MI, Kevin Gins-
berg, Detroit, MI, Alice Semerjian, Ann Arbor,
MI, Thomas Maatman, Grand Rapids, MI, John
Dibianco, Todd M. Morgan, Jeffrey S. Montgom-
ery, Mary Nowlin, Anna Johnson, Stephanie Fer-
rante, James E. Montie, Ann Arbor, MI, William
Johnston, Novi, MI, Mohammad Jafri, Bradley
Rosenberg, Royal Oak, MI, Richard Sarle,
Lansing, MI, Arvin K. George, for the Michigan
Urological Surgery Improvement Collaborative,
Ann Arbor, MI
7:10 PD54-02
REVISITING CURRENT NATIONAL
COMPREHENSIVE CANCER NETWORK
(NCCN) HIGH RISK PROSTATE CANCER
STRATIFICATION: A NATIONAL CANCER
DATABASE ANALYSIS
Harshit Garg*, Furkan Dursun, Ahmed
Elshabrawy, Hanzhang Wang, Michael Liss, Dhar-
am Kaushik, Ahmed Mansour, San Antonio, TX
7:20 PD54-03 ARTIFICIAL INTELLIGENCE IN
ROBOTIC-ASSISTED LAPAROSCOPIC
PROSTATECTOMY: DEVELOPING
PREDICTIVE MODELS FOR POSITIVE
SURGICAL MARGINS
Stephen Schmit*, Rebecca Ortiz, Philip Caffery,
Christopher Tucci, Carsten Eickhoff, Elias Hyams,
Gyan Pareek, Providence, RI
224
8:50 PD53-12 IMPACT OF TUMOUR-INFILTRATING
LYMPHOCYTES (TIL) IN SQUAMOUS CELL
CARCINOMA OF THE BLADDER
Severin Rodler*, Stephan Ledderose, Frederick
Klauschen, Alexander Buchner, Boris Schlen-
ker, Christian Stief, Lennert Eismann, Munich,
Germany
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
7:00 am – 9:00 am
ABSTRACT
TIME NUMBER TITLE
7:30 PD54-04 CHALLENGING THE DOGMA: SHOULD
UNILATERAL PELVIC LYMPH NODE
DISSECTION BE ENVISIONED IN THE
MULTIPARAMETRIC PROSTATE MRI ERA?
Alberto Martini*, Milan, Italy, Lieke Wever, Utrecht,
Netherlands, Arnas Rakauskas, Lausanne, Swazi-
land, Christian Daniel Fankhauser, Josias Bastian
Grogg, Zurich, Swaziland, Enrico Checcucci, Dan-
iele Amparore, Turin, Italy, Guillaume Ploussard,
Toulouse, France, Claudia Kesch, Essen, Germa-
ny, Fabio Zattoni, Udine, Italy, Alessandro Marquis,
Giancarlo Marra, Turin, Italy, Maria Apfelbeck, Mu-
nich, Germany, Ugo Giovanni Falagario, Foggia,
Italy, Otto Ettala, Turku, Finland, Mario de Angelis,
Donato Cannoletta, Alberto Briganti, Francesco
Montorsi, Milan, Italy, Ivan Jambor, Turku, Finland,
Alexander Kretschmer, Munich, Germany, Veeru
Kasivisvanathan, London, United Kingdom, Jan
Philipp Radtke, Essen, Germany, Hubert John,
Winterthur, Switzerland, Peter K Chiu, Honk Kong,
China, People’s Republic of, Francesco Porpiglia,
Turin, Italy, Thomas Hermanns, Zurich, Swaziland,
Roderick CN Van den Bergh, Utrecht, Nether-
lands, Giorgio Gandaglia, Milan, Italy, Massimo
Valerio, Lausanne, Swaziland
7:40 PD54-05 HALSTEADIAN VIEW OF PROSTATE
CANCER: DOES REMOVING MORE NODES
AT RADICAL PROSTATECTOMY AFFECT
BIOCHEMICAL RECURRENCE?
Lior Taich*, Los Angeles, CA, Lin Gu, Durham,
NC, Christopher L. Amling, Portland, OR, William
J. Aronson, Los Angeles, CA, Matthew R. Coop-
erberg, San Francisco, CA, Lourdes G. Rivera,
San Juan, Puerto Rico, Christopher J. Kane, San
Diego, CA, Zachary Klassen, Martha K. Terris, au-
gusta, GA, Stephen Freedland, Los Angeles, CA
7:50 PD54-06 ACTIVE OBSERVATION OF BIOCHEMICAL
RECURRENCE WITHOUT TREATMENT
FOLLOWING RADICAL PROSTATECTOMY:
LONG TERM ANALYSIS OF OUTCOMES
Erica Huang, Linda My Huynh, Adam Gordon,
Ryan Chandhoke, Orange, CA, Blanca Morales,
San Francisco, CA, Douglas Skarecky, Joshua
Tran, Thomas Ahlering*, Orange, CA
8:00 PD54-07 COMPARATIVE EFFECTIVENESS ANALYSES
OF SALVAGE PROSTATECTOMY AND
SALVAGE RADIOTHERAPY OUTCOMES
FOLLOWING FOCAL OR WHOLE-GLAND
ABLATIVE THERAPY (HIGH INTENSITY
FOCUSED ULTRASOUND (HIFU),
CRYOTHERAPY OR ELECTROPORATION)
FOR LOCALISED PROSTATE CANCER
Alexander Ng*, Arjun Nathan, Anita Mitra, Prasan-
na Sooriakumaran, Reena Davda, Sonam Patel,
London, United Kingdom, Monty Fricker, New-
castle, United Kingdom, John Kelly, Greg Shaw,
Prabhakar Rajan, Ashwin Sridhar, Senthil Nathan,
Heather Payne, London, United Kingdom
8:10 PD54-08 SINGLE-PORT EXTRAPERITONEAL
VS TRANSPERITONEAL ROBOTIC-
ASSISTED RADICAL PROSTATECTOMY:
8:30 PD54-10 DIFFERENCES OF QUALITY OF LIFE
BETWEEN GERMAN AND DUTCH
PROSTATE CANCER PATIENTS, WHO
ARE TREATED WITH ROBOT-ASSISTED
RADICAL PROSTATECTOMY: IMPLICATIONS
FOR INTERNATIONAL MULTICENTER
RANDOMIZED CONTROLLED TRIALS
Christian Wagner, Jorn Witt, Gronau, Germany,
Merkourios Kolvatzis, Thessaloniki, Greece,
Nikolaos Liakos, Theodoros Karagiotis, Miko-
laj Mendrek, Lukas Esch, Thomas Jankowski,
Andreas Schuette, Sami-Ramzi Leyh-Bannurah*,
Gronau, Germany
8:40 PD54-11 RESULTS OF THE PHASE 1 SAFETY
AND EFFICACY PROSTATE SPECIFIC
MEMBRANE ANTIGEN (PSMA) TARGETING
FLUOROPHORE FOR IMAGE GUIDED
SURGERY IN PATIENTS UNDERGOING
ROBOTIC PROSTATECTOMY
Hao Nguyen*, San Francisco, CA, Alexander
Antaris, Nynke Van den Berg, Sunnyvale, CA,
Lingru Xue, Scott Greenberg, San Francisco, CA,
Anna Muchnik, Alwin Klaassen, Sunnyvale, CA,
Jeff Simko, Pamela Munster, San Francisco, CA,
Sanjeev Dutta, Jonathan Sorger, Sunnyvale, CA,
Peter Carroll, San Francisco, CA

MONDAY
A MULTI-INSTITUTIONAL MATCHED-PAIR
COMPARISON OF OUTCOMES 8:50 PD54-12
68
GA-PSMA PET/CT FOR PREOPERATIVE
Mahmoud Abou Zeinab*, Ethan Ferguson, Aaron LYMPH NOSDE STAGING OF HIGH RISK
Kaviani, Alp T. Beksac, Cleveland, OH, Marcio PROSTATE CANCER
Moschovas, Celebration, FL, Luca Morgantini, Maximilian Schmautz*, David Pfister, Florian Hart-
Chicago, IL, Sij Hemal, Cleveland, OH, Susan Ta- mann, Axel Heidenreich, Cologne, Germany
lamini, Chicago, IL, Jean Joseph, Rochester, NY,
APPROVED FOR AMA PRA CATEGORY 2
Moses Kim, Laguna Hills, CA, Simone Crivellaro,
CREDITSTM
Chicago, IL, Vipul Patel, Celebration, FL, Jeffrey
Nix, Birmingham, AL, Jihad Kaouk, Cleveland, OH
8:20 PD54-09 COMPARISON OF ROBOTIC-ASSISTED
LAPAROSCOPIC PROSTATECTOMY: SP
VERSUS XI, A SINGLE INSTITUTION
EXPERIENCE
Samit Sunny Roy*, Chattanooga, TN, Aditya
Sathe, Memphis, TN, Matthew Watson, Bejamin
Waldorf, Amar Singh, Chattanooga, TN

Monday, May 16, 2022 7:00 am – 9:00 am

Video Session 11
PROSTATE, PENILE, TESTIS & MISC. ONCOLOGY II
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Costas Lallas, Anant Kumar & Ed Schaeffer

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
7:00 V11-01 OBTURATOR NERVE INJURY DURING
ROBOTIC PELVIC SURGERY: HOW TO
APPROACH IT?
Laura C. Perez, Aref S. Sayegh*, Anibal La Riva,
Luis G. Medina, Brittany Adamic, Ryan Powers,
Inderbir S. Gill, Rene Sotelo, Los Angeles, CA

*Presenting author 225

7:10 V11-02 99M-TECHNETIUM-PSMA RADIO-GUIDED 8:10 V11-08 SINGLE-PORT ROBOTIC ANTEGRADE
SURGERY TO DETECT NODAL METASTASES BILATERAL INGUINAL LYMPH NODE
IN PROSTATE CANCER PATIENTS DISSECTION
UNDERGOING RADICAL PROSTATECTOMY Nathan Cheng*, Hackensack, NJ, Christopher
AND EXTENDED PELVIC LYMPH NODE Wright, Nutley, NJ, Nizar Bou Diab, Hackensack,
DISSECTION: A PHASE 2 PROSPECTIVE, NJ, Mubashir Billah, Mutahar Ahmed, Nutley, NJ
SINGLE-INSTITUTION STUDY
8:20 V11-09 ROBOT-ASSISTED VIDEO-ENDOSCOPIC
Giorgio Gandaglia*, Elio Mazzone, Antony
RADICAL INGUINAL LYMPHADENECTOMY
Pellegrino, Milano, Italy, Nicola Fossati, Lugano,
FOR PENILE CANCER: SURGICAL ANATOMY
Switzerland, Armando Stabile, Francesco Barletta,
AND TECHNIQUE
Simone Scuderi, Riccardo Leni, Daniele Robesti,
Aldo Brassetti*, Alfredo Bove, Umberto Anceschi,
Lucia D’Ambrosio, Luca Maria Vitale, Ana Maria
Maria Consiglia Ferriero, Salvatore Guaglianone,
Samanes Gajate, Maria Picchio, Luigi Gianolli,
Riccardo Mastroianni, Leonardo Misuraca, Gabri-
Francesco Montorsi, Alberto Briganti, Milano, Italy
ele Tuderti, Giuseppe Simone, Rome, Italy
7:20 V11-03 REMOTE TRAINING FOR SURGICAL
8:30 V11-10 BILATERAL ROBOTIC-ASSISTED INGUINAL
PROCEDURES USING AUGMENTED
LYMPHADENECTOMY USING THE
REALITY: INSERTION OF A HYDROGEL
SYNCHROSEAL DEVICE: DESCRIPTION OF
RECTAL SPACER
THE TECHNIQUE
Michael Wilson*, Steven Griffith, Laura Kim,
Safiya-Hana Belbina*, Scott Spivey Provencio,
Jonathan Stone, Rochester, NY, Nelson Stone,
Pegah Taheri, Eric Giesler, Aaron A. Laviana,
Vail, CO
Austin, TX
7:30 V11-04 FOCAL CRYOTHERAPY FOR PROSTATE
8:40 V11-11 ROBOTIC-ASSISTED INGUINAL
CANCER USING MRI-ULTRASOUND FUSION
LYMPHADENECTOMY FOR PENILE CANCER:
ORGAN-BASED TRACKING AND NAIL-GRID
STEP-BY-STEP TECHNIQUE
GUIDANCE
Alberto Piana*, Josep Maria Gaya, Pietro Diana,
Peter Ka-Fung CHIU*, Jeremy Yuen-Chun Teoh,
Andrea Gallioli, Antonio Rosales, Pavel Gavrilov,
Chi Fai Ng, Chi Hang Yee, Hong Kong, Hong
Angelo Territo, Joan Palou, Alberto Breda, Barce-
Kong
lona, Spain
7:40 V11-05 DEVICE-FREE, TWO-SITE ENTRY
8:50 V11-12 ROBOT ASSISTED VIDEO ENDOSCOPIC
TRANSPERINEAL ULTRASOUND-GUIDED
INGUINAL LYMPH NODE DISSECTION (VEIL)
PROSTATE BIOPSY UTILIZING 14-GAUGE
IN POST CHEMOTHERAPY PENILE CANCERS
ANGIOCATHETERS
Kinju Adhikari*, Bangalore, India, Indraneel
Nicklaus Houston*, Johnathan Drevik, Serge Gin-
Banarjee, Calcutta, India, Raghunath SK, Tejus
zburg, Alexander Kutikov, Philadelphia, PA
Chiranjeevi, Bangalore, India
7:50 V11-06 DYNAMIC SENTINEL LYMPH NODE BIOPSY
APPROVED FOR AMA PRA CATEGORY 2
FOR PENILE CANCER: ACCURACY IS IN THE
CREDITSTM
TECHNIQUE
Jonathan O’Brien*, Jiasian Teh, Kenneth Chen,
Brian Kelly, Melbourne, Australia, Justin Chee,
East Melbourne, Australia, Nathan Lawrentschuk,
Melbourne, Australia
8:00 V11-07 A VIDEO DEMONSTRATION AND CASE
SERIES OF A MODIFIED SPLIT THICKNESS
SKIN GRAFT TECHNIQUE USING ARTISS
SEALANT® PERFORMED WITH PENILE
CANCER PROCEDURES
James A Churchill*, Christian Fankhauser,
Maurice W Lau, Vijay K Sangar, Arie S Parnham,
Manchester, United Kingdom

Monday, May 16, 2022 7:30 am – 12:10 pm

SOCIETY OF BENIGN PROSTATE DISEASE
Jefferson Ballroom @ Hilton New Orleans Riverside
7:30
INTERVIEWS W/ BPH EXPERTS: LESSONS FROM MISTS
THE PAST IN BPH MANAGEMENT – WHAT HAVE Kevin McVary
WE LEARNED?
PANEL WITH CASE DISCUSSION
Moderators: Naeem Bhojani, Peter Gilling, Kevin Zorn
Panelists: Steven Kaplan, Kevin McVary,
DIAGNOSTICS Claus Roehrborn
Steven Kaplan
8:30 BPH WARS AND HOW I DO IT
MEDICATION
MIDDLE LOBE: TO REMOVE ACUTELY OR NOT?
Claus Roehrborn
Dean Elterman, Amy Krambeck

226
 ANTICOAGULANT STRATEGY HOW I DO IT: HOW TO ADOPT NEW BPH TECHNOLOGIES INTO
TRANSURETHRAL RESECTION OF THE PROS- YOUR PRACTICE
TATE (TURP) Jaspreet Sandhu
VS. ENUCLEATION
11:40 RAPID FIRE
James Forde, Brian Helfand
BPH PROCEDURES: THE OR VS. THE OFFICE
MASSIVE PROSTATES: MY MANAGEMENT
Brian Mazzarella
Enrique Rijo, Alexis Te
DISPARITIES IN BPH CARE
9:15 BREAK
Charles Welliver
9:45 NON-CME INDUSTRY SPONSORED TALKS
DIET AND SUPPLEMENTS IN BPH
10:45 BREAK Gopal Badlani
11:15 BPH GUIDELINES: CONFLICT AND CONTRAST IN MICROBIOME AND BPH
THE AUA, EAU, NICE BPH GUIDELINES Bilal Chughtai
Neil Barber
IS MEDICAL THERAPY SAFE FOR LONG TERM
11:30 NEW TREATMENTS AND BPH RESEARCH IN MANAGEMENT OF BPH?
PRACTICE
LESSONS I LEARNED FROM FAILED BPH THERA-
HOW TO COUNCIL PATIENTS FOR NOVEL BPH PIES: ILC, TUNA, ETC.
TREATMENTS: THIS IS MY FIRST ONE! David Albala
Lori Lerner
APPROVED FOR AMA PRA CATEGORY
1 CREDITTM

Monday, May 16, 2022 8:00 am – 11:00 am

MONDAY
UROLOGICAL ASSOCIATION OF CENTRAL AMERICA & THE CARIBBEAN (AUCA)
St. Charles Ballroom @ Hilton New Orleans Riverside

Monday, May 16, 2022 8:45 am – 10:00 am

Moderated Poster Session 54

BLADDER CANCER: NON-INVASIVE II
Room 228 @ Ernest N. Morial Convention Center
Moderators: Kamal Pohar, Tracy Downs & Christopher Anderson

ABSTRACT ABSTRACT
NUMBER TITLE NUMBER TITLE
MP54-01 DISCORDANCE BETWEEN CLINICAL AND MP54-03 CORE1: PHASE 2, SINGLE ARM
PATHOLOGIC CARCINOMA IN SITU FOR STUDY OF CG0070 COMBINED WITH
TURBT AND RADICAL CYSTECTOMY IN PEMBROLIZUMAB IN PATIENTS WITH NON
PATIENTS WITH NON-MUSCLE INVASIVE MUSCLE INVASIVE BLADDER CANCER
BLADDER CANCER: IMPLICATIONS FOR BCG (NMIBC) UNRESPONSIVE TO BACILLUS
UNRESPONSIVE CLINICAL TRIAL DESIGN CALMETTE-GUERIN (BCG)
AND INTERPRETATION Roger Li*, Tampa, FL, Gary Steinberg, New York,
Manuel R. de Jesus Escano*, Carissa Chu, Song NY, Donald Lamm, Phoenix, AZ, Ed M. Uchio,
Jiang, Wesley Yip, New York, NY, Nima Almassi, Orange, CA, Paras Shah, Rochester, MN, Ashish
Cleveland, OH, Peter Reisz, Andrew Lenis, Nicole M. Kamat, Houston, TX, Nataliya Hnat, Irvine,
Benfante, Eugene Cha, Timothy F Donahue, Gui- CA, Michael J. Chisamore, Kenilworth, NJ, Paola
do Dalbagni, Alvin Goh, Bernard Bochner, Eugene Grandi, James Burke, Irvine, CA
Pietzak, New York, NY
MP54-04 A PHASE II STUDY OF CHECK POINT
MP54-02 TWO-YEAR EFFICACY FOLLOW-UP OF INHIBITOR, DURVALUMAB (MEDI4736)
A PHASE I TRIAL OF INTRAVESICAL FOR BACILLUS CALMETTE-GUERIN
BACILLUS CALMETTE-GUÉRIN COMBINED UNRESPONSIVE CARCINOMA IN SITU OF
WITH INTRAVENOUS PEMBROLIZUMAB IN THE BLADDER
RECURRENT OR PERSISTENT HIGH-GRADE Roger Li*, Kyle Rose, Michael Poch, Philippe
NON-MUSCLE-INVASIVE BLADDER CANCER Spiess, Scott Gilbert, Wade Sexton, Jingsong
AFTER PREVIOUS BACILLUS CALMETTE- Zhang, Tampa, FL
GUÉRIN TREATMENT
Shaheen Alanee, Detroit, MI, Jazzmyne Montgom-
ery*, Springfield, IL, Sherjeel Sana, Milwaukee, WI,
Ahmed El-Zawahry, Toledo, OH, James Peabody,
Tiffany Pearce, Nicole Adams, Mustafa Deebajah, De-
troit, MI, Danuta Dynda, Kara Babaian, Jane Crabtree,
Kristin Delfino, Springfield, IL, Kevin McVary, May-
wood, IL, Kathy Robinson, Krishna Rao, Springfield, IL

*Presenting author 227

 MP54-05 EVALUATING INTRAVESICAL
NADOFARAGENE FIRADENOVEC AND
IMMUNE CHECKPOINT BLOCKADE
COMBINATION THERAPY IN BCG-
UNRESPONSIVE NON-MUSCLE-INVASIVE
BLADDER CANCER: EVIDENCE FROM A
PHASE 3 TRIAL
Anirban P Mitra*, Sharada Mokkapati, Tanner S
Miest, Houston, TX, Vikram M Narayan, Atlanta,
GA, Richard Philipson, Stockholm, Sweden, Sep-
po Yla-Herttuala, David Sawutz, Nigel R Parker,
Kuopio, Finland, David J McConkey, Baltimore,
MD, Colin P N Dinney, Houston, TX
MP54-06 LONGITUDINAL HEALTH-RELATED QUALITY
OF LIFE OUTCOMES IN ADULTS WITH NON-
MUSCLE-INVASIVE BLADDER CANCER
RECEIVING A CHEMOABLATIVE GEL AS A
PRIMARY TREATMENT (OPTIMA II: PHASE
2B, SINGLE ARM, OPEN-LABEL TRIAL)
Angela Smith*, Ramsankar Basak, Dana Mueller,
Chapel Hill, NC, Robert Lipman, Bethesda, MD,
Randall Teal, Alison Hilton, Kara Giannone, Myra
Waheed, Angela Stover, Chapel Hill, NC
MP54-07 A URINE-BASED MOLECULAR ASSAY
REFINES THE RISK STRATIFICATION OF
THE RECENT AMERICAN UROLOGICAL
ASSOCIATION GUIDELINE ON HEMATURIA
Joep de Jong*, Olga Pijpers, Kim van Kessel,
Joost Boormans, Rotterdam, Netherlands, Wim
van Criekinge, Ghent, Belgium, Ellen Zwarthoff,
Rotterdam, Netherlands, Yair Lotan, Dallas, TX
MP54-08 URINARY COMPREHENSIVE GENOMIC
PROFILING PREDICTS CLINICAL
RECURRENCE IN PATIENTS UNDERGOING
SURVEILLANCE FOR UROTHELIAL
CARCINOMA
Jason Lee, Boston, MA, Vincent Bicocca, Vincent
Caruso, Brian Mazzarella, Kevin Phillips, Trevor
Levin, San Francisco, CA, Adam Feldman, Keyan
Salari*, Boston, MA
MP54-09 URINE COMPREHENSIVE GENOMIC
PROFILING PREDICTS RECURRENCE IN
PATIENTS WITH NON-MUSCLE INVASIVE
BLADDER CANCER TREATED WITH
INTRAVESICAL THERAPY
Goran Rac*, Shalin Desai, Hiten D. Patel, Chirag
Doshi, Ryan Dornbier, Maywood, IL, Vincent Ca-
ruso, Peter Lentz, Brian C. Mazzarella, Kevin G.
Phillips, Trevor Levin, South San Francisco, CA,
Alan J. Wolfe, Gopal N. Gupta, Maywood, IL
MP54-10 UTILITY OF A URINE-BASED DNA
METHYLATION TEST FOR SURVEILLANCE IN
NON-MUSCLE INVASIVE BLADDER CANCER:
A PILOT STUDY
Seyedeh Sanam Ladi Seyedian*, Alireza Ghoreifi,
Sidney Roberts, Farshad Sheybaee Moghad-
am, Hamed Ahmadi, Los Angeles, CA, Saum
Ghodoussipour, New Brunswick, CA, Muhannad
Alsyouf, Los Angeles, CA, Paolo Piatti, Benja-
min Jara, Lucy Sanossian, Irvine, CA, Sumeet
Bhanvadia, Anne Schuckman, Hooman Djaladat,
Gangning Liang, Siamak Daneshmand, Los
Angeles, CA
228
MP54-11 THE ROLE OF A DNA METHYLATION TEST IN
THE SURVEILLANCE OF BLADDER CANCER:
A SINGLE-CENTER BLINDED PROSPECTIVE
STUDY
Marialaura Righetto*, Daniele Modonutti, Monica
Montopoli, Francesco Pagano, Fabrizio Dal Moro,
Mariangela Mancini, Padova, Italy
MP54-12 T1 BLADDER CANCER: COMPARISON
OF THE PROGNOSTIC IMPACT OF TWO
SUBSTAGING SYSTEMS ON DISEASE
RECURRENCE AND PROGRESSION AND
SUGGESTION OF A NOVEL NOMOGRAM
Andrea Fuschi*, Yazan Al Salhi, Alessia Martoc-
cia, Lorenzo Capone, Silvio Scalzo, Paolo Pietro
Suraci, Antonio Carbone, Antonio Luigi Pastore,
Latina, Italy, Rossana Telesca, Rome, Italy, Gaia
Colalillo, Roberto Miano, Enrico Finazzi Agro’,
Anastasios Asimakopoulos, Rome, Italy
MP54-13 THE UPDATE FROM BLADDER CANCER ITALIAN
ACTIVE SURVEILLANCE (BIAS) PROJECT FOR
LOW-GRADE BLADDER TUMORS: LONG-TERM
ONCOLOGICAL OUTCOMES OF PATIENTS
UNDER ACTIVE SURVEILLANCE
Edoardo Beatrici*, Roberto Contieri, Nicola Frego,
Vittorio Fasulo, Pietro Diana, Marco Paciotti,
Davide Maffei, Pier Paol Avolio, Alessandro Uleri,
Cesare Saitta, Paola Arena, Giuseppe Chiarelli,
Andrea Gobbo, Nicolò Maria Buffi, Milan, Italy,
Massimo Lazzeri, Paolo Casale, Alberto Saita,
Milano, Italy, Giorgio Guazzoni, Giovanni Lughez-
zani, Milan, Italy, Rodolfo Hurle, Milano, Italy
MP54-14 SEQUENTIAL INTRAVESICAL GEMCITABINE/
DOCETAXEL PROVIDES A DURABLE
REMISSION IN RECURRENT HIGH RISK
NMIBC FOLLOWING BCG THERAPY
Kendrick Yim*, Kevin Melnick, Boston, MA, Sarah L
Mott, Iowa City, IA, Vani Gupta, Timothy N Clinton,
Filipe LF Carvalho, Matthew Mossanen, Graeme S
Steele, Kent Mouw, Boston, MA, Michael A O’Don-
nell, Iowa City, IA, Mark A Preston, Boston, MA
MP54-15 A MULTICENTER STUDY OF 2-YEAR
OUTCOMES FOLLOWING HYPERTHERMIA
THERAPY WITH MITOMYCIN C IN
TREATING BCG UNRESPONSIVE NON-
MUSCLE INVASIVE BLADDER CANCER:
RECIRCULANT HYPERTHERMIC
INTRAVESICAL CHEMOTHERAPY
Andrew Stemberger*, Wei Phin Tan, Camden, NJ,
Ana Plata Bello, Juan Carlos Garcia Alvarez, Canary
Islands, Spain, Félix Guerrero-Ramos, Daniel A.
González-Padilla, Madrid, Spain, Cajetan Nzeh,
Gladbeck, Germany, Jose Manuel de la Morena,
Ignacio Gonzalez Valcarcel de Torres, Madrid, Spain,
Kees Hendricksen, Amsterdam, Netherlands, Fran-
cisco Javier Díaz-Goizueta, J. Fernandez Del Alamo,
Madrid, Spain, Francesco Chiancone, Paolo Fedelini,
Naples, Italy, Massimiliano Poggio, Francesco
Porpiglia, Turin, Italy, Victoria C. Gonzalo Rodríguez,
Javier Montero Torres, Burgos, Spain, Daniel Wilby,
Richard Robinson, Portsmouth, United Kingdom,
Alejandro Sousa-Escandón, Juan León-Mata, Lugo,
Spain, Jose L Pontones Moreno, Francisco Delgado
Molina, Valencia, Spain, Miguel A. Adriazola Semino,
Palencia, Spain, Jesús Calleja-Escudero, Valladolid,
Spain, Joan Palou Redorta, Barcelona, Spain, Wei
Shen Tan, London, United Kingdom
 MP54-16 IMMEDIATE RADICAL CYSTECTOMY VS. BCG
IMMUNOTHERAPY FOR T1 HIGH GRADE
NON-MUSCLE-INVASIVE BLADDER CANCER:
AN INTERNATIONAL MULTICENTRE
COLLABORATION
Chiara Lonati*, Brescia, Italy, Luca Afferi, Lucerne,
Switzerland, Andrea Mari, Andrea Minervini, Flor-
ence, Italy, Wojciech Krajewski, Wroclaw, Poland,
Marco Borghesi, Genova, Italy, Gerald B. Schulz,
Munich, Germany, Michael Rink, Hamburg,
Germany, Francesco Montorsi, Alberto Briganti,
Alberto Martini, Milan, Italy, Stefania Zamboni,
Claudio Simeone, Brescia, Italy, Francesco
Soria, Turin, Italy, Jeremy Y.C. Teoh, Hong Kong,
China, People’s Republic of, Mathieu Roumiguié,
Toulouse, France, Morgan Roupret, Paris, France,
M. Carmen Mir, Valencia, Spain, Alessandro An-
tonelli, Verona, Italy, Kees Hendricksen, Amster-
dam, Netherlands, Roberto Carando, Christian D.
Fankhauser, Philipp Baumeister, Agostino Mattei,
Lucerne, Switzerland, Shahrokh F. Shariat, Vien-
na, Austria, Marco Moschini, Milan, Italy
MP54-17 TIMING OF RADICAL CYSTECTOMY FOR BCG
FAILURE
Patrick Hensley*, Niyati Lobo, Kelly Bree, Akshay
Sood, Neema Navai, Colin Dinney, Ashish Kamat,
Houston, TX
Monday, May 16, 2022
Moderated Poster Session 55
PROSTATE CANCER: LOCALIZED: ABLATIVE THERAPY
Room 225 @ Ernest N. Morial Convention Center
Moderators: Aaron Katz & Franz Schmidlin
ABSTRACT
NUMBER TITLE
MP55-01 CANCER CONTROL OUTCOMES FOLLOWING
FOCAL THERAPY USING HIFU IN 1,379
MEN WITH NON-METASTATIC PROSTATE
CANCER: A MULTI-INSTITUTE 15-YEAR
EXPERIENCE
Deepika Reddy*, London, United Kingdom, Max
Peters, Utrecht, Netherlands, Taimur Shah,
London, United Kingdom, Marieke van Son,
Utrecht, Netherlands, Mariana Tanaka Bertoncelli,
London, United Kingdom, Philipp Huber, Luzern,
Switzerland, Derek Lomas, Rochester, MN, Arnas
Rakauskas, Lausanne, Switzerland, Saiful Miah,
Amersham, United Kingdom, David Eldred-Evans,
Stephanie Guillaumier, Feargus Hosking-Jer-
vis, Ryan Engle, London, United Kingdom, Tim
Dudderidge, Southampton, United Kingdom,
Richard Hindley, Amr Emara, Basingstoke, United
Kingdom, Raj Nigam, Guildford, United King-
dom, Neil McCartan, London, United Kingdom,
Massimo Valerio, Lausanne, Switzerland, Naveed
Afzal, Dorchester, United Kingdom, Henry Lewi,
Chelmsford, United Kingdom, Clement Orczyk,
Chris Ogden, London, United Kingdom, Iqbal
Shergill, Wrexham, United Kingdom, Raj Persad,
Bristol, United Kingdom, Jaspal Virdi, Harlow,
United Kingdom, Caroline Moore, Manit Arya,
Mathias Winkler, Mark Emberton, Hashim Ahmed,
London, United Kingdom
*Presenting author
MP54-18 NOVEL THERAPEUTIC TARGETS AND
POTENTIAL DRUGS FOR BCG INCURABLE
NON-MUSCLE-INVASIVE BLADDER CANCER
Zhou Peng*, Hu Henglong, Wang Shaogang,
Wuhan, China, People’s Republic of
MP54-19 PROTEIN DISULFIDE ISOMERASE AS A
PREDICTIVE BIOMARKER FOR NON-MUSCLE
INVASIVE BLADDER CANCER RECURRENCE
Kit L. Yuen*, Chia-Hao Wu, Christopher R. Sil-
vers, Alexis Steinmetz, Hiroshi Miyamoto, Edward
M. Messing, Yi-Fen Lee, Rochester, NY
MP54-20 ROLE OF ORAL PENTOSAN POLYSULFATE
IN BACILLUS CALMETTE-GUERIN THERAPY
IN PATIENTS WITH NON-MUSCLE-INVASIVE
BLADDER CANCER
Yu Seong Hyeon, Chung Ho Seok*, Hwang Eu
Chang, Kim Sun-Ouck, Oh Kyung Jin, Jung
Seung Il, Kang Taek Won, Kwon Dongdeuk, Park
Kwangsung, Gwangju, Korea, Republic of
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
MONDAY
8:45 am – 10:00 am
ABSTRACT
NUMBER TITLE
MP55-02 REPEAT FOCAL THERAPY OF PROSTATE
CANCER
Nima Nassiri*, Caroline Wallner, David Kupper-
man, Shannon Richardson, Samantha Gonzalez,
Lorna Herbert, Leonard Marks, Los Angeles, CA
MP55-03 USING MAGNETIC RESONANCE IMAGING
TO DEFINE FOCAL THERAPY TEMPLATES
IN PATIENTS WITH INTERMEDIATE-RISK
PROSTATE CANCER
Alberto Pieretti*, Hyunseon Kang, Haesun Choi,
Miao Zhang, Brian Chapin, John Ward, Patricia
Troncoso, Justin Gregg, Houston, TX
MP55-04 THE PREDICTIVE VALUE OF TISSUE
CHANGE DURING ULTRASOUND GUIDED
HIGH INTENSITY FOCUSED ULTRASOUND
(USGHIFU) FOCAL THERAPY ON
TREATMENT SUCCESS
Yash Khandwala*, Shravan Morisetty, Sulaiman Vesal,
Richard E. Fan, Ahmed El Kaffas, Pejman Ghanouni,
Mirabela Rusu, Geoffrey A. Sonn, Palo Alto, CA
MP55-05 5-YEAR ONCOLOGIC OUTCOMES AT A
SINGLE-INSTITUTION FOLLOWING FOCAL
CRYOTHERAPY FOR PROSTATE CANCER
MANAGEMENT
Ashley Monaco*, Glen Head, NY, Jessica Sommer,
Garden City, NY, Meredith Akerman, Mineola, NY,
Anthony Corcoran, Aaron Katz, Garden City, NY
229
 MP55-06 FOCAL ABLATIVE SALVAGE THERAPY FOR
RADIO-RECURRENT PROSTATE CANCER:
6 YEAR ONCOLOGICAL AND SAFETY
OUTCOMES
Deepika Reddy*, London, United Kingdom,
Max Peters, Utrecht, Netherlands, Taimur Shah,
London, United Kingdom, Marieke van Son,
Utrecht, Netherlands, Mariana Tanaka Bertoncelli,
London, United Kingdom, Philipp Huber, Luzern,
Switzerland, Derek Lomas, Rochester, MN, Arnas
Rakauskas, Lausanne, Switzerland, Saiful Miah,
Amersham, United Kingdom, David Eldred-Evans,
Stephanie Guillaumier, Feargus Hosking-Jervis,
Ryan Engle, London, United Kingdom, Tim Dud-
deridge, Southampton, United Kingdom, Richard
Hindley, Amr Emara, Basingstoke, United Kingdom,
Raj Nigam, Guildford, United Kingdom, Neil McCa-
rtan, London, United Kingdom, Massimo Valerio,
Lausanne, Switzerland, Naveed Afzal, Dorchester,
United Kingdom, Henry Lewi, Chelmsford, United
Kingdom, Clement Orczyk, Chris Ogden, London,
United Kingdom, Iqbal Shergill, Wrexham, United
Kingdom, Raj Persad, Bristol, United Kingdom,
Jaspal Virdi, Harlow, United Kingdom, Stuart
McCracken, london, United Kingdom, Damian
Greene, Washington, United Kingdom, Caroline
Moore, Manit Arya, Mathias Winkler, Mark Ember-
ton, Hashim Ahmed, London, United Kingdom
MP55-07 PARTIAL ABLATION AND TOTAL ABLATION
WITH HIGH INTENSITY FOCUSED
ULTRASOUND (HIFU) COMPARED TO
RADICAL PROSTATECTOMY (RP): A
PROPENSITY SCORE-MATCHED STUDY
Changhee Ye*, Gyoohwan Jung, Hwanik Kim,
Jung Kwon Kim, Jong Jin Oh, Sangchul Lee,
Seong Jin Jeong, Sung Kyu Hong, Seok-Soo
Byun, Hakmin Lee, Seongnam, Korea,
Republic of
MP55-08 HIGH INTENSITY FOCUSED ULTRASOUND
AND CRYOABLATION FOCAL THERAPY FOR
INTERMEDIATE RISK PROSTATE CANCER:
ONCOLOGIC AND FUNCTIONAL OUTCOMES
Masatomo Kaneko*, Alireza Ghoreifi, Los An-
geles, CA, Samuel Peretsman, Charlotte, NC,
Dordaneh Sugano, Giovanni Cacciamani, Amir
Lebastchi, Suzanne Palmer, Manju Aron, Los
Angeles, CA, Osamu Ukimura, Kyoto, Japan,
Inderbir Gill, Andre Abreu, Los Angeles, CA
MP55-09 EARLY PERCENT PROSTATE-SPECIFIC
ANTIGEN REDUCTION POST CRYOTHERAPY
CAN PREDICT BIOCHEMICAL RECURRENCE
IN MEN WITH PROSTATE CANCER
Jessica Sommer*, Garden City, NY, Ashley Mona-
co, Glen Head, NY, Meredith Akerman, Mineola,
NY, Aaron Katz, Garden City, NY
MP55-10 A PROSPECTIVE LONGITUDINAL STUDY OF
ERECTILE FUNCTION FOLLOWING PARTIAL
GLAND CRYOABLATION FOR INTERMEDIATE
RISK PROSTATE CANCER
Sameer Thakker*, James Wysock, Rozalba
Gogaj, Herbert Lepor, New York, NY
230
MP55-11 PROSTATE CANCER FOCAL THERAPY –
LOCATIONS OF POST-ABLATION DISEASE
Hemant Chaparala*, Anis Davoudi, Gainesville,
FL, Alan M. Priester, Adam Kinnaird, David
Kuppermann, Ely R. Felker, Anthony E. Sisk,
Elizabeth Tran, Merdie K. Delfin, Leonard S.
Marks, Los Angeles, CA, Wayne G. Brisbane,
Gainesville, FL
MP55-12 MRI/US FUSION GUIDED CRYOTHERAPY
UNDER LOCAL ANESTHESIA: ONCOLOGICAL
OUTCOMES
Fernando Bianco*, Luna Eusebio, Alberto Lopez,
Edward Gheiler, Kaufman Ariel, Miami, FL, Far-
shad Shafizadeh, New York, NY, Michael Zachar-
eas, Beverly, MA, Gloria Egui-Benatuil, Dailianys
Barrios, Miami, FL, Juan Martinez-Salamanca,
Madrid, Spain
MP55-13 MULTIFOCALITY OF PROSTATE CANCER
AND CANDIDACY FOR FOCAL THERAPY
BASED ON MAGNETIC RESONANCE
IMAGING
Hiten Patel, Yudai Okabe, Goran Rac*, Gopal N.
Gupta, Maywood, IL
MP55-14 SALVAGE ROBOTIC RADICAL
PROSTATECTOMY AFTER FOCAL
THERAPY VERSUS RADIATION: A 10-YEAR
EXPERIENCE
Alireza Ghoreifi*, Masatomo Kaneko, Hooman
Djaladat, Andrew Hung, Rene Sotelo, Andre Berg-
er, Mihir Desai, Inderbir Gill, Monish Aron, Andre
Luis Abreu, Los Angeles, CA
MP55-15 CAN MRI LOCALIZE THE PROXIMITY OF
PROSTATE CANCER TO THE URETHRA IN
MEN WHO ARE CANDIDATES FOR FOCAL
GLAND ABLATION?
Neal Patel*, Alexa Hughes, Los Angeles, CA,
Wayne Brisbane, Gainsville, FL, Ali Rastegarpour,
Sohrab Afshari, Lorna Kwan, Anissa V Nguyen,
Anthony Sisk, Steven Raman, Robert Reiter, Los
Angeles, CA
MP55-16 FOCAL CRYOTHERAPY AND STEREOTACTIC
BODY RADIOTHERAPY HAVE SIMILAR
ONCOLOGIC AND FUNCTIONAL OUTCOMES
IN TREATMENT OF LOW-TO-INTERMEDIATE
UNILOBE PROSTATE CANCER
Ashley Monaco*, Glen Head, NY, Jessica Som-
mer, Garden City, NY, Chinyere Okpara, Jonathan
Haas, Mineola, NY, Anthony Corcoran, Aaron
Katz, Garden City, NY
MP55-17 SALVAGE LOCAL TREATMENT FOR
RECURRENT PROSTATE CANCER AFTER
FOCAL THERAPY: A SYSTEMATIC REVIEW
AND META-ANALYSIS
Oliver Claros*, Sao Paulo, Brazil, Rafael Tourinho,
Salvador, Brazil, Saulo Teles, Lucas Takemura,
Pedro Costa, Sao Paulo, Brazil, Rafael Sanchez-
Salas, Paris, France, Bruno Nahar, Abhishek
Bhat, Miami, FL, Ruben Olivares, Santiago, Chile,
Gustavo Lemos, Arie Carneiro, Sao Paulo, Brazil
 MP55-18 A NATIONAL COHORT STUDY OF CANCER
OUTCOMES FOLLOWING HIGH-INTENSITY
FOCUSED ULTRASOUND TREATMENT OF
CLINICALLY LOCALISED PROSTATE CANCER
Matthew Parry*, Arunan Sujenthiran, Julie Nossit-
er, Melanie Morris, Brendan Berry, Ajay Aggarwal,
Heather Payne, Jan van der Meulen, London, United
Kingdom, Noel Clarke, Manchester, United Kingdom
MP55-19 MRI ALONE IS NOT AN APPROPRIATE
SURVEILLANCE MECHANISM FOR PATIENTS
AFTER FOCAL CRYOABLATION FOR
LOCALIZED PROSTATE CANCER
Monday, May 16, 2022
Podium Session 55
STONE DISEASE: SURGICAL THERAPY (INCLUDING ESWL) IV
Room 252 @ Ernest N. Morial Convention Center
Moderators: Naeem Bhojani, Kenneth Pace & Husain Alenezi
ABSTRACT
TIME NUMBER TITLE
9:30 PD55-01 TAMSULOSIN AS MEDICAL EXPULSIVE
THERAPY AFTER SHOCK WAVE
LITHOTRIPSY FOR RENAL STONES,
A RANDOMIZED CONTROLLED TRIAL
(NCT05032287)
Abdelwahab Hashem*, Mahmoud Laymon,
Mostafa Elgamal, Doaa Elsayed Sharaf, Ahmed
E. Elzalouey, A. M. Elmeniar, Ahmed El-Assmy,
Yasser Osman, Khaled Z. Sheir, Mansoura,
Egypt
9:40 PD55-02 PREDICTION OF CHEMICAL COMPOSITION
OF URINARY STONE THROUGH DEEP
LEARNING
Ui Seok Kim*, Hyo Sang Kwon, Wonjong Yang,
Wonchul Lee, Changil Choi, Jong Keun Kim,
Seong Ho Lee, Jun Hyun Han, Hwaseong, Korea,
Republic of
9:50 PD55-03 PATIENT-REPORTED OUTCOMES
FOLLOWING HOME URETERAL STENT
REMOVAL AFTER URETEROSCOPY
John Graves*, John Bell, Lexington, KY, Amul
Bhalodi, Corbin, KY, Will Cranford, Adam Dugan,
Jason Bylund, Lexington, KY
10:00 PD55-04 PREDICTING THE NEED FOR
INTERVENTION IN RENAL COLIC DUE TO
A URETERAL STONE <5 MM: A MACHINE
LEARNING MODEL
Rennen Haramaty*, Nir Kleinmann, Miki Haifler,
Dorit E Zilberman, Ramat Gan, Israel
*Presenting author
Avi Baskin*, Leslie Charondo, Ashwin Balakr-
ishnan, Janet Cowan, Matthew Cooperberg, Peter
Carroll, Hao Nguyen, Katsuto Shinohara, San
Francisco, CA
MP55-20 OUTCOMES OF PRIMARY CRYOTHERAPY
FOR LOCALIZED PROSTATE CANCER:
14-YEARS SINGLE INSTITUTION
EXPERIENCE
Andrew Wang*, Greg Mansour, Robert Given,
Virginia Beach, VA
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
MONDAY
10:10 PD55-05 WORLDWIDE SURVEY ON THE CURRENT
PRACTICE OF ASYMPTOMATIC URINARY
STONE MANAGEMENT: A SURVEY FROM
EAU, YOUNG ACADEMIC UROLOGISTS
(YAU), ENDOUROLOGY AND UROLITHIASIS
WORKING PARTY
Tarik Emre Sener, Istanbul, Turkey, Thomas Tailly*,
Ghent, Belgium, Amelia Pietropaolo, Southampton,
United Kingdom, Etienne Xavier Keller, Zurich, Swit-
zerland, Yiloren Tanidir, Istanbul, Turkey, Juan Gomez
Rivas, Madrid, Spain, Zeeshan Hameed, Manipal,
India, Vincent De Coninck, Brasschaat, Belgium,
Tzevat Tefik, Kemal Sarica, Istanbul, Turkey, Ali
Serdar Gozen, Heilbronn, Germany, Andreas Skolar-
ikos, Athens, Greece, Olivier Traxer, Paris, France,
Bhaskar Somani, Southampton, United Kingdom
10:20 PD55-06 DOES DRAINAGE METHOD AFTER FLEXIBLE
URETEROSCOPY FOR RENAL STONES
AFFECT THE TREATMENT OUTCOMES OR
QUALITY OF LIFE?
Amr Elsawy*, Nasr El-Tabey, Mohamed Zahran,
Ahmed Shoma, Mansoura, Egypt
10:30 PD55-07 OUTCOMES AND PROCEDURAL COSTS
FOLLOWING MINI-PERCUTANEOUS
NEPHROLITHOTOMY OR FLEXIBLE
URETEROSCOPIC LITHOTRIPSY FOR KIDNEY
STONES BETWEEN 1-2CM: DATA FROM A
PROSPECTIVE, RANDOMIZED CLINICAL TRIAL
Rahul Dutta*, Prabhakar Mithal, Ilan Klein, Manish
Patel, Jorge Gutierrez-Aceves, Winston Salem, NC
10:40 PD55-08 OPTIMIZATION OF PERCUTANEOUS
NEPHROLITHOTOMY FOR A FREE-STANDING
AMBULATORY SURºGERY CENTER:
OUTCOMES FROM 1200 CASES
Daniel Rosen*, Meagan Dunne, Hanover, MD,
Max Drescher, Baltimore, MD, Brian Panish, Liam
Hatch, Washington, DC, Joel Abbott, Las Vegas,
NV, Julio Davalos, Hanover, MD
231
10:50 PD55-09 A NEWLY DESIGNED NOMOGRAM TO
PREDICT INFECTIOUS AND HEMORRHAGIC
COMPLICATIONS AFTER PERCUTANEOUS
NEPHROLITHOTOMY
Guohua Zeng, Giorgio Mazzon*, Guangzhou, China,
People’s Republic of, Caterina Gregorio, Trieste, Italy,
Jiehui Zhong, Chao Cai, Guangzhou, China, People’s
Republic of, Nicola Pavan, Trieste, Italy, Wen Zhong,
Guangzhou, China, People’s Republic of
11:00 PD55-10 MOSES 2.0 LASER IMPACT ON
INTRAOPERATIVE PARAMETERS
Samuel Antoine, Aurora, CO, Kerri Thurmon, Den-
ver, CO, Michael Atwell, Xavier Glover*, Miguel
Rodriguez-Homs, Fernando Kim, Aurora, CO,
Rodrigo Donalisio da Silva, Denver, CO
Monday, May 16, 2022
Podium Session 56
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY IV
Room 255 @ Ernest N. Morial Convention Center
Moderators: William C. Huang, Chandru Sundaram & Robert Abouassaly
ABSTRACT
TIME NUMBER TITLE
9:30 PD56-01 IMPROVED PREDICTION OF RENAL
FUNCTION AFTER RADICAL NEPHRECTOMY
Nityam Rathi*, Yosuke Yasuda, Diego Aguilar
Palacios, Cleveland, OH, Yunlin Ye, Guangzhou,
China, People’s Republic of, Jianbo Li, Chris-
topher Weight, Mohammed Eltemamy, Robert
Abouassaly, Steven Campbell, Cleveland, OH
9:40 PD56-02 THE DETRIMENTAL EFFECT OF FRAILTY
STATUS ON RENAL FUNCTION RECOVERY
AFTER PARTIAL NEPHRECTOMY – LONG-
TERM RESULTS FROM A PROSPECTIVE
SURGICAL COHORT
Giuseppe Rosiello*, Giuseppe Fallara, Giuseppe
Basile, Alberto Martini, Daniele Cignoli, Luigi
Nocera, Federico Belladelli, Gianmarco Colandrea,
Daniela Canibus, Chiara Re, Giacomo Musso,
Francesco Cei, Cristina Giancristofaro, Alberto
Briganti, Roberto Bertini, Andrea Necchi, Daniele
Raggi, Milan, Italy, Pierre I. Karakiewicz, Montreal,
Canada, Francesco Montorsi, Andrea Salonia, Ales-
sandro Larcher, Umberto Capitanio, Milan, Italy
9:50 PD56-03 CONTEMPORARY PERIOPERATIVE
COMPLICATIONS OF SURGERY FOR RENAL
CELL CARCINOMA WITH INFERIOR VENA
CAVA THROMBECTOMY
Daniel D. Joyce*, Andrew Zganjar, Vidit Shar-
ma, Christine M. Lohse, R. Houston Thompson,
Stephen A. Boorjian, John C. Cheville, Brian A.
Costello, Bradley C. Leibovich, Rochester, MN
10:00 PD56-04 ASSESSMENT OF CHANGES IN ARTERIAL
BLOOD PRESSURE AFTER NEPHRECTOMY
FOR KIDNEY CANCER VAPANCR (UROCCR
26)_PROSPECTIVE STUDY
Pierre Bigot*, Angers, France, Jean-Christophe
Bernhard, Bordeaux, France, Nicolas Doumerc,
François-Xavier Nouhaud, Toulouse, France, Idir
Ouzaid, Paris, France, Patrick Saulnier, Angers,
France, Arnaud Mejean, Morgan Rouprêt, Paris,
France, Karim Bensalah, Rennes, France
232
11:10 PD55-11 ERECTOR SPINAE PLANE BLOCKS FOR
ANALGESIA AFTER PERCUTANEOUS
NEPHROLITHOTOMY: A PATHWAY TO
REDUCE OPIATES
Waseem Abdou*, Jacob Roberts, John Ryan,
Saisantosh Attaluri, Roger Sur, John Finneran IV,
Seth Bechis, San Diego, CA
11:20 PD55-12 ULTRA-LOW DOSE INTRAOPERATIVE CT
CONFIRMS STONE-FREE STATUS DURING PCNL
USING ROBOTIC FLUOROSCOPY PLATFORM: A
PROSPECTIVE QUALITY IMPROVEMENT STUDY
Xavier Glover*, Eric Ballon-Landa, Mark Sawyer,
Denver, CO
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:10 PD56-05 SHORT AND INTERMEDIATE TERM
INFERIOR VENA CAVA PATENCY OUTCOMES
IN PATIENTS UNDERGOING RADICAL
NEPHRECTOMY AND VENOUS TUMOR
THROMBECTOMY FOR RENAL CELL
CARCINOMA
Harshit Garg*, Furkan Dursun, Robert Cooper,
Hanzang Wang, Michael Liss, Ahmed Mansour,
Ahmed Mansour, Robert Svatek, Ronald Rodri-
guez, Dharam Kaushik, Deepak Pruthi,
San Antonio, TX
10:20 PD56-06 SURGERY FOR RENAL MASSES IN
HORSESHOE KIDNEYS
Yosuke Yasuda*, JJ Zhang, Nityam Rathi,
Gustavo Roversi, Ao Zhang, Diego Palacios,
Jihad Kaouk, Georges-Pascal Haber, Venkatesh
Krishnamurthi, Robert Abouassaly, Christopher
Weight, Steven Campbell, Cleveland, OH
10:30 PD56-07 RENAL CELL CARCINOMA WITH IVC
INVASION: THE EVOLUTION OF CURRENT
CONCEPTS AND A NOVEL APPROACH FOR
HIGH LEVEL IVC TUMOR THROMBUS
John Libertino*, Concord, MA
10:40 PD56-08 EN BLOC RESECTION OF RIGHT RENAL
CELL CARCINOMA AND INFERIOR VENA
CAVA WITH TUMOR THROMBUS: IS IT SAFE
TO DIVIDE THE LEFT RENAL VEIN?
Laura Horodyski*, Miami, FL, Javier Gonzalez,
Madrid, Spain, Marina Tabbara, Jeffrey Gaynor,
Miami, FL, Maria Rodriguez-Cabero, Felipe
Herranz-Amo, Carlos Hernández, Madrid, Spain,
Rushi Shah, Gaetano Ciancio, Miami, FL
10:50 PD56-09 IMPACT OF MIXED REALITY APPLICATION
ON THE LEARNING CURVE OF
LAPAROSCOPIC NEPHRECTOMY
Roman Pogosyan*, Igor’ Semenyakin,
Amir Gabdullin, Moscow, Russian Federation
11:00 PD56-10 THE IMPORTANT ROLE OF TUMOR 11:20 PD56-12 SURGICAL OUTCOMES FOR OLDER
VOLUME ON THE SURGICAL APPROACH PATIENTS WITH RENAL CELL CARCINOMA
CHOICE, SURGICAL COMPLEXITY, AND AND INFERIOR VENA CAVA THROMBUS
POSTOPERATIVE COMPLICATIONS IN Yudai Ishiyama*, Tsunenori Kondo, Hidekazu
RENAL CELL CARCINOMA WITH VENOUS Tachibana, Hiroki Ishihara, Arakawa, Japan, Ka-
TUMOR THROMBUS FROM A LARGE zuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe,
CHINESE CENTER EXPERIENCE Toshio Takagi, Tokyo, Japan
Qais Baheen*, Zhuo Liu, Peking, China, People’s
APPROVED FOR AMA PRA CATEGORY 2
Republic of
CREDITSTM
11:10 PD56-11 COMPARISON OF INTERMEDIATE
OUTCOMES OF SINGLE PORT AND
MULTIPORT ROBOTIC ASSISTED PARTIAL
NEPHRECTOMY
Janmejay Hingu, Hackensack, NJ, Tanner Corse,
Jay Zaifman*, Nutley, NJ, Ruth Sanchez De La
Rosa, Bilal Ahmed Khan, Kevin Alter, Fahad
Sheckley, Suzannah Sorin, Gregory Lovallo,
Hackensack, NJ, Ravi Munver, Mutahar Ahmed,
Michael Stifelman, Nutley, NJ

Monday, May 16, 2022 9:30 am – 11:30 am

Podium Session 57
PROSTATE CANCER: DETECTION & SCREENING VI

MONDAY
TBD @ Ernest N. Morial Convention Center
Moderator: Janet Kukreja

ABSTRACT ABSTRACT
TIME NUMBER TITLE TIME NUMBER TITLE
9:30 PD57-01 MULTI-INSTITUTIONAL ANALYSIS OF CLINICAL 10:00 PD57-04 MRI-BASED PI-RADS SCORE PREDICTS ISUP
AND IMAGING RISK FACTORS FOR DETECTING UPGRADING AND ADVERSE PATHOLOGY AT
CLINICALLY SIGNIFICANT PROSTATE CANCER RADICAL PROSTATECTOMY IN MEN WITH
IN MEN WITH PI-RADS 3 LESIONS BIOPSY ISUP 1 PROSTATE CANCER
Andrew Fang*, Luke Shumaker, Kimberly Martin, Snir Dekalo, Tel Aviv, Israel, Jeremy Cepek*,
Birmingham, AL, Okechukwu Onah, Jamaal London, Canada, Mario Sofer, Sophie Barnes,
Jackson, Chicago, IL, Ghazal Khajir, New Haven, Ofer Yossepowitch, Roy Mano, Tel Aviv, Israel
CT, Richard Fan, Stanford, CA, Nachiketh Soo-
10:10 PD57-05 A RACE-STRATIFIED ANALYSIS OF THE
dana-Prakash, Miami, FL, Hiten Patel, Srinivas
ACCURACY OF PROSTATE MRI IN BIOPSY
Vourganti, Chicago, IL, Christopher Filson, Atlanta,
NAIVE MEN
GA, Preston Sprenkle, New Haven, CT, Geoffrey
Julio Meza*, Rilwan Babajide, Ragheed Saoud,
Sonn, Stanford, CA, Sanoj Punnen, Miami, FL,
Josephine Abelleria, Irene Helenowski, Adam
Gopal Gupta, Chicago, IL, Soroush Rais-Bahrami,
Murphy, Jeanne Horowitz, David Casalino,
Birmingham, AL
Chicago, IL
9:40 PD57-02 ASSESSMENT OF CLINICAL UTILITY OF
10:20 PD57-06 FACTORS PREDICTING CLINICALLY
PSA DENSITY IN RISK STRATIFICATION
SIGNIFICANT PROSTATE CANCER IN PIRADS
OF PI-RADS V2.1 CATEGORIES ON
3 LESIONS
PROSTATE MRI
Jasmine Lin*, Mohammad Rashid Siddiqui,
Gianluca Giannarini*, Rossano Girometti, Udine,
Eric Li, Jonathan Aguiar, Brandon Ansbro,
Italy, Valeria Panebianco, Rome, Italy, Silvio
Moataz Soliman, Jordan Rich, Johan Alfaro,
Maresca, Lorenzo Cereser, Maria De Martino,
Mary Kate Keeter, Edward Schaeffer, Ashley
Stefano Pizzolitto, Udine, Italy, Vincenzo Ficarra,
Ross, Chicago, IL
Messina, Italy, Chiara Zuiani, Claudio Valotto,
Udine, Italy 10:30 PD57-07 FACTORS PREDICTING CLINICALLY
SIGNIFICANT PROSTATE CANCER IN
9:50 PD57-03 PREDICTORS OF CONTRALATERAL DISEASE
PIRADS 4 LESIONS
IN MEN WITH UNILATERAL LESIONS ON
Mohammad Siddiqui*, Jasmine Lin, Jonathan
MULTIPARAMETRIC MRI
Aguiar, Brandon Ansbro, Moataz Soliman, Jordan
Vyom Sawhney*, Richard Huang, William C.
Rich, Johan Alfaro, Mary-Kate Keeter, Quan Mai,
Huang, Herbert Lepor, Samir S. Taneja, James
Edward Schaeffer, Ashley Ross, Chicago, IL
Wysock, New York, NY

*Presenting author 233

10:40 PD57-08 DEVELOPMENT OF A NOVEL RISK
STRATIFICATION NOMOGRAM FOR PIRADS
4 AND 5 PROSTATE CANCER ON MRI-
FUSION BIOPSY
Holly Houenstein, Ayat A. Shah*, Yousuf Ramahi,
Philippa Doherty, Kristopher Attwood, Zhe Jing,
James Mohler, Khurshid A. Guru,
Eric C. Kauffman, Ahmed A. Hussein, Buffalo, NY
10:50 PD57-09 THE IMPORTANCE OF MRI-TARGETED
BIOPSY FOR TUMORS IN ANTERIOR
FIBROMUSCULAR STROMA
Hayato Yamamoto*, Teppei Okamoto,
Toru Yoneyama, Chikara Ohyama,
Hirosaki, Japan
11:00 PD57-10 OPTIMIZING THE PROSTATE BIOPSY
TEMPLATE: ADDITIONAL VALUE OF
CONTRALATERAL AND IPSILATERAL
SYSTEMATIC BIOPSIES IN PATIENTS WITH
AN UNILATERAL LESION ON MAGNETIC
RESONANCE IMAGING
Auke Jager*, Luigi van Riel, Arnoud Postema,
Theo de Reijke, Tim van der Sluis, Jorg Oddens,
Amsterdam, Netherlands
Monday, May 16, 2022
Video Session 12
SEXUAL DYSFUNCTION/INFERTILITY/ANDROLOGY
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Gerard Henry, Stanton Honig & Jason Kovac
ABSTRACT
TIME NUMBER TITLE
9:30 V12-01 NEW BIPOLAR RADIOFREQUENCY SEALING
TOOL FOR TRANSDERMAL VASECTOMY IN
THE RABBIT MODEL: A PARADIGM SHIFT IN
VASECTOMY TECHNIQUE?
Gerard Henry, Ryan Griggs*, Bossier City, LA,
Michel Labrecque, Charlesbourg, Canada,
Joel Marmar, Bala Cynwyd, PA, Tariq Hakky,
Atlanta, GA
9:40 V12-02 BILATERAL HERNIA MESH OBSTRUCTION:
SUBINGUINAL VASOVASOSTOMIES WITH
LAPAROSCOPIC ASSISTANCE
Kevin Campbell*, Gainesville, FL, Jorge Rivera
Mirabal, Richard Link, Larry Lipshultz,
Houston, TX
9:50 V12-03 TRANSURETHRAL LASER INCISION OF
EJACULATORY DUCT OBSTRUCTION: AN
UNDERUSED TERMINOLOGY REAWAKEN BY
ENDOUROLOGY
Mohamed Omar*, Shbeen El Kom, Egypt
10:00 V12-04 TRANSURETHRAL RESECTION OF THE
EJACULATORY DUCTS
Wael Almajed*, New Orelans, LA, Christopher
Koller, New Orelans, LA, Wayne Hellstrom, New
Orelans, LA, Omer Raheem, Chicago, IL
234
11:10 PD57-11 IMPACT OF CONTACT SURFACE AREA AND
PI-RADS CATEGORY ON THE CAPSULAR
INVASION OF LOCALIZED CANCER WITH
SERUM PROSTATE-SPECIFIC ANTIGEN
LEVELS ≤20 NG/ML AND TUMOR-CAPSULE
CONTACT
Takahiro Ogawa*, Sunao Shoji, Isehara, Japan,
Kazuma Takeda, Hiratsuka, Japan, Takahi-
to Uchida, Soichiro Yuzuriha, Izumi Hanada,
Satoshi Kuroda, Isehara, Japan, Kentaro Nagao,
Okayama, Japan, Taro Higure, Chichibu, Japan,
Masayoshi Kawakami, Mayura Nakano, Masahiro
Nitta, Yoshiaki Kawamura, Masanori Hasegawa,
Akira Miyajima, Isehara, Japan
11:20 PD57-12 DUAL-TRACER PET/CT-TARGETED, MPMRI-
TARGETED, SYSTEMATIC BIOPSY, AND
COMBINED BIOPSY FOR THE DIAGNOSIS OF
PROSTATE CANCER
Dongxu Qiu, Jian Li, Jinwei Zhang, Minfeng
Chen, Xiaomei Gao, Yongxiang Tang, Ye Zhang,
Xiaoping Yi, Hongling Yin, Yu Gan, Guilin Wang,
Xiongbing Zu, Shuo Hu, Yi Cai*, Changsha,
China, People’s Republic of
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
9:30 am – 11:30 am
ABSTRACT
TIME NUMBER TITLE
10:10 V12-05 WHAT TREATMENT OPTIONS ARE THERE
FOR PEYRONIE’S DISEASE?
Consuelo Conde Redondo*, Alejandro García
Viña, María Núñez, Ana Ruano Mayo, Álvaro
Zamora Horcajada, Fernando Natal Rodriguez,
Luis Cuellar Martín, Valladolid, Spain
10:20 V12-06 PENILE PLAQUE INCISION AND GRAFTING:
OUR EXPERIENCE AND HOW WE DO IT
Preston Kerr*, Jane Kurtzman, Steven Brandes,
New York City, NY
10:30 V12-07 SURGICAL TECHNIQUE FOR CONCURRENT
PENILE PLICATION AND EXCISION WITH
GRAFTING FOR SEVERE PEYRONIE’S
DISEASE
Jacob Tannenbaum, Bryan Herzog, New Orleans,
LA, Omer Raheem*, Chicago, IL
10:40 V12-08 SST AND THE FROZEN PUMP
Engy Habashy*, Tobias Kohler, Rochester, MN
10:50 V12-09 CORPORAL DILATION TECHNIQUES DURING
A DIFFICULT PENILE IMPLANT
Tejash Shah, Egor Parkhomenko*, Ricardo Mu-
narriz, Boston, MA
11:00 V12-10 IPP CYLINDER EXTRUSION
Engy Habashy*, Tobias Kohler, Rochester, MN
11:10 V12-11 COMPLEX TREATMENT FOR COMPLEX
PATHOLOGY: INFLATABLE PENILE IMPLANT
AND PENILE CORPOROPLASTY WITH
COLLAGEN FLEECE GRAFT PLUS MALE
URETHRAL SLING
Pedro Simoes de Oliveira*, Afonso Castro, Miguel
Miranda, Anatoliy Sandul, Francisco Martins, José
Palma Reis, Lisboa, Portugal
Monday, May 16, 2022
Moderated Poster Session 56
BLADDER CANCER: INVASIVE V
Room 228 @ Ernest N. Morial Convention Center
Moderators: Brant Inman & Matthew Tollefson
ABSTRACT
NUMBER TITLE
MP56-01 RENAL FUNCTIONAL CHANGES AFTER
CYSTECTOMY: WHO IMPROVES AND WHO
DOES NOT?
Benjamin Croll*, Dattatraya Patil, Khushali Vashi,
Atlanta, GA, Mehrdad Alemozaffar, Anaheim, CA,
Viraj Master, Christopher Filson, Kenneth Ogan,
Vikram Narayan, Shreyas Joshi, Atlanta, GA
MP56-02 NEOADJUVANT PEMBROLIZUMAB MAY
RESULT IN LONG-TERM OUTCOME
IMPROVEMENT IN BIOMARKER-
UNSELECTED PATIENTS WITH
MUSCLE-INVASIVE BLADDER CANCER
(MIBC): UPDATED RESULTS FROM
PURE-01
Luigi Nocera*, Marco Moschini, Daniele Raggi,
Milan, Italy, Laura Marandino, Bellinzona, Swit-
zerland, Maurizio Colecchia, Roberta Lucianò,
Milan, Italy, Ewan Gibb, Vancouver, Canada,
Jeffrey Ross, Syracuse, NY, Antonella Messina,
Giuseppina Calareso, Milan, Italy, Andrea Gallina,
Lugano, Switzerland, Federico Dehò, Varese,
Italy, Alberto Briganti, Francesco Montorsi, Andrea
Necchi, Milan, Italy
MP56-03 CLINICAL OUTCOMES AND SURGICAL
MANAGEMENT OF URACHAL CARCINOMA:
AN ANALYSIS OF THE NATIONAL CANCER
DATABASE
Furkan Dursun, San Antonio, TX, Kelvin Lim*,
Evan Wenker, Jiaqiong Xu, Houston, TX, Robert
Svatek, Ahmed Mansor, San Antonio, TX, Zachary
Klaassen, Augusta, GA, Taliah Muhammed, Ziad
El-Zaatari, Steven Shen, Eleni Efstathiou, Hou-
ston, TX, Guru Sonpavade, Boston, MA, Christo-
pher Wallis, Toronto, Canada, Raj Satkunasivam,
Houston, TX
*Presenting author 235
11:20 V12-12 PENOSCROTAL DECOMPRESSION OF
REFRACTORY ISCHEMIC PRIAPISM:
SURGICAL TECHNIQUE
Nicholas Ottaiano, Ganesh Sanekommu, Chris-
topher Koller, Wayne Hellstrom, New Orleans,
LA, Allen Morey, Dallas, TX, Omer Raheem*,
Chicago, IL
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
10:30 am – 11:45 am
ABSTRACT
TIME NUMBER TITLE
MP56-04 THE ROLE OF FDG PET IN THE STAGING OF
BLADDER CANCER PATIENTS CANDIDATE
FOR RADICAL CYSTECTOMY
Luigi Nocera*, Giuseppe Basile, Riccardo Leni,
MONDAY
Mario De Angelis, Alberto Martini, Simone
Scuderi, Giorgio Gandaglia, Milan, Italy, Alex
Mottrie, Aalst, Belgium, Andrea Gallina, Lugano,
Switzerland, Daniele Raggi, Laura Marandino,
Andrea Necchi, Francesco Montorsi, Alberto
Briganti, Marco Moschini, Milan, Italy
MP56-05 IMPACT OF COMPREHENSIVE
MEASUREMENT OF SURGICAL OUTCOMES
ON SUBJECTIVE ASSESSMENT OF HEALTH
RELATED QUALITY OF LIFE IN PATIENTS
RECEIVING RADICAL CYSTECTOMY
WITH ORTHOTOPIC PADUA ILEAL
BLADDER: SINGLE CENTER RANDOMIZED
CONTROLLED TRIAL
Riccardo Mastroianni*, Gabriele Tuderti, Um-
berto Anceschi, Alfredo Maria Bove, Leonardo
Misuraca, Aldo Brassetti, Mariaconsiglia Ferri-
ero, Salvatore Guaglianone, Michele Gallucci,
Giuseppe Simone, Rome, Italy
MP56-06 ASSOCIATIONS BETWEEN SKELETAL
MUSCLE GAUGE AND SURVIVAL
FOLLOWING RADICAL CYSTECTOMY FOR
BLADDER CANCER: A NOVEL ASSESSMENT
OF MUSCLE MASS AND QUALITY
Meghana Noonavath*, Kevin Mun, Seattle,
WA, J. Peter Marquardt, Florian J. Fintelmann,
Boston, MA, Ryan O’Malley, Sarah K. Holt, Erin
Dwyer, Reno Maldonado, Seattle, WA, Leoni-
das Diamantopoulos, Pittsburgh, PA, Dimitrios
Makrakis, Grace Laidlaw, George R. Schade, Dan
W. Lin, Jonathan L. Wright, John L. Gore, Yaw
Nyame, Petros Grivas, Evan Yu, Bruce Montgom-
ery, Andrew C. Hsieh, Todd A. Yezefski, Michael
Schweizer, Heather H. Cheng, Sarah P. Psutka,
Seattle, WA
 MP56-07 PREDICTORS OF RESPONSE FOLLOWING
NEOADJUVANT CISPLATIN BASED
CHEMOTHERAPY FOR MUSCLE INVASIVE
UROTHELIAL BLADDER CANCER USING
MOLECULAR PROFILE
Ahmed Elkarta*, Ahmed Elhefnawy, Hassan Abol-
Enein, Ahmed Shokeir, Mansoura, Egypt
MP56-08 CLINICOPATHOLOGIC AND SURVIVAL AFTER
CYSTECTOMY OUTCOMES IN SQUAMOUS
CELL CARCINOMA OF THE BLADDER
Pranjal Agrawal*, Mary Rostom, Ridwan Alam,
Michael Biles, Noah M. Hahn, Andres Matoso,
Armine Smith, Baltimore, MD, Trinity J. Bivalac-
qua, Philadelphia, PA, Max Kates, Jean Hoff-
man-Censits, Sunil H. Patel, Baltimore, MD
MP56-09 RADIOMICS-BASED DEEP-LEARNING
IMPROVES CT-STAGING OF LYMPH NODE
STATUS FOR BLADDER CANCER PATIENTS
Eva Gresser, Piotr Woznicki, Katharina Messmer,
Wolfgang Kunz, Alexander Buchner, Christian
Stief, Jens Ricke, Munich, Germany, Dominik
Nörenberg, Mannheim, Germany, Gerald Schulz*,
Munich, Germany
MP56-10 CHARACTERIZATION AND FUNCTIONAL
ANALYSIS OF MICROBIOME IN BLADDER
CANCER
Laura Bukavina*, Philadelphia, PA, Adam Cala-
way, Ilaha Isali, Megan Prunty, Cleveland, OH,
Mohit Sindhani, Delhi, India, Mahmoud Ghan-
noum, Mauricio Retuerto, Gregory MacLennan,
Sarah Markt, Lee Ponsky, Cleveland, OH, Philip
Abbosh, Philadelphia, PA
MP56-11 THE ASSOCIATION BETWEEN EARLY POST-
RADICAL CYSTECTOMY ACUTE KIDNEY
INJURY AND PERIOPERATIVE OUTCOME IN
ENHANCED RECOVERY ERA
Sina Sobhani*, Hamed Ahmadi, Wenhao Yu,
Alireza Ghoreifi, Giovanni Cacciamani, Gus
Miranda, Jie Cai, Sumeet Bhanvadia, Anne
Schuckman, Monish Aron, Inderbir Gill, Siamak
Daneshmand, Mihir Desai, Hooman Djaladat, Los
Angeles, CA
MP56-12 UPPER TRACT RECURRENCE RISK BASED
ON DRAINAGE METHOD FOR URETERAL
OBSTRUCTION PRIOR TO RADICAL
CYSTECTOMY
Wesley Yip*, Daniel Sjoberg, Nathan Wong,
Manuel de Jesus Escano, Song Jiang, Carissa
Chu, Nicole Benfante, Sherri Donat, Harry Herr,
Guido Dalbagni, Bernard Bochner, Eugene Cha,
New York, NY
MP56-13 ROLE OF RADICAL CYSTECTOMY AND
LYMPH NODE DISSECTION IN PATIENTS
APPROVED FOR AMA PRA CATEGORY 1.25
WITH NON-METASTATIC CLINICALLY
CREDITSTM
ADVANCED LYMPH NODAL (CN2/N3)
BLADDER CANCER: AN ANALYSIS FROM
NATIONAL CANCER DATABASE
Harshit Garg*, Furkan Dursun, Ahmed
Elshabrawy, Hanzhang Wang, Michael Liss, Dhar-
am Kaushik, Robert Svatek, Ahmed Mansour, San
Antonio, TX
236
MP56-14 UTILIZING THE MODIFIED FRAILTY INDEX
TO PREDICT OUTCOMES AFTER RADICAL
CYSTECTOMY
Hannah Jarvis*, Andrew Harris, Lexington, KY
MP56-15 PERIOPERATIVE OUTCOMES OF
PATIENTS UNDERGOING CONCURRENT
NEPHROURETERECTOMY AND
CYSTECTOMY FOR UROTHELIAL CANCER:
AN NSQIP DATABASE ANALYSIS
Pratik Kanabur*, Sagar Patel, Guilherme Godoy,
Houston, TX
MP56-16 SURGICAL MANAGEMENT OF
CLINICALLY LOCALIZED URACHAL
CARCINOMA: EVALUATING THE ROLE OF
LYMPHADENECTOMY AS STANDARD OF
CARE
Kyle Rose*, Erica Roberts, Heather Huelster,
Andrew Chang, Logan Zemp, Alice Yu, Michael
Poch, Roger Li, Phillippe Spiess, Scott Gilbert,
Wade Sexton, Tampa, FL
MP56-17 RADICAL CYSTECTOMY VIDEO CONSENSUS:
A SIMPLE AND EFFECTIVE WAY TO IMPROVE
AWARENESS OF PATIENTS UNDERGOING
RADICAL CYSTECTOMY
Francesco Esperto, Francesco Prata*, Francesco
Tedesco, Alberto Ragusa, Noemi Deanesi, Anto-
nio Testa, Angelo Civitella, Piergiorgio Tuzzolo,
Luca Romei, Vito Giuseppe Crimi, Loris Cac-
ciatore, Gerardo Paolo Flammia, Antonio Alcini,
Annamaria Salerno, Rome, Italy, Salvatore Mario
Prata, Sora, Italy, Roberto Mario Scarpa, Rocco
Papalia, Rome, Italy
MP56-18 PREVALENCE AND PREDICTORS OF
PSYCHOLOGICAL DISTRESS AMONG
PATIENTS TREATED FOR BLADDER
CANCER
Nihal Mohamed*, Tung Ming Leung,
New York, NY
MP56-19 TRIMODAL THERAPY VERSUS RADICAL
CYSTECTOMY FOR T2 BLADDER CANCER:
REAL-WORLD EVIDENCE FROM ONTARIO
Marian Severin Wettstein*, Alejandro Berlin, Song
Pham, Srikala Sridhar, Peter Chung, Shabbir Al-
ibhai, Syed R. Qadri, Kathy Li, Ning Liu, Toronto,
Canada, Thomas Hermanns, Zurich, Switzerland,
Girish S. Kulkarni, Toronto, Canada
MP56-20 SURROGATE ENDPOINTS AS PREDICTORS
OF SURVIVAL IN METASTATIC UROTHELIAL
CANCER TRIALS
Fady Ghali*, Seattle, WA, Devin Patel, Denver,
CO, Teresa Jewell, John Gore, Jonathan Wright,
Seattle, WA
Monday, May 16, 2022
Moderated Poster Session 57
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY IV
Room 225 @ Ernest N. Morial Convention Center
Moderators: Simon Kim, Raj Pruthi & Christopher Warlick
ABSTRACT
NUMBER TITLE
MP57-01 POSTOPERATIVE RECURRENCE CAN
BE PREDICTED BY BOTH LENGTH AND
GLEASON PATTERN AT POSITIVE SURGICAL
MARGIN AFTER RADICAL PROSTATECTOMY
Masashi Kato*, Nagoya, Japan, Toyonori Tsuzuki,
Nagakute, Japan
MP57-02 MRI VERSUS NON-MRI DIAGNOSTIC
PATHWAYS BEFORE RADICAL
PROSTATECTOMY: IMPACT ON NERVE-
SPARING, POSITIVE SURGICAL MARGINS,
AND BIOCHEMICAL RECURRENCE
Hiten D. Patel, Goran Rac*, Yudai Okabe, Gaurav
Pahouja, Shalin Desai, Steven M. Shea, Alex
Gorbonos, Marcus L. Quek, Robert C. Flanigan,
Ari Goldberg, Gopal N. Gupta, Maywood, IL
MP57-03 IS ADVERSE PATHOLOGY AT THE TIME
OF RADICAL PROSTATECTOMY A USEFUL
PREDICTOR OF LONG-TERM OUTCOMES
IN ACTIVE SURVEILLANCE CANDIDATES?
RESULTS FROM THE SEARCH COHORT
Paige Kuhlmann*, Los Angeles, CA, Lauren How-
ard, Durham, NC, Zachary Klaassen, Augusta,
GA, Christopher Amling, Portland, OR, William
Aronson, Los Angeles, CA, Matthew Cooperberg,
San Francisco, CA, Christopher Kane, San Diego,
CA, Martha Terris, Augusta, GA, Stephen Freed-
land, Los Angeles, CA
MP57-04 ASSOCIATION BETWEEN FAMILY
HISTORY AND ONCOLOGIC OUTCOMES
AFTER RADICAL PROSTATECTOMY FOR
CLINICALLY NONMETASTATIC PROSTATE
CANCER
Paweł Rajwa*, Fahad Quhal, Stephan Korn,
Takafumi Yanagisawa, Tatsushi Kawada, Reza
Sari Motlagh, Hadi Mostafaei, Ekaterina Laukhti-
na, Abdulmajeed Aydh, Frederik König, Maximil-
ian Pallauf, Benjamin Pradere, Vienna, Austria,
Peter Nyirády, Budapest, Hungary, Mohammad
Abufaraj, Amman, Jordan, Alberto Briganti, Milan,
Italy, Pierre Karakiewicz, Montreal, Canada,
Ding-wei Ye, Shanghai, China, People’s Republic
of, Martin Haydter, Vienna, Austria, Piotr Chlosta,
Krakow, Poland, Petr Glybochko, Dmitry Enikeev,
Moscow, Russian Federation, Shahrokh Shariat,
Vienna, Austria
MP57-05 ONE NOVEL NOMOGRAM TO PREDICT
BIOCHEMICAL RECURRENCE MORE
ACCURATE IN RADICAL PROSTATECTOMY
Jian Lu*, Ji De He, Ye Yan, Xue Hua Zhu, Ze Nan
Liu, Hai Zhui Xia, Hai Bi, Bin Yang, Run Zhuo
Ma, Wei He, Zhi Ying Zhang, Yu Ting Zhang, Lu
Lin Ma, Xiao Fei Hou, Beijing, China, People’s
Republic of
*Presenting author
10:30 am – 11:45 am
ABSTRACT
NUMBER TITLE
MP57-06 EXTERNAL VALIDATION AND COMPARISON
OF TWO NOMOGRAMS PREDICTING
THE PROBABILITY OF LYMPH NODE
INVASION IN PATIENTS SUBJECTED TO
ROBOTIC RADICAL PROSTATECTOMY AND
CONCOMITANT LYMPH NODE DISSECTION
Nicola Frego*, Paciotti Marco, Davide Maffei,
Pier Paolo Avolio, Roberto Contieri, Alessandro
Uleri, Massimo Lazzeri, Alberto Saita, Paolo
Casale, Nicolò Maria Buffi, Giovanni Lughezzani,
Milan, Italy
MP57-07 IMPACT OF THE MINIMALLY INVASIVE
APPROACH ON MORBIDITY OF SALVAGE
RADICAL PROSTATECTOMY
Marlon Perera*, Antoni Vilaseca, Amy Tin, Daniel
Nguyen, Renato Carradi, Adam Touijer, Nicole
Benfante, Daniel Sjoberg, Vincent Laudone, Peter
MONDAY
Scardino, James Eastham, Karim Touijer, New
York, NY
MP57-08 SELECTIVE RADICAL PROSTATECTOMY IN
GRADE GROUP 1 PROSTATE CANCER
Masood Moghul*, Claire Mcnally, Kaljit Kaur, Netty
Kinsella, Derfel Dafydd, Aslam Sohaib, Steve
Hazell, Declan Cahill, London, United Kingdom
MP57-09 COMPARISON OF PERIOPERATIVE AND
SHORT-TERM FUNCTIONAL OUTCOMES
BETWEEN SINGLE-PORT TRANSVESICAL
AND MULTI-PORT TRANSPERITONEAL
ROBOTIC RADICAL PROSTATECTOMY
Alp Tuna Beksac*, Mahmoud Abou Zeinab,
Aaron Kaviani, Ethan Ferguson, Jihad Kaouk,
Cleveland, OH
MP57-10 SINGLE-PORT EXTRAPERITONEAL ROBOTIC-
ASSISTED RADICAL PROSTATECTOMY: A
MULTI-INSTITUTIONAL COHORT STUDY
Mahmoud Abou Zeinab*, Ethan Ferguson, Aaron
Kaviani, Alp T. Beksac, Cleveland, OH, Luca
Morgantini, Susan Talamini, Chicago, IL, Jean
Joseph, Rochester, NY, Moses Kim, Laguna Hills,
CA, Simone Crivellaro, Chicago, IL, Jeffrey Nix,
Birmingham, AL, Jihad Kaouk, Cleveland, OH
MP57-11 INTRAOPERATIVE WORKLOAD DURING
ROBOTIC RADICAL PROSTATECTOMY:
COMPARISON BETWEEN MULTI-PORT
DA VINCI XI AND SINGLE-PORT DA VINCI
SP ROBOTS
Mazeed Aro-Lambo*, Susan Hallbeck, Katherine
Law, Hamid Norasi, Matthew Tollefson,
Rochester, MN
237
 MP57-12 PATIENT REPORTED SEXUAL AND URINARY
FUNCTIONAL OUTCOMES IN MEN WITH
INTERMEDIATE RISK PROSTATE CANCER
UNDERGOING RADICAL PROSTATECTOMY:
ANALYSIS OF THE MUSIC REGISTRY
Roshan Paudel*, Ann Arbor, MI, John Cochrane,
Detroit, MI, Ji Qi, Ann Arbor, MI, Michael Cher,
Detroit, MI, Richard Sarle, Lansing, MI, James Pe-
abody, Detroit, MI, S. Mohammad Jafri, Royal Oak,
MI, Brian Lane, Grand Rapids, MI, Alice Semerjian,
Arvin George, Ann Arbor, MI, Kevin Ginsburg,
Detroit, MI, for the Michigan Urological Surgery
Improvement Collaborative, Ann Arbor, MI
MP57-13 SPIDER SILK NERVE RECONSTRUCTION
IN ROBOTIC RADICAL PROSTATECTOMY: A
FIRST IN MEN ANALYSIS
Nina N. Harke*, Sarah Strauss, Inga Peters, Olga
Katzendorn, Markus A. Kuczyk, Peter M. Vogt,
Hannover, Germany
MP57-14 MACHINE LEARNING PREDICTION OF
CONTINENCE RECOVERY OF ROBOTIC-
ASSISTED RADICAL PROSTATECTOMY
Adel Arezki*, Iman Sadri, David-Dan Nguyen,
Montreal, Canada, Ahmed S. Zakaria, Thunder
Bay, Canada, Assaad Elhakim, Malek Meskawi,
Pierre Karakiewicz, Kevin C. Zorn, Montreal,
Canada
MP57-15 PELVIC LYMPH NODE METASTASIS PREDICTION
WITH INDOCYANINE GREEN FLUORESCENCE
LYMPHANGIOGRAPHY IN ROBOTIC ASSISTED
RADICAL PROSTATECTOMY
YuFeng Chuang*, Chin-Heng Lu, Yi-Shang Lin,
Li-Hua Huang, Wei-Chun Weng, Chao-Yu Hsu,
Min-Che Tung, Yen-Chuan Ou,
Taichuang, Taiwan
MP57-16 IMPACT OF EXTENT OF LYMPHADENECTOMY
ON ALL CAUSE MORTALITY IN PATIENTS
WITH INTERMEDIATE AND HIGH-RISK
PROSTATE CANCER MANAGED WITH
RADICAL PROSTATECTOMY
Furkan Dursun*, Ahmed Elshabrawy,
Hanzhang Wang, Michael A. Liss,
Ronald Rodriguez, Dharam Kaushik,
Ahmed M. Mansour, San Antonio, TX
238
MP57-17 THE COLLAR TECHNIQUE FOR APICAL
DISSECTION DURING ROBOT-ASSISTED
RADICAL PROSTATECTOMY: UPDATED
SERIES AFTER FIVE YEARS FROM ITS
INTRODUCTION
Angelo Mottaran*, Bologna, Italy, Carlo Andrea
Bravi, Milan, Italy, Luca Sarchi, Modena, Italy,
Pietro Piazza, Bologna, Italy, Fernando Gonzalez
Meza, Marco Corsetti, Ghent, Belgium, Sophie
Knipper, Hamburg, Germany, Marco Paciotti,
Milan, Italy, Marco Amato, Modena, Italy, Rui
Farinha, Ghent, Belgium, Stefano Puliatti, Mode-
na, Italy, Simone Scarcella, Celine Sinatti, Ghent,
Belgium, Geert De Naeyer, Ruben De Groote,
Alexandre Mottrie, Aalst, Belgium
MP57-18 RATE OF BLADDER NECK CONTRACTURE
AFTER OPEN AND MINIMALLY INVASIVE
RADICAL PROSTATECTOMY OVER 18
YEARS AT THE VETERANS HEALTH
ADMINISTRATION
Mitch Hayes*, Michael Conlin, Portland, OR, Helen
Hougen, Portland, FL, Ryan Kopp, Portland, OR
MP57-19 VALIDATION OF PROSTATE SPECIFIC
ANTIGEN DOUBLING TIME KINETICS
FOLLOWING RADICAL PROSTATECTOMY
TO GUIDE ACTIVE OBSERVATION AND
INTERVENTION
Erica Huang*, Linda My Huynh, Adam Gordon,
Ryan Chandhoke, Orange, CA, Blanca Morales,
San Francisco, CA, Douglas Skarecky, Joshua
Tran, Thomas Ahlering, Orange, CA
MP57-20 SHORTER STANDARD HOSPITAL ADMISSION
FOLLOWING RADICAL PROSTATECTOMY
IS ASSOCIATED WITH LOWER RISK OF
POSTOPERATIVE COMPLICATIONS
Brittany Berk*, Boston, MA, Tzu-Hao Huang,
Taipei, Taiwan, Maheetha Bharadwaj, Adam Kibel,
Quoc-Dien Trinh, Boston, MA, Benjamin Chung,
Stanford, CA, Steven Chang, Boston, MA
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
Monday, May 16, 2022
Moderated Poster Session 58
PROSTATE CANCER: DETECTION & SCREENING VII
Room 228 @ Ernest N. Morial Convention Center
Moderators: Kevin Loughlin, Douglas Scherr & Peter Pinto
ABSTRACT
NUMBER TITLE
MP58-01 IS MRI AND FUSION BIOPSIES NECESSARY
IN PATIENTS WITH PSA LEVELS >10 NG/ML?
Lorenzo Maria Rovesti*, Riccardo Lombardo,
Rome, Italy, Antonio Nacchia, Rionero in Vulture,
Italy, Sara Riolo, Antonio Cicione, Beatrice Turchi,
Giacomo Gallo, Carmen Gravina, Alessandro
Guercio, Jordi Stira, Antonio Franco, Rome, Italy,
Ferdinando Di Giacomo, Giuseppe Disabato,
Rionero in Vulture, Italy, Giorgio Guarnotta, Elisa
Mancini, Olivia Alessandra Voglino, Valeria Bal-
dassarri, Simone D’Annunzio, Cosimo De Nunzio,
Andrea Tubaro, Rome, Italy
MP58-02 PSA-DENSITY DETERMINES THE NEED FOR
SYSTEMATIC BIOPSY IN MEN WITH PI-RADS
4/5 MRI
Zachary Feuer*, Richard Huang, Fang-Ming
Deng, James Wysock, William Huang, Samir
Taneja, New York, NY
MP58-03 PROSTATE CANCER SCREENING - A NOVEL
RISK PREDICTION TOOL WITH STANDARD
BIOPSIES VS. PSA WITH MRI-TARGETED
BIOPSIES
Lars Björnebo*, Andrea Discacciati, Martin
Eklund, Henrik Grönberg, Anna Lantz, Tobias
Nordström, Solna, Sweden
MP58-04 PSA DENSITY DIRECTLY CORRELATES WITH
PI-RADS LESION SCORE ON PROSTATE MRI
Clay Martin*, Jacob Gaines, Eric Macdonald, Max
Kuster, Simon Hall, New Hyde Park, NY
MP58-05 URINARY SMART TEST FOR EARLY
DETECTION OF PROSTATE CANCER
Sergio Occhipinti, Turin, Italy, Daniele Amparore,
Stefano Granato, Enrico Checcucci, Federico
Piramide, Sabrina De Cillis, Alberto Piana, Ga-
briele Volpi, Paolo Verri, Michele Sica, Stefano
Piscitello, Beatrice Carbonaro, Mariano Burgio,
Juliette Meziere, Edoardo Cisero, Edoardo Dibilio,
Giovanni Busacca, Matteo Manfredi, Cristian Fiori,
Francesco Porpiglia*, Orbassano (Turin), Italy
MP58-06 DIAGNOSTIC PERFORMANCE OF
MIXED TARGETED PROSTATE BIOPSY
APPROACHES USING MICRO-ULTRASOUND
AND MRI-FUSION BIOPSIES
Davide Maffei*, Cesare Saitta, Pier Paolo Avolio,
Marco Paciotti, Vittorio Fasulo, Nicola Frego, Piet-
ro Diana, Pieve Emanuele, Italy, Lazzeri Massimo,
Rodolfo Hurle, Alberto Rosario Saita, Rozzano, It-
aly, Giorgio Ferruccio Guazzoni, Pieve Emanuele,
Italy, Paolo Casale, Rozzano, Italy, Nicolò Maria
Buffi, Giovanni Lughezzani, Pieve Emanuele, Italy
*Presenting author
1:00 pm – 2:15 pm
ABSTRACT
NUMBER TITLE
MP58-07 CLINICALLY SIGNIFICANT PROSTATE
CANCER DETECTION RATE BY PI-RADS
SCORE AND PSA-DENSITY: A DESCRIPTIVE
ANALYSIS
Zachary Feuer*, Richard Huang, Fang-Ming
Deng, James Wysock, William Huang, Samir
Taneja, New York, NY
MP58-08 TRANSPERINEAL VS TRANSRECTAL MRI/
TRUS FUSION PROSTATE BIOPSY: A
MATCHED-PAIR COMPARISON
Masatomo Kaneko*, Luis Medina, Amir Lebastchi,
Giovanni Cacciamani, Alireza Ghoreifi, Marina
Lenon, Reid Senesac, Manju Aron, Vinay Duddal-
war, Suzanne Palmer, Inderbir Gill, Andre Abreu,
Los Angeles, CA
MP58-09 DIAGNOSTIC PERFORMANCE OF
MONDAY
FUSION (US/MRI GUIDED) PROSTATE
BIOPSY: PROPENSITY SCORE MATCHED
COMPARISON OF ELASTIC VERSUS RIGID
FUSION SYSTEM
Mariaconsiglia Ferriero*, Rome, Italy, Cristian
Fiori, Orbassano, Turin, Italy, Gabriele Tuderti,
Umberto Anceschi, Alfredo Maria Bove, Aldo
Brassetti, Leonardo Misuraca, Salvatore Guag-
lianone, Riccardo Mastroianni, Michele Gallucci,
Rome, Italy, Sabrina Decillis, Enrico Checcucci,
Francesco Porpiglia, Orbassano, Turin, Italy,
Giuseppe Simone, Rome, Italy
MP58-10 A NOVEL APPROACH FOR 3D
RECONSTRUCTION OF THE PROSTATE
GLAND THAT ALLOWS TUMOUR LOCATION,
VOLUME ESTIMATION, AND GLEASON
CHARACTERIZATION
Pedro Oliveira*, Manchester, United Kingdom,
Avaneesh Meena, Saikiran Bonthu, Nitin Singhal,
Mumbai, India, Ashwin Sachdeva, Yatin Jain,
Vijay Ramani, Manchester, United Kingdom
MP58-11 COMPARISON OF PROSTATE CANCER
DETECTION RATES BETWEEN TRANS-
RECTAL MRI/US FUSION AND TRANS-
PERINEAL COGNITIVE TARGETED
PROSTATE BIOPSY APPROACHES
Johnathan Drevik*, Zafardjan Dalimov, Allen
Rojhani, Phillip Abbosh, Steven Sterious, Joshua
Cohn, Jay Simhan, Justin Friedlander, Eric Ghiral-
di, Robert Uzzo, Serge Ginzburg, Philadelphia, PA
MP58-12 ADDITIONAL SYSTEMATIC TO MRI-
TARGETED BIOPSY IN PROSTATE CANCER
DIAGNOSIS: A DOUBLE-EDGED SWORD
Rodrigo Suarez-Ibarrola*, Cordula A. Jilg, Markus
Grabbert, Christian Gratzke, August Sigle, Frei-
burg, Germany
239
 MP58-13 ATM MUTATIONS ARE ASSOCIATED WITH
HIGH-RISK ARCHITECTURAL FEATURES IN
MEN WITH FAMILIAL PROSTATE CANCER
Romy Mondschein*, Bolton Damien, David Clou-
ston, Declan Murphy, Prudence Scott,
Renea Taylor, James Dowty, Heather Thorne,
Melbourne, Australia
MP58-14 DISCORDANCE BETWEEN PROSTATE
IMAGING REPORTING & DATA SYSTEM
SCORE AND TARGETED PROSTATE
BIOPSY: AN OPPORTUNITY FOR QUALITY
IMPROVEMENT
Rohith Arcot*, Srinath Kotamarti, Madison
Krischak, Zoe Michael, Isaac Alderete, Thomas
Polascik, Rajan Gupta, Durham, NC
MP58-15 ASSESSING THE ROLE OF HIGH-
RESOLUTION MICRO-ULTRASOUND
AMONG PATIENTS WITH A NEGATIVE
MULTIPARAMETRIC MRI AND A PERSISTENT
SUSPICION OF PROSTATE CANCER
Pier Paolo Avolio*, Milan, Italy, Vittorio Fasulo, Ce-
sare Saitta, Pietro Diana, Alessandro Uleri, Andrea
Gobbo, Paola Arena, Edoardo Beatrici, Giuseppe
Chiarelli, Contieri Roberto, Nicola Frego, Davide Ma-
ffei, Alberto Saita, Paolo Casale, Giorgio Ferruccio
Guazzoni, Massimo Lazzeri, Rodolfo Hurle, Giovan-
ni Lughezzani, Nicolò Maria Buffi, Milano, Italy
MP58-16 DOES VETERAN STATUS MITIGATE RACIAL
DISPARITIES IN PROSTATE CANCER
SCREENING? ANALYSIS OF PROSTATE-
SPECIFIC ANTIGEN SCREENING PATTERNS
IN THE 2018 BEHAVIORAL RISK FACTOR
SURVEILLANCE SYSTEM DATA
Khalid Alkhatib*, Muhieddine Labban, Logan
Briggs, David-Dan Nguyen, Peter Herzog, Alexan-
der P. Cole, Boston, MA, Austin Haag, Waco, TX,
Quoc-Dien Trinh, Boston, MA
Monday, May 16, 2022
Moderated Poster Session 59
BLADDER CANCER: NON-INVASIVE III
Room 225 @ Ernest N. Morial Convention Center
Moderators: Boris Gershman & Sumeet Bhanvadia
ABSTRACT
NUMBER TITLE
MP59-01 URINE MICRORNAS AS LIQUID BIOPSY
ASSAY FOR PREDICTING RESPONSE TO
INTRAVESICAL BCG THERAPY
Anirban P Mitra*, Sharada Mokkapati, H Barton
Grossman, Ashish M Kamat, Houston, TX, David
J McConkey, Baltimore, MD, Colin P N Dinney,
Houston, TX
240
MP58-17 BLACK-TAILORED PROSTATE BIOPSY RISK
CALCULATOR OUTPERFORMS PROSTATE
CANCER PREVENTION TRIAL 2.0
Neil Mistry*, Norma Marshall, Adam Murphy,
Chicago, IL
MP58-18 REAL WORLD APPLICATION AND
EXPERIENCE OF A PROSTATE SPECIFIC
ANTIGEN (PSA) MACHINE LEARNING MODEL
IN A SCREENING POPULATION
Marlon Perera*, Lewis Smith, Peter Swindle,
Brisbane, Australia, Anthony Costello, Melbourne,
Australia, Elliot Smith, Brisbane, Australia
MP58-19 COMPARISON OF URONAV TRUS AND
COGNITIVE FUSION TP BIOPSY IN
DETECTION OF CLINICALLY SIGNIFICANT
PROSTATE CANCER
Amanda Sherman*, Daneil Kuftinec, Burlington,
MA, Lori Lyn Price, Boston, MA, Alireza Moinza-
deh, William Faust, Burlington, MA
MP58-20 USE OF LOW-VALUE PROSTATE-SPECIFIC
ANTIGEN SCREENING AMONG YOUNG MEN
WITH PRIVATE INSURANCE
Jeffrey Vehawn*, Suzanne Lange, Mouneeb
Choudry, Jacob Ambrose, Benjamin Haaland,
Jonathan Chipman, Heidi A. Hanson, Brock
O’Neil, Salt Lake City, UT
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
1:00 pm – 2:15 pm
ABSTRACT
NUMBER TITLE
MP59-02 APPLICATION OF A MULTIPLEX
URINALYSIS TEST FOR THE PREDICTION
OF INTRAVESICAL BCG TREATMENT
RESPONSE: A PILOT STUDY
Kaoru Murakami, Los Angeles, CA, Ashish M.
Kamat, Houston, TX, Yunfeng Dai, Gainesville,
FL, Ian Pagano, Honolulu, HI, Runpu Chen,
Yijun Sun, Buffalo, NY, Amit Gupta, Nari Kim,
Los Angeles, CA, Steve Goodison, Jacksonville,
FL, Charles J. Rosser, Hideki Furuya*, Los
Angeles, CA
 MP59-03 A URINE-BASED MUTATION-METHYLATION
ASSAY FOR THE SURVEILLANCE OF HIGH
RISK NON-MUSCLE INVASIVE BLADDER
CANCER PATIENTS
Joep de Jong*, Florus de Jong, Angelique Ziel-
van der Made, Ties Hagdorn, Egbert Boevé,
Rotterdam, Netherlands, Hossain Roshani, The
Hague, Netherlands, Eric Oomens, Breda, Neth-
erlands, Rob Pelger, Ewout Steyerberg, Leiden,
Netherlands, Joost Boormans, Chris Bangma,
Tahlita Zuiverloon, Ellen Zwarthoff, Rotterdam,
Netherlands
MP59-04 BLADDER CANCER RECURRENCE
MONITORING BY URINARY EXTRACELLULAR
VESICLE RNA BIOMARKERS
Toru Harabayashi*, Takahiro Osawa, Hiroshi
Harada, Keita Minami, Norikata Takada, Akira
Kashiwagi, Haruka Miyata, Kazushi Hirakawa,
Yasuyuki Sato, Ryuji Matsumoto, Hiroshi Kikuchi,
Takashige Abe, Sachiyo Murai, Nobuo Shinohara,
Sapporo, Japan, Taku Murakami, Irvine, CA
MP59-05 FREQUENCY OF FIBROBLAST GROWTH
FACTOR RECEPTOR ALTERATIONS AND
ASSOCIATION WITH BACILLUS CALMETTE-
GUERIN OUTCOMES IN A REAL-WORLD
GENOMIC ANALYSIS OF HIGH-RISK NON-
MUSCLE-INVASIVE BLADDER CANCER
(GARNER) STUDY
Tahlita C.M Zuiverloon, Florus C. de Jong*,
Rotterdam, Netherlands, Jenna Cody Carcione,
Ramesh Sundaram, Titusville, NJ, Yoichiro Shiba-
ta, Durham, NC, Spyros Triantos, Ademi Santia-
go-Walker, Mahadi Baig, Titusville, NJ
MP59-06 PD-L1 EXPRESSION AND BCG RESPONSE IN
NON-MUSCLE INVASIVE BLADDER CANCER
Solomon Woldu*, Thomas Gerald, Vitaly Margulis,
Dallas, TX, Daniel Halstuch, Yaara Ber, Karin
Lifshitz, David Margel, Petah Tikva, Israel, Yair
Lotan, Liwei Jia, Dallas, TX
MP59-07 DOES THE URINARY MICROBIOME PROFILE
CHANGE AFTER TREATMENT OF BLADDER
CANCER?
Holly Houenstein, Yousuf Ramahi*, Ayat A. Shah,
Philippa Doherty, Zhe Jing, Eduardo Cortes Gomez,
Prashant K. Singh, Song Liu, Gary Smith, Li Tang,
Khurshid A. Guru, Ahmed A. Hussein, Buffalo, NY
MP59-08 DISPARITIES IN THE PREVALENCE AND
MANAGEMENT OF HIGH-RISK NON-MUSCLE
INVASIVE BLADDER CANCER
Angela Estevez*, Sumedh Kaul, Aaron Fleishman,
Ruslan Korets, Peter Chang, Andrew Wagner,
Joaquim Bellmunt, Aria Olumi, Heidi Rayala, Boris
Gershman, Boston, MA
*Presenting author
MP59-09 CHARACTERIZING MOLECULAR SUBTYPES OF
HIGH-RISK NON-MUSCLE-INVASIVE BLADDER
CANCER IN AFRICAN AMERICAN PATIENTS
Sungyong You, Minhyung Kim, Los Angeles, CA,
Stephen G. Widen, Alexander Yu, Eduardo J.
Eyzaguirre, Galveston, TX, Lars Dyrskjøt, Aarhus
N, Denmark, David McConkey, Woonyoung Choi,
Baltimore, MD, Dan Theodorescu, Keith S. Chan,
Los Angeles, CA, Yong Shan, Douglas S. Tyler,
Galveston, TX, Amanda M. De Hoedt, Durham,
NC, Stephen J. Freedland, Los Angeles, CA,
Stephen B. Williams*, Galveston, TX
MP59-10 EVALUATING EX VIVO INNATE IMMUNE
TRAINING AS A PREDICTIVE MEASURE
OF RESPONSIVENESS TO BCG
IMMUNOTHERAPY IN PATIENTS WITH NON-
MUSCLE INVASIVE BLADDER CANCER
Song Jiang*, Gil Redelman-Sidi,
Eugene J. Pietzak, Bernard H. Bochner,
Michael Glickman, New York, NY
MP59-11 EN BLOC RESECTION FOR BLADDER
TUMORS: AN UPDATED SYSTEMATIC
REVIEW AND META-ANALYSES OF ITS
DIFFERENTIAL EFFECT ON ITS SAFETY,
HISTOPATHOLOGY AND, RECURRENCE
MONDAY
Takafumi Yanagisawa*, Vienna, Austria, Keiichiro
Mori, Tokyo, Japan, Reza Sari Motlagh, Tatsushi
Kawada, Hadi Mostafaei, Fahad Quhal, Ekaterina
Laukhtina, Pawel Rajwa, Frederik König, Maximil-
ian Pallauf, Benjamin Pradere, David D’Andrea,
Eva Compérat, Vienna, Austria, Jun Miki, Takahiro
Kimura, Shin Egawa, Tokyo, Japan, Shahrokh F.
Shariat, Vienna, Austria
MP59-12 DEPTH OF ENDOSCOPIC PERFORATION
(DEEP SCALE): A NEW CLASSIFICATION
TO PREDICT EARLY POST-OPERATIVE
OUTCOMES IN THE ENDOSCOPIC
TREATMENT OF BLADDER CANCER
Alberto Piana*, Andrea Gallioli, Pietro Diana,
Angelo Territo, Matteo Fontana, Rodriguez Faba
Óscar, Josep Maria Gaya, Ruben Parada, Asier
Mercadé, Jorge Robalino, Joan Palou, Alberto
Breda, Barcelona, Spain
MP59-13 BLADDER TUMOR ACCURATE
RADIOFREQUENCY RESECTION: 38 CASES
REPORTS
SHENGKUN SUN*, Guangfu Chen, Weijun Fu,
Xu Zhang, Beijing, China, People’s Republic of
MP59-14 CROSS-SECTIONAL STUDY ASSESSING
UTILIZATION PATTERNS OF COMBINATION
INTRAVESICAL GEMCITABINE AND
DOCETAXEL IN THE MANAGEMENT OF
BLADDER CANCER
Andrew Gabrielson*, Sunil Patel, Noah Hahn,
Baltimore, MD, Angela Smith, Chapel Hill, NC,
Eugene Pietzak, New York, NY, Peter Black, Van-
couver, Canada, Trinity Bivalacqua, Philadelphia,
PA, Max Kates, Baltimore, MD
241
 MP59-15 INTRAVESICAL GEMCITABINE AND
DOCETAXEL (GEMDOCE) IN THE
TREATMENT OF MP17-11MUSCLE
INVASIVE UROTHELIAL CARCINOMA
OF THE BLADDER: UPDATES FROM A
PHASE 2 TRIAL
Sunil Patel*, Connie Collins, Nirmish Singla,
Andrew Gabrielson, Baltimore, MD, Trinity J
Bivalacqua, Philadelphia, PA, Noah Hahn, Max
Kates, Baltimore, MD
MP59-16 SEQUENTIAL INTRAVESICAL VALRUBICIN
AND DOCETAXEL FOR THE TREATMENT OF
NON-MUSCLE INVASIVE BLADDER CANCER
Ian M. McElree*, Vignesh T. Packiam, Ryan
L. Steinberg, Sarah L. Mott, Paul T. Gellhaus,
Kenneth G. Nepple, Michael A. O’Donnell, Iowa
City, IA
MP59-17 DEVELOPMENT AND INTERNAL
VALIDATION OF A PREDICTIVE MODEL FOR
RECURRENCE-FREE SURVIVAL IN PTA LOW-
GRADE BLADDER CANCER
Jorge Daza*, Buffalo, NY, Ralph Grauer, Sophie
Chen, Etienne Lavallèe, Shirin Razdan, New York,
NY, Linda Dey, Gunnar Steineck, Stockholm,
Sweden, Qiang Li, Aly Ahmed, Buffalo, NY, Reza
Mehrazin, Nikhil Waingankar, New York, NY,
Khurshid Guru, Buffalo, NY, Peter Wiklund, John
Sfakianos, New York, NY
Monday, May 16, 2022
Podium Session 58
BLADDER CANCER: UPPER TRACT TRANSITIONAL CELL CARCINOMA II
Room 252 @ Ernest N. Morial Convention Center
Moderators: Seth Lerner & Firas Petros
ABSTRACT
TIME NUMBER TITLE
1:00 PD58-01 PREVALENCE AND SPECTRUM OF
GERMLINE MUTATIONS IN PATIENTS
WITH UPPER TRACT UROTHELIAL
CARCINOMA
Hong Truong*, Rania Sheikh, Yelena Kemel, Ma-
nuel Jesus Escano, Andrew Lenis, Peter Reisz,
Alvin Goh, Eugene Cha, Bernard Bochner, Maria
Carlo, Hikmat Al-Ahmadie, Jonathan Coleman,
New York, NY
1:10 PD58-02 NOVEL USE OF CTDNA TO IDENTIFY
LOCALLY ADVANCED AND METASTATIC
UPPER TRACT UROTHELIAL CARCINOMA
Heather Huelster*, Elizabeth Green, Alex Soupir,
Kyle Rose, Esther Katende, Shreyas Naidu, Scott
Gilbert, Brandon Manley, Michael Poch, Wade
Sexton, Alice Yu, Youngchul Kim, Tampa, FL, Pan
Du, Shidong Jia, Il-Jin Kim, Lu Tan, Hayward, CA,
Liang Wang, Roger Li, Tampa, FL
242
MP59-18 INCIDENCE AND OUTCOMES OF NODAL
METASTASIS IN CLINICALLY NON-MUSCLE
INVASIVE BLADDER CANCER
Muhannad Alsyouf*, Sanam Ladi Seyedian,
Alireza Ghoreifi, Antoin Douglawi, Jie Cai, Gus
Miranda, Sumeet Bhanvadia, Anne Schuckman,
Hooman Djaladat, Siamak Daneshmand, Los
Angeles, CA
MP59-19 UPDATE OF TRUCE-02: AN OPEN LABEL,
SINGLE-ARM, PHASE 2 STUDY OF
TILELIZUMAB COMBINED WITH NAB-
PACLITAXEL FOR HIGH-RISK NON-
MUSCLE-INVASIVE UROTHELIAL BLADDER
CARCINOMA (HR-NMIBC) WHICH IS NOT
COMPLETELY RESECTABLE
Hailong Hu, Yuanjie Niu*, Haitao Wang, Chong
Shen, La Da, Gangjian Zhao, Lili Wang, Zhouliang
Wu, Zhe Zhang, Zhi Li, Zhan Jiang, Xuejian Zhan,
Shaobo Yang, Tianjin, China, People’s Republic of
MP59-20 [18F]-FDG PET/CT FOR BLADDER CANCER
STAGING AND DECISION-MAKING IN
PATIENTS WITH HIGH-RISK NON-MUSCLE
INVASIVE BLADDER CANCER (HR-NMIBC)
Rodolfo Hurle, Paolo Casale, Alberto Saita, Roz-
zano, Italy, NicolòMaria Buffi, Giovanni Lughezza-
ni, Roberto Contieri, Vittorio Fasulo, Nicola Frego,
Pieve Emanuele, Italy, Alessio Benetti, Rozzano,
Italy, Arturo Chiti, Pieve Emanuele, Italy, Marcello
Rodari, Rozzano, Italy, Martini Sollini, Cristiano
Pini, Fabrizia Gelardi, Giorgio Guazzoni, Pieve
Emanuele, Italy, Massimo Lazzeri*, Rozzano, Italy
APPROVED FOR AMA PRA CATEGORY 1.25
CREDITSTM
1:00 pm – 3:00 pm
ABSTRACT
TIME NUMBER TITLE
1:20 PD58-03 DETECTION OF INDIVIDUALIZED
MUTATION USING PLASMA AND URINARY
CIRCULATING TUMOR DNA IN PATIENTS
WITH UPPER TRACT UROTHELIAL
CARCINOMA
Daichi Tamura*, Masakazu Abe, Renpei Kato,
Yoichiro Kato, Shigekatsu Maekawa, Mitsugu
Kanehira, Ryo Takata, Yahaba, Japan, Yutaka
Suzuki, Kashiwa, Japan, Hidewaki Nakagawa,
Yokohama, Japan, Satoshi Nishizuka, Wataru
Obara, Yahaba, Japan
1:30 PD58-04 A COMPREHENSIVE LIQUID BIOPSY
TO DETECT PRIMARY UPPER TRACT
UROTHELIAL CARCINOMA: A PILOT STUDY
Alireza Ghoreifi*, Stephanie Shishido, Jeremy
Mason, George Courcoubetis, Manju Aron,
Inderbir Gill, Monish Aron, Mihir Desai, Siamak
Daneshmand, Peter Kuhn, Hooman Djaladat, Los
Angeles, CA
1:40 PD58-05 FINAL RESULTS OF A PHASE I TRIAL OF
WST11 (TOOKAD SOLUBLE) VASCULAR-
TARGETED PHOTODYNAMIC THERAPY
FOR UPPER TRACT UROTHELIAL
CARCINOMA
Wesley Yip*, Daniel Sjoberg, Lucas Nogueira,
Andrew Tracey, Ricardo Alvim, Peter Reisz,
Quinlan Demac, Nicole Benfante, Karan Nagar,
Jasmine Thomas, Jie Chen, Kwanghee Kim,
Oscar Lin, David Solit, New York, NY, Avigdor
Scherz, Rehovot, Israel, Jonathan Coleman,
New York, NY
1:50 PD58-06 ANTEGRADE ADMINISTRATION OF
REVERSE THERMAL MITOMYCIN GEL FOR
PRIMARY CHEMOABLATION OF UPPER
TRACT UROTHELIAL CARCINOMA VIA
PERCUTANEOUS NEPHROSTOMY TUBE:
A MULTI-INSTITUTIONAL REAL-WORLD
EXPERIENCE
Kyle Rose*, Tampa, FL, Gopal Narang, Scotts-
dale, AZ, Geoffrey Rosen, Columbia, MO,
Craig Labbate, Houston, TX, Justin Campagna,
Scottsdale, AZ, Alice Yu, Brandon Manley,
Phillipe Spiess, Roger Li, Tampa, FL, Mehrad
Adibi, Houston, TX, Katie Murray, Columbia, MO,
Wade Sexton, Tampa, FL, Mitchell Humphreys,
Scottsdale, AZ
2:00 PD58-07 IMPACT OF NODE COUNT ON SURVIVAL
OUTCOMES OF LYMPH NODE DISSECTION
IN NON-METASTATIC UPPER TRACT
UROTHELIAL CARCINOMA: ANALYSIS OF
THE ROBUUST REGISTRY
Kevin Hakimi*, La Jolla, CA, Umberto Carbonara,
Richmond, VA, Hooman Djaladat, Los Angeles, CA,
Reza Mehrazin, New York, NY, Daniel Eun, Adam
Reese, Philadelphia, PA, Mark Gonzalgo, Miami,
FL, Vitaly Margulis, Houston, TX, Robert Uzzo, Phil-
adelphia, PA, James Porter, Seattle, WA, Chandru
Sundaram, Indianapolis, IN, Firas Abdollah, Detroit,
MI, Alexandre Mottrie, Aalast, Belgium, Riccardo
Tellini, Florence, Italy, Matteo Ferro, Milan, Italy,
Margaret Meagher, Ava Saidian, Arman Walia, La
Jolla, CA, Alessandro Veccia, Richmond, VA, Al-
ireza Ghoreifi, Giovanni Cacciamani, Los Angeles,
CA, Amit Bhattu, Miami, FL, Xiaosong Meng, Hou-
ston, TX, Jason Farrow, Indianapolis, IN, Marcus
Jamil, Detroit, MI, Andrea Minervini, Florence, Italy,
Koon Rha, Seoul, Korea, Republic of, Zhenjie Wu,
Shanghai, China, People’s Republic of, Giuseppe
Simone, Rome, Italy, Riccardo Autorino, Richmond,
VA, Ithaar Derweesh, La Jolla, CA
2:10 PD58-08 SURVIVAL OUTCOMES IN SOLITARY KIDNEY
PATIENTS DIAGNOSED WITH UPPER TRACT
UROTHELIAL CARCINOMA
Ridwan Alam*, Joseph Cheaib, Michael Biles,
Baltimore, MD, Jared Winoker, New York City, NY,
Nirmish Singla, Baltimore, MD, Trinity Bivalacqua,
Phillip Pierorazio, Philadelphia, PA, Max Kates,
Sunil Patel, Baltimore, MD
*Presenting author
2:20 PD58-09 IS SEGMENTAL URETERECTOMY
ASSOCIATED WITH INFERIOR SURVIVAL
FOR LOCALIZED UPPER TRACT UROTHELIAL
CARCINOMA OF THE URETER COMPARED
TO RADICAL NEPHROURETERECTOMY
Marco Paciotti*, Rozzano, Italy, Khalid Alkhat-
ib, David-Dan Nguyen, Kendrick Yim, Stuart
R. Lipsitz, Matthew Mossanen, Adam S. Kibel,
Quoc-Dien Trinh, Boston, MA, Nicoló Buffi, Gio-
vanni Lughezzani, Rozzano, Italy, Alexander P.
Cole, Boston, MA
2:30 PD58-10 IMPLEMENTING THE FOLLOW-UP SCHEDULE
AFTER RADICAL NEPHROURETRECTOMY
FOR LOW RISK UPPER TRACT UROTHELIAL
CARCINOMA
Alberto Martini*, Riccardo Leni, Giuseppe Basile,
Simone Scuderi, Mario De Angelis, Luigi Nocera,
Giuseppe Rosiello, Milan, Italy, Chiara Lonati, Luca
Afferi, Lucerne, Switzerland, Giorgio Gandaglia,
Milan, Italy, Andrea Gallina, Lugano, Switzerland,
Pierre Karakiewicz, Montreal, Canada, Shahrokh
Shariat, Vienna, Austria, Francesco Montorsi, Alber-
to Briganti, Marco Moschini, Milan, Italy
2:40 PD58-11 IMPACT OF PRE-OPERATIVE KIDNEY
FUNCTION ON SURVIVAL OUTCOMES IN
MONDAY
UPPER TRACT UROTHELIAL CARCINOMA:
ANALYSIS OF THE ROBUUST REGISTRY
Kevin Hakimi*, La Jolla, CA, Umberto Carbonara,
Richmond, VA, Hooman Djaladat, Los Angeles,
CA, Reza Mehrazin, New York, NY, Daniel Eun,
Adam Reese, Philadelphia, PA, Mark Gonzalgo,
Miami, FL, Vitaly Margulis, Houston, TX, Robert
Uzzo, Philadelphia, PA, James Porter, Seattle,
WA, Chandru Sundaram, Indianapolis, IN, Firas
Abdollah, Detroit, MI, Alexandre Mottrie, Aalast,
Belgium, Riccardo Tellini, Florence, Italy, Matteo
Ferro, Milan, Italy, Margaret Meagher, Ava
Saidian, Arman Walia, La Jolla, CA, Alessandro
Veccia, Richmond, VA, Alireza Ghoreifi, Giovan-
ni Cacciamani, Los Angeles, CA, Amit Bhattu,
Miami, FL, Xiaosong Meng, Houston, TX, Jason
Farrow, Indianapolis, IN, Marcus Jamil, Detroit,
MI, Andrea Minervini, Florence, Italy, Koon Rha,
Seoul, Korea, Republic of, Zhenjie Wu, Shanghai,
China, People’s Republic of, Giuseppe Simone,
Rome, Italy, Riccardo Autorino, Richmond, VA,
Ithaar Derweesh, La Jolla, CA
2:50 PD58-12 CROSS-REACTIVITY BETWEEN THE FIRST-
LINE CHEMOTHERAPY AND SUBSEQUENT
IMMUNOTHERAPY IN PATIENTS WITH
UNRESECTABLE OR METASTATIC
UROTHELIAL CARCINOMA
Tomoko Hamaya*, Shingo Hatakeyama, Kai Oza-
ki, Kazutaka Okita, Yasuhiro Hashimoto, Chikara
Ohyama, Hirosaki, Japan
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
243
Monday, May 16, 2022
Podium Session 59
KIDNEY CANCER: ADVANCED (INCLUDING DRUG THERAPY) II
Room 255 @ Ernest N. Morial Convention Center
Moderator: Stephen Boorjian
ABSTRACT
TIME NUMBER TITLE
1:00 PD59-01 BAP1 LOSS IS ASSOCIATED WITH
METASTASIS IN ADVANCED CLEAR CELL
RENAL CELL CARCINOMA
Sari Khaleel*, Anne Reiner, Cameron Brennan,
Ibrahim Hussain, Samuel Berman, Ari Hakimi,
Nelson Moss, New York, NY
1:10 PD59-02 PROSTATE SPECIFIC MEMBRANE ANTIGEN
EXPRESSION IS ASSOCIATED WITH
ANGIOGENESIS AND TYROSINE KINASE
INHIBITOR RESPONSE IN CLEAR CELL
RENAL CELL CARCINOMA
Sari Khaleel*, Marlon Perera, Fengshen Kuo, Phil-
ip Rappold, Robert Motzer, Paul Russo, Jonathan
Coleman, Martin Voss, Eduard Reznik, Ari Hakimi,
New York, NY
1:20 PD59-03 ADJUVANT THERAPY AFTER SURGICAL
RESECTION OF NONMETASTATIC RENAL-
CELL CARCINOMA: ONE SIZE DOES NOT
FIT ALL
Zine-Eddine Khene*, Rennes, France, Axel
Bex, London, United Kingdom, Karim Bensalah,
Rennes, France
1:30 PD59-04 APPLICATION OF THE KEYNOTE-564 TRIAL
RESULTS TO REAL LIFE POPULATION:
WHICH PATIENTS WITH ADVANCED KIDNEY
CANCER SHOULD RECEIVE ADJUVANT
PEMBROLIZUMAB
Giuseppe Fallara*, Giuseppe Rosiello, Daniele
Raggi, Laura Marandino, Greta Malena, Giuseppe
Basile, Gianmarco Colandrea, Daniele Cignoli,
Federico Belladelli, Giacomo Musso, Francesco
Cei, Roberto Bertini, Alberto Briganti, Andrea
Salonia, Francesco Montorsi, Alessandro Larcher,
Andrea Necchi, Umberto Capitanio, Milan, Italy
1:40 PD59-05 COST EFFECTIVENESS OF ADJUVANT
PEMBROLIZUMAB AFTER NEPHRECTOMY
FOR RCC: INSIGHTS FOR PATIENT
SELECTION FROM A MARKOV MODEL
Vidit Sharma*, Kevin M Wymer, Daniel D Joyce,
James Moriarty, Bijan J Borah, R. Houston
Thompson, Brian A Costello, Bradley C Leibovich,
Stephen A Boorjian, Rochester, MN
244
1:00 pm – 3:00 pm
ABSTRACT
TIME NUMBER TITLE
1:50 PD59-06 PEMBROLIZUMAB OUTPERFORMS
TYROSINE KINASE INHIBITORS IN THE
ADJUVANT THERAPY OF PATIENTS WITH
HIGH-RISK RENAL CELL CARCINOMA: A
SYSTEMATIC REVIEW AND NETWORK META-
ANALYSIS
Ekaterina Laukhtina*, Fahad Quhal, Keiichiro
Mori, Reza Sari Motlagh, Satoshi Katayama,
Pawel Rajwa, Takafumi Yanagisawa, Nico C.
Grossmann, Hadi Mostafaei, Frederik König,
Abdulmajeed Aydh, Benjamin Pradere, Vienna,
Austria, Jeremy Yuen-Chun Teoh, Hong Kon,
China, People’s Republic of, Dmitry Enikeev,
Moscow, Russian Federation, Pierre I. Karakie-
wicz, Montreal, Canada, Manuela Schmidinger,
Shahrokh F. Shariat, Vienna, Austria
2:00 PD59-07 NEGLECTED LYMPH NODAL METASTASES
IN PATIENTS WITH RENAL CANCER: WHEN
TO EXTEND THE ANATOMICAL TEMPLATE
OF LYMPH NODE DISSECTION DURING
NEPHRECTOMY
Giuseppe Rosiello*, Giuseppe Fallara, Giuseppe
Basile, Daniele Cignoli, Alberto Martini, Francesco
De Cobelli, Giorgio Brembilla, Luigi Nocera, Fed-
erico Belladelli, Gianmarco Colandrea, Daniela
Canibus, Chiara Re, Giacomo Musso, Francesco
Cei, Rayan Matloob, Alberto Briganti, Roberto
Bertini, Andrea Necchi, Daniele Raggi, Milan, Italy,
Pierre I. Karakiewicz, Montreal, Canada, Frances-
co Montorsi, Andrea Salonia, Alessandro Larcher,
Umberto Capitanio, Milan, Italy
2:10 PD59-08 INTERNATIONAL MULTI-INSTITUTIONAL
CHARACTERIZATION OF THE
PERIOPERATIVE MORBIDITY OF
METASTASECTOMY FOR RENAL CELL
CARCINOMA
Timothy Lyon*, Jacksonville, FL, Eduard Rous-
sel, Leuven, Belgium, Vidit Sharma, Rochester,
MN, Gianpiero Carames, Jacksonville, FL,
Christine Lohse, Stephen Boorjian, Houston
Thompson, Rochester, MN, Steven Joniau,
Maarten Albersen, Leuven, Belgium, Bradley
Leibovich, Rochester, MN
2:20 PD59-09 OUTCOMES OF CYTOREDUCTIVE
NEPHRECTOMY FOLLOWED BY ACTIVE
SURVEILLANCE IN METASTATIC RENAL
CELL CARCINOMA
Sari Khaleel*, New York, NY, Andrew Silagy,
Melbourne, Australia, Cihan Duzgol, Ritesh Kote-
cha, Philip Rappold, Robert Motzer, Paul Russo,
Jonathan Coleman, Martin Voss, Ari Hakimi, New
York, NY
2:30 PD59-10 IMPROVING DECISION-MAKING FOR
CYTOREDUCTIVE NEPHRECTOMY
BY EVALUATING PRE-SURGICAL
RADIOGRAPHIC TUMOR CHARACTERISTICS
Daniel Shapiro*, Madison, WI, Jose Karam,
Alberto Pieretti, Mary Westerman, Houston, TX,
Philippe Spiess, Tampa, FL, Viraj Master, Atlanta,
GA, Jay Raman, Hershey, PA, Wade Sexton,
Tampa, FL, Glenn Allen, Madison, WI, Surena
Matin, Christopher Wood, Houston, TX, E. Jason
Abel, Madison, WI
2:40 PD59-11 ASSOCIATION BETWEEN IMMUNE-
RELATED ADVERSE EVENTS AND
CLINICAL OUTCOMES IN ADVANCED
GENITOURINARY CANCERS TREATED WITH
IMMUNOTHERAPY: A SYSTEMATIC REVIEW
AND META-ANALYSIS
Monday, May 16, 2022
Podium Session 60
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY V
Room 245 @ Ernest N. Morial Convention Center
Moderators: Leticia Ruiz & Reza Ghavamian
ABSTRACT
TIME NUMBER TITLE
1:00 PD60-01 THE IMPACT OF BASELINE HEALTH-
RELATED QUALITY OF LIFE ON
BIOCHEMICAL RECURRENCE FREE
SURVIVAL IN HIGH-RISK PROSTATE
CANCER PATIENTS FOLLOWING RADICAL
PROSTATECTOMY
Thilo Westhofen*, Alexander Buchner, Boris
Schlenker, Armin Becker, Christian G. Stief, Alex-
ander Kretschmer, Munich, Germany
1:10 PD60-02 CAN PELVIC LYMPH NODE DISSECTION
BE OMITTED AT THE TIME OF RADICAL
PROSTATECTOMY IN PATIENTS WITH A
NEGATIVE PREOPERATIVE 68GA-PSMA
PET/CT? THE IMPORTANCE OF PATIENT
RISK STRATIFICATION ACCORDING
TO INDIVIDUAL RISK OF LYMPH NODE
METASTASES
Elio Mazzone*, Milan, Italy, Daniele Robesti, Giorgio
Gandaglia, Armando Stabile, Carlo Andrea Bravi,
Andrea Necchi, Daniele Raggi, Laura Marandino,
Milano, Italy, Giuseppe Cirulli, Milan, Italy, Eleonora
Balestrazzi, Stefano Fanti, Bologna, Italy, Vito Cuc-
chiara, Milan, Italy, Andrea Farolfi, Lorenzo Bianchi,
Riccardo Schiavina, Bologna, Italy, Francesco
Montorsi, Alberto Briganti, Milano, Italy
*Presenting author 245
Junru Chen*, Yaowen Zhang, Yuchao Ni, Guangxi
Sun, Hao Zeng, Chengdu, China, People’s Re-
public of
2:50 PD59-12 MICROWAVE ABLATION COMBINED WITH
ANTI-PD-1/CTLA-4 THERAPY INDUCES ANTI-
TUMOR IMMUNE RESPONSE TO RENAL
CELL CARCINOMA IN A MURINE MODEL
Run-Qi Guo*, Jin-Zhao Peng, Xiao-Guang LI,
Beijing, China, People’s Republic of
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
1:00 pm – 3:00 pm
MONDAY
ABSTRACT
TIME NUMBER TITLE
1:20 PD60-03 THE IMPACT OF HISTOLOGICAL VARIANTS
ON THE PERFORMANCE CHARACTERISTICS
OF 68GA-PSMA PET/CT IN THE PRIMARY
AND RECURRENT SETTING
Simone Scuderi*, Elio Mazzone, Milano, Italy,
Giorgio Gandaglia, Milan, Italy, Roberta Lucianò,
Nazario Pio Tenace, Milano, Italy, Alessia Cimad-
amore, Ancona, Italy, Andrea Necchi, Daniele
Raggi, Laura Marandino, Riccardo Leni, Daniele
Robesti, Lorenzo Toneatto, Donato Cannoletta,
Leonardo Quarta, Milano, Italy, Mario De Angelis,
Francesco Pellegrino, Gabriele Sorce, Milan, Italy,
Francesco Barletta, Milano, Italy, Luigi Nocera,
Milan, Italy, Giuseppe Rosiello, Milano, Italy,
Armando Stabile, Milan, Italy, Francesco Montorsi,
Alberto Briganti, Milano, Italy
1:30 PD60-04 SURVIVAL AFTER RADICAL PROSTATECTOMY
VS. RADIATION THERAPY IN CLINICAL NODE-
POSITIVE PROSTATE CANCER
Francesco Chierigo*, Genova, Italy, Christoph
Würnschimmel, Hamburg, Germany, Rocco
Simone Flammia, Rome, Italy, Benedikt Horle-
mann, Montreal, Canada, Gabriele Sorce, Milan,
Italy, Benedikt Hoeh, Frankfurt, Germany, Zhe
Tian, Fred Saad, Montreal, Canada, Markus
Graefen, Hamburg, Germany, Michele Gallucci,
Rome, Italy, Alberto Briganti, Francesco Montorsi,
Milan, Italy, Felix K.H. Chun, Frankfurt, Germany,
Shahrokh F. Shariat, Vienna, Austria, Guglielmo
Mantica, Maro Borghesi, Nazareno Suardi, Carlo
Terrone, Genova, Italy, Pierre I Karakiewicz,
Montreal, Canada
1:40 PD60-05 A 20 YEAR FOLLOW-UP STUDY OF
ONCOLOGIC OUTCOMES, QUALITY OF
LIFE AND COMPLICATIONS IN PATIENTS
UNDERGOING ROBOTIC RADICAL
PROSTATECTOMY
Alexander Bandin*, Ilene Staff, Joseph Tortora,
Kevin Pinto, Tara McLaughlin, Rosa Negron, Lau-
ra OlivoValintin, Hartford, CT, Caner Dinlenc, New
York, NY, Joseph Wagner, Hartford, CT
1:50 PD60-06 PATIENT REPORTED OUTCOMES OF
URINARY INCONTINENCE RATES USING
VIABLE CRYOPRESERVED UMBILICAL
TISSUE OVER NEUROVASCULAR BUNDLES
DURING ROBOTIC ASSISTED RADICAL
PROSTATECTOMY
Mit Shah*, Alexander Geisenhoff, Samantha
Kraemer, Royal Oak, MI, Ji Qi, Ann Arbor, MI,
Chirag Dave, Fiona Sun, Sugandh Shetty, Brian
Seifman, Jason Hafron, Royal Oak, MI
2:00 PD60-07 OBJECTIVE RISK SCORE RELIABLY
PREDICTS MAJOR MORBIDITY
AND MORTALITY AFTER RADICAL
PROSTATECTOMY
Kristen Maatman*, Christopher Ledbetter, A. Lynn
Patterson, Robert Wake, Memphis, TN
2:10 PD60-08 OUTCOMES OF SALVAGE ROBOTIC-
ASSISTED RADICAL PROSTATECTOMY
COMPARING PATIENTS WITH PRIMARY
FOCAL THERAPY VERSUS WHOLE
GLAND ABLATION: A MULTICENTRIC
COLLABORATIVE DATA
Seetharam Bhat Kulthe Ramesh*, Celebration,
FL, Arjun Nathan, London, United Kingdom,
Marcio Moschovas, Celebration, India, Senthil
Nathan, London, United Kingdom, Vipul Patel,
Celebration, India
2:20 PD60-09 LAPAROSCOPIC VERSUS ROBOT-
ASSISTED RADICAL PROSTATECTOMY:
TEN-YEAR OUTCOME OF A PROSPECTIVE
RANDOMISED TRIAL
Enrico Checcucci, Orbassano (Turin), Italy, Euge-
nio Alladio, Turin, Italy, Sabrina De Cillis, Stefano
Granato, Daniele Amparore, Alberto Piana,
Federico Piramide, Gabriele Volpi, Michele Sica,
Paolo Verri, Beatrice Carbonaro, Juliette Meziere,
Davide Zamengo, Marcello Della Corte, Edoardo
Dibilio, Angela Pecoraro, Giovanni Cattaneo,
Orbassano (Turin), Italy, Michele Di Dio, Cosen-
za, Italy, Matteo Manfredi, Francesco Porpiglia*,
Orbassano (Turin), Italy
246
2:30 PD60-10 A MORE EXTENDED PELVIC LYMPH NODE
DISSECTION DECREASES RECURRENCE
RATES IN SELECTED PROSTATE CANCER
PATIENTS UNDERGOING RADICAL
PROSTATECTOMY
Giorgio Gandaglia*, Giuseppe Rosiello, Milano,
Italy, Francesco Pellegrino, Milan, Italy, Antony Pel-
legrino, Marco Bandini, Andrea Salonia, Manuela
Tutolo, Mario De angelis, Milano, Italy, Gabriele
Sorce, Elio Mazzone, Armando Stabile, Vito
Cucchiara, Emanuele Zaffuto, Milan, Italy, Pierre I.
Karakiewicz, Montreal, Canada, Shahrokh F. Shar-
iat, Vienna, Austria, Vincenzo Mirone, Napoli, Italy,
Francesco Montorsi, Alberto Briganti, Milano, Italy
2:40 PD60-11 IMPACT OF THE TIME ELAPSED BETWEEN
PROSTATE BIOPSY AND SURGERY ON THE
ACCURACY OF THE BRIGANTI NOMOGRAM
PREDICTING LYMPH NODE INVASION
IN MEN WITH CLINICALLY LOCALIZED
PROSTATE CANCER
Giorgio Gandaglia*, Elio Mazzone, Emanuele Zaf-
futo, Gabriele Sorce, Francesco Pellegrino, Luigi
Nocera, Armando Stabile, Umberto Capitanio,
Alessandro Larcher, Milan, Italy, Andrea Salonia,
Milano, Italy, Federico Dehò, Varese, Italy, Pierre
I. Karakiewicz, Montreal, Canada, Shahrokh F.
Shariat, Vienna, Austria, Francesco Montorsi,
Alberto Briganti, Milano, Italy
2:50 PD60-12 THE IMPACT OF FRAILTY STATUS ON
SURGICAL OUTCOMES AFTER ROBOT-
ASSISTED RADICAL PROSTATECTOMY
- A PROSPECTIVE ASSESSMENT USING A
STANDARDIZED COLLECTION SYSTEM FOR
PERIOPERATIVE OUTCOMES
Giuseppe Rosiello*, Simone Scuderi, Giorgio
Gandaglia, Elio Mazzone, Armando Stabile,
Francesco Barletta, Antony Pellegrino, Lorenzo
Toneatto, Donato Cannoletta, Leonardo Quarta,
Gianmarco Colandrea, Riccardo Leni, Dan-
iele Robesti, Milano, Italy, Umberto Capitanio,
Alessandro Larcher, Milan, Italy, Andrea Salonia,
Milano, Italy, Federico Dehò, Varese, Italy, Pierre
I. Karakiewicz, Montreal, Canada, Francesco
Montorsi, Alberto Briganti, Milano, Italy
APPROVED FOR AMA PRA CATEGORY 2
CREDITSTM
Monday, May 16, 2022 1:00 pm – 3:00 pm

Video Session 13
ADRENAL & RENAL ONCOLOGY II
Video Abstracts Theater @ Ernest N. Morial Convention Center
Moderators: Eric Kim, David Canes & Allen Chiu

ABSTRACT
TIME NUMBER TITLE
1:00 V13-01 SUPERIOR MESENTERIC ARTERY
INJURY DURING ROBOTIC LEFT RADICAL
NEPHRECTOMY: PREVENTION AND
MANAGEMENT
Aref S. Sayegh*, Anibal La Riva, Laura C. Perez,
Luis G. Medina, Edward Forsyth, Ryan Powers,
Los Angeles, CA, Ben Challacombe, London,
United Kingdom, Michael Stifelman, Hackensack,
NJ, Inderbir S. Gill, Rene Sotelo, Los Angeles, CA
1:10 V13-02 INTRAOPERATIVE RECOGNITION &
MANAGEMENT OF AN LATROGENIC
CLIPPING OF THE SUPERIOR MESENTERIC
ARTERY DURING ROBOTIC LEFT
CYTOREDUCTIVE NEPHRECTOMY
Brijesh Patel*, Daniel Roadman, Chicago, IL,
Mark Biebel, St. Louis, MO, Alexander Chow,
Chicago, IL, Robert Figenshau, St. Loius, MO
ABSTRACT
TIME NUMBER TITLE
2:00 V13-07 INFERIOR VENA CAVA MANAGEMENT
DURING LEFT-SIDED LEVEL III TUMOR
THROMBECºTOMY
Shawn Dason*, Columbus, OH
2:10 V13-08 ROBOT-ASSISTED LAPAROSCOPIC
NEPHROURETERECTOMY IN A
HORSESHOE KIDNEY IS FACILITATED WITH
INDOCYANINE GREEN AND NEAR-INFRARED
FLOURESCENCE IMAGING
Fahad Sheckley*, Nermarie Velazquez, Bethany
Desroches, Ravi Munver, Hackensack, NJ
2:20 V13-09 TRICUSPID INSUFFICIENCY CAUSED
BY RENAL ANGIOMYOLIPOMA WITH
EXTENSION TO THE INFERIOR VENA CAVA
AND RIGHT ATRIUM. A MULTIDISCIPLINARY
APPROACH

MONDAY
Ruben Santiago*, Omar Vieyra, Rodrigo Perez,
1:20 V13-03 EIGHT-YEAR EXPERIENCE OF ROBOTIC IVC Victor Osornio, Gerardo Garza, Roberto Lopez,
THROMBECTTOMY:SURGICAL TECHNIQUE, Mario Ortega, Estado de México, Mexico
PERIOPERATIVE AND ONCOLOGIC
2:30 V13-10 LINEAR STAPLING DEVICE IN
OUTCOMES
LAPAROSCOPIC PARTIAL ADRENALECTOMY
Leonardo Misuraca*, Umberto Anceschi, Gabriele
FOR PHEOCHROMOCYTOMA IN MULTIPLE
Tuderti, Riccardo Mastroianni, Mariaconsiglia
ENDOCRINE NEOPLASIA TYPE 2B
Ferriero, Aldo Brassetti, Alfredo Maria Bove,
Patricio Garcia Marchiñena*, Andrés Germán Alfi-
Salvatore Guaglianone, Rome, Italy, Mihir Desai,
eri, Facundo Barbagallo, Ricardo Hosman Basto,
Inderbir Singh Gill, Los Angeles, CA, Michele
Alberto Jurado, Buenos Aires, Argentina
Gallucci, Giuseppe Simone, Rome, Italy
2:40 V13-11 SINGLE PORT ROBOT-ASSISTED
1:30 V13-04 COMPLETE MINIMALLY-INVASIVE SURGERY
LAPAROSCOPIC ADRENALECTOMY VIA MINI
IS FEASIBLE FOR RENAL CANCER WITH
PFANNENSTIEL INCISION
LEVEL IV INTRACARDIAC TUMOUR
Justin James*, New York, NY, Arun Rai, Jacob
THROMBUS
Gaines, Eric Macdonald, Manish Vira, New Hyde
Paolo Dell’Oglio*, Mattia Longoni, Milan, Italy,
Park, NY
Stefano Tappero, Genova, Italy, Silvia Secco,
Milan, Italy, Erika Palagonia, Ancona, Italy, Alberto 2:50 V13-12 SINGLE PORT DA VINCI ROBOTIC RADICAL
Olivero, Francesca Mulazzani, Ombretta Amici, ADRENALECTOMY VIA MCBURNEY INCISION
Andrea Brunetti, Aldo Massimo Bocciardi, Antonio Jason Elyaguov*, Valhalla, NY, Mubashir Billah,
Galfano, Milan, Italy Michael Stifelman, Mutahar Ahmed, Nutley, NJ
1:40 V13-05 A NOVEL SUPINE APPROACH TO ROBOTIC
RADICAL NEPHRECTOMY AND LEVEL III APPROVED FOR AMA PRA CATEGORY 2
INFERIOR VENA CAVA THROMBECTOMY CREDITSTM
Christopher Dall*, James Mason, Charlotte Gold-
man, Sholklapper Tamir, Jason Hawksworth, Keith
Kowalczyk, Washington, DC
1:50 V13-06 OPEN RIGHT PARTIAL NEPHRECTOMY WITH
INFERIOR VENA CAVA THROMBECTOMY
FOR RENAL CELL CARCINOMA
Ryan Nasseri*, Devin Patel, Daniel Holst, Marga-
ret Meagher, Ithaar Derweesh, San Diego, CA

*Presenting author 247

NOTES
WE ARE COUNTING ON YOU
Visit the Census Booth
in to take the
Census or skip the line
and scan the QR code
to get started.
Visit the Merck Booth
and Learn More About
KEYTRUDA
• Approved indications

• Resources for health care professionals

• The Merck Access Program

• KEY+YOU Patient Support Program

Copyright © 2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
All rights reserved. US-KEY-04438 12/21 keytrudahcp.com